
<html lang="en"     class="pb-page"  data-request-id="6ab0b78e-8ae2-4fe5-9cc2-8d3d5c213403"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2021.64.issue-9;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c01914;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Small-Molecule Inhibitors of Reactive Oxygen Species Production" /></meta><meta name="dc.Creator" content="Elisa  Sassetti" /></meta><meta name="dc.Creator" content="Mads H.  Clausen" /></meta><meta name="dc.Creator" content="Luca  Laraia" /></meta><meta name="dc.Description" content="Reactive oxygen species (ROS) are involved in physiological cellular processes including differentiation, proliferation, and apoptosis by acting as signaling molecules or regulators of transcriptio..." /></meta><meta name="Description" content="Reactive oxygen species (ROS) are involved in physiological cellular processes including differentiation, proliferation, and apoptosis by acting as signaling molecules or regulators of transcriptio..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 15, 2021" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01914" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01914" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01914" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01914" /></link>
        
    
    

<title>Small-Molecule Inhibitors of Reactive Oxygen Species Production | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01914" /></meta><meta property="og:title" content="Small-Molecule Inhibitors of Reactive Oxygen Species Production" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0020.jpeg" /></meta><meta property="og:description" content="Reactive oxygen species (ROS) are involved in physiological cellular processes including differentiation, proliferation, and apoptosis by acting as signaling molecules or regulators of transcription factors. The maintenance of appropriate cellular ROS levels is termed redox homeostasis, a balance between their production and neutralization. High concentrations of ROS may contribute to severe pathological events including cancer, neurodegenerative, and cardiovascular diseases. In recent years, approaches to target the sources of ROS production directly in order to develop tool compounds or potential therapeutics have been explored. Herein, we briefly outline the major sources of cellular ROS production and comprehensively review the targeting of these by small-molecule inhibitors. We critically assess the value of ROS inhibitors with different mechanisms-of-action, including their potency, mode-of-action, known off-target effects, and clinical or preclinical status, while suggesting future avenues of research in the field." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01914"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01914">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01914&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01914&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01914&amp;href=/doi/10.1021/acs.jmedchem.0c01914" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 5252-5275</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01714" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c02200" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Small-Molecule Inhibitors of Reactive Oxygen Species Production</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Elisa Sassetti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elisa Sassetti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Nanomedicine and Theranostics, Department of Chemistry, Technical University of Denmark, Kemitorvet 207, 2800 Kgs. Lyngby, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elisa++Sassetti">Elisa Sassetti</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mads H. Clausen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mads H. Clausen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Nanomedicine and Theranostics, Department of Chemistry, Technical University of Denmark, Kemitorvet 207, 2800 Kgs. Lyngby, Denmark</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#a0cdc8c3e0cbc5cdc98ec4d4d58ec4cb"><span class="__cf_email__" data-cfemail="6904010a29020c0400470d1d1c470d02">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mads+H.++Clausen">Mads H. Clausen</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9649-1729" title="Orcid link">http://orcid.org/0000-0001-9649-1729</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Luca Laraia</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luca Laraia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Nanomedicine and Theranostics, Department of Chemistry, Technical University of Denmark, Kemitorvet 207, 2800 Kgs. Lyngby, Denmark</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#d4b8a1b7b8b5a694bfb1b9bdfab0a0a1fab0bf"><span class="__cf_email__" data-cfemail="3e524b5d525f4c7e555b5357105a4a4b105a55">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luca++Laraia">Luca Laraia</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6692-3412" title="Orcid link">http://orcid.org/0000-0001-6692-3412</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01914&amp;href=/doi/10.1021%2Facs.jmedchem.0c01914" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 5252–5275</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 15, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 November 2020</li><li><span class="item_label"><b>Published</b> online</span>15 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01914" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01914</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5252%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DElisa%2BSassetti%252C%2BMads%2BH.%2BClausen%252C%2BLuca%2BLaraia%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D9%26contentID%3Dacs.jmedchem.0c01914%26title%3DSmall-Molecule%2BInhibitors%2Bof%2BReactive%2BOxygen%2BSpecies%2BProduction%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5275%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01914"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2434</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01914" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Small-Molecule Inhibitors of Reactive Oxygen Species Production&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Elisa&quot;,&quot;last_name&quot;:&quot;Sassetti&quot;},{&quot;first_name&quot;:&quot;Mads&quot;,&quot;last_name&quot;:&quot;H. Clausen&quot;},{&quot;first_name&quot;:&quot;Luca&quot;,&quot;last_name&quot;:&quot;Laraia&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;5252-5275&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01914&quot;},&quot;abstract&quot;:&quot;Reactive oxygen species (ROS) are involved in physiological cellular processes including differentiation, proliferation, and apoptosis by acting as signaling molecules or regulators of transcription factors. The maintenance of appropriate cellular ROS levels is termed redox homeostasis, a balance between their production and neutralization. High concentrations of ROS may contribute to severe pathological events including cancer, neurodegenerative, and cardiovascular diseases. In recent years, approaches to target the sources of ROS production directly in order to develop tool compounds or potential therapeutics have been explored. Herein, we briefly outline the major sources of cellular ROS production and comprehensively review the targeting of these by small-molecule inhibitors. We critically assess the value of ROS inhibitors with different mechanisms-of-action, including their potency, mode-of-action, known off-target effects, and clinical or preclinical status, while suggesting future avenues of research &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01914&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01914" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01914&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01914" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01914&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01914" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01914&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01914&amp;href=/doi/10.1021/acs.jmedchem.0c01914" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01914" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01914" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01914%26sid%3Dliteratum%253Aachs%26pmid%3D33856791%26genre%3Darticle%26aulast%3DSassetti%26date%3D2021%26atitle%3DSmall-Molecule%2BInhibitors%2Bof%2BReactive%2BOxygen%2BSpecies%2BProduction%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D9%26spage%3D5252%26epage%3D5275%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290689" title="Oxides">Oxides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292169" title="Antioxidants">Antioxidants</a>,</li><li><a href="/action/doSearch?ConceptID=291376" title="Free radicals">Free radicals</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/jmcmar.2021.64.issue-9/20210513/jmcmar.2021.64.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Reactive oxygen species (ROS) are involved in physiological cellular processes including differentiation, proliferation, and apoptosis by acting as signaling molecules or regulators of transcription factors. The maintenance of appropriate cellular ROS levels is termed redox homeostasis, a balance between their production and neutralization. High concentrations of ROS may contribute to severe pathological events including cancer, neurodegenerative, and cardiovascular diseases. In recent years, approaches to target the sources of ROS production directly in order to develop tool compounds or potential therapeutics have been explored. Herein, we briefly outline the major sources of cellular ROS production and comprehensively review the targeting of these by small-molecule inhibitors. We critically assess the value of ROS inhibitors with different mechanisms-of-action, including their potency, mode-of-action, known off-target effects, and clinical or preclinical status, while suggesting future avenues of research in the field.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57327" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57327" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Reactive oxygen species (ROS) are chemical species derived from the partial reduction of O<sub>2</sub> that can be either free radicals, including superoxide (O<sub>2</sub><sup>•–</sup>), hydroxyl (OH<sup>•</sup>), and hydroperoxyl (HOO<sup>•</sup>) radicals, which are characterized by having an unpaired electron, or nonradical species with a high oxidation potential, such as hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> ROS produce different cellular effects according to their concentration and site of production in the cell (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Concentration-dependent physiological and pathological conditions correlated to intracellular ROS levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">At physiological concentrations, ROS play essential regulatory roles in maintaining intracellular homeostasis through signaling functions, regulation of transcription factors, and protein phosphorylation. They are involved in different cellular processes including differentiation, proliferation, growth, and apoptosis.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Pathological responses related to ROS occur either in their absence,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> as in the case of chronic granulomatous disease,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> or in the case of their overproduction due to a disruption in the reduction–oxidation (redox) balance within a cell.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Abnormally low ROS levels impact signaling pathways and host defense and are therefore connected to specific types of autoimmune disorders or decreased defenses against bacterial pathogens.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In contrast, excessive ROS concentrations can create cytotoxic events due to protein, lipid, and DNA damage through so-called oxidative stress and have been reported to be involved in aging and general inflammation<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> as well as in several pathologies. For this reason, molecules that target the mechanisms behind ROS production, with the ability to restore physiological ROS levels, have considerable therapeutic potential, and their development has attracted increasing attention in recent years. In this Perspective, we discuss approaches to reduce ROS production using small molecules. We compile a comprehensive list of small-molecule ROS inhibitors in various stages of (pre)clinical development and provide a detailed discussion of their modes-of-action and limitations.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">1.1.  ROS Types</h3><div class="NLM_p">ROS are products of normal aerobic metabolism<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and are created either by excitation or by reduction of atmospheric oxygen (O<sub>2</sub>, or dioxygen).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> O<sub>2</sub> can be the source of radical derivatives, such as superoxide (O<sub>2</sub><sup>•–</sup>), hydroxyl (HO<sup>•</sup>), hydroperoxyl (HO<sub>2</sub><sup>•</sup>), carbonate (CO<sub>3</sub><sup>•–</sup>), and carbon dioxide (CO<sub>2</sub><sup>•–</sup>) radicals, as well as nonradical ROS, including singlet oxygen (<sup>1</sup>O<sub>2</sub>), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), hypobromous acid (HOBr), and hypochlorous acid (HOCl)<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lewis structures of ROS divided by free radical ROS (left) and nonradical ROS (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The definition of a free radical is a chemical species which has one or more unpaired electrons.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Superoxide, O<sub>2</sub><sup>•–</sup>, is a radical anion which is stable for a short time and is generated when O<sub>2</sub> undergoes a one-electron reduction.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Subsequently, after a further reduction of superoxide to the peroxide anion (O<sub>2</sub><sup>2–</sup>), hydrogen peroxide is formed by protonation. Hydrogen peroxide, through a Fenton reaction with Fe<sup>2+</sup>, creates a hydroxyl radical, the most reactive oxygen radical. On the other hand, excitation of O<sub>2</sub> can lead to the formation of the highly reactive, nonradical, singlet oxygen.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The interconversion of the different ROS types can take place in the cell through nonenzymatic or enzyme-mediated mechanisms. An example is the dismutation of O<sub>2</sub><sup>•–</sup> to O<sub>2</sub> and H<sub>2</sub>O<sub>2</sub>, which can progress in a spontaneous manner or catalyzed by superoxide dismutase (SOD).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p last">In addition to oxygen derivatives, the broader category of reactive species also includes reactive chlorine, bromine, and nitrogen species. Reactive nitrogen species (RNS) are an important class of signaling molecules in living organisms. This class includes nitric oxide (NO<sup>•</sup>) and peroxynitrite (ONOO<sup>–</sup>), which is formed by the reaction of NO<sup>•</sup> with O<sub>2</sub><sup>•–</sup>.<a onclick="showRef(event, 'ref1 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref5">(1,5)</a> While important, the discussion of RNS and related reactive species will only be addressed briefly in this Perspective. Readers are directed to a comprehensive book chapter on the subject for further information.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">1.2.  Main Sites of ROS Production and Diffusion across Membranes</h3><div class="NLM_p">The major cellular source of ROS is mitochondria<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a). The mitochondrial electron transport chain (ETC) in the inner mitochondrial membrane is where most mitochondrial ROS are produced, through oxidative phosphorylation (OXPHOS) generating adenosine triphosphate (ATP).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The process begins with electrons that are abstracted from FADH<sub>2</sub> (complex II) or NADH (complex I), produced in the tricarboxylic acid cycle, and transferred by the ETC to complex IV which, under normal conditions, produces water via the reduction of O<sub>2</sub>. However, ROS are produced when the reduction does not proceed all the way to the formation of water but ends prior to the formation of superoxide. The mitochondrial membrane potential (Δψm) enables the generation of ATP by the action of the ATP synthase in complex V with redirection of the protons back in the matrix. The formation of superoxide from the reduction of oxygen is generated by the existence of an electron leakage in the ETC process.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overview of the main sites of endogenous ROS production. Bilayer: NADPH oxidases (NOX). Within the mitochondria: electron transport chain (ETC) complexes I–V and monoamine oxidases (MAOs). Within peroxisomes: nitric oxide synthase (NOS), urate oxidase (UO), xanthine oxidases (XO), acyl-CoA (ACO), <span class="smallcaps smallerCapital">d</span>-aspartate (DDO), and <span class="smallcaps smallerCapital">d</span>-amino acid (DAAO) oxidases. Within the endoplasmic reticulum (ER): ER oxidoreductin 1 (Ero1) and protein disulfide isomerase family (PDI). The inlays describe the following: (a) Structure and ROS forming processes of mitochondrial ETC (Q = ubiquinone, C = cytochrome c). (b) Structure and ROS forming process of NADPH oxidase 2 (NOX2) with all associated subunits (B = cytochrome <i>b</i>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to mitochondria, several other ROS sources have been reported.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> NADPH oxidases (NOX) are the only known enzymes to be exclusively dedicated to producing ROS.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> NOX are a family of seven transmembrane proteins: NOX 1–5 and dual oxidases (DUOX) 1 and 2 possess different activation methods (<i>vide infra</i>) and tissue distribution. Before NOX was characterized in other tissues,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> ROS production was thought to be limited to phagocytic cells.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The activation of NOX2, represented in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a as an example NOX family member, is characterized by the transient association between constitutively bound subunits p22/gp91 and cytoplasmic subunits p40, p47, p67, and rac. A conformational change occurs in response to the phosphorylation of p47, bringing p47 itself in contact with p22 and enabling the interaction of p67 with gp91, now in close proximity to p40. The last step consists of the interaction of rac with gp91 followed by p67 interaction<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b). In this context, the production of ROS by NOX is performed in two steps. The first consists of the transfer of electrons from nicotinamide adenine dinucleotide phosphate (NADPH) to flavin adenine dinucleotide (FAD) and is followed by a second step involving the transfer of electrons to the heme group of the cytochrome <i>b</i>, which reduces molecular oxygen resulting in the production of O<sub>2</sub><sup>•–</sup>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Another important class of ROS-producing enzymes are monoamine oxidases (MAO), which are specific flavoenzymes present in the outer mitochondrial membrane. Two MAO isoforms exist, MAO-A and MAO-B,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and their main biological role is the deamination of neurotransmitters and dietary amines.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> MAOs are able to produce hydrogen peroxide through oxidative deamination, starting from monoamines and employing FAD as cofactor, forming aldehydes as byproducts.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Xanthine oxidoreductase (XOR) is a dimeric molybdenum-containing flavoprotein which, starting from hypoxanthine, forms xanthine and uric acid while catalyzing oxidation steps. In mammals, the dehydrogenase enzymatic form (XDH) can generate the xanthine oxidase form (XO). The latter is of critical importance for the formation of ROS, since it can deliver the electrons needed for the reduction of molecular oxygen and use them as an acceptor to form uric acid and superoxide/hydrogen peroxide from xanthine. XOR can also form reactive nitrogen species such as peroxynitrite via a similar mechanism.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">A source of reactive nitrogen species is nitric oxide synthase (NOS), the enzyme responsible for the biosynthesis of nitric oxide and RNS derivatives.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> NOS exists in three isoforms, two constitutively expressed and regulated by Ca<sup>2+</sup> and calmodulin (nNOS, neuronal nitric oxide synthase, and eNOS, endothelial nitric oxide synthase), and an inducible form, iNOS (inducible nitric oxide synthase). The isoforms have different cellular functions correlated to their different tissue localization. nNOS, or type I NOS, is the neuronal NOS, and it serves as regulator of the synaptic transmission. The endothelial localization of eNOS (type III NOS), makes it responsible for the control of blood pressure, while type II NOS, known as iNOS, is induced in response to infection and inflammation in specific locations such as macrophages, monocytes, the endothelium, and smooth muscle tissue.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The synthesis of nitric oxide is carried out by all isoforms using molecular oxygen, NADPH, and <span class="smallcaps smallerCapital">l</span>-arginine as substrates. Electrons are transferred from NADPH to heme in the N-terminal oxygenase domain, passing though FAD and flavin mononucleotide (FMN), also involving the cofactor (6<i>R</i>)-5,6,7,8-tetrahydro-<span class="smallcaps smallerCapital">l</span>-biopterin (BH4). The result of this complex reaction is the formation of NO<sup>•</sup> and <span class="smallcaps smallerCapital">l</span>-citrulline from oxidation of <span class="smallcaps smallerCapital">l</span>-arginine.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Further sites of ROS production in the cell include peroxisomes and the endoplasmic reticulum (ER). Peroxisomes are organelles which have roles in several cellular pathways including fatty acid oxidation, glyoxylate metabolism, biosynthesis of ether-phospholipids, and the pentose phosphate pathway.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> During ordinary metabolism, peroxisomes are the sites of production of H<sub>2</sub>O<sub>2</sub> due to the action of several flavoproteins, including acyl-CoA (ACO), <span class="smallcaps smallerCapital">d</span>-aspartate (DDO), urate (UO), and <span class="smallcaps smallerCapital">d</span>-amino acid (DAAO) oxidases, in addition to the presence of xanthine oxidases and NOS which produce superoxide and nitric oxide, respectively.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Inside the ER, redox signals and ROS, in particular H<sub>2</sub>O<sub>2</sub>, are essential for oxidative folding and the generation of post-translational modifications. The production of hydrogen peroxide occurs through a catalytic process, involving Ero1, an oxidoreductase, starting from molecular oxygen. The process ends with the formation of disulfide bonds in proteins with the action of a member of the protein disulfide isomerase family (PDI).<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a></div><div class="NLM_p">Finally, a number of other cellular enzymes are known to be involved in the production of ROS, including aldehyde oxidase, cyclooxygenases, cytochrome P450 monooxygenase, dihydroorotate dehydrogenase, and tryptophan dioxygenase.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">In addition to their site and mode of production, the half-life and ability to diffuse of ROS must also be considered. O<sub>2</sub><sup>•–</sup> is characterized by instability due to its spontaneous dismutation to H<sub>2</sub>O<sub>2</sub> and its high reactivity toward iron–sulfur clusters. On the contrary, H<sub>2</sub>O<sub>2</sub> is quite stable, with a half-life of about 1 ms, and with a limited oxidant activity; in fact, H<sub>2</sub>O<sub>2</sub> toxicity is perhaps ascribable to its reduction to OH<sup>•</sup>. The latter is reported to react indiscriminately and not be able to diffuse far, given its half-life of 10<sup>–9</sup> s.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p last">In the past, it has been assumed that ROS are able to cross biological membranes freely in order to enter cells or to reach their target. However, membrane proteins have more recently been shown to facilitate ROS diffusion and permeation.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> For example, aquaporins (AQPs) are transmembrane proteins that enhance the bilayer diffusion of several molecules including nitric oxide<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and H<sub>2</sub>O<sub>2</sub>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Knockout of AQP8 has been reported to impair the release of H<sub>2</sub>O<sub>2</sub> from the mitochondria in hepatocytes, with subsequent accumulation of ROS and mitochondrial depolarization.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Extracellular O<sub>2</sub><sup>•–</sup>, which can be produced by NOX2 and dismutates to H<sub>2</sub>O<sub>2</sub>, is not permeable through the membrane, but can use aquaporins to cross, or chloride channels (CIC) as reported for CIC3 in endothelial cells.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">2.  Overview of the (Patho)physiological Roles of ROS</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88452" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88452" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An extensive discussion of the (patho)physiological roles of ROS is beyond the scope of this Perspective, and they are thus only introduced briefly here. We refer readers to excellent and extensive reviews in the field for further information (refs <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>). Additional reviews pertaining to specific disease indications are mentioned in the following sections, where appropriate.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.1.  Physiological Roles of ROS</h3><div class="NLM_p">In order for ROS to carry out their function as signaling molecules, the redox homeostasis, defined as the balance between ROS production and the antioxidant response, must be finely regulated.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Superoxide dismutases (SODs) are among the enzymatic antioxidants that the cell employs to reduce ROS. The role of SODs in different cellular compartments is to enhance a rapid dismutation of superoxide to hydrogen peroxide.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Hydrogen peroxide can be converted to water by the action of catalase, a tetrameric heme-containing enzyme, and glutathione peroxidase (GPX), which uses the reduced tripeptide glutathione (GSH) as a cofactor to catalyze the reaction.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> GPX is one of the major classes of selenoproteins present in the human body.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> The active site is characterized by the presence of glutamine, tryptophan, and selenocysteine.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Selenoproteins are known to regulate the production of thyroid hormones, growth, and the immune response and have an important role in the antioxidant response.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Selenoproteins, and their roles in health and disease, have been comprehensively reviewed, and we therefore refer the reader to an excellent review on this class of proteins.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">Other examples of endogenous antioxidant enzymes are peroxiredoxin, thioredoxin, NAD(P)H dehydrogenase (quinone) 1, and glutathione S-transferase (GST).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The expression of these antioxidant enzyme genes is regulated by the interaction between specific transcription factors, including the nuclear factor erythroid 2-related factor 2 (Nrf2) and antioxidant response element (ARE) promoter regions.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> One of the primary roles that ROS play inside a cell is the regulation of cell survival. Within the physiological concentration range, ROS are involved in signaling as secondary messengers in several vital processes, through the oxidation of target cysteine thiols. For example, ROS signaling mediates survival factors such as nuclear factor kappa B (NF-kB), an antiapoptotic and proproliferation transcription factor. ROS also have an important role in cellular adaptation to hypoxic conditions. This occurs when cells need to adapt to a low-oxygen environment to survive during pathological events including cancer or ischemia. Conversely, high ROS levels indicate the existence of a pathological situation that will lead to cell death by apoptosis, necrosis, or autophagy.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">Autophagy is a catabolic pathway conserved across species.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Here, the autophagosome, a double membrane vesicle, functions to degrade misfolded or nonessential proteins and even entire organelles after fusion with the acidic lysosome that contains proteolytic enzymes. The activation of autophagy comes in response to general stress conditions like infection, starvation, and ischemia,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> while the modulation of autophagy is regulated by redox-sensitive proteins, such as 5′ adenosine monophosphate-activated protein kinase (AMPK), which undergoes S-glutathionylation of two cysteine residues. A second ROS-related regulatory mechanism involves the oxidation of a cysteine residue of autophagy-related gene 4 (ATG4), a key autophagy protease, which cleaves a precursor form of microtubule-associated protein 1A/1B light chain 3 (pro-LC3) to LC3-I, which is responsible for autophagosome formation after downstream processing. A final example of the ROS–autophagy cross-talk is related to the creation of an impaired thiol redox state due to the release of reduced GSH in the extracellular environment.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">ROS also influence cellular proliferation through the regulation of several growth factors including the platelet-derived growth factor (PDGF), the epidermal growth factor (EGF), and the fibroblast growth factor (FGF). These require ROS for activation and phosphorylation of a tyrosine residue in their receptor tyrosine kinase domain.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Once activated, the growth factors promote cellular proliferation as well as cell survival via different signal transduction pathways.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Furthermore, ROS are interconnected with vascular formation by stimulating angiogenic factors such as the specific growth factor, the vascular and endothelial growth factor VEGF, and angiopoietin.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">ROS are involved in several aspects of the immune response. In fact, ROS can protect the body against pathogens either in a direct way or through phagocytosis.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The pathogenic invasion of bacteria and fungi is followed by a burst of ROS production inside phagocytes, such as neutrophils, which together with proteases destroy the pathogen.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The specific localization of NOX2 in phagocytes is of particular relevance, as it can produce ROS and NO<sup>•</sup> to directly cause an antipathogen response by oxidation of proteins and DNA inside the phagosome. ROS are also involved indirectly in stimulating the release of proteins capable of proteolytic degradation, such as elastase or cathepsin G, due to the increase of K<sup>+</sup> concentration in the phagosomal lumen in response to NOX2 activity.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Physiological concentrations of ROS are also necessary for the activation of T-cells. It has been found that ROS are involved in T-cell receptor (TCR) signaling pathways at several levels. For example, the release of Ca<sup>2+</sup> in response to the activation of cluster of differentiation 3 (CD3) is in turn responsible for ROS production, while mitochondrial ROS has been found to activate T-cell regulation through oxidation of interleukins 2 and 4 (IL-2 and IL-4).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> ROS are also involved in the response to viral pathogens. The activation of ROS production by NOX2 in endosomes is stimulated by the presence of viral RNA or DNA. It has therefore long been speculated that ROS may be employed in response to viral infections.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In the context of COVID-19 infection, excess ROS has been identified as one of the potential trigger factors for the development of a more severe disease, especially in patients with a pre-existing alteration in the redox balance. The lower expression of SOD together with activation of ROS production by neutrophils seems to lead to alveolar damage, thrombosis, and dysfunction of red blood cells.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p last">Furthermore, ROS have been shown to have significant effects in the fields of both synaptic plasticity and neurotransmission in several areas of the brain, such as the amygdala and the spinal cord. The amygdala regulates the emotional aspects of pain, and neurotransmission and excitability of its central nucleus (CeA) are increased by pain neuroplasticity controlled by ROS.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.2.  Pathophysiological Effects Correlated to High ROS Levels</h3><div class="NLM_p">Several pathologies have been connected to increased ROS levels. It has been demonstrated that ROS signaling is implicated in the proliferation and cell survival of many types of cancer.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> A characteristic of cancer is an increased production of intracellular ROS to promote tumorigenesis and differentiation.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> On the other hand, tumor cells develop an increased resistance to high ROS levels by increasing the capacity of their antioxidant machinery.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> This results in an altered redox homeostasis, which in turn could be exploited as a potential target for treatment.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The activation of certain growth factors stimulates the release of ROS, which act as secondary messengers and modulate important signaling cascades through oxidative inactivation of phosphatases.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Genomic instability due to unrepaired DNA damage is a key feature of oncogenic transformation. One source of this damage is the oxidation of DNA due to high ROS levels in the tumor microenvironment.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The high energy level present in cancer cells is maintained thanks to a shift to aerobic glycolysis, the so-called Warburg effect, and results in glucose consumption and subsequent lactic acid fermentation.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> This change in cellular metabolism is required for cancer cells to adapt to hypoxic conditions. The increased expression of the gene encoding for the hypoxia-inducible transcription factor (HIF-1α) is found in this type of pathology and may lead to several oncogenic events including metastasis and angiogenesis, in addition to a more general cell proliferation/growth, as mentioned before.<a onclick="showRef(event, 'ref3 ref51'); return false;" href="javascript:void(0);" class="ref ref3 ref51">(3,51)</a> Metastasis is a process that is redox-regulated, as ROS are involved in two crucial steps, the loss of cell adhesion and cell migration, which both depend on the binding between integrins and the extracellular matrix.<a onclick="showRef(event, 'ref15 ref33 ref50'); return false;" href="javascript:void(0);" class="ref ref15 ref33 ref50">(15,33,50)</a></div><div class="NLM_p">Neurodegenerative diseases (NDs), known as progressive and incurable diseases with mostly unknown etiology, are characterized by progressive loss of cognitive function and neuronal structure of specific neurons, resulting in the accumulation of protein aggregates and neuronal death.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The most common NDs are Alzheimer’s (AD), Parkinson’s (PD), and Huntington’s diseases. The link between ROS and neurodegeneration has been widely demonstrated; however, it is important to highlight that oxidative stress may not be a root cause of the diseases. Nonetheless, it is considered important in disease progression.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> In general, the fact that the neuronal cells are particularly susceptible to ROS is due to their high consumption of oxygen, a relatively weak antioxidant defense, and the abundance in the cell membrane of polyunsaturated fatty acids, which are susceptible to peroxidation.<a onclick="showRef(event, 'ref8 ref53'); return false;" href="javascript:void(0);" class="ref ref8 ref53">(8,53)</a></div><div class="NLM_p">Another important disease whose progression has been correlated with ROS is cardiovascular disease (CVD),<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> which includes atherosclerosis and myocardial infarction among others, some of the major causes of death worldwide.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Increased ROS concentrations have been correlated to CVD through the activation of several signaling cascades in the coronary endothelium, a vascular tissue, during pathogenic cardiovascular events.</div><div class="NLM_p">In the event of a stroke, the pathological role of ROS takes place during the reperfusion stage, which follows the acute event. During a stroke, the blood flow in certain areas of the brain is blocked.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Consequently, the supply of oxygen and glucose is impaired, and damage to the mitochondria may occur.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Even though the reperfusion is required in order to prevent the brain from further damage, this, at the same time, increases oxidative stress due to an accumulation of ROS,<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> resulting in cell death.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Several enzymes and organelles are known to be responsible for ROS overproduction during reperfusion, including NADPH,<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> XO,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> as well as mitochondria at the succinate-driven reverse electron transport level.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div><div class="NLM_p">Furthermore, ROS has been recognized to be involved in diabetes-correlated pathology.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> It has been reported that increased insulin resistance may be caused by ROS produced under diabetic conditions through glucose oxidation, lipid peroxidation, and protein glycation.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The progression of diabetes may cause significant complications such as cardiovascular diseases, retinopathy, and nephropathy.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p last">Control of free iron is another promising target in controlling ROS, as this controls the site and extent of generation of the highly aggressive hydroxyl radical. In this context, ferroptosis, a recently discovered form of cell death, is worth highlighting. This iron-dependent process, which is distinct from necrosis, apoptosis, or autophagy, was first discovered in 2012.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> It has been identified and described by employing erastin, an RAS-selective lethal compound that triggers ROS accumulation-driven cell death, inhibiting the cysteine-dependent glutathione synthesis, and therefore the antioxidant defense, by blocking the cysteine/glutamate antiporter (system x<sub>c</sub><sup>–</sup>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In addition to the involvement of iron and the accumulation of ROS, other key features of ferroptosis are the accumulation of lipid hydroperoxides and the inhibition of the enzyme glutathione peroxidase 4 (GPX4).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The modulation of ferroptosis has already been linked to several disease states and will undoubtedly be the subject of future research.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> In this context, inhibitors of ferroptosis have been reported to be efficacious in animal models of tissues damage connected to ischemia and reperfusion,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> while activators of ferroptosis are suggested to hold promise as anticancer agents.<a onclick="showRef(event, 'ref68 ref70'); return false;" href="javascript:void(0);" class="ref ref68 ref70">(68,70)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">3.  Small-Molecule Inhibitors of ROS Production</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Due to their wide-ranging roles in cellular (patho)physiology, inhibiting the production of ROS has become an important therapeutic strategy for combatting a range of diseases. The purpose of this section is to critically evaluate the most important inhibitors of ROS production that have been reported and assess their suitability as tool compounds and/or drug leads. Due to the breadth of this topic, we have chosen to focus on <i>small molecule</i> inhibitors.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Therefore, peptide-derived inhibitors such as NOXA1ds and NOXA2ds-tat will not be considered here but have been reviewed elsewhere.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> In addition to inhibiting ROS production directly, stimulating the cellular antioxidant system is another strategy to reduce ROS levels. This can be achieved by inhibiting the interaction between Nrf2 and Kelch-like ECH-associated protein 1 (Keap1), which in conditions of low oxidative stress targets Nrf2 for ubiquitination, thus preventing the induction of the antioxidant gene expression by this transcription factor.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> This strategy will not be discussed in this perspective, and interested viewers are referred to a recent comprehensive review on Nrf2-Keap1 inhibitors.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.1.  Nonselective Scavengers</h3><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">3.1.1.  Endogenous Scavengers with a Direct Mode-of-Action</h4><div class="NLM_p">The main endogenous intracellular ROS scavenger is <i>glutathione</i> (GSH, <b>1</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>),<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> a cysteine-containing tripeptide present in all cell types.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> The majority of GSH is localized in the cytosol; however, around 10% is present in the mitochondrial compartment, where it protects from oxidative stress during electron transport and oxidative phosphorylation.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> It has been reported that depletion of GSH leads to a permeability change of the mitochondrial membrane that results in membrane potential loss and consequent increase of ROS production.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> In the presence of H<sub>2</sub>O<sub>2</sub>, GSH is oxidized by GSH peroxidase, forming glutathione disulfide (GSSG) and explaining its ROS scavenging activity.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Small-molecule scavengers of ROS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A second ROS scavenger is <i>vitamin E</i>, in particular α-tocopherol (<b>2</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Vitamin E is an essential component of membranes and an effective antioxidant.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The oxidation reaction of α-tocopherol with unsaturated lipids results in the formation of nonradical dimers, trimers, and tocopherol-quinone (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79,80)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mode-of-action of α-tocopherol with radical species. ROO<sup>•</sup> = lipid-peroxyl radical; ROOH = lipid hydroperoxide; R<sub>1</sub> = 4,8,12-trimethyltridecyl; LOOH = lipid-peroxyl radical.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Nitrones are a class of antioxidant compounds with reported neuroprotective effects and potential as therapeutic agents, for example, in neurodegenerative diseases,<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> ischemic stroke,<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82,83)</a> and traumatic injuries.<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84,85)</a> Some nitrones, including the cyclic 5,5-dimethyl-1-pyrroline <i>N</i>-oxide (DMPO, <b>3</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), are in use as spin-trapping reagents to detect transient radical species in electron spin resonance techniques thanks to their characteristic reaction with ROS.<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86,87)</a> Radical addition to the nitrones traps the ROS (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), and subsequent decomposition proceeds with formation of NO.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> NXY-059 (disodium 2,4-disulfophenyl-<i>N</i>-<i>tert</i>-butylnitrone, <b>4</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), part of the phenyl-<i>N</i>-<i>tert</i>-butyl nitrones (PBNs),<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> has been studied in a phase III clinical trial as a potential treatment for acute ischemic stroke.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Unfortunately, the compound failed due to lack of activity.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Other nitrones including thiadiazole 4a (<b>5</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) and TBN (<b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), which show potential in both neurodegenerative diseases and ischemic stroke, have been reported.<a onclick="showRef(event, 'ref81 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref81 ref82 ref83">(81−83)</a> Recently, quinolyl nitrones such as QN23 (<b>7</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) have emerged as alternative nitrone-containing scavengers. QN23 was found to be a neuroprotective agent <i>in vivo</i> in cerebral ischemia models and to effectively trap hydroxyl radicals.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Analogue synthesis and SAR analysis resulted in the discovery of QN6 (<b>8</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) as a promising starting point for future optimization of new molecules for the treatment of stroke. QN6 demonstrated a neuroprotective effect in an oxygen and glucose deprivation cell culture model, good lipophilicity, and potent activity as a hydroxyl radical scavenger.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mechanism-of-action of nitrone ROS scavengers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Finally, a variety of natural products have been reported as putative antioxidants, the majority of which are polyphenols. The chemical biology of this compound family has been reviewed extensively<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> and will not be covered here. It is important to note that caution is warranted when working with such compounds, which have been reported as redox cyclers (i.e., pro- or antioxidants, depending on the environment) as well as nonspecific protein precipitants.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">3.1.2.  Scavengers with Both Direct and Indirect Modes-of-Action</h4><div class="NLM_p">Nicotinamide (<b>9</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), also known as vitamin B<sub>3</sub>, is an endogenous metabolite that can be converted to nicotinamide adenine dinucleotide (NAD).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> It has been found that nicotinamide may influence the activity of particular proteins, SIRT1 among others, which can modulate autophagy and apoptosis as a function of cell survival.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> The direct ROS scavenging action of nicotinamide and its metabolites has also been reported.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Nicotinamide is able to decrease the intracellular ROS levels by reducing the ETC together with the downregulation of the formation of the mitochondrial permeability transition pore. The latter leads to an increase of the membrane potential.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div><div class="NLM_p">An important member of the carotenoids and the principal provitamin A is β-carotene (<b>10</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). β-Carotene is also be able to modulate ROS levels by acting as an antioxidant<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> by directly quenching singlet oxygen or by reaction with, and inhibition of, lipid peroxidation.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The reactions between singlet oxygen and β-carotene can lead to the formation of β-carotene 5,8-endoperoxide and β-carotene 5,6-epoxide during methyl linolate chlorophyll-sensitized photo-oxidation, or the formation of cyclic monoendoperoxides and diendoperoxides in bacteriopheophytin-sensitized systems.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> In addition to its scavenging action, pro-oxidant effects have been reported for high concentrations of β-carotene.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div><div class="NLM_p">The glycolysis product pyruvate (<b>11</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) is reported to act as an antioxidant of hydrogen peroxide.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> A direct scavenging action of hydrogen peroxide has been reported by a nonenzymatic decarboxylation of pyruvate to acetate which, at the same time, reduces hydrogen peroxide to water.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Furthermore, an indirect scavenging action involves pyruvate metabolism, which results in the reduction of GSH by the involvement of NADPH.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></div><div class="NLM_p">Edaravone (<b>12</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) is an approved drug for the treatment of acute brain infarction. Edaravone is also a scavenger of free radicals and a lipid peroxidation inhibitor that has a low molecular weight, is lipophilic, and can cross the blood—brain barrier.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> The mechanism-of-action of edaravone is illustrated in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>.<a onclick="showRef(event, 'ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref102 ref103">(102,103)</a> It has also been reported that, in animal models of retinal diseases, edaravone prevents oxidative retinal damage to lipids and cell death resulting from oxidative stress.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Hypothetical mode-of-action of edaravone. RO<sup>•</sup> = radical species; RO<sup>–</sup> = anion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><i>N</i>-Acetyl cysteine (NAC, <b>13</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) is a cysteine prodrug, which has been broadly employed in cellular, animal, and clinical studies as an antioxidant<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> and is often considered an acetylated precursor of GSH.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> In addition to exerting its scavenging activity by directly interacting with ROS through its thiol,<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> another scavenging mechanism-of-action for NAC has been proposed to stem from its conversion to potent ROS scavenging sulfane species, by 3-mercaptopyruvate sulfurtransferase and sulfide-quinone oxidoreductase.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> In addition to its antioxidant properties, NAC can display other biological effects that raise questions about its utility as a tool compound. For instance, it has been observed that NAC has detrimental effects on cell viability by specifically modulating the redox state of certain kinases, which results in the activation of a cell-cycle-dependent kinase inhibitor, suggesting that it is not simply an ROS scavenger.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></div><div class="NLM_p">Melatonin (<i>N</i>-acetyl-5-methoxytryptamine, <b>14</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) is a tryptophan-derived endogenous hormone released from the pineal gland. It is involved in several biological processes such as immunity, sleep regulation, and cardiac functions.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Melatonin is considered a suicidal (or terminal) antioxidant, which reduces electrophilic radicals due to the electron-rich indole functioning as an electron donor.<a onclick="showRef(event, 'ref108 ref109'); return false;" href="javascript:void(0);" class="ref ref108 ref109">(108,109)</a> It has also been reported that its ring-opened metabolites, AMK (<i>N</i>1-acetyl-5-methoxykynuramine, <b>15</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) and AFMK (<i>N</i>1-acetyl-<i>N</i>2-formyl-5-methoxykynuramine, <b>16</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), also have ROS scavenging activity.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Melatonin has an additional, indirect antioxidant function by stimulating the antioxidant defense system, including SOD and GPx.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Several <i>in vivo</i> studies have been carried out to study the role of melatonin in protecting the brain from ischemic injuries, by initially inhibiting its release from the pineal gland.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> It is reported that the neurological injuries caused by the ischemic event were partially recovered when melatonin was reintroduced.<a onclick="showRef(event, 'ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref112 ref113">(112,113)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Melatonin and its ring-opened oxidation products.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.2.  Site-Specific ROS Inhibitors</h3><div class="NLM_p">Contrary to scavengers, site-specific inhibitors block ROS production by a specific mode-of-action, without the disadvantage of widespread ROS depletion that could also affect physiologically beneficial ROS functions.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">3.2.1.  NOX Inhibitors</h4><div class="NLM_p">NOX have been shown to be involved in several pathologies and to be isoform-tissue specific. In order to perform detailed, targeted studies of the different roles of single NOX isoforms, more specific tool compounds are required.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div><div class="NLM_p">One of the compounds most widely used as a NOX inhibitor is diphenyl iodonium (DPI) (<b>17</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> This compound is a potent inhibitor of all NOX isoforms<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> as well as a generic flavoprotein inhibitor, reported to be active against XO,<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> cytochrome P450,<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> and NOS enzymes<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> and to interfere with the mitochondrial respiratory chain.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> In the context of NOX inhibition, DPI reacts with the heme cofactors and FAD in the reduced state.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> The multitude of off-target activities make DPI unsuitable for therapeutic use and as a tool for studying NOX activity.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of NOX inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of NOX Inhibitors, Their Specific Target(s), and Clinical Indications</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">other activities/specificity</th><th class="colsep0 rowsep0" align="center">clinical indications</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DPI (<b>17</b>)</td><td class="colsep0 rowsep0" align="left">NOX<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></td><td class="colsep0 rowsep0" align="left">inhibits all NOX isoforms, XO,<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> cytochrome P450<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> and NOS enzymes,<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> ETC<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GKT136901 (<b>18</b>)</td><td class="colsep0 rowsep0" align="left">NOX1 (and NOX4)<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></td><td class="colsep0 rowsep0" align="left">peroxynitrite scavenger;<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> hydrogen peroxide scavenger;<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> selective for NOX1 and NOX4;<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> activity for DUOX;<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> interference with luminol and HRP/Amplex red assays<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></td><td class="colsep0 rowsep0" align="left">orally bioavailable;<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> kidney fibrosis and albuminuria<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GKT137831 (<b>19</b>)</td><td class="colsep0 rowsep0" align="left">NOX1 (NOX2 and NOX4)<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></td><td class="colsep0 rowsep0" align="left">selective for NOX1 over NOX4; low activity for NOX2<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></td><td class="colsep0 rowsep0" align="left">phase 2 clinical trials for diabetic nephropathy (setanaxib); orally bioavailable;<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> kidney fibrosis and albuminuria<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GKT771 (<b>20</b>)</td><td class="colsep0 rowsep0" align="left">NOX1<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">cancer (tumor growth suppressor and inhibition of angiogenesis)<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VAS2870 (<b>21</b>)</td><td class="colsep0 rowsep0" align="left">NOX1, NOX2, NOX4, and NOX5<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></td><td class="colsep0 rowsep0" align="left">slightly higher selectivity for NOX2 over the other isoforms;<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> cysteine residues thioalkylation (RyR1)<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></td><td class="colsep0 rowsep0" align="left">several therapeutic applications, including neurodegeneration,<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> cancer,<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> and thrombosis<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VAS3947 (<b>22</b>)</td><td class="colsep0 rowsep0" align="left">NOX1, NOX2, NOX4, and NOX5<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">higher solubility compare with VAS2870<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APX-115 (<b>23</b>)</td><td class="colsep0 rowsep0" align="left">NOX1, NOX2, and NOX4<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">orally bioavailable;<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> type 2 diabetes;<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> type 1 diabetes;<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> osteoporosis<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NOS31 (<b>24</b>)</td><td class="colsep0 rowsep0" align="left">NOX1<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></td><td class="colsep0 rowsep0" align="left">active in NOX2, NOX3, NOX4, and NOX5 (marginal activity)<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></td><td class="colsep0 rowsep0" align="left">cancer (NOX1 overexpression)<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK2795039 (<b>25</b>)</td><td class="colsep0 rowsep0" align="left">NOX2<a onclick="showRef(event, 'ref115 ref135'); return false;" href="javascript:void(0);" class="ref ref115 ref135">(115,135)</a></td><td class="colsep0 rowsep0" align="left">active in NOX1, NOX3, NOX4, and NOX5 in a range between 61% and 68% (activity for NOX2 98%); active in XO (100-fold lower compared to NOX2); active in eNOS (50% inhibition at 100 μM)<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></td><td class="colsep0 rowsep0" align="left">crosses blood–brain barrier; orally bioavailable<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CPP11H (<b>26</b>) and CPP11G (<b>27</b>)</td><td class="colsep0 rowsep0" align="left">NOX2<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">inflammation; vascular dysfunctions<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLX351322 (<b>28</b>)</td><td class="colsep0 rowsep0" align="left">NOX4 (and NOX2)<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td><td class="colsep0 rowsep0" align="left">NOX4 with 8-fold selectivity over NOX2<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td><td class="colsep0 rowsep0" align="left">diabetes<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GLX7013114 (<b>29</b>)</td><td class="colsep0 rowsep0" align="left">NOX4<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_p">During the past decade, a set of new, reportedly isoform-specific NOX inhibitors have been developed. However, since then not all have been demonstrated to be selective for a single isoform or even to be selective for NOX over other oxidases. GKT136901<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> and GKT137831<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> (respectively, <b>18</b> and <b>19</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) show preferential inhibition of NOX isoforms 1 and 4, with IC<sub>50</sub> values in the nanomolar range.<a onclick="showRef(event, 'ref114 ref119'); return false;" href="javascript:void(0);" class="ref ref114 ref119">(114,119)</a> GKT136901 is also reported to interfere with DUOX-1 and DUOX-2<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> while activity against NOX2 has also been reported for GKT137831, however with lower potency compared to NOX1 and NOX4.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Both compounds were shown to be inactive against xanthine oxidase and several unrelated targets, including Ca<sup>2+</sup>, K<sup>+</sup>, and Cl<sup>–</sup> channels, kinases, and G-protein coupled receptors.<a onclick="showRef(event, 'ref114 ref119'); return false;" href="javascript:void(0);" class="ref ref114 ref119">(114,119)</a> Both compounds are orally bioavailable<a onclick="showRef(event, 'ref114 ref120'); return false;" href="javascript:void(0);" class="ref ref114 ref120">(114,120)</a> and have been reported to be effective in the prevention of hypertensive cardiac remodeling in mice (GKT137831)<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> and to reduce oxidative stress and albuminuria in type I (GKT137831) and II diabetes mouse models (GKT136901).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> GKT137831 may be a promising therapeutic and is currently being tested for diabetic nephropathy in phase 2 clinical trials to reduce albuminuria (<a href="https://https:\\ClinicalTrials.gov" class="ext-link">ClinicalTrials.gov</a> reference number NCT02010242); however, it has also been shown to be a potent scavenger of peroxynitrite<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> and hydrogen peroxide.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> This is not surprising, given the fact that GKT137831 and GKT136901 both contain a dihydropyrazolone scaffold, also seen in the ROS scavenger edavarone (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), which is specifically required for its scavenging activity. Recently described issues concerning the interaction of GKT136901 with peroxidase-dependent (e.g., horseradish peroxidase (HRP)/Amplex red) assays have raised doubts about the correct interpretation of reported data for this compound and concerns regarding the actual mode-of-action and potency.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> GKT771 (<b>20</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, structure not disclosed) has been developed as a specific NOX1 inhibitor,<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> which does not inhibit other NOX isoforms, XO, or glucose oxidases with the same potency and does not act as an ROS scavenger. GKT771 suppressed tumor growth of colon carcinoma in mice by increasing immune cell recruitment and suppression of angiogenesis. It has been reported that the compound may act as a tumor suppressor if the immune system is intact.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><div class="NLM_p">VAS2870 (<b>21</b> in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) has been defined as a pan-NOX inhibitor, because of its reported action not only against NOX2, for which VAS2870 is reported to be selective, but also against NOX1, NOX4, and NOX5.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Activity as an ROS scavenger has not been reported for VAS2870, and it only weakly targets XO compared to NOX.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> VAS2870 may be potentially useful for several pathologies including neurodegeneration,<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> cardiovascular diseases,<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> tumors,<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> and thrombosis.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> However, off-target effects have been reported and are related to the thioalkylation of cysteine residues in the ryanodine receptor Ca<sup>2+</sup> channel (RyR1) by VAS2870 in skeletal muscle, which also leads to the abolishment of the nitrogen oxide regulatory activity over RyR1.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> An analogue, VAS3947 (<b>22</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), displays the same NOX inhibition activity and inactivity against XO and eNOS but with increased solubility compared to VAS2870.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> To summarize, VAS compounds appear to be good tools to investigate general NOX inhibition, but less useful if isoform selectivity is required.</div><div class="NLM_p">A similar assessment can be made with regards to APX-115 (<b>23</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), which is reported to be a promising compound for the treatment of type 2 diabetes.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> APX-115, also known as Ewha-18278, has shown activity against three NOX isoforms (NOX1, NOX2, and NOX4),<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> without acting as an ROS scavenger or as an inhibitor of xanthine and glucose oxidases.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> This orally available compound displays good pharmacokinetics<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> and has been found in mouse studies to have a comparable efficacy to losartan, a drug used in diabetic patients for kidney protection preventing kidney injury and protecting mitochondrial and peroxisomal functions from lipid peroxidation damage.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> It is also reported to be efficient in the protection of renal injury induced by type 2 diabetes<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> and in streptozotocin-induced type 1 diabetes<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> and has been found to be potentially useful in the treatment of osteoporosis.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div><div class="NLM_p">NOS31 (<b>24</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), a NOX1-selective inhibitor produced from <i>Streptomyces</i> sp.,<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> was found to inhibit tumor growth of several types of cancer cell lines associated with upregulated NOX1 expression, including stomach and colon cancer cell lines. It was shown to interfere only with cancer cell lines where NOX1 is overexpressed, and to not inhibit XO or act as a H<sub>2</sub>O<sub>2</sub> scavenger. Inhibition of NOX2, NOX3, NOX4, and NOX5 is reported to be at least 14 times weaker compared to NOX1.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> NOS31 may therefore be of interest as a tool compound, though further selectivity profiling is warranted before widespread adoption.</div><div class="NLM_p">GSK2795039 (<b>25</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), is a competitive inhibitor with NOX2 selectivity over other NOXs, XO, and eNOS.<a onclick="showRef(event, 'ref115 ref135'); return false;" href="javascript:void(0);" class="ref ref115 ref135">(115,135)</a> The activity against XO is reported to be 100-fold lower compared to NOX2. Moreover, eNOS is reported to only be 50% inhibited at 100 μM.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> GSK2795039 inhibits the production of ROS, passes the blood–brain barrier, and is orally bioavailable.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> It has been used in several cell-based studies<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> and in <i>in vivo</i> studies<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> as a NOX2 inhibitor. While GSK2795039 is a suitable tool to study NOX2, it is important to consider possible side-effects due to its weak activity against other flavoproteins and NOX isoforms.</div><div class="NLM_p">In order to address NOX2 in a more specific way, selective NOX2 inhibitors, CPP11G and CPP11H (respectively, <b>26</b> and <b>27</b> in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) may be used. These two bridged tetrahydroisoquinolines,<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> which were found to be inactive against NOX1, NOX4, NOX5, and XO, and not to directly interact with ROS, are reported to block the translocation of p47<sup>phox</sup> from the cytosol to the plasma membrane preventing the essential interactions between p47<sup>phox</sup> and p22. It has also been reported to prevent inflammation of the vascular endothelium in mice and vascular dysfunction stimulated by tumor necrosis factor α (TNFα).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Profiling of CPP11s is still limited, and their potency is somewhat low which limits their utility; however, their selectivity profile is promising and warrants further investigation.</div><div class="NLM_p last">GLX351322 (<b>28</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) is a reported NOX4 inhibitor with 8-fold selectivity <i>in vitro</i> over NOX2. GLX351322 has no scavenging activity and is reported to prevent the death of high-glucose-induced islet cells and release of high-glucose insulin in mice in a NOX4-dependent manner.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> A follow-up compound, GLX7013114 (<b>29</b>, in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, structure not disclosed),<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> is reported to target NOX4 specifically with increased potency, and with no reported activity against NOX1, NOX2, NOX3, and NOX5; XO; or glucose oxidase.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Contrary to the mechanism-of-action proposed for VAS2870, here the isoform selectivity supposedly arises from targeting a nonconserved subunit of NOX. <i>In vitro</i> studies report that GLX7013114 may protect against cell death, enhanced by either a combination of high glucose and palmitate concentrations or the presence of cytokines.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Furthermore, it was shown to negatively interfere with transforming growth factor β (TGFβ)-induced epithelial to mesenchymal transition in mice.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> This compound appears to be an excellent tool for NOX4-specific studies due to its high specificity and reported absence of off-target activity.</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">3.2.2.  Mitochondrial ROS Inhibitors</h4><div class="NLM_p">In this section, both mitochondria-targeted ROS scavengers and specific inhibitors of ROS produced by the mitochondrial respiratory chain are discussed. MitoQ (<b>30</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) is a ubiquinone-derived compound with demonstrated mitochondria-selective scavenging activity, which is also able to prevent lipid peroxidation and peroxide-induced apoptosis.<a onclick="showRef(event, 'ref143 ref144'); return false;" href="javascript:void(0);" class="ref ref143 ref144">(143,144)</a> Ubiquinone is an innermembrane component of the mitochondrial respiratory chain, which accepts two electrons from complex I and complex II, leading to its reduction to ubiquinol. The latter is an antioxidant that donates a hydrogen atom to a lipid peroxyl radical, decreasing mitochondrial lipid peroxidation.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> MitoQ consists of a ubiquinone moiety attached via a 10-carbon alkyl chain to a lipophilic tetraphenylphosphonium cation (TPP), which enables mitochondrial bilayer permeation due to the mitochondrial potential, allowing MitoQ to accumulate within the mitochondria.<a onclick="showRef(event, 'ref143 ref145'); return false;" href="javascript:void(0);" class="ref ref143 ref145">(143,145)</a> It has been reported that MitoQ blocks the activation of the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome by the reduction of mitochondrial ROS.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Recently, side-effects unrelated to the antioxidant activity of MitoQ have been reported, including mitochondrial swelling and depolarization in proximal tubules of renal cells.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Applying the same principle of an antioxidant coupled to a TPP group, Murphy and collaborators developed MitoTEMPO (<b>31</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxy) and TEMPO (2,2,6,6-tetramethylpiperidine-1-oxy) are both piperidine nitroxides, which are efficient antioxidants able to mimic the effect of superoxide dismutase, by oxidizing nitroxide to oxoammonium, which can itself be reduced by a molecule of superoxide to regenerate nitroxide.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> The addition of TPP to one of the piperidine nitroxides creates specific mitochondrial antioxidants,<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> such as MitoTEMPO, by increasing the accumulation of these molecules inside the mitochondria by a factor of 100.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> MitoTEMPO has been recognized to be an effective antioxidant in models of several pathologies like colitis, hypertension, toxicity-induced liver injury, and related-kidney injuries.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> MitoTEMPO may be reported as a promising therapeutic candidate;<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> however, its mechanism-of-action as a general mitochondrial ROS scavenger makes it less valuable as a tool compound.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of inhibitors of mitochondrial ROS production.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Summary of Mitochondrial ROS Inhibitors, Their Specific Target(s), and Clinical Indications</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">other activities/specificities</th><th class="colsep0 rowsep0" align="center">clinical indications</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MitoQ (<b>30</b>)</td><td class="colsep0 rowsep0" align="left">mitochondrial ROS<a onclick="showRef(event, 'ref143 ref144'); return false;" href="javascript:void(0);" class="ref ref143 ref144">(143,144)</a></td><td class="colsep0 rowsep0" align="left">scavenger; not target-specific</td><td class="colsep0 rowsep0" align="left">side-effects: mitochondrial swelling and depolarization in proximal tubules of renal cells<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MitoTEMPO (<b>31</b>)</td><td class="colsep0 rowsep0" align="left">mitochondrial ROS<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a></td><td class="colsep0 rowsep0" align="left">scavenger; not target-specific</td><td class="colsep0 rowsep0" align="left">colitis, hypertension, toxicity-induced liver injury, and related-kidney injuries<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S3QELs (<b>32</b>)</td><td class="colsep0 rowsep0" align="left">ETC complex III (III<sub>QO</sub> site)<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">hypoxia<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S1QELs (<b>33</b>)</td><td class="colsep0 rowsep0" align="left">ETC complex I (I<sub>Qr</sub> site)<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">hyperplasia; I/R<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></td></tr></tbody></table></div></div><div class="NLM_p last">Contrary to the mitochondrial scavengers, small molecules that inhibit the specific production of ROS by the ETC have recently been reported. These compounds were identified in high-throughput screening campaigns and have been named accordingly to their specific target site: S1QELs and S3QELs (example structures, respectively, <b>32</b> and <b>33</b> in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). S3QELs are a set of molecules that inhibit the electron leak of complex III of the mitochondrial ETC, specifically in the III<sub>QO</sub> site, while S1QELs suppress the electron leak from the I<sub>Q</sub> site of complex I.<a onclick="showRef(event, 'ref148 ref149 ref150 ref151'); return false;" href="javascript:void(0);" class="ref ref148 ref149 ref150 ref151">(148−151)</a> These compounds have been shown to inhibit the production of either superoxide or hydrogen peroxide with the main advantages of being selective for the electron leak, not possessing other known targets, and not suppressing normal electron flow or oxidative phosphorylation. S3QELs<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> were shown to modulate ROS-mediated signaling in response to hypoxia, by inhibiting the accumulation of HIF-1α.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> S1QELs may be further divided in two scaffold types: S1QEL1 is characterized by the presence of a thiazole core while S1QEL2 contains a piperazine.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> The precise mechanism-of-action is still unknown,<a onclick="showRef(event, 'ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref149 ref150">(149,150)</a> but it has been proposed that the site where S1QELs interfere with ROS production may be I<sub>Q</sub>r, without influencing any other components.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> S1QELs are reported to have promising therapeutic potential, by decreasing stem cell hyperplasia in <i>Drosophila</i> and by protecting mice against ischemia/reperfusion (I/R) injury.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">3.2.3.  MAO Inhibitors</h4><div class="NLM_p">MAO inhibitors (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) have been extensively used as antidepressants, and the first drug employed for this purpose was iproniazid (<b>34</b> in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), previously used as an antituberculosis agent.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Several side-effects were observed for this and similar MAO inhibiting compounds, including the so-called “cheese effect”, caused by inhibitory activity against MAO-A. This particular adverse reaction occurs through the build-up of dietary tyramine, often found in cheese, which in large quantities can give rise to a noradrenaline release and increased blood pressure.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Currently, inhibitors of monoamine oxidase are used in neurodegenerative diseases. Both isoforms, MAO-A and MAO-B, are involved in the degradation of neurotransmitters such as dopamine and serotonin and produce hydrogen peroxide or ammonia as byproducts in the oxidative deamination of biogenic amines.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Here, we highlight only the most important MAO inhibitors and refer the reader to a recent and comprehensive review for further details.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Inhibitors of monoamine oxidases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Summary of MAO Inhibitors, Their Specific Target(s), and Clinical Indications</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">other activities/specificities</th><th class="colsep0 rowsep0" align="center">clinical indications</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iproniazid (<b>34</b>)</td><td class="colsep0 rowsep0" align="left">MAO-A and MAO-B<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">depression, tuberculosis;<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> side-effects: “cheese effect”<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">selegiline (<b>35</b>)</td><td class="colsep0 rowsep0" align="left">MAO-B<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">in use for PD (in combination with <span class="smallcaps smallerCapital">l</span>-DOPA);<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> studied in AD,<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> cancer,<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> vascular function in diabetes<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rasagiline (<b>36</b>)</td><td class="colsep0 rowsep0" align="left">MAO-B<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></td><td class="colsep0 rowsep0" align="left">active in MAO-A (100-fold less potent than against MAO-B)<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></td><td class="colsep0 rowsep0" align="left">approved for PD<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">moclobemide (<b>37</b>)</td><td class="colsep0 rowsep0" align="left">MAO-A<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">depression,<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> PD (in combination with <span class="smallcaps smallerCapital">l</span>-DOPA),<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> inflammation<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ladostigil (<b>38</b>)</td><td class="colsep0 rowsep0" align="left">MAO-A and MAO-B<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a></td><td class="colsep0 rowsep0" align="left">inhibits acetylcholinesterase and butyrylcholinesterase<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a></td><td class="colsep0 rowsep0" align="left">PD, AD<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">contilisant (<b>39</b>)</td><td class="colsep0 rowsep0" align="left">MAO-A and MAO-B<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></td><td class="colsep0 rowsep0" align="left">inhibits acetylcholinesterase, antagonizes H3R;<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> S1R agonist<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a></td><td class="colsep0 rowsep0" align="left">AD<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">safinamide (<b>40</b>)</td><td class="colsep0 rowsep0" align="left">MAO-B<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a></td><td class="colsep0 rowsep0" align="left">modulates N-type calcium channels; blocks voltage-dependent sodium channels;<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> active in MAO-A (700-fold less potent than against MAO-B)<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a></td><td class="colsep0 rowsep0" align="left">approved for PD (in combination with <span class="smallcaps smallerCapital">l</span>-DOPA)<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">MAO-B<a onclick="showRef(event, 'ref172 ref173'); return false;" href="javascript:void(0);" class="ref ref172 ref173">(172,173)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">MAO-B<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">MAO-B<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">non-CNS-related inflammatory disease<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a></td></tr></tbody></table></div></div><div class="NLM_p">The beneficial effect of several MAO-B inhibitors in slowing down the progression of PD has been reported,<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> and among all, selegiline is one of the most promising.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Selegiline (or deprenyl, <b>35</b> in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), a selective MAO-B inhibitor, has been found to increase life expectancy of patients affected by PD in combination with <span class="smallcaps smallerCapital">l</span>-DOPA (levodopa)<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> and now is used as a treatment for PD.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> In addition to PD, selegiline has been studied in other diseases including AD<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> and cancer<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> and its effects correlated with vascular function in diabetes.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> Following the results of selegiline, another irreversible MAO-B inhibitor,<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> rasagiline (also named TVP-1012, <b>36</b> in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>),<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> has been approved for the treatment of PD in 2005 in the EU.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> This compound has shown selectivity for MAO-B over MAO-A, with an inhibitory potency more than 100-fold higher for the former compared to the latter, and it is reported to bind covalently to the FAD moiety of MAO-B.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></div><div class="NLM_p">Moclobemide (<b>37</b> in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) is a selective MAO-A inhibitor with a reversible mode-of-action, developed as an antidepressant since it has been shown to improve vigilance and memory in older patients. The main advantage of this compound is that it does not display the side-effects previously described including the cheese reaction, typical of nonspecific or irreversible MAO-A inhibitors.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Moclobemide was reported to be clinically effective against PD, particularly in combination with <span class="smallcaps smallerCapital">l</span>-DOPA.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Moreover, it was shown to also be active in the reduction of vascular inflammation.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a></div><div class="NLM_p">It is worth highlighting the MAO-A and MAO-B inhibitor ladostigil (TV3326, <b>38</b> in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). This propargylamine derivative has proven to be effective in neuroprotection and therefore employed in the treatment of PD and AD.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Intriguingly, the beneficial effect may be due to its polypharmacology, which includes acetylcholinesterase and butyrylcholinesterase inhibition.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Another multitargeted drug with promising preclinical activity is contilisant (<b>39</b> in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Contilisant is also described as a cell-permeable antioxidant compound which, in addition to inhibition of MAO and acetylcholinesterase, also antagonizes the histamine receptor subtype 3 (H3R)<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> and acts as a sigma 1 receptor (S1R) agonist.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a><i>In vivo</i> studies have confirmed the potential of this compound for the treatment of AD, and it is reported to be effective in restoring the cognitive deficit in mouse models of dementia.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a></div><div class="NLM_p">Recently the MAO-B inhibitor safinamide (<b>40</b> in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) has been approved for the treatment of mid- to late-stage PD patients in combination with <span class="smallcaps smallerCapital">l</span>-DOPA or other treatments. Safinamide is an α-aminoamide that has shown both dopaminergic and glutamatergic activity. While the glutamatergic action is involved in the inhibition of the glutamate release by modulation of (N-type) calcium channels and blockage of voltage-dependent sodium channels, the dopaminergic effect is correlated to the inhibition of MAO-B in the brain.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> It has been shown to be highly selective for MAO-B over MAO-A (>700-fold)<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> and to have no thiamine-correlated side-effect.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> It is a reversible MAO-B inhibitor, unlike selegiline and rasagiline.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> The available cocrystal of safinamide in human recombinant MAO-B (PDB 2 V5Z, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) shows that the molecule binds in two pockets, the substrate and the entrance pockets, which together form the protein active site. The aromatic ring of safinamide is oriented in the direction of the substrate cavity where FAD binds.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Two water molecules present in the crystal structure are thought to be involved in the binding interactions.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Cocrystal structure of safinamide in the active site of MAO-B (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a>). The α-sheet and β-barrel of the protein are shown in cyan and active site residues in gray. H-bonds are the orange dotted lines. Safinamide is represented in yellow, and water molecules are represented as red spheres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although MAOs have been explored as drug targets for decades, more recent advances have focused on new scaffolds (<b>41</b> in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>; <b>42</b> in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) with increased potency and selectivity for MAO-B,<a onclick="showRef(event, 'ref172 ref173 ref174'); return false;" href="javascript:void(0);" class="ref ref172 ref173 ref174">(172−174)</a> as well as non-blood–brain-barrier-permeable inhibitors (<b>43</b> in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) with applications in non-CNS-related inflammatory disease models.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a></div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">3.2.4.  XO Inhibitors</h4><div class="NLM_p">In addition to inhibiting ROS production, XO inhibitors were originally developed and approved as therapeutics for gout, acting through reduction of uric acid levels.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> Since XO appears to play a role in inflammatory, vascular, and heart-related conditions, XO inhibitors have been touted as potential treatments for these pathologies.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a></div><div class="NLM_p">The purine-like allopurinol (<b>44</b> in <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>)<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> was approved as a treatment for gout and hyperuricemia-related conditions. Allopurinol, the hydroxypyrazolopyrimidine analogue of hypoxanthine, and its active metabolite, oxypurinol, are both XO inhibitors. Oxypurinol is formed via oxidation of allopurinol by XO and is an analogue of xanthine.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> The fact that allopurinol efficiently lowers plasma levels of uric acid <i>in vivo</i> is counterbalanced by clinical side-effects such as necrosis, liver impairment, allergies, and rash, which are more probable in patients with impaired renal function,<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> as the drug is mostly excreted by the kidney.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> Moreover, allopurinol has been shown to inhibit enzymes that are part of pyrimidine biosynthesis, including orotidylate decarboxylase<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> and orotate phosphoribosyltransferase.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of XO inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary of XO Inhibitors, Their Specific Target(s), and Clinical Indications</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">other activities/specificities</th><th class="colsep0 rowsep0" align="center">clinical indications</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">allopurinol (<b>44</b>)</td><td class="colsep0 rowsep0" align="left">XO<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a></td><td class="colsep0 rowsep0" align="left">inhibits pyridine biosynthesis enzymes<a onclick="showRef(event, 'ref182 ref181'); return false;" href="javascript:void(0);" class="ref ref182 ref181">(182,181)</a></td><td class="colsep0 rowsep0" align="left">approved drug for gout and hyperuricemia, reduces uric acid;<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> clinical side-effects (as necrosis, liver impairment, allergies, and rash)<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">febuxostat (<b>45</b>)</td><td class="colsep0 rowsep0" align="left">XO<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">approved drug for gout, reduces uric acid; orally bioavailable; longer effect in reducing uric acid than allopurinol<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">topiroxostat (<b>46</b>)</td><td class="colsep0 rowsep0" align="left">XO<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a></td><td class="colsep0 rowsep0" align="left">weak inhibitor of cytochrome P450 3A4<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a></td><td class="colsep0 rowsep0" align="left">approved drug for hyperuricemia, reduces uric acid;<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> orally bioavailable<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a></td></tr></tbody></table></div></div><div class="NLM_p">Febuxostat (<b>45</b> in <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>),<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> also named TMX-67 and 6720, is a non-purine-like inhibitor of both the reduced and oxidized form of XO.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Febuxostat is characterized by oral bioavailability and a safe profile and is found in clinical studies to lower urate in serum in a more efficient way and with a longer effect compared to allopurinol.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> In contrast to allopurinol, no significant effects of febuxostat are reported against several purine or pyrimidine metabolic enzymes, making it a more suitable tool for exploring the roles of XO in disease.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Another approved nonpurine XO inhibitor is topiroxostat (<b>46</b> in <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), which is in use in Japan to treat hyperuricemia in both patients with and without gout.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> Topiroxostat, or FYX-051,<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> is reported to act by covalently binding to the molybdenum cofactor of the enzyme.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> This compound reduces the level of albumin in the urine and the level of urate in the serum.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> It is orally bioavailable and has a safe profile, due primarily to the fact that it is excreted as triazole N1-glucuronides and N2-glucuronides in urine.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> In addition, it is reported to be only a weak inhibitor of cytochrome P450 3A4.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> The binding mode of topiroxostat with bovine XOR is illustrated by an available crystal structure (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>). The molecule binds in the xanthine hydroxylation active site forming, via its metabolite trihydroxy-topiroxostat, an interaction with the molybdenum cofactor.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Cocrystal structure of topiroxostat in the active site of XO (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AM9">3AM9</a>). The α-sheet and β-barrel of the protein are shown in cyan. Active site residues are in gray. H-bonds are displayed as orange dotted lines. Topiroxostat is represented in yellow. Water molecules are represented as red spheres, and molybdenum cofactor is represented as green spheres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As a general guideline regarding the use of XO inhibitors in research, non-purine-like compounds may be preferable to purine-like inhibitors, in order to avoid side-effects related to the metabolism of other purines or pyridines.</div></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">3.2.5.  NOS Inhibitors</h4><div class="NLM_p">The primary focus of this Perspective is inhibitors of reactive oxygen species, and as such, molecules targeting NOS and thus inhibitors of reactive nitrogen species will only be discussed briefly. We have chosen to focus on molecules that in our opinion constitute the most promising tools for studying NOS activity and function and that also show therapeutic potential. The reader is referred to refs <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and <a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> for a more comprehensive coverage of NOS inhibitors.</div><div class="NLM_p">The production of nitric oxide by iNOS is reportedly correlated to neurodegenerative disorders and to a wide range of inflammatory pathologies including rheumatoid arthritis, osteoarthritis, and asthma. Consequently, iNOS has become a promising drug target. However, NOS isoform selectivity is a highly desirable characteristic of iNOS-targeting to avoid side-effects from nNOS or eNOS activity, such as hypertension.<a onclick="showRef(event, 'ref189 ref190'); return false;" href="javascript:void(0);" class="ref ref189 ref190">(189,190)</a> 1400W (<b>47</b> in <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) is a selective human iNOS inhibitor that shows approximately 500 times lower activity in eNOS and more than 200 times selectivity over nNOS.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> 1400W has been found to penetrate tissues<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> but unfortunately displays toxic effects in rats at high concentrations.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of NOS inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Summary of NOS Inhibitors, Their Specific Target(s), and Clinical Indications</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">other activities/specificities</th><th class="colsep0 rowsep0" align="center">clinical indications</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1400W (<b>47</b>)</td><td class="colsep0 rowsep0" align="left">iNOS<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a></td><td class="colsep0 rowsep0" align="left">activity in eNOS (500 times lower than iNOS) and in nNOS (200 times lower than iNOS)<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a></td><td class="colsep0 rowsep0" align="left">toxic<a onclick="showRef(event, 'ref186 ref191'); return false;" href="javascript:void(0);" class="ref ref186 ref191">(186,191)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">N-NIL (<b>48</b>)</td><td class="colsep0 rowsep0" align="left">iNOS<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a></td><td class="colsep0 rowsep0" align="left">activity in eNOS and in lower than iNOS<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a></td><td class="colsep0 rowsep0" align="left">I/R-associated kidney dysfunctions<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GW274150 (<b>49</b>)</td><td class="colsep0 rowsep0" align="left">iNOS<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a></td><td class="colsep0 rowsep0" align="left">activity in eNOS (248 times lower than iNOS) and in nNOS (81 times lower than iNOS)<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a></td><td class="colsep0 rowsep0" align="left">orally bioavailable;<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> collagen-induced arthritis;<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> I/R-related renal dysfunction;<a onclick="showRef(event, 'ref194 ref196'); return false;" href="javascript:void(0);" class="ref ref194 ref196">(194,196)</a> PD<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">nNOS<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td><td class="colsep0 rowsep0" align="left">activity in eNOS (2000 times lower than nNOS) and in iNOS (293 times lower than nNOS)<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">nNOS<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td><td class="colsep0 rowsep0" align="left">activity in eNOS (2676 times lower than nNOS) and in iNOS (807 times lower than nNOS)<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">iNOS (and nNOS)<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td><td class="colsep0 rowsep0" align="left">activity in nNOS (5 times lower than iNOS) and in eNOS (1000 times lower than iNOS)<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td><td class="colsep0 rowsep0" align="left"><i>in vivo</i> efficacy and cellular permeability<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">nNOS<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td><td class="colsep0 rowsep0" align="left">activity in eNOS (573 times lower than nNOS) and in iNOS(119 times lower than nNOS); activity in cytochrome P450 3A4 (1296 times lower than nNOS)<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">nNOS<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td><td class="colsep0 rowsep0" align="left">activity in eNOS (200 times lower than nNOS) and in iNOS (33 times lower than nNOS); activity in cytochrome P450 3A4 (17 times lower than nNOS)<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td><td class="colsep0 rowsep0" align="left">cellular permeability<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></td></tr></tbody></table></div></div><div class="NLM_p"><span class="smallcaps smallerCapital">l</span>-NIL, or <span class="smallcaps smallerCapital">l</span>-N<sup>6</sup>-(<span class="smallcaps smallerCapital">l</span>-iminoethyl)lysine<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> (<b>48</b> in <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), is a compound that effectively reduces kidney dysfunctions associated with I/R in rats.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> It is reportedly an irreversible inhibitor of iNOS with moderate selectivity for iNOS over other isoforms.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> On the other hand, another arginine analogue, GW274150 (<b>49</b> in <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), has demonstrated higher selectivity for human iNOS over the other two isoforms eNOS and nNOS, with 248- and 81-fold higher potency, respectively.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> As with 1400W, the inhibition of iNOS requires the presence of NADPH and proceeds slowly, in contrast with the fast and reversible inhibition of eNOS and nNOS.<a onclick="showRef(event, 'ref191 ref194'); return false;" href="javascript:void(0);" class="ref ref191 ref194">(191,194)</a> GW274150 has shown promise in experimental pathological conditions of collagen-induced arthritis<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> and I/R-related renal dysfunction<a onclick="showRef(event, 'ref194 ref196'); return false;" href="javascript:void(0);" class="ref ref194 ref196">(194,196)</a> and as a neuroprotective agent in rodent PD-models.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> The selectivity for one isoform over the others, together with the reported bioavailability and the absence of toxic effects,<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> makes this compound not only suitable as a research tool but also promising as a therapeutic agent.</div><div class="NLM_p">2-Aminopyridines have also been reported as NOS inhibitors. They interact in the conserved heme-binding pocket<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> and have been the subject of several studies aimed at obtaining isoform-specific compounds.<a onclick="showRef(event, 'ref199 ref200'); return false;" href="javascript:void(0);" class="ref ref199 ref200">(199,200)</a> As a result of these efforts, pyrrolidinomethyl-2-aminopyridines emerged as promising leads.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> Two compounds (<b>50</b> and <b>51</b> in <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>)<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> have been reported as particularly interesting, due to their isoform selectivity for nNOS of 2000- and 2676-fold over eNOS and 293/807-fold over iNOS, but unfortunately, neither was able to pass the blood–brain barrier.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> Another compound (<b>52</b> in <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>)<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> showed <i>in vivo</i> efficacy in rats and cellular permeability. However, it only demonstrated a slight selectivity for iNOS over nNOS (5-fold), while retaining a good selectivity over eNOS (1000-fold). Thanks to further lead-optimization studies, two new compounds with preference for nNOS over the other isoforms have been reported: compound <b>53</b> (selectivity: eNOS = 573, iNOS = 119) and <b>54</b> (selectivity: eNOS = 200, iNOS = 33) (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Notably, both compounds were found to be permeable in Caco-2 cell lines, but data pertaining to blood–brain barrier permeability were not reported. Furthermore, minor off-target activity against cytochrome P450 3A4 was reported. Compound <b>54</b> is 1296-fold selective for nNOS over P450, while for compound <b>53</b> this was only 17-fold.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> Further studies focused on increasing the blood–brain barrier permeability of these compounds are still required. As can be deduced from the cocrystal structure PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V3U">4V3U</a>, compound <b>50</b> appears to interact with a histidine residue in the hydrophilic pocket of the human form one nNOS by the nitrogen of the pyridine ring (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>).<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Cocrystal structure of <b>54</b> in the active site of nNOS (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V3U">4V3U</a>). The α-sheet and β-barrel of the protein are shown in cyan. Active site residues are in gray. H-bonds are displayed as orange dotted lines. Compound <b>54</b> is represented in yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">3.3.  Inhibitors of Ferroptosis</h3><div class="NLM_p">Inhibitors of ferroptosis are reported to act through several modes-of-action. The most common are radical trapping antioxidants (RTAs). These directly block a radical chain reaction, resulting in the inhibition of lipid peroxidation. RTAs, such as hindered secondary amines, react with peroxyl radicals through a fast hydrogen transfer due to weak hydrogen bonds (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>a). The resulting radicals react further with other peroxyl radicals to end as a nonradical species.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> Indirect inhibitors may interfere by depleting iron or by inhibiting acyl-CoA synthetase long-chain family member 4 (ACSL4), the ligase responsible for the synthesis of esterified polyunsaturated fatty acids.<a onclick="showRef(event, 'ref68 ref204'); return false;" href="javascript:void(0);" class="ref ref68 ref204">(68,204)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Mechanism and structures of radical trapping antioxidants. (a) Scavenging of peroxyl radicals by hindered secondary amines; (b) structures of ferroptosis inhibitors that act as RTAs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ferrostatin-1 (<b>55</b> in <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>b and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) has been reported as a ferroptosis inhibitor when the cellular process was first described as a distinctive cell death mechanism by Dixon et al.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Ferrostatin-1 is a scavenger of the alkoxy radicals that are created in the reaction between ferrous iron and lipid hydroperoxides.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> A recently published paper reports a series of ferrostatin-1 analogues with improved solubility, improved ADME (absorption, distribution, metabolism, and excretion) properties, and increased metabolic stability compared to ferrostatin-1 itself. The best compounds of the series, including UAMC-3203 (<b>56</b> in <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>b and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), also showed a significant increase in potency in mice with iron poisoning injuries.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> Another important ferroptosis inhibitor, which was identified in a high-throughput screening campaign, is liproxstatin-1 (<b>57</b> in <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>b and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> This compound is a derivative of spiroquinoxalinamine and acts similarly to ferrostatin-1, as an RTA inhibitor. Liproxstatin-1 was also found to be an antiferroptosis agent active in <i>Gpx4</i> knockout cells and preclinical models of hepatic tissue damage by ischemia/reperfusion.<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Summary of Ferroptosis Inhibitors, Their Mode-of-Action, and Clinical Indications</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">mode-of-action</th><th class="colsep0 rowsep0" align="center">clinical indications</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ferrostatin-1 (<b>55</b>)</td><td class="colsep0 rowsep0" align="left">scavenger (RTA)<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">UAMC-3203 (<b>56</b>)</td><td class="colsep0 rowsep0" align="left">scavenger (RTA)<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a></td><td class="colsep0 rowsep0" align="left">iron poisoning injuries<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liproxstatin-1 (<b>57</b>)</td><td class="colsep0 rowsep0" align="left">scavenger (RTA)<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a></td><td class="colsep0 rowsep0" align="left">ischemia/reperfusion<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phenoxazines (<b>58</b>)</td><td class="colsep0 rowsep0" align="left">scavenger (RTA)<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PHOXNO (<b>59</b>)</td><td class="colsep0 rowsep0" align="left">scavenger (RTA)<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a></td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_p">A recent study reported phenoxazines as a new scaffold with improved properties compared to previously described RTAs (e.g., ferrostatin-1). Phenoxazines (<b>58</b> in <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>a and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) showed increased potency as RTAs, both in solution and in a liposomal formulation, together with a comparable cell-toxicity profile and potency in inhibiting ferroptosis.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> Moreover, phenoxazine-derived nitroxides (PHOXNO, <b>59</b> in <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>a and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) appear to be particularly potent RTAs with a mode-of-action that involves the transfer of an electron from a superoxide radical to form oxygen and an oxoammonium ion, which is then protonated to form a hydroxylamine (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>b). The nitroxide can be reformed through hydrogen transfer to a peroxyl radical, or further reactions with superoxide radicals can lead to the formation of a phenoxazine, which is itself a potent RTA.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> This “cross-dismutation” activity is at the core of its potent biological activity. Due to the relatively recent discovery of ferroptosis and its relevance in several pathologies, we predict that the search for improved RTAs, their clinical application, and agents that target specific protein regulators of ferroptosis will continue in the near future.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structure and activity of phenoxazine-derived ferroptosis inhibitors. (a) Structure of phenoxazine <b>12</b> and phenoxazine-derived nitroxide; (b) suggested mechanism of superoxide and peroxyl radical quenching by PHOXNO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">3.4.  Inhibitors with Other Mechanisms-of-Action</h3><div class="NLM_p">In this section, we describe compounds that have been found to interfere with ROS neither by chemically scavenging ROS directly nor by interacting with one of the ROS production systems described in the sections above. Many, though not all, of these compounds possess unclear modes-of-action, and where relevant, we discourage the readers from using them as tool compounds.</div><div class="NLM_p">A well-reported and still widely used compound as a NOX inhibitor is apocynin (<b>60</b> in <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). The methoxy-substituted catechol (also known as acetovanillone) originates from the roots of <i>Picrorhiza kurroa</i>.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> It has been reported as a NOX inhibitor that impairs the assembly of p47<sup>phox</sup> and p67<sup>phox</sup> required for NOX in phagocytes.<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> More recently, this compound has been reported to act as an antioxidant scavenger in the vascular smooth muscle and endothelial cells<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> as well as an ROS inducer in nonphagocytic cells.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> Therefore, due to the contradictory nature of the data, we do not recommend its use as an ROS scavenger or NOX inhibitor.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of ROS inhibitors with other modes-of-action.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Summary of ROS Inhibitors with Other Mechanisms-of-Action, Their Specific Target(s), and Clinical Indications</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">other activities/specificities</th><th class="colsep0 rowsep0" align="center">clinical indications</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">apocynin (<b>60</b>)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">scavenger<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Shionogi1 (<b>61</b>) and Shionogi2 (<b>62</b>)</td><td class="colsep0 rowsep0" align="left">PKCβII (NOX2)<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">p47<sup>phox</sup> and p22<sup>phox</sup> PPI (NOX2)<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">riboflavin (<b>64</b>)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">modulates reductases, dehydrogenases, oxidases (NOX2)<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a></td><td class="colsep0 rowsep0" align="left">AD<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a></td></tr></tbody></table></div></div><div class="NLM_p">Shionogi 1 and 2 (respectively, <b>61</b> and <b>62</b> in <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>) are reported NOX2 inhibitors that do not interfere with the enzyme in a direct manner.<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> The actual mode-of-action of these compounds is the inhibition of protein kinase Cβ II (PKCβII), which consequently becomes unable to perform its task in p47<sup>phox</sup> translocation.<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> The resulting isoform specificity for NOX2 makes these compounds suitable for specific studies, but it is important to remember that their mechanism-of-action does not involve direct binding and inhibition of NOX2.</div><div class="NLM_p">Another compound that indirectly inhibits NOX2 has recently been reported (<b>63</b>, in <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Compound <b>63</b> is described as a reversible inhibitor of the p47<sup>phox</sup> and p22<sup>phox</sup> protein–protein interaction (PPI), required for the activation of NOX2. The compound has been developed by linking two fragments that have been identified previously during a fragment screening effort to be binders of two different domains of p47<sup>phox</sup>, SH3A and SH3B.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> While this interesting compound still requires further optimization, its mode-of-action provides one of the first examples of a PPI inhibitor that may lower ROS levels, which is a welcome addition to the catalytic site binders reported thus far.</div><div class="NLM_p last">Riboflavin (<b>64</b> in <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>), or vitamin B2, is a water-soluble compound composed of a lumiflavin ring connected to a sugar side chain.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> Its biological role consists of its conversion to flavin mononucleotide (FMN) and FAD, both important cofactors for the function of several oxidases such as NOX2, reductases, and dehydrogenases.<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a> A recent study demonstrated that vitamin B2 performs its antioxidant action by stimulating SOD as well as increasing the expression of Nrf2 in a mouse model of AD.<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a> Despite this, and its widespread use as a nutritional supplement, its pleiotropic effects may make it unsuitable as a tool compound in basic research.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">4.  Conclusion and Outlook</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pathologies driven or characterized by excessive ROS levels are numerous and include cancer, neurodegenerative diseases, cardiovascular diseases, hypertension, and diabetes. As a result, small molecules that are able to reduce ROS levels have been investigated for several decades, leading to a number of interesting findings and the identification of various inhibitors and ROS scavengers. Nonspecific scavengers have largely failed to deliver clinical benefits due to several drawbacks including the induction of reductive stress.<a onclick="showRef(event, 'ref219'); return false;" href="javascript:void(0);" class="ref ref219">(219)</a> This has led to a renewed search for compounds that are able to inhibit the <i>production</i> of ROS specifically. In this context, we summarized the main intracellular ROS production sites and critically evaluated small molecules developed to modulate cellular ROS levels in pathological situations. The major sources of ROS covered include the mitochondria, which can produce ROS from the ETC, as well as MAO, the NOX enzymes, XO, and nitric oxide synthases (NOS).</div><div class="NLM_p">Despite their lack of clinical efficacy, scavengers can still be used as tool compounds, but caution must be exercised when interpreting data resulting from their use. More specific radical scavengers aimed at inhibiting ferroptosis through the trapping of peroxyl radicals have been an active area of recent research, though their clinical utility remains to be determined. One of the major challenges in developing specific inhibitors of ROS production is isoform selectivity. Recent examples of reportedly isoform-selective NOX inhibitors are the NOX1 inhibitor NOS31 (<b>24</b>) as well as GKT771 (<b>20</b>). GSK2795039 (<b>25</b>) appears to target NOX2 with appreciable selectivity over other isoforms and flavoenzymes. CPP11G (<b>26</b>) and CPP11H (<b>28</b>) also show good NOX2 selectivity but poor potency, suggesting that their wider adoption as tools and leads is still a way off. The most advanced NOX inhibitor in clinical trials currently is GKT137831 (<b>19</b>), which targets both NOX2 and NOX4. The most interesting compounds that specifically reduce mitochondrial ROS are the ETC complex I inhibitors S1QELs and the ETC complex III inhibitors S3QELs. Mitochondria-targeted scavengers were initially viewed favorably but have recently been brought into question due to potential nonspecific activity as redox cyclers as well as undesired side-effects. XO inhibitors are already used clinically against gout and hyperuricemia and have shown good toxicity and safety profiles. Nevertheless, the non-purine-like compounds, as febuxostat (<b>45</b>) and topiroxostat (<b>46</b>), are preferred over the purine analogues to avoid off-target effects. Finally, promising compounds have been developed for nNOS, including the pyrrolidinomethyl-2-aminopyridine derivatives (<b>50</b>–<b>54</b>), and others, like GW274150 (<b>49</b>) are described as selective iNOS inhibitors; however, to the best of our knowledge, no selective eNOS inhibitors have been reported to date.</div><div class="NLM_p last">In summary, tool compounds and potential therapeutics against ROS-related pathologies exist; however, finding leads against ROS-producing enzymes has been challenging due to lack of specificity, off-target effects, toxicity, or lack of blood–brain barrier permeability. The latter is particularly relevant in diseases such as NDs. A continued and sustained effort to develop better tools and clinical candidates should eventually enable researchers in the field to determine whether ROS modulation can be used effectively as a therapeutic strategy in selected diseases.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01914" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73062" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73062" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mads H. Clausen</span> - <span class="hlFld-Affiliation affiliation">Center for Nanomedicine and
Theranostics, Department of Chemistry, Technical
University of Denmark, Kemitorvet 207, 2800 Kgs. Lyngby, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9649-1729" title="Orcid link">http://orcid.org/0000-0001-9649-1729</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0865606b48636d6561266c7c7d266c63"><span class="__cf_email__" data-cfemail="8de0e5eecde6e8e0e4a3e9f9f8a3e9e6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luca Laraia</span> - <span class="hlFld-Affiliation affiliation">Center for Nanomedicine and
Theranostics, Department of Chemistry, Technical
University of Denmark, Kemitorvet 207, 2800 Kgs. Lyngby, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6692-3412" title="Orcid link">http://orcid.org/0000-0001-6692-3412</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7e120b1d121f0c3e151b1317501a0a0b501a15"><span class="__cf_email__" data-cfemail="036f76606f62714368666e6a2d6777762d6768">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisa Sassetti</span> - <span class="hlFld-Affiliation affiliation">Center for Nanomedicine and
Theranostics, Department of Chemistry, Technical
University of Denmark, Kemitorvet 207, 2800 Kgs. Lyngby, Denmark</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions from all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45567" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45567" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Elisa Sassetti</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=BIO-d7e3457-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Elisa Sassetti</b> obtained her bachelor degree in Biological Science at the University of Florence and continued her studies at the same university achieving a master degree in Biology. During the master, she performed an internship at the University of Cambridge (Department of Genetics). She worked at Fraunhofer Institute in Hamburg as a researcher, within the Marie Skłodowska-Curie Actions ETN <i>Integrate</i>, and she obtained a PhD in Biochemistry in 2019 from Jacobs University Bremen, working on antibiotic drug discovery. Currently she is a postdoc fellow in the groups of Mads H. Clausen and Luca Laraia at DTU Chemistry. Her research is focused on studying the role of ROS in neurodegenerative diseases by finding new ROS inhibitors.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Mads H. Clausen</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=BIO-d7e3465-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mads H. Clausen</b>, born in 1974, studied chemistry at DTU where he obtained his PhD in 2002 with Professor Robert Madsen. Mads was a postdoctoral fellow at Harvard University from 2002 to 2004 with Professor Andrew Myers, where he worked on the synthesis of enediyne antibiotics. He returned to DTU as an assistant professor and group leader in 2004. In 2014, he became full professor of chemical biology. His research focuses on chemical biology, medicinal chemistry, and library synthesis. The group designs targeted prodrugs for chemotherapy and inflammatory disease, develops methodology to generate libraries of screening compounds, and is engaged in fragment-based drug discovery. The group also has a longstanding interest in carbohydrate chemistry and oligosaccharide synthesis, with applications in plant cell wall research and immuno-oncology.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Luca Laraia</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=BIO-d7e3470-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Luca Laraia</b> studied chemistry at Imperial College London, before moving to the University of Cambridge to carry out his Cancer Research UK-funded PhD in chemical biology with Prof. David R. Spring and Prof. Ashok R. Venkitaraman. After graduating in 2014, he moved to the Max Planck Institute of Molecular Physiology (Dortmund, Germany), first as an Alexander von Humboldt postdoctoral fellow and then as project leader in the chemical biology department with Prof. Herbert Waldmann. He moved to DTU in November 2017 to take up an assistant professorship and is now associate professor in chemical biology. His lab’s research is focused on the synthesis of natural product-inspired compound collections, identification of small-molecule modulators of cholesterol levels and localization, ROS levels and autophagy, as well as chemoproteomic methods for small-molecule target identification and validation.</p></figure></div><div class="ack" id="ACK-d7e3481-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Work in the M.H.C. and L.L. laboratories is supported by the Novo Nordisk Foundation (NNF19OC0055818), the Carlsberg Foundation (CF19-0072), and DTU. L.L. also acknowledges the Independent Research Fund Denmark (9041-00241B and 9041-00248B), the Novo Nordisk Foundation (NNF17OC0028366 and NNF19OC0058183), and the Carlsberg Foundation (CF19-0295) for support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term"><sup>1</sup>O<sub>2</sub></td><td class="NLM_def"><p class="first last">singlet oxygen</p></td></tr><tr><td class="NLM_term">AFMK</td><td class="NLM_def"><p class="first last"><i>N</i>1-acfetyl-<i>N</i>2-formyl-5-methoxykynuramine</p></td></tr><tr><td class="NLM_term">ACO</td><td class="NLM_def"><p class="first last">acyl-CoA</p></td></tr><tr><td class="NLM_term">ACSL4</td><td class="NLM_def"><p class="first last">acyl-CoA synthetase long-chain family member 4</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">AMK</td><td class="NLM_def"><p class="first last"><i>N</i>1-acetyl-5-methoxykynuramine</p></td></tr><tr><td class="NLM_term">AMPK</td><td class="NLM_def"><p class="first last">5′ adenosine monophosphate-activated protein kinase</p></td></tr><tr><td class="NLM_term">AQP</td><td class="NLM_def"><p class="first last">aquaporins</p></td></tr><tr><td class="NLM_term">ARE</td><td class="NLM_def"><p class="first last">antioxidant response element</p></td></tr><tr><td class="NLM_term">ATG4</td><td class="NLM_def"><p class="first last">autophagy-related gene 4</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BH4</td><td class="NLM_def"><p class="first last">(6<i>R</i>)-5,6,7,8-tetrahydro-<span class="smallcaps smallerCapital">l</span>-biopterin</p></td></tr><tr><td class="NLM_term">CeA</td><td class="NLM_def"><p class="first last">central nucleus</p></td></tr><tr><td class="NLM_term">CIC</td><td class="NLM_def"><p class="first last">chloride channels</p></td></tr><tr><td class="NLM_term">CO<sub>2</sub><sup>•</sup></td><td class="NLM_def"><p class="first last">carbon dioxide radicals</p></td></tr><tr><td class="NLM_term">CO<sub>3</sub><sup>•</sup></td><td class="NLM_def"><p class="first last">carbonate</p></td></tr><tr><td class="NLM_term">COVID-19</td><td class="NLM_def"><p class="first last">coronavirus disease 19</p></td></tr><tr><td class="NLM_term">CVD</td><td class="NLM_def"><p class="first last">cardiovascular disease</p></td></tr><tr><td class="NLM_term">DDO</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">DMPO</td><td class="NLM_def"><p class="first last">5,5-dimethyl-1-pyrroline N-oxide</p></td></tr><tr><td class="NLM_term">DPI</td><td class="NLM_def"><p class="first last">diphenyl iodonium</p></td></tr><tr><td class="NLM_term">DUOX</td><td class="NLM_def"><p class="first last">dual oxidase</p></td></tr><tr><td class="NLM_term">DAAO</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">d</span>-amino acid oxidases</p></td></tr><tr><td class="NLM_term">EGF</td><td class="NLM_def"><p class="first last">epidermal growth factor</p></td></tr><tr><td class="NLM_term">eNOS</td><td class="NLM_def"><p class="first last">endothelial nitric oxide synthase</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">Ero1</td><td class="NLM_def"><p class="first last">endoplasmic reticulum oxidoreductin 1</p></td></tr><tr><td class="NLM_term">ETC</td><td class="NLM_def"><p class="first last">mitochondrial electron transport chain</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">flavin adenine dinucleotide</p></td></tr><tr><td class="NLM_term">FGF</td><td class="NLM_def"><p class="first last">fibroblast growth factor</p></td></tr><tr><td class="NLM_term">FMN</td><td class="NLM_def"><p class="first last">flavin mononucleotide</p></td></tr><tr><td class="NLM_term">GPX</td><td class="NLM_def"><p class="first last">glutathione peroxidase</p></td></tr><tr><td class="NLM_term"><i>Gpx4</i></td><td class="NLM_def"><p class="first last">glutathione peroxidase 4</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">reduced tripeptide glutathione or glutathione</p></td></tr><tr><td class="NLM_term">GSSG</td><td class="NLM_def"><p class="first last">glutathione disulfide</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione S-transferase</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>O<sub>2</sub></td><td class="NLM_def"><p class="first last">hydrogen peroxide</p></td></tr><tr><td class="NLM_term">H3R</td><td class="NLM_def"><p class="first last">histamine receptor subtype 3</p></td></tr><tr><td class="NLM_term">HIF-1α</td><td class="NLM_def"><p class="first last">hypoxia-inducible transcription factor</p></td></tr><tr><td class="NLM_term">HO<sub>2</sub><sup>•</sup></td><td class="NLM_def"><p class="first last">hydroperoxyl</p></td></tr><tr><td class="NLM_term">HOBr</td><td class="NLM_def"><p class="first last">hypobromous acid</p></td></tr><tr><td class="NLM_term">HOCl</td><td class="NLM_def"><p class="first last">hypochlorous acid</p></td></tr><tr><td class="NLM_term">HRP</td><td class="NLM_def"><p class="first last">horseradish peroxidase</p></td></tr><tr><td class="NLM_term">I/R</td><td class="NLM_def"><p class="first last">ischemia/reperfusion</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">iNOS</td><td class="NLM_def"><p class="first last">inducible nitric oxide synthase</p></td></tr><tr><td class="NLM_term">Keap1</td><td class="NLM_def"><p class="first last">Kelch-like ECH-associated protein 1</p></td></tr><tr><td class="NLM_term">LC3</td><td class="NLM_def"><p class="first last">microtubule-associated protein 1A/1B light chain 3</p></td></tr><tr><td class="NLM_term"><span class="smallcaps smallerCapital">l</span>-DOPA</td><td class="NLM_def"><p class="first last">levodopa</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">NAC</td><td class="NLM_def"><p class="first last"><i>N</i>-acetyl cysteine</p></td></tr><tr><td class="NLM_term">NAD</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">NDs</td><td class="NLM_def"><p class="first last">neurodegenerative diseases</p></td></tr><tr><td class="NLM_term">NF-Kb</td><td class="NLM_def"><p class="first last">nuclear factor kappa B</p></td></tr><tr><td class="NLM_term">NLRP3</td><td class="NLM_def"><p class="first last">NOD-like receptor family pyrin domain containing 3</p></td></tr><tr><td class="NLM_term">nNOS p8</td><td class="NLM_def"><p class="first last">neuronal nitric oxide synthase</p></td></tr><tr><td class="NLM_term">NO<sup>•</sup></td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">NOS</td><td class="NLM_def"><p class="first last">nitric oxide synthase</p></td></tr><tr><td class="NLM_term">NOX</td><td class="NLM_def"><p class="first last">NADPH oxidases</p></td></tr><tr><td class="NLM_term">Nrf2</td><td class="NLM_def"><p class="first last">nuclear factor erythroid 2-related factor 2</p></td></tr><tr><td class="NLM_term">O<sub>2</sub><sup>•–</sup></td><td class="NLM_def"><p class="first last">superoxide</p></td></tr><tr><td class="NLM_term">OH<sup>•</sup></td><td class="NLM_def"><p class="first last">hydroxyl</p></td></tr><tr><td class="NLM_term">ONOO<sup>–</sup></td><td class="NLM_def"><p class="first last">peroxynitrite</p></td></tr><tr><td class="NLM_term">OXPHOS</td><td class="NLM_def"><p class="first last">oxidative phosphorylation</p></td></tr><tr><td class="NLM_term">PBN</td><td class="NLM_def"><p class="first last">phenyl-tert-<i>N</i>-butyl nitrones</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">PDGF</td><td class="NLM_def"><p class="first last">platelet-derived growth factor</p></td></tr><tr><td class="NLM_term">PDI</td><td class="NLM_def"><p class="first last">protein disulfide isomerase</p></td></tr><tr><td class="NLM_term">PKCβII</td><td class="NLM_def"><p class="first last">protein kinase Cβ II</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">redox</td><td class="NLM_def"><p class="first last">reduction–oxidation</p></td></tr><tr><td class="NLM_term">RNS</td><td class="NLM_def"><p class="first last">reactive nitrogen species</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">RTA</td><td class="NLM_def"><p class="first last">radical trapping antioxidant</p></td></tr><tr><td class="NLM_term">RyR1</td><td class="NLM_def"><p class="first last">ryanodine receptor Ca<sup>2+</sup> channel</p></td></tr><tr><td class="NLM_term">S1R</td><td class="NLM_def"><p class="first last">sigma 1 receptor</p></td></tr><tr><td class="NLM_term">SOD</td><td class="NLM_def"><p class="first last">superoxide dismutase</p></td></tr><tr><td class="NLM_term">TCR</td><td class="NLM_def"><p class="first last">T-cell receptor</p></td></tr><tr><td class="NLM_term">TGFβ</td><td class="NLM_def"><p class="first last">transforming growth factor β</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">TPP</td><td class="NLM_def"><p class="first last">tetraphenylphosphonium cation</p></td></tr><tr><td class="NLM_term">UO</td><td class="NLM_def"><p class="first last">urate oxidase</p></td></tr><tr><td class="NLM_term">XDH</td><td class="NLM_def"><p class="first last">xanthine dehydrogenase</p></td></tr><tr><td class="NLM_term">XO</td><td class="NLM_def"><p class="first last">xanthine oxidase</p></td></tr><tr><td class="NLM_term">XOR</td><td class="NLM_def"><p class="first last">xanthine oxidoreductase</p></td></tr><tr><td class="NLM_term">Δψm</td><td class="NLM_def"><p class="first last">mitochondrial membrane potential</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 219 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halliwell, B.</span>; <span class="NLM_string-name">Gutteridge, J. M. C.</span></span> <i>Free Radicals in Biology and Medicine</i>; <span class="NLM_publisher-name">Oxford University Press</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2015</span>.<span class="refDoi"> DOI: 10.1093/acprof:oso/9780198717478.001.0001</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1093%2Facprof%3Aoso%2F9780198717478.001.0001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+Halliwell&author=J.+M.+C.+Gutteridge&title=Free+Radicals+in+Biology+and+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Facprof%3Aoso%2F9780198717478.001.0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1093%252Facprof%253Aoso%252F9780198717478.001.0001%26sid%3Dliteratum%253Aachs%26aulast%3DHalliwell%26aufirst%3DB.%26btitle%3DFree%2520Radicals%2520in%2520Biology%2520and%2520Medicine%26pub%3DOxford%2520University%2520Press%26date%3D2015%26doi%3D10.1093%2Facprof%3Aoso%2F9780198717478.001.0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ray, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, Y.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species (ROS) Homeostasis and Redox Regulation in Cellular Signaling</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">990</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2012.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cellsig.2012.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22286106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1alu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=981-990&issue=5&author=P.+D.+Rayauthor=B.-W.+Huangauthor=Y.+Tsuji&title=Reactive+Oxygen+Species+%28ROS%29+Homeostasis+and+Redox+Regulation+in+Cellular+Signaling&doi=10.1016%2Fj.cellsig.2012.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling</span></div><div class="casAuthors">Ray, Paul D.; Huang, Bo-Wen; Tsuji, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">981-990</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are generated during mitochondrial oxidative metab. as well as in cellular response to xenobiotics, cytokines, and bacterial invasion.  Oxidative stress refers to the imbalance due to excess ROS or oxidants over the capability of the cell to mount an effective antioxidant response.  Oxidative stress results in macromol. damage and is implicated in various disease states such as atherosclerosis, diabetes, cancer, neurodegeneration, and aging.  Paradoxically, accumulating evidence indicates that ROS also serve as crit. signaling mols. in cell proliferation and survival.  While there is a large body of research demonstrating the general effect of oxidative stress on signaling pathways, less is known about the initial and direct regulation of signaling mols. by ROS, or what we term the "oxidative interface.  " Cellular ROS sensing and metab. are tightly regulated by a variety of proteins involved in the redox (redn./oxidn.) mechanism.  This review focuses on the mol. mechanisms through which ROS directly interact with crit. signaling mols. to initiate signaling in a broad variety of cellular processes, such as proliferation and survival (MAP kinases, PI3 kinase, PTEN, and protein tyrosine phosphatases), ROS homeostasis and antioxidant gene regulation (thioredoxin, peroxiredoxin, Ref-1, and Nrf-2), mitochondrial oxidative stress, apoptosis, and aging (p66Shc), iron homeostasis through iron-sulfur cluster proteins (IRE-IRP), and ATM-regulated DNA damage response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUbrGINEaS57Vg90H21EOLACvtfcHk0lgiBcCLLQZUKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1alu70%253D&md5=955f09c6b25d37d5548711a716902ddb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2012.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2012.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DRay%26aufirst%3DP.%2BD.%26aulast%3DHuang%26aufirst%3DB.-W.%26aulast%3DTsuji%26aufirst%3DY.%26atitle%3DReactive%2520Oxygen%2520Species%2520%2528ROS%2529%2520Homeostasis%2520and%2520Redox%2520Regulation%2520in%2520Cellular%2520Signaling%26jtitle%3DCell.%2520Signalling%26date%3D2012%26volume%3D24%26issue%3D5%26spage%3D981%26epage%3D990%26doi%3D10.1016%2Fj.cellsig.2012.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brieger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiavone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, F. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, K.-H.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species: From Health to Disease</span>. <i>Swiss Med. Wkly.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.4414/smw.2012.13659</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.4414%2Fsmw.2012.13659" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=1-14&author=K.+Briegerauthor=S.+Schiavoneauthor=F.+J.+Millerauthor=K.-H.+Krause&title=Reactive+Oxygen+Species%3A+From+Health+to+Disease&doi=10.4414%2Fsmw.2012.13659"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4414%2Fsmw.2012.13659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4414%252Fsmw.2012.13659%26sid%3Dliteratum%253Aachs%26aulast%3DBrieger%26aufirst%3DK.%26aulast%3DSchiavone%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DF.%2BJ.%26aulast%3DKrause%26aufirst%3DK.-H.%26atitle%3DReactive%2520Oxygen%2520Species%253A%2520From%2520Health%2520to%2520Disease%26jtitle%3DSwiss%2520Med.%2520Wkly.%26date%3D2012%26volume%3D142%26spage%3D1%26epage%3D14%26doi%3D10.4414%2Fsmw.2012.13659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mauch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Gorman, M. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zychlinsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oelschlägel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rösen-Wolff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesler, J.</span></span> <span> </span><span class="NLM_article-title">Chronic Granulomatous Disease (CGD) and Complete Myeloperoxidase Deficiency Both Yield Strongly Reduced Dihydrorhodamine 123 Test Signals but Can Be Easily Discerned in Routine Testing for CGD</span>. <i>Clin. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">896</span>, <span class="refDoi"> DOI: 10.1373/clinchem.2006.083444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1373%2Fclinchem.2006.083444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=17384005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFyqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2007&pages=890-896&issue=5&author=L.+Mauchauthor=A.+Lunauthor=M.+R.+G.+O%E2%80%99Gormanauthor=J.+S.+Harrisauthor=I.+Schulzeauthor=A.+Zychlinskyauthor=T.+Fuchsauthor=U.+Oelschl%C3%A4gelauthor=S.+Brennerauthor=D.+Kutterauthor=A.+R%C3%B6sen-Wolffauthor=J.+Roesler&title=Chronic+Granulomatous+Disease+%28CGD%29+and+Complete+Myeloperoxidase+Deficiency+Both+Yield+Strongly+Reduced+Dihydrorhodamine+123+Test+Signals+but+Can+Be+Easily+Discerned+in+Routine+Testing+for+CGD&doi=10.1373%2Fclinchem.2006.083444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD</span></div><div class="casAuthors">Mauch, Lysann; Lun, Andreas; O'Gorman, Maurice R. G.; Harris, John S.; Schulze, Ilka; Zychlinsky, Arturo; Fuchs, Tobias; Oelschlaegel, Uta; Brenner, Sebastian; Kutter, Dolphe; Roesen-Wolff, Angela; Roesler, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">890-896</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">The flow cytometric dihydrorhodamine 123 (DHR) assay is used as a screening test for chronic granulomatous disease (CGD), but complete myeloperoxidase (MPO) deficiency can also lead to a strongly decreased DHR signal.  The authors' aim was to devise simple lab. methods to differentiate MPO deficiency (false pos. for CGD) and NADPH oxidase abnormalities (true CGD).  The authors measured NADPH-oxidase and MPO activity in neutrophils from MPO-deficient patients, CGD patients, NADPH-oxidase-transfected K562 cells and cells with inhibited and substituted MPO.  Eosinophils from MPO-deficient individuals retain eosinophilic peroxidase and therefore generate a normal DHR signal.  The addn. of recombinant human MPO enhances the DHR signal when simply added to a suspension of MPO-deficient cells but not when added to NADPH-oxidase-deficient (CGD) cells.  Lucigenin-enhanced chemiluminescence (LCL) is increased in neutrophils from MPO-deficient patients, whereas neutrophils from patients with CGD show a decreased response.  A false-pos. result caused by MPO deficiency can be easily ascertained because, unlike cells from a CGD patient, cells from MPO-deficient patients (a) contain functionally normal eosinophils, (b) show a significant enhancement of the DHR signal following addn. of rhMPO, and (c) generate a strong LCL signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS2HaXZOA_jbVg90H21EOLACvtfcHk0lhVHy5fKBhLvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFyqtrc%253D&md5=23d61cc7d4317f0d2bee2e72cb7859cd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2006.083444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2006.083444%26sid%3Dliteratum%253Aachs%26aulast%3DMauch%26aufirst%3DL.%26aulast%3DLun%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Gorman%26aufirst%3DM.%2BR.%2BG.%26aulast%3DHarris%26aufirst%3DJ.%2BS.%26aulast%3DSchulze%26aufirst%3DI.%26aulast%3DZychlinsky%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DT.%26aulast%3DOelschl%25C3%25A4gel%26aufirst%3DU.%26aulast%3DBrenner%26aufirst%3DS.%26aulast%3DKutter%26aufirst%3DD.%26aulast%3DR%25C3%25B6sen-Wolff%26aufirst%3DA.%26aulast%3DRoesler%26aufirst%3DJ.%26atitle%3DChronic%2520Granulomatous%2520Disease%2520%2528CGD%2529%2520and%2520Complete%2520Myeloperoxidase%2520Deficiency%2520Both%2520Yield%2520Strongly%2520Reduced%2520Dihydrorhodamine%2520123%2520Test%2520Signals%2520but%2520Can%2520Be%2520Easily%2520Discerned%2520in%2520Routine%2520Testing%2520for%2520CGD%26jtitle%3DClin.%2520Chem.%26date%3D2007%26volume%3D53%26issue%3D5%26spage%3D890%26epage%3D896%26doi%3D10.1373%2Fclinchem.2006.083444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordgren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apanasets, O.</span></span> <span> </span><span class="NLM_article-title">Role of Peroxisomes in ROS/RNS-Metabolism: Implications for Human Disease</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1822</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1373</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2011.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.bbadis.2011.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOqt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1822&publication_year=2012&pages=1363-1373&issue=9&author=M.+Fransenauthor=M.+Nordgrenauthor=B.+Wangauthor=O.+Apanasets&title=Role+of+Peroxisomes+in+ROS%2FRNS-Metabolism%3A+Implications+for+Human+Disease&doi=10.1016%2Fj.bbadis.2011.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Role of peroxisomes in ROS/RNS-metabolism: Implications for human disease</span></div><div class="casAuthors">Fransen, Marc; Nordgren, Marcus; Wang, Bo; Apanasets, Oksana</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1822</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1363-1373</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Peroxisomes are cell organelles that play a central role in lipid metab.  At the same time, these organelles generate reactive oxygen and nitrogen species as byproducts.  Peroxisomes also possess intricate protective mechanisms to counteract oxidative stress and maintain redox balance.  An imbalance between peroxisomal reactive oxygen species/reactive nitrogen species prodn. and removal may possibly damage biomols., perturb cellular thiol levels, and deregulate cellular signaling pathways implicated in a variety of human diseases.  Somewhat surprisingly, the potential role of peroxisomes in cellular redox metab. has been underestimated for a long time.  However, in recent years, peroxisomal reactive oxygen species/reactive nitrogen species metab. and signaling have become the focus of a rapidly evolving and multidisciplinary research field with great prospects.  This review is mainly devoted to discuss evidence supporting the notion that peroxisomal metab. and oxidative stress are intimately interconnected and assocd. with age-related diseases.  We focus on several key aspects of how peroxisomes contribute to cellular reactive oxygen species/reactive nitrogen species levels in mammalian cells and how these cells cope with peroxisome-derived oxidative stress.  We also provide a brief overview of recent strategies that have been successfully employed to detect and modulate the peroxisomal redox status.  Finally, we highlight some gaps in our knowledge and propose potential avenues for further research.  This article is part of a Special Issue entitled: Metabolic Functions and Biogenesis of peroxisomes in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALzBYCdGlObVg90H21EOLACvtfcHk0lhVHy5fKBhLvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOqt7rJ&md5=8bedcd893e452de42037078173b68b6c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2011.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2011.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DFransen%26aufirst%3DM.%26aulast%3DNordgren%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DApanasets%26aufirst%3DO.%26atitle%3DRole%2520of%2520Peroxisomes%2520in%2520ROS%252FRNS-Metabolism%253A%2520Implications%2520for%2520Human%2520Disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2012%26volume%3D1822%26issue%3D9%26spage%3D1363%26epage%3D1373%26doi%3D10.1016%2Fj.bbadis.2011.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schieber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">ROS Function in Redox Signaling and Oxidative Stress</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">R453</span>– <span class="NLM_lpage">R462</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2014.03.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cub.2014.03.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24845678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVWktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=R453-R462&issue=10&author=M.+Schieberauthor=N.+S.+Chandel&title=ROS+Function+in+Redox+Signaling+and+Oxidative+Stress&doi=10.1016%2Fj.cub.2014.03.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">ROS Function in Redox Signaling and Oxidative Stress</span></div><div class="casAuthors">Schieber, Michael; Chandel, Navdeep S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">R453-R462</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Oxidative stress refers to elevated intracellular levels of reactive oxygen species (ROS) that cause damage to lipids, proteins and DNA.  Oxidative stress has been linked to a myriad of pathologies.  However, elevated ROS also act as signaling mols. in the maintenance of physiol. functions - a process termed redox biol.  In this review we discuss the two faces of ROS - redox biol. and oxidative stress - and their contribution to both physiol. and pathol. conditions.  Redox biol. involves a small increase in ROS levels that activates signaling pathways to initiate biol. processes, while oxidative stress denotes high levels of ROS that result in damage to DNA, protein or lipids.  Thus, the response to ROS displays hormesis, given that the opposite effect is obsd. at low levels compared with that seen at high levels.  Here, we argue that redox biol., rather than oxidative stress, underlies physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQKHDL4BvUHLVg90H21EOLACvtfcHk0lg84Uj56seGbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVWktL4%253D&md5=04979c81b50c4aefc5d19152d832febc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2014.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2014.03.034%26sid%3Dliteratum%253Aachs%26aulast%3DSchieber%26aufirst%3DM.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DROS%2520Function%2520in%2520Redox%2520Signaling%2520and%2520Oxidative%2520Stress%26jtitle%3DCurr.%2520Biol.%26date%3D2014%26volume%3D24%26issue%3D10%26spage%3DR453%26epage%3DR462%26doi%3D10.1016%2Fj.cub.2014.03.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mittler, R.</span></span> <span> </span><span class="NLM_article-title">ROS Are Good</span>. <i>Trends Plant Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.tplants.2016.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.tplants.2016.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27666517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKru7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=11-19&issue=1&author=R.+Mittler&title=ROS+Are+Good&doi=10.1016%2Fj.tplants.2016.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">ROS Are Good</span></div><div class="casAuthors">Mittler, Ron</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Plant Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-19</span>CODEN:
                <span class="NLM_cas:coden">TPSCF9</span>;
        ISSN:<span class="NLM_cas:issn">1360-1385</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are thought to play a dual role in plant biol.  They are required for many important signaling reactions, but are also toxic byproducts of aerobic metab.  Recent studies revealed that ROS are necessary for the progression of several basic biol. processes including cellular proliferation and differentiation.  Moreover, cell death-that was previously thought to be the outcome of ROS directly killing cells by oxidn., in other words via oxidative stress-is now considered to be the result of ROS triggering a physiol. or programmed pathway for cell death.  This Opinion focuses on the possibility that ROS are beneficial to plants, supporting cellular proliferation, physiol. function, and viability, and that maintaining a basal level of ROS in cells is essential for life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVUKReyEz3IrVg90H21EOLACvtfcHk0lg84Uj56seGbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKru7nF&md5=f857bb204a4f7876206ed99ffb46ed95</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tplants.2016.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tplants.2016.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DMittler%26aufirst%3DR.%26atitle%3DROS%2520Are%2520Good%26jtitle%3DTrends%2520Plant%2520Sci.%26date%3D2017%26volume%3D22%26issue%3D1%26spage%3D11%26epage%3D19%26doi%3D10.1016%2Fj.tplants.2016.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhie, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S.</span></span> <span> </span><span class="NLM_article-title">The Role of Oxidative Stress in Neurodegenerative Diseases</span>. <i>Exp. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.5607/en.2015.24.4.325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.5607%2Fen.2015.24.4.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26713080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC28rls12hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=325-340&issue=4&author=G.+H.+Kimauthor=J.+E.+Kimauthor=S.+J.+Rhieauthor=S.+Yoon&title=The+Role+of+Oxidative+Stress+in+Neurodegenerative+Diseases&doi=10.5607%2Fen.2015.24.4.325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Oxidative Stress in Neurodegenerative Diseases</span></div><div class="casAuthors">Kim Geon Ha; Kim Jieun E; Rhie Sandy Jeong; Yoon Sujung</div><div class="citationInfo"><span class="NLM_cas:title">Experimental neurobiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">325-40</span>
        ISSN:<span class="NLM_cas:issn">1226-2560</span>.
    </div><div class="casAbstract">Oxidative stress is induced by an imbalanced redox states, involving either excessive generation of reactive oxygen species (ROS) or dysfunction of the antioxidant system.  The brain is one of organs especially vulnerable to the effects of ROS because of its high oxygen demand and its abundance of peroxidation-susceptible lipid cells.  Previous studies have demonstrated that oxidative stress plays a central role in a common pathophysiology of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.  Antioxidant therapy has been suggested for the prevention and treatment of neurodegenerative diseases, although the results with regard to their efficacy of treating neurodegenerative disease have been inconsistent.  In this review, we will discuss the role of oxidative stress in the pathophysiology of neurodegenerative diseases and in vivo measurement of an index of damage by oxidative stress.  Moreover, the present knowledge on antioxidant in the treatment of neurodegenerative diseases and future directions will be outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrttl-His737JzI8owOhpDfW6udTcc2ea_bzoWGqLxqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rls12hsw%253D%253D&md5=0bab8c703855f561b023730c2c4d9447</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.5607%2Fen.2015.24.4.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5607%252Fen.2015.24.4.325%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DG.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DRhie%26aufirst%3DS.%2BJ.%26aulast%3DYoon%26aufirst%3DS.%26atitle%3DThe%2520Role%2520of%2520Oxidative%2520Stress%2520in%2520Neurodegenerative%2520Diseases%26jtitle%3DExp.%2520Neurobiol.%26date%3D2015%26volume%3D24%26issue%3D4%26spage%3D325%26epage%3D340%26doi%3D10.5607%2Fen.2015.24.4.325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayyan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashim, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">AlNashef, I. M.</span></span> <span> </span><span class="NLM_article-title">Superoxide Ion : Generation and Chemical Implications</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">3029</span>– <span class="NLM_lpage">3085</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVGqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=3029-3085&author=M.+Hayyanauthor=M.+A.+Hashimauthor=I.+M.+AlNashef&title=Superoxide+Ion%E2%80%AF%3A+Generation+and+Chemical+Implications&doi=10.1021%2Facs.chemrev.5b00407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Superoxide Ion: Generation and Chemical Implications</span></div><div class="casAuthors">Hayyan, Maan; Hashim, Mohd Ali; AlNashef, Inas M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3029-3085</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Superoxide ion (O2•-) is of great significance as a radical species implicated in diverse chem. and biol. systems.  However, the chem. knowledge of O2•- is rather scarce.  In addn., numerous studies on O2•- were conducted within the latter half of the 20th century.  Therefore, the current advancement in technol. and instrumentation will certainly provide better insights into mechanisms and products of O2•- reactions and thus will result in new findings.  This review emphasizes the state-of-the-art research on O2•- so as to enable researchers to venture into future research.  It comprises the main characteristics of O2•- followed by generation methods.  The reaction types of O2•- are reviewed, and its potential applications including the destruction of hazardous chems., synthesis of org. compds., and many other applications are highlighted.  The O2•- environmental chem. is also discussed.  The detection methods of O2•- are categorized and elaborated.  Special attention is given to the feasibility of using ionic liqs. as media for O2•-, addressing the latest progress of generation and applications.  The effect of electrodes on the O2•- electrochem. generation is reviewed.  Finally, some remarks and future perspectives are concluded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_icrPI8mpLVg90H21EOLACvtfcHk0lh4dxaK7HHC9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVGqsrw%253D&md5=ad9278a28e8776ce6b2fcb40c062c70c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00407%26sid%3Dliteratum%253Aachs%26aulast%3DHayyan%26aufirst%3DM.%26aulast%3DHashim%26aufirst%3DM.%2BA.%26aulast%3DAlNashef%26aufirst%3DI.%2BM.%26atitle%3DSuperoxide%2520Ion%25E2%2580%25AF%253A%2520Generation%2520and%2520Chemical%2520Implications%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D3029%26epage%3D3085%26doi%3D10.1021%2Facs.chemrev.5b00407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zorov, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juhaszova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollott, S. J.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">950</span>, <span class="refDoi"> DOI: 10.1152/physrev.00026.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1152%2Fphysrev.00026.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24987008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtl2qurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2014&pages=909-950&issue=3&author=D.+B.+Zorovauthor=M.+Juhaszovaauthor=S.+J.+Sollott&title=Mitochondrial+Reactive+Oxygen+Species+%28ROS%29+and+ROS-Induced+ROS+Release&doi=10.1152%2Fphysrev.00026.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release</span></div><div class="casAuthors">Zorov, Dmitry B.; Juhaszova, Magdalena; Sollott, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">909-950</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Byproducts of normal mitochondrial metab. and homeostasis include the buildup of potentially damaging levels of reactive oxygen species (ROS), Ca2+, etc., which must be normalized.  Evidence suggests that brief mitochondrial permeability transition pore (mPTP) openings play an important physiol. role maintaining healthy mitochondria homeostasis.  Adaptive and maladaptive responses to redox stress may involve mitochondrial channels such as mPTP and inner membrane anion channel (IMAC).  Their activation causes intra- and intermitochondrial redox-environment changes leading to ROS release.  This regenerative cycle of mitochondrial ROS formation and release was named ROS-induced ROS release (RIRR).  Brief, reversible mPTP opening-assocd. ROS release apparently constitutes an adaptive housekeeping function by the timely release from mitochondria of accumulated potentially toxic levels of ROS (and Ca2+).  At higher ROS levels, longer mPTP openings may release a ROS burst leading to destruction of mitochondria, and if propagated from mitochondrion to mitochondrion, of the cell itself.  The destructive function of RIRR may serve a physiol. role by removal of unwanted cells or damaged mitochondria, or cause the pathol. elimination of vital and essential mitochondria and cells.  The adaptive release of sufficient ROS into the vicinity of mitochondria may also activate local pools of redox-sensitive enzymes involved in protective signaling pathways that limit ischemic damage to mitochondria and cells in that area.  Maladaptive mPTP- or IMAC-related RIRR may also be playing a role in aging.  Because the mechanism of mitochondrial RIRR highlights the central role of mitochondria-formed ROS, we discuss all of the known ROS-producing sites (shown in vitro) and their relevance to the mitochondrial ROS prodn. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopLjJhfOUWnrVg90H21EOLACvtfcHk0lgcH085G89ECA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtl2qurbL&md5=78757beddebdedbf4d131a338ebd0d76</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00026.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00026.2013%26sid%3Dliteratum%253Aachs%26aulast%3DZorov%26aufirst%3DD.%2BB.%26aulast%3DJuhaszova%26aufirst%3DM.%26aulast%3DSollott%26aufirst%3DS.%2BJ.%26atitle%3DMitochondrial%2520Reactive%2520Oxygen%2520Species%2520%2528ROS%2529%2520and%2520ROS-Induced%2520ROS%2520Release%26jtitle%3DPhysiol.%2520Rev.%26date%3D2014%26volume%3D94%26issue%3D3%26spage%3D909%26epage%3D950%26doi%3D10.1152%2Fphysrev.00026.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, M. N.</span></span> <span> </span><span class="NLM_article-title">Chemistry of Nitric Oxide and Related Species</span>. In  <i>Methods in Enzymology. Globins and Other Nitric Oxide-Reactive Proteins, Part A</i>; <span class="NLM_publisher-name">Elsevier Inc.</span>: <span class="NLM_publisher-loc">San Diego</span>, <span class="NLM_year">2008</span>; Vol.  <span class="NLM_volume">436</span>, pp  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">19</span>.<span class="refDoi"> DOI: 10.1016/S0076-6879(08)36001-7</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2FS0076-6879%2808%2936001-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=3-19&author=M.+N.+Hughes&title=Methods+in+Enzymology.+Globins+and+Other+Nitric+Oxide-Reactive+Proteins%2C+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2808%2936001-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252808%252936001-7%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DM.%2BN.%26atitle%3DChemistry%2520of%2520Nitric%2520Oxide%2520and%2520Related%2520Species%26btitle%3DMethods%2520in%2520Enzymology.%2520Globins%2520and%2520Other%2520Nitric%2520Oxide-Reactive%2520Proteins%252C%2520Part%2520A%26pub%3DElsevier%2520Inc%26date%3D2008%26volume%3D436%26spage%3D3%26epage%3D19%26doi%3D10.1016%2FS0076-6879%2808%2936001-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muntean, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dǎnilǎ, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duicu, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mornoş, C.</span></span> <span> </span><span class="NLM_article-title">The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1155/2016/8254942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2016%2F8254942" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1&author=D.+M.+Munteanauthor=A.+Sturzaauthor=M.+D.+D%C7%8Enil%C7%8Eauthor=C.+Borzaauthor=O.+M.+Duicuauthor=C.+Morno%C5%9F&title=The+Role+of+Mitochondrial+Reactive+Oxygen+Species+in+Cardiovascular+Injury+and+Protective+Strategies&doi=10.1155%2F2016%2F8254942"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1155%2F2016%2F8254942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F8254942%26sid%3Dliteratum%253Aachs%26aulast%3DMuntean%26aufirst%3DD.%2BM.%26aulast%3DSturza%26aufirst%3DA.%26aulast%3DD%25C7%258Enil%25C7%258E%26aufirst%3DM.%2BD.%26aulast%3DBorza%26aufirst%3DC.%26aulast%3DDuicu%26aufirst%3DO.%2BM.%26aulast%3DMorno%25C5%259F%26aufirst%3DC.%26atitle%3DThe%2520Role%2520of%2520Mitochondrial%2520Reactive%2520Oxygen%2520Species%2520in%2520Cardiovascular%2520Injury%2520and%2520Protective%2520Strategies%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2016%26volume%3D2016%26spage%3D1%26doi%3D10.1155%2F2016%2F8254942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. F.</span></span> <span> </span><span class="NLM_article-title">Targeting Mitochondrial Reactive Oxygen Species as Novel Therapy for Inflammatory Diseases and Cancers</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">19</span>, <span class="refDoi"> DOI: 10.1186/1756-8722-6-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1186%2F1756-8722-6-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=23442817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=19&issue=1&author=X.+Liauthor=P.+Fangauthor=J.+Maiauthor=E.+T.+Choiauthor=H.+Wangauthor=X.+F.+Yang&title=Targeting+Mitochondrial+Reactive+Oxygen+Species+as+Novel+Therapy+for+Inflammatory+Diseases+and+Cancers&doi=10.1186%2F1756-8722-6-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span></div><div class="casAuthors">Li, Xinyuan; Fang, Pu; Mai, Jietang; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  There are multiple sources of reactive oxygen species (ROS) in the cell.  As a major site of ROS prodn., mitochondria have drawn considerable interest because it was recently discovered that mitochondrial ROS (mtROS) directly stimulate the prodn. of proinflammatory cytokines and pathol. conditions as diverse as malignancies, autoimmune diseases, and cardiovascular diseases all share common phenotype of increased mtROS prodn. above basal levels.  Several excellent reviews on this topic have been published, but ever-changing new discoveries mandated a more up-to-date and comprehensive review on this topic.  Therefore, we update recent understanding of how mitochondria generate and regulate the prodn. of mtROS and the function of mtROS both in physiol. and pathol. conditions.  In addn., we describe newly developed methods to probe or scavenge mtROS and compare these methods in detail.  Thorough understanding of this topic and the application of mtROS-targeting drugs in the research is significant towards development of better therapies to combat inflammatory diseases and inflammatory malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdw7mjnRfUbVg90H21EOLACvtfcHk0lgP4f-ufmXaJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D&md5=d041a496a1ede846460023f0cc54885a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-19%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DE.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%2BF.%26atitle%3DTargeting%2520Mitochondrial%2520Reactive%2520Oxygen%2520Species%2520as%2520Novel%2520Therapy%2520for%2520Inflammatory%2520Diseases%2520and%2520Cancers%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26issue%3D1%26spage%3D19%26doi%3D10.1186%2F1756-8722-6-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, K.-H.</span></span> <span> </span><span class="NLM_article-title">The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1152/physrev.00044.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1152%2Fphysrev.00044.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=17237347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVagsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2007&pages=245-313&author=K.+Bedardauthor=K.-H.+Krause&title=The+NOX+Family+of+ROS-Generating+NADPH+Oxidases%3A+Physiology+and+Pathophysiology&doi=10.1152%2Fphysrev.00044.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology</span></div><div class="casAuthors">Bedard, Karen; Krause, Karl-Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">245-313</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  For a long time, superoxide generation by an NADPH oxidase was considered as an oddity only found in professional phagocytes.  Over the last years, six homologs of the cytochrome subunit of the phagocyte NADPH oxidase were found: NOX1, NOX3, NOX4, NOX5, DUOX1, and DUOX2.  Together with the phagocyte NADPH oxidase itself (NOX2/gp91phox), the homologs are now referred to as the NOX family of NADPH oxidases.  These enzymes share the capacity to transport electrons across the plasma membrane and to generate superoxide and other downstream reactive oxygen species (ROS).  Activation mechanisms and tissue distribution of the different members of the family are markedly different.  The physiol. functions of NOX family enzymes include host defense, posttranslational processing of proteins, cellular signaling, regulation of gene expression, and cell differentiation.  NOX enzymes also contribute to a wide range of pathol. processes.  NOX deficiency may lead to immunosuppression, lack of otoconogenesis, or hypothyroidism.  Increased NOX activity also contributes to a large no. or pathologies, in particular cardiovascular diseases and neurodegeneration.  This review summarizes the current state of knowledge of the functions of NOX enzymes in physiol. and pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotquVpFu29UrVg90H21EOLACvtfcHk0lgiAZJDReuGOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVagsr4%253D&md5=515b5e86696b85d933b8226f4fe6ce59</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00044.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00044.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBedard%26aufirst%3DK.%26aulast%3DKrause%26aufirst%3DK.-H.%26atitle%3DThe%2520NOX%2520Family%2520of%2520ROS-Generating%2520NADPH%2520Oxidases%253A%2520Physiology%2520and%2520Pathophysiology%26jtitle%3DPhysiol.%2520Rev.%26date%3D2007%26volume%3D87%26spage%3D245%26epage%3D313%26doi%3D10.1152%2Fphysrev.00044.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panday, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osorio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidases: An Overview from Structure to Innate Immunity-Associated Pathologies</span>. <i>Cell. Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1038/cmi.2014.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fcmi.2014.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=25263488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFKksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=5-23&author=A.+Pandayauthor=M.+K.+Sahooauthor=D.+Osorioauthor=S.+Batra&title=NADPH+Oxidases%3A+An+Overview+from+Structure+to+Innate+Immunity-Associated+Pathologies&doi=10.1038%2Fcmi.2014.89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH oxidases: an overview from structure to innate immunity-associated pathologies</span></div><div class="casAuthors">Panday, Arvind; Sahoo, Malaya K.; Osorio, Diana; Batra, Sanjay</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-23</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">A review.  Oxygen-derived free radicals, collectively termed reactive oxygen species (ROS), play important roles in immunity, cell growth, and cell signaling.  In excess, however, ROS are lethal to cells, and the overprodn. of these mols. leads to a myriad of devastating diseases.  The key producers of ROS in many cells are the NOX family of NADPH oxidases, of which there are seven members, with various tissue distributions and activation mechanisms.  NADPH oxidase is a multisubunit enzyme comprising membrane and cytosolic components, which actively communicate during the host responses to a wide variety of stimuli, including viral and bacterial infections.  This enzymic complex has been implicated in many functions ranging from host defense to cellular signaling and the regulation of gene expression.  NOX deficiency might lead to immunosuppression, while the intracellular accumulation of ROS results in the inhibition of viral propagation and apoptosis.  However, excess ROS prodn. causes cellular stress, leading to various lethal diseases, including autoimmune diseases and cancer.  During the later stages of injury, NOX promotes tissue repair through the induction of angiogenesis and cell proliferation.  Therefore, a complete understanding of the function of NOX is important to direct the role of this enzyme towards host defense and tissue repair or increase resistance to stress in a timely and disease-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovoR8UTxBXK7Vg90H21EOLACvtfcHk0lgiAZJDReuGOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFKksg%253D%253D&md5=d0fad1541df4f25ca279394c210e5442</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fcmi.2014.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcmi.2014.89%26sid%3Dliteratum%253Aachs%26aulast%3DPanday%26aufirst%3DA.%26aulast%3DSahoo%26aufirst%3DM.%2BK.%26aulast%3DOsorio%26aufirst%3DD.%26aulast%3DBatra%26aufirst%3DS.%26atitle%3DNADPH%2520Oxidases%253A%2520An%2520Overview%2520from%2520Structure%2520to%2520Innate%2520Immunity-Associated%2520Pathologies%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2015%26volume%3D12%26spage%3D5%26epage%3D23%26doi%3D10.1038%2Fcmi.2014.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forrester, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandes, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griendling, K. K.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in Metabolic and Inflammatory Signaling</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">902</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.117.311401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1161%2FCIRCRESAHA.117.311401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29700084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksFWlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2018&pages=877-902&issue=6&author=S.+J.+Forresterauthor=D.+S.+Kikuchiauthor=M.+S.+Hernandesauthor=Q.+Xuauthor=K.+K.+Griendling&title=Reactive+Oxygen+Species+in+Metabolic+and+Inflammatory+Signaling&doi=10.1161%2FCIRCRESAHA.117.311401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species in Metabolic and Inflammatory Signaling</span></div><div class="casAuthors">Forrester, Steven J.; Kikuchi, Daniel S.; Hernandes, Marina S.; Xu, Qian; Griendling, Kathy K.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">877-902</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are well known for their role in mediating both physiol. and pathophysiol. signal transduction.  Enzymes and subcellular compartments that typically produce ROS are assocd. with metabolic regulation, and diseases assocd. with metabolic dysfunction may be influenced by changes in redox balance.  In this review, we summarize the current literature surrounding ROS and their role in metabolic and inflammatory regulation, focusing on ROS signal transduction and its relationship to disease progression.  In particular, we examine ROS prodn. in compartments such as the cytoplasm, mitochondria, peroxisome, and endoplasmic reticulum and discuss how ROS influence metabolic processes such as proteasome function, autophagy, and general inflammatory signaling.  We also summarize and highlight the role of ROS in the regulation metabolic/inflammatory diseases including atherosclerosis, diabetes mellitus, and stroke.  In order to develop therapies that target oxidative signaling, it is vital to understand the balance ROS signaling plays in both physiol. and pathophysiol., and how manipulation of this balance and the identity of the ROS may influence cellular and tissue homeostasis.  An increased understanding of specific sources of ROS prodn. and an appreciation for how ROS influence cellular metab. may help guide us in the effort to treat cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoohVEWPXhla7Vg90H21EOLACvtfcHk0liewbW16fnYCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksFWlsbg%253D&md5=c12d63316b8720b61ccc7d841725a798</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.117.311401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.117.311401%26sid%3Dliteratum%253Aachs%26aulast%3DForrester%26aufirst%3DS.%2BJ.%26aulast%3DKikuchi%26aufirst%3DD.%2BS.%26aulast%3DHernandes%26aufirst%3DM.%2BS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DGriendling%26aufirst%3DK.%2BK.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520Metabolic%2520and%2520Inflammatory%2520Signaling%26jtitle%3DCirc.%2520Res.%26date%3D2018%26volume%3D122%26issue%3D6%26spage%3D877%26epage%3D902%26doi%3D10.1161%2FCIRCRESAHA.117.311401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maggiorani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mialet-Perez, J.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidases, Oxidative Stress, and Altered Mitochondrial Dynamics in Cardiac Ageing</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1155/2017/3017947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2017%2F3017947" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1-8&author=D.+Maggioraniauthor=N.+Manzellaauthor=D.+E.+Edmondsonauthor=A.+Matteviauthor=A.+Pariniauthor=C.+Bindaauthor=J.+Mialet-Perez&title=Monoamine+Oxidases%2C+Oxidative+Stress%2C+and+Altered+Mitochondrial+Dynamics+in+Cardiac+Ageing&doi=10.1155%2F2017%2F3017947"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1155%2F2017%2F3017947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F3017947%26sid%3Dliteratum%253Aachs%26aulast%3DMaggiorani%26aufirst%3DD.%26aulast%3DManzella%26aufirst%3DN.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DParini%26aufirst%3DA.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DMialet-Perez%26aufirst%3DJ.%26atitle%3DMonoamine%2520Oxidases%252C%2520Oxidative%2520Stress%252C%2520and%2520Altered%2520Mitochondrial%2520Dynamics%2520in%2520Cardiac%2520Ageing%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D8%26doi%3D10.1155%2F2017%2F3017947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaludercic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivakumaran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedja, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mario, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Lisa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolocci, N.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase b Prompts Mitochondrial and Cardiac Dysfunction in Pressure Overloaded Hearts</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1089/ars.2012.4616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fars.2012.4616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=23581564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislOrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=267-280&issue=2&author=N.+Kaludercicauthor=A.+Carpiauthor=T.+Nagayamaauthor=V.+Sivakumaranauthor=G.+Zhuauthor=E.+W.+Laiauthor=D.+Bedjaauthor=A.+De+Marioauthor=K.+Chenauthor=K.+L.+Gabrielsonauthor=M.+L.+Lindseyauthor=K.+Pacakauthor=E.+Takimotoauthor=J.+C.+Shihauthor=D.+A.+Kassauthor=F.+Di+Lisaauthor=N.+Paolocci&title=Monoamine+Oxidase+b+Prompts+Mitochondrial+and+Cardiac+Dysfunction+in+Pressure+Overloaded+Hearts&doi=10.1089%2Fars.2012.4616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine Oxidase B Prompts Mitochondrial and Cardiac Dysfunction in Pressure Overloaded Hearts</span></div><div class="casAuthors">Kaludercic, Nina; Carpi, Andrea; Nagayama, Takahiro; Sivakumaran, Vidhya; Zhu, Guangshuo; Lai, Edwin W.; Bedja, Djahida; De Mario, Agnese; Chen, Kevin; Gabrielson, Kathleen L.; Lindsey, Merry L.; Pacak, Karel; Takimoto, Eiki; Shih, Jean C.; Kass, David A.; Di Lisa, Fabio; Paolocci, Nazareno</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-280</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: Monoamine oxidases (MAOs) are mitochondrial flavoenzymes responsible for neurotransmitter and biogenic amines catabolism.  MAO-A contributes to heart failure progression via enhanced norepinephrine catabolism and oxidative stress.  The potential pathogenetic role of the isoenzyme MAO-B in cardiac diseases is currently unknown.  Moreover, it is has not been detd. yet whether MAO activation can directly affect mitochondrial function.  Results: In wild type mice, pressure overload induced by transverse aortic constriction (TAC) resulted in enhanced dopamine catabolism, left ventricular (LV) remodeling, and dysfunction.  Conversely, mice lacking MAO-B (MAO-B-/-) subjected to TAC maintained concentric hypertrophy accompanied by extracellular signal regulated kinase (ERK)1/2 activation, and preserved LV function, both at early (3 wk) and late stages (9 wk).  Enhanced MAO activation triggered oxidative stress, and dropped mitochondrial membrane potential in the presence of ATP synthase inhibitor oligomycin both in neonatal and adult cardiomyocytes.  The MAO-B inhibitor pargyline completely offset this change, suggesting that MAO activation induces a latent mitochondrial dysfunction, causing these organelles to hydrolyze ATP.  Moreover, MAO-dependent aldehyde formation due to inhibition of aldehyde dehydrogenase 2 activity also contributed to alter mitochondrial bioenergetics.  Innovation: Our study unravels a novel role for MAO-B in the pathogenesis of heart failure, showing that both MAO-driven reactive oxygen species prodn. and impaired aldehyde metab. affect mitochondrial function.  Conclusion: Under conditions of chronic hemodynamic stress, enhanced MAO-B activity is a major determinant of cardiac structural and functional disarrangement.  Both increased oxidative stress and the accumulation of aldehyde intermediates are likely liable for these adverse morphol. and mech. changes by directly targeting mitochondria.  Antioxid. Redox Signal. 20, 267-280.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JiMLBoVkHLVg90H21EOLACvtfcHk0ljORhUSv4JwcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislOrsg%253D%253D&md5=c4291634416e80c5daa1b0f18f8bc6ae</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.4616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.4616%26sid%3Dliteratum%253Aachs%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DCarpi%26aufirst%3DA.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DSivakumaran%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DLai%26aufirst%3DE.%2BW.%26aulast%3DBedja%26aufirst%3DD.%26aulast%3DDe%2BMario%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DK.%2BL.%26aulast%3DLindsey%26aufirst%3DM.%2BL.%26aulast%3DPacak%26aufirst%3DK.%26aulast%3DTakimoto%26aufirst%3DE.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26aulast%3DKass%26aufirst%3DD.%2BA.%26aulast%3DDi%2BLisa%26aufirst%3DF.%26aulast%3DPaolocci%26aufirst%3DN.%26atitle%3DMonoamine%2520Oxidase%2520b%2520Prompts%2520Mitochondrial%2520and%2520Cardiac%2520Dysfunction%2520in%2520Pressure%2520Overloaded%2520Hearts%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D20%26issue%3D2%26spage%3D267%26epage%3D280%26doi%3D10.1089%2Fars.2012.4616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battelli, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, A.</span></span> <span> </span><span class="NLM_article-title">Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1155/2016/3527579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2016%2F3527579" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1&author=M.+G.+Battelliauthor=L.+Politoauthor=M.+Bortolottiauthor=A.+Bolognesi&title=Xanthine+Oxidoreductase-Derived+Reactive+Species%3A+Physiological+and+Pathological+Effects&doi=10.1155%2F2016%2F3527579"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1155%2F2016%2F3527579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F3527579%26sid%3Dliteratum%253Aachs%26aulast%3DBattelli%26aufirst%3DM.%2BG.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DBortolotti%26aufirst%3DM.%26aulast%3DBolognesi%26aufirst%3DA.%26atitle%3DXanthine%2520Oxidoreductase-Derived%2520Reactive%2520Species%253A%2520Physiological%2520and%2520Pathological%2520Effects%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2016%26volume%3D2016%26spage%3D1%26doi%3D10.1155%2F2016%2F3527579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, E. I.</span>; <span class="NLM_string-name">Serafim, R. A. M.</span></span> <span> </span><span class="NLM_article-title">Nitric Oxide Synthase Inhibitors</span>. In  <i>Nitric Oxide Synthase - Simple Enzyme-Complex Roles</i>; <span class="NLM_publisher-name">IntechOpen</span>: <span class="NLM_publisher-loc">Rijeka</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">237</span>.<span class="refDoi"> DOI: 10.5772/67027</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.5772%2F67027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=217-237&author=E.+I.+Ferreira&author=R.+A.+M.+Serafim&title=Nitric+Oxide+Synthase+-+Simple+Enzyme-Complex+Roles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.5772%2F67027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F67027%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DE.%2BI.%26atitle%3DNitric%2520Oxide%2520Synthase%2520Inhibitors%26btitle%3DNitric%2520Oxide%2520Synthase%2520-%2520Simple%2520Enzyme-Complex%2520Roles%26pub%3DIntechOpen%26date%3D2017%26spage%3D217%26epage%3D237%26doi%3D10.5772%2F67027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span> <span> </span><span class="NLM_article-title">The Dual Role of Inducible Nitric Oxide Synthase in Myocardial Ischemia/Reperfusion Injury: Friend or Foe?</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1155/2018/8364848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2018%2F8364848" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=1-7&author=X.+Yuauthor=L.+Geauthor=L.+Niuauthor=X.+Lianauthor=H.+Maauthor=L.+Pang&title=The+Dual+Role+of+Inducible+Nitric+Oxide+Synthase+in+Myocardial+Ischemia%2FReperfusion+Injury%3A+Friend+or+Foe%3F&doi=10.1155%2F2018%2F8364848"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1155%2F2018%2F8364848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F8364848%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DLian%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DL.%26atitle%3DThe%2520Dual%2520Role%2520of%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520in%2520Myocardial%2520Ischemia%252FReperfusion%2520Injury%253A%2520Friend%2520or%2520Foe%253F%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D7%26doi%3D10.1155%2F2018%2F8364848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Förstermann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sessa, W. C.</span></span> <span> </span><span class="NLM_article-title">Nitric Oxide Synthases: Regulation and Function</span>. <i>Eur. Heart J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1093/eurheartj/ehr304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1093%2Feurheartj%2Fehr304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=21890489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC38zlsFOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=829-837&issue=7&author=U.+F%C3%B6rstermannauthor=W.+C.+Sessa&title=Nitric+Oxide+Synthases%3A+Regulation+and+Function&doi=10.1093%2Feurheartj%2Fehr304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide synthases: regulation and function</span></div><div class="casAuthors">Forstermann Ulrich; Sessa William C</div><div class="citationInfo"><span class="NLM_cas:title">European heart journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">829-37, 837a-837d</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nitric oxide (NO), the smallest signalling molecule known, is produced by three isoforms of NO synthase (NOS; EC 1.14.13.39).  They all utilize l-arginine and molecular oxygen as substrates and require the cofactors reduced nicotinamide-adenine-dinucleotide phosphate (NADPH), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), and (6R-)5,6,7,8-tetrahydrobiopterin (BH(4)).  All NOS bind calmodulin and contain haem.  Neuronal NOS (nNOS, NOS I) is constitutively expressed in central and peripheral neurons and some other cell types.  Its functions include synaptic plasticity in the central nervous system (CNS), central regulation of blood pressure, smooth muscle relaxation, and vasodilatation via peripheral nitrergic nerves.  Nitrergic nerves are of particular importance in the relaxation of corpus cavernosum and penile erection.  Phosphodiesterase 5 inhibitors (sildenafil, vardenafil, and tadalafil) require at least a residual nNOS activity for their action.  Inducible NOS (NOS II) can be expressed in many cell types in response to lipopolysaccharide, cytokines, or other agents.  Inducible NOS generates large amounts of NO that have cytostatic effects on parasitic target cells.  Inducible NOS contributes to the pathophysiology of inflammatory diseases and septic shock.  Endothelial NOS (eNOS, NOS III) is mostly expressed in endothelial cells.  It keeps blood vessels dilated, controls blood pressure, and has numerous other vasoprotective and anti-atherosclerotic effects.  Many cardiovascular risk factors lead to oxidative stress, eNOS uncoupling, and endothelial dysfunction in the vasculature.  Pharmacologically, vascular oxidative stress can be reduced and eNOS functionality restored with renin- and angiotensin-converting enzyme-inhibitors, with angiotensin receptor blockers, and with statins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRK_7rA0a-WP2yYR5VtavbzfW6udTcc2eanX0AddXAsF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zlsFOltA%253D%253D&md5=5fa266fb718dd4b068fe6a86f4db7836</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehr304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehr304%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25B6rstermann%26aufirst%3DU.%26aulast%3DSessa%26aufirst%3DW.%2BC.%26atitle%3DNitric%2520Oxide%2520Synthases%253A%2520Regulation%2520and%2520Function%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2012%26volume%3D33%26issue%3D7%26spage%3D829%26epage%3D837%26doi%3D10.1093%2Feurheartj%2Fehr304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaube, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werstuck, G. H.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial ROS versus ER ROS: Which Comes First in Myocardial Calcium Dysregulation?</span>. <i>Front. Cardiovasc. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.3389/fcvm.2016.00036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3389%2Ffcvm.2016.00036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=1-5&author=R.+Chaubeauthor=G.+H.+Werstuck&title=Mitochondrial+ROS+versus+ER+ROS%3A+Which+Comes+First+in+Myocardial+Calcium+Dysregulation%3F&doi=10.3389%2Ffcvm.2016.00036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3389%2Ffcvm.2016.00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcvm.2016.00036%26sid%3Dliteratum%253Aachs%26aulast%3DChaube%26aufirst%3DR.%26aulast%3DWerstuck%26aufirst%3DG.%2BH.%26atitle%3DMitochondrial%2520ROS%2520versus%2520ER%2520ROS%253A%2520Which%2520Comes%2520First%2520in%2520Myocardial%2520Calcium%2520Dysregulation%253F%26jtitle%3DFront.%2520Cardiovasc.%2520Med.%26date%3D2016%26volume%3D3%26spage%3D1%26epage%3D5%26doi%3D10.3389%2Ffcvm.2016.00036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoboue, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, T.</span></span> <span> </span><span class="NLM_article-title">Redox Crosstalk at Endoplasmic Reticulum (ER) Membrane Contact Sites (MCS) Uses Toxic Waste to Deliver Messages</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1038/s41419-017-0033-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41419-017-0033-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29298988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVSksL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1-14&issue=3&author=E.+D.+Yoboueauthor=R.+Sitiaauthor=T.+Simmen&title=Redox+Crosstalk+at+Endoplasmic+Reticulum+%28ER%29+Membrane+Contact+Sites+%28MCS%29+Uses+Toxic+Waste+to+Deliver+Messages&doi=10.1038%2Fs41419-017-0033-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Redox crosstalk at endoplasmic reticulum (ER) membrane contact sites (MCS) uses toxic waste to deliver messages</span></div><div class="casAuthors">Yoboue, Edgar Djaha; Sitia, Roberto; Simmen, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Many cellular redox reactions housed within mitochondria, peroxisomes and the endoplasmic reticulum (ER) generate hydrogen peroxide (H2O2) and other reactive oxygen species (ROS).  The contribution of each organelle to the total cellular ROS prodn. is considerable, but varies between cell types and also over time.  Redox-regulatory enzymes are thought to assemble at a "redox triangle" formed by mitochondria, peroxisomes and the ER, assembling "redoxosomes" that sense ROS accumulations and redox imbalances.  The redoxosome enzymes use ROS, potentially toxic byproducts made by some redoxosome members themselves, to transmit inter-compartmental signals via chem. modifications of downstream proteins and lipids.  Interestingly, important components of the redoxosome are ER chaperones and oxidoreductases, identifying ER oxidative protein folding as a key ROS producer and controller of the tri-organellar membrane contact sites (MCS) formed at the redox triangle.  At these MCS, ROS accumulations could directly facilitate inter-organellar signal transmission, using ROS transporters.  In addn., ROS influence the flux of Ca2+ ions, since many Ca2+ handling proteins, including inositol 1,4,5 trisphosphate receptors (IP3Rs), SERCA pumps or regulators of the mitochondrial Ca2+ uniporter (MCU) are redox-sensitive.  Fine-tuning of these redox and ion signaling pathways might be difficult in older organisms, suggesting a dysfunctional redox triangle may accompany the aging process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2uytu_Vp8p7Vg90H21EOLACvtfcHk0lg6cay4lQr6uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVSksL7K&md5=ad2718a5b6999d6735994c962d0b1954</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fs41419-017-0033-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-017-0033-4%26sid%3Dliteratum%253Aachs%26aulast%3DYoboue%26aufirst%3DE.%2BD.%26aulast%3DSitia%26aufirst%3DR.%26aulast%3DSimmen%26aufirst%3DT.%26atitle%3DRedox%2520Crosstalk%2520at%2520Endoplasmic%2520Reticulum%2520%2528ER%2529%2520Membrane%2520Contact%2520Sites%2520%2528MCS%2529%2520Uses%2520Toxic%2520Waste%2520to%2520Deliver%2520Messages%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3D1%26epage%3D14%26doi%3D10.1038%2Fs41419-017-0033-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanburg, B. L.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in Cell Signaling</span>. <i>Am. J. lung cell Mol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">L1005</span>– <span class="NLM_lpage">L1028</span>, <span class="refDoi"> DOI: 10.1152/ajplung.2000.279.6.L1005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1152%2Fajplung.2000.279.6.L1005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11076791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptFSksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2000&pages=L1005-L1028&issue=6&author=V.+J.+Thannickalauthor=B.+L.+Fanburg&title=Reactive+Oxygen+Species+in+Cell+Signaling&doi=10.1152%2Fajplung.2000.279.6.L1005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species in cell signaling</span></div><div class="casAuthors">Thannickal, Victor J.; Fanburg, Barry L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">6, Pt. 1</span>),
    <span class="NLM_cas:pages">L1005-L1028</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review with 325 refs.  Reactive oxygen species (ROS) are generated as byproducts of cellular metab., primarily in the mitochondria.  When cellular prodn. of ROS overwhelms its antioxidant capacity, damage to cellular macromols. such as lipids, protein, and DNA may ensue.  Such a state of "oxidative stress" is thought to contribute to the pathogenesis of a no. of human diseases including those of the lung.  Recent studies have also implicated ROS that are generated by specialized plasma membrane oxidases in normal physiol. signaling by growth factors and cytokines.  In this review, we examine the evidence for ligand-induced generation of ROS, its cellular sources, and the signaling pathways that are activated.  Emerging concepts on the mechanisms of signal transduction by ROS that involve alterations in cellular redox state and oxidative modifications of proteins are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEH4w6eWY_ZLVg90H21EOLACvtfcHk0ljcOx1_NyosOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptFSksbg%253D&md5=ae6d8f77b43dcd22a5d41afa7ffba4c5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1152%2Fajplung.2000.279.6.L1005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.2000.279.6.L1005%26sid%3Dliteratum%253Aachs%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26aulast%3DFanburg%26aufirst%3DB.%2BL.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520Cell%2520Signaling%26jtitle%3DAm.%2520J.%2520lung%2520cell%2520Mol.%2520Physiol.%26date%3D2000%26volume%3D279%26issue%3D6%26spage%3DL1005%26epage%3DL1028%26doi%3D10.1152%2Fajplung.2000.279.6.L1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Autréaux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledano, M. B.</span></span> <span> </span><span class="NLM_article-title">ROS as Signalling Molecules: Mechanisms That Generate Specificity in ROS Homeostasis</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">824</span>, <span class="refDoi"> DOI: 10.1038/nrm2256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fnrm2256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=17848967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=813-824&issue=10&author=B.+D%E2%80%99Autr%C3%A9auxauthor=M.+B.+Toledano&title=ROS+as+Signalling+Molecules%3A+Mechanisms+That+Generate+Specificity+in+ROS+Homeostasis&doi=10.1038%2Fnrm2256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">ROS as signaling molecules: mechanisms that generate specificity in ROS homeostasis</span></div><div class="casAuthors">D'Autreaux, Benoit; Toledano, Michel B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">813-824</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Reactive O species (ROS) have been shown to be toxic but also to function as signaling mols.  This biol. paradox underlies mechanisms that are important for the integrity and fitness of living organisms and their aging.  The pathways that regulate ROS homeostasis are crucial for mitigating the toxicity of ROS and provide strong evidence about specificity in ROS signaling.  By taking advantage of the chem. of ROS, highly specific mechanisms have evolved that form the basis of oxidant scavenging and ROS signaling systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR5hZl87z2WLVg90H21EOLACvtfcHk0ljcOx1_NyosOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7rF&md5=5302fd59fdfaf8636793ea768f188219</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrm2256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2256%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Autr%25C3%25A9aux%26aufirst%3DB.%26aulast%3DToledano%26aufirst%3DM.%2BB.%26atitle%3DROS%2520as%2520Signalling%2520Molecules%253A%2520Mechanisms%2520That%2520Generate%2520Specificity%2520in%2520ROS%2520Homeostasis%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26issue%3D10%26spage%3D813%26epage%3D824%26doi%3D10.1038%2Fnrm2256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calamita, G.</span></span> <span> </span><span class="NLM_article-title">Aquaporin Membrane Channels in Oxidative Stress, Cell Signaling, and Aging: Recent Advances and Research Trends</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1155/2018/1501847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2018%2F1501847" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=1-14&author=G.+Tammaauthor=G.+Valentiauthor=E.+Grossiniauthor=S.+Donniniauthor=A.+Marinoauthor=R.+A.+Marinelliauthor=G.+Calamita&title=Aquaporin+Membrane+Channels+in+Oxidative+Stress%2C+Cell+Signaling%2C+and+Aging%3A+Recent+Advances+and+Research+Trends&doi=10.1155%2F2018%2F1501847"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1155%2F2018%2F1501847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F1501847%26sid%3Dliteratum%253Aachs%26aulast%3DTamma%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DG.%26aulast%3DGrossini%26aufirst%3DE.%26aulast%3DDonnini%26aufirst%3DS.%26aulast%3DMarino%26aufirst%3DA.%26aulast%3DMarinelli%26aufirst%3DR.%2BA.%26aulast%3DCalamita%26aufirst%3DG.%26atitle%3DAquaporin%2520Membrane%2520Channels%2520in%2520Oxidative%2520Stress%252C%2520Cell%2520Signaling%252C%2520and%2520Aging%253A%2520Recent%2520Advances%2520and%2520Research%2520Trends%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D14%26doi%3D10.1155%2F2018%2F1501847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvin, J. L.</span></span> <span> </span><span class="NLM_article-title">Aquaporin-1 Transports NO across Cell Membranes</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.0000223652.29338.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1161%2F01.HYP.0000223652.29338.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16682607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVSmtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2006&pages=157-164&issue=1&author=M.+Herreraauthor=N.+J.+Hongauthor=J.+L.+Garvin&title=Aquaporin-1+Transports+NO+across+Cell+Membranes&doi=10.1161%2F01.HYP.0000223652.29338.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aquaporin-1 Transports NO Across Cell Membranes</span></div><div class="casAuthors">Herrera, Marcela; Hong, Nancy J.; Garvin, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-164</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">NO plays a role in the regulation of blood pressure through its effects on renal, cardiovascular, and central nervous system function.  It is generally thought to freely diffuse through cell membranes without need for a specific transporter.  The water channel aquaporin-1 transports low mol. wt. gases in addn. to water and is expressed in cells that produce or are the targets of NO.  Consequently, we tested the hypothesis that aquaporin-1 transports NO.  In cells expressing aquaporin-1, NO permeability correlated with water permeability.  NO transport was reduced by 71% by HgCl2, an inhibitor of aquaporin-1.  Transport of NO by aquaporin-1 satd. at 3 μmol/L NO and displayed a K1/2 (the concn. of NO that produces half of the max. transport rate) of 0.54 μmol/L.  Reconstitution of purified aquaporin-1 into lipid vesicles increased NO influx by 316%.  In endothelial cells, lowering aquaporin-1 expression with a small interfering RNA (siRNA) blunted aquaporin-1 expression by 54% and NO release by 44%.  We conclude that NO transport by aquaporin-1 may allow cells to control intracellular NO levels and effects.  NO transport by aquaporin-1 may play a role in central nervous system, vascular and renal function, and consequently blood pressure.  Disruption of NO transport by aquaporin-1 offers an alternate cause for diseases currently explained by inadequate NO bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkb2viIRAdRLVg90H21EOLACvtfcHk0lgoEKCmKgC32Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVSmtr4%253D&md5=3e9136d4fba3f6f1c2870b0f0ea17d73</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000223652.29338.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000223652.29338.77%26sid%3Dliteratum%253Aachs%26aulast%3DHerrera%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DN.%2BJ.%26aulast%3DGarvin%26aufirst%3DJ.%2BL.%26atitle%3DAquaporin-1%2520Transports%2520NO%2520across%2520Cell%2520Membranes%26jtitle%3DHypertension%26date%3D2006%26volume%3D48%26issue%3D1%26spage%3D157%26epage%3D164%26doi%3D10.1161%2F01.HYP.0000223652.29338.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chauvigné, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerdà, J.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Aquaporin-8-Mediated Hydrogen Peroxide Transport Is Essential for Teleost Spermatozoon Motility</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1038/srep07789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fsrep07789" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=2-11&author=F.+Chauvign%C3%A9author=M.+Bojauthor=R.+N.+Finnauthor=J.+Cerd%C3%A0&title=Mitochondrial+Aquaporin-8-Mediated+Hydrogen+Peroxide+Transport+Is+Essential+for+Teleost+Spermatozoon+Motility&doi=10.1038%2Fsrep07789"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep07789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep07789%26sid%3Dliteratum%253Aachs%26aulast%3DChauvign%25C3%25A9%26aufirst%3DF.%26aulast%3DBoj%26aufirst%3DM.%26aulast%3DFinn%26aufirst%3DR.%2BN.%26aulast%3DCerd%25C3%25A0%26aufirst%3DJ.%26atitle%3DMitochondrial%2520Aquaporin-8-Mediated%2520Hydrogen%2520Peroxide%2520Transport%2520Is%2520Essential%2520for%2520Teleost%2520Spermatozoon%2520Motility%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D2%26epage%3D11%26doi%3D10.1038%2Fsrep07789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchissio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francés, D. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnovale, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, R. A.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Aquaporin-8 Knockdown in Human Hepatoma HepG2 Cells Causes ROS-Induced Mitochondrial Depolarization and Loss of Viability</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>264</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2012.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.taap.2012.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22910329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GksrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=2012&pages=246-254&issue=2&author=M.+J.+Marchissioauthor=D.+E.+A.+Franc%C3%A9sauthor=C.+E.+Carnovaleauthor=R.+A.+Marinelli&title=Mitochondrial+Aquaporin-8+Knockdown+in+Human+Hepatoma+HepG2+Cells+Causes+ROS-Induced+Mitochondrial+Depolarization+and+Loss+of+Viability&doi=10.1016%2Fj.taap.2012.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial aquaporin-8 knockdown in human hepatoma HepG2 cells causes ROS-induced mitochondrial depolarization and loss of viability</span></div><div class="casAuthors">Marchissio, Maria Julia; Frances, Daniel Eleazar Antonio; Carnovale, Cristina Ester; Marinelli, Raul Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-254</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Human aquaporin-8 (AQP8) channels facilitate the diffusional transport of H2O2 across membranes.  Since AQP8 is expressed in hepatic inner mitochondrial membranes, we studied whether mitochondrial AQP8 (mtAQP8) knockdown in human hepatoma HepG2 cells impairs mitochondrial H2O2 release, which may lead to organelle dysfunction and cell death.  We confirmed AQP8 expression in HepG2 inner mitochondrial membranes and found that 72 h after cell transfection with siRNAs targeting two different regions of the human AQP8 mol., mtAQP8 protein specifically decreased by around 60% (p < 0.05).  Studies in isolated mtAQP8-knockdown mitochondria showed that H2O2 release, assessed by Amplex Red, was reduced by about 45% (p < 0.05), an effect not obsd. in digitonin-permeabilized mitochondria. mtAQP8-knockdown cells showed an increase in mitochondrial ROS, assessed by dichlorodihydrofluorescein diacetate (+ 120%, p < 0.05) and loss of mitochondrial membrane potential (- 80%, p < 0.05), assessed by tetramethylrhodamine-coupled quant. fluorescence microscopy.  The mitochondria-targeted antioxidant MitoTempol prevented ROS accumulation and dissipation of mitochondrial membrane potential.  Cyclosporin A, a mitochondrial permeability transition pore blocker, also abolished the mtAQP8 knockdown-induced mitochondrial depolarization.  Besides, the loss of viability in mtAQP8 knockdown cells verified by MTT assay, LDH leakage, and trypan blue exclusion test could be prevented by cyclosporin A.  Our data on human hepatoma HepG2 cells suggest that mtAQP8 facilitates mitochondrial H2O2 release and that its defective expression causes ROS-induced mitochondrial depolarization via the mitochondrial permeability transition mechanism, and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtFDoMK1W8bLVg90H21EOLACvtfcHk0lhDoeNRT3eiLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GksrzK&md5=7ba731781edffd821c076e860f67e60e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2012.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2012.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DMarchissio%26aufirst%3DM.%2BJ.%26aulast%3DFranc%25C3%25A9s%26aufirst%3DD.%2BE.%2BA.%26aulast%3DCarnovale%26aufirst%3DC.%2BE.%26aulast%3DMarinelli%26aufirst%3DR.%2BA.%26atitle%3DMitochondrial%2520Aquaporin-8%2520Knockdown%2520in%2520Human%2520Hepatoma%2520HepG2%2520Cells%2520Causes%2520ROS-Induced%2520Mitochondrial%2520Depolarization%2520and%2520Loss%2520of%2520Viability%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2012%26volume%3D264%26issue%3D2%26spage%3D246%26epage%3D254%26doi%3D10.1016%2Fj.taap.2012.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pietro, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcón-Pérez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenza, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setty, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dell’Angelica, E. C.</span></span> <span> </span><span class="NLM_article-title">BLOC-1 Interacts with BLOC-2 and the AP-3 Complex to Facilitate Protein Trafficking on Endosomes</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4027</span>– <span class="NLM_lpage">4038</span>, <span class="refDoi"> DOI: 10.1091/mbc.e06-05-0379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1091%2Fmbc.e06-05-0379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16837549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1aksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=4027-4038&author=S.+M.+Di%0APietroauthor=J.+M.+Falc%C3%B3n-P%C3%A9rezauthor=D.+Tenzaauthor=S.+R.+G.+Settyauthor=M.+S.+Marksauthor=G.+Raposoauthor=E.+C.+Dell%E2%80%99Angelica&title=BLOC-1+Interacts+with+BLOC-2+and+the+AP-3+Complex+to+Facilitate+Protein+Trafficking+on+Endosomes&doi=10.1091%2Fmbc.e06-05-0379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate protein trafficking on endosomes</span></div><div class="casAuthors">Di Pietro, Santiago M.; Falcon-Perez, Juan M.; Tenza, Daniele; Setty, Subba R. G.; Marks, Michael S.; Raposo, Graca; Dell'Angelica, Esteban C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4027-4038</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The adaptor protein (AP)-3 complex is a component of the cellular machinery that controls protein sorting from endosomes to lysosomes and specialized related organelles such as melanosomes.  Mutations in an AP-3 subunit underlie a form of Hermansky-Pudlak syndrome (HPS), a disorder characterized by abnormalities in lysosome-related organelles.  HPS in humans can also be caused by mutations in genes encoding subunits of three complexes of unclear function, named biogenesis of lysosome-related organelles complex (BLOC)-1, -2, and -3.  Here, the authors report that BLOC-1 interacts phys. and functionally with AP-3 to facilitate the trafficking of a known AP-3 cargo, CD63, and of tyrosinase-related protein 1 (Tyrp1), a melanosomal membrane protein previously thought to traffic only independently of AP-3.  BLOC-1 also interacts with BLOC-2 to facilitate Tyrp1 trafficking by a mechanism apparently independent of AP-3 function.  Both BLOC-1 and -2 localize mainly to early endosome-assocd. tubules as detd. by immunoelectron microscopy.  These findings support the idea that BLOC-1 and -2 represent hitherto unknown components of the endosomal protein trafficking machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIAfnWuujIArVg90H21EOLACvtfcHk0lhDoeNRT3eiLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1aksr0%253D&md5=fbc596269cab6a837b0f797ade7a1dd1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e06-05-0379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e06-05-0379%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DS.%2BM.%26aulast%3DFalc%25C3%25B3n-P%25C3%25A9rez%26aufirst%3DJ.%2BM.%26aulast%3DTenza%26aufirst%3DD.%26aulast%3DSetty%26aufirst%3DS.%2BR.%2BG.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3DDell%25E2%2580%2599Angelica%26aufirst%3DE.%2BC.%26atitle%3DBLOC-1%2520Interacts%2520with%2520BLOC-2%2520and%2520the%2520AP-3%2520Complex%2520to%2520Facilitate%2520Protein%2520Trafficking%2520on%2520Endosomes%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2006%26volume%3D17%26spage%3D4027%26epage%3D4038%26doi%3D10.1091%2Fmbc.e06-05-0379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species (ROS) as Pleiotropic Physiological Signalling Agents</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1038/s41580-020-0230-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41580-020-0230-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32231263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=363-383&issue=7&author=H.+Siesauthor=D.+P.+Jones&title=Reactive+Oxygen+Species+%28ROS%29+as+Pleiotropic+Physiological+Signalling+Agents&doi=10.1038%2Fs41580-020-0230-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species (ROS) as pleiotropic physiological signalling agents</span></div><div class="casAuthors">Sies, Helmut; Jones, Dean P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">363-383</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: 'Reactive oxygen species' (ROS) is an umbrella term for an array of derivs. of mol. oxygen that occur as a normal attribute of aerobic life.  Elevated formation of the different ROS leads to mol. damage, denoted as 'oxidative distress'.  Here we focus on ROS at physiol. levels and their central role in redox signalling via different post-translational modifications, denoted as 'oxidative eustress'.  Two species, hydrogen peroxide (H2O2) and the superoxide anion radical (O2·-), are key redox signalling agents generated under the control of growth factors and cytokines by more than 40 enzymes, prominently including NADPH oxidases and the mitochondrial electron transport chain.  At the low physiol. levels in the nanomolar range, H2O2 is the major agent signalling through specific protein targets, which engage in metabolic regulation and stress responses to support cellular adaptation to a changing environment and stress.  In addn., several other reactive species are involved in redox signalling, for instance nitric oxide, hydrogen sulfide and oxidized lipids.  Recent methodol. advances permit the assessment of mol. interactions of specific ROS mols. with specific targets in redox signalling pathways.  Accordingly, major advances have occurred in understanding the role of these oxidants in physiol. and disease, including the nervous, cardiovascular and immune systems, skeletal muscle and metabolic regulation as well as ageing and cancer.  In the past, unspecific elimination of ROS by use of low mol. mass antioxidant compds. was not successful in counteracting disease initiation and progression in clin. trials.  However, controlling specific ROS-mediated signalling pathways by selective targeting offers a perspective for a future of more refined redox medicine.  This includes enzymic defense systems such as those controlled by the stress-response transcription factors NRF2 and nuclear factor-κB, the role of trace elements such as selenium, the use of redox drugs and the modulation of environmental factors collectively known as the exposome (for example, nutrition, lifestyle and irradn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUOGVldjysxrVg90H21EOLACvtfcHk0lhlat-l68icRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtrY%253D&md5=52e3327385f2c2910d1ffc5f4062eb77</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41580-020-0230-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41580-020-0230-3%26sid%3Dliteratum%253Aachs%26aulast%3DSies%26aufirst%3DH.%26aulast%3DJones%26aufirst%3DD.%2BP.%26atitle%3DReactive%2520Oxygen%2520Species%2520%2528ROS%2529%2520as%2520Pleiotropic%2520Physiological%2520Signalling%2520Agents%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2020%26volume%3D21%26issue%3D7%26spage%3D363%26epage%3D383%26doi%3D10.1038%2Fs41580-020-0230-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chio, I. I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span> <span> </span><span class="NLM_article-title">ROS in Cancer: The Burning Question</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2017.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.molmed.2017.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28427863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1WiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=411-429&issue=5&author=I.+I.+C.+Chioauthor=D.+A.+Tuveson&title=ROS+in+Cancer%3A+The+Burning+Question&doi=10.1016%2Fj.molmed.2017.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">ROS in Cancer: The Burning Question</span></div><div class="casAuthors">Chio, Iok In Christine; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-429</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">An unanswered question in human health is whether antioxidn. prevents or promotes cancer.  Antioxidn. has historically been viewed as chemopreventive, but emerging evidence suggests that antioxidants may be supportive of neoplasia.  We posit this contention to be rooted in the fact that ROS do not operate as one single biochem. entity, but as diverse secondary messengers in cancer cells.  This cautions against therapeutic strategies to increase ROS at a global level.  To leverage redox alterations towards the development of effective therapies necessitates the application of biophys. and biochem. approaches to define redox dynamics and to functionally elucidate specific oxidative modifications in cancer vs. normal cells.  An improved understanding of the sophisticated workings of redox biol. is imperative to defeating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0BkT0gWhumrVg90H21EOLACvtfcHk0lhlat-l68icRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1WiurY%253D&md5=74ce7fb3d8db3718d6c97b9030deb0da</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2017.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2017.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DChio%26aufirst%3DI.%2BI.%2BC.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DROS%2520in%2520Cancer%253A%2520The%2520Burning%2520Question%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2017%26volume%3D23%26issue%3D5%26spage%3D411%26epage%3D429%26doi%3D10.1016%2Fj.molmed.2017.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hariharan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaraj, S.</span></span> <span> </span><span class="NLM_article-title">Selenium and Selenoproteins: It’s Role in Regulation of Inflammation</span>. <i>Inflammopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1007/s10787-020-00690-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs10787-020-00690-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32144521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslGjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=667-695&issue=3&author=S.+Hariharanauthor=S.+Dharmaraj&title=Selenium+and+Selenoproteins%3A+It%E2%80%99s+Role+in+Regulation+of+Inflammation&doi=10.1007%2Fs10787-020-00690-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium and selenoproteins: it's role in regulation of inflammation</span></div><div class="casAuthors">Hariharan, Sneha; Dharmaraj, Selvakumar</div><div class="citationInfo"><span class="NLM_cas:title">Inflammopharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">667-695</span>CODEN:
                <span class="NLM_cas:coden">IAOAES</span>;
        ISSN:<span class="NLM_cas:issn">0925-4692</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Abstr.: Selenium is an essential immunonutrient which holds the human's metabolic activity with its chem. bonds.  Glutathione peroxidase (GPX) is the major selenoprotein present in the human body, which assists in the control of excessive prodn. of free radical at the site of inflammation.  Other than GPX, other selenoproteins include selenoprotein-S that regulates the inflammatory cytokines and selenoprotein-P that serves as an inducer of homeostasis.  Previously, reports were mainly focused on the cellular and mol. mechanism of wound healing with ref. to various animal models and cell lines.  In this review, the role of selenium and its possible routes in translational decoding of selenocysteine, synthesis of selenoproteins, systemic action of selenoproteins and their indirect assimilation in the process of wound healing are explained in detail.  Some of the selenium contg. compds. which can acts as cancer preventive and therapeutics are also discussed.  These compds. directly or indirectly exhibit antioxidant properties which can sustain the intracellular redox status and these activities protect the healthy cells from reactive oxygen species induced oxidative damage.  Although the review covers the importance of selenium/selenoproteins in wound healing process, still some unresolved mystery persists which may be resolved in near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8NUS50S5hw7Vg90H21EOLACvtfcHk0lhih5AflQEamA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslGjsr0%253D&md5=fec080fb12b68dddba303e4e5b8f0ee6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs10787-020-00690-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10787-020-00690-x%26sid%3Dliteratum%253Aachs%26aulast%3DHariharan%26aufirst%3DS.%26aulast%3DDharmaraj%26aufirst%3DS.%26atitle%3DSelenium%2520and%2520Selenoproteins%253A%2520It%25E2%2580%2599s%2520Role%2520in%2520Regulation%2520of%2520Inflammation%26jtitle%3DInflammopharmacology%26date%3D2020%26volume%3D28%26issue%3D3%26spage%3D667%26epage%3D695%26doi%3D10.1007%2Fs10787-020-00690-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arbogast, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreiro, A.</span></span> <span> </span><span class="NLM_article-title">Selenoproteins and Protection against Oxidative Stress: Selenoprotein N as a Novel Player at the Crossroads of Redox Signaling and Calcium Homeostasis</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1089/ars.2009.2890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fars.2009.2890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=19769461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFOjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=893-904&issue=7&author=S.+Arbogastauthor=A.+Ferreiro&title=Selenoproteins+and+Protection+against+Oxidative+Stress%3A+Selenoprotein+N+as+a+Novel+Player+at+the+Crossroads+of+Redox+Signaling+and+Calcium+Homeostasis&doi=10.1089%2Fars.2009.2890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Selenoproteins and protection against oxidative stress: selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis</span></div><div class="casAuthors">Arbogast, Sandrine; Ferreiro, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">893-904</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Healthy cells continually produce low levels of reactive oxygen species (ROS), which are buffered by multiple antioxidant systems.  Imbalance between ROS prodn. and elimination results in oxidative stress, which has been implicated in aging and in numerous human diseases, including cancer and diabetes.  Selenoproteins are a family of proteins that contain the amino acid selenocysteine, encoded by an in-frame UGA.  Those selenoproteins whose function is identified are catalytically active in redox processes, representing one of the main enzymic antioxidant systems and important mediators of the beneficial role of selenium in human health.  Nevertheless, the function of most selenoproteins remains unknown; this included Selenoprotein N (SelN), the only selenoprotein directly assocd. with a human genetic disease.  Mutations of the SelN gene cause SEPN1-related myopathy, a particular early-onset muscle disorder.  Recent studies have identified SelN as a key protein in cell protection against oxidative stress and redox-related calcium homeostasis.  Furthermore, an effective ex vivo treatment of SelN deficiency has been identified, paving the way to a clin. therapy.  In this review we discuss the physiol. and pathophysiol. role of SelN and the interest of SEPN1-related myopathy as a model paradigm to understand and target therapeutically other selenoproteins involved in human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0FTiUZMy73LVg90H21EOLACvtfcHk0lhih5AflQEamA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFOjsbo%253D&md5=55556e3ebbb8a09f3a07cb92c3339d8b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1089%2Fars.2009.2890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2009.2890%26sid%3Dliteratum%253Aachs%26aulast%3DArbogast%26aufirst%3DS.%26aulast%3DFerreiro%26aufirst%3DA.%26atitle%3DSelenoproteins%2520and%2520Protection%2520against%2520Oxidative%2520Stress%253A%2520Selenoprotein%2520N%2520as%2520a%2520Novel%2520Player%2520at%2520the%2520Crossroads%2520of%2520Redox%2520Signaling%2520and%2520Calcium%2520Homeostasis%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D12%26issue%3D7%26spage%3D893%26epage%3D904%26doi%3D10.1089%2Fars.2009.2890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maiorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aumann, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigelius-Flohe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den
Heuvel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohé, L.</span></span> <span> </span><span class="NLM_article-title">Probing the Presumed Catalytic Triad of Selenium-Containing Peroxidases by Mutational Analysis of Phospholipid Hydroperoxide Glutathione Peroxidase (PHGPx)</span>. <i>Biol. Chem. Hoppe-Seyler</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>376</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1515/bchm3.1995.376.11.651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1515%2Fbchm3.1995.376.11.651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=8962674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2MXpvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=651-660&issue=11&author=M.+Maiorinoauthor=K.+D.+Aumannauthor=R.+Brigelius-Floheauthor=F.+Ursiniauthor=J.+van+den%0AHeuvelauthor=J.+McCarthyauthor=L.+Floh%C3%A9&title=Probing+the+Presumed+Catalytic+Triad+of+Selenium-Containing+Peroxidases+by+Mutational+Analysis+of+Phospholipid+Hydroperoxide+Glutathione+Peroxidase+%28PHGPx%29&doi=10.1515%2Fbchm3.1995.376.11.651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the presumed catalytic triad of selenium-containing peroxidases by mutational analysis of phospholipid hydroperoxide glutathione peroxidase (PHGPx)</span></div><div class="casAuthors">Maiorino, Matilde; Aumann, Klaus-Dieter; Brigelius-Flohe, Regina; Doria, Denise; van den Heuvel, Joop; McCarthy, John; Roveri, Antonella; Ursini, Fulvio; Flohe, Leopold</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry Hoppe-Seyler</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">651-60</span>CODEN:
                <span class="NLM_cas:coden">BCHSEI</span>;
        ISSN:<span class="NLM_cas:issn">0177-3593</span>.
    
            (<span class="NLM_cas:orgname">de Gruyter</span>)
        </div><div class="casAbstract">Single and double site mutants affecting the presumed catalytic center of the selenoenzyme PHGPx were subjected to functional anal.  The rate consts. k+1 and k'+2, for the oxidn. and the regeneration of the ground state enzyme were estd., resp.  Moreover, the alkylation rate of the reactive center by iodoacetate (kinact.) was also analyzed.  The substitution of the catalytically competent selenocysteine 46 by cysteine (PHGPxcys46) decreased k+1 and k'+2 by about three orders of magnitude, although leaving unaffected kinact.  Furthermore, mutations of PHGPxcys46 involving the other residues of the triad decreased both kinact. and k+1, thus highlighting the involvement of Gln 81 and Trp 136 in the dissocn./activation of the nucleophilic cysteine thiol.  In general, substitutions of Gln 81 or Trp 136 by acidic residues in PHGPxcys46 most dramatically depressed the k+1 values, because they practically prevented the dissocn. of the thiol group, while neutral or pos. charged residues in these positions allowed an intermediate dissocn. and induced a corresponding reactivity of the thiol.  The data, for the first time, reveal that the presumed triad of selenocysteine, glutamine and tryptophan residues represents a novel type of catalytic center, whose integrity is essential for the full catalytic function of glutathione peroxidases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqytuVxqIvurLVg90H21EOLACvtfcHk0lhih5AflQEamA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpvVClsbo%253D&md5=09e0d5acc0fcc1ac99d4b3cf875977d4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1515%2Fbchm3.1995.376.11.651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbchm3.1995.376.11.651%26sid%3Dliteratum%253Aachs%26aulast%3DMaiorino%26aufirst%3DM.%26aulast%3DAumann%26aufirst%3DK.%2BD.%26aulast%3DBrigelius-Flohe%26aufirst%3DR.%26aulast%3DUrsini%26aufirst%3DF.%26aulast%3Dvan%2Bden%2BHeuvel%26aufirst%3DJ.%26aulast%3DMcCarthy%26aufirst%3DJ.%26aulast%3DFloh%25C3%25A9%26aufirst%3DL.%26atitle%3DProbing%2520the%2520Presumed%2520Catalytic%2520Triad%2520of%2520Selenium-Containing%2520Peroxidases%2520by%2520Mutational%2520Analysis%2520of%2520Phospholipid%2520Hydroperoxide%2520Glutathione%2520Peroxidase%2520%2528PHGPx%2529%26jtitle%3DBiol.%2520Chem.%2520Hoppe-Seyler%26date%3D1995%26volume%3D376%26issue%3D11%26spage%3D651%26epage%3D660%26doi%3D10.1515%2Fbchm3.1995.376.11.651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">Non-Covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8088</span>– <span class="NLM_lpage">8103</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00358</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00358" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8088-8103&author=J.+S.+Pallesenauthor=K.+T.+Tranauthor=A.+Bach&title=Non-Covalent+Small-Molecule+Kelch-like+ECH-Associated+Protein+1%E2%80%93Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Keap1%E2%80%93Nrf2%29+Inhibitors+and+Their+Potential+for+Targeting+Central+Nervous+System+Diseases&doi=10.1021%2Facs.jmedchem.8b00358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases</span></div><div class="casAuthors">Pallesen, Jakob S.; Tran, Kim T.; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8088-8103</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) diseases.  Inhibition of the protein-protein interaction (PPI) between Nrf2 and its repressor protein, Kelch-like ECH-assocd. protein 1 (Keap1), leads to translocation of Nrf2 from the cytosol to the nucleus and expression of detoxifying antioxidant enzymes.  To date, several non-covalent small-mol. Keap1-Nrf2 inhibitors have been identified; however, many of them contain carboxylic acids and are rather large in size, which likely prevents or decreases CNS permeability.  This Perspective describes current small-mol. Keap1-Nrf2 inhibitors with exptl. evidence for the ability to inhibit the Keap1-Nrf2 interaction by binding to Keap1 in a non-covalent manner.  Binding data, biostructural studies, and biol. activity are summarized for the inhibitors, and their potential as CNS tool compds. is discussed by analyzing physicochem. properties, including CNS multiparameter optimization (MPO) scoring algorithms.  Finally, several strategies for identifying CNS-targeting Keap1 inhibitors are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAnObBnG8ca7Vg90H21EOLACvtfcHk0lgCToqKg3p67Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D&md5=0492259af2532169001a1d4ef532fdbb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00358%26sid%3Dliteratum%253Aachs%26aulast%3DPallesen%26aufirst%3DJ.%2BS.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DNon-Covalent%2520Small-Molecule%2520Kelch-like%2520ECH-Associated%2520Protein%25201%25E2%2580%2593Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Keap1%25E2%2580%2593Nrf2%2529%2520Inhibitors%2520and%2520Their%2520Potential%2520for%2520Targeting%2520Central%2520Nervous%2520System%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8088%26epage%3D8103%26doi%3D10.1021%2Facs.jmedchem.8b00358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azad, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, S. B.</span></span> <span> </span><span class="NLM_article-title">Regulation of Autophagy by Reactive OxygenSpecies (ROS): Implications for Cancer Progression and Treatment</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">777</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1089/ars.2008.2270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fars.2008.2270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18828708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlWiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=777-790&issue=4&author=M.+B.+Azadauthor=Y.+Chenauthor=S.+B.+Gibson&title=Regulation+of+Autophagy+by+Reactive+OxygenSpecies+%28ROS%29%3A+Implications+for+Cancer+Progression+and+Treatment&doi=10.1089%2Fars.2008.2270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Autophagy by Reactive Oxygen Species (ROS): Implications for Cancer Progression and Treatment</span></div><div class="casAuthors">Azad, Meghan B.; Chen, Yongqiang; Gibson, Spencer B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">777-790</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) have been identified as signaling mols. in various pathways regulating both cell survival and cell death.  Autophagy, a self-digestion process that degrades intracellular structures in response to stress, such as nutrient starvation, is also involved in both cell survival and cell death.  Alterations in both ROS and autophagy regulation contribute to cancer initiation and progression, and both are targets for developing therapies to induce cell death selectively in cancer cells.  Many stimuli that induce ROS generation also induce autophagy, including nutrient starvation, mitochondrial toxins, hypoxia, and oxidative stress.  Some of these stimuli are under clin. investigation as cancer treatments, such as 2-methoxyestrodial and arsenic trioxide.  Recently, it was demonstrated that ROS can induce autophagy through several distinct mechanisms involving Atg4, catalase, and the mitochondrial electron transport chain (mETC).  This leads to both cell-survival and cell-death responses and could be selective toward cancer cells.  In this review, we give an overview of the roles ROS and autophagy play in cell survival and cell death, and their importance to cancer.  Furthermore, we describe how autophagy is mediated by ROS and the implications of this regulation to cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxdbKzM77o-bVg90H21EOLACvtfcHk0liAb3NAAH8dcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlWiu7Y%253D&md5=44f69c5abd553fd0e4914b49a4346fc9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1089%2Fars.2008.2270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2008.2270%26sid%3Dliteratum%253Aachs%26aulast%3DAzad%26aufirst%3DM.%2BB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGibson%26aufirst%3DS.%2BB.%26atitle%3DRegulation%2520of%2520Autophagy%2520by%2520Reactive%2520OxygenSpecies%2520%2528ROS%2529%253A%2520Implications%2520for%2520Cancer%2520Progression%2520and%2520Treatment%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2009%26volume%3D11%26issue%3D4%26spage%3D777%26epage%3D790%26doi%3D10.1089%2Fars.2008.2270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scherz-shouval, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elazar, Z.</span></span> <span> </span><span class="NLM_article-title">Regulation of Autophagy by ROS : Physiology and Pathology</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2010.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.tibs.2010.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=20728362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=30-38&issue=1&author=R.+Scherz-shouvalauthor=Z.+Elazar&title=Regulation+of+Autophagy+by+ROS%E2%80%AF%3A+Physiology+and+Pathology&doi=10.1016%2Fj.tibs.2010.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of autophagy by ROS: physiology and pathology</span></div><div class="casAuthors">Scherz-Shouval, Ruth; Elazar, Zvulun</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-38</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are small and highly reactive mols. that can oxidize proteins, lipids and DNA.  When tightly controlled, ROS serve as signaling mols. by modulating the activity of the oxidized targets.  Accumulating data point to an essential role for ROS in the activation of autophagy.  Be the outcome of autophagy survival or death and the initiation conditions starvation, pathogens or death receptors, ROS are invariably involved.  The nature of this involvement, however, remains unclear.  Moreover, although connections between ROS and autophagy are obsd. in diverse pathol. conditions, the mode of activation of autophagy and its potential protective role remain incompletely understood.  Notably, recent advances in the field of redox regulation of autophagy focus on the role of mitochondria as a source of ROS and on mitophagy as a means for clearance of ROS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptRenFq2B6YbVg90H21EOLACvtfcHk0liAb3NAAH8dcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFKgtw%253D%253D&md5=249d7f7c7ac185d457044121e80d880a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2010.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2010.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DScherz-shouval%26aufirst%3DR.%26aulast%3DElazar%26aufirst%3DZ.%26atitle%3DRegulation%2520of%2520Autophagy%2520by%2520ROS%25E2%2580%25AF%253A%2520Physiology%2520and%2520Pathology%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2011%26volume%3D36%26issue%3D1%26spage%3D30%26epage%3D38%26doi%3D10.1016%2Fj.tibs.2010.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filomeni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Zio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecconi, F.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress and Autophagy : The Clash between Damage and Metabolic Needs</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1038/cdd.2014.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fcdd.2014.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=25257172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ChsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=377-388&issue=3&author=G.+Filomeniauthor=D.+De+Zioauthor=F.+Cecconi&title=Oxidative+Stress+and+Autophagy%E2%80%AF%3A+The+Clash+between+Damage+and+Metabolic+Needs&doi=10.1038%2Fcdd.2014.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and autophagy: the clash between damage and metabolic needs</span></div><div class="casAuthors">Filomeni, G.; De Zio, D.; Cecconi, F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-388</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autophagy is a catabolic process aimed at recycling cellular components and damaged organelles in response to diverse conditions of stress, such as nutrient deprivation, viral infection and genotoxic stress.  A growing amt. of evidence in recent years argues for oxidative stress acting as the converging point of these stimuli, with reactive oxygen species (ROS) and reactive nitrogen species (RNS) being among the main intracellular signal transducers sustaining autophagy.  This review aims at providing novel insight into the regulatory pathways of autophagy in response to glucose and amino acid deprivation, as well as their tight interconnection with metabolic networks and redox homeostasis.  The role of oxidative and nitrosative stress in autophagy is also discussed in the light of its being harmful for both cellular biomols. and signal mediator through reversible posttranslational modifications of thiol-contg. proteins.  The redox-independent relationship between autophagy and antioxidant response, occurring through the p62/Keap1/Nrf2 pathway, is also addressed in order to provide a wide perspective upon the interconnection between autophagy and oxidative stress.  Herein, we also attempt to afford an overview of the complex crosstalk between autophagy and DNA damage response (DDR), focusing on the main pathways activated upon ROS and RNS overprodn.  Along these lines, the direct and indirect role of autophagy in DDR is dissected in depth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwn5KtqIqiJrVg90H21EOLACvtfcHk0ljQdpKnga_FeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ChsbbN&md5=54ea9102602e513e1b3877599a4b1865</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2014.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2014.150%26sid%3Dliteratum%253Aachs%26aulast%3DFilomeni%26aufirst%3DG.%26aulast%3DDe%2BZio%26aufirst%3DD.%26aulast%3DCecconi%26aufirst%3DF.%26atitle%3DOxidative%2520Stress%2520and%2520Autophagy%25E2%2580%25AF%253A%2520The%2520Clash%2520between%2520Damage%2520and%2520Metabolic%2520Needs%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2015%26volume%3D22%26issue%3D3%26spage%3D377%26epage%3D388%26doi%3D10.1038%2Fcdd.2014.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundaresan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrans, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkel, T.</span></span> <span> </span><span class="NLM_article-title">Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span> (<span class="NLM_issue">5234</span>),  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1126/science.270.5234.296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1126%2Fscience.270.5234.296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=7569979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2MXoslehs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=296-299&issue=5234&author=M.+Sundaresanauthor=Z.+Yuauthor=V.+J.+Ferransauthor=K.+Iraniauthor=T.+Finkel&title=Requirement+for+Generation+of+H2O2+for+Platelet-Derived+Growth+Factor+Signal+Transduction&doi=10.1126%2Fscience.270.5234.296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for generation of H2O2 for platelet-derived growth factor signal transduction</span></div><div class="casAuthors">Sundaresan, Maitrayee; Yu, Zu-Xi; Ferrans, Victor J.; Irani, Kaikobad; Finkel, Toren</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">5234</span>),
    <span class="NLM_cas:pages">296-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Stimulation of rat vascular smooth muscle cells (VSMCs) by platelet-derived growth factor (PDGF) transiently increased the intracellular concn. of hydrogen peroxide (H2O2).  This increase could be blunted by increasing the intracellular concn. of the scavenging enzyme catalase or by the chem. antioxidant N-acetylcysteine.  The response of VSMCs to PDGF, which includes tyrosine phosphorylation, mitogen-activated protein kinase stimulation, DNA synthesis, and chemotaxis, was inhibited when the growth factor-stimulated rise in H2O2 concn. was blocked.  These results suggest that H2O2 may act as a signal-transducing mol., and they suggest a potential mechanism for the cardioprotective effects of antioxidants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY7kya9xgydLVg90H21EOLACvtfcHk0ljQdpKnga_FeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslehs7c%253D&md5=d5c8c7d54f0cbecbe855883fe50d03e6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscience.270.5234.296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.270.5234.296%26sid%3Dliteratum%253Aachs%26aulast%3DSundaresan%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DFerrans%26aufirst%3DV.%2BJ.%26aulast%3DIrani%26aufirst%3DK.%26aulast%3DFinkel%26aufirst%3DT.%26atitle%3DRequirement%2520for%2520Generation%2520of%2520H2O2%2520for%2520Platelet-Derived%2520Growth%2520Factor%2520Signal%2520Transduction%26jtitle%3DScience%26date%3D1995%26volume%3D270%26issue%3D5234%26spage%3D296%26epage%3D299%26doi%3D10.1126%2Fscience.270.5234.296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in Vascular Formation and Development</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1155/2013/374963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2013%2F374963" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=1-14&author=Y.+Zhouauthor=H.+Yanauthor=M.+Guoauthor=J.+Zhuauthor=Q.+Xiaoauthor=L.+Zhang&title=Reactive+Oxygen+Species+in+Vascular+Formation+and+Development&doi=10.1155%2F2013%2F374963"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1155%2F2013%2F374963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F374963%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520Vascular%2520Formation%2520and%2520Development%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D14%26doi%3D10.1155%2F2013%2F374963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazhin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakhanova, S.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in the Immune System</span>. <i>Int. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.3109/08830185.2012.755176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3109%2F08830185.2012.755176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=23617726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslCnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=249-270&issue=3&author=Y.+Yangauthor=A.+V.+Bazhinauthor=J.+Wernerauthor=S.+Karakhanova&title=Reactive+Oxygen+Species+in+the+Immune+System&doi=10.3109%2F08830185.2012.755176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species in the Immune System</span></div><div class="casAuthors">Yang, Yuhui; Bazhin, Alexandr V.; Werner, Jens; Karakhanova, Svetlana</div><div class="citationInfo"><span class="NLM_cas:title">International Reviews of Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-270</span>CODEN:
                <span class="NLM_cas:coden">IRIMEH</span>;
        ISSN:<span class="NLM_cas:issn">0883-0185</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are a group of highly reactive chems. contg. oxygen produced either exogenously or endogenously.  ROS are related to a wide variety of human disorders, such as chronic inflammation, age-related diseases and cancers.  Besides, ROS are also essential for various biol. functions, including cell survival, cell growth, proliferation and differentiation, and immune response.  At present there are a no. of excellent publications including some reviews about functions of these mols. either in normal cell biol. or in pathophysiol.  In this work, we reviewed available information and recent advances about ROS in the main immune cell types and gave summary about functions of these highly reactive mols. both in innate immunity as conservative defense mechanisms and in essential immune cells involved in adaptive immunity, and particularly in immune suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhUSJEYJjbcLVg90H21EOLACvtfcHk0ljfyZjszO4S4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslCnsL4%253D&md5=97ddf4d53073235ea70337eaf25b05ad</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3109%2F08830185.2012.755176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08830185.2012.755176%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBazhin%26aufirst%3DA.%2BV.%26aulast%3DWerner%26aufirst%3DJ.%26aulast%3DKarakhanova%26aufirst%3DS.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520the%2520Immune%2520System%26jtitle%3DInt.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D32%26issue%3D3%26spage%3D249%26epage%3D270%26doi%3D10.3109%2F08830185.2012.755176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selemidis, S.</span></span> <span> </span><span class="NLM_article-title">Targeting Reactive Oxygen Species for Respiratory Infection: Fact or Fancy?</span>. <i>Respirology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1111/resp.13417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fresp.13417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30295360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BB3czmslOhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=15-16&issue=1&author=S.+Selemidis&title=Targeting+Reactive+Oxygen+Species+for+Respiratory+Infection%3A+Fact+or+Fancy%3F&doi=10.1111%2Fresp.13417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting reactive oxygen species for respiratory infection: Fact or fancy?</span></div><div class="casAuthors">Selemidis Stavros; Selemidis Stavros</div><div class="citationInfo"><span class="NLM_cas:title">Respirology (Carlton, Vic.)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDhdgDcof-FZw7prLlxLOzfW6udTcc2ebdkkpguFN_t7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czmslOhtQ%253D%253D&md5=2aded28d9d2a0b8d543819d9d63af870</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fresp.13417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fresp.13417%26sid%3Dliteratum%253Aachs%26aulast%3DSelemidis%26aufirst%3DS.%26atitle%3DTargeting%2520Reactive%2520Oxygen%2520Species%2520for%2520Respiratory%2520Infection%253A%2520Fact%2520or%2520Fancy%253F%26jtitle%3DRespirology%26date%3D2019%26volume%3D24%26issue%3D1%26spage%3D15%26epage%3D16%26doi%3D10.1111%2Fresp.13417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1155/2016/1580967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2016%2F1580967" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1-10&author=X.+Chenauthor=M.+Songauthor=B.+Zhangauthor=Y.+Zhang&title=Reactive+Oxygen+Species+Regulate+T+Cell+Immune+Response+in+the+Tumor+Microenvironment&doi=10.1155%2F2016%2F1580967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1155%2F2016%2F1580967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F1580967%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DReactive%2520Oxygen%2520Species%2520Regulate%2520T%2520Cell%2520Immune%2520Response%2520in%2520the%2520Tumor%2520Microenvironment%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2016%26volume%3D2016%26spage%3D1%26epage%3D10%26doi%3D10.1155%2F2016%2F1580967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">To, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlahos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halls, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reading, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobey, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broughton, B. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starkey, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Sluis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozinovski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, L. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, C. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selemidis, S.</span></span> <span> </span><span class="NLM_article-title">Endosomal NOX2 Oxidase Exacerbates Virus Pathogenicity and Is a Target for Antiviral Therapy</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">69</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-00057-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41467-017-00057-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28701733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC1cjmvFOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=69&issue=1&author=E.+E.+Toauthor=R.+Vlahosauthor=R.+Luongauthor=M.+L.+Hallsauthor=P.+C.+Readingauthor=P.+T.+Kingauthor=C.+Chanauthor=G.+R.+Drummondauthor=C.+G.+Sobeyauthor=B.+R.+S.+Broughtonauthor=M.+R.+Starkeyauthor=R.+Van+Der+Sluisauthor=S.+R.+Lewinauthor=S.+Bozinovskiauthor=L.+A.+J.+O%E2%80%99Neillauthor=T.+Quachauthor=C.+J.+H.+Porterauthor=D.+A.+Brooksauthor=J.+J.+O%E2%80%99Learyauthor=S.+Selemidis&title=Endosomal+NOX2+Oxidase+Exacerbates+Virus+Pathogenicity+and+Is+a+Target+for+Antiviral+Therapy&doi=10.1038%2Fs41467-017-00057-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy</span></div><div class="casAuthors">To Eunice E; Vlahos Ross; Bozinovski Steven; Selemidis Stavros; To Eunice E; Luong Raymond; Chan Christopher; Broughton Brad R S; Selemidis Stavros; Halls Michelle L; Reading Patrick C; King Paul T; Chan Christopher; Drummond Grant R; Sobey Christopher G; Starkey Malcolm R; van der Sluis Renee; Lewin Sharon R; Lewin Sharon R; O'Neill Luke A J; Quach Tim; Porter Christopher J H; Quach Tim; Quach Tim; Porter Christopher J H; Brooks Doug A; O'Leary John J; O'Leary John J; O'Leary John J</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The imminent threat of viral epidemics and pandemics dictates a need for therapeutic approaches that target viral pathology irrespective of the infecting strain.  Reactive oxygen species are ancient processes that protect plants, fungi and animals against invading pathogens including bacteria.  However, in mammals reactive oxygen species production paradoxically promotes virus pathogenicity by mechanisms not yet defined.  Here we identify that the primary enzymatic source of reactive oxygen species, NOX2 oxidase, is activated by single stranded RNA and DNA viruses in endocytic compartments resulting in endosomal hydrogen peroxide generation, which suppresses antiviral and humoral signaling networks via modification of a unique, highly conserved cysteine residue (Cys98) on Toll-like receptor-7.  Accordingly, targeted inhibition of endosomal reactive oxygen species production abrogates influenza A virus pathogenicity.  We conclude that endosomal reactive oxygen species promote fundamental molecular mechanisms of viral pathogenicity, and the specific targeting of this pathogenic process with endosomal-targeted reactive oxygen species inhibitors has implications for the treatment of viral disease.Production of reactive oxygen species is an ancient antimicrobial mechanism, but its role in antiviral defense in mammals is unclear.  Here, To et al. show that virus infection activates endosomal NOX2 oxidase and restricts TLR7 signaling, and that an endosomal NOX2 inhibitor decreases viral pathogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgOfKItXMUyUBuFdjgVNKSfW6udTcc2eZQ7nfDdMTUlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjmvFOhtg%253D%253D&md5=3d4eda2676922e6705101745500849ba</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-00057-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-00057-x%26sid%3Dliteratum%253Aachs%26aulast%3DTo%26aufirst%3DE.%2BE.%26aulast%3DVlahos%26aufirst%3DR.%26aulast%3DLuong%26aufirst%3DR.%26aulast%3DHalls%26aufirst%3DM.%2BL.%26aulast%3DReading%26aufirst%3DP.%2BC.%26aulast%3DKing%26aufirst%3DP.%2BT.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DDrummond%26aufirst%3DG.%2BR.%26aulast%3DSobey%26aufirst%3DC.%2BG.%26aulast%3DBroughton%26aufirst%3DB.%2BR.%2BS.%26aulast%3DStarkey%26aufirst%3DM.%2BR.%26aulast%3DVan%2BDer%2BSluis%26aufirst%3DR.%26aulast%3DLewin%26aufirst%3DS.%2BR.%26aulast%3DBozinovski%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26aulast%3DQuach%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DC.%2BJ.%2BH.%26aulast%3DBrooks%26aufirst%3DD.%2BA.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DJ.%2BJ.%26aulast%3DSelemidis%26aufirst%3DS.%26atitle%3DEndosomal%2520NOX2%2520Oxidase%2520Exacerbates%2520Virus%2520Pathogenicity%2520and%2520Is%2520a%2520Target%2520for%2520Antiviral%2520Therapy%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D69%26doi%3D10.1038%2Fs41467-017-00057-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laforge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frère, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hémadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massaad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoliel, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span> <span> </span><span class="NLM_article-title">Tissue Damage from Neutrophil-Induced Oxidative Stress in COVID-19</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1038/s41577-020-0407-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41577-020-0407-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32728221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVygtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2020&pages=515-516&issue=9&author=M.+Laforgeauthor=C.+Elbimauthor=C.+Fr%C3%A8reauthor=M.+H%C3%A9madiauthor=C.+Massaadauthor=P.+Nussauthor=J.+J.+Benolielauthor=C.+Becker&title=Tissue+Damage+from+Neutrophil-Induced+Oxidative+Stress+in+COVID-19&doi=10.1038%2Fs41577-020-0407-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue damage from neutrophil-induced oxidative stress in COVID-19</span></div><div class="casAuthors">Laforge, Mireille; Elbim, Carole; Frere, Corinne; Hemadi, Miryana; Massaad, Charbel; Nuss, Philippe; Benoliel, Jean-Jacques; Becker, Chrystel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">515-516</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The high neutrophil to lymphocyte ratio obsd. in critically ill patients with COVID-19 is assocd. with excessive levels of reactive oxygen species (ROS), which promote a cascade of biol. events that drive pathol. host responses.  ROS induce tissue damage, thrombosis and red blood cell dysfunction, which contribute to COVID-19 disease severity.  We suggest that free radical scavengers could be beneficial for the most vulnerable patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoacJYd-pg1irVg90H21EOLACvtfcHk0lgOdXwXTv4c4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVygtLvO&md5=20d4ed56aad2a7f1971c7325aea76ad8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fs41577-020-0407-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41577-020-0407-1%26sid%3Dliteratum%253Aachs%26aulast%3DLaforge%26aufirst%3DM.%26aulast%3DElbim%26aufirst%3DC.%26aulast%3DFr%25C3%25A8re%26aufirst%3DC.%26aulast%3DH%25C3%25A9madi%26aufirst%3DM.%26aulast%3DMassaad%26aufirst%3DC.%26aulast%3DNuss%26aufirst%3DP.%26aulast%3DBenoliel%26aufirst%3DJ.%2BJ.%26aulast%3DBecker%26aufirst%3DC.%26atitle%3DTissue%2520Damage%2520from%2520Neutrophil-Induced%2520Oxidative%2520Stress%2520in%2520COVID-19%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2020%26volume%3D20%26issue%3D9%26spage%3D515%26epage%3D516%26doi%3D10.1038%2Fs41577-020-0407-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beckhauser, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis-Oliveira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pasquale, R.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species : Physiological and Physiopathological Effects on Synaptic Plasticity</span>. <i>J. Exp. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">S1</span>),  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.4137/JEN.S39887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.4137%2FJEN.S39887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27625575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotl2ns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=23-48&issue=S1&author=T.+F.+Beckhauserauthor=J.+Francis-Oliveiraauthor=R.+De+Pasquale&title=Reactive+Oxygen+Species%E2%80%AF%3A+Physiological+and+Physiopathological+Effects+on+Synaptic+Plasticity&doi=10.4137%2FJEN.S39887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species: physiological and physiopathological effects on synaptic plasticity</span></div><div class="casAuthors">Beckhauser, Thiago Fernando; Francis-Oliveira, Jose; De Pasquale, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">Suppl.1</span>),
    <span class="NLM_cas:pages">23-48</span>CODEN:
                <span class="NLM_cas:coden">JENOCY</span>;
        ISSN:<span class="NLM_cas:issn">1179-0695</span>.
    
            (<span class="NLM_cas:orgname">Libertas Academica Ltd.</span>)
        </div><div class="casAbstract">In the mammalian central nervous system, reactive oxygen species (ROS) generation is counterbalanced by antioxidant defenses.  When large amts. of ROS accumulate, antioxidant mechanisms become overwhelmed and oxidative cellular stress may occur.  Therefore, ROS are typically characterized as toxic mols., oxidizing membrane lipids, changing the conformation of proteins, damaging nucleic acids, and causing deficits in synaptic plasticity.  High ROS concns. are assocd. with a decline in cognitive functions, as obsd. in some neurodegenerative disorders and agedependent decay of neuroplasticity.  Nevertheless, controlled ROS prodn. provides the optimal redox state for the activation of transductional pathways involved in synaptic changes.  Since ROS may regulate neuronal activity and elicit neg. effects at the same time, the distinction between beneficial and deleterious consequences is unclear.  In this regard, this review assesses current research and describes the main sources of ROS in neurons, specifying their involvement in synaptic plasticity and distinguishing between physiol. and pathol. processes implicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR5VWPv5dTH7Vg90H21EOLACvtfcHk0lgOdXwXTv4c4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotl2ns74%253D&md5=f6279d31e5aacf3f9b3943135c507990</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.4137%2FJEN.S39887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4137%252FJEN.S39887%26sid%3Dliteratum%253Aachs%26aulast%3DBeckhauser%26aufirst%3DT.%2BF.%26aulast%3DFrancis-Oliveira%26aufirst%3DJ.%26aulast%3DDe%2BPasquale%26aufirst%3DR.%26atitle%3DReactive%2520Oxygen%2520Species%25E2%2580%25AF%253A%2520Physiological%2520and%2520Physiopathological%2520Effects%2520on%2520Synaptic%2520Plasticity%26jtitle%3DJ.%2520Exp.%2520Neurosci.%26date%3D2016%26volume%3D10%26issue%3DS1%26spage%3D23%26epage%3D48%26doi%3D10.4137%2FJEN.S39887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liou, G.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storz, P.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in Cancer</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.3109/10715761003667554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3109%2F10715761003667554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=20370557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVyhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=479-496&issue=5&author=G.-Y.+Liouauthor=P.+Storz&title=Reactive+Oxygen+Species+in+Cancer&doi=10.3109%2F10715761003667554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species in cancer</span></div><div class="casAuthors">Liou, Geou-Yarh; Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">479-496</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Elevated rates of reactive oxygen species (ROS) have been detected in almost all cancers, where they promote many aspects of tumor development and progression.  However, tumor cells also express increased levels of antioxidant proteins to detoxify from ROS, suggesting that a delicate balance of intracellular ROS levels is required for cancer cell function.  Further, the radical generated, the location of its generation, as well as the local concn. is important for the cellular functions of ROS in cancer.  A challenge for novel therapeutic strategies will be the fine tuning of intracellular ROS signalling to effectively deprive cells from ROS-induced tumor promoting events, towards tipping the balance to ROS-induced apoptotic signalling.  Alternatively, therapeutic antioxidants may prevent early events in tumor development, where ROS are important.  However, to effectively target cancer cells specific ROS-sensing signalling pathways that mediate the diverse stress-regulated cellular functions need to be identified.  This review discusses the generation of ROS within tumor cells, their detoxification, their cellular effects, as well as the major signalling cascades they utilize, but also provides an outlook on their modulation in therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwtVSe56knA7Vg90H21EOLACvtfcHk0liETyU4QvDfkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVyhu78%253D&md5=74d17b013387120ba165302bd7c282df</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3109%2F10715761003667554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715761003667554%26sid%3Dliteratum%253Aachs%26aulast%3DLiou%26aufirst%3DG.-Y.%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520Cancer%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2010%26volume%3D44%26issue%3D5%26spage%3D479%26epage%3D496%26doi%3D10.3109%2F10715761003667554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reczek, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">The Two Faces of Reactive Oxygen Species in Cancer</span>. <i>Annu. Rev. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1146/annurev-cancerbio-041916-065808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1146%2Fannurev-cancerbio-041916-065808" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2017&pages=79-98&author=C.+R.+Reczekauthor=N.+S.+Chandel&title=The+Two+Faces+of+Reactive+Oxygen+Species+in+Cancer&doi=10.1146%2Fannurev-cancerbio-041916-065808"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1146%2Fannurev-cancerbio-041916-065808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-cancerbio-041916-065808%26sid%3Dliteratum%253Aachs%26aulast%3DReczek%26aufirst%3DC.%2BR.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DThe%2520Two%2520Faces%2520of%2520Reactive%2520Oxygen%2520Species%2520in%2520Cancer%26jtitle%3DAnnu.%2520Rev.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D1%26spage%3D79%26epage%3D98%26doi%3D10.1146%2Fannurev-cancerbio-041916-065808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badana, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murali
Mohan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shailender, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malla, R. R.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species: A Key Constituent in Cancer Survival</span>. <i>Biomarker Insights</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1177/1177271918755391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1177%2F1177271918755391" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1-9&author=S.+Kumariauthor=A.+K.+Badanaauthor=G.+Murali%0AMohanauthor=G.+Shailenderauthor=R.+R.+Malla&title=Reactive+Oxygen+Species%3A+A+Key+Constituent+in+Cancer+Survival&doi=10.1177%2F1177271918755391"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1177%2F1177271918755391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1177271918755391%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DS.%26aulast%3DBadana%26aufirst%3DA.%2BK.%26aulast%3DMurali%2BMohan%26aufirst%3DG.%26aulast%3DShailender%26aufirst%3DG.%26aulast%3DMalla%26aufirst%3DR.%2BR.%26atitle%3DReactive%2520Oxygen%2520Species%253A%2520A%2520Key%2520Constituent%2520in%2520Cancer%2520Survival%26jtitle%3DBiomarker%2520Insights%26date%3D2018%26volume%3D13%26spage%3D1%26epage%3D9%26doi%3D10.1177%2F1177271918755391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanicka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotter, T. G.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase-Generated Hydrogen Peroxide Induces DNA Damage in Mutant FLT3-Expressing Leukemia Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">9348</span>– <span class="NLM_lpage">9361</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.510495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.M113.510495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=25697362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmt1Ohs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=9348-9361&issue=15&author=J.+Stanickaauthor=E.+G.+Russellauthor=J.+F.+Woolleyauthor=T.+G.+Cotter&title=NADPH+Oxidase-Generated+Hydrogen+Peroxide+Induces+DNA+Damage+in+Mutant+FLT3-Expressing+Leukemia+Cells&doi=10.1074%2Fjbc.M113.510495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH oxidase-generated hydrogen peroxide induces DNA damage in mutant FLT3-expressing leukemia cells</span></div><div class="casAuthors">Stanicka, Joanna; Russell, Eileen G.; Woolley, John F.; Cotter, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">9348-9361</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Internal tandem duplication of the FMS-like tyrosine kinase (FLT3-ITD) receptor is present in 20% of acute myeloid leukemia (AML) patients and it has been assocd. with an aggressive AML phenotype.  FLT3-ITD expressing cell lines have been shown to generate increased levels of reactive oxygen species (ROS) and DNA double strand breaks (DSBs).  However, the mol. basis of how FLT3-ITD-driven ROS leads to the aggressive form of AML is not clearly understood.  Our group has previously reported that inhibition of FLT3-ITD signaling results in post-translational down-regulation of p22phox, a small membrane-bound subunit of the NADPH oxidase (NOX) complex.  Here we demonstrated that 32D cells, a myeloblast-like cell line transfected with FLT3-ITD, have a higher protein level of p22phox and p22phox-interacting NOX isoforms than 32D cells transfected with the wild type FLT3 receptor (FLT3-WT).  The inhibition of NOX proteins, p22phox, and NOX protein knockdowns caused a redn. in ROS, as measured with a hydrogen peroxide (H2O2)-specific dye, peroxy orange 1 (PO1), and nuclear H2O2, as measured with nuclear peroxy emerald 1 (NucPE1).  These redns. in the level of H2O2 following the NOX knockdowns were accompanied by a decrease in the no. of DNA DSBs.  We showed that 32D cells that express FLT3-ITD have a higher level of both oxidized DNA and DNA DSBs than their wild type counterparts.  We also obsd. that NOX4 and p22phox localize to the nuclear membrane in MV4-11 cells expressing FLT3-ITD.  Taken together these data indicate that NOX and p22phox mediate the ROS prodn. from FLT3-ITD that signal to the nucleus causing genomic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW8UDk0nrMIrVg90H21EOLACvtfcHk0lhcAwlZ7egFVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmt1Ohs74%253D&md5=da768d255b29d3d90cc65b4c0254d383</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.510495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.510495%26sid%3Dliteratum%253Aachs%26aulast%3DStanicka%26aufirst%3DJ.%26aulast%3DRussell%26aufirst%3DE.%2BG.%26aulast%3DWoolley%26aufirst%3DJ.%2BF.%26aulast%3DCotter%26aufirst%3DT.%2BG.%26atitle%3DNADPH%2520Oxidase-Generated%2520Hydrogen%2520Peroxide%2520Induces%2520DNA%2520Damage%2520in%2520Mutant%2520FLT3-Expressing%2520Leukemia%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D15%26spage%3D9348%26epage%3D9361%26doi%3D10.1074%2Fjbc.M113.510495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrion, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, L.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1155/2017/2525967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2017%2F2525967" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1-11&author=Z.+Liuauthor=T.+Zhouauthor=A.+C.+Zieglerauthor=P.+Dimitrionauthor=L.+Zuo&title=Oxidative+Stress+in+Neurodegenerative+Diseases%3A+From+Molecular+Mechanisms+to+Clinical+Applications&doi=10.1155%2F2017%2F2525967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1155%2F2017%2F2525967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F2525967%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DZiegler%26aufirst%3DA.%2BC.%26aulast%3DDimitrion%26aufirst%3DP.%26aulast%3DZuo%26aufirst%3DL.%26atitle%3DOxidative%2520Stress%2520in%2520Neurodegenerative%2520Diseases%253A%2520From%2520Molecular%2520Mechanisms%2520to%2520Clinical%2520Applications%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D11%26doi%3D10.1155%2F2017%2F2525967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paudel, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parajuli, K.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species : A Key Hallmark of Cardiovascullar Disease</span>. <i>Adv. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1155/2016/9152732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2016%2F9152732" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1-12&author=N.+Panthauthor=K.+R.+Paudelauthor=K.+Parajuli&title=Reactive+Oxygen+Species%E2%80%AF%3A+A+Key+Hallmark+of+Cardiovascullar+Disease&doi=10.1155%2F2016%2F9152732"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1155%2F2016%2F9152732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F9152732%26sid%3Dliteratum%253Aachs%26aulast%3DPanth%26aufirst%3DN.%26aulast%3DPaudel%26aufirst%3DK.%2BR.%26aulast%3DParajuli%26aufirst%3DK.%26atitle%3DReactive%2520Oxygen%2520Species%25E2%2580%25AF%253A%2520A%2520Key%2520Hallmark%2520of%2520Cardiovascullar%2520Disease%26jtitle%3DAdv.%2520Med.%26date%3D2016%26volume%3D2016%26spage%3D1%26epage%3D12%26doi%3D10.1155%2F2016%2F9152732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jha, J. C.</span>; <span class="NLM_string-name">Bose, M.</span>; <span class="NLM_string-name">Jandeleit-Dahm, M.</span></span> <span> </span><span class="NLM_article-title">Modulation of Oxidative Stress in Cardiovascular Diseases</span>. In  <i>Modulation of Oxidative Stress in Heart Disease</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Singapore</span>, <span class="NLM_year">2019</span>; pp  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">253</span>.<span class="refDoi"> DOI: 10.1007/978-981-13-8946-7_10</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2F978-981-13-8946-7_10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=237-253&author=J.+C.+Jha&author=M.+Bose&author=M.+Jandeleit-Dahm&title=Modulation+of+Oxidative+Stress+in+Heart+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2F978-981-13-8946-7_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-981-13-8946-7_10%26sid%3Dliteratum%253Aachs%26aulast%3DJha%26aufirst%3DJ.%2BC.%26atitle%3DModulation%2520of%2520Oxidative%2520Stress%2520in%2520Cardiovascular%2520Diseases%26btitle%3DModulation%2520of%2520Oxidative%2520Stress%2520in%2520Heart%2520Disease%26pub%3DSpringer%26date%3D2019%26spage%3D237%26epage%3D253%26doi%3D10.1007%2F978-981-13-8946-7_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrabi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parvez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabassum, H.</span></span> <span> </span><span class="NLM_article-title">Ischemic Stroke and Mitochondria: Mechanisms and Targets</span>. <i>Protoplasma</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>257</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1007/s00709-019-01439-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs00709-019-01439-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31612315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BB3MnnvVGntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=2020&pages=335-343&issue=2&author=S.+S.+Andrabiauthor=S.+Parvezauthor=H.+Tabassum&title=Ischemic+Stroke+and+Mitochondria%3A+Mechanisms+and+Targets&doi=10.1007%2Fs00709-019-01439-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Ischemic stroke and mitochondria: mechanisms and targets</span></div><div class="casAuthors">Andrabi Syed Suhail; Andrabi Syed Suhail; Parvez Suhel; Tabassum Heena</div><div class="citationInfo"><span class="NLM_cas:title">Protoplasma</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">335-343</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Stroke is one of the main causes of mortality and disability in most countries of the world.  The only way of managing patients with ischemic stroke is the use of intravenous tissue plasminogen activator and endovascular thrombectomy.  However, very few patients receive these treatments as the therapeutic time window is narrow after an ischemic stroke.  The paucity of stroke management approaches can only be addressed by identifying new possible therapeutic targets.  Mitochondria have been a rare target in the clinical management of stroke.  Previous studies have only investigated the bioenergetics and apoptotic roles of this organelle; however, the mitochondrion is now considered as a key organelle that participates in many cellular and molecular functions.  This review discusses the mitochondrial mechanisms in cerebral ischemia such as its role in reactive oxygen species (ROS) generation, apoptosis, and electron transport chain dysfunction.  Understanding the mechanisms of mitochondria in neural cell death during ischemic stroke might help to design new therapeutic targets for ischemic stroke as well as other neurological diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkp58BVUNu9GHOrQ6qeX-mfW6udTcc2ebKoVHEPi-Cu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnnvVGntQ%253D%253D&md5=361ab2bd0c146b064c3b42ebaadc57eb</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs00709-019-01439-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00709-019-01439-2%26sid%3Dliteratum%253Aachs%26aulast%3DAndrabi%26aufirst%3DS.%2BS.%26aulast%3DParvez%26aufirst%3DS.%26aulast%3DTabassum%26aufirst%3DH.%26atitle%3DIschemic%2520Stroke%2520and%2520Mitochondria%253A%2520Mechanisms%2520and%2520Targets%26jtitle%3DProtoplasma%26date%3D2020%26volume%3D257%26issue%3D2%26spage%3D335%26epage%3D343%26doi%3D10.1007%2Fs00709-019-01439-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Revuelta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elicegui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Cugnon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bührer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matheu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, T.</span></span> <span> </span><span class="NLM_article-title">Ischemic Stroke in Neonatal and Adult Astrocytes</span>. <i>Mech. Ageing Dev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">111147</span>, <span class="refDoi"> DOI: 10.1016/j.mad.2019.111147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.mad.2019.111147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31493435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVSru7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2019&pages=111147&author=M.+Revueltaauthor=A.+Eliceguiauthor=L.+Moreno-Cugnonauthor=C.+B%C3%BChrerauthor=A.+Matheuauthor=T.+Schmitz&title=Ischemic+Stroke+in+Neonatal+and+Adult+Astrocytes&doi=10.1016%2Fj.mad.2019.111147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Ischemic stroke in neonatal and adult astrocytes</span></div><div class="casAuthors">Revuelta, Miren; Elicegui, Amaia; Moreno-Cugnon, Leire; Buehrer, Christoph; Matheu, Ander; Schmitz, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Mechanisms of Ageing and Development</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111147</span>CODEN:
                <span class="NLM_cas:coden">MAGDA3</span>;
        ISSN:<span class="NLM_cas:issn">0047-6374</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The objective of this paper is to review current information regarding astrocytes function after a stroke in neonatal and adult brain.  Based on the current literature, there are some mol. differences related to blood brain barrier (BBB) homeostasis disruption, inflammation and reactive oxygen species (ROS) mediated injury between the immature and mature brain after an ischemic event.  In particular, astrocytes, the main glial cells in brain, play a different role in neonatal and adult brain after stroke, as time course of glial activation is strongly age dependent.  Moreover, the present review provides further insight into the therapeutic approaches of using neonatal and adult astrocytes after stroke.  More research will be needed in order to translate them into an effective treatment against stroke, the second main cause of death and disability worldwide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2z6Ucx4O1aLVg90H21EOLACvtfcHk0lgxEGJzhVKHeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVSru7vP&md5=b69f885b3aeedce7ac66768fac9891f4</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.mad.2019.111147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mad.2019.111147%26sid%3Dliteratum%253Aachs%26aulast%3DRevuelta%26aufirst%3DM.%26aulast%3DElicegui%26aufirst%3DA.%26aulast%3DMoreno-Cugnon%26aufirst%3DL.%26aulast%3DB%25C3%25BChrer%26aufirst%3DC.%26aulast%3DMatheu%26aufirst%3DA.%26aulast%3DSchmitz%26aufirst%3DT.%26atitle%3DIschemic%2520Stroke%2520in%2520Neonatal%2520and%2520Adult%2520Astrocytes%26jtitle%3DMech.%2520Ageing%2520Dev.%26date%3D2019%26volume%3D183%26spage%3D111147%26doi%3D10.1016%2Fj.mad.2019.111147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sims, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yew, W. P.</span></span> <span> </span><span class="NLM_article-title">Reactive Astrogliosis in Stroke: Contributions of Astrocytes to Recovery of Neurological Function</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2016.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.neuint.2016.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28057555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFant7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2017&pages=88-103&author=N.+R.+Simsauthor=W.+P.+Yew&title=Reactive+Astrogliosis+in+Stroke%3A+Contributions+of+Astrocytes+to+Recovery+of+Neurological+Function&doi=10.1016%2Fj.neuint.2016.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive astrogliosis in stroke: Contributions of astrocytes to recovery of neurological function</span></div><div class="casAuthors">Sims, Neil R.; Yew, Wai Ping</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-103</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alterations in neuronal connectivity, particularly in the "peri-infarct" tissue adjacent to the region of ischemic damage, are important contributors to the spontaneous recovery of function that commonly follows stroke.  Peri-infarct astrocytes undergo reactive astrogliosis and play key roles in modulating the adaptive responses in neurons.  This reactive astrogliosis shares many features with that induced by other forms of damage to the central nervous system but also differs in details that potentially influence neurol. recovery.  A subpopulation of astrocytes within a few hundred micrometers of the infarct proliferate and are centrally involved in the development of the glial scar that separates the damaged tissue in the infarct from surrounding normal brain.  The intertwined processes of astrocytes adjacent to the infarct provide the core structural component of the mature scar.  Interventions that cause early disruption of glial scar formation typically impede restoration of neurol. function.  Marked reactive astrogliosis also develops in cells more distant from the infarct but these cells largely remain in the spatial territories they occupied prior to stroke.  These cells play important roles in controlling the extracellular environment and release proteins and other mols. that are able to promote neuronal plasticity and improve functional recovery.  Treatments manipulating aspects of reactive astrogliosis can enhance neuronal plasticity following stroke.  Optimizing these treatments for use in human stroke would benefit from a more complete characterization of the specific responses of peri-infarct astrocytes to stroke as well as a better understanding of the influence of other factors including age, sex, comorbidities and reperfusion of the ischemic tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyrP_ujED1sLVg90H21EOLACvtfcHk0lgKjPEefuvcsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFant7o%253D&md5=a86de3bdabf86c7af53efd93fd144dee</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2016.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2016.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DSims%26aufirst%3DN.%2BR.%26aulast%3DYew%26aufirst%3DW.%2BP.%26atitle%3DReactive%2520Astrogliosis%2520in%2520Stroke%253A%2520Contributions%2520of%2520Astrocytes%2520to%2520Recovery%2520of%2520Neurological%2520Function%26jtitle%3DNeurochem.%2520Int.%26date%3D2017%26volume%3D107%26spage%3D88%26epage%3D103%26doi%3D10.1016%2Fj.neuint.2016.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, W.</span></span> <span> </span><span class="NLM_article-title">Mitophagy, a Potential Therapeutic Target for Stroke</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">87</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1186/s12929-018-0487-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1186%2Fs12929-018-0487-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29295709" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=1-16&issue=87&author=R.+Guanauthor=W.+Zouauthor=X.+Daiauthor=X.+Yuauthor=H.+Liuauthor=Q.+Chenauthor=W.+Teng&title=Mitophagy%2C+a+Potential+Therapeutic+Target+for+Stroke&doi=10.1186%2Fs12929-018-0487-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1186%2Fs12929-018-0487-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12929-018-0487-4%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DTeng%26aufirst%3DW.%26atitle%3DMitophagy%252C%2520a%2520Potential%2520Therapeutic%2520Target%2520for%2520Stroke%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2018%26volume%3D25%26issue%3D87%26spage%3D1%26epage%3D16%26doi%3D10.1186%2Fs12929-018-0487-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhandapani, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brann, D. W.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase 2 Regulates NLRP3 Inflammasome Activation in the Brain after Traumatic Brain Injury</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1155/2017/6057609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2017%2F6057609" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1&author=M.+W.+Maauthor=J.+Wangauthor=K.+M.+Dhandapaniauthor=D.+W.+Brann&title=NADPH+Oxidase+2+Regulates+NLRP3+Inflammasome+Activation+in+the+Brain+after+Traumatic+Brain+Injury&doi=10.1155%2F2017%2F6057609"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1155%2F2017%2F6057609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F6057609%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DM.%2BW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDhandapani%26aufirst%3DK.%2BM.%26aulast%3DBrann%26aufirst%3DD.%2BW.%26atitle%3DNADPH%2520Oxidase%25202%2520Regulates%2520NLRP3%2520Inflammasome%2520Activation%2520in%2520the%2520Brain%2520after%2520Traumatic%2520Brain%2520Injury%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2017%26volume%3D2017%26spage%3D1%26doi%3D10.1155%2F2017%2F6057609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngarashi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferdaus, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahid, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabika, T.</span></span> <span> </span><span class="NLM_article-title">Dual Inhibition of NADPH Oxidases and Xanthine Oxidase Potently Prevents Salt-Induced Stroke in Stroke-Prone Spontaneously Hypertensive Rats</span>. <i>Hypertens. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1038/s41440-019-0246-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41440-019-0246-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30850755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2isLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2019&pages=981-989&issue=7&author=D.+Ngarashiauthor=K.+Fujikawaauthor=M.+Z.+Ferdausauthor=H.+M.+Zahidauthor=H.+Oharaauthor=T.+Nabika&title=Dual+Inhibition+of+NADPH+Oxidases+and+Xanthine+Oxidase+Potently+Prevents+Salt-Induced+Stroke+in+Stroke-Prone+Spontaneously+Hypertensive+Rats&doi=10.1038%2Fs41440-019-0246-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition of NADPH oxidases and xanthine oxidase potently prevents salt-induced stroke in stroke-prone spontaneously hypertensive rats</span></div><div class="casAuthors">Ngarashi, Davis; Fujikawa, Koichi; Ferdaus, Mohammed Zubaerul; Zahid, Hasan M.; Ohara, Hiroki; Nabika, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">981-989</span>CODEN:
                <span class="NLM_cas:coden">HRESE4</span>;
        ISSN:<span class="NLM_cas:issn">0916-9636</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Oxidative stress has been implicated in the pathophysiol. of cerebral stroke.  As NADPH oxidases (NOXs) play major roles in the regulation of oxidative stress, we hypothesized that redn. of NOX activity by depletion of p22phox, an essential subunit of NOX complexes, would prevent cerebral stroke.  To investigate this, we used the stroke-prone spontaneously hypertensive rat (SHRSP) and the p22phox-deleted congenic SHRSP.  Although p22phox depletion reduced blood pressure under salt loading, it did not ameliorate oxidative stress or reduce the incidence of salt-induced stroke in SHRSPs.  Addnl. pharmacol. redn. of oxidative stress using antioxidant reagents with different mechanisms of action was necessary to prevent stroke, indicating that NOX was not the major target in salt-induced stroke in SHRSPs.  On the other hand, oxidative stress measured based on urinary isoprostane levels showed significant correlations with blood pressure, stroke latency and urinary protein excretion under salt loading, suggesting an important role of oxidative stress per se in hypertension and hypertensive organ damage.  Overall, our results imply that oxidative stress from multiple sources influences stroke susceptibility and other hypertensive disorders in salt-loaded SHRSPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD9dnMA4JitLVg90H21EOLACvtfcHk0ljntqBuy9TCYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2isLvJ&md5=54a5a57bb2cf697cff93f5076b10297c</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fs41440-019-0246-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41440-019-0246-2%26sid%3Dliteratum%253Aachs%26aulast%3DNgarashi%26aufirst%3DD.%26aulast%3DFujikawa%26aufirst%3DK.%26aulast%3DFerdaus%26aufirst%3DM.%2BZ.%26aulast%3DZahid%26aufirst%3DH.%2BM.%26aulast%3DOhara%26aufirst%3DH.%26aulast%3DNabika%26aufirst%3DT.%26atitle%3DDual%2520Inhibition%2520of%2520NADPH%2520Oxidases%2520and%2520Xanthine%2520Oxidase%2520Potently%2520Prevents%2520Salt-Induced%2520Stroke%2520in%2520Stroke-Prone%2520Spontaneously%2520Hypertensive%2520Rats%26jtitle%3DHypertens.%2520Res.%26date%3D2019%26volume%3D42%26issue%3D7%26spage%3D981%26epage%3D989%26doi%3D10.1038%2Fs41440-019-0246-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calmettes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, J. N.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species Production Induced by Pore Opening in Cardiac Mitochondria: The Role of Complex II</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">9896</span>– <span class="NLM_lpage">9905</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.768325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.M116.768325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28450394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVShtLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=9896-9905&issue=24&author=P.+Korgeauthor=S.+A.+Johnauthor=G.+Calmettesauthor=J.+N.+Weiss&title=Reactive+Oxygen+Species+Production+Induced+by+Pore+Opening+in+Cardiac+Mitochondria%3A+The+Role+of+Complex+II&doi=10.1074%2Fjbc.M116.768325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species production induced by pore opening in cardiac mitochondria: The role of complex II</span></div><div class="casAuthors">Korge, Paavo; John, Scott A.; Calmettes, Guillaume; Weiss, James N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9896-9905</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Succinate-driven reverse electron transport (RET) through complex I is hypothesized to be a major source of reactive oxygen species (ROS) that induces permeability transition pore (PTP) opening and damages the heart during ischemia/reperfusion.  Because RET can only generate ROS when mitochondria are fully polarized, this mechanism is self-limiting once PTP opens during reperfusion.  In an accompanying article, we showed that ROS prodn. after PTP opening could be sustained when complex III was damaged (simulated by antimycin).  Here, we show that complex II can also contribute to sustained ROS prodn. in isolated rabbit cardiac mitochondria following inner membrane pore formation induced by either alamethicin or Ca2+-induced PTP opening.  Two conditions were required to maximize malonate-sensitive ROS prodn. by complex II in isolated mitochondria: (1) complex II inhibition by atpenin A5 or complex III inhibition by stigmatellin that results in succinate-dependent redn. of the dicarboxylate-binding site of complex II (site IIf) and (2) pore opening in the inner membrane resulting in rapid efflux of succinate/fumarate and other dicarboxylates capable of competitively binding to site IIf.  The decrease in matrix [dicarboxylate] allowed O2 access to reduced site IIf, thereby making electron donation to O2 possible, explaining the rapid increase in ROS prodn. provided that site IIf was reduced.  Because ischemia is known to inhibit complexes II and III and increase matrix succinate/fumarate levels, we hypothesized that by allowing dicarboxylate efflux from the matrix, PTP opening during reperfusion may activate sustained ROS prodn. by this mechanism after RET-driven ROS prodn. has ceased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFSD3K9nl2_rVg90H21EOLACvtfcHk0ljntqBuy9TCYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVShtLzP&md5=6b97ade06bf3f75f7a446a3a24b9be38</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.768325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.768325%26sid%3Dliteratum%253Aachs%26aulast%3DKorge%26aufirst%3DP.%26aulast%3DJohn%26aufirst%3DS.%2BA.%26aulast%3DCalmettes%26aufirst%3DG.%26aulast%3DWeiss%26aufirst%3DJ.%2BN.%26atitle%3DReactive%2520Oxygen%2520Species%2520Production%2520Induced%2520by%2520Pore%2520Opening%2520in%2520Cardiac%2520Mitochondria%253A%2520The%2520Role%2520of%2520Complex%2520II%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D24%26spage%3D9896%26epage%3D9905%26doi%3D10.1074%2Fjbc.M116.768325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaludercic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Lisa, F.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy</span>. <i>Front. Cardiovasc. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.3389/fcvm.2020.00012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3389%2Ffcvm.2020.00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32039241" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2020&pages=1-15&author=N.+Kaludercicauthor=F.+Di+Lisa&title=Mitochondrial+ROS+Formation+in+the+Pathogenesis+of+Diabetic+Cardiomyopathy&doi=10.3389%2Ffcvm.2020.00012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3389%2Ffcvm.2020.00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcvm.2020.00012%26sid%3Dliteratum%253Aachs%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DDi%2BLisa%26aufirst%3DF.%26atitle%3DMitochondrial%2520ROS%2520Formation%2520in%2520the%2520Pathogenesis%2520of%2520Diabetic%2520Cardiomyopathy%26jtitle%3DFront.%2520Cardiovasc.%2520Med.%26date%3D2020%26volume%3D7%26spage%3D1%26epage%3D15%26doi%3D10.3389%2Ffcvm.2020.00012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asmat, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismail, K.</span></span> <span> </span><span class="NLM_article-title">Diabetes Mellitus and Oxidative Stress-A Concise Review</span>. <i>Saudi Pharm. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1016/j.jsps.2015.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.jsps.2015.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27752226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC2srhsFOisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=547-553&issue=5&author=U.+Asmatauthor=K.+Abadauthor=K.+Ismail&title=Diabetes+Mellitus+and+Oxidative+Stress-A+Concise+Review&doi=10.1016%2Fj.jsps.2015.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Diabetes mellitus and oxidative stress-A concise review</span></div><div class="casAuthors">Asmat Ullah; Abad Khan; Ismail Khan</div><div class="citationInfo"><span class="NLM_cas:title">Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">547-553</span>
        ISSN:<span class="NLM_cas:issn">1319-0164</span>.
    </div><div class="casAbstract">Human body is continuously exposed to different types of agents that results in the production of reactive species called as free radicals (ROS/RNS) which by the transfer of their free unpaired electron causes the oxidation of cellular machinery.  In order to encounter the deleterious effects of such species, body has got endogenous antioxidant systems or it obtains exogenous antioxidants from diet that neutralizes such species and keeps the homeostasis of body.  Any imbalance between the RS and antioxidants leads to produce a condition known as "oxidative stress" that results in the development of pathological condition among which one is diabetes.  Most of the studies reveal the inference of oxidative stress in diabetes pathogenesis by the alteration in enzymatic systems, lipid peroxidation, impaired Glutathione metabolism and decreased Vitamin C levels.  Lipids, proteins, DNA damage, Glutathione, catalane and superoxide dismutase are various biomarkers of oxidative stress in diabetes mellitus.  Oxidative stress induced complications of diabetes may include stroke, neuropathy, retinopathy and nephropathy.  The basic aim of this review was to summarize the basics of oxidative stress in diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwn9gu9848Z5dYoSR9eyvsfW6udTcc2eYQfRocnvL_w7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srhsFOisQ%253D%253D&md5=5650d4a24d863ddeb5ab1dcb0a55601c</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.jsps.2015.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsps.2015.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DAsmat%26aufirst%3DU.%26aulast%3DAbad%26aufirst%3DK.%26aulast%3DIsmail%26aufirst%3DK.%26atitle%3DDiabetes%2520Mellitus%2520and%2520Oxidative%2520Stress-A%2520Concise%2520Review%26jtitle%3DSaudi%2520Pharm.%2520J.%26date%3D2016%26volume%3D24%26issue%3D5%26spage%3D547%26epage%3D553%26doi%3D10.1016%2Fj.jsps.2015.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fakhruddin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alanazi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, K. E.</span></span> <span> </span><span class="NLM_article-title">Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury</span>. <i>J. Diabetes Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1155/2017/8379327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2017%2F8379327" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1-30&author=S.+Fakhruddinauthor=W.+Alanaziauthor=K.+E.+Jackson&title=Diabetes-Induced+Reactive+Oxygen+Species%3A+Mechanism+of+Their+Generation+and+Role+in+Renal+Injury&doi=10.1155%2F2017%2F8379327"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1155%2F2017%2F8379327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F8379327%26sid%3Dliteratum%253Aachs%26aulast%3DFakhruddin%26aufirst%3DS.%26aulast%3DAlanazi%26aufirst%3DW.%26aulast%3DJackson%26aufirst%3DK.%2BE.%26atitle%3DDiabetes-Induced%2520Reactive%2520Oxygen%2520Species%253A%2520Mechanism%2520of%2520Their%2520Generation%2520and%2520Role%2520in%2520Renal%2520Injury%26jtitle%3DJ.%2520Diabetes%2520Res.%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D30%26doi%3D10.1155%2F2017%2F8379327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemberg, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaitsev, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleason, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cell.2012.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22632970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1060-1072&issue=5&author=S.+J.+Dixonauthor=K.+M.+Lembergauthor=M.+R.+Lamprechtauthor=R.+Skoutaauthor=E.+M.+Zaitsevauthor=C.+E.+Gleasonauthor=D.+N.+Patelauthor=A.+J.+Bauerauthor=A.+M.+Cantleyauthor=W.+S.+Yangauthor=B.+Morrisonauthor=B.+R.+Stockwell&title=Ferroptosis%3A+An+Iron-Dependent+Form+of+Nonapoptotic+Cell+Death&doi=10.1016%2Fj.cell.2012.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death</span></div><div class="casAuthors">Dixon, Scott J.; Lemberg, Kathryn M.; Lamprecht, Michael R.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Morrison, Barclay; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathol. states.  The oncogenic RAS-selective lethal small mol. erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis.  Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphol., biochem., and genetically distinct from apoptosis, necrosis, and autophagy.  We identify the small mol. ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes.  Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system xc-), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death.  Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzDzMapViBQ7Vg90H21EOLACvtfcHk0lg_QzfTcO60lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D&md5=5d3b8c55a053dfde7e758cc1701ef71b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DLemberg%26aufirst%3DK.%2BM.%26aulast%3DLamprecht%26aufirst%3DM.%2BR.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DZaitsev%26aufirst%3DE.%2BM.%26aulast%3DGleason%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DD.%2BN.%26aulast%3DBauer%26aufirst%3DA.%2BJ.%26aulast%3DCantley%26aufirst%3DA.%2BM.%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520An%2520Iron-Dependent%2520Form%2520of%2520Nonapoptotic%2520Cell%2520Death%26jtitle%3DCell%26date%3D2012%26volume%3D149%26issue%3D5%26spage%3D1060%26epage%3D1072%26doi%3D10.1016%2Fj.cell.2012.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Latunde-Dada, G. O.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: Role of Lipid Peroxidation, Iron and Ferritinophagy</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1861</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1893</span>– <span class="NLM_lpage">1900</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2017.05.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.bbagen.2017.05.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28552631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1ektrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1861&publication_year=2017&pages=1893-1900&issue=8&author=G.+O.+Latunde-Dada&title=Ferroptosis%3A+Role+of+Lipid+Peroxidation%2C+Iron+and+Ferritinophagy&doi=10.1016%2Fj.bbagen.2017.05.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy</span></div><div class="casAuthors">Latunde-Dada, Gladys O.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1861</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1893-1900</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a form of regulated cell death that is dependent on iron and reactive oxygen species (ROS) and is characterized by lipid peroxidn.  It is morphol. and biochem. distinct and disparate from other processes of cell death.  As ferroptosis is induced by inhibition of cysteine uptake or inactivation of the lipid repair enzyme glutathione peroxidase 4 (GPX4), the process is favored by chem. or mutational inhibition of the cystine/glutamate antiporter and culminates in the accumulation of reactive oxygen species (ROS) in the form of lipid hydroperoxides.  Excessive lipid peroxidn. leads to death by ferroptosis and the phenotype is accentuated resp. by the repletion and depletion of iron and glutathione in cells.  Furthermore, oxidized phosphatidylethanolamines (PE) harboring arachidonoyl (AA) and adrenoyl moieties (AdA) have been shown as proximate executioners of ferroptosis.  Induction of ferroptosis due to cysteine depletion leads to the degrdn. of ferritin (i.e. ferritinophagy), which releases iron via the NCOA4-mediated autophagy pathway.  Evidence of the manifestation of ferroptosis in vivo in iron overload mice mutants is emerging.  Thus, a concerted synchronization of iron availability, ROS generation, glutamate excess and cysteine deficit leads to ferroptosis.  A no. of questions on the mol. mechanisms of some features of ferroptosis are highlighted as subjects for future investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9y7eDu1zclbVg90H21EOLACvtfcHk0lg_QzfTcO60lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1ektrk%253D&md5=d7fee5296d4774497c55b610b0e85d58</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2017.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2017.05.019%26sid%3Dliteratum%253Aachs%26aulast%3DLatunde-Dada%26aufirst%3DG.%2BO.%26atitle%3DFerroptosis%253A%2520Role%2520of%2520Lipid%2520Peroxidation%252C%2520Iron%2520and%2520Ferritinophagy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2017%26volume%3D1861%26issue%3D8%26spage%3D1893%26epage%3D1900%26doi%3D10.1016%2Fj.bbagen.2017.05.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span> <span> </span><span class="NLM_article-title">The Metabolic Underpinnings of Ferroptosis</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2020.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cmet.2020.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=33217331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVyntLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2020&pages=920-937&issue=6&author=J.+Zhengauthor=M.+Conrad&title=The+Metabolic+Underpinnings+of+Ferroptosis&doi=10.1016%2Fj.cmet.2020.10.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">The Metabolic Underpinnings of Ferroptosis</span></div><div class="casAuthors">Zheng, Jiashuo; Conrad, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">920-937</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Acute or chronic cellular stress resulting from aberrant metabolic and biochem. processes may trigger a pervasive non-apoptotic form of cell death, generally known as ferroptosis.  Ferroptosis is unique among the different cell death modalities, as it has been mostly linked to pathophysiol. conditions and because several metabolic pathways, such as (seleno)thiol metab., fatty acid metab., iron handling, mevalonate pathway, and mitochondrial respiration, directly impinge on the cells' sensitivity toward lipid peroxidn. and ferroptosis.  Addnl., key cellular redox systems, such as selenium-dependent glutathione peroxidase 4 and the NAD(P)H/ferroptosis suppressor protein-1/ubiquinone axis, are at play that constantly surveil and neutralize oxidative damage to cellular membranes.  Since this form of cell death emerges to be the root cause of a no. of diseases and since it offers various pharmacol. tractable nodes for therapeutic intervention, there has been overwhelming interest in the last few years aiming for a better mol. understanding of the ferroptotic death process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUEuMthPCIOrVg90H21EOLACvtfcHk0lg_QzfTcO60lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVyntLrK&md5=0e3fb5c87dead6d92537694393196aba</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2020.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2020.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DConrad%26aufirst%3DM.%26atitle%3DThe%2520Metabolic%2520Underpinnings%2520of%2520Ferroptosis%26jtitle%3DCell%2520Metab.%26date%3D2020%26volume%3D32%26issue%3D6%26spage%3D920%26epage%3D937%26doi%3D10.1016%2Fj.cmet.2020.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swarup, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwind, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seravalli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansing, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emma, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hondal, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cave, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagdullaev, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karuppagounder, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratan, R. R.</span></span> <span> </span><span class="NLM_article-title">Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>177</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1279.e25</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2019.03.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cell.2019.03.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31056284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovVOmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2019&pages=1262-1279.e25&issue=5&author=I.+Alimauthor=J.+T.+Caulfieldauthor=Y.+Chenauthor=V.+Swarupauthor=D.+H.+Geschwindauthor=E.+Ivanovaauthor=J.+Seravalliauthor=Y.+Aiauthor=L.+H.+Sansingauthor=E.+J.+Emmaauthor=R.+J.+Hondalauthor=S.+Mukherjeeauthor=J.+W.+Caveauthor=B.+T.+Sagdullaevauthor=S.+S.+Karuppagounderauthor=R.+R.+Ratan&title=Selenium+Drives+a+Transcriptional+Adaptive+Program+to+Block+Ferroptosis+and+Treat+Stroke&doi=10.1016%2Fj.cell.2019.03.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke</span></div><div class="casAuthors">Alim, Ishraq; Caulfield, Joseph T.; Chen, Yingxin; Swarup, Vivek; Geschwind, Daniel H.; Ivanova, Elena; Seravalli, Javier; Ai, Youxi; Sansing, Lauren H.; Ste. Marie, Emma J.; Hondal, Robert J.; Mukherjee, Sushmita; Cave, John W.; Sagdullaev, Botir T.; Karuppagounder, Saravanan S.; Ratan, Rajiv R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1262-1279.e25</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Ferroptosis, a non-apoptotic form of programmed cell death, is triggered by oxidative stress in cancer, heat stress in plants, and hemorrhagic stroke.  A homeostatic transcriptional response to ferroptotic stimuli is unknown.  We show that neurons respond to ferroptotic stimuli by induction of selenoproteins, including antioxidant glutathione peroxidase 4 (GPX4).  Pharmacol. selenium (Se) augments GPX4 and other genes in this transcriptional program, the selenome, via coordinated activation of the transcription factors TFAP2c and Sp1 to protect neurons.  Remarkably, a single dose of Se delivered into the brain drives antioxidant GPX4 expression, protects neurons, and improves behavior in a hemorrhagic stroke model.  Altogether, we show that pharmacol. Se supplementation effectively inhibits GPX4-dependent ferroptotic death as well as cell death induced by excitotoxicity or ER stress, which are GPX4 independent.  Systemic administration of a brain-penetrant selenopeptide activates homeostatic transcription to inhibit cell death and improves function when delivered after hemorrhagic or ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-L0sQKjjFEbVg90H21EOLACvtfcHk0lhFZrkACA4SPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovVOmtr8%253D&md5=015bfffdefacade3893519cedf4cfa87</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2019.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2019.03.032%26sid%3Dliteratum%253Aachs%26aulast%3DAlim%26aufirst%3DI.%26aulast%3DCaulfield%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSwarup%26aufirst%3DV.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DIvanova%26aufirst%3DE.%26aulast%3DSeravalli%26aufirst%3DJ.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DSansing%26aufirst%3DL.%2BH.%26aulast%3DEmma%26aufirst%3DE.%2BJ.%26aulast%3DHondal%26aufirst%3DR.%2BJ.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DCave%26aufirst%3DJ.%2BW.%26aulast%3DSagdullaev%26aufirst%3DB.%2BT.%26aulast%3DKaruppagounder%26aufirst%3DS.%2BS.%26aulast%3DRatan%26aufirst%3DR.%2BR.%26atitle%3DSelenium%2520Drives%2520a%2520Transcriptional%2520Adaptive%2520Program%2520to%2520Block%2520Ferroptosis%2520and%2520Treat%2520Stroke%26jtitle%3DCell%26date%3D2019%26volume%3D177%26issue%3D5%26spage%3D1262%26epage%3D1279.e25%26doi%3D10.1016%2Fj.cell.2019.03.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belavgeni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornstein, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Mässenhausen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonnus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Othmar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanczkowski, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroiss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hantel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassnacht, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krone, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span> <span> </span><span class="NLM_article-title">Exquisite Sensitivity of Adrenocortical Carcinomas to Induction of Ferroptosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">22269</span>– <span class="NLM_lpage">22274</span>, <span class="refDoi"> DOI: 10.1073/pnas.1912700116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1073%2Fpnas.1912700116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31611400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVOhtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=22269-22274&issue=44&author=A.+Belavgeniauthor=S.+R.+Bornsteinauthor=A.+Von+M%C3%A4ssenhausenauthor=W.+Tonnusauthor=J.+Stumpfauthor=C.+Meyerauthor=E.+Othmarauthor=M.+Latkauthor=W.+Kanczkowskiauthor=M.+Kroissauthor=C.+Hantelauthor=C.+Hugoauthor=M.+Fassnachtauthor=C.+G.+Zieglerauthor=A.+V.+Schallyauthor=N.+P.+Kroneauthor=A.+Linkermann&title=Exquisite+Sensitivity+of+Adrenocortical+Carcinomas+to+Induction+of+Ferroptosis&doi=10.1073%2Fpnas.1912700116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis</span></div><div class="casAuthors">Belavgeni, Alexia; Bornstein, Stefan R.; von Massenhausen, Anne; Tonnus, Wulf; Stumpf, Julian; Meyer, Claudia; Othmar, Evelyn; Latk, Markus; Kanczkowski, Waldemar; Kroiss, Matthias; Hantel, Constanze; Hugo, Christian; Fassnacht, Martin; Ziegler, Christian G.; Schally, Andrew V.; Krone, Nils P.; Linkermann, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">22269-22274</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Adrenocortical carcinomas (ACCs) are rare and highly malignant cancers assocd. with poor survival of patients.  Currently, mitotane, a nonspecific deriv. of the pesticide DDT (1,1-(dichlorobiphenyl)-2,2-dichloroethane), is used as the std. treatment, but its mechanism of action in ACCs remains elusive.  Here we demonstrate that the human ACC NCI-H295R cell line is remarkably sensitive to induction of ferroptosis, while mitotane does not induce this iron-dependent mode of regulated necrosis.  Supplementation with insulin, transferrin, and selenium (ITS) is commonly used to keep NCI-H295R cells in cell culture.  We show that this supplementation prevents spontaneous ferroptosis, esp. when it contains polyunsatd. fatty acids (PUFAs), such as linoleic acid.  Inhibitors of apoptosis (zVAD, emricasan) do not prevent the mitotane-induced cell death but morphol. prevent membrane blebbing.  The expression of glutathione peroxidase 4 (GPX4) in H295R cells, however, is significantly higher when compared to HT1080 fibrosarcoma cells, suggesting a role for ferroptosis.  Direct inhibition of GPX4 in H295R cells led to high necrotic populations compared to control, while cotreatment with ferrostatin-1 (Fer-1) completely reverted ferroptosis.  Interestingly, the anal. of public databases revealed that several key players of the ferroptosis pathway are hypermethylated and/or mutated in human ACCs.  Finally, we also detected that growth hormone-releasing hormone (GHRH) antagonists, such as MIA602, kill H295R cells in a nonapoptotic manner.  In summary, we found elevated expression of GPX4 and higher sensitivity to ferroptosis in ACCs.  We hypothesize that instead of treatment with mitotane, human adrenocortical carcinomas may be much more sensitive to induction of ferroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9XsAECLe-BrVg90H21EOLACvtfcHk0ljYkdalPP4eWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVOhtLbF&md5=2cfa61e0d4cc9b05d73217ae22ee53c3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1912700116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1912700116%26sid%3Dliteratum%253Aachs%26aulast%3DBelavgeni%26aufirst%3DA.%26aulast%3DBornstein%26aufirst%3DS.%2BR.%26aulast%3DVon%2BM%25C3%25A4ssenhausen%26aufirst%3DA.%26aulast%3DTonnus%26aufirst%3DW.%26aulast%3DStumpf%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DC.%26aulast%3DOthmar%26aufirst%3DE.%26aulast%3DLatk%26aufirst%3DM.%26aulast%3DKanczkowski%26aufirst%3DW.%26aulast%3DKroiss%26aufirst%3DM.%26aulast%3DHantel%26aufirst%3DC.%26aulast%3DHugo%26aufirst%3DC.%26aulast%3DFassnacht%26aufirst%3DM.%26aulast%3DZiegler%26aufirst%3DC.%2BG.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26aulast%3DKrone%26aufirst%3DN.%2BP.%26aulast%3DLinkermann%26aufirst%3DA.%26atitle%3DExquisite%2520Sensitivity%2520of%2520Adrenocortical%2520Carcinomas%2520to%2520Induction%2520of%2520Ferroptosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26issue%3D44%26spage%3D22269%26epage%3D22274%26doi%3D10.1073%2Fpnas.1912700116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gurevich, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurevich, V. V.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Potential of Small Molecules and Engineered Proteins</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>219</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1007/978-3-642-41199-1_1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2F978-3-642-41199-1_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24292822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFOhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=2014&pages=1-12&author=E.+V.+Gurevichauthor=V.+V.+Gurevich&title=Therapeutic+Potential+of+Small+Molecules+and+Engineered+Proteins&doi=10.1007%2F978-3-642-41199-1_1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Small Molecules and Engineered Proteins</span></div><div class="casAuthors">Gurevich, Eugenia V.; Gurevich, Vsevolod V.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">Arrestins</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Virtually all currently used therapeutic agents are small mols., largely because the development and delivery of small mol. drugs is relatively straightforward.  Small mols. have serious limitations: drugs of this type can be fairly good enzyme inhibitors, receptor ligands, or allosteric modulators.  However, most cellular functions are mediated by protein interactions with other proteins, and targeting protein-protein interactions by small mols. presents challenges that are unlikely to be overcome with these compds. as the only tools.  Recent advances in gene delivery techniques and characterization of cell type-specific promoters open the prospect of using reengineered signaling-biased proteins as next-generation therapeutics.  The first steps in targeted engineering of proteins with desired functional characteristics look very promising.  As quintessential scaffolds that act strictly via interactions with other proteins in the cell, arrestins represent a perfect model for the development of these novel therapeutic agents with enormous potential: custom-designed signaling proteins will allow us to tell the cell what to do and when to do it in a way it cannot disobey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBZ0F6zAOUM7Vg90H21EOLACvtfcHk0lgvE2qXKdXnww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFOhu78%253D&md5=3aac593512d8fb34ec56c72c0f8b4ae9</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-41199-1_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-41199-1_1%26sid%3Dliteratum%253Aachs%26aulast%3DGurevich%26aufirst%3DE.%2BV.%26aulast%3DGurevich%26aufirst%3DV.%2BV.%26atitle%3DTherapeutic%2520Potential%2520of%2520Small%2520Molecules%2520and%2520Engineered%2520Proteins%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2014%26volume%3D219%26spage%3D1%26epage%3D12%26doi%3D10.1007%2F978-3-642-41199-1_1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chocry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leloup, L.</span></span> <span> </span><span class="NLM_article-title">The NADPH Oxidase Family and Its Inhibitors</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1089/ars.2019.7915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fars.2019.7915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31826639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFyitrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2020&pages=332-353&author=M.+Chocryauthor=L.+Leloup&title=The+NADPH+Oxidase+Family+and+Its+Inhibitors&doi=10.1089%2Fars.2019.7915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The NADPH Oxidase Family and Its Inhibitors</span></div><div class="casAuthors">Chocry, Mathieu; Leloup, Ludovic</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">332-353</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: The oxidative stress, resulting from an imbalance in the prodn. and scavenging of reactive oxygen species (ROS), is known to be involved in the development and progression of several pathologies.  The excess of ROS prodn. is often due to an overactivation of NADP (NADPH) oxidases (NOX) and for this reason these enzymes became promising therapeutic targets.  However, even if NOX are now well characterized, the development of new therapies is limited by the lack of highly isoform-specific inhibitors.  Recent Advances: In the past decade, several groups and labs. have screened thousands of mols. to identify new specific inhibitors with low off-target effects.  These works have led to the characterization of several new potent NOX inhibitors; however, their specificity varies a lot depending on the mols.  Crit. Issues: Here, we are reviewing more than 25 known NOX inhibitors, focusing mainly on the newly identified ones such as APX-115, NOS31, Phox-I1 and 2, GLX7013114, and GSK2795039.  To have a better overall view of these mols., the inhibitors were classified according to their specificity, from pan-NOX inhibitors to highly isoform-specific ones.  We are also presenting the use of these compds. both in vitro and in vivo.  Future Directions: Several of these new mols. are potent and very specific inhibitors that could be good candidates for the development of new drugs.  Even if the results are very promising, most of these compds. were only validated in vitro or in mice models and further investigations will be required before using them as potential therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_LEFSki4Kn7Vg90H21EOLACvtfcHk0lgvE2qXKdXnww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFyitrzJ&md5=702fec90994e7bf4141b4c66dea8eb2d</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1089%2Fars.2019.7915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2019.7915%26sid%3Dliteratum%253Aachs%26aulast%3DChocry%26aufirst%3DM.%26aulast%3DLeloup%26aufirst%3DL.%26atitle%3DThe%2520NADPH%2520Oxidase%2520Family%2520and%2520Its%2520Inhibitors%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2020%26volume%3D33%26spage%3D332%26epage%3D353%26doi%3D10.1089%2Fars.2019.7915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haenen, G. R. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bast, A.</span></span> <span> </span><span class="NLM_article-title">Glutathione Revisited : A Better Scavenger than Previously Thought</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.3389/fphar.2014.00260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3389%2Ffphar.2014.00260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24478702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSjs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1-5&author=G.+R.+M.+M.+Haenenauthor=A.+Bast&title=Glutathione+Revisited%E2%80%AF%3A+A+Better+Scavenger+than+Previously+Thought&doi=10.3389%2Ffphar.2014.00260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione revisited: a better scavenger than previously thought</span></div><div class="casAuthors">Haenen, Guido R. M. M.; Bast, Aalt</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Glutathione (GSH) is the classical example of a scavenging antioxidant.  It forms the first line of defense and efficiently scavenges reactive species, e.g., hypochlorous acid (HOCl), before they inflict damage to biomols.  Scavenging antioxidant activity is best established in competition assays (that closely mimics mol. mechanism of the biol. effect).  In this type of assay, the antioxidant competes with a mol. that functions as an easy read-out detector for a reactive species.  It is generally assumed that the scavenging antioxidant activity reflects the reaction rate const. of the antioxidant with the reactive species (ka).  However, crit. appraisal of several competition assays of GSH with HOCl as reactive species, reveals that ka does not det. the scavenging antioxidant activity.  Assays using acetylcholine esterase, alpha1-antiprotease, methionine, and albumin as detector are compared.  The total no. of mols. of the reactive species scavenged by GSH plus that by partially oxidized forms of the GSH, reflect the scavenging activity of GSH.  The contribution of the partially oxidized forms of GSH depends on the reactivity of the competing mol.  In several assays the partially oxidized forms of GSH have a substantial contribution to the scavenging activity of GSH.  In contrast to the prevailing perception, not the reaction rate but rather the total no. of mols. of the reactive species scavenged reflects the true scavenging activity of an antioxidant like GSH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUJuGoXVC-aLVg90H21EOLACvtfcHk0lhqJn4uH5erwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSjs73N&md5=ccc6f762f951cc5afb7314b8b75efe8f</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2014.00260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2014.00260%26sid%3Dliteratum%253Aachs%26aulast%3DHaenen%26aufirst%3DG.%2BR.%2BM.%2BM.%26aulast%3DBast%26aufirst%3DA.%26atitle%3DGlutathione%2520Revisited%25E2%2580%25AF%253A%2520A%2520Better%2520Scavenger%2520than%2520Previously%2520Thought%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D5%26spage%3D1%26epage%3D5%26doi%3D10.3389%2Ffphar.2014.00260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Benedetto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varı, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filesi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, C.</span></span> <span> </span><span class="NLM_article-title">Novel Mechanisms of Natural Antioxidant Compounds in Biological Systems : Involvement of Glutathione and Glutathione-Related Enzymes</span>. <i>J. Nutr. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1016/j.jnutbio.2005.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.jnutbio.2005.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16111877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVegurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=577-586&issue=10&author=R.+Masellaauthor=R.+Di+Benedettoauthor=R.+Var%C4%B1author=C.+Filesiauthor=C.+Giovannini&title=Novel+Mechanisms+of+Natural+Antioxidant+Compounds+in+Biological+Systems%E2%80%AF%3A+Involvement+of+Glutathione+and+Glutathione-Related+Enzymes&doi=10.1016%2Fj.jnutbio.2005.05.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes</span></div><div class="casAuthors">Masella, Roberta; Di Benedetto, Roberta; Vari, Rosaria; Filesi, Carmela; Giovannini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutritional Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">577-586</span>CODEN:
                <span class="NLM_cas:coden">JNBIEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-2863</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Polyphenols are wide variety of compds. that occur in fruits and vegetables, wine, tea, extra virgin olive oil, chocolate and other cocoa products.  Several polyphenols have been demonstrated to have clear antioxidant properties in vitro, and many of their biol. actions have been attributed to their intrinsic reducing capabilities.  However, this concept appears now to be a simplistic way to conceive their activity.  Evidence is indeed accumulating that polyphenols might exert several other specific biol. effects that are as yet poorly understood.  In this article we review the most recent data on the subject and describe the addnl. functions that polyphenols can have in biol. systems, focusing on their effects on glutathione and its related enzymes.  Exptl. data indicate that polyphenols may offer an indirect protection by activating endogenous defense systems.  Several lines of evidence suggest a tight connection between exogenous and endogenous antioxidants that appear to act in a coordinated fashion.  It is reasonable to hypothesize that this is achieved, at least in part, through antioxidant responsive elements (AREs) present in the promoter regions of many of the genes inducible by oxidative and chem. stress.  The latest studies strongly suggest that dietary polyphenols can stimulate antioxidant transcription and detoxification defense systems through ARE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ7M3hcqTt_bVg90H21EOLACvtfcHk0lhqJn4uH5erwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVegurzN&md5=7cc613623b3e1cd8024c09af6336a273</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.jnutbio.2005.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jnutbio.2005.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DMasella%26aufirst%3DR.%26aulast%3DDi%2BBenedetto%26aufirst%3DR.%26aulast%3DVar%25C4%25B1%26aufirst%3DR.%26aulast%3DFilesi%26aufirst%3DC.%26aulast%3DGiovannini%26aufirst%3DC.%26atitle%3DNovel%2520Mechanisms%2520of%2520Natural%2520Antioxidant%2520Compounds%2520in%2520Biological%2520Systems%25E2%2580%25AF%253A%2520Involvement%2520of%2520Glutathione%2520and%2520Glutathione-Related%2520Enzymes%26jtitle%3DJ.%2520Nutr.%2520Biochem.%26date%3D2005%26volume%3D16%26issue%3D10%26spage%3D577%26epage%3D586%26doi%3D10.1016%2Fj.jnutbio.2005.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinauer, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irish, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecane, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrell, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peehl, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, S. J.</span></span> <span> </span><span class="NLM_article-title">Role of Glutathione Depletion and Reactive Oxygen Species Generation in Apoptotic Signaling in a Human B Lymphoma Cell Line</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4400959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fsj.cdd.4400959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11859408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVWmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=252-263&issue=3&author=J.+S.+Armstrongauthor=K.+K.+Steinauerauthor=B.+Hornungauthor=J.+M.+Irishauthor=P.+Lecaneauthor=G.+W.+Birrellauthor=D.+M.+Peehlauthor=S.+J.+Knox&title=Role+of+Glutathione+Depletion+and+Reactive+Oxygen+Species+Generation+in+Apoptotic+Signaling+in+a+Human+B+Lymphoma+Cell+Line&doi=10.1038%2Fsj.cdd.4400959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line</span></div><div class="casAuthors">Armstrong, J. S.; Steinauer, K. K.; Hornung, B.; Irish, J. M.; Lecane, P.; Birrell, G. W.; Peehl, D. M.; Knox, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-263</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The primary objective of this study was to det. the sequence of biochem. signaling events that occur after modulation of the cellular redox state in the B cell lymphoma line, PW, with emphasis on the role of mitochondrial signaling.  L-Buthionine sulfoximine (BSO), which inhibits gamma glutamyl cysteine synthetase (γGCS), was used to modulate the cellular redox status.  The sequence and role of mitochondrial events and downstream apoptotic signals and mediators was studied.  After BSO treatment, there was an early decline in cellular glutathione (GSH), followed by an increase in reactive oxygen species (ROS) prodn., which induced a variety of apoptotic signals (detectable at different time points) in the absence of any external apoptotic stimuli.  The sequence of biochem. events accompanying apoptosis included a 95% decrease in total GSH and a partial (25%) preservation of mitochondrial GSH, without a significant increase in ROS prodn. at 24 h.  Early activation and nuclear translocation of the nuclear factor kappa B subunit Rel A was obsd. at approx. 3 h after BSO treatment.  Cytochrome c release into the cytosol was also seen after 24 h of BSO treatment.  P53 protein expression was unchanged after redox modulation for up to 72 h, and p21waf1 independent loss of cellular proliferation was obsd.  Surprisingly, a truncated form of p53 was expressed in a time-dependent manner, beginning at 24 h after BSO incubation.  Irreversible commitment to apoptosis occurred between 48 and 72 h after BSO treatment when mitochondrial GSH was depleted, and there was an increase in ROS prodn.  Procaspase 3 protein levels showed a time-dependent redn. following incubation with BSO, notably after 48 h, that corresponded with increasing ROS levels.  At 96 h, caspase 3 cleavage products were detectable.  The pancaspase inhibitor zVADfmk, partially blocked the induction of apoptosis at 48 h, and was ineffective after 72 h.  PW cells could be rescued from apoptosis by removing them from BSO after up to 48, but not 72 h incubation with BSO.  Mitochondrial transmembrane potential (Δψm) remained intact in most of the cells during the 72 h observation period, indicating that Δψm dissipation is not an early signal for the induction of redox dependent apoptosis in PW cells.  These data suggest that a decrease in GSH alone can act as a potent early activator of apoptotic signaling.  Increased ROS prodn. following mitochondrial GSH depletion, represents a crucial event, which irreversibly commits PW cells to apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3wno4BN01b7Vg90H21EOLACvtfcHk0lia0sWyQ0q8vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVWmsLg%253D&md5=e85925befc7a1b497d5bcbde1cb07fc2</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4400959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4400959%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DJ.%2BS.%26aulast%3DSteinauer%26aufirst%3DK.%2BK.%26aulast%3DHornung%26aufirst%3DB.%26aulast%3DIrish%26aufirst%3DJ.%2BM.%26aulast%3DLecane%26aufirst%3DP.%26aulast%3DBirrell%26aufirst%3DG.%2BW.%26aulast%3DPeehl%26aufirst%3DD.%2BM.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26atitle%3DRole%2520of%2520Glutathione%2520Depletion%2520and%2520Reactive%2520Oxygen%2520Species%2520Generation%2520in%2520Apoptotic%2520Signaling%2520in%2520a%2520Human%2520B%2520Lymphoma%2520Cell%2520Line%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2002%26volume%3D9%26issue%3D3%26spage%3D252%26epage%3D263%26doi%3D10.1038%2Fsj.cdd.4400959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swamy, S. M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huat, B. T. K.</span></span> <span> </span><span class="NLM_article-title">Intracellular Glutathione Depletion and Reactive Oxygen Species Generation Are Important in α-Hederin-Induced Apoptosis of P388 Cells</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>245</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1023/A:1022807207948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1023%2FA%3A1022807207948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=12708752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks12jsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=2003&pages=127-139&issue=1%E2%80%932&author=S.+M.+K.+Swamyauthor=B.+T.+K.+Huat&title=Intracellular+Glutathione+Depletion+and+Reactive+Oxygen+Species+Generation+Are+Important+in+%CE%B1-Hederin-Induced+Apoptosis+of+P388+Cells&doi=10.1023%2FA%3A1022807207948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular glutathione depletion and reactive oxygen species generation are important in α-hederin-induced apoptosis of P388 cells</span></div><div class="casAuthors">Huat, Benny Tan Kwong; Swamy, S. Muthu Kumara</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">1&2</span>),
    <span class="NLM_cas:pages">127-139</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">α-Hederin, a pentacyclic triterpene saponin isolated from the seeds of Nigella sativa, was recently reported to have potent in vivo antitumor activity against LL/2 (Lewis Lung carcinoma) in BDF1 mice.  In this study we obsd. that α-hederin caused a dose- and time-dependent increase in apoptosis of murine leukemia P388 cells.  In order to evaluate the possible mechanisms for apoptosis, the effects of α-hederin on intracellular thiol concn., including reduced glutathione (GSH), and protein thiols, and the effects of pretreatment with N-acetlycysteine (NAC), a precursor of intracellular GSH synthesis, or buthionine sulfoxime (BSO), a specific inhibitor of intracellular GSH synthesis, on α-hederin-induced apoptosis were investigated.  It was found that α-hederin rapidly depleted intracellular GSH and protein thiols prior to the occurrence of apoptosis.  NAC significantly alleviated α-hederin-induced apoptosis, while BSO augmented α-hederin-induced apoptosis significantly.  The depletion of cellular thiols obsd. after α-hederin treatment caused disruption of mitochondrial membrane potential (ΔΨm) and subsequently increased the prodn. of reactive oxygen species (ROS) in P388 cells at an early time point.  Bongkrekic acid (BA), a ligand of the mitochondrial adenine nucleotide translocator, and cyclosporin (CsA) attenuated the α-hederin-induced loss of ΔΨm, and ROS prodn.  Thus, oxidative stress after α-hederin treatment is an important event in α-hederin-induced apoptosis.  As obsd. in this study, permeability transition of mitochondrial membrane occurs after depletion of GSH and precedes a state of reactive oxygen species (ROS) generation.  Further, we obsd. that α-hederin caused the release of cytochrome c from the mitochondria to cytosol, leading to caspase-3 activation.  Our findings thus demonstrate that changes in intracellular thiols and redox status leading to perturbance of mitochondrial functions are important components in the mechanism of α-hederin-induced cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmXWcnQ8OgHLVg90H21EOLACvtfcHk0lia0sWyQ0q8vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks12jsbs%253D&md5=6abb92e48d452edf6c32e92a278417d2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022807207948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022807207948%26sid%3Dliteratum%253Aachs%26aulast%3DSwamy%26aufirst%3DS.%2BM.%2BK.%26aulast%3DHuat%26aufirst%3DB.%2BT.%2BK.%26atitle%3DIntracellular%2520Glutathione%2520Depletion%2520and%2520Reactive%2520Oxygen%2520Species%2520Generation%2520Are%2520Important%2520in%2520%25CE%25B1-Hederin-Induced%2520Apoptosis%2520of%2520P388%2520Cells%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2003%26volume%3D245%26issue%3D1%25E2%2580%25932%26spage%3D127%26epage%3D139%26doi%3D10.1023%2FA%3A1022807207948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, G. C.</span></span> <span> </span><span class="NLM_article-title">Hemoglobin Catabolism I. Glutathione Peroxidase, An Erythrocyte Enzyme Which Protects Hemoglobin From Oxidative Breakdown</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>229</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(18)70608-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2FS0021-9258%2818%2970608-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=13491573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaG1cXjsFKltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1957&pages=189-198&author=G.+C.+Mills&title=Hemoglobin+Catabolism+I.+Glutathione+Peroxidase%2C+An+Erythrocyte+Enzyme+Which+Protects+Hemoglobin+From+Oxidative+Breakdown&doi=10.1016%2FS0021-9258%2818%2970608-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown</span></div><div class="casAuthors">Mills, Gordon C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">189-97</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The presence was shown of a heat-labile, nondialyzable factor in erythrocytes which acts with glutathione to protect hemoglobin from oxidative breakdown.  Studies with H2O2 indicate that the enzyme catalyzes the oxidation of reduced glutathione by H2O2, and thus can be termed a glutathione peroxidase.  It is not inhibited by cyanide or azide, and is more effective than catalase in protecting hemoglobin from the oxidative breakdown brought about by low concns. of ascorbic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqky0RLY9ZAILVg90H21EOLACvtfcHk0ljd-exzfIDC6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXjsFKltA%253D%253D&md5=d1d2bc6b265687a25b975e8833c4d63d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2970608-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252970608-X%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DG.%2BC.%26atitle%3DHemoglobin%2520Catabolism%2520I.%2520Glutathione%2520Peroxidase%252C%2520An%2520Erythrocyte%2520Enzyme%2520Which%2520Protects%2520Hemoglobin%2520From%2520Oxidative%2520Breakdown%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1957%26volume%3D229%26spage%3D189%26epage%3D198%26doi%3D10.1016%2FS0021-9258%2818%2970608-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quintana-Cabrera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Fernandez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobo-Jimenez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escobar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolaños, J. P.</span></span> <span> </span><span class="NLM_article-title">γ 3-Glutamylcysteine Detoxifies Reactive Oxygen Species by Acting as Glutathione Peroxidase-1 Cofactor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1722</span>, <span class="refDoi"> DOI: 10.1038/ncomms1722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fncomms1722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSntbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1722&author=R.+Quintana-Cabreraauthor=S.+Fernandez-Fernandezauthor=V.+Bobo-Jimenezauthor=J.+Escobarauthor=J.+Sastreauthor=A.+Almeidaauthor=J.+P.+Bola%C3%B1os&title=%CE%B3+3-Glutamylcysteine+Detoxifies+Reactive+Oxygen+Species+by+Acting+as+Glutathione+Peroxidase-1+Cofactor&doi=10.1038%2Fncomms1722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor</span></div><div class="casAuthors">Quintana-Cabrera, Ruben; Fernandez-Fernandez, Seila; Bob-Jimenez, Veronica; Escobar, Javier; Sastre, Juan; Almeida, Angeles; Bolanos, Juan P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">March</span>),
    <span class="NLM_cas:pages">1722/1-1722/8</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reactive oxygen species regulate redox-signaling processes, but in excess they can cause cell damage, hence underlying the etiol. of several neurol. diseases.  Through its ability to down modulate reactive oxygen species, glutathione is considered an essential thiol-antioxidant deriv., yet under certain circumstances it is dispensable for cell growth and redox control.  Here we show, by directing the biosynthesis of γ-glutamylcysteine - the immediate glutathione precursor - to mitochondria, that it efficiently detoxifies hydrogen peroxide and superoxide anion, regardless of cellular glutathione concns.  Knocking down glutathione peroxidase-1 drastically increases superoxide anion in cells synthesizing mitochondrial γ-glutamylcysteine.  In vitro, γ-glutamylcysteine is as efficient as glutathione in disposing of hydrogen peroxide by glutathione peroxidase-1.  In primary neurons, endogenously synthesized γ-glutamylcysteine fully prevents apoptotic death in several neurotoxic paradigms and, in an in vivo mouse model of neurodegeneration, γ-glutamylcysteine protects against neuronal loss and motor impairment.  Thus, γ-glutamylcysteine takes over the antioxidant and neuroprotective functions of glutathione by acting as glutathione peroxidase-1 cofactor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc-Kul25XaS7Vg90H21EOLACvtfcHk0ljd-exzfIDC6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSntbvI&md5=c15df1736e948a1d805d33656a2c6368</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fncomms1722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1722%26sid%3Dliteratum%253Aachs%26aulast%3DQuintana-Cabrera%26aufirst%3DR.%26aulast%3DFernandez-Fernandez%26aufirst%3DS.%26aulast%3DBobo-Jimenez%26aufirst%3DV.%26aulast%3DEscobar%26aufirst%3DJ.%26aulast%3DSastre%26aufirst%3DJ.%26aulast%3DAlmeida%26aufirst%3DA.%26aulast%3DBola%25C3%25B1os%26aufirst%3DJ.%2BP.%26atitle%3D%25CE%25B3%25203-Glutamylcysteine%2520Detoxifies%2520Reactive%2520Oxygen%2520Species%2520by%2520Acting%2520as%2520Glutathione%2520Peroxidase-1%2520Cofactor%26jtitle%3DNat.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D1722%26doi%3D10.1038%2Fncomms1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Csallany, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draper, H. H.</span></span> <span> </span><span class="NLM_article-title">Oxidation Products of α-Tocopherol Formed in Autoxidizing Methyl Linoleate</span>. <i>Lipids</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1007/BF02531096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2FBF02531096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaE3cXhtFWlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1970&pages=63-70&author=A.+S.+Csallanyauthor=M.+Chiuauthor=H.+H.+Draper&title=Oxidation+Products+of+%CE%B1-Tocopherol+Formed+in+Autoxidizing+Methyl+Linoleate&doi=10.1007%2FBF02531096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation products of α-tocopherol formed in autoxidizing methyl linoleate</span></div><div class="casAuthors">Csallany, A. Saari; Chiu, Mei; Draper, H. H.</div><div class="citationInfo"><span class="NLM_cas:title">Lipids</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-70</span>CODEN:
                <span class="NLM_cas:coden">LPDSAP</span>;
        ISSN:<span class="NLM_cas:issn">0024-4201</span>.
    </div><div class="casAbstract">The oxidn. products of α-tocopherol-14C (I) formed by heating with Me linoleate in air at 60° or 100° were investigated.  The products included a dimer, trimer, and dihydroxy dimer, α-tocopherol quinone (II) and unidentified degradation compds.  The dimer and trimer were the major products present after heating for 70 hr at 60°.  After 70 hr at 100° most of the α-tocopherol-14C was converted to degradation products; part of the 14C originally present in the 5-Me group wa s recovered as 14CO2 and 14CH3OH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2VNzkSGpUVbVg90H21EOLACvtfcHk0lhvskHd433XwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXhtFWlsbw%253D&md5=b82bb56ba5edb2c2e544b11fdb7f3ad9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2FBF02531096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02531096%26sid%3Dliteratum%253Aachs%26aulast%3DCsallany%26aufirst%3DA.%2BS.%26aulast%3DChiu%26aufirst%3DM.%26aulast%3DDraper%26aufirst%3DH.%2BH.%26atitle%3DOxidation%2520Products%2520of%2520%25CE%25B1-Tocopherol%2520Formed%2520in%2520Autoxidizing%2520Methyl%2520Linoleate%26jtitle%3DLipids%26date%3D1970%26volume%3D5%26spage%3D63%26epage%3D70%26doi%3D10.1007%2FBF02531096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, R.</span></span> <span> </span><span class="NLM_article-title">Vitamin E: Mechanism of Its Antioxidant Activity</span>. <i>Food Sci. Technol. Int., Tokyo</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.3136/fsti9596t9798.3.301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3136%2Ffsti9596t9798.3.301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK1cXhtVWls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=301-309&issue=4&author=R.+Yamauchi&title=Vitamin+E%3A+Mechanism+of+Its+Antioxidant+Activity&doi=10.3136%2Ffsti9596t9798.3.301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Vitamin E: mechanism of its antioxidant activity</span></div><div class="casAuthors">Yamauchi, Ryo</div><div class="citationInfo"><span class="NLM_cas:title">Food Science and Technology International, Tokyo</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-309</span>CODEN:
                <span class="NLM_cas:coden">FTINF2</span>;
        ISSN:<span class="NLM_cas:issn">1341-7592</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for Food Science and Technology</span>)
        </div><div class="casAbstract">A review with 67 refs.  The antioxidant activity of vitamin E (α-tocopherol) during the peroxidn. of unsatd. lipids has been reviewed based on its reaction products.  Free-radical scavenging reactions of α-tocopherol take place via the α-tocopheroxyl radical as an intermediate.  If a suitable free radical is present, a non-radical product can be formed from the coupling of the free radical with the α-tocopheroxyl radical.  The reaction products of α-tocopherol with lipid-peroxyl radicals are 8a-(lipid-dioxy)-α-tocopherones which are hydrolyzed to α-tocopherylquinone.  If the supply of oxygen is insufficient, α-tocopherol can trap the carbon-centered radicals of lipids to form 6-O-(lipid-alkyl)-α-tocopherols.  On the other hand, the dimer and trimer of α-tocopherol is formed by the bimol. self-reaction of the α-tocopheroxyl radical in a reaction mixt. contg. a large amt. of α-tocopherol.  The other product-forming pathway yields isomeric epoxy-α-tocopherylquinones and their precursors, epoxyhydroperoxy-α-tocopherones, but the mechanism of this pathway remains unknown.  The reaction products of other vitamin E compds. (γ- and δ-tocopherols) during lipid peroxidn. are almost the same as those formed from the α-tocopherol.  The tocopheroxyl radicals of γ- and δ-tocopherols prefer to react with each other to form dimeric products that are still effective as antioxidants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0FT2z8U_ZFbVg90H21EOLACvtfcHk0lhvskHd433XwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtVWls74%253D&md5=4cbf15b5bb357b100baebc6936ddf33d</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.3136%2Ffsti9596t9798.3.301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3136%252Ffsti9596t9798.3.301%26sid%3Dliteratum%253Aachs%26aulast%3DYamauchi%26aufirst%3DR.%26atitle%3DVitamin%2520E%253A%2520Mechanism%2520of%2520Its%2520Antioxidant%2520Activity%26jtitle%3DFood%2520Sci.%2520Technol.%2520Int.%252C%2520Tokyo%26date%3D1997%26volume%3D3%26issue%3D4%26spage%3D301%26epage%3D309%26doi%3D10.3136%2Ffsti9596t9798.3.301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cancela, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canclini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourglia-Ettlin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlino, A.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective Effects of Novel Nitrones: In Vitro and in Silico Studies</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>871</i></span>,  <span class="NLM_fpage">172926</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2020.172926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.ejphar.2020.172926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31958456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFGjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=871&publication_year=2020&pages=172926&author=S.+Cancelaauthor=L.+Cancliniauthor=G.+Mourglia-Ettlinauthor=P.+Hern%C3%A1ndezauthor=A.+Merlino&title=Neuroprotective+Effects+of+Novel+Nitrones%3A+In+Vitro+and+in+Silico+Studies&doi=10.1016%2Fj.ejphar.2020.172926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective effects of novel nitrones: In vitro and in silico studies</span></div><div class="casAuthors">Cancela, Saira; Canclini, Lucia; Mourglia-Ettlin, Gustavo; Hernandez, Paola; Merlino, Alicia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">871</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">172926</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases affect millions of people around the world.  Several studies point out caspase-3 as a key player in the development and progression of neurol. disorders including amyotrophic lateral sclerosis, Alzheimer's, Parkinson's and Huntington's diseases.  Furthermore, oxidative stress and mitochondrial dysfunction plays an important role in neurodegenerative pathologies leading to neuronal damage and cell death.  Pharmacol. properties of nitrones such as free radical trapping and neuroprotection has been previously described.  In the present work, we have assessed ten non-cytotoxic nitrones for their ability to inhibit apoptosis plus their potential to reduce active caspase-3 and oxidative stress in the hippocampal neuronal cell line HT22.  Our results highlight the faculty of nitrones to inhibit apoptosis by a mechanism that involves active caspase-3 redn. and decrease of reactive oxygen species.  Moreover, docking and mol. dynamics approaches lead to a detailed anal. at the at. level of the nitrones binding mode to caspase-3 suggesting that compds. bind in a region close to the catalytic site.  All these data place these mols. as excellent hits for further efforts to redesign novel compds. in the search of a new therapy against neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-DqzsjqZlbVg90H21EOLACvtfcHk0lhYZPT_YkQseg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFGjtrc%253D&md5=36e8eac32472aa6215cdd05e9743f525</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2020.172926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2020.172926%26sid%3Dliteratum%253Aachs%26aulast%3DCancela%26aufirst%3DS.%26aulast%3DCanclini%26aufirst%3DL.%26aulast%3DMourglia-Ettlin%26aufirst%3DG.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DP.%26aulast%3DMerlino%26aufirst%3DA.%26atitle%3DNeuroprotective%2520Effects%2520of%2520Novel%2520Nitrones%253A%2520In%2520Vitro%2520and%2520in%2520Silico%2520Studies%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2020%26volume%3D871%26spage%3D172926%26doi%3D10.1016%2Fj.ejphar.2020.172926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nash, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiefer, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Z. A.</span></span> <span> </span><span class="NLM_article-title">Development of a Reactive Oxygen Species-Sensitive Nitric Oxide Synthase Inhibitor for the Treatment of Ischemic Stroke</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2017.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2017.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29275014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVCkur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=395-404&author=K.+M.+Nashauthor=I.+T.+Schieferauthor=Z.+A.+Shah&title=Development+of+a+Reactive+Oxygen+Species-Sensitive+Nitric+Oxide+Synthase+Inhibitor+for+the+Treatment+of+Ischemic+Stroke&doi=10.1016%2Fj.freeradbiomed.2017.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a reactive oxygen species-sensitive nitric oxide synthase inhibitor for the treatment of ischemic stroke</span></div><div class="casAuthors">Nash, Kevin M.; Schiefer, Isaac T.; Shah, Zahoor A.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">395-404</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ischemic stroke is caused by a blockage of cerebral blood flow resulting in neuronal and glial hypoxia leading to inflammatory and reactive oxygen species (ROS)-mediated cell death.  Nitric oxide (NO) formed by NO synthase (NOS) is known to be protective in ischemic stroke, however NOS has been shown to 'uncouple' under oxidative conditions to instead produce ROS.  Nitrones are antioxidant mols. that are shown to trap ROS to then decomp. and release NO.  In this study, the nitrone 5 (N-tert-butyl-a-(3-[ethanimidamidomethyl]phenyl)nitrone) was designed such that its decompn. product is a NOS inhibitor, 6, effectively leading to NOS inhibition specifically at the site of ROS prodn.  The ability of 5 to spin-trap radicals and decomp. to 6 was obsd. using EPR and LC-MS/MS.  The pro-drug concept was tested in vitro by measuring cell viability and 6 formation in SH-SY5Y cells subjected to oxygen glucose deprivation (OGD).  5 Was found to be more efficacious and more potent than PBN, and was able to increase phospho-Akt while reducing nitrotyrosine and cleaved caspase-3 levels.  6 Treatment, but not 5, was found to decrease NO prodn. in LPS-stimulated microglia.  Doppler flowmetry on anesthetized mice showed increased cerebral blood flow upon i.v. administration of 1 mg/kg of 5, but a return to baseline upon administration of 10 mg/kg, likely due to its dual nature of antioxidant/NO-donor and NOS-inhibition.  Mice treated with 5 after permanent ischemia exhibited a >30% redn. in infarct vol., and higher formation of 6 in ischemic tissue resulting in region specific effects limited to the infarct area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo24ZADxBHaDLVg90H21EOLACvtfcHk0lhYZPT_YkQseg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVCkur%252FP&md5=f6a2a5a377af35afb793e3fdcf830bf1</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2017.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2017.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DNash%26aufirst%3DK.%2BM.%26aulast%3DSchiefer%26aufirst%3DI.%2BT.%26aulast%3DShah%26aufirst%3DZ.%2BA.%26atitle%3DDevelopment%2520of%2520a%2520Reactive%2520Oxygen%2520Species-Sensitive%2520Nitric%2520Oxide%2520Synthase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Ischemic%2520Stroke%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2018%26volume%3D115%26spage%3D395%26epage%3D404%26doi%3D10.1016%2Fj.freeradbiomed.2017.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Recent Advances on Nitrones Design for Stroke Treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">13413</span>– <span class="NLM_lpage">13427</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00976</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00976" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslejs7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=13413-13427&issue=22&author=J.+Marco-Contelles&title=Recent+Advances+on+Nitrones+Design+for+Stroke+Treatment&doi=10.1021%2Facs.jmedchem.0c00976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances on Nitrones Design for Stroke Treatment</span></div><div class="casAuthors">Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">13413-13427</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The recent advances of tetramethylpyrazine nitrones and quinolylnitrones for the treatment of stroke have been reviewed and compared with other agents, showing promising therapeutic applications.  As a result of a functional transformation of natural product ligustrazine, (Z)-N-tert-butyl-1-(3,5,6-trimethylpyrazin-2-yl)methanimine oxide (6) is a multitarget small nitrone showing potent thrombolytic activity and free radicals scavenging power, in addn. to nontoxicity and blood-brain barrier permeability.  Similarly, antioxidant (Z)-N-tert-butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine oxide (17) is a novel agent for cerebral ischemia therapy as it is able to scavenge different types of free radical species, showing strong neuroprotection and reduced infarct size.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF_xOnJwnJBrVg90H21EOLACvtfcHk0lgwMFShyhlmaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslejs7rO&md5=99aa3098f732879825b1f8861ba0d657</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00976%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520Advances%2520on%2520Nitrones%2520Design%2520for%2520Stroke%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D22%26spage%3D13413%26epage%3D13427%26doi%3D10.1021%2Facs.jmedchem.0c00976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marklund, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewén, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillered, L.</span></span> <span> </span><span class="NLM_article-title">The Nitrone Free Radical Scavenger NXY-059 Is Neuroprotective When Administered after Traumatic Brain Injury in the Rat</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1449</span>– <span class="NLM_lpage">1457</span>, <span class="refDoi"> DOI: 10.1089/neu.2008.0585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fneu.2008.0585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=19118455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BD1M3otlOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=1449-1457&issue=12&author=F.+Clausenauthor=N.+Marklundauthor=A.+Lew%C3%A9nauthor=L.+Hillered&title=The+Nitrone+Free+Radical+Scavenger+NXY-059+Is+Neuroprotective+When+Administered+after+Traumatic+Brain+Injury+in+the+Rat&doi=10.1089%2Fneu.2008.0585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">The nitrone free radical scavenger NXY-059 is neuroprotective when administered after traumatic brain injury in the rat</span></div><div class="casAuthors">Clausen Fredrik; Marklund Niklas; Lewen Anders; Hillered Lars</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1449-57</span>
        ISSN:<span class="NLM_cas:issn">0897-7151</span>.
    </div><div class="casAbstract">Reactive oxygen species (ROS) are important contributors to the secondary injury cascade following traumatic brain injury (TBI), and ROS inhibition has consistently been shown to be neuroprotective following experimental TBI.  NXY-059, a nitrone free radical trapping compound, has been shown to be neuroprotective in models of ischemic stroke but has not been evaluated in experimental TBI.  In the present study, a continuous 24-h intravenous infusion of NXY-059 or vehicle was initiated 30 min following a severe lateral fluid percussion brain injury (FPI) in adult rats (n=22), and histological and behavioral outcomes were evaluated.  Sham-injured animals (n=22) receiving identical drug infusion were used as controls.  Visuospatial learning was evaluated in the Morris water maze at post-injury days 11-14, followed by a probe trial (memory test) at day 18.  The animals were sacrificed at day 18, and loss of hemispheric brain tissue was measured in microtubule-associated protein (MAP)-2 stained sections.  Brain-injured, NXY-059-treated animals showed a significant reduction of visuospatial learning deficits when compared to the brain-injured, vehicle-treated control animals (p < 0.05).  NXY-059-treated animals significantly reduced the loss of hemispheric tissue compared to brain-injured controls (43.0 +/- 11 mm3 versus 74.4 +/- 19 mm3, respectively; p < 0.01).  The results show that post-injury treatment with NXY-059 significantly attenuated the loss of injured brain tissue and improved cognitive outcome, suggesting a major role for ROS in the pathophysiology of TBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSjMCLuN1s-_6AExegM5LLfW6udTcc2eaSkSoJaHmI07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3otlOguw%253D%253D&md5=3bfe28cda55707504c14807603d28868</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1089%2Fneu.2008.0585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2008.0585%26sid%3Dliteratum%253Aachs%26aulast%3DClausen%26aufirst%3DF.%26aulast%3DMarklund%26aufirst%3DN.%26aulast%3DLew%25C3%25A9n%26aufirst%3DA.%26aulast%3DHillered%26aufirst%3DL.%26atitle%3DThe%2520Nitrone%2520Free%2520Radical%2520Scavenger%2520NXY-059%2520Is%2520Neuroprotective%2520When%2520Administered%2520after%2520Traumatic%2520Brain%2520Injury%2520in%2520the%2520Rat%26jtitle%3DJ.%2520Neurotrauma%26date%3D2008%26volume%3D25%26issue%3D12%26spage%3D1449%26epage%3D1457%26doi%3D10.1089%2Fneu.2008.0585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marklund, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewander, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillered, L.</span></span> <span> </span><span class="NLM_article-title">Effects of the Nitrone Radical Scavengers PBN and S-PBN on in Vivo Trapping of Reactive Oxygen Species after Traumatic Brain Injury in Rats</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1267</span>, <span class="refDoi"> DOI: 10.1097/00004647-200111000-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1097%2F00004647-200111000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11702041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1WktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=1259-1267&issue=11&author=N.+Marklundauthor=T.+Lewanderauthor=F.+Clausenauthor=L.+Hillered&title=Effects+of+the+Nitrone+Radical+Scavengers+PBN+and+S-PBN+on+in+Vivo+Trapping+of+Reactive+Oxygen+Species+after+Traumatic+Brain+Injury+in+Rats&doi=10.1097%2F00004647-200111000-00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the nitrone radical scavengers PBN and S-PBN on in vivo trapping of reactive oxygen species after traumatic brain injury in rats</span></div><div class="casAuthors">Marklund, Niklas; Lewander, Tommy; Clausen, Fredrik; Hillered, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1259-1267</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">In previous studies, the authors showed that the nitrone radical scavenger α-phenyl-N-tert-butylnitrone (PBN) and its sulfo-deriv., 2-sulfophenyl-N-tert-butylnitrone (S-PBN), attenuated cognitive disturbance and reduced tissue damage after traumatic brain injury (TBI) in rats.  In the current study, the prodn. of reactive oxygen species (ROS) after TBI was monitored with microdialysis and the 4-hydroxybenzoic acid (4-HBA) trapping method.  A single dose of PBN (30 mg/kg) or an equimolar dose of S-PBN (47 mg/kg) was administered i.v. 30 min before a controlled cortical contusion injury in rats.  Plasma and brain tissue drug concns. were analyzed at the end of the microdialysis expt. (3 h after injury) and, in a sep. expt. with S-PBN, at 30 and 60 min after injury.  Traumatic brain injury caused a significant increase in ROS formation that lasted for 60 min after the injury as evidenced by increased 3,4-dihydroxybenzoic acid (3,4-DHBA) concns. in the dialyzate.  PBN and S-PBN equally and significantly attenuated the posttraumatic increase in 3,4-DHBA formation.  High PBN concns. were found bilaterally in brain tissue up to 3 h after injury.  In contrast, S-PBN was rapidly cleared from the circulation and was not detectable in brain at 30 min after injury or at any later time point.  The results suggest that scavenging of ROS after TBI may contribute to the neuroprotective properties obsd. with nitrone spin-trapping agents.  S-PBN, which remained undetectable even in traumatized brain tissue, reduced ROS prodn. to the same extent as PBN that readily crossed the blood-brain barrier.  This finding supports an important role for ROS prodn. at the blood-endothelial interface in TBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjTghvGL7cSLVg90H21EOLACvtfcHk0lgf2CulEWVRNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1WktbY%253D&md5=ea0c7fad22081de4164eb6d0bb96b582</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1097%2F00004647-200111000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-200111000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DMarklund%26aufirst%3DN.%26aulast%3DLewander%26aufirst%3DT.%26aulast%3DClausen%26aufirst%3DF.%26aulast%3DHillered%26aufirst%3DL.%26atitle%3DEffects%2520of%2520the%2520Nitrone%2520Radical%2520Scavengers%2520PBN%2520and%2520S-PBN%2520on%2520in%2520Vivo%2520Trapping%2520of%2520Reactive%2520Oxygen%2520Species%2520after%2520Traumatic%2520Brain%2520Injury%2520in%2520Rats%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2001%26volume%3D21%26issue%3D11%26spage%3D1259%26epage%3D1267%26doi%3D10.1097%2F00004647-200111000-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villamena, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, K. M.</span></span> <span> </span><span class="NLM_article-title">Potential Implication of the Chemical Properties and Bioactivity of Nitrone Spin Traps for Therapeutics</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1171</span>– <span class="NLM_lpage">1207</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.74</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.4155%2Ffmc.12.74" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22709256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38Xoslaltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1171-1207&issue=9&author=F.+A.+Villamenaauthor=A.+Dasauthor=K.+M.+Nash&title=Potential+Implication+of+the+Chemical+Properties+and+Bioactivity+of+Nitrone+Spin+Traps+for+Therapeutics&doi=10.4155%2Ffmc.12.74"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Potential implication of the chemical properties and bioactivity of nitrone spin traps for therapeutics</span></div><div class="casAuthors">Villamena, Frederick A.; Das, Amlan; Nash, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1171-1207</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Nitrone therapeutics has been employed in the treatment of oxidative stress-related diseases such as neurodegeneration, cardiovascular disease and cancer.  The nitrone-based compd. NXY-059, which is the first drug to reach clin. trials for the treatment of acute ischemic stroke, has provided promise for the development of more robust pharmacol. agents.  However, the specific mechanism of nitrone bioactivity remains unclear.  In this review, we present a variety of nitrone chem. and biol. activity that could be implicated for the nitrone's pharmacol. activity.  The chemistries of spin trapping and spin adduct reveal insights on the possible roles of nitrones for altering cellular redox status through radical scavenging or nitric oxide donation, and their biol. effects are presented.  An interdisciplinary approach towards the development of novel synthetic antioxidants with improved pharmacol. properties encompassing theor., synthetic, biochem. and in vitro/in vivo studies is covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryiCxMpHZdtrVg90H21EOLACvtfcHk0lgf2CulEWVRNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xoslaltr8%253D&md5=0db6aee0517ae193ff15cb2ad280b8d3</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.74&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.74%26sid%3Dliteratum%253Aachs%26aulast%3DVillamena%26aufirst%3DF.%2BA.%26aulast%3DDas%26aufirst%3DA.%26aulast%3DNash%26aufirst%3DK.%2BM.%26atitle%3DPotential%2520Implication%2520of%2520the%2520Chemical%2520Properties%2520and%2520Bioactivity%2520of%2520Nitrone%2520Spin%2520Traps%2520for%2520Therapeutics%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26issue%3D9%26spage%3D1171%26epage%3D1207%26doi%3D10.4155%2Ffmc.12.74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Locigno, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweier, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villamena, F. A.</span></span> <span> </span><span class="NLM_article-title">Nitric Oxide Release from the Unimolecular Decomposition of the Superoxide Radical Anion Adduct of Cyclic Nitrones in Aqueous Medium</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">3220</span>– <span class="NLM_lpage">3227</span>, <span class="refDoi"> DOI: 10.1039/b507530k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1039%2Fb507530k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16106305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotVSmsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=3220-3227&issue=17&author=E.+J.+Locignoauthor=J.+L.+Zweierauthor=F.+A.+Villamena&title=Nitric+Oxide+Release+from+the+Unimolecular+Decomposition+of+the+Superoxide+Radical+Anion+Adduct+of+Cyclic+Nitrones+in+Aqueous+Medium&doi=10.1039%2Fb507530k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide release from the unimolecular decomposition of the superoxide radical anion adduct of cyclic nitrones in aqueous medium</span></div><div class="casAuthors">Locigno, Edward J.; Zweier, Jay L.; Villamena, Frederick A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3220-3227</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Nitrones such as 5,5-dimethyl-1-pyrroline N-oxide (DMPO), 5-diethoxyphosphoryl-5-methyl-1-pyrroline N-oxide (DEPMPO) and 5-ethoxycarbonyl-5-methyl-1-pyrroline N-oxide (EMPO) have become the spin-traps of choice for the detection of transient radical species in chem. and biol. systems using ESR spectroscopy.  The mechanism of decompn. of the superoxide radical anion (O2•-) adducts of DMPO, DEPMPO and EMPO in aq. solns. was investigated.  The authors' findings suggest that nitric oxide (NO) was formed during the decompn. of the O2•- adduct as detected by EPR spin trapping using Fe(II) N-methyl-D-glucamine dithiocarbamate (MGD).  Nitric oxide release was obsd. from the O2•- adduct formed from hypoxanthine-xanthine oxidase, PMA-activated human neutrophils, and DMSO soln. of KO2.  Nitric oxide formation was not obsd. from the independently generated hydroxyl radical adduct.  Formation of nitric oxide was also indirectly detected as nitrite (NO2-) utilizing the Griess assay.  Nitrite concn. increases with increasing O2•- concn. at const. DMPO concn., while NO2- formation is suppressed at anaerobic conditions.  Moreover, large excess of DMPO also inhibits NO2- formation which can be attributed to the oxidn. of DMPO to hydroxamic acid nitroxide (DMPO-X) by nitrogen dioxide (NO2), a precursor to NO2-.  Product anal. was also conducted to further elucidate the mechanism of adduct decay using gas chromatog.-mass spectrometry (GC-MS) technique.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG8JUExMIrnLVg90H21EOLACvtfcHk0lgf2CulEWVRNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotVSmsrs%253D&md5=a14449facc380f99ba554e52e1dfe7eb</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1039%2Fb507530k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb507530k%26sid%3Dliteratum%253Aachs%26aulast%3DLocigno%26aufirst%3DE.%2BJ.%26aulast%3DZweier%26aufirst%3DJ.%2BL.%26aulast%3DVillamena%26aufirst%3DF.%2BA.%26atitle%3DNitric%2520Oxide%2520Release%2520from%2520the%2520Unimolecular%2520Decomposition%2520of%2520the%2520Superoxide%2520Radical%2520Anion%2520Adduct%2520of%2520Cyclic%2520Nitrones%2520in%2520Aqueous%2520Medium%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26issue%3D17%26spage%3D3220%26epage%3D3227%26doi%3D10.1039%2Fb507530k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shuaib, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lees, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davalos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashwood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasiewski, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emeribe, U.</span></span> <span> </span><span class="NLM_article-title">NXY-059 for the Treatment of Acute Ischemic Stroke</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>357</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa070240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1056%2FNEJMoa070240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=17687131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVSjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=562-571&issue=6&author=A.+Shuaibauthor=K.+R.+Leesauthor=P.+Lydenauthor=J.+Grottaauthor=A.+Davalosauthor=S.+M.+Davisauthor=H.-C.+Dienerauthor=T.+Ashwoodauthor=W.+W.+Wasiewskiauthor=U.+Emeribe&title=NXY-059+for+the+Treatment+of+Acute+Ischemic+Stroke&doi=10.1056%2FNEJMoa070240"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">NXY-059 for the treatment of acute ischemic stroke</span></div><div class="casAuthors">Shuaib, Ashfaq; Lees, Kennedy R.; Lyden, Patrick; Grotta, James; Davalos, Antonio; Davis, Stephen M.; Diener, Hans-Christoph; Ashwood, Tim; Wasiewski, Warren W.; Emeribe, Ugochi</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">562-571</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: The free-radical-trapping agent NXY-059 showed promise as a neuroprotectant in the Stroke-Acute Ischemic NXY Treatment I (SAINT I) trial, reducing disability when given to patients who had acute ischemic stroke.  We sought confirmation of efficacy in a second, larger trial.  Methods: We enrolled 3306 patients with acute ischemic stroke in a randomized, double-blind trial to receive a 72-h infusion of i.v. NXY-059 or placebo within 6 h after the. onset of stroke symptoms.  Our primary end point was the distribution of disability scores on the modified Rankin scale at 90 days.  We examd. scores on neurol. and activities-of-daily-living scales as secondary end points.  We also tested the hypothesis that NXY-059 would reduce alteplase-related intracranial hemorrhages.  Results: The efficacy anal. was based on 3195 patients.  Prognostic factors were well balanced between the treatment groups.  Mortality was equal in the two groups, and adverse-event rates were similar.  The distribution of scores on the modified Rankin scale did not differ between the group treated with NXY-059 (1588 patients) and the placebo group (1607 patients; P = 0.33 by the Cochran-Mantel-Haenszel test; odds ratio for limiting disability, 0.94; 95% confidence interval [CI], 0.83 to 1.06).  Anal. of categorized scores on the modified Rankin scale confirmed the lack of benefit: the odds ratio for trichotomization into modified Rankin scale scores of 0 to 1 vs. 2 to 3 vs. 4 to 6 was 0.92 (95% CI, 0.80 to 1.06).  There was no evidence of efficacy for any of the secondary end points.  Among patients treated with alteplase, there was no difference between the NXY-059 group and the placebo group in the frequency of symptomatic or asymptomatic hemorrhage.  Conclusions: NXY-059 is ineffective for the treatment of acute ischemic stroke within 6 h after the onset of symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF9Lz8mJUaG7Vg90H21EOLACvtfcHk0lhLZ58yEIJ2uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVSjsLc%253D&md5=4a249bb6f8aa45b485496c9c91bede82</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa070240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa070240%26sid%3Dliteratum%253Aachs%26aulast%3DShuaib%26aufirst%3DA.%26aulast%3DLees%26aufirst%3DK.%2BR.%26aulast%3DLyden%26aufirst%3DP.%26aulast%3DGrotta%26aufirst%3DJ.%26aulast%3DDavalos%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DS.%2BM.%26aulast%3DDiener%26aufirst%3DH.-C.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DWasiewski%26aufirst%3DW.%2BW.%26aulast%3DEmeribe%26aufirst%3DU.%26atitle%3DNXY-059%2520for%2520the%2520Treatment%2520of%2520Acute%2520Ischemic%2520Stroke%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D357%26issue%3D6%26spage%3D562%26epage%3D571%26doi%3D10.1056%2FNEJMoa070240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Alonso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalo-Gobernado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayuso, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escobar-Peso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infantes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjipavlou-Litina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcázar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective (Z)- N- Tert-Butyl-1-(2-Chloro-6-Methoxyquinolin-3-Yl)Methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2184</span>– <span class="NLM_lpage">2201</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01987</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01987" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2184-2201&issue=4&author=M.+Chiouaauthor=E.+Mart%C3%ADnez-Alonsoauthor=R.+Gonzalo-Gobernadoauthor=M.+I.+Ayusoauthor=A.+Escobar-Pesoauthor=L.+Infantesauthor=D.+Hadjipavlou-Litinaauthor=J.+J.+Montoyaauthor=J.+Montanerauthor=A.+Alc%C3%A1zarauthor=J.+Marco-Contelles&title=New+Quinolylnitrones+for+Stroke+Therapy%3A+Antioxidant+and+Neuroprotective+%28Z%29-+N-+Tert-Butyl-1-%282-Chloro-6-Methoxyquinolin-3-Yl%29Methanimine+Oxide+as+a+New+Lead-Compound+for+Ischemic+Stroke+Treatment&doi=10.1021%2Facs.jmedchem.8b01987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective (Z)-N-tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment</span></div><div class="casAuthors">Chioua, Mourad; Martinez-Alonso, Emma; Gonzalo-Gobernado, Rafael; Ayuso, Maria I.; Escobar-Peso, Alejandro; Infantes, Lourdes; Hadjipavlou-Litina, Dimitra; Montoya, Juan J.; Montaner, Joan; Alcazar, Alberto; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2184-2201</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe herein the synthesis and neuroprotective capacity of an array of 31 compds. comprising quinolyloximes, quinolylhydrazones, quinolylimines, QNs, and related heterocyclic azolylnitrones.  Neuronal cultures subjected to oxygen-glucose deprivation (OGD), as exptl. model for ischemic conditions, were treated with our mols. at the onset of recovery period after OGD and showed that most of these QNs, but not the azo mols., improved neuronal viability 24 h after recovery.  Esp., QN (Z)-N-tert-butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine oxide (I) was shown as a very potent neuroprotective agent.  Antioxidant anal. based on the ability of I to trap different types of toxic radical oxygenated species supported and confirmed its strong neuroprotective capacity.  Finally, I showed also neuroprotection induction in two in vivo models of cerebral ischemia, decreasing neuronal death and reducing infarct size, allowing us to conclude that I can be considered as new lead-compd. for ischemic stroke treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCp1AW7e0XLVg90H21EOLACvtfcHk0lhMXoPsc-oATQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWjtbs%253D&md5=0f23023ae2328f11dab4bf332442d636</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01987%26sid%3Dliteratum%253Aachs%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez-Alonso%26aufirst%3DE.%26aulast%3DGonzalo-Gobernado%26aufirst%3DR.%26aulast%3DAyuso%26aufirst%3DM.%2BI.%26aulast%3DEscobar-Peso%26aufirst%3DA.%26aulast%3DInfantes%26aufirst%3DL.%26aulast%3DHadjipavlou-Litina%26aufirst%3DD.%26aulast%3DMontoya%26aufirst%3DJ.%2BJ.%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DA.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DNew%2520Quinolylnitrones%2520for%2520Stroke%2520Therapy%253A%2520Antioxidant%2520and%2520Neuroprotective%2520%2528Z%2529-%2520N-%2520Tert-Butyl-1-%25282-Chloro-6-Methoxyquinolin-3-Yl%2529Methanimine%2520Oxide%2520as%2520a%2520New%2520Lead-Compound%2520for%2520Ischemic%2520Stroke%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D4%26spage%3D2184%26epage%3D2201%26doi%3D10.1021%2Facs.jmedchem.8b01987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quideau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deffieux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douat-Casassus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouységu, L.</span></span> <span> </span><span class="NLM_article-title">Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">586</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1002/anie.201000044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fanie.201000044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFGjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=586-621&author=S.+Quideauauthor=D.+Deffieuxauthor=C.+Douat-Casassusauthor=L.+Pouys%C3%A9gu&title=Plant+Polyphenols%3A+Chemical+Properties%2C+Biological+Activities%2C+and+Synthesis&doi=10.1002%2Fanie.201000044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Plant polyphenols: Chemical properties, biological activities, and synthesis</span></div><div class="casAuthors">Quideau, Stephane; Deffieux, Denis; Douat-Casassus, Celine; Pouysegu, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">586-621</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Eating five servings of fruits and vegetables per day!!This is what is highly recommended and heavily advertised nowadays to the general public to stay fit and healthy! Drinking green tea on a regular basis, eating chocolate from time to time, as well as savoring a couple of glasses of red wine per day have been claimed to increase life expectancy even further! Why The answer is in fact still under scientific scrutiny, but a particular class of compds. naturally occurring in fruits and vegetables is considered to be crucial for the expression of such human health benefits: the polyphenols! What are these plant products really What are their physicochem. properties How do they express their biol. activity Are they really valuable for disease prevention Can they be used to develop new pharmaceutical drugs What recent progress has been made toward their prepn. by org. synthesis This Review gives answers from a chem. perspective, summarizes the state of the art, and highlights the most significant advances in the field of polyphenol research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6yStrEg5Z0rVg90H21EOLACvtfcHk0lhMXoPsc-oATQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFGjsw%253D%253D&md5=e1469df2ccba3b121680dff0b43b696a</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1002%2Fanie.201000044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201000044%26sid%3Dliteratum%253Aachs%26aulast%3DQuideau%26aufirst%3DS.%26aulast%3DDeffieux%26aufirst%3DD.%26aulast%3DDouat-Casassus%26aufirst%3DC.%26aulast%3DPouys%25C3%25A9gu%26aufirst%3DL.%26atitle%3DPlant%2520Polyphenols%253A%2520Chemical%2520Properties%252C%2520Biological%2520Activities%252C%2520and%2520Synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D586%26epage%3D621%26doi%3D10.1002%2Fanie.201000044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laraia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkitaraman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Profiling of Tellimagrandin I and Analogues Reveals That the Medium Ring Can Significantly Modulate Biological Activity</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2590</span>– <span class="NLM_lpage">2593</span>, <span class="refDoi"> DOI: 10.1039/c2ob25065a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1039%2Fc2ob25065a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22361895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFKls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=2590-2593&issue=13&author=S.+Zhengauthor=L.+Laraiaauthor=C.+J.+O%E2%80%99Connorauthor=D.+Sorrellauthor=Y.+S.+Tanauthor=Z.+Xuauthor=A.+R.+Venkitaramanauthor=W.+Wuauthor=D.+R.+Spring&title=Synthesis+and+Biological+Profiling+of+Tellimagrandin+I+and+Analogues+Reveals+That+the+Medium+Ring+Can+Significantly+Modulate+Biological+Activity&doi=10.1039%2Fc2ob25065a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological profiling of tellimagrandin I and analogues reveals that the medium ring can significantly modulate biological activity</span></div><div class="casAuthors">Zheng, Shaojun; Laraia, Luca; O'Connor, Cornelius J.; Sorrell, David; Tan, Yaw Sing; Xu, Zhaochao; Venkitaraman, Ashok R.; Wu, Wenjun; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2590-2593</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel synthesis of the ellagitannin natural product tellimagrandin I and a series of medium ring analogs is described.  These compds. were all subsequently screened for redox activity, ability to ppt. protein and cellular phenotype in HeLa cells.  From this we have shown that all properties can be modulated independently by varying ring size and by moving the ester out of conjugation with the biaryl ring system.  Increasing ring size increased redox activity and cytotoxicity, leading to the identification of a compd. I which was significantly more cytotoxic.  In addn. compds. identified with a redox active scaffold and low cytotoxicity may be employed as a new class of redox probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRjoF409LiY7Vg90H21EOLACvtfcHk0lhK_A8E3HEFYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFKls7k%253D&md5=4ee784ca806b669e9e44526c31f62099</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25065a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25065a%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DLaraia%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DC.%2BJ.%26aulast%3DSorrell%26aufirst%3DD.%26aulast%3DTan%26aufirst%3DY.%2BS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DSynthesis%2520and%2520Biological%2520Profiling%2520of%2520Tellimagrandin%2520I%2520and%2520Analogues%2520Reveals%2520That%2520the%2520Medium%2520Ring%2520Can%2520Significantly%2520Modulate%2520Biological%2520Activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26issue%3D13%26spage%3D2590%26epage%3D2593%26doi%3D10.1039%2Fc2ob25065a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, E. S.</span></span> <span> </span><span class="NLM_article-title">High-Dose Nicotinamide Suppresses ROS Generation and Augments Population Expansion during CD8 + T Cell Activation</span>. <i>Mol. Cells</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.14348/molcells.2015.0168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.14348%2Fmolcells.2015.0168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26442863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFCjsbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2015&pages=918-924&issue=10&author=H.+J.+Choiauthor=S.+Jangauthor=E.+S.+Hwang&title=High-Dose+Nicotinamide+Suppresses+ROS+Generation+and+Augments+Population+Expansion+during+CD8+%2B+T+Cell+Activation&doi=10.14348%2Fmolcells.2015.0168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">High-dose nicotinamide suppresses reactive oxygen species (ROS) generation and augments population expansion during CD8+ T cell activation</span></div><div class="casAuthors">Choi, Ho Jin; Jang, So-Young; Hwang, Eun Seong</div><div class="citationInfo"><span class="NLM_cas:title">Molecules and Cells</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">918-924</span>CODEN:
                <span class="NLM_cas:coden">MOCEEK</span>;
        ISSN:<span class="NLM_cas:issn">1016-8478</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Molecular and Cellular Biology</span>)
        </div><div class="casAbstract">During T cell activation, mitochondrial content increases to meet the high energy demand of rapid cell proliferation.  With this increase, the level of reactive oxygen species (ROS) also increases and causes the rapid apoptotic death of activated cells, thereby facilitating T cell homeostasis.  Nicotinamide (NAM) has previously been shown to enhance mitochondria quality and extend the replicative life span of human fibroblasts.  In this study, the authors examd. the effect of NAM on CD8+ T cell activation.  NAM treatment attenuated the increase of mitochondrial content and ROS in T cells activated by CD3/CD28 antibodies.  This was accompanied by an accelerated and higher-level clonal expansion resulting from attenuated apoptotic death but not increased division of the activated cells.  Attenuation of ROS-triggered pro-apoptotic events and upregulation of Bcl-2 expression appeared to be involved.  Although cells activated in the presence of NAM exhibited compromised cytokine gene expression, the results suggest a means to augment the size of T cell expansion during activation without consuming their limited replicative potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZTDQ7kl77LVg90H21EOLACvtfcHk0lhK_A8E3HEFYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFCjsbrF&md5=5891355837032c9b5dd09c8d1e6ccd06</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.14348%2Fmolcells.2015.0168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14348%252Fmolcells.2015.0168%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DJang%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DE.%2BS.%26atitle%3DHigh-Dose%2520Nicotinamide%2520Suppresses%2520ROS%2520Generation%2520and%2520Augments%2520Population%2520Expansion%2520during%2520CD8%2520%252B%2520T%2520Cell%2520Activation%26jtitle%3DMol.%2520Cells%26date%3D2015%26volume%3D38%26issue%3D10%26spage%3D918%26epage%3D924%26doi%3D10.14348%2Fmolcells.2015.0168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sikora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szajerski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piotrowski, Ł.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielonka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ã, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerzy, G.</span></span> <span> </span><span class="NLM_article-title">Radical Scavenging Properties of Nicotinamide and Its Metabolites</span>. <i>Radiat. Phys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/j.radphyschem.2007.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.radphyschem.2007.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKrs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2008&pages=259-266&issue=3&author=A.+Sikoraauthor=P.+Szajerskiauthor=%C5%81.+Piotrowskiauthor=J.+Zielonkaauthor=J.+Adamusauthor=A.+M.+%C3%83author=G.+Jerzy&title=Radical+Scavenging+Properties+of+Nicotinamide+and+Its+Metabolites&doi=10.1016%2Fj.radphyschem.2007.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Radical scavenging properties of nicotinamide and its metabolites</span></div><div class="casAuthors">Sikora, Adam; Szajerski, Piotr; Piotrowski, Lukasz; Zielonka, Jacek; Adamus, Jan; Marcinek, Andrzej; Gebicki, Jerzy</div><div class="citationInfo"><span class="NLM_cas:title">Radiation Physics and Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">259-266</span>CODEN:
                <span class="NLM_cas:coden">RPCHDM</span>;
        ISSN:<span class="NLM_cas:issn">0969-806X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">By means of pulse radiolysis the reactivity of nicotinamide, its metabolites and selected pyridinium salts towards reactive oxygen species was tested and compared with the pharmacol. efficacy of this group of compds.  It was found that pyridinium salts are poor radical scavengers but the pos. charge distribution enhances their interactions with immobilized heparin.  Thus, superior pharmacol. efficacy of 1-methylnicotinamide may be related to its ability to interact with biol. tissues rather than to its direct antioxidant properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBTYJgRId2ZbVg90H21EOLACvtfcHk0liFy0cjP3vmxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKrs7rP&md5=c225e3c0dbea3f5ef98a1c2f5bf2af5b</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.radphyschem.2007.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.radphyschem.2007.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DSikora%26aufirst%3DA.%26aulast%3DSzajerski%26aufirst%3DP.%26aulast%3DPiotrowski%26aufirst%3D%25C5%2581.%26aulast%3DZielonka%26aufirst%3DJ.%26aulast%3DAdamus%26aufirst%3DJ.%26aulast%3D%25C3%2583%26aufirst%3DA.%2BM.%26aulast%3DJerzy%26aufirst%3DG.%26atitle%3DRadical%2520Scavenging%2520Properties%2520of%2520Nicotinamide%2520and%2520Its%2520Metabolites%26jtitle%3DRadiat.%2520Phys.%2520Chem.%26date%3D2008%26volume%3D77%26issue%3D3%26spage%3D259%26epage%3D266%26doi%3D10.1016%2Fj.radphyschem.2007.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeoun, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, E. S.</span></span> <span> </span><span class="NLM_article-title">Molecules and Cells Modulation of Mitochondrial Membrane Potential and ROS Generation by Nicotinamide in a Manner Independent of SIRT1 and Mitophagy</span>. <i>Mol. Cells</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">514</span>, <span class="refDoi"> DOI: 10.14348/molcells.2017.0081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.14348%2Fmolcells.2017.0081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28736426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOhu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2017&pages=503-514&issue=7&author=S.+B.+Songauthor=S.+Jangauthor=H.+T.+Kangauthor=B.+Weiauthor=U.+Jeounauthor=G.+S.+Yoonauthor=E.+S.+Hwang&title=Molecules+and+Cells+Modulation+of+Mitochondrial+Membrane+Potential+and+ROS+Generation+by+Nicotinamide+in+a+Manner+Independent+of+SIRT1+and+Mitophagy&doi=10.14348%2Fmolcells.2017.0081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of mitochondrial membrane potential and ROS generation by nicotinamide in a manner independent of SIRT1 and mitophagy</span></div><div class="casAuthors">Song, Seon Beom; Jang, So-Young; Kang, Hyun Tae; Wei, Bie; Jeoun, Un-woo; Yoon, Gye Soon; Hwang, Eun Seong</div><div class="citationInfo"><span class="NLM_cas:title">Molecules and Cells</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">503-514</span>CODEN:
                <span class="NLM_cas:coden">MOCEEK</span>;
        ISSN:<span class="NLM_cas:issn">1016-8478</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Molecular and Cellular Biology</span>)
        </div><div class="casAbstract">Nicotinamide (NAM) plays essential roles in physiol. through facilitating NAD+ redox homeostasis.  Importantly, at high doses, it protects cells under oxidative stresses, and has shown therapeutic effectiveness in a variety of disease conditions.  In our previous studies, NAM lowered reactive oxygen species (ROS) levels and extended cellular life span in primary human cells.  In the treated cells, levels of NAD+/NADH and SIRT1 activity increased, while mitochondrial content decreased through autophagy activation.  The remaining mitochondria were marked with low superoxide levels and high membrane potentials (Δψm); we posited that the treatment of NAM induced an activation of mitophagy that is selective for depolarized mitochondria, which produce high levels of ROS.  However, evidence for the selective mitophagy that is mediated by SIRT1 has never been provided.  This study sought to explain the mechanisms by which NAM lowers ROS levels and increases Δψm.  Our results showed that NAM and SIRT1 activation exert quite different effects on mitochondrial physiol.  Furthermore, the changes in ROS and Δψm were not found to be mediated through autophagy or SIRT activation.  Rather, NAM suppressed superoxide generation via a direct redn. of electron transport, and increased Δψm via suppression of mitochondrial permeability transition pore formation.  Our results dissected the effects of cellular NAD+ redox modulation, and emphasized the importance of the NAD+/NADH ratio in the mitochondria as well as the cytosol in maintaining mitochondrial quality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw5qivlQwOIrVg90H21EOLACvtfcHk0liFy0cjP3vmxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOhu7zK&md5=731eac70b949226a5035861c47bd12bc</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.14348%2Fmolcells.2017.0081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14348%252Fmolcells.2017.0081%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DS.%2BB.%26aulast%3DJang%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DH.%2BT.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DJeoun%26aufirst%3DU.%26aulast%3DYoon%26aufirst%3DG.%2BS.%26aulast%3DHwang%26aufirst%3DE.%2BS.%26atitle%3DMolecules%2520and%2520Cells%2520Modulation%2520of%2520Mitochondrial%2520Membrane%2520Potential%2520and%2520ROS%2520Generation%2520by%2520Nicotinamide%2520in%2520a%2520Manner%2520Independent%2520of%2520SIRT1%2520and%2520Mitophagy%26jtitle%3DMol.%2520Cells%26date%3D2017%26volume%3D40%26issue%3D7%26spage%3D503%26epage%3D514%26doi%3D10.14348%2Fmolcells.2017.0081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maoka, T.</span></span> <span> </span><span class="NLM_article-title">Reaction and Scavenging Mechanism of β -Carotene and Zeaxanthin with Reactive Oxygen Species</span>. <i>J. Oleo Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.5650/jos.ess16107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.5650%2Fjos.ess16107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27928140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosVCjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=77-84&issue=1&author=A.+Nishinoauthor=H.+Yasuiauthor=T.+Maoka&title=Reaction+and+Scavenging+Mechanism+of+%CE%B2+-Carotene+and+Zeaxanthin+with+Reactive+Oxygen+Species&doi=10.5650%2Fjos.ess16107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction and scavenging mechanism of β-carotene and zeaxanthin with reactive oxygen species</span></div><div class="casAuthors">Nishino, Azusa; Yasui, Hiroyuki; Maoka, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Oleo Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">JOSOAP</span>;
        ISSN:<span class="NLM_cas:issn">1345-8957</span>.
    
            (<span class="NLM_cas:orgname">Japan Oil Chemists' Society</span>)
        </div><div class="casAbstract">In order to investigate chem. scavenging mechanism of singlet oxygen, superoxide anion radical, and hydroxyl radical by carotenoids, reaction products obtained by reacting β-carotene or zeaxanthin with singlet oxygen, superoxide anion radical, and hydroxyl radical were analyzed by LC/PDA ESI-MS, and ESR spectrometry. β-Carotene endoperoxides were identified as the major reaction products of β-carotene and singlet oxygen, while β-carotene epoxides were the major reaction products of β-carotene and superoxide anion or hydroxyl radical.  Similar results to those for β-carotene were obtained with zeaxanthin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkHE3oy4J6qbVg90H21EOLACvtfcHk0lhRimcdmmk6vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosVCjtL8%253D&md5=73fe8d0d52aaf63eb00a09c39b46126b</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.5650%2Fjos.ess16107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5650%252Fjos.ess16107%26sid%3Dliteratum%253Aachs%26aulast%3DNishino%26aufirst%3DA.%26aulast%3DYasui%26aufirst%3DH.%26aulast%3DMaoka%26aufirst%3DT.%26atitle%3DReaction%2520and%2520Scavenging%2520Mechanism%2520of%2520%25CE%25B2%2520-Carotene%2520and%2520Zeaxanthin%2520with%2520Reactive%2520Oxygen%2520Species%26jtitle%3DJ.%2520Oleo%2520Sci.%26date%3D2017%26volume%3D66%26issue%3D1%26spage%3D77%26epage%3D84%26doi%3D10.5650%2Fjos.ess16107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, S.</span></span> <span> </span><span class="NLM_article-title">Anti-Inflammatory Activity of β-Carotene, Lycopene and Tri- n -Butylborane, a Scavenger of Reactive Oxygen Species</span>. <i>In Vivo (Brooklyn)</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.21873/invivo.11232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.21873%2Finvivo.11232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=255-264&author=A.+Kawataauthor=Y.+Murakamiauthor=S.+Suzukiauthor=S.+Fujisawa&title=Anti-Inflammatory+Activity+of+%CE%B2-Carotene%2C+Lycopene+and+Tri-+n+-Butylborane%2C+a+Scavenger+of+Reactive+Oxygen+Species&doi=10.21873%2Finvivo.11232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.21873%2Finvivo.11232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Finvivo.11232%26sid%3Dliteratum%253Aachs%26aulast%3DKawata%26aufirst%3DA.%26aulast%3DMurakami%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DFujisawa%26aufirst%3DS.%26atitle%3DAnti-Inflammatory%2520Activity%2520of%2520%25CE%25B2-Carotene%252C%2520Lycopene%2520and%2520Tri-%2520n%2520-Butylborane%252C%2520a%2520Scavenger%2520of%2520Reactive%2520Oxygen%2520Species%26jtitle%3DIn%2520Vivo%2520%2528Brooklyn%2529%26date%3D2018%26volume%3D32%26spage%3D255%26epage%3D264%26doi%3D10.21873%2Finvivo.11232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varma, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devamanoharan, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A. H.</span></span> <span> </span><span class="NLM_article-title">Prevention of Intracellular Oxidative Stress to Lens by Pyruvate and Its Ester</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.3109/10715769809065799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3109%2F10715769809065799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=9645390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFemu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1998&pages=131-135&issue=2&author=S.+D.+Varmaauthor=P.+S.+Devamanoharanauthor=A.+H.+Ali&title=Prevention+of+Intracellular+Oxidative+Stress+to+Lens+by+Pyruvate+and+Its+Ester&doi=10.3109%2F10715769809065799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of intracellular oxidative stress to lens by pyruvate and its ester</span></div><div class="casAuthors">Varma, S. D.; Devamanoharan, P. S.; Ali, A. H.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-135</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">Pyruvate is a well-known scavenger of hydrogen peroxide (H2O2).  In addn., it scavenges superoxide radical (O2•-).  However, evidence on its intracellular antioxidant function is meager at present.  Hence, we have examd. the effectiveness of this metabolite and its Et ester against intracellular oxidative damage to the lens under organ culture.  Menadione, a redoxcycling quinone, was used to generate the reactive oxygen species (ROS).  It was found to inhibit lens metab. as evidenced by a decrease of ATP.  Addnl., tissue oxidn. was apparent by loss of glutathione (GSH), and increase in the level of oxidized glutathione (GSSG), coupled with increase of the urea sol. proteins (water insol.).  The overall-physiol. damage was apparent by the inhibition of the Na+-K+-ATPase dependent cation pump, as evidenced by a decreased rubidium transport.  These deleterious effects were attenuated by pyruvate and ethyl-pyruvate.  The later was found to be more effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlliR_5xl66rVg90H21EOLACvtfcHk0lhRimcdmmk6vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFemu78%253D&md5=ebbfd3a28f9c2a0845a4cab9e0c41c05</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.3109%2F10715769809065799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715769809065799%26sid%3Dliteratum%253Aachs%26aulast%3DVarma%26aufirst%3DS.%2BD.%26aulast%3DDevamanoharan%26aufirst%3DP.%2BS.%26aulast%3DAli%26aufirst%3DA.%2BH.%26atitle%3DPrevention%2520of%2520Intracellular%2520Oxidative%2520Stress%2520to%2520Lens%2520by%2520Pyruvate%2520and%2520Its%2520Ester%26jtitle%3DFree%2520Radical%2520Res.%26date%3D1998%26volume%3D28%26issue%3D2%26spage%3D131%26epage%3D135%26doi%3D10.3109%2F10715769809065799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crestanello, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamelgard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitman, G. J. R.</span></span> <span> </span><span class="NLM_article-title">The Cumulative Nature of Pyruvate’s Dual Mechanism for Myocardial Protection</span>. <i>J. Surg. Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1006/jsre.1995.1154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1006%2Fjsre.1995.1154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=7630128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2MXotFGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1995&pages=198-204&author=J.+A.+Crestanelloauthor=J.+Kamelgardauthor=G.+J.+R.+Whitman&title=The+Cumulative+Nature+of+Pyruvate%E2%80%99s+Dual+Mechanism+for+Myocardial+Protection&doi=10.1006%2Fjsre.1995.1154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">The cumulative nature of pyruvate's dual mechanism for myocardial protection</span></div><div class="casAuthors">Crestanello, Juan A.; Kamelgard, Joseph; Whitman, Glenn J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Surgical Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">JSGRA2</span>;
        ISSN:<span class="NLM_cas:issn">0022-4804</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Pyruvate (PYR) supplementation protects myocardium from ischemia reperfusion injury.  This study was designed to characterize and quantify the mechanism underlying this protection: specifically whether this ability resides in PYR's metabolic effect or in its antioxidant effect.  Isolated perfused rat hearts (/group) were subjected to 15 min of equilibration (EQ), 25 min of ischemia, and 10 min of reperfusion (RP).  Glucose was the sole metabolic substrate (Control) or was supplemented with PYR (5 mM) during (a) EQ only (PYREQ group), (b) RP only (PYRRP group), or (c) EQ and RP (PYREQ-RP group).  Left ventricular developed pressure (DP) and ± dP/dt were recorded throughout the expt.  ATP concns. and intracellular pH were detd. by 31P NMR spectroscopy.  Myocardial creatine kinase (CK) activity was assayed at end EQ and end RP.  In vitro, purified CK was assayed and, after exposure to H2O2 (200 μM) and increasing concns. of PYR (0-6 mM) for 10 min, reassayed to det. the antioxidant effect of PYR.  In all cases PYR improved recovery of mech. function at end RP (DP: Control, 11%; PYRRP, 23%; PYREQ, 34%; PYREQ-RP, 53%; between all groups and Control).  Ischemic contracture was delayed in hearts that received PYR during EQ (PYREQ and PYREQ-RP: 17.8 vs 12.5 min).  PYR during EQ (PYREQ and PYREQ-RP) led to higher end ischemic ATP levels (32% vs 14%) and a more acidic end ischemic pH (5.92 vs 5.98 in Control and PYRRP).  PYREQ-RP showed the highest end reperfusion ATP levels (55% vs 38%, vs other groups).  PYR during reperfusion (PYREQ-RP and PYRRP) showed more end reperfusion CK activity (501 IU/gV vs 446 IU/gV).  In vitro, CK exposure to H2O2 abolished 65% of its activity, while in the presence of PYR 6 mM it abolished only 9%.  The authors conclude that PYR given during EQ stimulates anaerobic glycolysis during ischemia as seen by the lower pH and higher end ischemic ATP with a correlative delay in onset of contracture and improvement in DP at end RP.  PYR during RP protects CK from hydrogen peroxide-induced inactivation and improves recovery of function.  PYR given during EQ and RP has a cumulative effect leading to an even greater recovery of function.  PYR must be present both prior to ischemia and during reperfusion for best utilization of its metabolic and antioxidant effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6pKgNmE6VILVg90H21EOLACvtfcHk0lgfOgBRx-qQiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotFGntL8%253D&md5=dfae633e6c5882493e1cec6fa5fe6e80</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1006%2Fjsre.1995.1154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjsre.1995.1154%26sid%3Dliteratum%253Aachs%26aulast%3DCrestanello%26aufirst%3DJ.%2BA.%26aulast%3DKamelgard%26aufirst%3DJ.%26aulast%3DWhitman%26aufirst%3DG.%2BJ.%2BR.%26atitle%3DThe%2520Cumulative%2520Nature%2520of%2520Pyruvate%25E2%2580%2599s%2520Dual%2520Mechanism%2520for%2520Myocardial%2520Protection%26jtitle%3DJ.%2520Surg.%2520Res.%26date%3D1995%26volume%3D59%26spage%3D198%26epage%3D204%26doi%3D10.1006%2Fjsre.1995.1154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavallini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigobello, M. P.</span></span> <span> </span><span class="NLM_article-title">The Protective Action of Pyruvate on Recovery of Ischemic Rat Heart: Comparison with Other Oxidizable Substrates</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/0022-2828(90)91111-J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2F0022-2828%2890%2991111-J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=2182887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK3cXktFOlt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1990&pages=143-154&issue=2&author=L.+Cavalliniauthor=M.+Valenteauthor=M.+P.+Rigobello&title=The+Protective+Action+of+Pyruvate+on+Recovery+of+Ischemic+Rat+Heart%3A+Comparison+with+Other+Oxidizable+Substrates&doi=10.1016%2F0022-2828%2890%2991111-J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The protective action of pyruvate on recovery of ischemic rat heart:  comparison with other oxidizable substrates</span></div><div class="casAuthors">Cavallini, Lucia; Valente, Marina; Rigobello, Maria Pia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-54</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    </div><div class="casAbstract">The recovery of both contractile performance and metabolic response of rat heart following 1 h of ischemia after equil. with glucose + insulin (glucose-ischemia) or with pyruvate (pyruvate-ischemia), was tested in nontoxic reperfusion in the presence of glucose + insulin, pyruvate, lactate, or acetate.  In glucose-ischemia only reperfusion with pyruvate results in a complete recovery of the contractile force (left ventricular pressure, LVP) (170%) and good recovery of high-energy phosphate compds.  Lower LVP and tissue energy charge were found in glucose reperfusion and even less in lactate and acetate reperfusion.  Disappearance of the IMP accumulated during ischemia is evident only in the pyruvate reperfusion indicating a higher metabolic recovery.  On the contrary, in pyruvate-ischemia all types of reperfusion tested were effective in reactivating the contractile force (acetate to a lesser extent); the contractile activity was accompanied by a good recovery of phosphocreatine, ATP, energy charge and by the decrease of IMP.  Large decreases of adenine nucleotides and NADP and lower decreases of NAD are obsd. during ischemia/reperfusion in both systems.  Pyruvate-ischemia is quite similar to, if not worse than glucose-ischemia, for all the metabolic parameters considered, but not worse for the possibility of recovery.  Some specific effect of pyruvate should be exerted during the ischemic phase.  The mechanism of pyruvate protection is discussed in relationship to: (i) the possible activation of pyruvate dehydrogenase, (ii) the activation of NADPH-dependent peroxide scavenging systems, and (iii) the direct scavenging action of pyruvate on H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQUSPZ0fUTZrVg90H21EOLACvtfcHk0lgfOgBRx-qQiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktFOlt7c%253D&md5=4612a230405485d9570a1cfba1f7b7a8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2F0022-2828%2890%2991111-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2828%252890%252991111-J%26sid%3Dliteratum%253Aachs%26aulast%3DCavallini%26aufirst%3DL.%26aulast%3DValente%26aufirst%3DM.%26aulast%3DRigobello%26aufirst%3DM.%2BP.%26atitle%3DThe%2520Protective%2520Action%2520of%2520Pyruvate%2520on%2520Recovery%2520of%2520Ischemic%2520Rat%2520Heart%253A%2520Comparison%2520with%2520Other%2520Oxidizable%2520Substrates%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D1990%26volume%3D22%26issue%3D2%26spage%3D143%26epage%3D154%26doi%3D10.1016%2F0022-2828%2890%2991111-J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, K.</span></span> <span> </span><span class="NLM_article-title">Free-Radical Scavenger Edaravone Inhibits Both Formation and Development of Abdominal Aortic Aneurysm in Rats</span>. <i>J. Vasc. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1749</span>– <span class="NLM_lpage">1758</span>, <span class="refDoi"> DOI: 10.1016/j.jvs.2011.11.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.jvs.2011.11.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22341578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC38vjt1KhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1749-1758&issue=6&author=K.+Morimotoauthor=T.+Hasegawaauthor=A.+Tanakaauthor=B.+Wulanauthor=N.+Morimotoauthor=Y.+Okitaauthor=K.+Okada&title=Free-Radical+Scavenger+Edaravone+Inhibits+Both+Formation+and+Development+of+Abdominal+Aortic+Aneurysm+in+Rats&doi=10.1016%2Fj.jvs.2011.11.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats</span></div><div class="casAuthors">Morimoto Keisuke; Hasegawa Tomomi; Tanaka Akiko; Wulan Bao; Yu Jie; Morimoto Naoto; Okita Yutaka; Okada Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of vascular surgery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1749-58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  An ideal pharmaceutical treatment for abdominal aortic aneurysm (AAA) is to prevent aneurysm formation and development (further dilatation of pre-existing aneurysm).  Recent studies have reported that oxidative stress with reactive oxygen species (ROS) is crucial in aneurysm formation.  We hypothesized that edaravone, a free-radical scavenger, would attenuate vascular oxidative stress and inhibit AAA formation and development.  METHODS:  An AAA model induced with intraluminal elastase and extraluminal calcium chloride was created in 42 rats.  Thirty-six rats were divided three groups: a low-dose (group LD; 1 mg/kg/d), high-dose (group HD; 5 mg/kg/d), and control (group C, saline).  Edaravone or saline was intraperitoneally injected twice daily, starting 30 minutes before aneurysm preparation.  The remaining six rats (group DA) received a delayed edaravone injection (5 mg/kg/d) intraperitoneally, starting 7 days after aneurysm preparation to 28 days.  AAA dilatation ratio was calculated.  Pathologic examination was performed.  ROS expression was semi-quantified by dihydroethidium staining and the oxidative product of DNA induced by ROS, 8-hydroxydeoxyguanosine (8-OHdG), by immunohistochemical staining.  RESULTS:  At day 7, ROS expression and 8-OHdG-positive cells in aneurysm walls were decreased by edaravone treatment (ROS expression: 3.0 ± 0.5 in group LD, 1.7 ± 0.3 in group HD, and 4.8 ± 0.7 in group C; 8-OHdG-positive cells: 106.2 ± 7.8 cells in group LD, 64.5 ± 7.7 cells in group HD, and 136.6 ± 7.4 cells in group C; P < .0001), compared with group C.  Edaravone treatment significantly reduced messenger RNA expressions of cytokines and matrix metalloproteinases (MMPs) in aneurysm walls (MMP-2: 1.1 ± 0.5 in group LD, 0.6 ± 0.1 in group HD, and 2.3 ± 0.4 in group C; P < .001; MMP-9: 1.2 ± 0.1 in group LD, 0.2 ± 0.6 in group HD, and 2.4 ± 0.2 in group C; P < .001).  At day 28, aortic walls in groups LD and HD were less dilated, with increased wall thickness and elastin content than those in group C (dilatation ratio: 204.7% ± 16.0% in group C, 156.5% ± 6.6% in group LD, 136.7% ± 2.0% in group HD; P < .0001).  Delayed edaravone administration significantly prevented further aneurysm dilatation, with increased elastin content (155.2% ± 2.9% at day 7, 153.1% ± 11.6% at day 28; not significant).  CONCLUSIONS:  Edaravone inhibition of ROS can prevent aneurysm formation and expansion in the rat AAA model.  Free-radical scavenger edaravone might be an effective pharmaceutical agent for AAA in clinical practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVTCC_7r7pdr5XHngOXiV_fW6udTcc2eYm7MG9SW31Q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vjt1KhsQ%253D%253D&md5=34990b19b8ccc121d05d966c38cb45ac</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.jvs.2011.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jvs.2011.11.059%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DWulan%26aufirst%3DB.%26aulast%3DMorimoto%26aufirst%3DN.%26aulast%3DOkita%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DK.%26atitle%3DFree-Radical%2520Scavenger%2520Edaravone%2520Inhibits%2520Both%2520Formation%2520and%2520Development%2520of%2520Abdominal%2520Aortic%2520Aneurysm%2520in%2520Rats%26jtitle%3DJ.%2520Vasc.%2520Surg.%26date%3D2012%26volume%3D55%26issue%3D6%26spage%3D1749%26epage%3D1758%26doi%3D10.1016%2Fj.jvs.2011.11.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inokuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimazawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, H.</span></span> <span> </span><span class="NLM_article-title">Edaravone, a Free Radical Scavenger, Protects against Retinal Damage in Vitro and in Vivo</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>329</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.148676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1124%2Fjpet.108.148676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=19201991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Ols7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=687-698&issue=2&author=Y.+Inokuchiauthor=S.+Imaiauthor=Y.+Nakajimaauthor=M.+Shimazawaauthor=M.+Aiharaauthor=M.+Araieauthor=H.+Hara&title=Edaravone%2C+a+Free+Radical+Scavenger%2C+Protects+against+Retinal+Damage+in+Vitro+and+in+Vivo&doi=10.1124%2Fjpet.108.148676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo</span></div><div class="casAuthors">Inokuchi, Yuta; Imai, Shunsuke; Nakajima, Yoshimi; Shimazawa, Masamitsu; Aihara, Makoto; Araie, Makoto; Hara, Hideaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">687-698</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a free radical scavenger, is used for the treatment of acute cerebral infarction.  In this study, we investigated whether edaravone is neuroprotective against retinal damage.  In vitro, we used a radical-scavenging capacity assay using reactive oxygen species-sensitive probes to investigate the effects of edaravone on H2O2, superoxide anion (O-·2), and hydroxyl radical (·OH) prodn. in a rat retinal ganglion cell line (RGC-5).  The effect of edaravone on oxygen-glucose deprivation (OGD)-induced RGC-5 damage was evaluated using a 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt assay of cell viability.  Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) significantly decreased radical generation and reduced the cell death induced by OGD stress.  In vivo, retinal damage was induced by intravitreous injection of N-methyl-D-aspartate (NMDA; 5 nmol) and was evaluated by examg. ganglion cell layer cell loss, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining, and the expressions of two oxidant-stress markers [4-hydroxy-2-nonenal (4-HNE) and 8-hydroxy-2-deoxyguanosine (8-OHdG)].  In addn., activations of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated protein kinases (ERK), c-Jun N-terminal kinases (JNK), and p38 MAPK], as downstream signal pathways after NMDA receptor activation, were measured using immunoblotting and immunostaining.  Edaravone at 5 and 50 nmol intravitreous injection or at 1 and 3 mg/kg i.v. significantly protected against NMDA-induced retinal cell death.  At 50 nmol intravitreous injection, it (1) decreased the retinal expressions of TUNEL-pos. cells, 4-HNE, and 8-OHdG and (2) reduced the retinal expressions of NMDA-induced phosphorylated JNK and phosphorylated p38 but not that of phosphorylated ERK.  These findings suggest that oxidative stress plays a pivotal role in retinal damage and that edaravone may be a candidate for the effective treatment of retinal diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZo0jj-UiqXbVg90H21EOLACvtfcHk0liU35IpqgGGsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Ols7s%253D&md5=3e52d4762a0395cb3411fb646e0435d6</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.148676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.148676%26sid%3Dliteratum%253Aachs%26aulast%3DInokuchi%26aufirst%3DY.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DShimazawa%26aufirst%3DM.%26aulast%3DAihara%26aufirst%3DM.%26aulast%3DAraie%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DH.%26atitle%3DEdaravone%252C%2520a%2520Free%2520Radical%2520Scavenger%252C%2520Protects%2520against%2520Retinal%2520Damage%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26issue%3D2%26spage%3D687%26epage%3D698%26doi%3D10.1124%2Fjpet.108.148676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todo, S.</span></span> <span> </span><span class="NLM_article-title">The Novel Antioxidant Edaravone: From Bench to Bedside</span>. <i>Cardiovasc. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1111/j.1527-3466.2008.00041.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fj.1527-3466.2008.00041.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18485133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFGnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=101-114&issue=2&author=T.+Watanabeauthor=M.+Taharaauthor=S.+Todo&title=The+Novel+Antioxidant+Edaravone%3A+From+Bench+to+Bedside&doi=10.1111%2Fj.1527-3466.2008.00041.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">The novel antioxidant edaravone: from bench to bedside</span></div><div class="casAuthors">Watanabe, Toshiaki; Tahara, Munenori; Todo, Satoru</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-114</span>CODEN:
                <span class="NLM_cas:coden">CTAHCA</span>;
        ISSN:<span class="NLM_cas:issn">1755-5914</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Over the last decade, important advances have been made to support the fact that reactive oxygen species (ROS) are generated and play a harmful role during the acute and late stages of cerebral ischemia.  Several drugs, such as radical scavengers and antioxidants, have been evaluated in preclin. and clin. studies.  Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one; Radicut, Mitsubishi Tanabe Pharma Corporation) is a novel antioxidant that is currently used in Japan for the treatment of patients in the acute stage of cerebral infarction.  Edaravone scavenges ROS and inhibits proinflammatory responses after brain ischemia in animals and humans.  In particular, postischemic inflammation, leading to brain edema and infarction due to neuronal damage and endothelial cell death, can be ameliorated by edaravone.  In addn. to these antistroke effects, edaravone has also been shown to prevent oxidative damage to various extracerebral organs.  Therefore, in addn. to its usefulness in the treatment of stroke, edaravone is expected to play an integral role in the treatment of many oxidative stress-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGors8VWWQ0eL7Vg90H21EOLACvtfcHk0lgQ5FPACalSlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFGnsbs%253D&md5=f755fd3e59771a75e91140707738f6af</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3466.2008.00041.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3466.2008.00041.x%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DTahara%26aufirst%3DM.%26aulast%3DTodo%26aufirst%3DS.%26atitle%3DThe%2520Novel%2520Antioxidant%2520Edaravone%253A%2520From%2520Bench%2520to%2520Bedside%26jtitle%3DCardiovasc.%2520Ther.%26date%3D2008%26volume%3D26%26issue%3D2%26spage%3D101%26epage%3D114%26doi%3D10.1111%2Fj.1527-3466.2008.00041.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwahara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span> <span> </span><span class="NLM_article-title">Antioxidant Activity of 3-Methyl-1-Phenyl-2-Pyrazolin-5-One</span>. <i>Redox Rep.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">338</span>, <span class="refDoi"> DOI: 10.1080/13510002.1996.11747069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1080%2F13510002.1996.11747069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27406414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2sXjsl2qtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=333-338&issue=5&author=Y.+Yamamotoauthor=T.+Kuwaharaauthor=K.+Watanabeauthor=K.+Watanabe&title=Antioxidant+Activity+of+3-Methyl-1-Phenyl-2-Pyrazolin-5-One&doi=10.1080%2F13510002.1996.11747069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one</span></div><div class="casAuthors">Yamamoto, Y.; Kuwahara, T.; Watanabe, K.; Watanabe, K.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Report</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">333-338</span>CODEN:
                <span class="NLM_cas:coden">RDRPE4</span>;
        ISSN:<span class="NLM_cas:issn">1351-0002</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">The antioxidant activity of an anti-ischemic agent, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), was examd.  The pKa value of MCI-186 is 7.0 and the rate of oxidn. of MCI-186 initiated with an azo compd. increased with increasing pH, suggesting that the anionic from of MCI-186 is much more reactive than the non-ionic form.  The major products were 3-methyl-1-phenyl-2-pyrazolin-4,5-dione and 2-oxo-3-(phenylhydrazono)-butanoic acid (OPB).  Hydrolysis of 4,5-dione gave OPB.  The minor intermediate product was 4-hydroxy-4-(3-methyl-1-phenyl-1H-pyrazolin-5-on-4-yl)-3-methyl-1-phenyl-1H-pyrazolin-5-one (BPOH).  The nucleophilic attack of the anionic form of MCI-186 to 4,5-dione is likely to give BPOH.  MCI-186 (50 μM) inhibited the aerobic oxidn. at 37° of 5.2 mM unilamellar soybean phosphatidylcholine (PC) liposomal membranes, initiated with a water-sol. initiator, as efficiently as did ascorbate (100 μM).  MCI-186 (50 μM) also inhibited the oxidn. of the same PC liposomal membranes, this time initiated with a lipid-sol. initiator, almost as efficiently as did α-tocopherol (2 μM).  Furthermore, the combination of MCI-186 with ascorbate or α-tocopherol showed almost complete inhibition of PC oxidn. induced by both initiators.  These data suggest that MCI-186 may work as a good antioxidant in cellular systems as well as in cell-free systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPVPWkUubv07Vg90H21EOLACvtfcHk0lgQ5FPACalSlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsl2qtg%253D%253D&md5=83089f672dfc8b58e5c406f3f9fd4510</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1080%2F13510002.1996.11747069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13510002.1996.11747069%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuwahara%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DK.%26atitle%3DAntioxidant%2520Activity%2520of%25203-Methyl-1-Phenyl-2-Pyrazolin-5-One%26jtitle%3DRedox%2520Rep.%26date%3D1996%26volume%3D2%26issue%3D5%26spage%3D333%26epage%3D338%26doi%3D10.1080%2F13510002.1996.11747069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ezerina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezerin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T. P.</span></span> <span> </span><span class="NLM_article-title">N-Acetyl Cysteine Functions as a Fast-Acting Antioxidant by Triggering Intracellular H2S and Sulfane Sulfur Production</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2018.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.chembiol.2018.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29429900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFehtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=447-459&issue=4&author=D.+Ezerinaauthor=Y.+Takanoauthor=K.+Hanaokaauthor=Y.+Uranoauthor=T.+P.+Dickauthor=D.+Ezerinauthor=Y.+Takanoauthor=K.+Hanaokaauthor=Y.+Uranoauthor=T.+P.+Dick&title=N-Acetyl+Cysteine+Functions+as+a+Fast-Acting+Antioxidant+by+Triggering+Intracellular+H2S+and+Sulfane+Sulfur+Production&doi=10.1016%2Fj.chembiol.2018.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">N-Acetyl Cysteine Functions as a Fast-Acting Antioxidant by Triggering Intracellular H2S and Sulfane Sulfur Production</span></div><div class="casAuthors">Ezerina, Daria; Takano, Yoko; Hanaoka, Kenjiro; Urano, Yasuteru; Dick, Tobias P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">447-459.e4</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The cysteine prodrug N-acetyl cysteine (NAC) is widely used as a pharmacol. antioxidant and cytoprotectant.  It has been reported to lower endogenous oxidant levels and to protect cells against a wide range of pro-oxidative insults.  As NAC itself is a poor scavenger of oxidants, the mol. mechanisms behind the antioxidative effects of NAC have remained uncertain.  Here we show that NAC-derived cysteine is desulfurated to generate hydrogen sulfide, which in turn is oxidized to sulfane sulfur species, predominantly within mitochondria.  We provide evidence suggesting the possibility that sulfane sulfur species produced by 3-mercaptopyruvate sulfurtransferase and sulfide:quinone oxidoreductase are the actual mediators of the immediate antioxidative and cytoprotective effects provided by NAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptxutwGdwRO7Vg90H21EOLACvtfcHk0ljS0Ws4ztmpYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFehtbs%253D&md5=6b3a5d867fcdd84fd3dfce2af4fb86bd</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2018.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2018.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DEzerina%26aufirst%3DD.%26aulast%3DTakano%26aufirst%3DY.%26aulast%3DHanaoka%26aufirst%3DK.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DDick%26aufirst%3DT.%2BP.%26aulast%3DEzerin%26aufirst%3DD.%26aulast%3DTakano%26aufirst%3DY.%26aulast%3DHanaoka%26aufirst%3DK.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DDick%26aufirst%3DT.%2BP.%26atitle%3DN-Acetyl%2520Cysteine%2520Functions%2520as%2520a%2520Fast-Acting%2520Antioxidant%2520by%2520Triggering%2520Intracellular%2520H2S%2520and%2520Sulfane%2520Sulfur%2520Production%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2018%26volume%3D25%26issue%3D4%26spage%3D447%26epage%3D459%26doi%3D10.1016%2Fj.chembiol.2018.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monks, T. J.</span></span> <span> </span><span class="NLM_article-title">The Cytoprotective Effect of N-Acetyl- L -Cysteine against ROS-Induced Cytotoxicity Is Independent of Its Ability to Enhance Glutathione Synthesis</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>120</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfq364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1093%2Ftoxsci%2Fkfq364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=21135414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1eksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2011&pages=87-97&issue=1&author=F.+Zhangauthor=S.+S.+Lauauthor=T.+J.+Monks&title=The+Cytoprotective+Effect+of+N-Acetyl-+L+-Cysteine+against+ROS-Induced+Cytotoxicity+Is+Independent+of+Its+Ability+to+Enhance+Glutathione+Synthesis&doi=10.1093%2Ftoxsci%2Fkfq364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">The Cytoprotective Effect of N-acetyl-L-cysteine against ROS-Induced Cytotoxicity Is Independent of Its Ability to Enhance Glutathione Synthesis</span></div><div class="casAuthors">Zhang, Fengjiao; Lau, Serrine S.; Monks, Terrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-97</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">2,3,5-Tris(glutathion-S-yl)-hydroquinone (TGHQ), a metabolite of hydroquinone, is toxic to renal proximal tubule epithelial cells.  TGHQ retains the ability to redox cycle and create an oxidative stress.  To assist in elucidating the contribution of reactive oxygen species (ROS) to TGHQ-induced toxicity, we detd. whether the antioxidant, N-acetyl-L-cysteine (NAC), could protect human kidney proximal tubule epithelial cells (HK-2 cell line) against TGHQ-induced toxicity.  NAC provided remarkable protection against TGHQ-induced toxicity to HK-2 cells.  NAC almost completely inhibited TGHQ-induced cell death, mitochondrial membrane potential collapse, as well as ROS prodn.  NAC also attenuated TGHQ-induced DNA damage and the subsequent activation of poly (ADP-ribose) polymerase and ATP depletion.  Moreover, NAC significantly attenuated c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase phosphorylation induced by TGHQ.  In contrast, NAC itself markedly increased extracellular regulated kinase 1/2 (ERK1/2) activation, and the upstream mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor, PD-98059, only partially inhibited this activation, suggesting that NAC can directly activate ERK1/2 activity.  However, although NAC is frequently utilized as a glutathione (GSH) precursor, the cytoprotection afforded by NAC in HK-2 cells was not a consequence of increased GSH levels.  We speculate that NAC exerts its protective effect in part by directly scavenging ROS and in part via ERK1/2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWva1NiCpBObVg90H21EOLACvtfcHk0ljS0Ws4ztmpYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1eksb0%253D&md5=dbc9e747382de8570cb883ce2cbf87ff</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq364%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLau%26aufirst%3DS.%2BS.%26aulast%3DMonks%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520Cytoprotective%2520Effect%2520of%2520N-Acetyl-%2520L%2520-Cysteine%2520against%2520ROS-Induced%2520Cytotoxicity%2520Is%2520Independent%2520of%2520Its%2520Ability%2520to%2520Enhance%2520Glutathione%2520Synthesis%26jtitle%3DToxicol.%2520Sci.%26date%3D2011%26volume%3D120%26issue%3D1%26spage%3D87%26epage%3D97%26doi%3D10.1093%2Ftoxsci%2Fkfq364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhim, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-S.</span></span> <span> </span><span class="NLM_article-title">N-Acetylcysteine Induces Cell Cycle Arrest in Hepatic Stellate Cells through Its Reducing Activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">40591</span>– <span class="NLM_lpage">40598</span>, <span class="refDoi"> DOI: 10.1074/jbc.M100975200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.M100975200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11509553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVKhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=40591-40598&issue=44&author=K.-Y.+Kimauthor=T.+Y.+Rhimauthor=I.+Choiauthor=S.-S.+Kim&title=N-Acetylcysteine+Induces+Cell+Cycle+Arrest+in+Hepatic+Stellate+Cells+through+Its+Reducing+Activity&doi=10.1074%2Fjbc.M100975200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">N-Acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity</span></div><div class="casAuthors">Kim, Ki-Yong; Rhim, TaiYoun; Choi, Inpyo; Kim, Soung-Soo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">40591-40598</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Activation of hepatic stellate cells (HSC) has been identified as a crit. step in hepatic fibrogenesis and is regulated by several factors including cytokines and oxidative stress.  However, the mol. mechanism for HSC inactivation is not well understood.  We investigated an N-acetyl-L-cysteine (NAC)-mediated signaling pathway involved in HSC inactivation.  NAC, which acting through its reducing activity, induced cell arrest at G1 via the mitogen-activated protein kinase (MAPK) kinase (MEK)/MAPK pathway in a Ras-independent manner.  The sustained activation of this extracellular signal-regulated kinase induced the expression of p21Cip1/WAF1, a cell cycle-dependent kinase inhibitor, and mediated cell growth arrest through the Sp1 transcription activator-dependent mechanism.  These effects of NAC were all reversed by treatment of HSC with MEK inhibitor PD98059 followed by culturing HSC on type I collagen-coated flasks.  The collagen-mediated suppression of NAC-induced arrest may be due to an overriding of the cell cycle arrest through an acceleration of integrin-induced cell growth.  NAC action is actually dependent on modulating the redox states of cysteine residues of target proteins such as Raf-1, MEK, and ERK.  In conclusion, an understanding of the NAC signaling pathway in HSC should provide the theor. basis for clin. approaches using antioxidant therapies in liver fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS-B_6XF2wArVg90H21EOLACvtfcHk0ljSbjXeh3zQNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVKhtL8%253D&md5=c1c48fffb7845c68e9d584e31dfed1bf</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M100975200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M100975200%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.-Y.%26aulast%3DRhim%26aufirst%3DT.%2BY.%26aulast%3DChoi%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DS.-S.%26atitle%3DN-Acetylcysteine%2520Induces%2520Cell%2520Cycle%2520Arrest%2520in%2520Hepatic%2520Stellate%2520Cells%2520through%2520Its%2520Reducing%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D44%26spage%3D40591%26epage%3D40598%26doi%3D10.1074%2Fjbc.M100975200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hacışevki, A.</span>; <span class="NLM_string-name">Baba, B.</span></span> <span> </span><span class="NLM_article-title">An Overview of Melatonin as an Antioxidant Molecule: A Biochemical Approach</span>. In  <i>Melatonin-molecular biology, clinical and pharmaceutical approaches</i>; <span class="NLM_publisher-name">IntechOpen</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2018</span>; pp  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">88</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.5772%2Fintechopen.79421" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=59-88&author=A.+Hac%C4%B1%C5%9Fevki&author=B.+Baba&title=Melatonin-molecular+biology%2C+clinical+and+pharmaceutical+approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.5772%2Fintechopen.79421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252Fintechopen.79421%26sid%3Dliteratum%253Aachs%26aulast%3DHac%25C4%25B1%25C5%259Fevki%26aufirst%3DA.%26atitle%3DAn%2520Overview%2520of%2520Melatonin%2520as%2520an%2520Antioxidant%2520Molecule%253A%2520A%2520Biochemical%2520Approach%26btitle%3DMelatonin-molecular%2520biology%252C%2520clinical%2520and%2520pharmaceutical%2520approaches%26pub%3DIntechOpen%26date%3D2018%26spage%3D59%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chainy, G. B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, D. K.</span></span> <span> </span><span class="NLM_article-title">Hormones and Oxidative Stress: An Overview</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1080/10715762.2019.1702656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1080%2F10715762.2019.1702656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31868060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGju7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2020&pages=1-26&issue=1&author=G.+B.+N.+Chainyauthor=D.+K.+Sahoo&title=Hormones+and+Oxidative+Stress%3A+An+Overview&doi=10.1080%2F10715762.2019.1702656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Hormones and oxidative stress: an overview</span></div><div class="casAuthors">Chainy, Gagan B. N.; Sahoo, Dipak Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1029-2470</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  In aerobes, oxygen is essential for maintenance of life.  However, incomplete redn. of oxygen leads to generation of reactive oxygen species.  These oxidants oxidise biol. macromols. present in their vicinity and thereby impair cellular functions causing oxidative stress (OS).  Aerobes have evolved both enzymic and nonenzymic antioxidant defences to protect themselves from OS.  Although hormones as means of biol. coordination involve in regulation of physiol. activities of tissues by regulating metab., any change in their normal titer leads to pathophysiol. states.  While, hormones such as melatonin, insulin, estrogen, progesterone display antioxidant features, thyroid hormone, corticosteroids and catecholamines elicit free radical generation and OS, and the role of testosterone in inducing OS is debateable.  This review is an attempt to understand the impact of free radical generation and cross talk between the hormones modulating antioxidant defense system under various pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphorHBm69KfLVg90H21EOLACvtfcHk0ljkzvCccdW9SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGju7jJ&md5=5e7e60d2ccab5370939555147907f86f</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1080%2F10715762.2019.1702656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715762.2019.1702656%26sid%3Dliteratum%253Aachs%26aulast%3DChainy%26aufirst%3DG.%2BB.%2BN.%26aulast%3DSahoo%26aufirst%3DD.%2BK.%26atitle%3DHormones%2520and%2520Oxidative%2520Stress%253A%2520An%2520Overview%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2020%26volume%3D54%26issue%3D1%26spage%3D1%26epage%3D26%26doi%3D10.1080%2F10715762.2019.1702656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klitzke, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onuki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prado, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, M. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di
Mascio, P.</span></span> <span> </span><span class="NLM_article-title">Measurement of Melatonin and Its Metabolites: Importance for the Evaluation of Their Biological Roles</span>. <i>Endocr. J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1385/ENDO:27:2:111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1385%2FENDO%3A27%3A2%3A111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=111-118&issue=2&author=G.+R.+Martinezauthor=E.+A.+Almeidaauthor=C.+F.+Klitzkeauthor=J.+Onukiauthor=F.+M.+Pradoauthor=M.+H.+G.+Medeirosauthor=P.+Di%0AMascio&title=Measurement+of+Melatonin+and+Its+Metabolites%3A+Importance+for+the+Evaluation+of+Their+Biological+Roles&doi=10.1385%2FENDO%3A27%3A2%3A111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1385%2FENDO%3A27%3A2%3A111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FENDO%253A27%253A2%253A111%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DG.%2BR.%26aulast%3DAlmeida%26aufirst%3DE.%2BA.%26aulast%3DKlitzke%26aufirst%3DC.%2BF.%26aulast%3DOnuki%26aufirst%3DJ.%26aulast%3DPrado%26aufirst%3DF.%2BM.%26aulast%3DMedeiros%26aufirst%3DM.%2BH.%2BG.%26aulast%3DDi%2BMascio%26aufirst%3DP.%26atitle%3DMeasurement%2520of%2520Melatonin%2520and%2520Its%2520Metabolites%253A%2520Importance%2520for%2520the%2520Evaluation%2520of%2520Their%2520Biological%2520Roles%26jtitle%3DEndocr.%2520J.%26date%3D2005%26volume%3D27%26issue%3D2%26spage%3D111%26epage%3D118%26doi%3D10.1385%2FENDO%3A27%3A2%3A111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krausz, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceraulo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">Urinary Metabolites and Antioxidant Products of Exogenous Melatonin in the Mouse</span>. <i>J. Pineal Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1111/j.1600-079X.2006.00321.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fj.1600-079X.2006.00321.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16635022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Oitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2006&pages=343-349&issue=4&author=X.+Maauthor=J.+R.+Idleauthor=K.+W.+Krauszauthor=D.+X.+Tanauthor=L.+Cerauloauthor=F.+J.+Gonzalez&title=Urinary+Metabolites+and+Antioxidant+Products+of+Exogenous+Melatonin+in+the+Mouse&doi=10.1111%2Fj.1600-079X.2006.00321.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary metabolites and antioxidant products of exogenous melatonin in the mouse</span></div><div class="casAuthors">Ma, Xiaochao; Idle, Jeffrey R.; Krausz, Kristopher W.; Tan, Dun-Xian; Ceraulo, Leopoldo; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pineal Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">JPRSE9</span>;
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Exogenous melatonin is widely used for sleep disorders and has potential value in neuroprotection, cardioprotection and as an antioxidant.  Here, a novel method is described for the detn. of melatonin and six metabolites in mouse urine by use of LC-MS/MS and GC-MS.  LC-MS/MS is used for the measurement of melatonin, N1-acetyl-5-methoxykynuramine (AMK), N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and 6-hydroxymelatonin (6-HMEL), while GC/MS is used for the detn. of N-[2-(5-methoxy-2-oxo-2,3-dihydro-1H-indol-3-yl)-ethyl]-acetamide (2-OMEL) and cyclic 3-hydroxymelatonin (3-HMEL) with detection limits on column of 0.02-0.5 pmol, depending on the metabolite.  Following oral administration of melatonin to mice, a 0-24 h urine collection revealed the presence of melatonin (0.2% dose), 6-HMEL (37.1%) and NAS (3.1%) comprising >90% of the total metabolites; AMK and AFMK were also detected at 0.01% each; 2-OMEL was found at 2.2% of the dose, which is >100 times more than the AMK/AFMK pathway, and comprises >5% of the melatonin-related material detected in mouse urine.  3-HMEL was largely found as a sulfate conjugate.  These studies establish sensitive assays for detn. of six melatonin metabolites in mouse urine and confirm the potential for antioxidant activity of melatonin through the identification in vivo of AMK and AFMK, ring-opened metabolites with a high capacity for scavenging reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuz5gNusD4OLVg90H21EOLACvtfcHk0liSvYJE9zGRqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Oitbg%253D&md5=ea39643e832ad3a856660662c7c1d139</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-079X.2006.00321.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-079X.2006.00321.x%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DIdle%26aufirst%3DJ.%2BR.%26aulast%3DKrausz%26aufirst%3DK.%2BW.%26aulast%3DTan%26aufirst%3DD.%2BX.%26aulast%3DCeraulo%26aufirst%3DL.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DUrinary%2520Metabolites%2520and%2520Antioxidant%2520Products%2520of%2520Exogenous%2520Melatonin%2520in%2520the%2520Mouse%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2006%26volume%3D40%26issue%3D4%26spage%3D343%26epage%3D349%26doi%3D10.1111%2Fj.1600-079X.2006.00321.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antolín, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáinz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uría, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotler, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Colunga, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolivia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menéndez-Peláez, A.</span></span> <span> </span><span class="NLM_article-title">Neurohormone Melatonin Prevents Cell Damage: Effect on Gene Expression for Antioxidant Enzymes</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">882</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1096/fasebj.10.8.8666165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1096%2Ffasebj.10.8.8666165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=8666165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK28XjslSrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=882-890&issue=8&author=I.+Antol%C3%ADnauthor=C.+Rodr%C3%ADguezauthor=R.+M.+S%C3%A1inzauthor=J.+C.+Mayoauthor=H.+Ur%C3%ADaauthor=M.+L.+Kotlerauthor=M.+J.+Rodr%C3%ADguez-Colungaauthor=D.+Toliviaauthor=A.+Men%C3%A9ndez-Pel%C3%A1ez&title=Neurohormone+Melatonin+Prevents+Cell+Damage%3A+Effect+on+Gene+Expression+for+Antioxidant+Enzymes&doi=10.1096%2Ffasebj.10.8.8666165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes</span></div><div class="casAuthors">Antolin, Isaac; Rodriguez, Carmen; Sainz, Rosa M.; Mayo, Juan C.; Uria, Higinio; Kotler, Monica L.; Rodriguez-Colunga, Maria J.; Tolivia, Delio; Menendez-Pelaez, Armando</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">882-890</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">It is well known that porphyrins cause a toxic light-mediated effect due to their capability to generate free radicals.  Several reports have proved that melatonin is a potent free radical scavenger.  The aim of this work has been to study the ability of melatonin to prevent the cell damage caused by porphyrins in the Harderian gland of female Syrian hamsters.  Cell injury was evaluated estg. the percentage of damaged cells found in the gland and analyzing the degree of this damage at ultrastructural level.  To explain the mechanism by which this hormone could prevent the cell damage caused by porphyrins, its capability to both decrease porphyrins, its capability to both decrease porphyrin synthesis and increase the mRNA levels for antioxidant enzymes was evaluated.  Our results demonstrate that melatonin administration decreases the percentage of damaged cells, porphyrin synthesis, and aminolevulinate synthase (ALA-S) mRNA levels and increases the mRNA levels for manganese superoxide-dismutase and copper-zinc superoxide dismutase.  When obsd. under an electron microscope, the lesions in the clear cells of the treated females were much less severe than in the corresponding cells of the control animals.  Melatonin exerts a cytoprotective effect by inhibiting the ALA-S gene expression (and so porphyrin synthesis) and by raising the mRNA levels for several antioxidant enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT58i8cjuKvbVg90H21EOLACvtfcHk0liSvYJE9zGRqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjslSrsLc%253D&md5=d32d8d848dc8a9c71bb5634801b47182</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.10.8.8666165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.10.8.8666165%26sid%3Dliteratum%253Aachs%26aulast%3DAntol%25C3%25ADn%26aufirst%3DI.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DC.%26aulast%3DS%25C3%25A1inz%26aufirst%3DR.%2BM.%26aulast%3DMayo%26aufirst%3DJ.%2BC.%26aulast%3DUr%25C3%25ADa%26aufirst%3DH.%26aulast%3DKotler%26aufirst%3DM.%2BL.%26aulast%3DRodr%25C3%25ADguez-Colunga%26aufirst%3DM.%2BJ.%26aulast%3DTolivia%26aufirst%3DD.%26aulast%3DMen%25C3%25A9ndez-Pel%25C3%25A1ez%26aufirst%3DA.%26atitle%3DNeurohormone%2520Melatonin%2520Prevents%2520Cell%2520Damage%253A%2520Effect%2520on%2520Gene%2520Expression%2520for%2520Antioxidant%2520Enzymes%26jtitle%3DFASEB%2520J.%26date%3D1996%26volume%3D10%26issue%3D8%26spage%3D882%26epage%3D890%26doi%3D10.1096%2Ffasebj.10.8.8666165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patiño, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-Martín, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parada, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">los Rios, C. de</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span> <span> </span><span class="NLM_article-title">Ischemic Brain Injury: New Insights on the Protective Role of Melatonin</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">2016</span>),  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2017.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2017.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28065781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2017&pages=32-53&issue=2016&author=E.+Ramosauthor=P.+Pati%C3%B1oauthor=R.+J.+Reiterauthor=E.+Gil-Mart%C3%ADnauthor=J.+Marco-Contellesauthor=E.+Paradaauthor=C.+de+los+Riosauthor=A.+Romeroauthor=J.+Egea&title=Ischemic+Brain+Injury%3A+New+Insights+on+the+Protective+Role+of+Melatonin&doi=10.1016%2Fj.freeradbiomed.2017.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Ischemic brain injury: New insights on the protective role of melatonin</span></div><div class="casAuthors">Ramos, Eva; Patino, Paloma; Reiter, Russel J.; Gil-Martin, Emilio; Marco-Contelles, Jose; Parada, Esther; los Rios, Cristobal de; Romero, Alejandro; Egea, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-53</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Stroke represents one of the most common causes of brain's vulnerability for many millions of people worldwide.  The plethora of physiopathol. events assocd. with brain ischemia are regulate through multiple signaling pathways leading to the activation of oxidative stress process, Ca2+ dyshomeostasis, mitochondrial dysfunction, proinflammatory mediators, excitotoxicity and/or programmed neuronal cell death.  Understanding this cascade of mol. events is mandatory in order to develop new therapeutic strategies for stroke.  In this review article, we have highlighted the pleiotropic effects of melatonin to counteract the multiple processes of the ischemic cascade.  Addnl., exptl. evidence supports its actions to ameliorate ischemic long-term behavioral and neuronal deficits, preserving the functional integrity of the blood-brain barrier, inducing neurogenesis and cell proliferation through receptor-dependent mechanism, as well as improving synaptic transmission.  Consequently, the synthesis of melatonin derivs. designed as new multitarget-directed products has focused a great interest in this area.  This latter has been reinforced by the low cost of melatonin and its reduced toxicity.  Furthermore, its spectrum of usages seems to be wide and with the potential for improving human health.  Nevertheless, the mol. and cellular mechanisms underlying melatonin's actions need to be further exploration and accordingly, new clin. studies should be conducted in human patients with ischemic brain pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo9ZaHk9KREbVg90H21EOLACvtfcHk0lik8QIzQXubPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlyjtA%253D%253D&md5=b1d6a17a6c50b8f7e17f50e49a778815</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2017.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2017.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DRamos%26aufirst%3DE.%26aulast%3DPati%25C3%25B1o%26aufirst%3DP.%26aulast%3DReiter%26aufirst%3DR.%2BJ.%26aulast%3DGil-Mart%25C3%25ADn%26aufirst%3DE.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DParada%26aufirst%3DE.%26aulast%3Dlos%2BRios%26aufirst%3DC.%2Bde%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DEgea%26aufirst%3DJ.%26atitle%3DIschemic%2520Brain%2520Injury%253A%2520New%2520Insights%2520on%2520the%2520Protective%2520Role%2520of%2520Melatonin%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2017%26volume%3D104%26issue%3D2016%26spage%3D32%26epage%3D53%26doi%3D10.1016%2Fj.freeradbiomed.2017.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Özdemir, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keleştimur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalkara, T.</span></span> <span> </span><span class="NLM_article-title">Pinealectomy Aggravates and Melatonin Administration Attenuates Brain Damage in Focal Ischemia</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1097/00004647-199905000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1097%2F00004647-199905000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10326718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVCqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=511-516&issue=5&author=E.+Kilicauthor=Y.+G.+%C3%96zdemirauthor=H.+Bolayauthor=H.+Kele%C5%9Ftimurauthor=T.+Dalkara&title=Pinealectomy+Aggravates+and+Melatonin+Administration+Attenuates+Brain+Damage+in+Focal+Ischemia&doi=10.1097%2F00004647-199905000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia</span></div><div class="casAuthors">Kilic, Ertugrul; Ozdemir, Yasemin Gursoy; Bolay, Hayrunnisa; Kelestimur, Haluk; Dalkara, Turgay</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-516</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Large infarcts develop in pinealectomized rats subjected to middle cerebral artery occlusion, which was attributed to loss of antioxidant action of melatonin.  However, melatonin also has vascular actions, and pinealectomy may induce hypertension.  The authors investigated whether hemodynamic factors contribute to infarct development in pinealectomized rats, whether melatonin administration can reverse the unfavorable effect of pinealectomy on infarct formation, and whether melatonin can reduce the infarct vol. in nonpinealectomized rats subjected to focal transient ischemia (2 h middle cerebral artery occlusion, 22 h reperfusion).  Rats were pinealectomized 3 mo before ischemia to eliminate any possible action of pinealectomy-induced hypertension on stroke.  Blood pressure and regional CBF values during ischemia and reperfusion were not significantly different between pinealectomized and sham-operated rats, suggesting that pinealectomy-induced increase in infarct was not related to hemodynamic factors.  The infarct vol. resumed to the level of sham-operated rats on melatonin administration.  Injection of melatonin (4 mg/kg) before both ischemia and reperfusion reduced infarct vol. by 40% and significantly improved neurol. deficit scores in pinealectomized as well as sham-operated rats subjected to middle cerebral artery occlusion.  These data suggest that physiol. melatonin release as well as exogenously given melatonin has a neuroprotective action in focal cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG3jpFq1CZ9LVg90H21EOLACvtfcHk0lik8QIzQXubPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVCqtro%253D&md5=cdc560a7edcce9a5bebe9a120af31b4e</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1097%2F00004647-199905000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-199905000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DKilic%26aufirst%3DE.%26aulast%3D%25C3%2596zdemir%26aufirst%3DY.%2BG.%26aulast%3DBolay%26aufirst%3DH.%26aulast%3DKele%25C5%259Ftimur%26aufirst%3DH.%26aulast%3DDalkara%26aufirst%3DT.%26atitle%3DPinealectomy%2520Aggravates%2520and%2520Melatonin%2520Administration%2520Attenuates%2520Brain%2520Damage%2520in%2520Focal%2520Ischemia%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1999%26volume%3D19%26issue%3D5%26spage%3D511%26epage%3D516%26doi%3D10.1097%2F00004647-199905000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laleu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaggini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orchard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioraso-Cartier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houngninou-Molango, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duboux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szyndralewiez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, P.</span></span> <span> </span><span class="NLM_article-title">First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7715</span>– <span class="NLM_lpage">7730</span>, <span class="refDoi"> DOI: 10.1021/jm100773e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100773e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1OqtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7715-7730&issue=21&author=B.+Laleuauthor=F.+Gagginiauthor=M.+Orchardauthor=L.+Fioraso-Cartierauthor=L.+Cagnonauthor=S.+Houngninou-Molangoauthor=A.+Gradiaauthor=G.+Dubouxauthor=C.+Merlotauthor=F.+Heitzauthor=C.+Szyndralewiezauthor=P.+Page&title=First+in+Class%2C+Potent%2C+and+Orally+Bioavailable+NADPH+Oxidase+Isoform+4+%28Nox4%29+Inhibitors+for+the+Treatment+of+Idiopathic+Pulmonary+Fibrosis&doi=10.1021%2Fjm100773e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Laleu, Benoit; Gaggini, Francesca; Orchard, Mike; Fioraso-Cartier, Laetitia; Cagnon, Laurene; Houngninou-Molango, Sophie; Gradia, Angelo; Duboux, Guillaume; Merlot, Cedric; Heitz, Freddy; Szyndralewiez, Cedric; Page, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7715-7730</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design, synthesis, and optimization of first-in-class series of inhibitors I (R1 = H, MeCO, 4-FC6H4CH2, etc.; R2 = Ph, 2-ClC6H4, 2-benzothiazolyl, etc.; R3 = Me, 2-FC6H4, 1-pyrrolidinylmethyl, PhCH2NMeCH2, etc.; R4 = MeOCH2CH2, 3-pyridylmethyl, 4-morpholinyl, etc.) of NADPH oxidase isoform 4 (Nox4), an enzyme implicated in several pathologies, in particular idiopathic pulmonary fibrosis, a life-threatening and orphan disease, is described.  Initially, several moderately potent pyrazolopyridine dione derivs. were found during a high-throughput screening campaign.  SAR investigation around the pyrazolopyridine dione core led to the discovery of several double-digit nanomolar inhibitors in cell free assays of reactive oxygen species (ROS) prodn., showing high potency on Nox4 and Nox1.  The compds. have little affinity for Nox2 isoform and are selective for Nox4/1 isoforms.  The specificity of these compds. was confirmed in an extensive in vitro pharmacol. profile, as well as in a counterscreening assay for potential ROS scavenging.  Concomitant benefits are good oral bioavailability and high plasma concns. in vivo, allowing further clin. trials for the potential treatment of fibrotic diseases, cancers, and cardiovascular and metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNSPjijoh4dLVg90H21EOLACvtfcHk0lh9PmcVh2Vt0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1OqtbzI&md5=39f3be6bed0d02fce6693e626788f125</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fjm100773e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100773e%26sid%3Dliteratum%253Aachs%26aulast%3DLaleu%26aufirst%3DB.%26aulast%3DGaggini%26aufirst%3DF.%26aulast%3DOrchard%26aufirst%3DM.%26aulast%3DFioraso-Cartier%26aufirst%3DL.%26aulast%3DCagnon%26aufirst%3DL.%26aulast%3DHoungninou-Molango%26aufirst%3DS.%26aulast%3DGradia%26aufirst%3DA.%26aulast%3DDuboux%26aufirst%3DG.%26aulast%3DMerlot%26aufirst%3DC.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DSzyndralewiez%26aufirst%3DC.%26aulast%3DPage%26aufirst%3DP.%26atitle%3DFirst%2520in%2520Class%252C%2520Potent%252C%2520and%2520Orally%2520Bioavailable%2520NADPH%2520Oxidase%2520Isoform%25204%2520%2528Nox4%2529%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Idiopathic%2520Pulmonary%2520Fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D21%26spage%3D7715%26epage%3D7730%26doi%3D10.1021%2Fjm100773e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Augsburger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seredenina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maghzal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahiout, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen-Dürr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, U. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroshow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaquet, V.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Characterization of the Seven Human NOX Isoforms and Their Inhibitors</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">101272</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.redox.2019.101272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31330481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVWksbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=101272&author=F.+Augsburgerauthor=A.+Filippovaauthor=D.+Rastiauthor=T.+Seredeninaauthor=M.+Lamauthor=G.+Maghzalauthor=Z.+Mahioutauthor=P.+Jansen-D%C3%BCrrauthor=U.+G.+Knausauthor=J.+Doroshowauthor=R.+Stockerauthor=K.+H.+Krauseauthor=V.+Jaquet&title=Pharmacological+Characterization+of+the+Seven+Human+NOX+Isoforms+and+Their+Inhibitors&doi=10.1016%2Fj.redox.2019.101272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the seven human NOX isoforms and their inhibitors</span></div><div class="casAuthors">Augsburger, Fiona; Filippova, Aleksandra; Rasti, Delphine; Seredenina, Tamara; Lam, Magdalena; Maghzal, Ghassan; Mahiout, Zahia; Jansen-Durr, Pidder; Knaus, Ulla G.; Doroshow, James; Stocker, Roland; Krause, Karl-Heinz; Jaquet, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101272</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NADPH oxidases (NOX) are a family of flavoenzymes that catalyze the formation of superoxide anion radical (O-2) and/or hydrogen peroxide (H2/O2).  As major oxidant generators, NOX are assocd. with oxidative damage in numerous diseases and represent promising drug targets for several pathologies.  Various small mol. NOX inhibitors are used in the literature, but their pharmacol. characterization is often incomplete in terms of potency, specificity and mode of action.  We used cell lines expressing high levels of human NOX isoforms (NOX1-5, DUOX1 and 2) to detect NOX-derived O-2/or H2O2 using a variety of specific probes.  NOX inhibitory activity of diphenylene iodonium (DPI), apocynin, diapocynin, ebselen, GKT136901 and VAS2870 was tested on NOX isoforms in cellular and membrane assays.  Addnl. assays were used to identify potential off target effects, such as antioxidant activity, interference with assays or acute cytotoxicity.  Cells expressing active NOX isoforms formed O/2, except for DUOX1 and 2, and in all cases activation of NOX isoforms was assocd. with the detection of extracellular H2O2.  Among all mols. tested, DPI elicited dose-dependent inhibition of all isoforms in all assays, however all other mols. tested displayed interesting pharmacol. characteristics, but did not meet criteria for bona fide NOX inhibitors.  Our findings indicate that exptl. results obtained with widely used NOX inhibitors must be carefully interpreted and highlight the challenge of developing reliable pharmacol. inhibitors of these key mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxV_rnN-nPA7Vg90H21EOLACvtfcHk0li13AR5vMVDRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVWksbrJ&md5=a963942896468f59f1464c41ff0505ff</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101272%26sid%3Dliteratum%253Aachs%26aulast%3DAugsburger%26aufirst%3DF.%26aulast%3DFilippova%26aufirst%3DA.%26aulast%3DRasti%26aufirst%3DD.%26aulast%3DSeredenina%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DM.%26aulast%3DMaghzal%26aufirst%3DG.%26aulast%3DMahiout%26aufirst%3DZ.%26aulast%3DJansen-D%25C3%25BCrr%26aufirst%3DP.%26aulast%3DKnaus%26aufirst%3DU.%2BG.%26aulast%3DDoroshow%26aufirst%3DJ.%26aulast%3DStocker%26aufirst%3DR.%26aulast%3DKrause%26aufirst%3DK.%2BH.%26aulast%3DJaquet%26aufirst%3DV.%26atitle%3DPharmacological%2520Characterization%2520of%2520the%2520Seven%2520Human%2520NOX%2520Isoforms%2520and%2520Their%2520Inhibitors%26jtitle%3DRedox%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D101272%26doi%3D10.1016%2Fj.redox.2019.101272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aalbers, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">A Closer Look into NADPH Oxidase Inhibitors: Validation and Insight into Their Mechanism of Action</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">101466</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2020.101466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.redox.2020.101466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32105983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjvVKgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2020&pages=101466&author=J.+Reisauthor=M.+Massariauthor=S.+Marcheseauthor=M.+Cecconauthor=F.+S.+Aalbersauthor=F.+Coranaauthor=S.+Valenteauthor=A.+Maiauthor=F.+Magnaniauthor=A.+Mattevi&title=A+Closer+Look+into+NADPH+Oxidase+Inhibitors%3A+Validation+and+Insight+into+Their+Mechanism+of+Action&doi=10.1016%2Fj.redox.2020.101466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">A closer look into NADPH oxidase inhibitors: Validation and insight into their mechanism of action</span></div><div class="casAuthors">Reis, Joana; Massari, Marta; Marchese, Sara; Ceccon, Marta; Aalbers, Friso S.; Corana, Federica; Valente, Sergio; Mai, Antonello; Magnani, Francesca; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101466</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NADPH-oxidases (NOXs) purposefully produce reactive-oxygen-species (ROS) and are found in most kingdoms of life.  The seven human NOXs are each characterized by a specific expression profile and a fine regulation to spatio-temporally tune ROS concn. in cells and tissues.  One of the best known roles for NOXs is in host protection against pathogens but ROS themselves are important second messengers involved in tissue regeneration and the modulation of pathways that induce and sustain cell proliferation.  As such, NOXs are attractive pharmacol. targets in immunomodulation, fibrosis and cancer.  We have studied an extensive no. of available NOX inhibitors, with the specific aim to identify bona fide ligands vs. ROS-scavenging mols.  Accordingly, we have established a comprehensive platform of biochem. and biophys. assays.  Most of the investigated small mols. revealed ROS-scavenging and/or assay-interfering properties to various degrees.  A few compds., however, were also demonstrated to directly engage one or more NOX enzymes.  Diphenylene iodonium was found to react with the NOXs' flavin and heme prosthetic groups to form stable adducts.  We also discovered that two compds., VAS2870 and VAS3947, inhibit NOXs through the covalent alkylation of a cysteine residue.  Importantly, the amino acid involved in covalent binding was found to reside in the dehydrogenase domain, where the nicotinamide ring of NADPH is bound.  This work can serve as a springboard to guide further development of bona fide ligands with either agonistic or antagonistic properties toward NOXs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5KH3K8WuaeLVg90H21EOLACvtfcHk0li13AR5vMVDRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjvVKgs74%253D&md5=6251e232aa3b02be3497e3e3ad8b8b41</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2020.101466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2020.101466%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DMassari%26aufirst%3DM.%26aulast%3DMarchese%26aufirst%3DS.%26aulast%3DCeccon%26aufirst%3DM.%26aulast%3DAalbers%26aufirst%3DF.%2BS.%26aulast%3DCorana%26aufirst%3DF.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DMagnani%26aufirst%3DF.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DA%2520Closer%2520Look%2520into%2520NADPH%2520Oxidase%2520Inhibitors%253A%2520Validation%2520and%2520Insight%2520into%2520Their%2520Mechanism%2520of%2520Action%26jtitle%3DRedox%2520Biol.%26date%3D2020%26volume%3D32%26spage%3D101466%26doi%3D10.1016%2Fj.redox.2020.101466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szilagyi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleksunes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heindel, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laskin, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laskin, J. D.</span></span> <span> </span><span class="NLM_article-title">Selective Targeting of Heme Protein in Cytochrome P450 and Nitric Oxide Synthase by Diphenyleneiodonium</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>151</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfw031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1093%2Ftoxsci%2Fkfw031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26880746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSisbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2016&pages=150-159&issue=1&author=J.+T.+Szilagyiauthor=V.+Mishinauthor=D.+E.+Heckauthor=Y.+H.+Janauthor=L.+M.+Aleksunesauthor=J.+R.+Richardsonauthor=N.+D.+Heindelauthor=D.+L.+Laskinauthor=J.+D.+Laskin&title=Selective+Targeting+of+Heme+Protein+in+Cytochrome+P450+and+Nitric+Oxide+Synthase+by+Diphenyleneiodonium&doi=10.1093%2Ftoxsci%2Fkfw031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Selective targeting of heme protein in cytochrome P450 and nitric oxide synthase by diphenyleneiodonium</span></div><div class="casAuthors">Szilagyi, John T.; Mishin, Vladimir; Heck, Diane E.; Jan, Yi-Hua; Aleksunes, Lauren M.; Richardson, Jason R.; Heindel, Ned D.; Laskin, Debra L.; Laskin, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-159</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Cytochrome P 450 (CYP) enzymes mediate mixed-function oxidn. reactions important in drug metab.  The arom. heterocyclic cation, diphenyleneiodonium (DPI), binds flavin in cytochrome P 450 reductase and inhibits CYP-mediated activity.  DPI also inhibits CYP by directly interacting with heme.  Herein, we report that DPI effectively inhibits a no. of CYP-related monooxygenase reactions including NADPH oxidase, a microsomal enzyme activity that generates hydrogen peroxide in the absence of metabolizing substrates.  Inhibition of monooxygenase by DPI was time and concn. dependent with IC50's ranging from 0.06 to 1.9 μM.  Higher (4.6-23.9 μM), but not lower (0.06-1.9 μM), concns. of DPI inhibited electron flow via cytochrome P 450 reductase, as measured by its ability to reduce cytochrome c and mediate quinone redox cycling.  Similar results were obsd. with inducible nitric oxide synthase (iNOS), an enzyme contg. a C-terminal reductase domain homologous to cytochrome P 450 reductase that mediates redn. of cytochrome c, and an N-terminal heme-thiolate oxygenase domain mediating nitric oxide prodn.  Significantly greater concns. of DPI were required to inhibit cytochrome c redn. by iNOS (IC50=3.5 μM) than nitric oxide prodn. (IC50=0.16 μM).  Difference spectra of liver microsomes, recombinant CYPs, and iNOS demonstrated that DPI altered heme-carbon monoxide interactions.  In the presence of NADPH, DPI treatment of microsomes and iNOS yielded a type II spectral shift.  These data indicate that DPI interacts with both flavin and heme in CYPs and iNOS.  Increased sensitivity for inhibition of CYP-mediated metab. and nitric oxide prodn. by iNOS indicates that DPI targets heme moieties within the enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK3MwmIS0zzbVg90H21EOLACvtfcHk0lgxL9UoGjvYtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSisbrO&md5=d7482e5b058e90a784db594a2e5ee529</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfw031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfw031%26sid%3Dliteratum%253Aachs%26aulast%3DSzilagyi%26aufirst%3DJ.%2BT.%26aulast%3DMishin%26aufirst%3DV.%26aulast%3DHeck%26aufirst%3DD.%2BE.%26aulast%3DJan%26aufirst%3DY.%2BH.%26aulast%3DAleksunes%26aufirst%3DL.%2BM.%26aulast%3DRichardson%26aufirst%3DJ.%2BR.%26aulast%3DHeindel%26aufirst%3DN.%2BD.%26aulast%3DLaskin%26aufirst%3DD.%2BL.%26aulast%3DLaskin%26aufirst%3DJ.%2BD.%26atitle%3DSelective%2520Targeting%2520of%2520Heme%2520Protein%2520in%2520Cytochrome%2520P450%2520and%2520Nitric%2520Oxide%2520Synthase%2520by%2520Diphenyleneiodonium%26jtitle%3DToxicol.%2520Sci.%26date%3D2016%26volume%3D151%26issue%3D1%26spage%3D150%26epage%3D159%26doi%3D10.1093%2Ftoxsci%2Fkfw031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stuehr, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasehun, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C. F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Macrophage and Endothelial Cell Nitric Synthase by Diphenyleneiodonium and Its Analogs</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1096/fasebj.5.1.1703974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1096%2Ffasebj.5.1.1703974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1703974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK3MXhtFOmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1991&pages=98-103&issue=1&author=D.+J.+Stuehrauthor=O.+A.+Fasehunauthor=N.+S.+Kwonauthor=S.+Grossauthor=J.+A.+Gonzalezauthor=R.+Leviauthor=C.+F.+Nathan&title=Inhibition+of+Macrophage+and+Endothelial+Cell+Nitric+Synthase+by+Diphenyleneiodonium+and+Its+Analogs&doi=10.1096%2Ffasebj.5.1.1703974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs</span></div><div class="casAuthors">Stuehr, Dennis J.; Fasehun, Olufunmilayo A.; Kwon, Nyoun Soo; Gross, Steven S.; Gonzalez, Jose A.; Levi, Roberto; Nathan, Carl F.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-103</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    </div><div class="casAbstract">The cofactor requirements of macrophage nitric oxide (NO) synthase suggest involvement of an NADPH-dependent flavoprotein.  Therefore the effect of the flavoprotein inhibitors diphenyleneiodonium (DPI), di-2-thienyliodonium (DTI), and iodoniumdiphenyl (ID) on the NO synthases of macrophages and endothelium was tested.  DPI, DTI, and ID completely inhibited NO synthesis by mouse macrophages, their lysates, and partially purified macrophage NO synthase.  Inhibition of NO synthase by these agents was potent (IC50's 50-150 nM), irreversible, dependent on time and temp., and independent of enzyme catalysis.  The inhibition by DPI was blocked by NADPH, NADP, or 2',5'-ADP, but not by NADH.  Likewise, FAD or FMN, but not riboflavin or adenosine 5'-diphosphoribose, protected NO synthase from inhibition by DPI.  Neither NADPH nor FAD reacted with DPI.  Once NO synthase was inhibited by DPI, neither NADPH nor FAD could restore its activity.  DPI also inhibited acetylcholine-induced relaxation of norepinephrine-preconstricted rabbit aortic rings (IC50 300 nM).  Inhibition of acetylcholine-induced relaxation persisted for at least 2 h after DPI was washed out.  In contrast, DPI had no effect on norepinephrine-induced vasoconstriction itself nor on vasorelaxation induced by the NO-generating agent sodium nitroprusside.  These results suggest that NO synthesis in both macrophages and endothelial cells depends on an NADPH-utilizing flavoprotein.  As a new class of NO synthase inhibitors, DPI and its analogs are likely to prove useful in analyzing the physiol. and pathophysiol. roles of NO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwou5S41-mY7Vg90H21EOLACvtfcHk0ljWc53QqwoCQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtFOmsL8%253D&md5=726ee653d19952b1a3886ecbaebcd8eb</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.5.1.1703974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.5.1.1703974%26sid%3Dliteratum%253Aachs%26aulast%3DStuehr%26aufirst%3DD.%2BJ.%26aulast%3DFasehun%26aufirst%3DO.%2BA.%26aulast%3DKwon%26aufirst%3DN.%2BS.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DGonzalez%26aufirst%3DJ.%2BA.%26aulast%3DLevi%26aufirst%3DR.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26atitle%3DInhibition%2520of%2520Macrophage%2520and%2520Endothelial%2520Cell%2520Nitric%2520Synthase%2520by%2520Diphenyleneiodonium%2520and%2520Its%2520Analogs%26jtitle%3DFASEB%2520J.%26date%3D1991%26volume%3D5%26issue%3D1%26spage%3D98%26epage%3D103%26doi%3D10.1096%2Ffasebj.5.1.1703974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laleu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaggini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioraso-Cartier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molango, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szyndralewiez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D. D.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide Adenine Dinucleotide Phosphate Oxidase (NOX) in Experimental Liver Fibrosis: GKT137831 as a Novel Potential Therapeutic Agent</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2316</span>– <span class="NLM_lpage">2327</span>, <span class="refDoi"> DOI: 10.1002/hep.25938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fhep.25938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22806357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSmtb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=2316-2327&issue=6&author=T.+Aoyamaauthor=Y.-H.+Paikauthor=S.+Watanabeauthor=B.+Laleuauthor=F.+Gagginiauthor=L.+Fioraso-Cartierauthor=S.+Molangoauthor=F.+Heitzauthor=C.+Merlotauthor=C.+Szyndralewiezauthor=P.+Pageauthor=D.+D.+Brenner&title=Nicotinamide+Adenine+Dinucleotide+Phosphate+Oxidase+%28NOX%29+in+Experimental+Liver+Fibrosis%3A+GKT137831+as+a+Novel+Potential+Therapeutic+Agent&doi=10.1002%2Fhep.25938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent</span></div><div class="casAuthors">Aoyama, Tomonori; Paik, Yong-Han; Watanabe, Sumio; Laleu, Benoit; Gaggini, Francesca; Fioraso-Cartier, Laetitia; Molango, Sophie; Heitz, Freddy; Merlot, Cedric; Szyndralewiez, Cedric; Page, Patrick; Brenner, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2316-2327</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">NADP (NADPH) oxidase (NOX) generates reactive oxygen species (ROS) in hepatic stellate cells (HSCs) during liver fibrosis.  In response to fibrogenic agonists, such as angiotensin II (Ang II), the NOX1 components form an active complex, including Ras-related botulinum toxin substrate 1 (Rac1).  Superoxide dismutase 1 (SOD1) interacts with the NOX-Rac1 complex to stimulate NOX activity.  NOX4 is also induced in activated HSCs/myofibroblast by increased gene expression.  Here, we investigate the role of an enhanced activity SOD1 G37R mutation (SODmu) and the effects of GKT137831, a dual NOX1/4 inhibitor, on HSCs and liver fibrosis.  To induce liver fibrosis, wild-type (WT) and SOD1mu mice were treated with CCl4 or bile duct ligation (BDL).  Then, to address the role of NOX-SOD1-mediated ROS prodn. in HSC activation and liver fibrosis, mice were treated with a NOX1/4 inhibitor.  Fibrosis and ROS generation was assessed by histol. and measurement of thiobarbituric acid reactive substances and NOX-related genes.  Primary cultured HSCs isolated from WT, SODmu, and NOX1 knockout (KO) mice were assessed for ROS prodn., Rac1 activity, and NOX gene expression.  Liver fibrosis was increased in SOD1mu mice, and ROS prodn. and Rac1 activity were increased in SOD1mu HSCs.  The NOX1/4 inhibitor, GKT137831, attenuated liver fibrosis and ROS prodn. in both SOD1mu and WT mice as well as mRNA expression of fibrotic and NOX genes.  Treatment with GKT137831 suppressed ROS prodn. and NOX and fibrotic gene expression, but not Rac1 activity, in SOD1mut and WT HSCs.  Both Ang II and tumor growth factor beta up-regulated NOX4, but Ang II required NOX1.  Conclusions: SOD1mu induces excessive NOX1 activation through Rac1 in HSCs, causing enhanced NOX4 up-regulation, ROS generation, and liver fibrosis.  Treatment targeting NOX1/4 may be a new therapy for liver fibrosis. (HEPATOl. 2012).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBHJRPuQUHUrVg90H21EOLACvtfcHk0ljWc53QqwoCQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSmtb3F&md5=993f393975771b613669a8624d06d6cc</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1002%2Fhep.25938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.25938%26sid%3Dliteratum%253Aachs%26aulast%3DAoyama%26aufirst%3DT.%26aulast%3DPaik%26aufirst%3DY.-H.%26aulast%3DWatanabe%26aufirst%3DS.%26aulast%3DLaleu%26aufirst%3DB.%26aulast%3DGaggini%26aufirst%3DF.%26aulast%3DFioraso-Cartier%26aufirst%3DL.%26aulast%3DMolango%26aufirst%3DS.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DMerlot%26aufirst%3DC.%26aulast%3DSzyndralewiez%26aufirst%3DC.%26aulast%3DPage%26aufirst%3DP.%26aulast%3DBrenner%26aufirst%3DD.%2BD.%26atitle%3DNicotinamide%2520Adenine%2520Dinucleotide%2520Phosphate%2520Oxidase%2520%2528NOX%2529%2520in%2520Experimental%2520Liver%2520Fibrosis%253A%2520GKT137831%2520as%2520a%2520Novel%2520Potential%2520Therapeutic%2520Agent%26jtitle%3DHepatology%26date%3D2012%26volume%3D56%26issue%3D6%26spage%3D2316%26epage%3D2327%26doi%3D10.1002%2Fhep.25938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Q.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.-k.</span></span> <span> </span><span class="NLM_article-title">Nox1/4 Dual Inhibitor GKT137831 Attenuates Hypertensive Cardiac Remodelling Associating with the Inhibition of ADAM17-Dependent Proinflammatory Cytokines-Induced Signalling Pathways in the Rats with Abdominal Artery Constriction</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">1907</span>– <span class="NLM_lpage">1914</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.11.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.biopha.2018.11.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30551445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGgtLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2019&pages=1907-1914&author=S.-y.+Zengauthor=L.+Yangauthor=Q.-j.+Yanauthor=L.+Gaoauthor=H.-q.+Luauthor=P.-k.+Yan&title=Nox1%2F4+Dual+Inhibitor+GKT137831+Attenuates+Hypertensive+Cardiac+Remodelling+Associating+with+the+Inhibition+of+ADAM17-Dependent+Proinflammatory+Cytokines-Induced+Signalling+Pathways+in+the+Rats+with+Abdominal+Artery+Constriction&doi=10.1016%2Fj.biopha.2018.11.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Nox1/4 dual inhibitor GKT137831 attenuates hypertensive cardiac remodelling associating with the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways in the rats with abdominal artery constriction</span></div><div class="casAuthors">Zeng, Si-yu; Yang, Li; Yan, Qiu-jiang; Gao, Ling; Lu, Hui-qin; Yan, Peng-ke</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1907-1914</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">NADPH oxidases (Noxs) 1/4 dual inhibitor GKT137831 prevents hypertensive cardiac remodelling in angiotensin II-infused transgenic mice with cardiomyocyte-specific human Nox4 (c-hNo x 4 Tg); however, further research is still required to det. the beneficial role of GKT137831 in hypertensive cardiac remodelling in other types of hypertensive models because this hypertensive model is insufficient to mimic the complicated pathol. mechanisms of hypertension.  A disintegrin and metalloprotease 17 (ADAM17) promotes the shedding of tumor necrosis factor α (TNF-α), TNF-α receptor, interleukin 1 receptor-II and interleukin 6 (IL-6) receptor from cells, thereby mediating the signalling pathways induced by corresponding proinflammatory cytokines.  This study aimed to det. whether GKT137831 prevents hypertensive cardiac remodelling and its mechanisms of action in the rats with abdominal artery coarctation (AAC).  The rats subjected to AAC were orally given GKT137831 for a consecutive period of 28 days.  Echocardiog. and histol. anal. were performed to evaluate cardiac remodelling; and immunohistochem. and real-time PCR were used to detect the expression of proinflammatory cytokines.  GKT137831 significantly suppressed hypertensive cardiac remodelling in AAC-induced hypertensive rats.  Concurrently, Nox1/4 dual inhibitor GKT137831 reduced the protein and mRNA levels of proinflammatory cytokines interleukin 1β (IL-1β), IL-6, and TNF-α in the left ventricle of AAC-induced hypertensive rats.  Moreover, the treatment with GKT137831 markedly diminished the protein and mRNA levels of ADAM17 in the left ventricle of AAC-induced hypertensive rats.  In summary, Nox1/4 dual inhibitor GKT137831 protects against hypertensive cardiac remodelling in AAC-induced hypertensive rats, and the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways are related to its beneficial effect on hypertensive cardiac remodelling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorgsTJlb4fP7Vg90H21EOLACvtfcHk0lhsJMWZp5QMbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGgtLvM&md5=8bdf8cd7fd889cca72ecbb2631511acb</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.11.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.11.077%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DS.-y.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DQ.-j.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DH.-q.%26aulast%3DYan%26aufirst%3DP.-k.%26atitle%3DNox1%252F4%2520Dual%2520Inhibitor%2520GKT137831%2520Attenuates%2520Hypertensive%2520Cardiac%2520Remodelling%2520Associating%2520with%2520the%2520Inhibition%2520of%2520ADAM17-Dependent%2520Proinflammatory%2520Cytokines-Induced%2520Signalling%2520Pathways%2520in%2520the%2520Rats%2520with%2520Abdominal%2520Artery%2520Constriction%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D109%26spage%3D1907%26epage%3D1914%26doi%3D10.1016%2Fj.biopha.2018.11.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedeek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutsol, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montezano, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen Dinh Cat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, C. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jandeleit-Dahm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szyndralewiez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebert, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touyz, R. M.</span></span> <span> </span><span class="NLM_article-title">Renoprotective Effects of a Novel Nox1/4 Inhibitor in a Mouse Model of Type 2 Diabetes</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1042/CS20120330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1042%2FCS20120330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WqsL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2013&pages=191-202&issue=3&author=M.+Sedeekauthor=A.+Gutsolauthor=A.+C.+Montezanoauthor=D.+Burgerauthor=A.+Nguyen+Dinh+Catauthor=C.+R.+J.+Kennedyauthor=K.+D.+Burnsauthor=M.+E.+Cooperauthor=K.+Jandeleit-Dahmauthor=P.+Pageauthor=C.+Szyndralewiezauthor=F.+Heitzauthor=R.+L.+Hebertauthor=R.+M.+Touyz&title=Renoprotective+Effects+of+a+Novel+Nox1%2F4+Inhibitor+in+a+Mouse+Model+of+Type+2+Diabetes&doi=10.1042%2FCS20120330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes</span></div><div class="casAuthors">Sedeek, Mona; Gutsol, Alex; Montezano, Augusto C.; Burger, Dylan; Nguyen, Dinh Cat Aurelie; Kennedy, Chris R. J.; Burns, Kevin D.; Cooper, Mark E.; Jandeleit-Dahm, Karin; Page, Patrick; Szyndralewiez, Cedric; Heitz, Freddy; Hebert, Richard L.; Touyz, Rhian M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-202</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Nox (NADPH oxidase)-derived ROS (reactive oxygen species) have been implicated in the development of diabetic nephropathy.  Of the Nox isoforms in the kidney, Nox4 is important because of its renal abundance.  In the present study, we tested the hypothesis that GKT136901, a Nox1/4 inhibitor, prevents the development of nephropathy in db/db (diabetic) mice.  Six groups of male mice (8-wk-old) were studied: (i) untreated control db/m, (ii) low-dose GKT136901-treated db/m (30 mg/kg of body wt. per day), (iii) high-dose GKT136901-treated db/m (90 mg/kg of body wt. per day), (iv) untreated db/db; (v) low dose GKT136901-treated db/db; and (vi) high-dose GKT136901-treated db/db.  GKT136901, in chow, was administered for 16 wk. db/db mice developed diabetes and nephropathy as evidenced by hyperglycemia, albuminuria and renal injury (mesangial expansion, tubular dystrophy and glomerulosclerosis).  GKT136901 treatment had no effect on plasma glucose or BP (blood pressure) in any of the groups.  Plasma and urine TBARSs (thiobarbituric acid-reacting substances) levels, markers of systemic and renal oxidative stress, resp., were increased in diabetic mice.  Renal mRNA expression of Nox4, but not of Nox2, increased, Nox1 was barely detectable in db/db.  Expression of the antioxidant enzyme SOD-1 (superoxide dismutase 1) decreased in db/db mice.  Renal content of fibronectin, pro-collagen, TGFβ (transforming growth factor β) and VCAM-1 (vascular cell adhesion mol. 1) and phosphorylation of ERK1/2 (extracellular-signal-regulated kinase 1/2) were augmented in db/db kidneys, with no change in p38 MAPK (mitogen-activated protein kinase) and JNK (c-Jun N-terminal kinase).  Treatment reduced albuminuria, TBARS and renal ERK1/2 phosphorylation and preserved renal structure in diabetic mice.  Our findings suggest a renoprotective effect of the Nox1/4 inhibitor, possibly through reduced oxidative damage and decreased ERK1/2 activation.  These phenomena occur independently of improved glucose control, suggesting GKT136901-sensitive targets are involved in complications of diabetes rather than in the disease process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6mu_O0B-J2LVg90H21EOLACvtfcHk0lhsJMWZp5QMbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WqsL3F&md5=8386e4df0677405bbe29a264ab61086c</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1042%2FCS20120330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20120330%26sid%3Dliteratum%253Aachs%26aulast%3DSedeek%26aufirst%3DM.%26aulast%3DGutsol%26aufirst%3DA.%26aulast%3DMontezano%26aufirst%3DA.%2BC.%26aulast%3DBurger%26aufirst%3DD.%26aulast%3DNguyen%2BDinh%2BCat%26aufirst%3DA.%26aulast%3DKennedy%26aufirst%3DC.%2BR.%2BJ.%26aulast%3DBurns%26aufirst%3DK.%2BD.%26aulast%3DCooper%26aufirst%3DM.%2BE.%26aulast%3DJandeleit-Dahm%26aufirst%3DK.%26aulast%3DPage%26aufirst%3DP.%26aulast%3DSzyndralewiez%26aufirst%3DC.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DHebert%26aufirst%3DR.%2BL.%26aulast%3DTouyz%26aufirst%3DR.%2BM.%26atitle%3DRenoprotective%2520Effects%2520of%2520a%2520Novel%2520Nox1%252F4%2520Inhibitor%2520in%2520a%2520Mouse%2520Model%2520of%2520Type%25202%2520Diabetes%26jtitle%3DClin.%2520Sci.%26date%3D2013%26volume%3D124%26issue%3D3%26spage%3D191%26epage%3D202%26doi%3D10.1042%2FCS20120330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schildknecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robotta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drescher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquardt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daiber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leist, M.</span></span> <span> </span><span class="NLM_article-title">The NOX1/4 Inhibitor GKT136901 as Selective and Direct Scavenger of Peroxynitrite</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.2174/09298673113209990179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.2174%2F09298673113209990179" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=365-376&issue=3&author=S.+Schildknechtauthor=A.+Weberauthor=H.+Gerdingauthor=R.+Papeauthor=M.+Robottaauthor=M.+Drescherauthor=A.+Marquardtauthor=A.+Daiberauthor=B.+Fergerauthor=M.+Leist&title=The+NOX1%2F4+Inhibitor+GKT136901+as+Selective+and+Direct+Scavenger+of+Peroxynitrite&doi=10.2174%2F09298673113209990179"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990179%26sid%3Dliteratum%253Aachs%26aulast%3DSchildknecht%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DGerding%26aufirst%3DH.%26aulast%3DPape%26aufirst%3DR.%26aulast%3DRobotta%26aufirst%3DM.%26aulast%3DDrescher%26aufirst%3DM.%26aulast%3DMarquardt%26aufirst%3DA.%26aulast%3DDaiber%26aufirst%3DA.%26aulast%3DFerger%26aufirst%3DB.%26aulast%3DLeist%26aufirst%3DM.%26atitle%3DThe%2520NOX1%252F4%2520Inhibitor%2520GKT136901%2520as%2520Selective%2520and%2520Direct%2520Scavenger%2520of%2520Peroxynitrite%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D3%26spage%3D365%26epage%3D376%26doi%3D10.2174%2F09298673113209990179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dao, V. T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbatreek, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altenhöfer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachado, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neullens, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, U. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. H. H. W.</span></span> <span> </span><span class="NLM_article-title">Isoform-Selective NADPH Oxidase Inhibitor Panel for Pharmacological Target Validation</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2019.12.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2019.12.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31883469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFCnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2020&pages=60-69&author=V.+T.+V.+Daoauthor=M.+H.+Elbatreekauthor=S.+Altenh%C3%B6ferauthor=A.+I.+Casasauthor=M.+P.+Pachadoauthor=C.+T.+Neullensauthor=U.+G.+Knausauthor=H.+H.+H.+W.+Schmidt&title=Isoform-Selective+NADPH+Oxidase+Inhibitor+Panel+for+Pharmacological+Target+Validation&doi=10.1016%2Fj.freeradbiomed.2019.12.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation</span></div><div class="casAuthors">Dao, Vu Thao-Vi; Elbatreek, Mahmoud H.; Altenhofer, Sebastian; Casas, Ana I.; Pachado, Mayra P.; Neullens, Christopher T.; Knaus, Ulla G.; Schmidt, Harald H. H. W.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60-69</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dysfunctional reactive oxygen species (ROS) signaling is considered an important disease mechanism.  Therapeutically, non-selective scavenging of ROS by antioxidants, however, has failed in multiple clin. trials to provide patient benefit.  Instead, pharmacol. modulation of disease-relevant, enzymic sources of ROS appears to be an alternative, more promising and meanwhile successfully validated approach.  With respect to targets, the family of NADPH oxidases (NOX) stands out as main and dedicated ROS sources.  Validation of the different NOX isoforms has been mainly through genetically modified rodent models and is lagging behind in other species.  It is unclear whether the different NOX isoforms are sufficiently distinct to allow selective pharmacol. modulation.  Here we show for five widely used NOX inhibitors that isoform selectivity can be achieved, although individual compd. specificity is as yet insufficient.  NOX1 was most potently (IC50) targeted by ML171 (0.1μM); NOX2, by VAS2870 (0.7μM); NOX4, by M13 (0.01μM) and NOX5, by ML090 (0.01μM).  In addn., some non-specific antioxidant and assay artifacts may limit the interpretation of data, which included, surprisingly, the clin. advanced NOX inhibitor, GKT136901.  In a human ischemic blood-brain barrier hyperpermeability model where genetic target validation is not an option, we provide proof-of-principle that pharmacol. target validation for different NOX isoforms is possible by applying an inhibitor panel at IC50 concns.  Moreover, our findings encourage further lead optimization and development efforts for isoform-selective NOX inhibitors in different indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHoebSJGneMrVg90H21EOLACvtfcHk0li6QVCpiKw2JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFCnt7Y%253D&md5=0ce490f236e5053d5680c304cef203e8</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2019.12.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2019.12.038%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DV.%2BT.%2BV.%26aulast%3DElbatreek%26aufirst%3DM.%2BH.%26aulast%3DAltenh%25C3%25B6fer%26aufirst%3DS.%26aulast%3DCasas%26aufirst%3DA.%2BI.%26aulast%3DPachado%26aufirst%3DM.%2BP.%26aulast%3DNeullens%26aufirst%3DC.%2BT.%26aulast%3DKnaus%26aufirst%3DU.%2BG.%26aulast%3DSchmidt%26aufirst%3DH.%2BH.%2BH.%2BW.%26atitle%3DIsoform-Selective%2520NADPH%2520Oxidase%2520Inhibitor%2520Panel%2520for%2520Pharmacological%2520Target%2520Validation%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2020%26volume%3D148%26spage%3D60%26epage%3D69%26doi%3D10.1016%2Fj.freeradbiomed.2019.12.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stalin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido-Urbani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szyndralewiez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemelin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coquoz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruegg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, B. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Host NOX1 Blocks Tumor Growth and Enhances Checkpoint Inhibitor–Based Immunotherapy</span>. <i>Life Sci. Alliance</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">e201800265</span>, <span class="refDoi"> DOI: 10.26508/lsa.201800265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.26508%2Flsa.201800265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31249132" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2019&pages=e201800265&issue=4&author=J.+Stalinauthor=S.+Garrido-Urbaniauthor=F.+Heitzauthor=C.+Szyndralewiezauthor=S.+Jemelinauthor=O.+Coquozauthor=C.+Rueggauthor=B.+A.+Imhof&title=Inhibition+of+Host+NOX1+Blocks+Tumor+Growth+and+Enhances+Checkpoint+Inhibitor%E2%80%93Based+Immunotherapy&doi=10.26508%2Flsa.201800265"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.26508%2Flsa.201800265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26508%252Flsa.201800265%26sid%3Dliteratum%253Aachs%26aulast%3DStalin%26aufirst%3DJ.%26aulast%3DGarrido-Urbani%26aufirst%3DS.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DSzyndralewiez%26aufirst%3DC.%26aulast%3DJemelin%26aufirst%3DS.%26aulast%3DCoquoz%26aufirst%3DO.%26aulast%3DRuegg%26aufirst%3DC.%26aulast%3DImhof%26aufirst%3DB.%2BA.%26atitle%3DInhibition%2520of%2520Host%2520NOX1%2520Blocks%2520Tumor%2520Growth%2520and%2520Enhances%2520Checkpoint%2520Inhibitor%25E2%2580%2593Based%2520Immunotherapy%26jtitle%3DLife%2520Sci.%2520Alliance%26date%3D2019%26volume%3D2%26issue%3D4%26spage%3De201800265%26doi%3D10.26508%2Flsa.201800265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschnitz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grund, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armitage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barthel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmann, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meuth, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrewe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gailus-Durner, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klopstock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Angelis, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jandeleit-Dahm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. H. H. W.</span></span> <span> </span><span class="NLM_article-title">Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">e1000479</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1000479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1371%2Fjournal.pbio.1000479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=20877715" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=e1000479&issue=9&author=C.+Kleinschnitzauthor=H.+Grundauthor=K.+Winglerauthor=M.+E.+Armitageauthor=E.+Jonesauthor=M.+Mittalauthor=D.+Baritauthor=T.+Schwarzauthor=C.+Geisauthor=P.+Kraftauthor=K.+Barthelauthor=M.+K.+Schuhmannauthor=A.+M.+Herrmannauthor=S.+G.+Meuthauthor=G.+Stollauthor=S.+Meurerauthor=A.+Schreweauthor=L.+Beckerauthor=V.+Gailus-Durnerauthor=H.+Fuchsauthor=T.+Klopstockauthor=M.+H.+de+Angelisauthor=K.+Jandeleit-Dahmauthor=A.+M.+Shahauthor=N.+Weissmannauthor=H.+H.+H.+W.+Schmidt&title=Post-Stroke+Inhibition+of+Induced+NADPH+Oxidase+Type+4+Prevents+Oxidative+Stress+and+Neurodegeneration&doi=10.1371%2Fjournal.pbio.1000479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1000479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1000479%26sid%3Dliteratum%253Aachs%26aulast%3DKleinschnitz%26aufirst%3DC.%26aulast%3DGrund%26aufirst%3DH.%26aulast%3DWingler%26aufirst%3DK.%26aulast%3DArmitage%26aufirst%3DM.%2BE.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DMittal%26aufirst%3DM.%26aulast%3DBarit%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DT.%26aulast%3DGeis%26aufirst%3DC.%26aulast%3DKraft%26aufirst%3DP.%26aulast%3DBarthel%26aufirst%3DK.%26aulast%3DSchuhmann%26aufirst%3DM.%2BK.%26aulast%3DHerrmann%26aufirst%3DA.%2BM.%26aulast%3DMeuth%26aufirst%3DS.%2BG.%26aulast%3DStoll%26aufirst%3DG.%26aulast%3DMeurer%26aufirst%3DS.%26aulast%3DSchrewe%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DL.%26aulast%3DGailus-Durner%26aufirst%3DV.%26aulast%3DFuchs%26aufirst%3DH.%26aulast%3DKlopstock%26aufirst%3DT.%26aulast%3Dde%2BAngelis%26aufirst%3DM.%2BH.%26aulast%3DJandeleit-Dahm%26aufirst%3DK.%26aulast%3DShah%26aufirst%3DA.%2BM.%26aulast%3DWeissmann%26aufirst%3DN.%26aulast%3DSchmidt%26aufirst%3DH.%2BH.%2BH.%2BW.%26atitle%3DPost-Stroke%2520Inhibition%2520of%2520Induced%2520NADPH%2520Oxidase%2520Type%25204%2520Prevents%2520Oxidative%2520Stress%2520and%2520Neurodegeneration%26jtitle%3DPLoS%2520Biol.%26date%3D2010%26volume%3D8%26issue%3D9%26spage%3De1000479%26doi%3D10.1371%2Fjournal.pbio.1000479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuo, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z. S.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase Inhibitor Regulates MicroRNAs with Improved Outcome after Mechanical Reperfusion</span>. <i>J. Neurointerv. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">702</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1136/neurintsurg-2016-012463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1136%2Fneurintsurg-2016-012463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27325364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC2s7hvV2quw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=702-706&issue=7&author=Z.+Liuauthor=Y.+H.+Tuoauthor=J.+W.+Chenauthor=Q.+Y.+Wangauthor=S.+Liauthor=M.+C.+Liauthor=G.+Daiauthor=J.+S.+Wangauthor=Y.+L.+Zhangauthor=L.+Fengauthor=Z.+S.+Shi&title=NADPH+Oxidase+Inhibitor+Regulates+MicroRNAs+with+Improved+Outcome+after+Mechanical+Reperfusion&doi=10.1136%2Fneurintsurg-2016-012463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH oxidase inhibitor regulates microRNAs with improved outcome after mechanical reperfusion</span></div><div class="casAuthors">Liu Zhong; Tuo Yong-Hua; Wang Qing-Yuan; Wang Jin-Shan; Shi Zhong-Song; Chen Jian-Wen; Li Songlin; Li Ming-Chang; Dai Gang; Zhang Yong-Li; Feng Lei; Shi Zhong-Song</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurointerventional surgery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">702-706</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Inhibition of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) pathway improves the neurological outcome in the transient middle cerebral artery occlusion (tMCAO) animal model.  In this study we analyzed the microRNAs profile targeting NOX2 and NOX4 genes and its response to NOX2/4 inhibitor VAS2870 to understand the mechanisms of this protective effect.  METHODS:  The intraluminal filament tMCAO model was established in hyperglycemic rats (n=106) with 5 hours ischemia followed by 19 hours reperfusion.  NOX inhibitor VAS2870 was delivered intravenously before reperfusion.  Infarct volume, hemorrhagic transformation, and mortality were determined at 24 hours after cerebral ischemia.  MicroRNAs profile targeting NOX2 and NOX4 genes were predicted by microRNA databases and further evaluated by microRNA microarray and quantitative RT-PCR.  RESULTS:  Ten microRNAs potentially targeting NOX2 and NOX4 genes (including microRNA-29a, microRNA-29c, microRNA-126a, microRNA-132, microRNA-136, microRNA-138, microRNA-139, microRNA-153, microRNA-337, and microRNA-376a) were significantly downregulated in the ischemic hemisphere in the tMCAO group compared with the sham-operated group, as shown by microRNA microarray and quantitative RT-PCR (all p<0.05).  Intravenous treatment with NOX inhibitor VAS2870 before reperfusion increased the expression of microRNA-29a, microRNA-29c, microRNA-126a, and microRNA-132 compared with the tMCAO group (all p<0.05).  CONCLUSIONS:  Several microRNAs potentially targeting NOX2 and NOX4 genes displayed altered levels in hyperglycemic rats with the tMCAO model, suggesting their regulatory roles and targeting potentials for acute ischemic stroke treatment.  Targeting specific microRNAs may represent a novel intervention opportunity to improve outcome and reduce hemorrhagic transformation after mechanical reperfusion for acute ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIGso_NfqkwJPlX7E30qdzfW6udTcc2ebP-4XBTZVqBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7hvV2quw%253D%253D&md5=01fe1f3159c1f8cf317a40ee387c33f9</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1136%2Fneurintsurg-2016-012463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fneurintsurg-2016-012463%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DTuo%26aufirst%3DY.%2BH.%26aulast%3DChen%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DM.%2BC.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DJ.%2BS.%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DZ.%2BS.%26atitle%3DNADPH%2520Oxidase%2520Inhibitor%2520Regulates%2520MicroRNAs%2520with%2520Improved%2520Outcome%2520after%2520Mechanical%2520Reperfusion%26jtitle%3DJ.%2520Neurointerv.%2520Surg.%26date%3D2017%26volume%3D9%26issue%3D7%26spage%3D702%26epage%3D706%26doi%3D10.1136%2Fneurintsurg-2016-012463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sancho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabregat, I.</span></span> <span> </span><span class="NLM_article-title">The NADPH Oxidase Inhibitor VAS2870 Impairs Cell Growth and Enhances TGF-β-Induced Apoptosis of Liver Tumor Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.bcp.2011.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=21276422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFGkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=917-924&issue=7&author=P.+Sanchoauthor=I.+Fabregat&title=The+NADPH+Oxidase+Inhibitor+VAS2870+Impairs+Cell+Growth+and+Enhances+TGF-%CE%B2-Induced+Apoptosis+of+Liver+Tumor+Cells&doi=10.1016%2Fj.bcp.2011.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-β-induced apoptosis of liver tumor cells</span></div><div class="casAuthors">Sancho, Patricia; Fabregat, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">917-924</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Liver tumor cells show several mol. alterations which favor pro-survival signaling.  Among those, we have proposed the NADPH oxidase NOX1 as a prosurvival signal for liver tumor cells.  On the one side, we have described that FaO rat hepatoma cells show NOX1-dependent partial resistance to apoptosis induced by Transforming Growth Factor beta (TGF-β).  On the other side, we have shown that FaO cells, as well as different human hepatocellular carcinoma (HCC) cell lines, are able to proliferate in the absence of serum through the activation of a NOX1-dependent signaling pathway.  The aim of this work was to analyze the effects of NADPH oxidase pharmacol. inhibition in liver tumor cells using the inhibitor VAS2870.  This compd. inhibits dose-dependently autocrine increase of cell no. in FaO rat hepatoma cells, and almost completely blocked ROS prodn. and thymidine incorporation when used at 25 μM.  Such inhibitory effect on autocrine growth is coincident with lower mRNA levels of EGFR (Epidermal Growth Factor Receptor) and its ligand TGF-α (Transforming Growth Factor-alpha), and decreased phosphorylation of the EGFR itself and other downstream targets, such as SRC or AKT.  Moreover, NADPH oxidase pharmacol. inhibition also effectively attenuates serum-dependent growth and phosphorylation of AKT and ERK.  Importantly, these inhibitory effects on either autocrine or serum-dependent cell growth are obsd. in several human HCC cell lines.  Finally, we have obsd. that VAS2870 is also effective in enhancing apoptosis induced by a physiol. stimulus, such as TGF-β.  In summary, NADPH oxidase pharmacol. inhibition could be considered a promising tool in the treatment of liver cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqd6eXEeGTfbVg90H21EOLACvtfcHk0liVPVydXSL7eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFGkt78%253D&md5=571095e0ee96d9fec66b96fc7ca51e2f</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DSancho%26aufirst%3DP.%26aulast%3DFabregat%26aufirst%3DI.%26atitle%3DThe%2520NADPH%2520Oxidase%2520Inhibitor%2520VAS2870%2520Impairs%2520Cell%2520Growth%2520and%2520Enhances%2520TGF-%25CE%25B2-Induced%2520Apoptosis%2520of%2520Liver%2520Tumor%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26issue%3D7%26spage%3D917%26epage%3D924%26doi%3D10.1016%2Fj.bcp.2011.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamler, J. S.</span></span> <span> </span><span class="NLM_article-title">Off-Target Thiol Alkylation by the NADPH Oxidase Inhibitor 3- Benzyl-7-(2-Benzoxazolyl)Thio-1,2,3-Triazolo[4,5-d]Pyrimidine (VAS2870)</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1897</span>– <span class="NLM_lpage">1902</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2012.02.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2012.02.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22406319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlWmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1897-1902&issue=9&author=Q.-A.+Sunauthor=D.+T.+Hessauthor=B.+Wangauthor=M.+Miyagiauthor=J.+S.+Stamler&title=Off-Target+Thiol+Alkylation+by+the+NADPH+Oxidase+Inhibitor+3-+Benzyl-7-%282-Benzoxazolyl%29Thio-1%2C2%2C3-Triazolo%5B4%2C5-d%5DPyrimidine+%28VAS2870%29&doi=10.1016%2Fj.freeradbiomed.2012.02.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine (VAS2870)</span></div><div class="casAuthors">Sun, Qi-An; Hess, Douglas T.; Wang, Benlian; Miyagi, Masaru; Stamler, Jonathan S.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1897-1902</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Specific inhibitors of the prodn. of reactive oxygen species (ROS) by the NADPH oxidases (Nox's) are potentially important therapeutic agents in the wide range of human diseases that are characterized by excessive ROS prodn.  It has been proposed that VAS2870 (3-benzyl-7-(2-benzoxazolyl)thio-1,2,3- triazolo[4,5-d]pyrimidine), identified as an inhibitor of Nox2 by small-mol. screening, may serve as an example of such an agent.  Here we show that VAS2870 inhibits ROS prodn. in the sarcoplasmic reticulum (SR) of mammalian skeletal muscle, previously identified with Nox4, and thereby abrogates O2-coupled redox regulation of the ryanodine receptor-Ca2+ channel (RyR1).  However, we also find that VAS2870 modifies directly identified cysteine thiols within RyR1.  Mass spectrometric anal. of RyR1 exposed in situ to VAS2870 and of VAS2870-treated glutathione indicated that thiol modification is through alkylation by the benzyltriazolopyrimidine moiety of VAS2870.  Thus, VAS2870 exerts significant off-target effects, and thiol alkylation by VAS2870 (and closely related Nox inhibitors) may in fact replicate some of the effects of ROS on cellular thiol redox status.  In addn., we show that SR-localized Nox4 is inhibited by other thiol-alkylating agents, consistent with a causal role for cysteine modification in the inhibition of ROS prodn. by VAS2870.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSMAxkJX1GbbVg90H21EOLACvtfcHk0liVPVydXSL7eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlWmsLs%253D&md5=43dae8c22f646bd49a41392cf6d092f9</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2012.02.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2012.02.046%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.-A.%26aulast%3DHess%26aufirst%3DD.%2BT.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMiyagi%26aufirst%3DM.%26aulast%3DStamler%26aufirst%3DJ.%2BS.%26atitle%3DOff-Target%2520Thiol%2520Alkylation%2520by%2520the%2520NADPH%2520Oxidase%2520Inhibitor%25203-%2520Benzyl-7-%25282-Benzoxazolyl%2529Thio-1%252C2%252C3-Triazolo%255B4%252C5-d%255DPyrimidine%2520%2528VAS2870%2529%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26issue%3D9%26spage%3D1897%26epage%3D1902%26doi%3D10.1016%2Fj.freeradbiomed.2012.02.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wind, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuerlein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eucker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armitage, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingler, K.</span></span> <span> </span><span class="NLM_article-title">Comparative Pharmacology of Chemically Distinct NADPH Oxidase Inhibitors</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>161</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00920.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fj.1476-5381.2010.00920.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=20860666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kju7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=885-898&issue=4&author=S.+Windauthor=K.+Beuerleinauthor=T.+Euckerauthor=H.+M%C3%BCllerauthor=P.+Scheurerauthor=M.+Armitageauthor=H.+Hoauthor=H.+Schmidtauthor=K.+Wingler&title=Comparative+Pharmacology+of+Chemically+Distinct+NADPH+Oxidase+Inhibitors&doi=10.1111%2Fj.1476-5381.2010.00920.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative pharmacology of chemically distinct NADPH oxidase inhibitors</span></div><div class="casAuthors">Wind, S.; Beuerlein, K.; Eucker, T.; Mueller, H.; Scheurer, P.; Armitage, M. E.; Ho, H.; Schmidt, H. H. H. W.; Wingler, K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">885-898</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Oxidative stress [i.e. increased levels of reactive oxygen species (ROS)] was suggested as a pathomechanism of different diseases, although the disease-relevant sources of ROS remain to be identified.  One of these sources may be NADPH oxidases.  However, due to increasing concerns about the specificity of the compds. commonly used as NADPH oxidase inhibitors, data obtained with these compds. may have to be re-interpreted.  We compared the pharmacol. profiles of the commonly used NADPH oxidase inhibitors, diphenylene iodonium (DPI), apocynin and 4-(2-amino-ethyl)-benzolsulfonyl-fluoride (AEBSF), as well as the novel triazolo pyrimidine VAS3947.  We used several assays for detecting cellular and tissue ROS, as none of them is specific and artifact free.  DPI abolished NADPH oxidase-mediated ROS formation, but also inhibited other flavo-enzymes such as NO synthase (NOS) and xanthine oxidase (XOD).  Apocynin interfered with ROS detection and varied considerably in efficacy and potency, as did AEBSF.  Conversely, the novel NADPH oxidase inhibitor, VAS3947, consistently inhibited NADPH oxidase activity in low micromolar concns., and interfered neither with ROS detection nor with XOD or eNOS activities.  VAS3947 attenuated ROS formation in aortas of spontaneously hypertensive rats (SHRs), where NOS or XOD inhibitors were without effect.  These data suggest that triazolo pyrimidines such as VAS3947 are specific NADPH oxidase inhibitors, while DPI and apocynin can no longer be recommended.  Based on the effects of VAS3947, NADPH oxidases appear to be a major source of ROS in aortas of SHRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0O304hImDGbVg90H21EOLACvtfcHk0liXlvXgEudRug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kju7zN&md5=c8f1238e49b693771df03b590ed524b8</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00920.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00920.x%26sid%3Dliteratum%253Aachs%26aulast%3DWind%26aufirst%3DS.%26aulast%3DBeuerlein%26aufirst%3DK.%26aulast%3DEucker%26aufirst%3DT.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DScheurer%26aufirst%3DP.%26aulast%3DArmitage%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DSchmidt%26aufirst%3DH.%26aulast%3DWingler%26aufirst%3DK.%26atitle%3DComparative%2520Pharmacology%2520of%2520Chemically%2520Distinct%2520NADPH%2520Oxidase%2520Inhibitors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26issue%3D4%26spage%3D885%26epage%3D898%26doi%3D10.1111%2Fj.1476-5381.2010.00920.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cha, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y. S.</span></span> <span> </span><span class="NLM_article-title">APX-115, a First-in-Class Pan-NADPH Oxidase (Nox) Inhibitor, Protects Db/Db Mice from Renal Injury</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1038/labinvest.2017.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Flabinvest.2017.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28165467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFGltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2017&pages=419-431&issue=4&author=D.+R.+Chaauthor=J.+J.+Chaauthor=H.+S.+Minauthor=K.+T.+Kimauthor=J.+E.+Kimauthor=J.+Y.+Gheeauthor=H.+W.+Kimauthor=J.+E.+Leeauthor=J.+Y.+Hanauthor=G.+Leeauthor=H.+J.+Haauthor=Y.+S.+Baeauthor=S.+R.+Leeauthor=S.+H.+Moonauthor=S.+C.+Leeauthor=G.+Kimauthor=Y.+S.+Kang&title=APX-115%2C+a+First-in-Class+Pan-NADPH+Oxidase+%28Nox%29+Inhibitor%2C+Protects+Db%2FDb+Mice+from+Renal+Injury&doi=10.1038%2Flabinvest.2017.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury</span></div><div class="casAuthors">Cha, Jin Joo; Min, Hye Sook; Kim, Ki Tae; Kim, Jung Eun; Ghee, Jung Yeon; Kim, Hyun Wook; Lee, Ji Eun; Han, Jee Young; Lee, Gayoung; Ha, Hun Joo; Bae, Yun Soo; Lee, Sae Rom; Moon, Sung Hwan; Lee, Sung Chan; Kim, Ganghyun; Kang, Young Sun; Cha, Dae Ryong</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory Investigation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-431</span>CODEN:
                <span class="NLM_cas:coden">LAINAW</span>;
        ISSN:<span class="NLM_cas:issn">0023-6837</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recent studies have suggested that renal Nox is important in the progression of diabetic nephropathy.  Therefore, we investigated the effect of a novel pan-NOX-inhibitor, APX-115, on diabetic nephropathy in type 2 diabetic mice.  Eight- week-old db/m and db/db mice were treated with APX-115 for 12 wk.  APX-115 was administered by oral gavage at a dose of 60 mg/kg per day.  To compare the effects of APX-115 with a dual Nox1/Nox4 inhibitor, db/db mice were treated with GKT137831 according to the same protocol.  APX-115 significantly improved insulin resistance in diabetic mice, similar to GKT137831.  Oxidative stress as measured by plasma 8-isoprostane level was decreased in the APX-115 group compared with diabetic controls.  All lipid profiles, both in plasma and tissues improved with Nox inhibition.  APX-115 treatment decreased Nox1, Nox2, and Nox4 protein expression in the kidney.  APX-115 decreased urinary albumin excretion and preserved creatinine level.  In diabetic kidneys, APX-115 significantly improved mesangial expansion, but GKT137831 did not.  In addn., F4/80 infiltration in the adipose tissue and kidney decreased with APX-115 treatment.  We also found that TGF-β stimulated ROS generation in primary mouse mesangial cells (pMMCs) from wild-type, Nox1 KO, and Duox1 KO mice, but did not induce Nox activity in pMMCs from Nox2 knockout (KO), Nox4 KO, or Duox2 KO mice.  These results indicate that activating Nox2, Nox4, or Duox2 in pMMCs is essential for TGF-β-mediated ROS generation.  Our findings suggest that APX-115 may be as effective or may provide better protection than the dual Nox1/Nox4 inhibitor, and pan-Nox inhibition with APX-115 might be a promising therapy for diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvE3keDiQgirVg90H21EOLACvtfcHk0lhf9zPaub0B-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFGltLo%253D&md5=1228945e1a6780e9b68a46695d3fa4e3</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.2017.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.2017.2%26sid%3Dliteratum%253Aachs%26aulast%3DCha%26aufirst%3DD.%2BR.%26aulast%3DCha%26aufirst%3DJ.%2BJ.%26aulast%3DMin%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DK.%2BT.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DGhee%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DHan%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DBae%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BR.%26aulast%3DMoon%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DKim%26aufirst%3DG.%26aulast%3DKang%26aufirst%3DY.%2BS.%26atitle%3DAPX-115%252C%2520a%2520First-in-Class%2520Pan-NADPH%2520Oxidase%2520%2528Nox%2529%2520Inhibitor%252C%2520Protects%2520Db%252FDb%2520Mice%2520from%2520Renal%2520Injury%26jtitle%3DLab.%2520Invest.%26date%3D2017%26volume%3D97%26issue%3D4%26spage%3D419%26epage%3D431%26doi%3D10.1038%2Flabinvest.2017.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goo, J. Il</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baek, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. S.</span></span> <span> </span><span class="NLM_article-title">A Novel Pyrazole Derivative Protects from Ovariectomy-Induced Osteoporosis through the Inhibition of NADPH Oxidase</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1038/srep22389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fsrep22389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28442746" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=1-14&author=J.+H.+Jooauthor=J.+E.+Huhauthor=J.+H.+Leeauthor=D.+R.+Parkauthor=Y.+Leeauthor=S.+G.+Leeauthor=S.+Choiauthor=H.+J.+Leeauthor=S.+W.+Songauthor=Y.+Jeongauthor=J.+Il+Gooauthor=Y.+Choiauthor=H.+K.+Baekauthor=S.+S.+Yiauthor=S.+J.+Parkauthor=J.+E.+Leeauthor=S.+K.+Kuauthor=W.+J.+Leeauthor=K.+I.+Leeauthor=S.+Y.+Leeauthor=Y.+S.+Bae&title=A+Novel+Pyrazole+Derivative+Protects+from+Ovariectomy-Induced+Osteoporosis+through+the+Inhibition+of+NADPH+Oxidase&doi=10.1038%2Fsrep22389"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1038%2Fsrep22389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22389%26sid%3Dliteratum%253Aachs%26aulast%3DJoo%26aufirst%3DJ.%2BH.%26aulast%3DHuh%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DD.%2BR.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%2BG.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DSong%26aufirst%3DS.%2BW.%26aulast%3DJeong%26aufirst%3DY.%26aulast%3DGoo%26aufirst%3DJ.%2BIl%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DBaek%26aufirst%3DH.%2BK.%26aulast%3DYi%26aufirst%3DS.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DKu%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BI.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DBae%26aufirst%3DY.%2BS.%26atitle%3DA%2520Novel%2520Pyrazole%2520Derivative%2520Protects%2520from%2520Ovariectomy-Induced%2520Osteoporosis%2520through%2520the%2520Inhibition%2520of%2520NADPH%2520Oxidase%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D1%26epage%3D14%26doi%3D10.1038%2Fsrep22389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic Study of NADPH Oxidase Inhibitor Ewha-18278, a Pyrazole Derivative</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">482</span>, <span class="refDoi"> DOI: 10.3390/pharmaceutics11090482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3390%2Fpharmaceutics11090482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmvF2lurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=482&issue=9&author=S.+G.+Leeauthor=J.+Leeauthor=K.+M.+Kimauthor=K.+I.+Leeauthor=Y.+S.+Baeauthor=H.+J.+Lee&title=Pharmacokinetic+Study+of+NADPH+Oxidase+Inhibitor+Ewha-18278%2C+a+Pyrazole+Derivative&doi=10.3390%2Fpharmaceutics11090482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic study of NADPH oxidase inhibitor Ewha-18278, a pyrazole derivative</span></div><div class="casAuthors">Lee, Seul Gee; Lee, Jaeok; Kim, Kyung Min; Lee, Kee-In; Bae, Yun Soo; Lee, Hwa Jeong</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">482</span>CODEN:
                <span class="NLM_cas:coden">PHARK5</span>;
        ISSN:<span class="NLM_cas:issn">1999-4923</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In a previous study, the specific NOX1/2/4 inhibitor Ewha-18278 was confirmed as a possible treatment for osteoporosis both in vitro and in vivo.  Here, we investigated the pharmacokinetics (PK) of the compd. by i.v. (IV) and oral administrations to rats.  Di-Me sulfoxide (DMSO)-based and diazepam injection-based formulations were used to dissolve the compd.  In the latter formulation applicable to humans, the changes in PK parameters were monitored at two different concns. (1 mg/mL and 2 mg/mL).  The area under the plasma concn.-time curve from zero time to infinity (AUCinf) of Ewha-18278 was highest in the DMSO-based formulation (2 mg/mL).  Also, the concn. was increased 1.6-fold at the low concn. of the diazepam injection-based formulation compared to the high concn.  There was no statistical significance in the AUCinf of the compd. between DMSO-based formulation (2 mg/mL) and diazepam injection-based formulation (1 mg/mL).  These results suggest that Ewha-18278 can be delivered to humans by both IV and oral routes.  In addn., the diazepam injection-based formulation of Ewha-18278 appears to be a suitable candidate for dosage development for future toxicity test and clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCVlezw2qPlLVg90H21EOLACvtfcHk0ljD7niglHkPKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmvF2lurk%253D&md5=7d6440d5548eab81903d8656adcc8728</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics11090482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics11090482%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BG.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%2BM.%26aulast%3DLee%26aufirst%3DK.%2BI.%26aulast%3DBae%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26atitle%3DPharmacokinetic%2520Study%2520of%2520NADPH%2520Oxidase%2520Inhibitor%2520Ewha-18278%252C%2520a%2520Pyrazole%2520Derivative%26jtitle%3DPharmaceutics%26date%3D2019%26volume%3D11%26issue%3D9%26spage%3D482%26doi%3D10.3390%2Fpharmaceutics11090482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorotea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H.</span></span> <span> </span><span class="NLM_article-title">A Pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats</span>. <i>Pharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1159/000491398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1159%2F000491398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30099457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslaqt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2018&pages=180-189&issue=3%E2%80%934&author=D.+Doroteaauthor=G.+Kwonauthor=J.+H.+Leeauthor=E.+Saundersauthor=Y.+S.+Baeauthor=S.+H.+Moonauthor=S.+J.+Leeauthor=D.+R.+Chaauthor=H.+Ha&title=A+Pan-NADPH+Oxidase+Inhibitor+Ameliorates+Kidney+Injury+in+Type+1+Diabetic+Rats&doi=10.1159%2F000491398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">A pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats</span></div><div class="casAuthors">Dorotea, Debra; Kwon, Guideock; Lee, Jung Hwa; Saunders, Erika; Bae, Yun Soo; Moon, Sung Hwan; Lee, Soo Jin; Cha, Dae Ryong; Ha, Hunjoo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">180-189</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: NADPH oxidases (Nox) is a major enzyme system contributing to oxidative stress, which plays an important role in the pathogenesis of diabetic kidney disease (DKD).  We have shown an elevation of renal Nox1, Nox2, and Nox4 in diabetic mice.  APX-115, a pan-Nox inhibitor, attenuated the progression of DKD in mice.  As the std. diabetic mice cannot fully mimic human DKD, the present study was aimed to show the dose-dependent effect and to provide a confirmatory evidence of APX-115 in attenuating DKD in diabetic rats.  Method: Type 1 diabetes was induced by a single 60 mg/kg i.p. injection of streptozotocin in Sprague-Dawley rats. 0.5, 5, or 30 mg APX-115/kg/day or losartan 1 mg/kg/day were administered orally to diabetic rats for 8 wk.  Results: APX-115 treatment showed an improvement in kidney function and tubular and podocyte -injury, as well as attenuation of inflammation, fibrosis, and oxidative stress as much as losartan, a comparative drug and mainstay treatment in DKD.  Therapeutic effect of APX-115 was exhibited in a dose-dependent manner; a dose of 30 mg/kg displayed a superior efficacy.  Conclusion: This finding verified the pre-clin. data of APX-115 in protecting against DKD, which is important to bring APX-115 toward the next stage of drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_DemfCK7hD7Vg90H21EOLACvtfcHk0ljD7niglHkPKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslaqt7vO&md5=6db3af54eb5aebf07d3a96db68a9971d</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1159%2F000491398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000491398%26sid%3Dliteratum%253Aachs%26aulast%3DDorotea%26aufirst%3DD.%26aulast%3DKwon%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DSaunders%26aufirst%3DE.%26aulast%3DBae%26aufirst%3DY.%2BS.%26aulast%3DMoon%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DCha%26aufirst%3DD.%2BR.%26aulast%3DHa%26aufirst%3DH.%26atitle%3DA%2520Pan-NADPH%2520Oxidase%2520Inhibitor%2520Ameliorates%2520Kidney%2520Injury%2520in%2520Type%25201%2520Diabetic%2520Rats%26jtitle%3DPharmacology%26date%3D2018%26volume%3D102%26issue%3D3%25E2%2580%25934%26spage%3D180%26epage%3D189%26doi%3D10.1159%2F000491398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiomi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanibuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamata, T.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of a Novel NADPH Oxidase 1 (Nox1) Inhibitor That Suppresses Proliferation of Colon and Stomach Cancer Cells</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1248/bpb.b17-00804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1248%2Fbpb.b17-00804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29269607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWhsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=419-426&issue=3&author=T.+Yamamotoauthor=H.+Nakanoauthor=K.+Shiomiauthor=K.+Wanibuchiauthor=H.+Masuiauthor=T.+Takahashiauthor=Y.+Uranoauthor=T.+Kamata&title=Identification+and+Characterization+of+a+Novel+NADPH+Oxidase+1+%28Nox1%29+Inhibitor+That+Suppresses+Proliferation+of+Colon+and+Stomach+Cancer+Cells&doi=10.1248%2Fbpb.b17-00804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a novel NADPH oxidase 1 (noxl) inhibitor that suppresses proliferation of colon and stomach cancer cells</span></div><div class="casAuthors">Yamamoto, Tsuyoshi; Nakano, Hirofumi; Shiomi, Kazuro; Wanibuchi, Kiyofumi; Masui, Hisashi; Takahashi, Takashi; Urano, Yasuteru; Kamata, Tohru</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">419-426</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) generated by reduced NADP (NADPH) oxidase (Nox)l mediate cellular signalings i.m. oh ed in normal physiol. processes, and aberrant control of Noxl has been implicated in the pathogenesis of various diseases.  Therefore, Noxl could have great potential as a therapeutic target.  Here, we identified a novel Nox1 inhibitor.  NOS31 secreted from Stretomyces sp. and analyzed its chem. structure.  Furthermore, NOS31 was found to selectively inhibit Noxl-mediated ROS generation, with only a marginal effect on other Nox isoforms (Nox2-5) and no ROS scavenging activity.  This compd. blocked both Nox organizer I (NOXOI)/Nox activator I (NOXA1)-dependent and phorbol 12-myristatc 13-acetate-stimulated Noxl-mediatcd ROS prodn. in colon cancer cells.  NOS31 inhibited the proliferation of several colon carcinoma and gastric cancer cell lines that uprcgulate the Noxl system, whereas it had no appreciable effect on normal cells with low levels or Nox1.  The finding suggests that NOS331 is a unique, potent Noxl inhibitor of microbial origin and raises its possibility as a therapeutic agent for inhibiting gastrointestinal cancer cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN-FOsZej6MLVg90H21EOLACvtfcHk0liYeDaKUu_CNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWhsb3J&md5=dc104452d63f966ee58d9b2ae7443e0c</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b17-00804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b17-00804%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DShiomi%26aufirst%3DK.%26aulast%3DWanibuchi%26aufirst%3DK.%26aulast%3DMasui%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DKamata%26aufirst%3DT.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520Novel%2520NADPH%2520Oxidase%25201%2520%2528Nox1%2529%2520Inhibitor%2520That%2520Suppresses%2520Proliferation%2520of%2520Colon%2520and%2520Stomach%2520Cancer%2520Cells%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2018%26volume%3D41%26issue%3D3%26spage%3D419%26epage%3D426%26doi%3D10.1248%2Fbpb.b17-00804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chueng, A. L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunne, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seredenina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulyanidewi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aw, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oon, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaquet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutter, A. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1089/ars.2014.6202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fars.2014.6202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26135714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWmurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=358-374&issue=5&author=K.+Hiranoauthor=W.+S.+Chenauthor=A.+L.+W.+Chuengauthor=A.+A.+Dunneauthor=T.+Seredeninaauthor=A.+Filippovaauthor=S.+Ramachandranauthor=A.+Bridgesauthor=L.+Chaudryauthor=G.+Pettmanauthor=C.+Allanauthor=S.+Duncanauthor=K.+C.+Leeauthor=J.+Limauthor=M.+T.+Maauthor=A.+B.+Ongauthor=N.+Y.+Yeauthor=S.+Nasirauthor=S.+Mulyanidewiauthor=C.+C.+Awauthor=P.+P.+Oonauthor=S.+Liaoauthor=D.+Liauthor=D.+G.+Johnsauthor=N.+D.+Millerauthor=C.+H.+Daviesauthor=E.+R.+Browneauthor=Y.+Matsuokaauthor=D.+W.+Chenauthor=V.+Jaquetauthor=A.+R.+Rutter&title=Discovery+of+GSK2795039%2C+a+Novel+Small+Molecule+NADPH+Oxidase+2+Inhibitor&doi=10.1089%2Fars.2014.6202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor</span></div><div class="casAuthors">Hirano, Kazufumi; Chen, Woei Shin; Chueng, Adeline L. W.; Dunne, Angela A.; Seredenina, Tamara; Filippova, Aleksandra; Ramachandran, Sumitra; Bridges, Angela; Chaudry, Laiq; Pettman, Gary; Allan, Craig; Duncan, Sarah; Lee, Kiew Ching; Lim, Jean; Ma, May Thu; Ong, Agnes B.; Ye, Nicole Y.; Nasir, Shabina; Mulyanidewi, Sri; Aw, Chiu Cheong; Oon, Pamela P.; Liao, Shihua; Li, Dizheng; Johns, Douglas G.; Miller, Neil D.; Davies, Ceri H.; Browne, Edward R.; Matsuoka, Yasuji; Chen, Deborah W.; Jaquet, Vincent; Rutter, A. Richard</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">358-374</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: The NADPH oxidase (NOX) family of enzymes catalyzes the formation of reactive oxygen species (ROS).  NOX enzymes not only have a key role in a variety of physiol. processes but also contribute to oxidative stress in certain disease states.  To date, while numerous small mol. inhibitors have been reported (in particular for NOX2), none have demonstrated inhibitory activity in vivo.  As such, there is a need for the identification of improved NOX inhibitors to enable further evaluation of the biol. functions of NOX enzymes in vivo as well as the therapeutic potential of NOX inhibition.  In this study, both the in vitro and in vivo pharmacol. profiles of GSK2795039, a novel NOX2 inhibitor, were characterized in comparison with other published NOX inhibitors.  Results: GSK2795039 inhibited both the formation of ROS and the utilization of the enzyme substrates, NADPH and oxygen, in a variety of semirecombinant cell-free and cell-based NOX2 assays.  It inhibited NOX2 in an NADPH competitive manner and was selective over other NOX isoforms, xanthine oxidase, and endothelial nitric oxide synthase enzymes.  Following systemic administration in mice, GSK2795039 abolished the prodn. of ROS by activated NOX2 enzyme in a paw inflammation model.  Furthermore, GSK2795039 showed activity in a murine model of acute pancreatitis, reducing the levels of serum amylase triggered by systemic injection of caerulein.  Innovation and Conclusions: GSK2795039 is a novel NOX2 inhibitor that is the first small mol. to demonstrate inhibition of the NOX2 enzyme in vivo.  Antioxid. Redox Signal. 23, 358-374.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfXOnm82DryrVg90H21EOLACvtfcHk0ljWpcQKyCZhAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWmurvO&md5=5a33ec778532e641db86dcda7c65e6a3</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1089%2Fars.2014.6202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2014.6202%26sid%3Dliteratum%253Aachs%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DW.%2BS.%26aulast%3DChueng%26aufirst%3DA.%2BL.%2BW.%26aulast%3DDunne%26aufirst%3DA.%2BA.%26aulast%3DSeredenina%26aufirst%3DT.%26aulast%3DFilippova%26aufirst%3DA.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DBridges%26aufirst%3DA.%26aulast%3DChaudry%26aufirst%3DL.%26aulast%3DPettman%26aufirst%3DG.%26aulast%3DAllan%26aufirst%3DC.%26aulast%3DDuncan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DK.%2BC.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DM.%2BT.%26aulast%3DOng%26aufirst%3DA.%2BB.%26aulast%3DYe%26aufirst%3DN.%2BY.%26aulast%3DNasir%26aufirst%3DS.%26aulast%3DMulyanidewi%26aufirst%3DS.%26aulast%3DAw%26aufirst%3DC.%2BC.%26aulast%3DOon%26aufirst%3DP.%2BP.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DJohns%26aufirst%3DD.%2BG.%26aulast%3DMiller%26aufirst%3DN.%2BD.%26aulast%3DDavies%26aufirst%3DC.%2BH.%26aulast%3DBrowne%26aufirst%3DE.%2BR.%26aulast%3DMatsuoka%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DD.%2BW.%26aulast%3DJaquet%26aufirst%3DV.%26aulast%3DRutter%26aufirst%3DA.%2BR.%26atitle%3DDiscovery%2520of%2520GSK2795039%252C%2520a%2520Novel%2520Small%2520Molecule%2520NADPH%2520Oxidase%25202%2520Inhibitor%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2015%26volume%3D23%26issue%3D5%26spage%3D358%26epage%3D374%26doi%3D10.1089%2Fars.2014.6202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yauger, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermudez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoica, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrnes, K. R.</span></span> <span> </span><span class="NLM_article-title">Iron Accentuated Reactive Oxygen Species Release by NADPH Oxidase in Activated Microglia Contributes to Oxidative Stress in Vitro</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1186/s12974-019-1430-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1186%2Fs12974-019-1430-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30606213" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=1-15&issue=1&author=Y.+J.+Yaugerauthor=S.+Bermudezauthor=K.+E.+Moritzauthor=E.+Glaserauthor=B.+Stoicaauthor=K.+R.+Byrnes&title=Iron+Accentuated+Reactive+Oxygen+Species+Release+by+NADPH+Oxidase+in+Activated+Microglia+Contributes+to+Oxidative+Stress+in+Vitro&doi=10.1186%2Fs12974-019-1430-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1186%2Fs12974-019-1430-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-019-1430-7%26sid%3Dliteratum%253Aachs%26aulast%3DYauger%26aufirst%3DY.%2BJ.%26aulast%3DBermudez%26aufirst%3DS.%26aulast%3DMoritz%26aufirst%3DK.%2BE.%26aulast%3DGlaser%26aufirst%3DE.%26aulast%3DStoica%26aufirst%3DB.%26aulast%3DByrnes%26aufirst%3DK.%2BR.%26atitle%3DIron%2520Accentuated%2520Reactive%2520Oxygen%2520Species%2520Release%2520by%2520NADPH%2520Oxidase%2520in%2520Activated%2520Microglia%2520Contributes%2520to%2520Oxidative%2520Stress%2520in%2520Vitro%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2019%26volume%3D16%26issue%3D1%26spage%3D1%26epage%3D15%26doi%3D10.1186%2Fs12974-019-1430-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span> <span> </span><span class="NLM_article-title">An Effective NADPH Oxidase 2 Inhibitor Provides Neuroprotection and Improves Functional Outcomes in Animal Model of Traumatic Brain Injury</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1097</span>– <span class="NLM_lpage">1106</span>, <span class="refDoi"> DOI: 10.1007/s11064-020-02987-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs11064-020-02987-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32072445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtlagtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2020&pages=1097-1106&issue=5&author=M.+Wangauthor=L.+Luo&title=An+Effective+NADPH+Oxidase+2+Inhibitor+Provides+Neuroprotection+and+Improves+Functional+Outcomes+in+Animal+Model+of+Traumatic+Brain+Injury&doi=10.1007%2Fs11064-020-02987-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">An Effective NADPH Oxidase 2 Inhibitor Provides Neuroprotection and Improves Functional Outcomes in Animal Model of Traumatic Brain Injury</span></div><div class="casAuthors">Wang, Mengwei; Luo, Le</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1097-1106</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: Traumatic brain injury (TBI) has become a leading cause of death and disability all over the world.  Pharmacol. suppression of NADP (NADPH) oxidase 2 (NOX2) can inhibit oxidative stress which is implicated in the pathol. of TBI.  GSK2795039 was reported to target NOX2 to inhibit O.-2 and ROS prodn.  The present study aimed to investigate the effect of GSK2795039 on NOX2 activity and neurol. deficits in a TBI mouse model.  TBI mouse model was established by a wt.-drop to mouse skull.  GSK2795039 at a dose of 100 mg/kg was administrated to mice 30 min before TBI.  NOX2 expression and activity were detected by Western blot and biochem. method.  Neurol. damage and apoptosis were detected by behavioral test and terminal deoxynucleotidyl transferase dUTP nick end labeling staining.  GSK2795039 significantly inhibited NOX2 expression and activity in the TBI mouse model.  It also attenuated TBI-induced neurol. deficits, apoptosis, and neurol. recovery.  The results indicate that GSK2795039 can be used as a potential drug for TBI treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGSeJFnsKck7Vg90H21EOLACvtfcHk0lhkj4UXFOROQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtlagtLo%253D&md5=0179d06e17ee7bff26773e5063c62bd0</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1007%2Fs11064-020-02987-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-020-02987-3%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DL.%26atitle%3DAn%2520Effective%2520NADPH%2520Oxidase%25202%2520Inhibitor%2520Provides%2520Neuroprotection%2520and%2520Improves%2520Functional%2520Outcomes%2520in%2520Animal%2520Model%2520of%2520Traumatic%2520Brain%2520Injury%26jtitle%3DNeurochem.%2520Res.%26date%3D2020%26volume%3D45%26issue%3D5%26spage%3D1097%26epage%3D1106%26doi%3D10.1007%2Fs11064-020-02987-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cifuentes-Pagano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csányi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Ghouleh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrıguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wipf, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skoda, E. M.</span></span> <span> </span><span class="NLM_article-title">Bridged Tetrahydroisoquinolines as Selective NADPH Oxidase 2 (Nox2) Inhibitors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1039/c3md00061c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1039%2Fc3md00061c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24466406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSiu77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1085-1092&issue=7&author=E.+Cifuentes-Paganoauthor=J.+Sahaauthor=G.+Cs%C3%A1nyiauthor=I.+Al+Ghoulehauthor=S.+Sahooauthor=A.+Rodr%C4%B1guezauthor=P.+Wipfauthor=P.+J.+Paganoauthor=E.+M.+Skoda&title=Bridged+Tetrahydroisoquinolines+as+Selective+NADPH+Oxidase+2+%28Nox2%29+Inhibitors&doi=10.1039%2Fc3md00061c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors</span></div><div class="casAuthors">Cifuentes-Pagano, Eugenia; Saha, Jaideep; Csanyi, Gabor; Al Ghouleh, Imad; Sahoo, Sanghamitra; Rodriguez, Andres; Wipf, Peter; Pagano, Patrick J.; Skoda, Erin M.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1085-1092</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">(1SR,4RS)-3,3-Dimethyl-1,2,3,4-tetrahydro-1,4-(epiminomethano)naphthalenes were synthesized in 2-3 steps from com. available materials and assessed for specificity and effectiveness across a range of Nox isoforms.  The N-pentyl and N-methylenethiophene substituted analogs 11g and 11h emerged as selective Nox2 inhibitors with cellular IC50 values of 20 and 32 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHNPDpo6oc5LVg90H21EOLACvtfcHk0lhkj4UXFOROQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSiu77J&md5=22132923bdf946990bac6a67c8699b5a</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1039%2Fc3md00061c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00061c%26sid%3Dliteratum%253Aachs%26aulast%3DCifuentes-Pagano%26aufirst%3DE.%26aulast%3DSaha%26aufirst%3DJ.%26aulast%3DCs%25C3%25A1nyi%26aufirst%3DG.%26aulast%3DAl%2BGhouleh%26aufirst%3DI.%26aulast%3DSahoo%26aufirst%3DS.%26aulast%3DRodr%25C4%25B1guez%26aufirst%3DA.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DPagano%26aufirst%3DP.%2BJ.%26aulast%3DSkoda%26aufirst%3DE.%2BM.%26atitle%3DBridged%2520Tetrahydroisoquinolines%2520as%2520Selective%2520NADPH%2520Oxidase%25202%2520%2528Nox2%2529%2520Inhibitors%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26issue%3D7%26spage%3D1085%26epage%3D1092%26doi%3D10.1039%2Fc3md00061c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cifuentes-Pagano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVallance, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jesus, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijles, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croix, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, P. J.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase 2 Inhibitors CPP11G and CPP11H Attenuate Endothelial Cell Inflammation & Vessel Dysfunction and Restore Mouse Hind-Limb Flow</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">101143</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.redox.2019.101143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30897521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltFygsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2019&pages=101143&author=Y.+Liauthor=E.+Cifuentes-Paganoauthor=E.+R.+DeVallanceauthor=D.+S.+de+Jesusauthor=S.+Sahooauthor=D.+N.+Meijlesauthor=D.+Koesauthor=C.+J.+Camachoauthor=M.+Rossauthor=C.+Croixauthor=P.+J.+Pagano&title=NADPH+Oxidase+2+Inhibitors+CPP11G+and+CPP11H+Attenuate+Endothelial+Cell+Inflammation+%26+Vessel+Dysfunction+and+Restore+Mouse+Hind-Limb+Flow&doi=10.1016%2Fj.redox.2019.101143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH oxidase 2 inhibitors CPP11G and CPP11H attenuate endothelial cell inflammation & vessel dysfunction and restore mouse hind-limb flow</span></div><div class="casAuthors">Li, Y.; Cifuentes-Pagano, E.; DeVallance, E. R.; de Jesus, D. S.; Sahoo, S.; Meijles, D. N.; Koes, D.; Camacho, C. J.; Ross, M.; St Croix, C.; Pagano, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101143</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">First described as essential to the phagocytic activity of leukocytes, Nox2-derived ROS have emerged as mediators of a range of cellular and tissue responses across species from salubrious to deleterious consequences.  Knowledge of their role in inflammation is limited, however.  We postulated that TNFα-induced endothelial reactive oxygen species (ROS) generation and pro-inflammatory signaling would be ameliorated by targeting Nox2.  Herein, we in silico-modelled two first-in-class Nox2 inhibitors developed in our lab., explored their cellular mechanism of action and tested their efficacy in in vitro and mouse in vivo models of inflammation.  Our data show that these inhibitors (CPP11G and CPP11H) disrupted canonical Nox2 organizing factor, p47phox, translocation to Nox2 in the plasma membrane; and abolished ROS prodn., markedly attenuated stress-responsive MAPK signaling and downstream AP-1 and NFκB nuclear translocation in human cells.  Consequently, cell adhesion mol. expression and monocyte adherence were significantly inhibited by both inhibitors.  In vivo, TNFα-induced ROS and inflammation were ameliorated by targeted Nox2 inhibition, which, in turn, improved hind-limb blood flow.  These studies identify a proximal role for Nox2 in propagated inflammatory signaling and support therapeutic value of Nox2 inhibitors in inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFWFzZYP-Zn7Vg90H21EOLACvtfcHk0lg1WvPtuYo-uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltFygsLs%253D&md5=98d54bb8d0e14ec2333c9829e1fa3952</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101143%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCifuentes-Pagano%26aufirst%3DE.%26aulast%3DDeVallance%26aufirst%3DE.%2BR.%26aulast%3Dde%2BJesus%26aufirst%3DD.%2BS.%26aulast%3DSahoo%26aufirst%3DS.%26aulast%3DMeijles%26aufirst%3DD.%2BN.%26aulast%3DKoes%26aufirst%3DD.%26aulast%3DCamacho%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DM.%26aulast%3DCroix%26aufirst%3DC.%26aulast%3DPagano%26aufirst%3DP.%2BJ.%26atitle%3DNADPH%2520Oxidase%25202%2520Inhibitors%2520CPP11G%2520and%2520CPP11H%2520Attenuate%2520Endothelial%2520Cell%2520Inflammation%2520%2526%2520Vessel%2520Dysfunction%2520and%2520Restore%2520Mouse%2520Hind-Limb%2520Flow%26jtitle%3DRedox%2520Biol.%26date%3D2019%26volume%3D22%26spage%3D101143%26doi%3D10.1016%2Fj.redox.2019.101143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anvari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikström, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walum, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, N.</span></span> <span> </span><span class="NLM_article-title">The Novel NADPH Oxidase 4 Inhibitor GLX351322 Counteracts Glucose Intolerance in High-Fat Diet-Treated C57BL/6 Mice</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1318</span>, <span class="refDoi"> DOI: 10.3109/10715762.2015.1067697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3109%2F10715762.2015.1067697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26118714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCqtb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2015&pages=1308-1318&issue=11&author=E.+Anvariauthor=P.+Wikstr%C3%B6mauthor=E.+Walumauthor=N.+Welsh&title=The+Novel+NADPH+Oxidase+4+Inhibitor+GLX351322+Counteracts+Glucose+Intolerance+in+High-Fat+Diet-Treated+C57BL%2F6+Mice&doi=10.3109%2F10715762.2015.1067697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice</span></div><div class="casAuthors">Anvari, E.; Wikstroem, P.; Walum, E.; Welsh, N.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1308-1318</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1029-2470</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">In type 2 diabetes, it has been proposed that pancreatic beta-cell dysfunction is promoted by oxidative stress caused by NADPH oxidase (NOX) overactivity.  Five different NOX enzymes (NOX1-5) have been characterized, among which NOX1 and NOX2 have been proposed to neg. affect beta-cells, but the putative role of NOX4 in type 2 diabetes-assocd. beta-cell dysfunction and glucose intolerance is largely unknown.  Therefore, we presently investigated the importance of NOX4 for high-fat diet or HFD-induced glucose intolerance using male C57BL/6 mice using the new NOX4 inhibitor GLX351322, which has relative NOX4 selectivity over NOX2.  In HFD-treated male C57BL/6 mice a two-week treatment with GLX351322 counteracted non-fasting hyperglycemia and impaired glucose tolerance.  This effect occurred without any change in peripheral insulin sensitivity.  To ascertain that NOX4 also plays a role for the function of human beta-cells, we obsd. that glucose- and sodium palmitate-induced insulin release from human islets in vitro was increased in response to NOX4 inhibitors.  In long-term expts. (1-3 days), high-glucose-induced human islet cell reactive oxygen species (ROS) prodn. and death were prevented by GLX351322.  We propose that while short-term NOX4-generated ROS prodn. is a physiol. requirement for beta-cell function, persistent NOX4 activity, for example, during conditions of high-fat feeding, promotes ROS-mediated beta-cell dysfunction.  Thus, selective NOX inhibition may be a therapeutic strategy in type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZjFHOAuFikrVg90H21EOLACvtfcHk0lg1WvPtuYo-uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCqtb%252FJ&md5=7cdc414d304b79261c621c63c91a16dd</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.3109%2F10715762.2015.1067697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715762.2015.1067697%26sid%3Dliteratum%253Aachs%26aulast%3DAnvari%26aufirst%3DE.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DP.%26aulast%3DWalum%26aufirst%3DE.%26aulast%3DWelsh%26aufirst%3DN.%26atitle%3DThe%2520Novel%2520NADPH%2520Oxidase%25204%2520Inhibitor%2520GLX351322%2520Counteracts%2520Glucose%2520Intolerance%2520in%2520High-Fat%2520Diet-Treated%2520C57BL%252F6%2520Mice%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2015%26volume%3D49%26issue%3D11%26spage%3D1308%26epage%3D1318%26doi%3D10.3109%2F10715762.2015.1067697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elksnis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikström, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walum, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, P. O.</span></span> <span> </span><span class="NLM_article-title">The Novel NADPH Oxidase 4 Selective Inhibitor GLX7013114 Counteracts Human Islet Cell Death in Vitro</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">e0204271</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0204271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1371%2Fjournal.pone.0204271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30265686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlais77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=e0204271&issue=9&author=X.+Wangauthor=A.+Elksnisauthor=P.+Wikstr%C3%B6mauthor=E.+Walumauthor=N.+Welshauthor=P.+O.+Carlsson&title=The+Novel+NADPH+Oxidase+4+Selective+Inhibitor+GLX7013114+Counteracts+Human+Islet+Cell+Death+in+Vitro&doi=10.1371%2Fjournal.pone.0204271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro</span></div><div class="casAuthors">Wang, Xuan; Elksnis, Andris; Wikstroem, Per; Walum, Erik; Welsh, Nils; Carlsson, Per-Ola</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0204271/1-e0204271/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The aim of the present study was to evaluate the efficacy of novel Nox inhibitors as protective agents against cytokine- or high glucose + palmitate-induced human beta-cell death.  The Nox2 protein was present mainly in the cytoplasm and was induced by cytokines.  Nox4 protein immunoreactivity, with some nuclear accumulation, was obsd. in human islet cells, and was not affected by islet culture in the presence of cytokines or high glucose + palmitate.  Nox inhibitors with partial or no isoform selectivity (DPI, dapsone, GLX351322, and GLX481372) all reduced ROS prodn. of human islet cells exposed to high glucose + palmitate.  The Nox1 selective inhibitor ML171 failed to reduce human islet cell death in response to both cytokines and high glucose + palmitate.  The selective Nox2 inhibitor Phox-I2 also failed to protect against cytokines, but protected partially against high glucose + palmitate-induced cellular death.  The highly selective Nox4 inhibitor GLX7013114 protected islet cells against both cytokines and high glucose + palmitate.  However, as no osmotic control for high glucose was used, we cannot exclude the possibility that the high glucose effect was due to osmosis.  It is concluded that Nox4 may participate in stress-induced islet cell death in human islets in vitro.  We propose that Nox4 mediates pro-apoptotic effects in intact islets under stressful conditions and that selective Nox4-inhibition may be a therapeutic strategy in type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryI4sqraHD_bVg90H21EOLACvtfcHk0ljJRxyRAiAPEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlais77I&md5=964257d9fb03458d4eea5f626d2313fe</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0204271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0204271%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DElksnis%26aufirst%3DA.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DP.%26aulast%3DWalum%26aufirst%3DE.%26aulast%3DWelsh%26aufirst%3DN.%26aulast%3DCarlsson%26aufirst%3DP.%2BO.%26atitle%3DThe%2520Novel%2520NADPH%2520Oxidase%25204%2520Selective%2520Inhibitor%2520GLX7013114%2520Counteracts%2520Human%2520Islet%2520Cell%2520Death%2520in%2520Vitro%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26issue%3D9%26spage%3De0204271%26doi%3D10.1371%2Fjournal.pone.0204271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikström, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walum, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovicu, F. J.</span></span> <span> </span><span class="NLM_article-title">A Novel NADPH Oxidase Inhibitor Targeting Nox4 in TGFβ-Induced Lens Epithelial to Mesenchymal Transition</span>. <i>Exp. Eye Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">107692</span>, <span class="refDoi"> DOI: 10.1016/j.exer.2019.107692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.exer.2019.107692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31189078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtF2nsbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2019&pages=107692&author=S.+Dasauthor=P.+Wikstr%C3%B6mauthor=E.+Walumauthor=F.+J.+Lovicu&title=A+Novel+NADPH+Oxidase+Inhibitor+Targeting+Nox4+in+TGF%CE%B2-Induced+Lens+Epithelial+to+Mesenchymal+Transition&doi=10.1016%2Fj.exer.2019.107692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">A novel NADPH oxidase inhibitor targeting Nox4 in TGFβ-induced lens epithelial to mesenchymal transition</span></div><div class="casAuthors">Das, Shannon; Wikstrom, Per; Walum, Erik; Lovicu, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107692</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In the present study, we use a newly developed highly selective Nox4 inhibitor, GLX7013114, to modulate TGFβ-induced lens epithelial to mesenchymal transition (EMT).  Rat lens epithelial explants were pre-treated with 0.3μM of GLX7013114, and then treated with 200 pg/mL of TGF-β2 to induce lens EMT.  ROS prodn. was visualized microscopically using the superoxide fluorogenic probe, DHE.  The EMT process was documented using phase-contrast microscopy, and mol. EMT markers were immunolabeled. qPCR was also performed to observe changes in EMT-assocd. genes.  TGFβ-induced ROS was evident at 8 h of culture and its intensity was found to be significantly reduced when GLX7013114 was applied, comparable to ROS levels measured in untreated explants.  Using phase-contrast microscopy to follow TGFβ-induced EMT over 5 days in the presence of the inhibitor, lens epithelial cells in explants became myofibroblastic by day 2 and underwent progressive apoptosis to reveal a bare lens capsule by day 5.  Explants treated with TGFβ and GLX7013114 had some increased cell survival; however, these differences were not significant.  For the first time, Nox4 inhibition by GLX7013114 was shown to reduce the TGFβ-induced gene expression of α-SMA, collagen 1a and fibronectin.  GLX7013114, given that it appears to block aspects of TGFβ-induced EMT, including ROS prodn., may be a new useful Nox4-selective inhibitor for further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWUXQ3FQty1rVg90H21EOLACvtfcHk0ljJRxyRAiAPEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtF2nsbfK&md5=32e4193a16132b2d5edcd2bb37b751ec</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2019.107692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2019.107692%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DS.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DP.%26aulast%3DWalum%26aufirst%3DE.%26aulast%3DLovicu%26aufirst%3DF.%2BJ.%26atitle%3DA%2520Novel%2520NADPH%2520Oxidase%2520Inhibitor%2520Targeting%2520Nox4%2520in%2520TGF%25CE%25B2-Induced%2520Lens%2520Epithelial%2520to%2520Mesenchymal%2520Transition%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2019%26volume%3D185%26spage%3D107692%26doi%3D10.1016%2Fj.exer.2019.107692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelso, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porteous, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulter, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porteous, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledgerwood, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span> <span> </span><span class="NLM_article-title">Selective Targeting of a Redox-Active Ubiquinone to Mitochondria within Cells: Antioxidant and Antiapoptotic Properties</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">4588</span>– <span class="NLM_lpage">4596</span>, <span class="refDoi"> DOI: 10.1074/jbc.M009093200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.M009093200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11092892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlOqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=4588-4596&issue=7&author=G.+F.+Kelsoauthor=C.+M.+Porteousauthor=C.+V.+Coulterauthor=G.+Hughesauthor=W.+K.+Porteousauthor=E.+C.+Ledgerwoodauthor=R.+A.+J.+Smithauthor=M.+P.+Murphy&title=Selective+Targeting+of+a+Redox-Active+Ubiquinone+to+Mitochondria+within+Cells%3A+Antioxidant+and+Antiapoptotic+Properties&doi=10.1074%2Fjbc.M009093200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Selective targeting of a redox-active ubiquinone to mitochondria within cells. Antioxidant and antiapoptotic properties</span></div><div class="casAuthors">Kelso, Geoffrey F.; Porteous, Carolyn M.; Coulter, Carolyn V.; Hughes, Gillian; Porteous, William K.; Ledgerwood, Elizabeth C.; Smith, Robin A. J.; Murphy, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4588-4596</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">With the recognition of the central role of mitochondria in apoptosis, there is a need to develop specific tools to manipulate mitochondrial function within cells.  Here we report on the development of a novel antioxidant that selectively blocks mitochondrial oxidative damage, enabling the roles of mitochondrial oxidative stress in different types of cell death to be inferred.  This antioxidant, named mitoQ, is a ubiquinone deriv. targeted to mitochondria by covalent attachment to a lipophilic triphenylphosphonium cation through an aliph. carbon chain.  Due to the large mitochondrial membrane potential, the cation was accumulated within mitochondria inside cells, where the ubiquinone moiety inserted into the lipid bilayer and was reduced by the respiratory chain.  The ubiquinol deriv. thus formed was an effective antioxidant that prevented lipid peroxidn. and protected mitochondria from oxidative damage.  After detoxifying the reactive oxygen species peroxynitrite, the ubiquinol moiety was regenerated by the respiratory chain enabling its antioxidant activity to be recycled.  In cell culture studies, the mitochondrially localized antioxidant protected mammalian cells from hydrogen peroxide-induced apoptosis but not from apoptosis induced by staurosporine or tumor necrosis factor-α.  This was compared with untargeted ubiquinone analogs, which were ineffective in preventing apoptosis.  These results suggest that mitochondrial oxidative stress may be a crit. step in apoptosis induced by hydrogen peroxide but not for apoptosis induced by staurosporine or tumor necrosis factor-α.  We have shown that selectively manipulating mitochondrial antioxidant status with targeted and recyclable antioxidants is a feasible approach to investigate the role of mitochondrial oxidative damage in apoptotic cell death.  This approach will have further applications in investigating mitochondrial dysfunction in a range of exptl. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphRgJVKubqmLVg90H21EOLACvtfcHk0lgHSotz84vmlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlOqsb0%253D&md5=15c370855eea13a79a56073e464e71c2</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M009093200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M009093200%26sid%3Dliteratum%253Aachs%26aulast%3DKelso%26aufirst%3DG.%2BF.%26aulast%3DPorteous%26aufirst%3DC.%2BM.%26aulast%3DCoulter%26aufirst%3DC.%2BV.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DPorteous%26aufirst%3DW.%2BK.%26aulast%3DLedgerwood%26aufirst%3DE.%2BC.%26aulast%3DSmith%26aufirst%3DR.%2BA.%2BJ.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26atitle%3DSelective%2520Targeting%2520of%2520a%2520Redox-Active%2520Ubiquinone%2520to%2520Mitochondria%2520within%2520Cells%253A%2520Antioxidant%2520and%2520Antiapoptotic%2520Properties%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D7%26spage%3D4588%26epage%3D4596%26doi%3D10.1074%2Fjbc.M009093200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dashdorj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KR, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. S.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-Targeted Antioxidant MitoQ Ameliorates Experimental Mouse Colitis by Suppressing NLRP3 Inflammasome-Mediated Inflammatory Cytokines</span>. <i>BMC Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1186/1741-7015-11-178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1186%2F1741-7015-11-178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=23281898" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=1-13&author=A.+Dashdorjauthor=J.+KRauthor=S.+Limauthor=A.+Joauthor=M.+N.+Nguyenauthor=J.+Haauthor=K.+S.+Yoonauthor=H.+J.+Kimauthor=J.+H.+Parkauthor=M.+P.+Murphyauthor=S.+S.+Kim&title=Mitochondria-Targeted+Antioxidant+MitoQ+Ameliorates+Experimental+Mouse+Colitis+by+Suppressing+NLRP3+Inflammasome-Mediated+Inflammatory+Cytokines&doi=10.1186%2F1741-7015-11-178"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-11-178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-11-178%26sid%3Dliteratum%253Aachs%26aulast%3DDashdorj%26aufirst%3DA.%26aulast%3DKR%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DJo%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DM.%2BN.%26aulast%3DHa%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DKim%26aufirst%3DS.%2BS.%26atitle%3DMitochondria-Targeted%2520Antioxidant%2520MitoQ%2520Ameliorates%2520Experimental%2520Mouse%2520Colitis%2520by%2520Suppressing%2520NLRP3%2520Inflammasome-Mediated%2520Inflammatory%2520Cytokines%26jtitle%3DBMC%2520Med.%26date%3D2013%26volume%3D11%26spage%3D1%26epage%3D13%26doi%3D10.1186%2F1741-7015-11-178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottwald, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugarski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haenni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuh, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landau, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A. M.</span></span> <span> </span><span class="NLM_article-title">The Targeted Anti-Oxidant MitoQ Causes Mitochondrial Swelling and Depolarization in Kidney Tissue</span>. <i>Physiol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">e13667</span>, <span class="refDoi"> DOI: 10.14814/phy2.13667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.14814%2Fphy2.13667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29611340" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=e13667&issue=7&author=E.+M.+Gottwaldauthor=M.+Dussauthor=M.+Bugarskiauthor=D.+Haenniauthor=C.+D.+Schuhauthor=E.+M.+Landauauthor=A.+M.+Hall&title=The+Targeted+Anti-Oxidant+MitoQ+Causes+Mitochondrial+Swelling+and+Depolarization+in+Kidney+Tissue&doi=10.14814%2Fphy2.13667"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.14814%2Fphy2.13667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14814%252Fphy2.13667%26sid%3Dliteratum%253Aachs%26aulast%3DGottwald%26aufirst%3DE.%2BM.%26aulast%3DDuss%26aufirst%3DM.%26aulast%3DBugarski%26aufirst%3DM.%26aulast%3DHaenni%26aufirst%3DD.%26aulast%3DSchuh%26aufirst%3DC.%2BD.%26aulast%3DLandau%26aufirst%3DE.%2BM.%26aulast%3DHall%26aufirst%3DA.%2BM.%26atitle%3DThe%2520Targeted%2520Anti-Oxidant%2520MitoQ%2520Causes%2520Mitochondrial%2520Swelling%2520and%2520Depolarization%2520in%2520Kidney%2520Tissue%26jtitle%3DPhysiol.%2520Rep.%26date%3D2018%26volume%3D6%26issue%3D7%26spage%3De13667%26doi%3D10.14814%2Fphy2.13667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farhood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, H.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-Targeted Antioxidant Mito-Tempo Protects against Acetaminophen Hepatotoxicity</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">773</span>, <span class="refDoi"> DOI: 10.1007/s00204-016-1692-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs00204-016-1692-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27002509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1CksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2017&pages=761-773&issue=2&author=K.+Duauthor=A.+Farhoodauthor=H.+Jaeschke&title=Mitochondria-Targeted+Antioxidant+Mito-Tempo+Protects+against+Acetaminophen+Hepatotoxicity&doi=10.1007%2Fs00204-016-1692-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity</span></div><div class="casAuthors">Du, Kuo; Farhood, Anwar; Jaeschke, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">761-773</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Acetaminophen (APAP) hepatotoxicity is characterized by an extensive mitochondrial oxidant stress.  However, its importance as a drug target has not been clarified.  To investigate this, fasted C57BL/6J mice were treated with 300 mg/kg APAP and the mitochondria-targeted antioxidant Mito-Tempo (MT) was given 1.5 h later.  APAP caused severe liver injury in mice, as indicated by the increase in plasma ALT activities and centrilobular necrosis.  MT dose-dependently reduced the injury.  Importantly, MT did not affect APAP-protein adducts formation, glutathione depletion or c-jun N-terminal kinase activation and its mitochondrial translocation.  In contrast, hepatic glutathione disulfide and peroxynitrite formation were dose-dependently reduced by MT, indicating its effective mitochondrial oxidant stress scavenging capacity.  Consequently, mitochondrial translocation of Bax and release of mitochondrial intermembrane proteins such as apoptosis-inducing factor were prevented, and nuclear DNA fragmentation was eliminated.  To demonstrate the importance of mitochondria-specific antioxidant property of MT, we compared its efficacy with Tempo, which has the same pharmacol. mode of action as MT but lacks the mitochondria targeting moiety.  In contrast to the dramatic protection by MT, the same molar dose of Tempo did not significantly reduce APAP hepatotoxicity.  In contrast, even a 3 h post-treatment with MT reduced 70 % of the injury, and the combination of MT with N-acetylcysteine (NAC) provided superior protection than NAC alone.  We conclude that MT protects against APAP overdose in mice by attenuating the mitochondrial oxidant stress and preventing peroxynitrite formation and the subsequent mitochondrial dysfunction.  MT is a promising therapeutic agent for APAP overdose patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkdu8xQ6kSLVg90H21EOLACvtfcHk0lh0VTMKFujtqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1CksLo%253D&md5=24cc176d47d5867b8dceda3735e8ba83</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs00204-016-1692-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-016-1692-0%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DK.%26aulast%3DFarhood%26aufirst%3DA.%26aulast%3DJaeschke%26aufirst%3DH.%26atitle%3DMitochondria-Targeted%2520Antioxidant%2520Mito-Tempo%2520Protects%2520against%2520Acetaminophen%2520Hepatotoxicity%26jtitle%3DArch.%2520Toxicol.%26date%3D2017%26volume%3D91%26issue%3D2%26spage%3D761%26epage%3D773%26doi%3D10.1007%2Fs00204-016-1692-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trnka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaikie, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span> <span> </span><span class="NLM_article-title">A Mitochondria-Targeted Nitroxide Is Reduced to Its Hydroxylamine by Ubiquinol in Mitochondria</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1406</span>– <span class="NLM_lpage">1419</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2007.12.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2007.12.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18206669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktV2gt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2008&pages=1406-1419&issue=7&author=J.+Trnkaauthor=F.+H.+Blaikieauthor=R.+A.+J.+Smithauthor=M.+P.+Murphy&title=A+Mitochondria-Targeted+Nitroxide+Is+Reduced+to+Its+Hydroxylamine+by+Ubiquinol+in+Mitochondria&doi=10.1016%2Fj.freeradbiomed.2007.12.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria</span></div><div class="casAuthors">Trnka, Jan; Blaikie, Frances H.; Smith, Robin A. J.; Murphy, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1406-1419</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Piperidine nitroxides such as TEMPOL act as antioxidants in vivo due to their interconversion among nitroxide, hydroxylamine, and oxoammonium derivs., but the mechanistic details of these reactions are unclear.  As mitochondria are a significant site of piperidine nitroxide metab. and action, we synthesized a mitochondria-targeted nitroxide, MitoTEMPOL, by conjugating TEMPOL to the lipophilic triphenylphosphonium cation.  MitoTEMPOL was accumulated several hundred-fold into energized mitochondria where it was reduced to the hydroxylamine by direct reaction with ubiquinol.  This reaction occurred by transfer of H· from ubiquinol to the nitroxide, with the ubisemiquinone radical product predominantly dismutating to ubiquinone and ubiquinol, together with a small amt. reacting with oxygen to form superoxide.  The piperidine nitroxides TEMPOL, TEMPO, and butylTEMPOL reacted similarly with ubiquinol in org. solvents but in mitochondrial membranes the rates varied in the order: MitoTEMPOL > butylTEMPOL > TEMPO > TEMPOL, which correlated with the extent of access of the nitroxide moiety to ubiquinol within the membrane.  These findings suggest ways of using mitochondria-targeted compds. to modulate the coenzyme Q pool within mitochondria in vivo, and indicate that the antioxidant effects of mitochondria-targeted piperidine nitroxides can be ascribed to their corresponding hydroxylamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnMKwk46GgQLVg90H21EOLACvtfcHk0liKBXY3cM1T_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktV2gt74%253D&md5=0602de5ab5c90283b05183a2eec565f0</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2007.12.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2007.12.036%26sid%3Dliteratum%253Aachs%26aulast%3DTrnka%26aufirst%3DJ.%26aulast%3DBlaikie%26aufirst%3DF.%2BH.%26aulast%3DSmith%26aufirst%3DR.%2BA.%2BJ.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26atitle%3DA%2520Mitochondria-Targeted%2520Nitroxide%2520Is%2520Reduced%2520to%2520Its%2520Hydroxylamine%2520by%2520Ubiquinol%2520in%2520Mitochondria%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2008%26volume%3D44%26issue%3D7%26spage%3D1406%26epage%3D1419%26doi%3D10.1016%2Fj.freeradbiomed.2007.12.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brand, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, R. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerencser, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borch Jensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardov, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrassi, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeusen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perevoshchikova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasper, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookes, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ainscow, E. K.</span></span> <span> </span><span class="NLM_article-title">Suppressors of Superoxide-H2O2 Production at Site IQ of Mitochondrial Complex I Protect against Stem Cell Hyperplasia and Ischemia-Reperfusion Injury</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2016.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cmet.2016.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27667666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGru7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=582-592&issue=4&author=M.+D.+Brandauthor=R.+L.+S.+Goncalvesauthor=A.+L.+Orrauthor=L.+Vargasauthor=A.+A.+Gerencserauthor=M.+Borch+Jensenauthor=Y.+T.+Wangauthor=S.+Melovauthor=C.+N.+Turkauthor=J.+T.+Matzenauthor=V.+J.+Dardovauthor=H.+M.+Petrassiauthor=S.+L.+Meeusenauthor=I.+V.+Perevoshchikovaauthor=H.+Jasperauthor=P.+S.+Brookesauthor=E.+K.+Ainscow&title=Suppressors+of+Superoxide-H2O2+Production+at+Site+IQ+of+Mitochondrial+Complex+I+Protect+against+Stem+Cell+Hyperplasia+and+Ischemia-Reperfusion+Injury&doi=10.1016%2Fj.cmet.2016.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Suppressors of Superoxide-H2O2 Production at Site IQ of Mitochondrial Complex I Protect against Stem Cell Hyperplasia and Ischemia-Reperfusion Injury</span></div><div class="casAuthors">Brand, Martin D.; Goncalves, Renata L. S.; Orr, Adam L.; Vargas, Leonardo; Gerencser, Akos A.; Borch Jensen, Martin; Wang, Yves T.; Melov, Simon; Turk, Carolina N.; Matzen, Jason T.; Dardov, Victoria J.; Petrassi, H. Michael; Meeusen, Shelly L.; Perevoshchikova, Irina V.; Jasper, Heinrich; Brookes, Paul S.; Ainscow, Edward K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">582-592</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Using high-throughput screening we identified small mols. that suppress superoxide and/or H2O2 prodn. during reverse electron transport through mitochondrial respiratory complex I (site IQ) without affecting oxidative phosphorylation (suppressors of site IQ electron leak, "S1QELs").  S1QELs diminished endogenous oxidative damage in primary astrocytes cultured at ambient or low oxygen tension, showing that site IQ is a normal contributor to mitochondrial superoxide-H2O2 prodn. in cells.  They diminished stem cell hyperplasia in Drosophila intestine in vivo and caspase activation in a cardiomyocyte cell model driven by endoplasmic reticulum stress, showing that superoxide-H2O2 prodn. by site IQ is involved in cellular stress signaling.  They protected against ischemia-reperfusion injury in perfused mouse heart, showing directly that superoxide-H2O2 prodn. by site IQ is a major contributor to this pathol.  S1QELs are tools for assessing the contribution of site IQ to cell physiol. and pathol. and have great potential as therapeutic leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS7_SIYiA6r7Vg90H21EOLACvtfcHk0liKBXY3cM1T_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGru7%252FL&md5=a4dc498852fcb85c3e741fd378a6158f</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2016.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2016.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DM.%2BD.%26aulast%3DGoncalves%26aufirst%3DR.%2BL.%2BS.%26aulast%3DOrr%26aufirst%3DA.%2BL.%26aulast%3DVargas%26aufirst%3DL.%26aulast%3DGerencser%26aufirst%3DA.%2BA.%26aulast%3DBorch%2BJensen%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DMelov%26aufirst%3DS.%26aulast%3DTurk%26aufirst%3DC.%2BN.%26aulast%3DMatzen%26aufirst%3DJ.%2BT.%26aulast%3DDardov%26aufirst%3DV.%2BJ.%26aulast%3DPetrassi%26aufirst%3DH.%2BM.%26aulast%3DMeeusen%26aufirst%3DS.%2BL.%26aulast%3DPerevoshchikova%26aufirst%3DI.%2BV.%26aulast%3DJasper%26aufirst%3DH.%26aulast%3DBrookes%26aufirst%3DP.%2BS.%26aulast%3DAinscow%26aufirst%3DE.%2BK.%26atitle%3DSuppressors%2520of%2520Superoxide-H2O2%2520Production%2520at%2520Site%2520IQ%2520of%2520Mitochondrial%2520Complex%2520I%2520Protect%2520against%2520Stem%2520Cell%2520Hyperplasia%2520and%2520Ischemia-Reperfusion%2520Injury%26jtitle%3DCell%2520Metab.%26date%3D2016%26volume%3D24%26issue%3D4%26spage%3D582%26epage%3D592%26doi%3D10.1016%2Fj.cmet.2016.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monternier, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, M. D.</span></span> <span> </span><span class="NLM_article-title">S1QELs Suppress Mitochondrial Superoxide/Hydrogen Peroxide Production from Site IQ without Inhibiting Reverse Electron Flow through Complex I</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2019.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2019.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31518685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVSrtrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2019&pages=545-559&author=H.+S.+Wongauthor=P.+A.+Monternierauthor=M.+D.+Brand&title=S1QELs+Suppress+Mitochondrial+Superoxide%2FHydrogen+Peroxide+Production+from+Site+IQ+without+Inhibiting+Reverse+Electron+Flow+through+Complex+I&doi=10.1016%2Fj.freeradbiomed.2019.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">S1QELs suppress mitochondrial superoxide/hydrogen peroxide production from site IQ without inhibiting reverse electron flow through Complex I</span></div><div class="casAuthors">Wong, Hoi-Shan; Monternier, Pierre-Axel; Brand, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">545-559</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mitochondria are important sources of superoxide and hydrogen peroxide in cell signaling and disease.  In particular, superoxide/hydrogen peroxide prodn. during reverse electron transport from ubiquinol to NAD+ though Complex I is implicated in several physiol. and pathol. processes.  S1QELs are small mols. that suppress superoxide/hydrogen peroxide prodn. at Complex I without affecting forward electron transport.  Their mechanism of action is disputed.  To test different mechanistic models, we compared the effects of two inhibitors of Complex I electron transport (piericidin A and rotenone) and two S1QELs from different chem. families on superoxide/hydrogen peroxide prodn. and electron transport by Complex I in isolated mitochondria.  Piericidin A and rotenone (and S1QEL1.1 at higher concns.) prevented superoxide/hydrogen peroxide prodn. from sites IQ and IF in Complex I by inhibiting reverse electron transport into the complex.  S1QELs decreased the potency of electron transport inhibition by piericidin A and rotenone, suggesting that S1QELs bind directly to Complex I.  S1QEL2.1 (and S1QEL1.1 at lower concns.) suppressed site IQ without affecting reverse electron transport or site IF, showing that sites IQ and IF are distinct, and that S1QELs do not work simply by decreasing reverse electron transport to site IF (or site IQ).  S1QELs did not affect the redn. of NAD+ or the rate of site IF driven by reverse electron transport, therefore they do not alter the driving forces for reverse electron transport and that is not how they suppress site IQ.  We conclude that S1QELs bind to Complex I to influence the conformation of the piericidin A and rotenone binding sites and directly suppress superoxide/hydrogen peroxide prodn. at site IQ, which is a sep. site from site IF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlNvqJ_wqcrVg90H21EOLACvtfcHk0ljBfhZXTZYmpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVSrtrfM&md5=34459a70d21e2fa459401798dd302c03</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2019.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2019.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DMonternier%26aufirst%3DP.%2BA.%26aulast%3DBrand%26aufirst%3DM.%2BD.%26atitle%3DS1QELs%2520Suppress%2520Mitochondrial%2520Superoxide%252FHydrogen%2520Peroxide%2520Production%2520from%2520Site%2520IQ%2520without%2520Inhibiting%2520Reverse%2520Electron%2520Flow%2520through%2520Complex%2520I%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2019%26volume%3D143%26spage%3D545%26epage%3D559%26doi%3D10.1016%2Fj.freeradbiomed.2019.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyoshi, H.</span></span> <span> </span><span class="NLM_article-title">Defining the Mechanism of Action of S1QELs, Specific Suppressors of Superoxide Production in the Quinone-Reaction Site in Mitochondrial Complex I</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">6550</span>– <span class="NLM_lpage">6561</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA119.007687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.RA119.007687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30824536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1Oju7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=6550-6561&issue=16&author=A.+Banbaauthor=A.+Tsujiauthor=H.+Kimuraauthor=M.+Muraiauthor=H.+Miyoshi&title=Defining+the+Mechanism+of+Action+of+S1QELs%2C+Specific+Suppressors+of+Superoxide+Production+in+the+Quinone-Reaction+Site+in+Mitochondrial+Complex+I&doi=10.1074%2Fjbc.RA119.007687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the mechanism of action of S1QELs, specific suppressors of superoxide production in the quinone-reaction site in mitochondrial complex I</span></div><div class="casAuthors">Banba, Atsushi; Tsuji, Atsuhito; Kimura, Hironori; Murai, Masatoshi; Miyoshi, Hideto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6550-6562</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Site-specific suppressors of superoxide prodn. (named S1QELs) in the quinone-reaction site in mitochondrial respiratory complex I during reverse electron transfer have been previously reported; however, their mechanism of action remains elusive.  Using bovine heart submitochondrial particles, we herein investigated the effects of S1QELs on complex I functions.  We found that the inhibitory effects of S1QELs on complex I are distinctly different from those of other known quinone-site inhibitors.  For example, the inhibitory potencies of S1QELs significantly varied depending on the direction of electron transfer (forward or reverse).  S1QELs marginally suppressed the specific chem. modification of Asp160 in the 49-kDa subunit, located deep in the quinone-binding pocket, by the tosyl chem. reagent AL1.  S1QELs also failed to suppress the binding of a photoreactive quinazoline-type inhibitor ([125I]AzQ) to the 49-kDa subunit.  Moreover, a photoaffinity labeling expt. with photoreactive S1QEL derivs. indicated that they bind to a segment in the ND1 subunit that is not considered to make up the binding pocket for quinone or inhibitors.  These results indicate that unlike known quinone-site inhibitors, S1QELs do not occupy the quinone- or inhibitor-binding pocket; rather, they may indirectly modulate the quinone-redox reactions by inducing structural changes of the pocket through binding to ND1.  We conclude that this indirect effect may be a prerequisite for S1QELs' direction-dependent modulation of electron transfer.  This, in turn, may be responsible for the suppression of superoxide prodn. during reverse electron transfer without significantly interfering with forward electron transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomYxrR9X_lkLVg90H21EOLACvtfcHk0ljBfhZXTZYmpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1Oju7fN&md5=13b1780e7672fc8c86f48f04003d8c95</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.007687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.007687%26sid%3Dliteratum%253Aachs%26aulast%3DBanba%26aufirst%3DA.%26aulast%3DTsuji%26aufirst%3DA.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DMurai%26aufirst%3DM.%26aulast%3DMiyoshi%26aufirst%3DH.%26atitle%3DDefining%2520the%2520Mechanism%2520of%2520Action%2520of%2520S1QELs%252C%2520Specific%2520Suppressors%2520of%2520Superoxide%2520Production%2520in%2520the%2520Quinone-Reaction%2520Site%2520in%2520Mitochondrial%2520Complex%2520I%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26issue%3D16%26spage%3D6550%26epage%3D6561%26doi%3D10.1074%2Fjbc.RA119.007687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orr, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baaten, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardov, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attle, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quackenbush, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, R. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perevoshchikova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrassi, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeusen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ainscow, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, M. D.</span></span> <span> </span><span class="NLM_article-title">Suppressors of Superoxide Production from Mitochondrial Complex III</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fnchembio.1910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26368590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2ltrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=834-836&issue=11&author=A.+L.+Orrauthor=L.+Vargasauthor=C.+N.+Turkauthor=J.+E.+Baatenauthor=J.+T.+Matzenauthor=V.+J.+Dardovauthor=S.+J.+Attleauthor=J.+Liauthor=D.+C.+Quackenbushauthor=R.+L.+S.+Goncalvesauthor=I.+V.+Perevoshchikovaauthor=H.+M.+Petrassiauthor=S.+L.+Meeusenauthor=E.+K.+Ainscowauthor=M.+D.+Brand&title=Suppressors+of+Superoxide+Production+from+Mitochondrial+Complex+III&doi=10.1038%2Fnchembio.1910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Suppressors of superoxide production from mitochondrial complex III</span></div><div class="casAuthors">Orr, Adam L.; Vargas, Leonardo; Turk, Carolina N.; Baaten, Janine E.; Matzen, Jason T.; Dardov, Victoria J.; Attle, Stephen J.; Li, Jing; Quackenbush, Douglas C.; Goncalves, Renata L. S.; Perevoshchikova, Irina V.; Petrassi, H. Michael; Meeusen, Shelly L.; Ainscow, Edward K.; Brand, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">834-836</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mitochondrial electron transport drives ATP synthesis but also generates reactive oxygen species, which are both cellular signals and damaging oxidants.  Superoxide prodn. by respiratory complex III is implicated in diverse signaling events and pathologies, but its role remains controversial.  Using high-throughput screening, we identified compds. that selectively eliminate superoxide prodn. by complex III without altering oxidative phosphorylation; they modulate retrograde signaling including cellular responses to hypoxic and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4G_jKAOfBC7Vg90H21EOLACvtfcHk0lhRgbSQJ5MxrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2ltrrL&md5=3837c206c33c8a051409893a63019a7b</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1910%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%26aufirst%3DA.%2BL.%26aulast%3DVargas%26aufirst%3DL.%26aulast%3DTurk%26aufirst%3DC.%2BN.%26aulast%3DBaaten%26aufirst%3DJ.%2BE.%26aulast%3DMatzen%26aufirst%3DJ.%2BT.%26aulast%3DDardov%26aufirst%3DV.%2BJ.%26aulast%3DAttle%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DD.%2BC.%26aulast%3DGoncalves%26aufirst%3DR.%2BL.%2BS.%26aulast%3DPerevoshchikova%26aufirst%3DI.%2BV.%26aulast%3DPetrassi%26aufirst%3DH.%2BM.%26aulast%3DMeeusen%26aufirst%3DS.%2BL.%26aulast%3DAinscow%26aufirst%3DE.%2BK.%26aulast%3DBrand%26aufirst%3DM.%2BD.%26atitle%3DSuppressors%2520of%2520Superoxide%2520Production%2520from%2520Mitochondrial%2520Complex%2520III%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D11%26spage%3D834%26epage%3D836%26doi%3D10.1038%2Fnchembio.1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manzoor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoda, N.</span></span> <span> </span><span class="NLM_article-title">A Comprehensive Review of Monoamine Oxidase Inhibitors as Anti-Alzheimer’s Disease Agents: A Review</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">112787</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.ejmech.2020.112787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32942081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVymsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2020&pages=112787&author=S.+Manzoorauthor=N.+Hoda&title=A+Comprehensive+Review+of+Monoamine+Oxidase+Inhibitors+as+Anti-Alzheimer%E2%80%99s+Disease+Agents%3A+A+Review&doi=10.1016%2Fj.ejmech.2020.112787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review</span></div><div class="casAuthors">Manzoor, Shoaib; Hoda, Nasimul</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112787</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidases (MAO-A and MAO-B) are mammalian flavoenzyme, which catalyze the oxidative deamination of several neurotransmitters like norepinephrine, dopamine, tyramine, serotonin, and some other amines.  The oxidative deamination produces several harmful side products like ammonia, peroxides, and aldehydes during the biochem. reaction.  The concn. of biochem. neurotransmitter alteration in the brain by MAO is directly related with several neurol. disorders like Alzheimer's disease and Parkinson's disease (PD).  Activated MAO also contributes to the amyloid beta (Aβ) aggregation by two successive cleft β-secretase and γ-secretase of amyloid precursor protein (APP).  Addnl., activated MAO is also involved in aggregation of neurofibrillary tangles and cognitive destruction through the cholinergic neuronal damage and disorder of the cholinergic system.  MAO inhibition has general anti-Alzheimer's disease effect as a consequence of oxidative stress redn. prompted by MAO enzymes.  In this review, we outlined and addressed recent understanding on MAO enzymes such as their structure, physiol. function, catalytic mechanism, and possible therapeutic goals in AD.  In addn., it also highlights the current development and discovery of potential MAO inhibitors (MAOIs) from various chem. scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBQku5jXLi7bVg90H21EOLACvtfcHk0lhmvaZFX3pkJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVymsr%252FF&md5=b8f8f175d700bb36dd0aab708f197b4d</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112787%26sid%3Dliteratum%253Aachs%26aulast%3DManzoor%26aufirst%3DS.%26aulast%3DHoda%26aufirst%3DN.%26atitle%3DA%2520Comprehensive%2520Review%2520of%2520Monoamine%2520Oxidase%2520Inhibitors%2520as%2520Anti-Alzheimer%25E2%2580%2599s%2520Disease%2520Agents%253A%2520A%2520Review%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D206%26spage%3D112787%26doi%3D10.1016%2Fj.ejmech.2020.112787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B. H.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase Inhibitors, and Iron Chelators in Depressive Illness and Neurodegenerative Diseases</span>. <i>J. Neural Transm.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1719</span>– <span class="NLM_lpage">1733</span>, <span class="refDoi"> DOI: 10.1007/s00702-018-1942-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs00702-018-1942-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30341696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvF2murjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2018&pages=1719-1733&issue=11&author=M.+B.+H.+Youdim&title=Monoamine+Oxidase+Inhibitors%2C+and+Iron+Chelators+in+Depressive+Illness+and+Neurodegenerative+Diseases&doi=10.1007%2Fs00702-018-1942-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases</span></div><div class="casAuthors">Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1719-1733</span>CODEN:
                <span class="NLM_cas:coden">JNTRF3</span>;
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag GmbH</span>)
        </div><div class="casAbstract">In early 1920s, tyramine oxidase was discovered that metabolized tyramine and in 1933 Blaschko demonstrated that this enzyme also metabolized adrenaline, noradrenaline and dopamine.  Zeller gave it the name monoamine oxidase (MAO) to distinguish it from the enzyme that oxidatively deaminated diamines.  MAO was recognized as an enzyme of crucial interest to pharmacologists because it catalyzed the major inactivation pathway for the catecholamines (and, later, 5-hydroxytryptamine, as well).  Within the few decade, the inhibitors of MAO were discovered and introduced for the treatment of depressive illness which was established clin.  However, the first clin. use exposed serious side effects, pharmacol. interest in, and investigation of, MAO continued, resulting in the characterization of two forms, distinct forms, MAO-A and -B, and selective inhibitors for them.  Selective inhibitors of MAO-B (selegiline, rasagiline and safinamide) have found a therapeutic role in the treatment of Parkinson's disease and reversible inhibitors of MAO-A offered antidepressant activity without the serious side effects of the earlier nonselective MAO inhibitors.  Subsequent mol. pharmacol. have also generated the concept of neuroprotection, reflecting the possibility of slowing, halting and maybe reversing, neurodegeneration in Parkinson's or Alzheimer's diseases.  Increased levels of oxidative stress through the accumulation of iron in the Parkinsonian and Alzheimer brains has been suggested to be crit. for the initiation and progress of neurodegeneration.  Selective inhibition of brain MAO could contribute importantly to lowering such stress, preventing the formation of hydrogen peroxide.  Interaction of Iron with hydrogen peroxide and lead to Fenton reaction and prodn. of the most reactive radical, namely hydroxyl radical.  There are complex interactions between free iron levels in brain and MAO, and cascade of neurotoxic events may have practical outcomes for depressive disorders and neurodegenerative diseases.  As consequence recent novel therapeutic drugs for neurodegenerative diseases has led to the development of multi target drugs, that possess selective brain MAO A and B inhibitory moiety, iron chelating and antioxidant activities and the ability to increase brain levels of endogenous neurotrophins, such as BDNF, GDNF VEGF and erythropoietin and induce mitochondrial biogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgtDqxCd-iILVg90H21EOLACvtfcHk0lhmvaZFX3pkJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvF2murjO&md5=23e9c21513fbe64a91d0d7e1d38c78db</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1007%2Fs00702-018-1942-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-018-1942-9%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DMonoamine%2520Oxidase%2520Inhibitors%252C%2520and%2520Iron%2520Chelators%2520in%2520Depressive%2520Illness%2520and%2520Neurodegenerative%2520Diseases%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2018%26volume%3D125%26issue%3D11%26spage%3D1719%26epage%3D1733%26doi%3D10.1007%2Fs00702-018-1942-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aminoff, Michael J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christine, Chadwick W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhall, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umeh, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stover, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leehey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweig, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholas, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodis-Wollner</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivan Willis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieburtz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, B. C.</span></span> <span> </span><span class="NLM_article-title">Longer Duration of MAO-b Inhibitor Exposure Is Associated with Less Clinical Decline in Parkinson’s Disease: An Analysis of NETPD LS1</span>. <i>J. Parkinson's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.3233/JPD-160965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3233%2FJPD-160965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27911341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1ehsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=117-127&issue=1&author=R.+A.+Hauserauthor=R.+Liauthor=A.+P%C3%A9rezauthor=X.+Renauthor=D.+Weintraubauthor=J.+Elmauthor=J.+L.+Goudreauauthor=J.+C.+Morganauthor=J.+Y.+Fangauthor=Michael+J.+Aminoffauthor=Chadwick+W.+Christineauthor=R.+Dhallauthor=C.+C.+Umehauthor=J.+T.+Boydauthor=N.+Stoverauthor=M.+Leeheyauthor=R.+M.+Zweigauthor=A.+P.+Nicholasauthor=+Bodis-Wollnerauthor=A.+Ivan+Willisauthor=K.+Kieburtzauthor=B.+C.+Tilley&title=Longer+Duration+of+MAO-b+Inhibitor+Exposure+Is+Associated+with+Less+Clinical+Decline+in+Parkinson%E2%80%99s+Disease%3A+An+Analysis+of+NETPD+LS1&doi=10.3233%2FJPD-160965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1</span></div><div class="casAuthors">Hauser, Robert A.; Li, Ruosha; Perez, Adriana; Ren, Xuehan; Weintraub, Dan; Elm, Jordan; Goudreau, John L.; Morgan, John C.; Fang, John Y.; Aminoff, Michael J.; Christine, Chadwick W.; Dhall, Rohit; Umeh, Chizoba C.; Boyd, James T.; Stover, Natividad; Leehey, Maureen; Zweig, Richard M.; Nicholas, Anthony P.; Bodis-Wollner, Ivan; Willis, Allison; Kieburtz, Karl; Tilley, Barbara C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Parkinson's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-127</span>CODEN:
                <span class="NLM_cas:coden">JPDOAP</span>;
        ISSN:<span class="NLM_cas:issn">1877-7171</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Monoamine oxidase type B (MAO-B) inhibitors exhibit neuroprotective effects in preclin. models of PD but clin. trials have failed to convincingly demonstrate disease modifying benefits in PD patients.  To perform a secondary anal. of NET-PD LS1 to det. if longer duration of MAO-B inhibitor exposure was assocd. with less clin. decline.  The primary outcome measure was the Global Outcome (GO), comprised of 5 measures: change from baseline in the Schwab and England (ADL) scale, the 39-item Parkinson's Disease Questionnaire (PDQ-39), the UPDRS Ambulatory Capacity Scale, the Symbol Digit Modalities Test, and the most recent Modified Rankin Scale.  A linear mixed model was used to explore the assocn. between the cumulative duration of MAO-B inhibitor exposure and the GO, adjusting for necessary factors and confounders.  Assocns. between MAO-B inhibitor exposure and each of the five GO components were then studied individually.  A 1616 participants comprised the analytic sample.  Mean observation was 4.1 (SD = 1.4) years, and 784 (48.5%) participants received an MAO-B inhibitor.  The regression coeff. of cumulative duration of MAO-B inhibitor exposure (in years) on the GO was - 0.0064 (SE = 0.002, p = 0.001).  Significant assocns. between duration of MAO-B inhibitor exposure and less progression were obsd. for ADL (p < 0.001), Ambulatory Capacity (p < 0.001), and the Rankin (p = 0.002).  Our anal. identified a significant assocn. between longer duration of MAO-B inhibitor exposure and less clin. decline.  These findings support the possibility that MAO-B inhibitors slow clin. disease progression and suggest that a definitive prospective trial should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV12MdI0aLkLVg90H21EOLACvtfcHk0ljR8m9nT-H6TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1ehsLo%253D&md5=b8479eaa9608eb8368e736609a4585a5</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.3233%2FJPD-160965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJPD-160965%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DP%25C3%25A9rez%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DWeintraub%26aufirst%3DD.%26aulast%3DElm%26aufirst%3DJ.%26aulast%3DGoudreau%26aufirst%3DJ.%2BL.%26aulast%3DMorgan%26aufirst%3DJ.%2BC.%26aulast%3DFang%26aufirst%3DJ.%2BY.%26aulast%3DAminoff%26aufirst%3DMichael%2BJ.%26aulast%3DChristine%26aufirst%3DChadwick%2BW.%26aulast%3DDhall%26aufirst%3DR.%26aulast%3DUmeh%26aufirst%3DC.%2BC.%26aulast%3DBoyd%26aufirst%3DJ.%2BT.%26aulast%3DStover%26aufirst%3DN.%26aulast%3DLeehey%26aufirst%3DM.%26aulast%3DZweig%26aufirst%3DR.%2BM.%26aulast%3DNicholas%26aufirst%3DA.%2BP.%26aulast%3DBodis-Wollner%26aulast%3DIvan%2BWillis%26aufirst%3DA.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DTilley%26aufirst%3DB.%2BC.%26atitle%3DLonger%2520Duration%2520of%2520MAO-b%2520Inhibitor%2520Exposure%2520Is%2520Associated%2520with%2520Less%2520Clinical%2520Decline%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520An%2520Analysis%2520of%2520NETPD%2520LS1%26jtitle%3DJ.%2520Parkinson%2527s%2520Dis.%26date%3D2017%26volume%3D7%26issue%3D1%26spage%3D117%26epage%3D127%26doi%3D10.3233%2FJPD-160965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binde, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tvete, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gåsemyr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natvig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemp, M.</span></span> <span> </span><span class="NLM_article-title">A Multiple Treatment Comparison Meta-Analysis of Monoamine Oxidase Type B Inhibitors for Parkinson’s Disease</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1917</span>– <span class="NLM_lpage">1927</span>, <span class="refDoi"> DOI: 10.1111/bcp.13651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fbcp.13651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29847694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFSqs7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2018&pages=1917-1927&issue=9&author=C.+D.+Bindeauthor=I.+F.+Tveteauthor=J.+G%C3%A5semyrauthor=B.+Natvigauthor=M.+Klemp&title=A+Multiple+Treatment+Comparison+Meta-Analysis+of+Monoamine+Oxidase+Type+B+Inhibitors+for+Parkinson%E2%80%99s+Disease&doi=10.1111%2Fbcp.13651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson's disease</span></div><div class="casAuthors">Binde, C. D.; Tvete, I. F.; Gasemyr, J.; Natvig, B.; Klemp, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1917-1927</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : To the best of our knowledge, there are no systematic reviews or meta-analyses that compare rasagiline, selegiline and safinamide.  Therefore, we aimed to perform a drug class review comparing all available monoamine oxidase type B (MAO-B) inhibitors in a multiple treatment comparison.  Methods : We performed a systematic literature search to identify randomized controlled trials assessing the efficacy of MAO-B inhibitors in patients with Parkinson's disease.  MAO-B inhibitors were evaluated either as monotherapy or in combination with levodopa or dopamine agonists.  Endpoints of interest were change in the Unified Parkinson's Disease Rating Scale (UPDRS) score and serious adverse events.  We estd. the relative effect of each MAO-B inhibitor vs. the comparator drug by creating three networks of direct and indirect comparisons.  For each of the networks, we considered a joint model.  Results : The systematic literature search and study selection process identified 27 publications eligible for our three network analyses.  We found the relative effects of rasagiline, safinamide and selegiline treatment given alone and compared to placebo in a model without explanatory variables to be 1.560 (1.409, 1.734), 1.449 (0.873, 2.413) and 1.532 (1.337, 1.757) resp.  We also found all MAO-B inhibitors to be efficient when given together with levodopa.  When ranking the MAO-B inhibitors given in combination with levodopa, selegiline was the most effective and rasagiline was the second best.  Conclusions : All of the included MAO-B inhibitors were effective compared to placebo when given as monotherapy.  Combination therapy with MAO-B inhibitors and levodopa showed that all three MAO-B inhibitors were effective compared to placebo, but selegiline was the most effective drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMvwb5upOqhLVg90H21EOLACvtfcHk0ljR8m9nT-H6TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFSqs7fF&md5=47cee0ca410f382f9ac829d46848fe03</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13651%26sid%3Dliteratum%253Aachs%26aulast%3DBinde%26aufirst%3DC.%2BD.%26aulast%3DTvete%26aufirst%3DI.%2BF.%26aulast%3DG%25C3%25A5semyr%26aufirst%3DJ.%26aulast%3DNatvig%26aufirst%3DB.%26aulast%3DKlemp%26aufirst%3DM.%26atitle%3DA%2520Multiple%2520Treatment%2520Comparison%2520Meta-Analysis%2520of%2520Monoamine%2520Oxidase%2520Type%2520B%2520Inhibitors%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2018%26volume%3D84%26issue%3D9%26spage%3D1917%26epage%3D1927%26doi%3D10.1111%2Fbcp.13651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birkmayer, W.</span></span> <span> </span><span class="NLM_article-title">Deprenyl (Selegiline) in the Treatment of Parkinson ’ s Disease</span>. <i>Acta Neurol. Scand.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">S95</span>),  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0404.1983.tb01522.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fj.1600-0404.1983.tb01522.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1983&pages=103-106&issue=S95&author=W.+Birkmayer&title=Deprenyl+%28Selegiline%29+in+the+Treatment+of+Parkinson+%E2%80%99+s+Disease&doi=10.1111%2Fj.1600-0404.1983.tb01522.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0404.1983.tb01522.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0404.1983.tb01522.x%26sid%3Dliteratum%253Aachs%26aulast%3DBirkmayer%26aufirst%3DW.%26atitle%3DDeprenyl%2520%2528Selegiline%2529%2520in%2520the%2520Treatment%2520of%2520Parkinson%2520%25E2%2580%2599%2520s%2520Disease%26jtitle%3DActa%2520Neurol.%2520Scand.%26date%3D1983%26volume%3D68%26issue%3DS95%26spage%3D103%26epage%3D106%26doi%3D10.1111%2Fj.1600-0404.1983.tb01522.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D. R. P.</span></span> <span> </span><span class="NLM_article-title">Rasagiline (TVP-1012): A New Selective Monoamine Oxidase Inhibitor for Parkinson’s Disease</span>. <i>Am. J. Geriatr. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1016/j.amjopharm.2006.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.amjopharm.2006.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=17296539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFequr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=330-346&issue=4&author=D.+R.+P.+Guay&title=Rasagiline+%28TVP-1012%29%3A+A+New+Selective+Monoamine+Oxidase+Inhibitor+for+Parkinson%E2%80%99s+Disease&doi=10.1016%2Fj.amjopharm.2006.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease</span></div><div class="casAuthors">Guay, David R. P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Geriatric Pharmacotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">330-346</span>CODEN:
                <span class="NLM_cas:coden">AJGPB5</span>;
        ISSN:<span class="NLM_cas:issn">1543-5946</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Objective: This article reviews the chem., pharmacodynamics, pharmacokinetics, clin. efficacy, tolerability, drug-interaction potential, indications, dosing, and potential role of rasagiline mesylate, a new selective monoamine oxidase (MAO) type B (MAO-B) inhibitor, in the treatment of Parkinson's disease.  Methods: A MEDLINE/PUBMED search (1986 through Sept. 2006) was conducted to identify studies involving rasagiline written in English.  Addnl. refs. were obtained from the bibliogs. of these studies.  All studies evaluating any aspect of rasagiline, including in vitro, in vivo (animal), and human studies, were reviewed.  Results: Rasagiline mesylate was developed with the goal of producing a selective MAO-B inhibitor that is not metabolized to (presumed) toxic metabolites (eg, amphetamine and methamphetamine, which are byproducts of the metab. of selegiline, another selective MAO-B inhibitor).  In vitro and in vivo data have confirmed the drug's selectivity for MAO-B.  Rasagiline is almost completely eliminated by oxidative metab. (catalyzed by cytochrome P 450 [CYP] isoenzyme 1A2) followed by renal excretion of conjugated parent compd. and metabolites.  Drug clearance is sufficiently slow to allow once-daily dosing.  Several studies have documented its efficacy as monotherapy for early-stage disease and as adjunctive therapy in L-dopa recipients with motor fluctuations.  As monotherapy, rasagiline is well tolerated with an adverse-effect profile similar to that of placebo.  As adjunctive therapy, it exhibits the expected adverse effects of dopamine excess, which can be ameliorated by reducing the L-dopa dosage.  CYP1A2 inhibitors slow the elimination of rasagiline and mandate dosage redn.  Hepatic impairment has an analogous effect.  The recommended dosage regimens for monotherapy and adjunctive therapy are 1 and 0.5 mg PO QD, resp.  Conclusions: Despite the well-documented selectivity of rasagiline, the manufacturer recommends virtually all of the dietary (vis-a-vis tyramine) and drug restrictions of the nonselective MAO inhibitors.  Although useful, selective MAO-B inhibitors have a limited role in Parkinson's disease.  Of greater interest is the potential neuroprotective effect of rasagiline and its major metabolite, 1(R)-aminoindan, which may have great utility in a wide variety of neurodegenerative disorders of aging.  In addn., bifunctional mols. combining selective MAO-B inhibition (based on the active moiety of rasagiline) with acetylcholinesterase inhibition or iron chelation may eventually be useful in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcnBFh20xisrVg90H21EOLACvtfcHk0li2OdhNY3Cb-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFequr8%253D&md5=222d796493466e8fad7f46e59ce04e85</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.amjopharm.2006.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjopharm.2006.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DGuay%26aufirst%3DD.%2BR.%2BP.%26atitle%3DRasagiline%2520%2528TVP-1012%2529%253A%2520A%2520New%2520Selective%2520Monoamine%2520Oxidase%2520Inhibitor%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Pharmacother.%26date%3D2006%26volume%3D4%26issue%3D4%26spage%3D330%26epage%3D346%26doi%3D10.1016%2Fj.amjopharm.2006.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filip, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolibás, E.</span></span> <span> </span><span class="NLM_article-title">Selegiline in the Treatment of Alzheimer’s Disease: A Long-Term Randomized Placebo-Controlled Trial</span>. <i>J. Psychiatry Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10354658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADyaK1M3otlSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1999&pages=234-243&issue=3&author=V.+Filipauthor=E.+Kolib%C3%A1s&title=Selegiline+in+the+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+A+Long-Term+Randomized+Placebo-Controlled+Trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group</span></div><div class="casAuthors">Filip V; Kolibas E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">234-43</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the efficacy and adverse effects of the type B monoamine oxidase inhibitor selegiline (also known as I-deprenyl) in the treatment of Alzheimer's disease.  DESIGN:  Long-term, double-blind, placebo-controlled trial.  SETTING:  Seven cities (1 or 2 nursing homes in each city) in the Czech and Slovak Republics.  PATIENTS:  A total of 173 nursing-home residents fulfilling the DSM-III criteria for mild to moderate Alzheimer's disease.  INTERVENTIONS:  Selegiline (10 mg per day) or placebo (both including 50 mg ascorbic acid) administered for 24 weeks.  OUTCOME MEASURES:  Clinical Global Impressions scale and Nurses Observation Scale for Inpatient Evaluation at baseline and at weeks 6, 12 and 24; Clock Drawing Test at baseline and 24 weeks, results of which were evaluated as normal or pathologic, and quantitatively on a modified 6-point scale; Sternberg's Memory Scanning test at baseline and at weeks 6, 12 and 24; Mini Mental State Examination, and electroencephalogram at baseline and 24 weeks; Structured Adverse Effects Rating Scale; physical, laboratory, hematological and electrocardiographic examinations at baseline and weeks 12 and 24.  RESULTS:  A total of 143 subjects completed enough of the trial to be entered in the analysis.  Subjects were analyzed by 2 subgroups depending on whether they had a normal or pathologic result of the Clock Drawing Test.  Analysis of variance showed significant improvement with selegiline versus placebo among those with a normal result of the Clock Drawing Test on the Mini Mental Status Examination (total score and orientation-place subscale) and among those with a pathologic result of the Clock Drawing Test of Sternberg's Memory Scanning test (for both speed and accuracy), on the Clinical Global Impressions scale as well as in terms of the dominant frequency on electroencephalograms.  CONCLUSION:  Selegiline has a long-term beneficial effect in Alzheimer's disease on memory modalities that reflect the function of the prefrontal areas of the brain, which are rich in dopamine receptors.  The delayed appearance of differences between selegiline and placebo supports the notion that the mechanism of action is through neuronal rescue or neuroprotection.  The differential response of patients with normal and pathologic results of the Clock Drawing Test may reflect the fact that the evaluation methods' sensitivity to change depends on the severity of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVoSjqXqI3-5w7prLlxLOzfW6udTcc2ebwMQPeo8FFNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3otlSmtw%253D%253D&md5=6b09940e9f47d21c45dd440df17b91bd</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFilip%26aufirst%3DV.%26aulast%3DKolib%25C3%25A1s%26aufirst%3DE.%26atitle%3DSelegiline%2520in%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Long-Term%2520Randomized%2520Placebo-Controlled%2520Trial%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D1999%26volume%3D24%26issue%3D3%26spage%3D234%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kweon, G. R.</span></span> <span> </span><span class="NLM_article-title">L-Deprenyl Exerts Cytotoxicity towards Acute Myeloid Leukemia through Inhibition of Mitochondrial Respiration</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">3869</span>– <span class="NLM_lpage">3878</span>, <span class="refDoi"> DOI: 10.3892/or.2018.6753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3892%2For.2018.6753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30272370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFahu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=3869-3878&author=I.+Ryuauthor=M.+J.+Ryuauthor=J.+Hanauthor=S.+J.+Kimauthor=M.+J.+Leeauthor=X.+Juauthor=B.+H.+Yooauthor=Y.+L.+Leeauthor=Y.+Jangauthor=I.+C.+Songauthor=W.+Chungauthor=E.+Ohauthor=J.+Y.+Heoauthor=G.+R.+Kweon&title=L-Deprenyl+Exerts+Cytotoxicity+towards+Acute+Myeloid+Leukemia+through+Inhibition+of+Mitochondrial+Respiration&doi=10.3892%2For.2018.6753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">L-Deprenyl exerts cytotoxicity towards acute myeloid leukemia through inhibition of mitochondrial respiration</span></div><div class="casAuthors">Ryu, Ilhwan; Ryu, Min Jeong; Han, Jeongsu; Kim, Soo Jeong; Lee, Min Joung; Ju, Xianshu; Yoo, Byeong Hyeon; Lee, Yu Lim; Jang, Yunseon; Song, Ik-Chan; Chung, Woosuk; Oh, Eungseok; Heo, Jun Young; Kweon, Gi Ryang</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3869-3878</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The identification of large nos. of genetic mutations in immature myeloid cells has made it difficult to identify specific targets for acute myeloid leukemia (AML) therapy.  Although current pharmacol. targets for controlling cancer are focused on identifying genetic mutations, it is hard to develop the specific drugs to achieve complete remission due to complex and variable genetic mutations.  To overcome the failure of the genetic mutation theory, the present study targeted mitochondrial metab. as a strategy for inducing anti.leukemic activity, based on evidence that AML cells have an abnormally high amt. of mitochondria and that somatic mutations can alter metabolic flux in cancer.  It was found that L.deprenyl, which is clin. available for the treatment of Parkinson's disease, exerts anti.mitochondria activity in KG.1α cells, as assessed by detection of oxygen consumption rate (OCR) and extracellular acidification (ECAR) using XF analyzer, resp.  Using a luciferase assay for detecting ATP (ATP) content, it was found that suppression of mitochondrial activity led to ATP depletion and was assocd. with potent cytotoxic activity.  Consistent with the aforementioned results, treatment with L-deprenyl reduced the mRNA level of mitochondrial respiration. and glycolysis.related genes.  Collectively, the present results identify L-deprenyl as a novel candidate for the treatment of AML through inhibition of mitochondrial respiration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxO4qJeJrAJ7Vg90H21EOLACvtfcHk0lifHJB9FgzrQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFahu73M&md5=5fb5f18450cbc7a25b85117e536dfb1c</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.3892%2For.2018.6753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2018.6753%26sid%3Dliteratum%253Aachs%26aulast%3DRyu%26aufirst%3DI.%26aulast%3DRyu%26aufirst%3DM.%2BJ.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DJu%26aufirst%3DX.%26aulast%3DYoo%26aufirst%3DB.%2BH.%26aulast%3DLee%26aufirst%3DY.%2BL.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DI.%2BC.%26aulast%3DChung%26aufirst%3DW.%26aulast%3DOh%26aufirst%3DE.%26aulast%3DHeo%26aufirst%3DJ.%2BY.%26aulast%3DKweon%26aufirst%3DG.%2BR.%26atitle%3DL-Deprenyl%2520Exerts%2520Cytotoxicity%2520towards%2520Acute%2520Myeloid%2520Leukemia%2520through%2520Inhibition%2520of%2520Mitochondrial%2520Respiration%26jtitle%3DOncol.%2520Rep.%26date%3D2018%26spage%3D3869%26epage%3D3878%26doi%3D10.3892%2For.2018.6753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lighezan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duicu, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceausu, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaduva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feier, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lighezan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muntean, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mornos, C.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase Inhibition Improves Vascular Function in Mammary Arteries from Nondiabetic and Diabetic Patients with Coronary Heart Disease</span>. <i>Can. J. Physiol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1040</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1139/cjpp-2015-0580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1139%2Fcjpp-2015-0580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27322151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVClu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2016&pages=1040-1047&issue=10&author=R.+Lighezanauthor=A.+Sturzaauthor=O.+M.+Duicuauthor=R.+A.+Ceausuauthor=A.+Vaduvaauthor=M.+Gasparauthor=H.+Feierauthor=M.+Vaidaauthor=V.+Ivanauthor=D.+Lighezanauthor=D.+M.+Munteanauthor=C.+Mornos&title=Monoamine+Oxidase+Inhibition+Improves+Vascular+Function+in+Mammary+Arteries+from+Nondiabetic+and+Diabetic+Patients+with+Coronary+Heart+Disease&doi=10.1139%2Fcjpp-2015-0580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase inhibition improves vascular function in mammary arteries from nondiabetic and diabetic patients with coronary heart disease1</span></div><div class="casAuthors">Lighezan, Rodica; Sturza, Adrian; Duicu, Oana M.; Ceausu, Raluca A.; Vaduva, Adrian; Gaspar, Marian; Feier, Horea; Vaida, Monica; Ivan, Viviana; Lighezan, Daniel; Muntean, Danina M.; Mornos, Cristian</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1040-1047</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    
            (<span class="NLM_cas:orgname">Canadian Science Publishing</span>)
        </div><div class="casAbstract">Monoamine oxidases (MAOs) are mitochondrial enzymes with 2 isoforms that have emerged as important contributors to cardiovascular oxidative stress via the const. generation of hydrogen peroxide.  The present study was purported to assess whether MAO-derived H2O2 contributes to the endothelial dysfunction in mammary arteries harvested from coronary heart disease patients with and without diabetes mellitus subjected to coronary artery bypass grafting.  To this aim, the effects of MAO inhibition on vascular contractility to phenylephrine and endothelial-dependent relaxation (EDR) in response to acetylcholine were studied in vascular segments.  Clorgyline (irreversible MAO-A inhibitor), selegiline (irreversible MAO-B inhibitor), and moclobemide (reversible MAO-A inhibitor) were applied in the organ bath (10 μmol/L).  MAO expression was assessed by immunohistochem.  We found a const. impairment of EDR that has been significantly attenuated in the presence of the MAO-A and MAO-B inhibitors in both groups of coronary heart disease patients.  MAO-B was the dominant isoform in all human diseased vessels.  In conclusion, in vitro inhibition of MAO significantly improved EDR in human mammary arteries, regardless of the presence of diabetes.  These data suggest that MAO inhibitors might be useful in restoring endothelial response in clin. conditions assocd. with increased oxidative stress, such as coronary artery disease and diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFvITuv3YxZ7Vg90H21EOLACvtfcHk0ljZokVLdRA3fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVClu73N&md5=162ab83d05c60f7e7d5a0fdb26fbc5af</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1139%2Fcjpp-2015-0580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fcjpp-2015-0580%26sid%3Dliteratum%253Aachs%26aulast%3DLighezan%26aufirst%3DR.%26aulast%3DSturza%26aufirst%3DA.%26aulast%3DDuicu%26aufirst%3DO.%2BM.%26aulast%3DCeausu%26aufirst%3DR.%2BA.%26aulast%3DVaduva%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DM.%26aulast%3DFeier%26aufirst%3DH.%26aulast%3DVaida%26aufirst%3DM.%26aulast%3DIvan%26aufirst%3DV.%26aulast%3DLighezan%26aufirst%3DD.%26aulast%3DMuntean%26aufirst%3DD.%2BM.%26aulast%3DMornos%26aufirst%3DC.%26atitle%3DMonoamine%2520Oxidase%2520Inhibition%2520Improves%2520Vascular%2520Function%2520in%2520Mammary%2520Arteries%2520from%2520Nondiabetic%2520and%2520Diabetic%2520Patients%2520with%2520Coronary%2520Heart%2520Disease%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D2016%26volume%3D94%26issue%3D10%26spage%3D1040%26epage%3D1047%26doi%3D10.1139%2Fcjpp-2015-0580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tábi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vécsei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riederer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szökő, É.</span></span> <span> </span><span class="NLM_article-title">Selegiline: A Molecule with Innovative Potential</span>. <i>J. Neural Transm.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1007/s00702-019-02082-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs00702-019-02082-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31562557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BB3MnivV2lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2020&pages=831-842&issue=5&author=T.+T%C3%A1biauthor=L.+V%C3%A9cseiauthor=M.+B.+Youdimauthor=P.+Riedererauthor=%C3%89.+Sz%C3%B6k%C5%91&title=Selegiline%3A+A+Molecule+with+Innovative+Potential&doi=10.1007%2Fs00702-019-02082-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Selegiline: a molecule with innovative potential</span></div><div class="casAuthors">Tabi Tamas; Szoko Eva; Vecsei Laszlo; Youdim Moussa B; Riederer Peter; Riederer Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission (Vienna, Austria : 1996)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">831-842</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Monoamine oxidase B (MAO-B) inhibitors have an established role in the treatment of Parkinson's disease as monotherapy or adjuvant to levodopa.  Two major recognitions were required for their introduction into this therapeutic field.  The first was the elucidation of the novel pharmacological properties of selegiline as a selective MAO-B inhibitor by Knoll and Magyar and the original idea of Riederer and Youdim, supported by Birkmayer, to explore its effect in parkinsonian patients with on-off phases.  In the 1960s, MAO inhibitors were mainly studied as potential antidepressants, but Birkmayer found that combined use of levodopa and various MAO inhibitors improved akinesia in Parkinson's disease.  However, the serious side effects of the first non-selective MAO inhibitors prevented their further use.  Later studies demonstrated that MAO-B, mainly located in glial cells, is important for dopamine metabolism in the brain.  Recently, cell and molecular studies revealed interesting properties of selegiline opening new possibilities for neuroprotective mechanisms and a disease-modifying effect of MAO-B inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCmt7Ed9RBS1m8bhe6roZYfW6udTcc2ea7ttltNi5Kybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnivV2lsg%253D%253D&md5=66071187e7bbde6e9f565793a90be63b</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1007%2Fs00702-019-02082-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-019-02082-0%26sid%3Dliteratum%253Aachs%26aulast%3DT%25C3%25A1bi%26aufirst%3DT.%26aulast%3DV%25C3%25A9csei%26aufirst%3DL.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DSz%25C3%25B6k%25C5%2591%26aufirst%3D%25C3%2589.%26atitle%3DSelegiline%253A%2520A%2520Molecule%2520with%2520Innovative%2520Potential%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2020%26volume%3D127%26issue%3D5%26spage%3D831%26epage%3D842%26doi%3D10.1007%2Fs00702-019-02082-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroutiunian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarovici, P.</span></span> <span> </span><span class="NLM_article-title">Rasagiline - A Novel MAO B Inhibitor in Parkinson’s Disease Therapy</span>. <i>Ther. Clin. Risk Manag.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18488080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1Cqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=467-474&issue=3&author=S.+Lechtauthor=S.+Haroutiunianauthor=A.+Hoffmanauthor=P.+Lazarovici&title=Rasagiline+-+A+Novel+MAO+B+Inhibitor+in+Parkinson%E2%80%99s+Disease+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy</span></div><div class="casAuthors">Lecht, Shimon; Haroutiunian, Simon; Hoffman, Amnon; Lazarovici, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutics and Clinical Risk Management</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">467-474</span>CODEN:
                <span class="NLM_cas:coden">TCRMA6</span>;
        ISSN:<span class="NLM_cas:issn">1176-6336</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a progressive neurodegenerative, dopamine deficiency disorder.  The main therapeutic strategies for PD treatment relies on dopamine precursors (levodopa), inhibition of dopamine metab. (monoamine oxidase [MAO] B and catechol-O-Me transferase inhibitors), and dopamine receptor agonists.  Recently, a novel selective and irreversible MAO B propargylamine inhibitor rasagiline (N-propargyl-1-R-aminoindan, Azilect) was approved for PD therapy.  In contrast to selegiline, the prototype of MAO B inhibitors, rasagiline is not metabolized to potentially toxic amphetamine metabolites.  The oral bioavailability of rasagiline is 35%, it reaches Tmax after 0.5-1 h and its half-life is 1.5-3.5 h.  Rasagiline undergoes extensive hepatic metab. primarily by cytochrome P 450 type 1A2 (CYP1A2).  Rasagiline is initiated at 1 mg once-daily dosage as monotherapy in early PD patients and at 0.5-1 mg once-daily as adjunctive to levodopa in advanced PD patients.  Rasagiline treatment was not assocd. with "cheese effect" and up to 20 mg per day was well tolerated.  In PD patients with hepatic impairment, rasagiline dosage should be carefully adjusted.  Rasagiline should not be administered with other MAO inhibitors and co-administration with certain antidepressants and opioids should be avoided.  Although further clin. evidence is needed on the neuroprotective effects of rasagiline in PD patients, this drug provides an addnl. tool for PD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUhIhJ2-qIxrVg90H21EOLACvtfcHk0lgyM2X7uye4hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1Cqtro%253D&md5=946444380187310c2fb8925676cd8376</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLecht%26aufirst%3DS.%26aulast%3DHaroutiunian%26aufirst%3DS.%26aulast%3DHoffman%26aufirst%3DA.%26aulast%3DLazarovici%26aufirst%3DP.%26atitle%3DRasagiline%2520-%2520A%2520Novel%2520MAO%2520B%2520Inhibitor%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%2520Therapy%26jtitle%3DTher.%2520Clin.%2520Risk%2520Manag.%26date%3D2007%26volume%3D3%26issue%3D3%26spage%3D467%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sieradzan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Channon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramponi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lees, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span> <span> </span><span class="NLM_article-title">The Therapeutic Potential of Moclobemide, a Reversible Selective Monoamine Oxidase A Inhibitor in Parkinson’s Disease</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">51S</span>– <span class="NLM_lpage">59S</span>, <span class="refDoi"> DOI: 10.1097/00004714-199508001-00010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1097%2F00004714-199508001-00010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=7593732" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=51S-59S&issue=4&author=K.+Sieradzanauthor=S.+Channonauthor=C.+Ramponiauthor=G.+M.+Sternauthor=A.+J.+Leesauthor=M.+B.+Youdim&title=The+Therapeutic+Potential+of+Moclobemide%2C+a+Reversible+Selective+Monoamine+Oxidase+A+Inhibitor+in+Parkinson%E2%80%99s+Disease&doi=10.1097%2F00004714-199508001-00010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1097%2F00004714-199508001-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199508001-00010%26sid%3Dliteratum%253Aachs%26aulast%3DSieradzan%26aufirst%3DK.%26aulast%3DChannon%26aufirst%3DS.%26aulast%3DRamponi%26aufirst%3DC.%26aulast%3DStern%26aufirst%3DG.%2BM.%26aulast%3DLees%26aufirst%3DA.%2BJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DThe%2520Therapeutic%2520Potential%2520of%2520Moclobemide%252C%2520a%2520Reversible%2520Selective%2520Monoamine%2520Oxidase%2520A%2520Inhibitor%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1995%26volume%3D15%26issue%3D4%26spage%3D51S%26epage%3D59S%26doi%3D10.1097%2F00004714-199508001-00010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vuohelainen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hämäläinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paavonen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moilanen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennander, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Monoamine Oxidase A Increases Recovery after Experimental Cardiac Arrest</span>. <i>Interact. Cardiovasc. Thorac. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1093/icvts/ivv175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1093%2Ficvts%2Fivv175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26116370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC2MbnsF2ntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=441-449&issue=4&author=V.+Vuohelainenauthor=M.+H%C3%A4m%C3%A4l%C3%A4inenauthor=T.+Paavonenauthor=S.+Karlssonauthor=E.+Moilanenauthor=A.+Mennander&title=Inhibition+of+Monoamine+Oxidase+A+Increases+Recovery+after+Experimental+Cardiac+Arrest&doi=10.1093%2Ficvts%2Fivv175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase A increases recovery after experimental cardiac arrest</span></div><div class="casAuthors">Vuohelainen Vilma; Mennander Ari; Hamalainen Mari; Moilanen Eeva; Paavonen Timo; Karlsson Sari</div><div class="citationInfo"><span class="NLM_cas:title">Interactive cardiovascular and thoracic surgery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Perioperative myocardial infarction (MI) with ischaemia-reperfusion injury (IRI) is a devastating entity occurring in 1-2% of patients after cardiac surgery.  The molecular pathway leading to myocardial cellular destruction after MI may include monoamine oxidases.  We experimentally investigated whether moclobemide, a monoamine oxidase inhibitor, enhances myocardial recovery after cardiac arrest and MI.  METHODS:  Fifty-six syngeneic Fischer rats underwent heterotopic cardiac transplantation to induce reversible IRI after cardiac arrest.  Twenty-eight rats also underwent permanent ligation of the left anterior descending coronary artery to induce MI after cardiac arrest.  Twenty-eight rats with or without MI were treated with subcutaneous moclobemide 10 mg/kg/day.  Methods used to study myocardial recovery were microdialysis for intramyocardial metabolism, histology and quantitative reverse-transcription polymerase chain reaction for high-mobility group box-1 (HMGB1), haeme oxygenase-1 (HO-1), interleukin-6, hypoxia-inducible factor 1α and macrophages (CD68).  RESULTS:  Pyruvate increased in MI treated with moclobemide versus IRI with moclobemide (29.19 ± 7.64 vs 13.86 ± 8.49 μM, P = 0.028), reflecting metabolic activity after cardiac arrest and reperfusion.  Myocardial inflammation increased in MI compared with IRI after 1 h (0.80 ± 0.56 vs 0, point score units [PSUs], P = 0.003), but decreased after 5 days in MI treated with moclobemide versus MI alone (0.80 ± 0.83 vs 2.00 ± 0.70, PSU, P = 0.033).  Expressions of HMGB1, CD68 and HO-1 decreased in MI treated with moclobemide versus MI alone (1.33 ± 0.20 vs 1.75 ± 0.24, fold changes [FCs], P = 0.028; 5.15 ± 1.10 vs 9.59 ± 2.75, FC, P = 0.050; 10.41 ± 4.17 vs 21.28 ± 10.01, FC, P = 0.047), indicating myocardial recovery and increased cellularity of remote intramyocardial arteries.  CONCLUSIONS:  Moclobemide enhances myocardial recovery after cardiac arrest and MI; inhibition of remote myocardial changes may be achieved by targeting treatment against monoamine oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1_KCoddCWLq-9TkgmBqTqfW6udTcc2eaou-X_UhPjM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbnsF2ntA%253D%253D&md5=4e63d058aed5ded8c0634665d537f3b6</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1093%2Ficvts%2Fivv175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ficvts%252Fivv175%26sid%3Dliteratum%253Aachs%26aulast%3DVuohelainen%26aufirst%3DV.%26aulast%3DH%25C3%25A4m%25C3%25A4l%25C3%25A4inen%26aufirst%3DM.%26aulast%3DPaavonen%26aufirst%3DT.%26aulast%3DKarlsson%26aufirst%3DS.%26aulast%3DMoilanen%26aufirst%3DE.%26aulast%3DMennander%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520Monoamine%2520Oxidase%2520A%2520Increases%2520Recovery%2520after%2520Experimental%2520Cardiac%2520Arrest%26jtitle%3DInteract.%2520Cardiovasc.%2520Thorac.%2520Surg.%26date%3D2015%26volume%3D21%26issue%3D4%26spage%3D441%26epage%3D449%26doi%3D10.1093%2Ficvts%2Fivv175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-x.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-k.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S.-n.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-d.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel Propargylamine-Modified 4-Aminoalkyl Imidazole Substituted Pyrimidinylthiourea Derivatives as Multifunctional Agents for the Treatment of Alzheimer’s Disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.ejmech.2017.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29172081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKhsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=33-47&author=Y.-x.+Xuauthor=H.+Wangauthor=X.-k.+Liauthor=S.-n.+Dongauthor=W.-w.+Liuauthor=Q.+Gongauthor=T.-d.-y.+Wangauthor=Y.+Tangauthor=J.+Zhuauthor=J.+Liauthor=H.-y.+Zhangauthor=F.+Mao&title=Discovery+of+Novel+Propargylamine-Modified+4-Aminoalkyl+Imidazole+Substituted+Pyrimidinylthiourea+Derivatives+as+Multifunctional+Agents+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.ejmech.2017.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Xu, Yi-xiang; Wang, Huan; Li, Xiao-kang; Dong, Sheng-nan; Liu, Wen-wen; Gong, Qi; Wang, Tian-duan-yi; Tang, Yun; Zhu, Jin; Li, Jian; Zhang, Hai-yan; Mao, Fei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33-47</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel propargylamine-modified pyrimidinylthiourea derivs. were designed and synthesized as multifunctional agents for Alzheimer's disease (AD) therapy, and their potential was evaluated through various biol. expts.  Among these derivs., compd. 1b (I) displayed good selective inhibitory activity against AChE (vs BuChE, IC50 = 0.324 μM, SI > 123) and MAO-B (vs MAO-A, IC50 = 1.427 μM, SI > 35).  Mol. docking study showed that the pyrimidinylthiourea moiety of 1b could bind to the catalytic active site (CAS) of AChE, and the propargylamine moiety interacted directly with the FAD of MAO-B.  Moreover, 1b demonstrated mild antioxidant ability, good copper chelating property, effective inhibitory activity against Cu2+-induced Aβ1-42 aggregation, moderate neuroprotection, low cytotoxicity, and appropriate blood-brain barrier (BBB) permeability in vitro and was capable of ameliorating scopolamine-induced cognitive impairment in mice.  These results indicated that 1b has the potential to be a multifunctional candidate for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB7tdzpIhKRbVg90H21EOLACvtfcHk0lhE5THN00WIfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKhsLjP&md5=d16df6d9494814e95096f04d50cc35b8</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.-x.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.-k.%26aulast%3DDong%26aufirst%3DS.-n.%26aulast%3DLiu%26aufirst%3DW.-w.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DT.-d.-y.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.-y.%26aulast%3DMao%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520Novel%2520Propargylamine-Modified%25204-Aminoalkyl%2520Imidazole%2520Substituted%2520Pyrimidinylthiourea%2520Derivatives%2520as%2520Multifunctional%2520Agents%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D33%26epage%3D47%26doi%3D10.1016%2Fj.ejmech.2017.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Basis of Neuroprotective Activities of Rasagiline and the Anti-Alzheimer Drug TV3326 [(N-Propargyl-(3R)Aminoindan-5-YL)-Ethyl Methyl Carbamate]</span>. <i>Cell. Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1023/A:1015131516649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1023%2FA%3A1015131516649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=12043833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BD38zgt12ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=555-573&issue=6&author=M.+B.+H.+Youdimauthor=M.+Weinstock&title=Molecular+Basis+of+Neuroprotective+Activities+of+Rasagiline+and+the+Anti-Alzheimer+Drug+TV3326+%5B%28N-Propargyl-%283R%29Aminoindan-5-YL%29-Ethyl+Methyl+Carbamate%5D&doi=10.1023%2FA%3A1015131516649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]</span></div><div class="casAuthors">Youdim M B; Weinstock M</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and molecular neurobiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">555-73</span>
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    </div><div class="casAbstract">Rasagiline (N-propargyl-1-(R)-aminoindan) is a selective, irreversible monoamine oxidase B (MAO B) inhibitor which has been developed as an anti-Parkinson drug.  In controlled monotherapy and as adjunct to L-dopa it has shown anti-Parkinson activity.  In cell culture (PC-12 and neuroblastoma SH-SY5Y cells) it exhibits neuroprotective and anti-apoptotic activity against several neurotoxins (SIN-1, MPTP, 6-hydroxydopamine and N-methyl-(R)-salsolinol) and ischemia.  In vivo, it reduces the sequelae of traumatic brain injury in mice and speeds their recovery.  The neuroprotective activity of rasagaline does not result from MAO B inhibition, since its S-enantiomer, TVP1022, which has 1000-fold weaker MAO inhibitory activity, exhibits similar neuroprotective properties.  Introduction of a carbamate moiety into the rasagiline molecule to confer cholinesterase inhibitory activity for the treatment of Alzheimer's disease, resulted in compounds TV3326 [(N-Propargyl-(3R)Aminoindan-5-YL)-Ethyl Methyl Carbamate] and its S-enantiomer TV3279 [(N-Propargyl-(3S)Aminoindan-5-YL)-Ethyl Methyl Carbamate], which retain the neuroprotective activities of rasagiline and TVP1022.  They also antagonize scopolamine-induced impairments in spatial memory.  In addition, TV3326 exhibits brain-selective MAO A and B inhibitory activity after chronic administration and has antidepressant-like activity in the forced swim test.  This is associated with an increase in brain levels of serotonin.  The anti-apoptotic activity of these propargylamine-containing derivatives may be related to their ability to delay the opening of voltage-dependent anion channels (VDAC), which are part of the mitochondrial permeability transition pore.  The propargylamine moiety is responsible for the increase in the mitochondrial family of Bcl-2 proteins, prevention in the fall in mitochondrial membrane potential, prevention of the activation of caspase 3, and of translocation of glyceraldehyde-3-phosphate dehydrogenase from the cytoplasm to the nucleus.  The latter processes are closely associated with neurotoxin-induced apoptosis.  Rasagiline interacts with and prevents the binding of PKI 1195 to the pro-apoptotic peripheral benzodiazepine receptor, which together with Bcl-2, hexokinase, porin, and adenine nucleotide translocator constitutes part of the VDAC.  Furthermore, rasagiline, TV3326 and TV3279 are able to influence the processing of amyloid precursor protein by activation of alpha-secretase and increasing the release of soluble alpha APP in rat PC-12 and human neuroblastoma SH-SY5Y cells and in rat and mice cortex and hippocampus.  This process has been shown to involve the upregulation of PKC and MAP kinase.  It is quite likely that the induction of Bcl-2 and activation of PKC by rasagiline and TV3326 is closely linked to the anti-apoptotic action of these drugs and their ability to process APP by activation of alpha-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQR3CdWC5jGOz0SWnHPWbmmfW6udTcc2ebycCyI64-vbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zgt12ksQ%253D%253D&md5=0909d8e1af5f7cbdcd55ad7d48ebfc15</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015131516649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015131516649%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DMolecular%2520Basis%2520of%2520Neuroprotective%2520Activities%2520of%2520Rasagiline%2520and%2520the%2520Anti-Alzheimer%2520Drug%2520TV3326%2520%255B%2528N-Propargyl-%25283R%2529Aminoindan-5-YL%2529-Ethyl%2520Methyl%2520Carbamate%255D%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2001%26volume%3D21%26issue%3D6%26spage%3D555%26epage%3D573%26doi%3D10.1023%2FA%3A1015131516649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, Ó. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino-Antolin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farré-Alins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joffrin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimeno, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janočková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwed, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero Martínez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Muñoz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">12765</span>– <span class="NLM_lpage">12769</span>, <span class="refDoi"> DOI: 10.1002/anie.201706072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fanie.201706072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVekt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=12765-12769&issue=41&author=%C3%93.+M.+Bautista-Aguileraauthor=S.+Hagenowauthor=A.+Palomino-Antolinauthor=V.+Farr%C3%A9-Alinsauthor=L.+Ismailiauthor=P.+L.+Joffrinauthor=M.+L.+Jimenoauthor=O.+Soukupauthor=J.+Jano%C4%8Dkov%C3%A1author=L.+Kalinowskyauthor=E.+Proschakauthor=I.+Iriepaauthor=I.+Moraledaauthor=J.+S.+Schwedauthor=A.+Romero+Mart%C3%ADnezauthor=F.+L%C3%B3pez-Mu%C3%B1ozauthor=M.+Chiouaauthor=J.+Egeaauthor=R.+R.+Ramsayauthor=J.+Marco-Contellesauthor=H.+Stark&title=Multitarget-Directed+Ligands+Combining+Cholinesterase+and+Monoamine+Oxidase+Inhibition+with+Histamine+H3R+Antagonism+for+Neurodegenerative+Diseases&doi=10.1002%2Fanie.201706072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases</span></div><div class="casAuthors">Bautista-Aguilera, Oscar M.; Hagenow, Stefanie; Palomino-Antolin, Alejandra; Farre-Alins, Victor; Ismaili, Lhassane; Joffrin, Pierre-Louis; Jimeno, Maria L.; Soukup, Ondrej; Janockova, Jana; Kalinowsky, Lena; Proschak, Ewgenij; Iriepa, Isabel; Moraleda, Ignacio; Schwed, Johannes S.; Romero Martinez, Alejandro; Lopez-Munoz, Francisco; Chioua, Mourad; Egea, Javier; Ramsay, Rona R.; Marco-Contelles, Jose; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12765-12769</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The therapy of complex neurodegenerative diseases requires the development of multitarget-directed drugs (MTDs).  Novel indole derivs. with inhibitory activity towards acetyl/butyrylcholinesterases and monoamine oxidases A/B as well as the histamine H3 receptor (H3R) were obtained by optimization of the neuroprotectant ASS234 by incorporating generally accepted H3R pharmacophore motifs.  These small-mol. hits demonstrated balanced activities at the targets, mostly in the nanomolar concn. range.  Addnl. in vitro studies showed antioxidative neuroprotective effects as well as the ability to penetrate the blood-brain barrier.  With this promising in vitro profile, contilisant (at 1 mg kg-1 i.p.) also significantly improved lipopolysaccharide-induced cognitive deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2wNLAClUFULVg90H21EOLACvtfcHk0lhVcthDibfUjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVekt73L&md5=4a962ad1ada3f5b8e8102add09cd4e60</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706072%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3D%25C3%2593.%2BM.%26aulast%3DHagenow%26aufirst%3DS.%26aulast%3DPalomino-Antolin%26aufirst%3DA.%26aulast%3DFarr%25C3%25A9-Alins%26aufirst%3DV.%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3DJoffrin%26aufirst%3DP.%2BL.%26aulast%3DJimeno%26aufirst%3DM.%2BL.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DJano%25C4%258Dkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DKalinowsky%26aufirst%3DL.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DSchwed%26aufirst%3DJ.%2BS.%26aulast%3DRomero%2BMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez-Mu%25C3%25B1oz%26aufirst%3DF.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DMultitarget-Directed%2520Ligands%2520Combining%2520Cholinesterase%2520and%2520Monoamine%2520Oxidase%2520Inhibition%2520with%2520Histamine%2520H3R%2520Antagonism%2520for%2520Neurodegenerative%2520Diseases%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D41%26spage%3D12765%26epage%3D12769%26doi%3D10.1002%2Fanie.201706072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, Ó. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Muñoz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Contilisant, a Tetratarget Small Molecule for Alzheimer’s Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6937</span>– <span class="NLM_lpage">6943</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00848</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00848" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Cqu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6937-6943&issue=15&author=%C3%93.+M.+Bautista-Aguileraauthor=J.+Budniauthor=F.+Minaauthor=E.+B.+Medeirosauthor=W.+Deuther-Conradauthor=J.+M.+Entrenaauthor=I.+Moraledaauthor=I.+Iriepaauthor=F.+L%C3%B3pez-Mu%C3%B1ozauthor=J.+Marco-Contelles&title=Contilisant%2C+a+Tetratarget+Small+Molecule+for+Alzheimer%E2%80%99s+Disease+Therapy+Combining+Cholinesterase%2C+Monoamine+Oxidase+Inhibition%2C+and+H3R+Antagonism+with+S1R+Agonism+Profile&doi=10.1021%2Facs.jmedchem.8b00848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile</span></div><div class="casAuthors">Bautista-Aguilera, Oscar M.; Budni, Josiane; Mina, Francielle; Medeiros, Eduarda Behenck; Deuther-Conrad, Winnie; Entrena, Jose M.; Moraleda, Ignacio; Iriepa, Isabel; Lopez-Munoz, Francisco; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6937-6943</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Contilisant, a permeable, antioxidant, and neuroprotectant agent, showing high nM affinity at H3R and excellent inhibition of the monoamine oxidases and cholinesterases, is an affine and selective S1R agonist in the nanomolar range, based on the binding affinity and functional expt., a result confirmed by mol. modeling.  In addn., contilisant significantly restores the cognitive deficit induced by Aβ1-42 in the radial maze assay in an in vivo Alzheimer's disease test, comparing very favorably with donepezil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRam68D-99zLVg90H21EOLACvtfcHk0lhtm64uCK8Kng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Cqu7nM&md5=526d2eedfb4f6ae6f69a4116f87a633a</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00848%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3D%25C3%2593.%2BM.%26aulast%3DBudni%26aufirst%3DJ.%26aulast%3DMina%26aufirst%3DF.%26aulast%3DMedeiros%26aufirst%3DE.%2BB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DL%25C3%25B3pez-Mu%25C3%25B1oz%26aufirst%3DF.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DContilisant%252C%2520a%2520Tetratarget%2520Small%2520Molecule%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Therapy%2520Combining%2520Cholinesterase%252C%2520Monoamine%2520Oxidase%2520Inhibition%252C%2520and%2520H3R%2520Antagonism%2520with%2520S1R%2520Agonism%2520Profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D15%26spage%3D6937%26epage%3D6943%26doi%3D10.1021%2Facs.jmedchem.8b00848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blair, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhillon, S.</span></span> <span> </span><span class="NLM_article-title">Safinamide: A Review in Parkinson’s Disease</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1007/s40263-017-0408-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs40263-017-0408-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28110399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=169-176&issue=2&author=H.+A.+Blairauthor=S.+Dhillon&title=Safinamide%3A+A+Review+in+Parkinson%E2%80%99s+Disease&doi=10.1007%2Fs40263-017-0408-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Safinamide: A Review in Parkinson's Disease</span></div><div class="casAuthors">Blair, Hannah A.; Dhillon, Sohita</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-176</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Safinamide (Xadago) is an orally active, selective, reversible monoamine oxidase-B inhibitor with both dopaminergic and non-dopaminergic (glutamatergic) properties.  In the EU, safinamide is approved for the treatment of mid- to late-stage fluctuating Parkinson's disease (PD) as add-on therapy to a stable dose of levodopa alone or in combination with other PD medications.  Safinamide 50-100 mg/day administered as a fixed or flexible dose significantly increased daily 'on' time without dyskinesia (primary endpoint) in patients with mid- to late-stage PD with motor fluctuations in 24-wk, placebo-controlled clin. trials.  Other outcomes, including motor function, overall clin. status and health-related quality of life, were also generally improved with safinamide.  Furthermore, in an 18-mo extension of one study, although dyskinesia (primary endpoint) was not significantly improved with safinamide relative to placebo, treatment benefits in other outcomes were generally sustained over 24 mo of treatment.  Safinamide was generally well tolerated in clin. trials; dyskinesia was the most common adverse event.  Although further studies are needed, including comparative and long-term studies, current evidence indicates that safinamide extends the treatment options available for use as add-on therapy to levodopa and other PD medications in patients with mid- to late-stage PD experiencing motor fluctuations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsl8UyUX-7XrVg90H21EOLACvtfcHk0lhtm64uCK8Kng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeisrc%253D&md5=7adc3525326e5274c2f9fac22d39cb28</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1007%2Fs40263-017-0408-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-017-0408-1%26sid%3Dliteratum%253Aachs%26aulast%3DBlair%26aufirst%3DH.%2BA.%26aulast%3DDhillon%26aufirst%3DS.%26atitle%3DSafinamide%253A%2520A%2520Review%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCNS%2520Drugs%26date%3D2017%26volume%3D31%26issue%3D2%26spage%3D169%26epage%3D176%26doi%3D10.1007%2Fs40263-017-0408-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">5848</span>– <span class="NLM_lpage">5852</span>, <span class="refDoi"> DOI: 10.1021/jm070677y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&issue=23&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+of+Human+Monoamine+Oxidase+B+Complexes+with+Selective+Noncovalent+Inhibitors%3A+Safinamide+and+Coumarin+Analogs&doi=10.1021%2Fjm070677y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span></div><div class="casAuthors">Binda, Claudia; Wang, Jin; Pisani, Leonardo; Caccia, Carla; Carotti, Angelo; Salvati, Patricia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5848-5852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivs., all sharing a common benzyloxy substituent, were detd. by x-ray crystallog.  These compds. competitively inhibit MAO B with Ki values in the 0.1-0.5 μM range that are 30-700-fold lower than those obsd. with MAO A.  The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPIubufo89bVg90H21EOLACvtfcHk0lhtm64uCK8Kng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI&md5=448f65696f4870e2301f46a6f015e35c</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%2520Complexes%2520with%2520Selective%2520Noncovalent%2520Inhibitors%253A%2520Safinamide%2520and%2520Coumarin%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D23%26spage%3D5848%26epage%3D5852%26doi%3D10.1021%2Fjm070677y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fariello, R. G.</span></span> <span> </span><span class="NLM_article-title">Pressor Response to Intravenous Tyramine in Healthy Subjects after Safinamide, a Novel Neuroprotectant with Selective, Reversible Monoamine Oxidase B Inhibition</span>. <i>Clin. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1097/00002826-200307000-00012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1097%2F00002826-200307000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=12897643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFars7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=213-217&issue=4&author=C.+Cattaneoauthor=C.+Cacciaauthor=A.+Marzoauthor=R.+Majauthor=R.+G.+Fariello&title=Pressor+Response+to+Intravenous+Tyramine+in+Healthy+Subjects+after+Safinamide%2C+a+Novel+Neuroprotectant+with+Selective%2C+Reversible+Monoamine+Oxidase+B+Inhibition&doi=10.1097%2F00002826-200307000-00012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition</span></div><div class="casAuthors">Cattaneo, Carlo; Caccia, Carla; Marzo, Antonio; Maj, Roberto; Fariello, Ruggero G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Neuropharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">213-217</span>CODEN:
                <span class="NLM_cas:coden">CLNEDB</span>;
        ISSN:<span class="NLM_cas:issn">0362-5664</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Safinamide is a novel neuroprotectant combining Na and Ca channel blocking properties with selective, reversible monoamine oxidase type B (MAO B) inhibition.  Phase 1 studies have demonstrated that in healthy volunteers, the ED50 (a dose that inhibits enzyme activity by 50% in 50% of treated subjects) for MAO B inhibition is 87.5 μg/kg/day orally, and that no MAO A inhibition occurs after 10-mg/kg oral dosing.  To assess the risk of inducing the "cheese effect," the effect of safinamide and placebo on the pressor response to tyramine was investigated in a group of healthy male volunteers.  The study was an open, single-dose placebo-controlled trial with the 2 treatments in sequence.  An increase of 30 mm Hg systolic blood pressure was obtained by i.v. tyramine administered by 0.5-mg incremental boluses injected at 15-min intervals.  The amt. of tyramine necessary to achieve such a blood pressure increase was the same after the safinamide 2-mg/kg oral load compared with placebo.  These results suggest that dietary restrictions for food with high tyramine content should not be required under safinamide treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8o0I5Vj9N0LVg90H21EOLACvtfcHk0lgn4gidoL9K-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFars7k%253D&md5=4a017f58f984638d43b15bdcea466c35</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1097%2F00002826-200307000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002826-200307000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DCattaneo%26aufirst%3DC.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DMarzo%26aufirst%3DA.%26aulast%3DMaj%26aufirst%3DR.%26aulast%3DFariello%26aufirst%3DR.%2BG.%26atitle%3DPressor%2520Response%2520to%2520Intravenous%2520Tyramine%2520in%2520Healthy%2520Subjects%2520after%2520Safinamide%252C%2520a%2520Novel%2520Neuroprotectant%2520with%2520Selective%252C%2520Reversible%2520Monoamine%2520Oxidase%2520B%2520Inhibition%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2003%26volume%3D26%26issue%3D4%26spage%3D213%26epage%3D217%26doi%3D10.1097%2F00002826-200307000-00012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mialet-Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span> <span> </span><span class="NLM_article-title">Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4203</span>– <span class="NLM_lpage">4212</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00357</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00357" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFSnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4203-4212&issue=9&author=J.+Reisauthor=N.+Manzellaauthor=F.+Cagideauthor=J.+Mialet-Perezauthor=E.+Uriarteauthor=A.+Pariniauthor=F.+Borgesauthor=C.+Binda&title=Tight-Binding+Inhibition+of+Human+Monoamine+Oxidase+B+by+Chromone+Analogs%3A+A+Kinetic%2C+Crystallographic%2C+and+Biological+Analysis&doi=10.1021%2Facs.jmedchem.8b00357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis</span></div><div class="casAuthors">Reis, Joana; Manzella, Nicola; Cagide, Fernando; Mialet-Perez, Jeanne; Uriarte, Eugenio; Parini, Angelo; Borges, Fernanda; Binda, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4203-4212</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO-B) is a validated drug target for Parkinson's disease.  Chromone derivs. were identified as novel potent and reversible MAO-B inhibitors, and herewith we report on a crystallog. and biochem. anal. to investigate their inhibition mechanism.  The crystal structures of human MAO-B in complex with three chromone analogs bearing different substituents on the exocyclic arom. ring (detd. at 1.6-1.8 Å resoln.) showed that they all bind in the active site cavity of the protein with the chromone moiety located in front of the FAD cofactor.  These inhibitors form two hydrogen bonds with Tyr435 and Cys172 and perfectly fit the hydrophobic flat active site of human MAO-B.  This is reflected in their tight-binding mechanism of inhibition with Ki values of 55, 17, and 31 nM for N-(3',4'-dimethylphenyl)-4-oxo-4H-chromene-3-carboxamide (1), N-(3'-chlorophenyl)-4-oxo-4H-chromene-3-carboxamide (2), and N-(3'-fluorophenyl)-4-oxo-4H-chromene-3-carboxamide (3), resp.  These compds. were also 1000-fold more effective than L-deprenyl in reducing the cellular levels of reactive oxygen species (ROS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4_ZAaYfpTbVg90H21EOLACvtfcHk0lgn4gidoL9K-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsFSnsrw%253D&md5=129e0b5bbd744bc3ef74a75bda97a550</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00357%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DManzella%26aufirst%3DN.%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DMialet-Perez%26aufirst%3DJ.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DParini%26aufirst%3DA.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DBinda%26aufirst%3DC.%26atitle%3DTight-Binding%2520Inhibition%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%2520by%2520Chromone%2520Analogs%253A%2520A%2520Kinetic%252C%2520Crystallographic%252C%2520and%2520Biological%2520Analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D9%26spage%3D4203%26epage%3D4212%26doi%3D10.1021%2Facs.jmedchem.8b00357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remião, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5879</span>– <span class="NLM_lpage">5893</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00527</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00527" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XovVWksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5879-5893&issue=12&author=J.+Reisauthor=F.+Cagideauthor=D.+Chavarriaauthor=T.+Silvaauthor=C.+Fernandesauthor=A.+Gasparauthor=E.+Uriarteauthor=F.+Remi%C3%A3oauthor=S.+Alcaroauthor=F.+Ortusoauthor=F.+Borges&title=Discovery+of+New+Chemical+Entities+for+Old+Targets%3A+Insights+on+the+Lead+Optimization+of+Chromone-Based+Monoamine+Oxidase+B+%28MAO-B%29+Inhibitors&doi=10.1021%2Facs.jmedchem.6b00527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors</span></div><div class="casAuthors">Reis, Joana; Cagide, Fernando; Chavarria, Daniel; Silva, Tiago; Fernandes, Carlos; Gaspar, Alexandra; Uriarte, Eugenio; Remiao, Fernando; Alcaro, Stefano; Ortuso, Francesco; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5879-5893</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of new chem. entities endowed with potent, selective, and reversible monoamine oxidase B inhibitory activity is a clin. relevant subject.  Therefore, a small library of chromone derivs. was synthesized and screened toward human monoamine oxidase isoforms (hMAO-A and hMAO-B).  The structure-activity relationships studies strengthen the importance of the amide spacer and the direct linkage of carbonyl group to the γ-pyrone ring, along with the presence of meta and para substituents in the exocyclic ring.  The most potent MAO-B inhibitors were N-(3'-chlorophenyl)-4-oxo-4H-chromene-3-carboxamide (20) (IC50 = 403 pM) and N-(3',4'-dimethylphenyl)-4-oxo-4H-chromene-3-carboxamide (27) (IC50 = 669 pM), acting as competitive and noncompetitive reversible inhibitors, resp.  Computational docking studies provided insights into enzyme-inhibitor interactions and a rationale for the obsd. selectivity and potency.  Compd. 27 stands out due to its favorable toxicol. profile and physicochem. properties, which pointed toward blood-brain barrier permeability, thus being a valid candidate for subsequent animal studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWONk5yTkyN7Vg90H21EOLACvtfcHk0ljIwXbMvGWqiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovVWksb8%253D&md5=361d3dde07c197e2bdc41d08746a35f6</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00527%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DRemi%25C3%25A3o%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520New%2520Chemical%2520Entities%2520for%2520Old%2520Targets%253A%2520Insights%2520on%2520the%2520Lead%2520Optimization%2520of%2520Chromone-Based%2520Monoamine%2520Oxidase%2520B%2520%2528MAO-B%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D12%26spage%3D5879%26epage%3D5893%26doi%3D10.1021%2Facs.jmedchem.6b00527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tzvetkov, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Küppers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastreich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Indazole-and Indole-5-Carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6679</span>– <span class="NLM_lpage">6703</span>, <span class="refDoi"> DOI: 10.1021/jm500729a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500729a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVentLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6679-6703&issue=15&author=N.+T.+Tzvetkovauthor=S.+Hinzauthor=P.+K%C3%BCppersauthor=M.+Gastreichauthor=C.+E.+M%C3%BCller&title=Indazole-and+Indole-5-Carboxamides%3A+Selective+and+Reversible+Monoamine+Oxidase+B+Inhibitors+with+Subnanomolar+Potency&doi=10.1021%2Fjm500729a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Indazole- and Indole-5-carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency</span></div><div class="casAuthors">Tzvetkov, Nikolay T.; Hinz, Sonja; Kueppers, Petra; Gastreich, Marcus; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6679-6703</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indazole- and indole-carboxamides were discovered as highly potent, selective, competitive, and reversible inhibitors of monoamine oxidase B (MAO-B).  The compds. are easily accessible by std. synthetic procedures with high overall yields.  The most potent derivs. were N-(3,4-dichlorophenyl)-1-methyl-1H-indazole-5-carboxamide (38a, PSB-1491, IC50 human MAO-B 0.386 nM, >25000-fold selective vs. MAO-A) and N-(3,4-dichlorophenyl)-1H-indole-5-carboxamide (53, PSB-1410, IC50 human MAO-B 0.227 nM, >5700-fold selective vs. MAO-A).  Replacement of the carboxamide linker with a methanimine spacer leading to (E)-N-(3,4-dichlorophenyl)-1-(1H-indazol-5-yl)methanimine (58) represents a further novel class of highly potent and selective MAO-B inhibitors (IC50 human MAO-B 0.612 nM, >16000-fold selective vs. MAO-A).  In N-3,4-difluorophenyl-1H-indazole-5-carboxamide (30, PSB-1434, IC50 human MAO-B 1.59 nM, selectivity vs. MAO-A >6000-fold), high potency and selectivity are optimally combined with superior physicochem. properties.  Computational docking studies provided insights into the inhibitors' interaction with the enzyme binding site and a rationale for their high potency despite their small mol. size.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx38ZSIgn0B7Vg90H21EOLACvtfcHk0lgwXwlK0oxWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVentLzO&md5=dc379b26fd57276ac41fe7a1331dd4c6</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Fjm500729a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500729a%26sid%3Dliteratum%253Aachs%26aulast%3DTzvetkov%26aufirst%3DN.%2BT.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DK%25C3%25BCppers%26aufirst%3DP.%26aulast%3DGastreich%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DIndazole-and%2520Indole-5-Carboxamides%253A%2520Selective%2520and%2520Reversible%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%2520with%2520Subnanomolar%2520Potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D15%26spage%3D6679%26epage%3D6703%26doi%3D10.1021%2Fjm500729a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gealageas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devineau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, P. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surendradoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwalder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebeler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dullaghan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grierson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putnins, E. E.</span></span> <span> </span><span class="NLM_article-title">Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7043</span>– <span class="NLM_lpage">7064</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01588</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01588" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCns7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7043-7064&issue=16&author=R.+Gealageasauthor=A.+Devineauauthor=P.+P.+L.+Soauthor=C.+M.+J.+Kimauthor=J.+Surendradossauthor=C.+Buchwalderauthor=M.+Hellerauthor=V.+Goebelerauthor=E.+M.+Dullaghanauthor=D.+S.+Griersonauthor=E.+E.+Putnins&title=Development+of+Novel+Monoamine+Oxidase-B+%28MAO-B%29+Inhibitors+with+Reduced+Blood-Brain+Barrier+Permeability+for+the+Potential+Management+of+Noncentral+Nervous+System+%28CNS%29+Diseases&doi=10.1021%2Facs.jmedchem.7b01588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases</span></div><div class="casAuthors">Gealageas, Ronan; Devineau, Alice; So, Pauline P. L.; Kim, Catrina M. J.; Surendradoss, Jayakumar; Buchwalder, Christian; Heller, Markus; Goebeler, Verena; Dullaghan, Edith M.; Grierson, David S.; Putnins, Edward E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7043-7064</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Studies indicate that MAO-B is induced in peripheral inflammatory diseases.  To target peripheral tissues using MAO-B inhibitors that do not permeate the blood-brain barrier (BBB) the MAO-B-selective inhibitor deprenyl was remodeled by replacing the terminal acetylene with a CO2H function, and incorporating a para-OCH2Ar motif (compds. 10a-s).  Further, in compd. 32 ((S)-N-[1-cyano-3-[4-[(3,4-dichlorobenzyl)oxy]phenyl]propan-2-yl]-N-methylglycine hydrochloride) the C-2 side chain corresponded to CH2CN.  In vitro, 10c (N-[(R)-[1-[4-(3-chlorobenzyloxy)phenyl]propan-2-yl](methyl)]glycine hydrochloride), 10j, 10k, and 32 were identified as potent reversible MAO-B inhibitors, and all four compds. were more stable than deprenyl in plasma, liver microsomal, and hepatocyte stability assays.  In vivo, they demonstrated greater plasma bioavailability.  Assessment of in vitro BBB permeability showed that compd. 10k is a P-glycoprotein (P-gp) substrate and 10j displayed mild interaction.  Importantly, compds. 10c, 10j, 10k, and 32 displayed significantly reduced BBB permeability after i.v., s.c., and oral administration.  These polar MAO-B inhibitors are pertinent leads for evaluation of efficacy in noncentral nervous system (CNS) inflammatory disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxwJVafqtiYrVg90H21EOLACvtfcHk0lgwXwlK0oxWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCns7bL&md5=46d24762b2205d7e1fef6543ff26997b</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01588%26sid%3Dliteratum%253Aachs%26aulast%3DGealageas%26aufirst%3DR.%26aulast%3DDevineau%26aufirst%3DA.%26aulast%3DSo%26aufirst%3DP.%2BP.%2BL.%26aulast%3DKim%26aufirst%3DC.%2BM.%2BJ.%26aulast%3DSurendradoss%26aufirst%3DJ.%26aulast%3DBuchwalder%26aufirst%3DC.%26aulast%3DHeller%26aufirst%3DM.%26aulast%3DGoebeler%26aufirst%3DV.%26aulast%3DDullaghan%26aufirst%3DE.%2BM.%26aulast%3DGrierson%26aufirst%3DD.%2BS.%26aulast%3DPutnins%26aufirst%3DE.%2BE.%26atitle%3DDevelopment%2520of%2520Novel%2520Monoamine%2520Oxidase-B%2520%2528MAO-B%2529%2520Inhibitors%2520with%2520Reduced%2520Blood-Brain%2520Barrier%2520Permeability%2520for%2520the%2520Potential%2520Management%2520of%2520Noncentral%2520Nervous%2520System%2520%2528CNS%2529%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D16%26spage%3D7043%26epage%3D7064%26doi%3D10.1021%2Facs.jmedchem.7b01588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bredemeier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenreich, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bongiorno, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Avila, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morsch, A. L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva Stein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, G. G. D.</span></span> <span> </span><span class="NLM_article-title">Xanthine Oxidase Inhibitors for Prevention of Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials</span>. <i>BMC Cardiovasc. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1186/s12872-018-0757-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1186%2Fs12872-018-0757-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29301486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKksbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=1-11&issue=1&author=M.+Bredemeierauthor=L.+M.+Lopesauthor=M.+A.+Eisenreichauthor=S.+Hickmannauthor=G.+K.+Bongiornoauthor=R.+d%E2%80%99Avilaauthor=A.+L.+B.+Morschauthor=F.+da+Silva+Steinauthor=G.+G.+D.+Campos&title=Xanthine+Oxidase+Inhibitors+for+Prevention+of+Cardiovascular+Events%3A+A+Systematic+Review+and+Meta-Analysis+of+Randomized+Controlled+Trials&doi=10.1186%2Fs12872-018-0757-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials</span></div><div class="casAuthors">Bredemeier, Markus; Lopes, Lediane Moreira; Eisenreich, Matheus Augusto; Hickmann, Sheila; Bongiorno, Guilherme Kopik; D'Avila, Rui; Morsch, Andre Luis Bittencourt; Da Silva Stein, Fernando; Campos, Guilherme Gomes Dias</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cardiovascular Disorders</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">BCDMBB</span>;
        ISSN:<span class="NLM_cas:issn">1471-2261</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Xanthine oxidase inhibitors (XOI), classified as purine-like (allopurinol and oxypurinol) and non-purine (febuxostat and topiroxostat) XOI, present antioxidant properties by reducing the prodn. of reactive oxygen species derived from purine metab.  Oxidative stress is an important factor related to endothelial dysfunction and ischemia-reperfusion injury, and may be implicated in the pathogenesis of heart failure, hypertension, and ischemic heart disease.  However, there is contradictory evidence regarding the possible cardiovascular (CV) protective effect exerted by XOI.  Our objective is to compare the incidence of major adverse cardiovascular events (MACE), mortality, total (TCE) and specific CV events in randomized controlled trials (RCTs) testing XOI against placebo or no treatment.  Methods: PubMed, EMBASE, Web of Science, Cochrane Central, Lilacs databases were searched from inception to Dec 30 2016, along with hand searching.  RCTs including exclusively adult individuals, lasting ≥4 wk, with no language restriction, were eligible.  Independent paired researchers selected studies and extd. data.  Considering the expected rarity of events, Peto and DerSimonian/Laird odds ratios (OR), the latter in case of heterogeneity, were used for anal.  Random-effects meta-regression was used to explore heterogeneity.  Results: The anal. of MACE included 81 articles (10,684 patients, 6434 patient-years).  XOI did not significantly reduce risk of MACE (ORP = 0.71, 95% CI 0.46-1.09) and death (0.89, 0.59-1.33), but reduced risk of TCE (0.60, 0.44-0.82; serious TCE: 0.64, 0.46 to 0.89), and hypertension (0.54, 0.37 to 0.80).  There was protection for MACE in patients with previous ischemic events (0.42, 0.23-0.76).  Allopurinol protected for myocardial infarction (0.38, 0.17-0.83), hypertension (0.32, 0.18-0.58), TCE (0.48, 0.31 to 0.75, I2 = 55%) and serious TCE (0.56, 0.36 to 0.86, I2 = 44%).  Meta-regression assocd. increasing dose of allopurinol with higher risk of TCE and serious TCE (P < 0.05).  Accordingly, lower doses (≤ 300 mg/day) of allopurinol reduced the risk of TCE, unlike higher doses.  Non-purine-like XOI did not significantly reduce or increase the risk of adverse CV events, but confidence intervals were wide.  Quality of evidence was generally low to moderate.  Conclusions: Purine-like XOI may reduce the incidence of adverse CV outcomes.  However, higher doses of allopurinol (> 300 mg/day) may be assocd. with loss of CV protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr73GYoHbb2ZLVg90H21EOLACvtfcHk0lgYMB-5z_xU-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKksbzP&md5=eadf4605be5c48c26ccf9a36574fada9</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1186%2Fs12872-018-0757-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12872-018-0757-9%26sid%3Dliteratum%253Aachs%26aulast%3DBredemeier%26aufirst%3DM.%26aulast%3DLopes%26aufirst%3DL.%2BM.%26aulast%3DEisenreich%26aufirst%3DM.%2BA.%26aulast%3DHickmann%26aufirst%3DS.%26aulast%3DBongiorno%26aufirst%3DG.%2BK.%26aulast%3Dd%25E2%2580%2599Avila%26aufirst%3DR.%26aulast%3DMorsch%26aufirst%3DA.%2BL.%2BB.%26aulast%3Dda%2BSilva%2BStein%26aufirst%3DF.%26aulast%3DCampos%26aufirst%3DG.%2BG.%2BD.%26atitle%3DXanthine%2520Oxidase%2520Inhibitors%2520for%2520Prevention%2520of%2520Cardiovascular%2520Events%253A%2520A%2520Systematic%2520Review%2520and%2520Meta-Analysis%2520of%2520Randomized%2520Controlled%2520Trials%26jtitle%3DBMC%2520Cardiovasc.%2520Disord.%26date%3D2018%26volume%3D18%26issue%3D1%26spage%3D1%26epage%3D11%26doi%3D10.1186%2Fs12872-018-0757-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nivorozhkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabó, C.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1124/pr.58.1.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1124%2Fpr.58.1.6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16507884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlCqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=87-114&issue=1&author=P.+Pacherauthor=A.+Nivorozhkinauthor=C.+Szab%C3%B3&title=Therapeutic+Effects+of+Xanthine+Oxidase+Inhibitors%3A+Renaissance+Half+a+Century+after+the+Discovery+of+Allopurinol&doi=10.1124%2Fpr.58.1.6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol</span></div><div class="casAuthors">Pacher, Pal; Nivorozhkin, Alex; Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-114</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The prototypical xanthine oxidase (XO) inhibitor allopurinol, has been the cornerstone of the clin. management of gout and conditions assocd. with hyperuricemia for several decades.  More recent data indicate that XO also plays an important role in various forms of ischemic and other types of tissue and vascular injuries, inflammatory diseases, and chronic heart failure.  Allopurinol and its active metabolite oxypurinol showed considerable promise in the treatment of these conditions both in exptl. animals and in small-scale human clin. trials.  Although some of the beneficial effects of these compds. may be unrelated to the inhibition of the XO, the encouraging findings rekindled significant interest in the development of addnl., novel series of XO inhibitors for various therapeutic indications.  Here we present a crit. overview of the effects of XO inhibitors in various pathophysiol. conditions and also review the various emerging therapeutic strategies offered by this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoshSwZZNciVrVg90H21EOLACvtfcHk0lgYMB-5z_xU-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlCqsLs%253D&md5=8dfe2e35a22c02431fdaf561ef494f5e</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.1.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.1.6%26sid%3Dliteratum%253Aachs%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DNivorozhkin%26aufirst%3DA.%26aulast%3DSzab%25C3%25B3%26aufirst%3DC.%26atitle%3DTherapeutic%2520Effects%2520of%2520Xanthine%2520Oxidase%2520Inhibitors%253A%2520Renaissance%2520Half%2520a%2520Century%2520after%2520the%2520Discovery%2520of%2520Allopurinol%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26issue%3D1%26spage%3D87%26epage%3D114%26doi%3D10.1124%2Fpr.58.1.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robins, R. K.</span></span> <span> </span><span class="NLM_article-title">Potential Purine Antagonists. I. Synthesis of Some 4,6-Substituted Pyrazolo [3,4-d] Pyrimidines</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1021/ja01585a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01585a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaG28XmvFCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1956&pages=784-790&issue=4&author=R.+K.+Robins&title=Potential+Purine+Antagonists.+I.+Synthesis+of+Some+4%2C6-Substituted+Pyrazolo+%5B3%2C4-d%5D+Pyrimidines&doi=10.1021%2Fja01585a023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Potential purine antagonists. I. Synthesis of some 4,6-substituted pyrazolo[3,4-d]pyrimidines</span></div><div class="casAuthors">Robins, Roland K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">784-90</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">EtOCH2CH(CN)2 (150 g.) added in 3-5-g. portions to 100 g. 85% N2H4.H2O with slight cooling, the mixt. heated 1 hr. on the steam bath, dild. with 100 cc. H2O, and refrigerated overnight, the mushy soln. filtered, and the solid washed with cold H2O yielded 97 g. 3-amino-4-cyanopyrazole (I), m. 174-5° (from H2O).  I (0.5 g.) refluxed 8 hrs. with 100 cc. AcCl and evapd. to dryness on the steam bath, and the residue dissolved in 25 cc. boiling H2O, neutralized with NH4OH, and cooled gave 0.4 g. Ac deriv. of I, m. 221-2° (from H2O).  Finely powd. I (50 g.) added with stirring below 40° to 170 cc. concd. H2SO4 (cooled to 20°) during 0.5 hr., and the soln. stirred 1 hr. at room temp., poured with stirring into 500 cc. H2O and 250 cc. ice, refrigerated overnight, and filtered yielded 67.0 g. 3-amino-4-pyrazolecarboxamide-0.5H2SO4 (II) (II.0.5H2SO4), m. 222-5° (from H2O).  II.0.5H2SO4 (3 g.) in 50 cc. H2O adjusted with NH4OH to pH 9 and allowed to stand 3 days deposited 1.1 g. II, m. 187-9° (from H2O).  II.0.5H2SO4 (75 g.) and 200 cc. HCONH2 heated 45 min. at 180-90°, cooled, dild. with 1 l. cold H2O, and filtered yielded 48.0 g. 4-hydroxypyrazolo[3,4-d]pyrimidine (III).  II.0.5H2SO4 (100 g.) and 200 g. urea heated 20 min. at 160° and then 20 min. at 190° and dissolved in hot dil. aq. NaOH, the boiling basic soln. carefully acidified with AcOH and filtered after 10 min. yielded 74 g. 90-5% pure 4,6-di-OH analog (IIIa) of III.  I (35 g.) and 70 g. CS(NH2)2 heated 0.5 hr. at 180° and 10 min. at 200°, cooled, and dissolved in hot dil. aq. NaOH, the hot soln. treated with C, and the boiling filtrate carefully acidified with glacial AcOH yielded 26.0 g. 4-amino-6-mercaptopyrazolo[3,4-d]pyrimidine (IV), light tan material.  II.0.5H2SO4 (50 g.) with 100 g. CS(NH2)2 gave similarly 24.0 g. 4-OH analog (V) of IV.  Dry III (10 g.) added to 300 cc. POCl3, the mixt. refluxed 1.5 hrs. with 30 cc. PhNMe2, the excess POCl3 removed in vacuo, the sirupy residue poured with stirring into 100 cc. H2O and 400 g. crushed ice and extd. with Et2O, and the ext. worked up gave 9.8 g. 4-chloropyrazolo[3,4-d]pyrimidine (VI), decompd. at 130-5° (from C6H6).  III (10 g.) finely powd. and mixt. with 50 g. P2S5, the mixt. added in small portions with stirring to 300 cc. Tetralin at 165° during 0.5 hr., the mixt. heated 4 hrs. with stirring at 190-5°, cooled, and filtered, the filter residue washed with petr. ether, dried, added carefully to 1 l. H2O at 80°, boiled 10 min., and treated with enough KOH to effect soln., the soln. stirred with C and filtered, and the hot filtrate acidified with AcOH gave 10.1 g. 4-mercaptopyrazolo[3,4-d]pyrimidine (VII), white crystals, m. above 360° (from 30% EtOH).  VI (2 g.) and 2 g. CS(NH2)2 refluxed 2 hrs. with 100 cc. abs. EtOH cooled and filtered gave 1.6 g. crude VII.  VI (3 g.) in 150 cc. concd. NH4OH concd. on the steam bath to 50 cc., dild. with 200 cc. concd. NH4OH, concd. on the steam bath to 150 cc., boiled with C, filtered, and cooled gave 0.85 g. 4-aminopyrazolo[3,4-d]pyrimidine (VIII), colorless needles.  I (30 g.) boiled 0.5 hr. with 60 cc. HCONH2, cooled, dild. with 100 cc. cold H2O, and filtered, the residue suspended in 400 cc. hot H2O, treated with 50 cc. concd. HCl, boiled 15 min. with C, and the hot filtrate adjusted to pH 8 with concd. NH4OH and cooled to room temp. gave 21.0 g. VIII, colorless solid.  VI (5.0 g.) and alc. NH3 heated 12 hrs. at 100° in a bomb and filtered, and the crude residue dissolved in dil. HCl and repptd. with NH4OH gave 3.9 g. VIII.  IIIa (10 g.) and 30 cc. PhNMe2 refluxed 1 hr. with 250 cc. POCl3, the mixt. worked up in the usual manner, and the product isolated with Et2O gave 2.4 g. compd. C12H10ClN4(sic), light yellow needles, m. 225-7° (from xylene).  V (14 g.) and 10 g. NaOH in 300 cc. H2O shaken 10 min. at 5° with 12 g. MeI, charcoaled, filtered, and acidified with AcOH yielded 12.0 g. 4-hydroxy-6-methylmercaptopyrazolo[3,4-d]pyrimidine (IX).  I (10 g.) heated 20 min. with 20 g. urea at 180-200°, the cooled solid dissolved in 2N NaOH, the soln. boiled gently 10 min. with C, and the boiling filtrate acidified with glacial AcOH gave 4-amino-6-hydroxypyrazolo[3,4-d]-pyrimidine which was purified by repptn.  IX (22.0 g.), 400 cc. POCl3, and 30 cc. PhNMe2 refluxed 0.5 hr. gave 16 g. 4-Cl analog of IX, m. 178-9° (decompn.) (from heptane).  VII (5 g.) in 65 cc. 0.8N NaOH shaken 15 min. at 20° with 5.0 g. MeI, treated with C, filtered, and acidified with AcOH, the crude ppt. suspended in 100 cc. H2O and adjusted with NH4OH to pH 9 and filtered, and the residue washed and recrystd. from H2O yielded 4.1 g. 4-MeS analog of VII, m. 193°.  IIIa (15 g.) and 80 g. P2S5 refluxed 4 hrs. with 900 cc. dry pyridine and evapd. in vacuo on the steam bath, the residue dild. with 600 cc. ice H2O, allowed to stand 0.5 hr. at room temp., heated 2 hrs. on the steam bath, the soln. refrigerated overnight, and the crude ppt. repptd. with AcOH from boiling aq. alkali gave 12.6 g. 4-mercapto-6-hydroxypyrazolo[3,4-d]pyrimidine, light green needles.  V (15 g.) and 65 g. P2S5 in 900 cc. dry pyridine gave similarly 12.0 g. 4,6-dimercaptopyrazolo[3,4-d]pyrimidine, light green solid.  Finely powd. VI (4.5 g.) in 150 cc. H2O and 4 cc. concd. NH4OH hydrogenated about 6 hrs. at 20 lb. pressure over 1.0 g. 10% Pd-C and filtered, the residue extd. with 100 cc. boiling H2O, the combined filtrates evapd. to dryness on the steam bath, the residue extd. 18 hrs. with 200 cc. PhMe in a Soxhlet app., the ext. evapd., and the residue sublimed at 180-200° and 15 mm. yielded 2.65 g. pyrazolo[3,4-d]pyrimidine (X), colorless needles, m. 213-14°.  VI (3.0 g.) heated 1 hr. on the steam bath with 0.6 g. Na dissolved in 30 cc. abs. EtOH, dild. with 20 cc. H2O, and neutralized with AcOH gave 1.3 g. 4-EtO deriv. of X, m. 168-9°.  4-Cl analog (XI) of X (7.0 g.) in 150 cc. EtOH and 10 cc. concd. NH4OH hydrogenated 24 hrs. over 2.7 g. Pd-C at 20 lb. pressure, filtered, and evapd. to dryness on the steam bath yielded 1.7 g. 6-methylmercaptopyrazolo[3,4-d]pyrimidine, white crystals, m. 210-12° (from 80% EtOH).  XI (4.0 g.) heated 4 hrs. on the steam bath with 1.0 g. Na in 75 cc. abs. MeOH, neutralized with glacial AcOH, and cooled gave 3.1 g. 4-MeO analog of IX, m. 193-4° (from aq. MeOH).  VI (5-10 g.) added to 50-100 cc. of a 25-40% aq. soln. of a primary or secondary amine, heated 4 hrs. on the steam bath, refrigerated overnight, and filtered, and the residue washed with a little ice water and recrystd. gave the corresponding N-substituted-4-aminopyrazolo[3,4-d]pyrimidines (XII) (method A); VI (5-10 g.) added to about 0.15 mole primary or secondary amine in 150 cc. abs. EtOH, heated 4 hrs. on the steam bath, cooled overnight and filtered, and the crude product recrystd. gave the corresponding XII (method B) (N-substituents, m.p., % yield, and method given): H, Me, 227-8° (from H2O), 83, A; Me, Me, 233-4° (from C6H6-EtOH), 61, A; Et, Et, 186-7° (from aq. EtOH), 85, A; H, iso-Pr, 253-4° (from H2O), 70, A; H, Ph, 263-4° (from EtOH), 55, B; H, PhCH2, 215-17° (from aq. EtOH), 78, B; H, Et, 259-60° (from aq. EtOH), 77, A; H, 1-furylmethyl, 223-5° (from EtOH), 82, B; Me, Ph, 234-6° (from EtOH), 63, B; H, Bu, 205-6° (from aq. EtOH), 75, B; H, o-MeC6H4, 260-1° (from EtOH), 85, B.  XI gave similarly the 6-MeS derivs. of XII (N-substituents, m.p., % yield, and method given): H, H, above 300° (from H2O), 58, A; Me, Me, 263-5° (aq. EtOH), 45, A; H, NH2, above 300° (from H2O), 30, A; H, (CH2)2NEt2, 130-2° (from EtOH), 35, B.  The solubilities of a no. of 4,6-disubstituted-pyrazolo[3,4-d]pyrimidines (XIII) are tabulated (4 and 6-substituents, and soly. in H2O at 100° in parts of H2O necessary to dissolve 1 part XIII given): OH, H, 190; OH, OH, 800; NH2, H, 1000; MeNH, H, 10; Me2N, H, 10; SH, H, 500; H, MeS, 350; MeS, H, 300; H, H, 200 (at 30°).  The ultraviolet absorption max. of the various XIII described at pH 1 and 11 are listed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYvGReip6s2rVg90H21EOLACvtfcHk0lg9xhVwZRFHMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG28XmvFCmsA%253D%253D&md5=eae2de5e3fe6c85303a32fb1af2a8868</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1021%2Fja01585a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01585a023%26sid%3Dliteratum%253Aachs%26aulast%3DRobins%26aufirst%3DR.%2BK.%26atitle%3DPotential%2520Purine%2520Antagonists.%2520I.%2520Synthesis%2520of%2520Some%25204%252C6-Substituted%2520Pyrazolo%2520%255B3%252C4-d%255D%2520Pyrimidines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1956%26volume%3D78%26issue%3D4%26spage%3D784%26epage%3D790%26doi%3D10.1021%2Fja01585a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, T.</span></span> <span> </span><span class="NLM_article-title">Clinical Efficacy and Safety of Topiroxostat in Japanese Hyperuricemic Patients with or without Gout: A Randomized, Double-Blinded, Controlled Phase 2b Study</span>. <i>Clin. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1007/s10067-016-3474-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs10067-016-3474-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27832384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC2snkvFWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=649-656&issue=3&author=T.+Hosoyaauthor=T.+Sasakiauthor=T.+Ohashi&title=Clinical+Efficacy+and+Safety+of+Topiroxostat+in+Japanese+Hyperuricemic+Patients+with+or+without+Gout%3A+A+Randomized%2C+Double-Blinded%2C+Controlled+Phase+2b+Study&doi=10.1007%2Fs10067-016-3474-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study</span></div><div class="casAuthors">Hosoya Tatsuo; Sasaki Tomomitsu; Ohashi Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical rheumatology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-656</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Topiroxostat, a selective xanthine oxidoreductase inhibitor, is used in Japan for the treatment of hyperuricemic patients with or without gout.  In terms of the effectiveness of topiroxostat in lowering serum urate levels, the dose-response relationship has been evaluated; however, it remains to be verified.  A randomized, multi-center, double-blinded study of topiroxostat was performed for Japanese hyperuricemic patients with or without gout.  During the 16-week study, 157 Japanese hyperuricemic patients with or without gout were randomly assigned to receive a placebo, topiroxostat at 120 or 160 mg/day, or allopurinol at 200 mg/day.  The primary endpoint of this study was to determine the lowering rate of serum uric acid levels compared to those of baseline at the end of administration.  A dose-response relationship (regarding decreases in the serum urate levels) was confirmed for the placebo and topiroxostat at 120 and at 160 mg/day.  Moreover, at the end of administration, the lowering rate of serum urate levels was determined to be -44.8% in the topiroxostat 160-mg/day group.  No significant difference in the incidence of adverse events was observed among all groups, including the allopurinol group.  The serum urate-lowering effect of topiroxostat was found to have a dose-response relationship in Japanese hyperuricemic patients with or without gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5pG6DwTHCNPxQvRxYU81tfW6udTcc2eZaiyF16PZAsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snkvFWqtQ%253D%253D&md5=0592ff206f65665041b853d5eb27fa11</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1007%2Fs10067-016-3474-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10067-016-3474-8%26sid%3Dliteratum%253Aachs%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DOhashi%26aufirst%3DT.%26atitle%3DClinical%2520Efficacy%2520and%2520Safety%2520of%2520Topiroxostat%2520in%2520Japanese%2520Hyperuricemic%2520Patients%2520with%2520or%2520without%2520Gout%253A%2520A%2520Randomized%252C%2520Double-Blinded%252C%2520Controlled%2520Phase%25202b%2520Study%26jtitle%3DClin.%2520Rheumatol.%26date%3D2017%26volume%3D36%26issue%3D3%26spage%3D649%26epage%3D656%26doi%3D10.1007%2Fs10067-016-3474-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palo, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eustace, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernillet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph-Ridge, N.</span></span> <span> </span><span class="NLM_article-title">Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase: A Twenty-Eight-Day, Multicenter, Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Response Clinical Trial Examining Safety and Efficacy in Patients with Gout</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.1002/art.20935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fart.20935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=15751090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVGjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=916-923&issue=3&author=M.+A.+Beckerauthor=H.+R.+Schumacherauthor=R.+L.+Wortmannauthor=P.+A.+MacDonaldauthor=W.+A.+Paloauthor=D.+Eustaceauthor=L.+Vernilletauthor=N.+Joseph-Ridge&title=Febuxostat%2C+a+Novel+Nonpurine+Selective+Inhibitor+of+Xanthine+Oxidase%3A+A+Twenty-Eight-Day%2C+Multicenter%2C+Phase+II%2C+Randomized%2C+Double-Blind%2C+Placebo-Controlled%2C+Dose-Response+Clinical+Trial+Examining+Safety+and+Efficacy+in+Patients+with+Gout&doi=10.1002%2Fart.20935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout</span></div><div class="casAuthors">Becker, Michael A.; Schumacher, H. Ralph, Jr.; Wortmann, Robert L.; MacDonald, Patricia A.; Palo, William A.; Eustace, Denise; Vernillet, Laurent; Joseph-Ridge, Nancy</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">916-923</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Gout affects ∼1-2% of the American population.  Current options for treating hyperuricemia in chronic gout are limited.  The purpose of this study was to assess the safety and efficacy of febuxostat, a nonpurine selective inhibitor of xanthine oxidase, in establishing normal serum urate (sUA) concns. in gout patients with hyperuricemia (≥8.0 mg/dL).  We conducted a phase II, randomized, double-blind, placebo-controlled trial in 153 patients (ages 23-80 years).  Subjects received febuxostat (40 mg, 80 mg, 120 mg) or placebo once daily for 28 days and colchicine prophylaxis for 14 days prior to and 14 days after randomization.  The primary end point was the proportion of subjects with sUA levels <6.0 mg/dL on day 28.  Greater proportions of febuxostat-treated patients than placebo-treated patients achieved an sUA level <6.0 mg/dL at each visit (P < 0.001 for each comparison).  The targeted sUA level was attained on day 28 in 0% of those taking placebo and in 56% of those taking 40 mg, 76% taking 80 mg, and 94% taking 120 mg of febuxostat.  The mean sUA redn. from baseline to day 28 was 2% in the placebo group and 37% in the 40-mg, 44% in the 80-mg, and 59% in the 120-mg febuxostat groups.  Gout flares occurred with similar frequency in the placebo (37%) and 40-mg febuxostat (35%) groups and with increased frequency in the higher dosage febuxostat groups (43% taking 80 mg; 55% taking 120 mg).  During colchicine prophylaxis, gout flares occurred less frequently (8-13%).  Incidences of treatment-related adverse events were similar in the febuxostat and placebo groups.  Treatment with febuxostat resulted in a significant redn. of sUA levels at all dosages.  Febuxostat therapy was safe and well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWFODs8VOwZLVg90H21EOLACvtfcHk0lgwWkPudCe2NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVGjtbo%253D&md5=b1cc068ac997158b0775268a411e0983</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1002%2Fart.20935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.20935%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DM.%2BA.%26aulast%3DSchumacher%26aufirst%3DH.%2BR.%26aulast%3DWortmann%26aufirst%3DR.%2BL.%26aulast%3DMacDonald%26aufirst%3DP.%2BA.%26aulast%3DPalo%26aufirst%3DW.%2BA.%26aulast%3DEustace%26aufirst%3DD.%26aulast%3DVernillet%26aufirst%3DL.%26aulast%3DJoseph-Ridge%26aufirst%3DN.%26atitle%3DFebuxostat%252C%2520a%2520Novel%2520Nonpurine%2520Selective%2520Inhibitor%2520of%2520Xanthine%2520Oxidase%253A%2520A%2520Twenty-Eight-Day%252C%2520Multicenter%252C%2520Phase%2520II%252C%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%252C%2520Dose-Response%2520Clinical%2520Trial%2520Examining%2520Safety%2520and%2520Efficacy%2520in%2520Patients%2520with%2520Gout%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26issue%3D3%26spage%3D916%26epage%3D923%26doi%3D10.1002%2Fart.20935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beardmore, T. D.</span></span> <span> </span><span class="NLM_article-title">Allopurinol : Alteration in Pyrimidine Metabolism in Man</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>169</i></span> (<span class="NLM_issue">3943</span>),  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1126/science.169.3943.388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1126%2Fscience.169.3943.388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=5450375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaE3cXkvVKnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=1970&pages=388-390&issue=3943&author=W.+N.+Kelleyauthor=T.+D.+Beardmore&title=Allopurinol%E2%80%AF%3A+Alteration+in+Pyrimidine+Metabolism+in+Man&doi=10.1126%2Fscience.169.3943.388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Allopurinol:  alteration in pyrimidine metabolism in man</span></div><div class="casAuthors">Kelley, William N.; Beardmore, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3943</span>),
    <span class="NLM_cas:pages">388-90</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">In addn. to its well-established inhibitory effect on uric acid synthesis, allopurinol appears to alter substantially pyrimidine metabolism, as evidenced by a striking increase in the urinary excretion of orotidine and orotic acid.  Allopurinol ribonucleotide and xanthosine 5'-monophosphate are potent inhibitors of human erythrocyte orotidylic decarboxylase and provide a possible mechanism for this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0joHQgN9qmLVg90H21EOLACvtfcHk0lgwWkPudCe2NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXkvVKnt7g%253D&md5=9d7f04953ef1e77381d4a069f8f8f349</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1126%2Fscience.169.3943.388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.169.3943.388%26sid%3Dliteratum%253Aachs%26aulast%3DKelley%26aufirst%3DW.%2BN.%26aulast%3DBeardmore%26aufirst%3DT.%2BD.%26atitle%3DAllopurinol%25E2%2580%25AF%253A%2520Alteration%2520in%2520Pyrimidine%2520Metabolism%2520in%2520Man%26jtitle%3DScience%26date%3D1970%26volume%3D169%26issue%3D3943%26spage%3D388%26epage%3D390%26doi%3D10.1126%2Fscience.169.3943.388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Royse-Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, W. J.</span></span> <span> </span><span class="NLM_article-title">Orotidinuria Induced by Allopurinol</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>168</i></span> (<span class="NLM_issue">3933</span>),  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1126/science.168.3933.861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1126%2Fscience.168.3933.861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=5444063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaE3cXksVersLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=1970&pages=861-862&issue=3933&author=R.+M.+Foxauthor=D.+Royse-Smithauthor=W.+J.+O%E2%80%99Sullivan&title=Orotidinuria+Induced+by+Allopurinol&doi=10.1126%2Fscience.168.3933.861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Orotidinuria induced by allopurinol</span></div><div class="casAuthors">Fox, R. M.; Royse-Smith, D.; O'Sullivan, William James</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3933</span>),
    <span class="NLM_cas:pages">861-2</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The administration of allopurinol to patients suffering from hyperuricemia and to normal subjects results in increased excretion of the pyrimidine nucleoside orotidine.  Evidence is presented for the interference by allopurinol of the de novo biosynthesis of uridine 5'-phosphate in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW9gPE0GHzrLVg90H21EOLACvtfcHk0liuVaq3F4__nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXksVersLg%253D&md5=dd4078bc405afaf386d45f39ef348635</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1126%2Fscience.168.3933.861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.168.3933.861%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DR.%2BM.%26aulast%3DRoyse-Smith%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DW.%2BJ.%26atitle%3DOrotidinuria%2520Induced%2520by%2520Allopurinol%26jtitle%3DScience%26date%3D1970%26volume%3D168%26issue%3D3933%26spage%3D861%26epage%3D862%26doi%3D10.1126%2Fscience.168.3933.861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span> <span> </span><span class="NLM_article-title">A Facile One-Pot Synthesis Of 4-Alkoxy-1,3. Benzenedicarbonitrile</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.3987/COM-97-S(N)89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3987%2FCOM-97-S%28N%2989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK1cXit1yhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=857-864&issue=2&author=M.+Hasegawa&title=A+Facile+One-Pot+Synthesis+Of+4-Alkoxy-1%2C3.+Benzenedicarbonitrile&doi=10.3987%2FCOM-97-S%28N%2989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">A facile one-pot synthesis of 4-alkoxy-1,3-benzenedicarbonitriles</span></div><div class="casAuthors">Hasegawa, Masaichi</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">857-864</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">The introduction of cyano group to 4-nitrobenzonitrile with KCN in dry DMSO followed by quenching with alkyl halides afforded 4-alkoxy-1,3-benzenedicarbonitriles in good yield.  The reaction was completed in dry DMSO, while no reaction occurred in dry DMF.  This observation can be suggested by the participation of DMSO in the reaction.  2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxlic acid (TEI-6720) was prepd. from 4-nitrobenzonitrile via 4-isobutoxy-1,3-benzenedicarbonitrile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAyj3aRtZd7Vg90H21EOLACvtfcHk0liuVaq3F4__nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1yhs74%253D&md5=5d5de4cc3295ff62c9921292d10903a0</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.3987%2FCOM-97-S%28N%2989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-97-S%2528N%252989%26sid%3Dliteratum%253Aachs%26aulast%3DHasegawa%26aufirst%3DM.%26atitle%3DA%2520Facile%2520One-Pot%2520Synthesis%2520Of%25204-Alkoxy-1%252C3.%2520Benzenedicarbonitrile%26jtitle%3DHeterocycles%26date%3D1998%26volume%3D47%26issue%3D2%26spage%3D857%26epage%3D864%26doi%3D10.3987%2FCOM-97-S%28N%2989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase-Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, M. A.</span></span> <span> </span><span class="NLM_article-title">Selectivity of Febuxostat, a Novel Non-Purine Inhibitor of Xanthine Oxidase/Xanthine Dehydrogenase</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">1835</span>– <span class="NLM_lpage">1847</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2004.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.lfs.2004.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=15698861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2005&pages=1835-1847&issue=16&author=Y.+Takanoauthor=K.+Hase-Aokiauthor=H.+Horiuchiauthor=L.+Zhaoauthor=Y.+Kasaharaauthor=S.+Kondoauthor=M.+A.+Becker&title=Selectivity+of+Febuxostat%2C+a+Novel+Non-Purine+Inhibitor+of+Xanthine+Oxidase%2FXanthine+Dehydrogenase&doi=10.1016%2Fj.lfs.2004.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase</span></div><div class="casAuthors">Takano, Yasuhiro; Hase-Aoki, Kumiko; Horiuchi, Hideki; Zhao, Lin; Kasahara, Yoshinori; Kondo, Shiro; Becker, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1835-1847</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purine analog, allopurinol, has been in clin. use for more than 30 years as an inhibitor of xanthine oxidase (XO) in the treatment of hyperuricemia and gout.  As consequences of structural similarities to purine compds., however, allopurinol, its major active product, oxypurinol, and their resp. metabolites inhibit other enzymes involved in purine and pyrimidine metab.  Febuxostat (TEI-6720, TMX-67) is a potent, non-purine inhibitor of XO, currently under clin. evaluation for the treatment of hyperuricemia and gout.  In this study, we investigated the effects of febuxostat on several enzymes in purine and pyrimidine metab. and characterized the mechanism of febuxostat inhibition of XO activity.  Febuxostat displayed potent mixed-type inhibition of the activity of purified bovine milk XO, with Ki and Ki' values of 0.6 and 3.1 nM resp., indicating inhibition of both the oxidized and reduced forms of XO.  In contrast, at concns. up to 100 μM, febuxostat had no significant effects on the activities of the following enzymes of purine and pyrimidine metab.: guanine deaminase, hypoxanthine-guanine phosphoribosyltransferase, purine nucleoside phosphorylase, orotate phosphoribosyltransferase and orotidine-5'-monophosphate decarboxylase.  These results demonstrate that febuxostat is a potent non-purine, selective inhibitor of XO, and could be useful for the treatment of hyperuricemia and gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt94NMipTWUbVg90H21EOLACvtfcHk0lhn1g3v49xIoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGrt7s%253D&md5=d425eb40e5605c943e2d9a0b7c0794f7</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2004.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2004.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DY.%26aulast%3DHase-Aoki%26aufirst%3DK.%26aulast%3DHoriuchi%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DM.%2BA.%26atitle%3DSelectivity%2520of%2520Febuxostat%252C%2520a%2520Novel%2520Non-Purine%2520Inhibitor%2520of%2520Xanthine%2520Oxidase%252FXanthine%2520Dehydrogenase%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D76%26issue%3D16%26spage%3D1835%26epage%3D1847%26doi%3D10.1016%2Fj.lfs.2004.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hille, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eger, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, T.</span></span> <span> </span><span class="NLM_article-title">The Crystal Structure of Xanthine Oxidoreductase during Catalysis: Implications for Reaction Mechanism and Enzyme Inhibition</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7931</span>– <span class="NLM_lpage">7936</span>, <span class="refDoi"> DOI: 10.1073/pnas.0400973101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1073%2Fpnas.0400973101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=15148401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkslCis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=7931-7936&issue=21&author=K.+Okamotoauthor=K.+Matsumotoauthor=R.+Hilleauthor=B.+T.+Egerauthor=E.+F.+Paiauthor=T.+Nishino&title=The+Crystal+Structure+of+Xanthine+Oxidoreductase+during+Catalysis%3A+Implications+for+Reaction+Mechanism+and+Enzyme+Inhibition&doi=10.1073%2Fpnas.0400973101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of xanthine oxidoreductase during catalysis: Implications for reaction mechanism and enzyme inhibition</span></div><div class="casAuthors">Okamoto, Ken; Matsumoto, Koji; Hille, Russ; Eger, Bryan T.; Pai, Emil F.; Nishino, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7931-7936</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Molybdenum is widely distributed in biol. and is usually found as a mononuclear metal center in the active sites of many enzymes catalyzing oxygen atom transfer.  The molybdenum hydroxylases are distinct from other biol. systems catalyzing hydroxylation reactions in that the oxygen atom incorporated into the product is derived from water rather than mol. oxygen.  Here, we present the crystal structure of the key intermediate in the hydroxylation reaction of xanthine oxidoreductase with a slow substrate, in which the carbon-oxygen bond of the product is formed, yet the product remains complexed to the molybdenum.  This intermediate displays a stable broad charge-transfer band at ≈640 nm.  The crystal structure of the complex indicates that the catalytically labile Mo-OH oxygen has formed a bond with a carbon atom of the substrate.  In addn., the Mo=S group of the oxidized enzyme has become protonated to afford Mo-SH on redn. of the molybdenum center.  In contrast to previous assignments, we find this last ligand at an equatorial position in the square-pyramidal metal coordination sphere, not the apical position.  A water mol. usually seen in the active site of the enzyme is absent in the present structure, which probably accounts for the stability of this intermediate toward ligand displacement by hydroxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6sp0ZWs19-rVg90H21EOLACvtfcHk0lhn1g3v49xIoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkslCis7k%253D&md5=c1454067285fc6cdd4e7b847b3d09c9e</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0400973101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0400973101%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DHille%26aufirst%3DR.%26aulast%3DEger%26aufirst%3DB.%2BT.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DNishino%26aufirst%3DT.%26atitle%3DThe%2520Crystal%2520Structure%2520of%2520Xanthine%2520Oxidoreductase%2520during%2520Catalysis%253A%2520Implications%2520for%2520Reaction%2520Mechanism%2520and%2520Enzyme%2520Inhibition%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D21%26spage%3D7931%26epage%3D7936%26doi%3D10.1073%2Fpnas.0400973101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashizawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwanaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, O.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3-(3-Cyano-4-Pyridyl)-5-(4-Pyridyl)-1,2,4-Triazole, FYX-051-a Xanthine Oxidoreductase Inhibitor for the Treatment of Hyperuricemia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6225</span>– <span class="NLM_lpage">6229</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.bmcl.2009.08.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=19783139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GmurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6225-6229&issue=21&author=T.+Satoauthor=N.+Ashizawaauthor=K.+Matsumotoauthor=T.+Iwanagaauthor=H.+Nakamuraauthor=T.+Inoueauthor=O.+Nagata&title=Discovery+of+3-%283-Cyano-4-Pyridyl%29-5-%284-Pyridyl%29-1%2C2%2C4-Triazole%2C+FYX-051-a+Xanthine+Oxidoreductase+Inhibitor+for+the+Treatment+of+Hyperuricemia&doi=10.1016%2Fj.bmcl.2009.08.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia</span></div><div class="casAuthors">Sato, Takahiro; Ashizawa, Naoki; Matsumoto, Koji; Iwanaga, Takashi; Nakamura, Hiroshi; Inoue, Tsutomu; Nagata, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6225-6229</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A previous study identified 2-[2-(2-methoxy-ethoxy)-ethoxy]-5-[5-(2-methyl-4-pyridyl)-1H-[1,2,4]triazol-3-yl]-benzonitrile as a safe and potent xanthine oxidoreductase (XOR) inhibitor for the treatment of hyperuricemia.  A series of 3,5-dipyridyl-1,2,4-triazole derivs. were synthesized and their in vivo activity in lowering the serum uric acid levels in rats was examd.  As a result, 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole (FYX-051) to be one of the most potent XOR inhibitors; it exhibited an extremely potent in vivo activity, weak CYP3A4-inhibitory activity and a better pharmacokinetic profile than the previously identified compd.  FYX-051 is currently being evaluated in a phase 2 clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBzt8AQ13SK7Vg90H21EOLACvtfcHk0lgPZG2SHQozWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GmurjK&md5=515ed8e433aca32b3e8e1b199963c160</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.091%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DT.%26aulast%3DAshizawa%26aufirst%3DN.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DIwanaga%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DO.%26atitle%3DDiscovery%2520of%25203-%25283-Cyano-4-Pyridyl%2529-5-%25284-Pyridyl%2529-1%252C2%252C4-Triazole%252C%2520FYX-051-a%2520Xanthine%2520Oxidoreductase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hyperuricemia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D21%26spage%3D6225%26epage%3D6229%26doi%3D10.1016%2Fj.bmcl.2009.08.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashizawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, T.</span></span> <span> </span><span class="NLM_article-title">FYX-051: A Novel and Potent Hybrid-Type Inhibitor of Xanthine Oxidoreductase</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>336</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.174540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1124%2Fjpet.110.174540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=20952484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1ersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=95-103&issue=1&author=K.+Matsumotoauthor=K.+Okamotoauthor=N.+Ashizawaauthor=T.+Nishino&title=FYX-051%3A+A+Novel+and+Potent+Hybrid-Type+Inhibitor+of+Xanthine+Oxidoreductase&doi=10.1124%2Fjpet.110.174540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">FYX-051: a novel and potent hybrid-type inhibitor of xanthine oxidoreductase</span></div><div class="casAuthors">Matsumoto, Koji; Okamoto, Ken; Ashizawa, Naoki; Nishino, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-103</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">4-[5-(Pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile (FYX-051) is a potent inhibitor of bovine milk xanthine oxidoreductase (XOR).  Steady-state kinetics study showed that it initially behaved as a competitive-type inhibitor with a Ki value of 5.7 × 10-9 M, then after a few minutes it formed a tight complex with XOR via a Mo-oxygen-carbon atom covalent linkage, as reported previously.  Thus, FYX-051 is a hybrid-type inhibitor exhibiting both structure- and mechanism-based inhibition.  The FYX-051-XOR complex decompd. with a half-life of 20.4 h, but the enzyme activity did not fully recover.  This was found to be caused by XOR-mediated conversion of FYX-051 to 4-[5-(2-hydroxypyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile (2-hydroxy-FYX-051), as well as formation of 6-hydroxy-4-[5-(2-hydroxypyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile (dihydroxy-FYX-051) and 4-[5-(2,6-dihydroxypyridin-4-yl)-1H-1,2,4-triazol-3-yl]-6-hydroxypyridine-2-carbonitrile (trihydroxy-FYX-051) during prolonged incubation for up to 72 h.  A distinct charge-transfer band was obsd. concomitantly with the formation of the trihydroxy-FYX-051-XOR complex.  Crystallog. anal. of the charge-transfer complex indicated that a Mo-nitrogen-carbon bond was formed between molybdenum of XOR and the nitrile group of trihydroxy-FYX-051.  FYX-051 showed a potent and long-lasting hypouricemic effect in a rat model of potassium oxonate-induced hyperuricemia, and it seems to be a promising candidate for the clin. treatment of hyperuricemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8aMcZkNAFgLVg90H21EOLACvtfcHk0lgPZG2SHQozWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1ersw%253D%253D&md5=39aacb2b3979a17f58a425680ddd6091</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.174540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.174540%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DAshizawa%26aufirst%3DN.%26aulast%3DNishino%26aufirst%3DT.%26atitle%3DFYX-051%253A%2520A%2520Novel%2520and%2520Potent%2520Hybrid-Type%2520Inhibitor%2520of%2520Xanthine%2520Oxidoreductase%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26issue%3D1%26spage%3D95%26epage%3D103%26doi%3D10.1124%2Fjpet.110.174540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minhas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, G.</span></span> <span> </span><span class="NLM_article-title">Inducible Nitric Oxide Synthase Inhibitors: A Comprehensive Update</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">855</span>, <span class="refDoi"> DOI: 10.1002/med.21636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fmed.21636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31502681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlantbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&pages=823-855&issue=3&author=R.+Minhasauthor=Y.+Bansalauthor=G.+Bansal&title=Inducible+Nitric+Oxide+Synthase+Inhibitors%3A+A+Comprehensive+Update&doi=10.1002%2Fmed.21636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Inducible nitric oxide synthase inhibitors: A comprehensive update</span></div><div class="casAuthors">Minhas, Richa; Bansal, Yogita; Bansal, Gulshan</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">823-855</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Inducible nitric oxide synthase (iNOS), which is expressed in response to bacterial/proinflammatory stimuli, generates nitric oxide (NO) that provides cytoprotection.  Overexpression of iNOS increases the levels of NO, and this increased NO level is implicated in pathophysiol. of complex multifactorial diseases like Parkinson's disease, Alzheimer's disease, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease.  Selective inhibition of iNOS is an effective approach in treatment of such complex diseases.  -Arginine, being a substrate for iNOS, is the natural lead to develop iNOS inhibitors.  More than 200 research reports on development of nitric oxide synthase inhibitors by different research groups across the globe have appeared in literature so far.  In the present review, all reports on both natural and synthetic iNOS inhibitors, published 2002 onwards, are studied, classified, and discussed to provide comprehensive information on iNOS inhibitors.  The latter are further classified into amidines, five- or six-membered heterocyclics, fused cyclics, steroidal type, and chalcones analogs.  Structures of the most/significantly potent compds. from each report are provided to know the functional groups important for incurring iNOS inhibitory activity and selectivity.  This review is aimed to provide a comprehensive view to the medicinal chemists for rational designing of novel and potent iNOS inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUTlomCGpTELVg90H21EOLACvtfcHk0ljXEhOfKvVBgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlantbo%253D&md5=54fe69326cbeb700ae5592beaf7fa702</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1002%2Fmed.21636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21636%26sid%3Dliteratum%253Aachs%26aulast%3DMinhas%26aufirst%3DR.%26aulast%3DBansal%26aufirst%3DY.%26aulast%3DBansal%26aufirst%3DG.%26atitle%3DInducible%2520Nitric%2520Oxide%2520Synthase%2520Inhibitors%253A%2520A%2520Comprehensive%2520Update%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2020%26volume%3D40%26issue%3D3%26spage%3D823%26epage%3D855%26doi%3D10.1002%2Fmed.21636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alderton, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angell, A. D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moncada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monkhouse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waslidge, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowles, R. G.</span></span> <span> </span><span class="NLM_article-title">GW274150 and GW273629 Are Potent and Highly Selective Inhibitors of Inducible Nitric Oxide Synthase in Vitro and in Vivo</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>145</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0706168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fsj.bjp.0706168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=15778742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Gntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2005&pages=301-312&issue=3&author=W.+K.+Aldertonauthor=A.+D.+R.+Angellauthor=C.+Craigauthor=J.+Dawsonauthor=E.+Garveyauthor=S.+Moncadaauthor=J.+Monkhouseauthor=D.+Reesauthor=L.+J.+Russellauthor=R.+J.+Russellauthor=S.+Schwartzauthor=N.+Waslidgeauthor=R.+G.+Knowles&title=GW274150+and+GW273629+Are+Potent+and+Highly+Selective+Inhibitors+of+Inducible+Nitric+Oxide+Synthase+in+Vitro+and+in+Vivo&doi=10.1038%2Fsj.bjp.0706168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo</span></div><div class="casAuthors">Alderton, Wendy K.; Angell, Anthony D. R.; Craig, Caroline; Dawson, John; Garvey, Edward; Moncada, Salvador; Monkhouse, Jayne; Rees, Daryl; Russell, Linda J.; Russell, Rachel J.; Schwartz, Sheila; Waslidge, Neil; Knowles, Richard G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-312</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">GW274150 ([2-[(1-iminoethyl) amino]ethyl]-L-homocysteine) and GW273629 (3-[[2-[(1-iminoethyl)amino]ethyl]sulfonyl]-L-alanine) are potent, time-dependent, highly selective inhibitors of human inducible nitric oxide synthase (iNOS) vs. endothelial NOS (eNOS) (>100-fold) or neuronal NOS (nNOS) (>80-fold).  GW274150 and GW273629 are arginine competitive, NADPH-dependent inhibitors of human iNOS with steady state Kd values of <40 and <90 nM, resp.  GW274150 and GW273629 inhibited intracellular iNOS in J774 cells in a time-dependent manner, reaching IC50 values of 0.2±0.04 and 1.3±0.16 μM, resp.  They were also acutely selective in intact rat tissues: GW274150 was >260-fold and 219-fold selective for iNOS against eNOS and nNOS, resp., while GW273629 was >150-fold and 365-fold selective for iNOS against eNOS and nNOS, resp.  The pharmacokinetic profile of GW274150 was biphasic in healthy rats and mice with a terminal half-life of ∼6 h.  That of GW273629 was also biphasic in rats, producing a terminal half-life of ∼3 h.  In mice however, elimination of GW273629 appeared monophasic and more rapid (∼10 min).  Both compds. show a high oral bioavailability (>90%) in rats and mice.  GW274150 was effective in inhibiting LPS-induced plasma NOx levels in mice with an ED50 of 3.2±0.7 mg kg-1 after 14 h i.p. and 3.8±1.5 mg kg-1 after 14 h when administered orally.  GW274150 was effective in inhibiting LPS-induced plasma NOx levels in mice with an ED50 of 3.2±0.7 mg kg-1 after 14 h i.p. and 3.8±1.5 mg kg-1 after 14 h when administered orally.  GW273629 showed shorter-lived effects on plasma NOx and an ED50 of 9±2 mg kg-1 after 2 h when administered i.p.  The effects of GW274150 and GW273629 in vivo were consistent with high selectivity for iNOS, as these inhibitors were of low potency against nNOS in the rat cerebellum and did not cause significant effects on blood pressure in instrumented mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquFYuHFmJTFLVg90H21EOLACvtfcHk0lhAaE-ExihnzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Gntbs%253D&md5=15b026f9a4e0cff55024719c98e55f85</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706168%26sid%3Dliteratum%253Aachs%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAngell%26aufirst%3DA.%2BD.%2BR.%26aulast%3DCraig%26aufirst%3DC.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DGarvey%26aufirst%3DE.%26aulast%3DMoncada%26aufirst%3DS.%26aulast%3DMonkhouse%26aufirst%3DJ.%26aulast%3DRees%26aufirst%3DD.%26aulast%3DRussell%26aufirst%3DL.%2BJ.%26aulast%3DRussell%26aufirst%3DR.%2BJ.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DWaslidge%26aufirst%3DN.%26aulast%3DKnowles%26aufirst%3DR.%2BG.%26atitle%3DGW274150%2520and%2520GW273629%2520Are%2520Potent%2520and%2520Highly%2520Selective%2520Inhibitors%2520of%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D145%26issue%3D3%26spage%3D301%26epage%3D312%26doi%3D10.1038%2Fsj.bjp.0706168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strub, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, W.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesslinger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltze, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchß, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strassner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehner, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boer, R.</span></span> <span> </span><span class="NLM_article-title">The Novel Imidazopyridine 2- [ 2- (4-Methoxy-Pyridin-2-Yl) -Ethyl ] - 3 H -Imidazo [ 4, 5- b ] Pyridine (BYK191023) Is a Highly Selective Inhibitor of the Inducible Nitric-Oxide Synthase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1124/mol.105.017087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1124%2Fmol.105.017087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16223957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD28XktlWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=328-337&issue=1&author=A.+Strubauthor=W.-R.+Ulrichauthor=C.+Hesslingerauthor=M.+Eltzeauthor=T.+Fuch%C3%9Fauthor=J.+Strassnerauthor=S.+Strandauthor=M.+D.+Lehnerauthor=R.+Boer&title=The+Novel+Imidazopyridine+2-+%5B+2-+%284-Methoxy-Pyridin-2-Yl%29+-Ethyl+%5D+-+3+H+-Imidazo+%5B+4%2C+5-+b+%5D+Pyridine+%28BYK191023%29+Is+a+Highly+Selective+Inhibitor+of+the+Inducible+Nitric-Oxide+Synthase&doi=10.1124%2Fmol.105.017087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">The novel imidazopyridine 2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase</span></div><div class="casAuthors">Strub, Andreas; Ulrich, Wolf-Ruediger; Hesslinger, Christian; Eltze, Manfrid; Fuchss, Thomas; Strassner, Jochen; Strand, Susanne; Lehner, Martin D.; Boer, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">328-337</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have identified imidazopyridine derivs. as a novel class of NO synthase inhibitors with high selectivity for the inducible isoform.  2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) showed half-maximal inhibition of crudely purified human inducible (iNOS), neuronal (nNOS), and endothelial (eNOS) NO synthases at 86 nM, 17 μM, and 162 μM, resp.  Inhibition of inducible NO synthase was competitive with L-arginine, pointing to an interaction of BYK191023 with the catalytic center of the enzyme.  In radioligand and surface plasmon resonance expts., BYK191023 exhibited an affinity for iNOS, nNOS, and eNOS of 450 nM, 30 μM, and >500 μM, resp.  Inhibition of cellular nitrate/nitrite synthesis in RAW, rat mesangium, and human embryonic kidney 293 cells after iNOS induction showed 40- to 100-fold higher IC50 values than at the isolated enzyme, in agreement with the much higher L-arginine concns. in cell culture media and inside intact cells.  BYK191023 did not show any toxicity in various rodent and human cell lines up to high micromolar concns.  The inhibitory potency of BYK191023 was tested in isolated organ models of iNOS (lipopolysaccharide-treated and phenylephrine-precontracted rat aorta; IC50 = 7 μM), eNOS (arecaidine propargyl ester-induced relaxation of phenylephrine-precontracted rat aorta; IC50 > 100 μM), and nNOS (field-stimulated relaxation of phenylephrine-precontracted rabbit corpus cavernosum; IC50 > 100 μM).  These data confirm the high selectivity of BYK191023 for iNOS over eNOS and nNOS found at isolated enzymes.  In summary, we have identified a new highly selective iNOS inhibitor structurally unrelated to known compds. and L-arginine.  BYK191023 is a valuable tool for the investigation of iNOS-mediated effects in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmoCXREGVIZrVg90H21EOLACvtfcHk0lhAaE-ExihnzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktlWmtA%253D%253D&md5=ac863b02e078326c40b0212d1c78970d</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.017087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.017087%26sid%3Dliteratum%253Aachs%26aulast%3DStrub%26aufirst%3DA.%26aulast%3DUlrich%26aufirst%3DW.-R.%26aulast%3DHesslinger%26aufirst%3DC.%26aulast%3DEltze%26aufirst%3DM.%26aulast%3DFuch%25C3%259F%26aufirst%3DT.%26aulast%3DStrassner%26aufirst%3DJ.%26aulast%3DStrand%26aufirst%3DS.%26aulast%3DLehner%26aufirst%3DM.%2BD.%26aulast%3DBoer%26aufirst%3DR.%26atitle%3DThe%2520Novel%2520Imidazopyridine%25202-%2520%255B%25202-%2520%25284-Methoxy-Pyridin-2-Yl%2529%2520-Ethyl%2520%255D%2520-%25203%2520H%2520-Imidazo%2520%255B%25204%252C%25205-%2520b%2520%255D%2520Pyridine%2520%2528BYK191023%2529%2520Is%2520a%2520Highly%2520Selective%2520Inhibitor%2520of%2520the%2520Inducible%2520Nitric-Oxide%2520Synthase%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26issue%3D1%26spage%3D328%26epage%3D337%26doi%3D10.1124%2Fmol.105.017087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oplinger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furfine, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiff, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittle, B. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowles, R. G.</span></span> <span> </span><span class="NLM_article-title">1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-Oxide Synthase in Vitro and in Vivo</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4959</span>– <span class="NLM_lpage">4963</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.8.4959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.272.8.4959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=9030556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2sXhsValtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=4959-4963&issue=8&author=E.+P.+Garveyauthor=J.+A.+Oplingerauthor=E.+S.+Furfineauthor=R.+J.+Kiffauthor=F.+Laszloauthor=B.+J.+R.+Whittleauthor=R.+G.+Knowles&title=1400W+Is+a+Slow%2C+Tight+Binding%2C+and+Highly+Selective+Inhibitor+of+Inducible+Nitric-Oxide+Synthase+in+Vitro+and+in+Vivo&doi=10.1074%2Fjbc.272.8.4959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo</span></div><div class="casAuthors">Garvey, Edward P.; Oplinger, Jeffrey A.; Furfine, Eric S.; Kiff, Rachel J.; Laszlo, Ferenc; Whittle, Brenden J. R.; Knowles, Richard G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4959-4963</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-(3-(aminomethyl)benzyl)acetamidine (1400W) was a slow, tight binding inhibitor of human inducible nitric oxide synthase (iNOS).  The slow onset of inhibition by 1400W showed satn. kinetics with a maximal rate const. of 0.028 s-1 and a binding const. of 2.0 μM.  Inhibition was dependent on the cofactor NADPH.  L-Arginine was a competitive inhibitor of 1400W binding with a Ks value of 3.0 μM.  Inhibited enzyme did not recover activity after 2 h.  Thus, 1400W was either an irreversible inhibitor or an extremely slowly reversible inhibitor of human iNOS with a Kd value ≤ 7 nM.  In contrast, inhibition of human neuronal NOS and endothelial NOS (eNOS) was relatively weaker, rapidly reversible, and competitive with L-arginine, with Ki values of 2 μM and 50 μM, resp.  Thus, 1400W was at least 5000-fold selective for iNOS vs. eNOS.  This selectivity was similar to that obsd. in rat aortic rings, in which 1400W was greater than 1000-fold more potent against rat iNOS than eNOS.  Finally, 1400W was greater than 50-fold more potent against iNOS than eNOS in a rat model of endotoxin-induced vascular injury.  Thus, the potency and selectivity of 1400W inhibition of iNOS both in vitro and in vivo were far greater than of any previously described iNOS inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe5tgzssWloLVg90H21EOLACvtfcHk0liXjDm4jcq14Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsValtLY%253D&md5=c6c9d901c810e1ab4e8817c63995b9c8</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.8.4959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.8.4959%26sid%3Dliteratum%253Aachs%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DOplinger%26aufirst%3DJ.%2BA.%26aulast%3DFurfine%26aufirst%3DE.%2BS.%26aulast%3DKiff%26aufirst%3DR.%2BJ.%26aulast%3DLaszlo%26aufirst%3DF.%26aulast%3DWhittle%26aufirst%3DB.%2BJ.%2BR.%26aulast%3DKnowles%26aufirst%3DR.%2BG.%26atitle%3D1400W%2520Is%2520a%2520Slow%252C%2520Tight%2520Binding%252C%2520and%2520Highly%2520Selective%2520Inhibitor%2520of%2520Inducible%2520Nitric-Oxide%2520Synthase%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D8%26spage%3D4959%26epage%3D4963%26doi%3D10.1074%2Fjbc.272.8.4959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjoeng, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misko, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, M. G.</span></span> <span> </span><span class="NLM_article-title">L-N6-(1-Iminoethyl)Lysine: Selective Inhibitor of Inducible Nitric Oxide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">3886</span>– <span class="NLM_lpage">3888</span>, <span class="refDoi"> DOI: 10.1021/jm00049a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00049a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2MXhs12htr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3886-3888&author=W.+M.+Mooreauthor=R.+K.+Webberauthor=G.+M.+Jeromeauthor=F.+S.+Tjoengauthor=T.+P.+Miskoauthor=M.+G.+Currie&title=L-N6-%281-Iminoethyl%29Lysine%3A+Selective+Inhibitor+of+Inducible+Nitric+Oxide&doi=10.1021%2Fjm00049a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">L-N6-(1-Iminoethyl)lysine: A Selective Inhibitor of Inducible Nitric Oxide Synthase</span></div><div class="casAuthors">Moore, William M.; Webber, R. Keith; Jerome, Gina M.; Tjoeng, Foe S.; Misko, Thomas P.; Currie, Mark G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3886-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">L-N6-(1-iminoethyl)lysine (L-NIL) has been synthesized and is shown to be both a potent and selective inhibitor of mouse-inducible nitric oxide synthase (miNOS).  L-NIL has an IC50 of 3.3 μM for miNOS compared to an IC50 of 92 μM for rat brain constitutive NOS indicating that L-NIL is 28-fold more selective for inducible NOS.  L-N5-(1-iminoethyl)ornithine (L-NIO), which differes from L-NIL by having one less methylene group, has very similar potency for inducible NOS, but lacks selectivity.  DL-N7-(1-iminoethyl)homolysine was also synthesized and found to be substantially less potent than L-NIL or L-NIO, with intermediate selectivity for inducible NOS.  These data suggest that L-NIL may be useful as a selective inhibitor of inducible NOS for detg. the role of this enzyme in disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3m3-Er1JDnbVg90H21EOLACvtfcHk0liXjDm4jcq14Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhs12htr8%253D&md5=34710a372ba204cc1f8f3211822fbc5f</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Fjm00049a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00049a007%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DW.%2BM.%26aulast%3DWebber%26aufirst%3DR.%2BK.%26aulast%3DJerome%26aufirst%3DG.%2BM.%26aulast%3DTjoeng%26aufirst%3DF.%2BS.%26aulast%3DMisko%26aufirst%3DT.%2BP.%26aulast%3DCurrie%26aufirst%3DM.%2BG.%26atitle%3DL-N6-%25281-Iminoethyl%2529Lysine%253A%2520Selective%2520Inhibitor%2520of%2520Inducible%2520Nitric%2520Oxide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3886%26epage%3D3888%26doi%3D10.1021%2Fjm00049a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvale, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota-Filipe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Inducible Nitric Oxide Synthase Reduces Renal Ischemia/Reperfusion Injury</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">862</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1046/j.1523-1755.2002.00234.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1046%2Fj.1523-1755.2002.00234.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11849439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1agur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=862-871&issue=3&author=P.+K.+Chatterjeeauthor=N.+S.+A.+Patelauthor=E.+O.+Kvaleauthor=S.+Cuzzocreaauthor=P.+A.+J.+Brownauthor=K.+N.+Stewartauthor=H.+Mota-Filipeauthor=C.+Thiemermann&title=Inhibition+of+Inducible+Nitric+Oxide+Synthase+Reduces+Renal+Ischemia%2FReperfusion+Injury&doi=10.1046%2Fj.1523-1755.2002.00234.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury</span></div><div class="casAuthors">Chatterjee, Prabal K.; Patel, Nimesh S. A.; Kvale, Espen O.; Cuzzocrea, Salvatore; Brown, Paul A. J.; Stewart, Keith N.; Mota-Filipe, Helder; Thiemermann, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-871</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">NO (NO), produced via inducible NO synthase (iNOS), is implicated in the pathophysiol. of renal ischemia/reperfusion (I/R) injury.  The aim of this study was to investigate the effects of the iNOS inhibitors L-N6-(1-iminoethyl)lysine (L-NIL) and aminoethyl-isothiourea (AE-ITU) on (a) renal dysfunction and injury mediated by bilateral I/R of rat kidneys in vivo and (b) cytokine-stimulated NO prodn. by primary cultures of rat proximal tubule (PT) cells.  Male Wistar rats subjected to bilateral renal ischemia (45 min) followed by reperfusion (6 h).  Rats were administered either L-NIL (3 mg/kg IV bolus 15 min prior to I/R followed by 1 mg/kg/h throughout I/R) or AE-ITU (1 mg/kg IV bolus 15 min prior to I/R followed by 1 mg/kg/h throughout I/R).  Blood serum and urinary biochem. indicators of renal dysfunction and injury were measured; serum creatinine (SCr, glomerular dysfunction), fractional excretion of Na+ (FENa, tubular dysfunction), serum Asp aminotransferase (sAST, I/R injury) and urinary N-acetyl-β-D-glucosaminidase (uNAG, tubular injury).  Addnl., renal sections were used for histol. grading of renal injury and for immunol. evidence of nitrotyrosine formation.  Nitrate/nitrate levels in plasma were measured using the Griess assay and used as an indicator of NO prodn.  Primary cultures of rat PT cells were incubated with interferon-γ (IFN-γ, 100 IU/mL) and lipopolysaccharide (LPS, 10 μg/mL) for 24 h, either in the absence or presence of increasing concns. of L-NIL or AE-ITU (0.001 to 1 mmol/L) after which nitrite/nitrate levels were measured using the Griess assay.  L-NIL and AE-ITU significantly reduced the I/R-mediated increases in SCr, FENa, sAST, and uNAG, indicating attenuation of I/R-mediated renal dysfunction and injury.  Specifically, L-NIL and AE-ITU reduced the I/R-mediated glomerular and tubular dysfunction and biochem. and histol. evidence of tubular injury.  Both L-NIL and AE-ITU attenuated the plasma levels of nitrate (indicating reduced NO prodn.) and the immunohistochem. evidence of the formation of nitrotyrosine.  In vitro, L-NIL and AE-ITU both significantly reduced cytokine-stimulated NO prodn. by primary cultures of rat PT cells in a dose-dependent manner.  These results suggest that L-NIL and AE-ITU reduce the renal dysfunction and injury assocd. with I/R of the kidney, via inhibition of iNOS activity and subsequent redn. of NO (and peroxynitrite) generation.  The authors propose that selective and specific inhibitors of iNOS activity may be useful against the NO-mediated renal dysfunction and injury assocd. with I/R of the kidney.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ckx8dxSJ47Vg90H21EOLACvtfcHk0ljxIB4JefVLoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1agur4%253D&md5=78ad771fd687a37367cc870c2694df33</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.2002.00234.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.2002.00234.x%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DP.%2BK.%26aulast%3DPatel%26aufirst%3DN.%2BS.%2BA.%26aulast%3DKvale%26aufirst%3DE.%2BO.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DStewart%26aufirst%3DK.%2BN.%26aulast%3DMota-Filipe%26aufirst%3DH.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DInhibition%2520of%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520Reduces%2520Renal%2520Ischemia%252FReperfusion%2520Injury%26jtitle%3DKidney%2520Int.%26date%3D2002%26volume%3D61%26issue%3D3%26spage%3D862%26epage%3D871%26doi%3D10.1046%2Fj.1523-1755.2002.00234.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivarajah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvale, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota-Filipe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaqoob, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">GW274150, a Potent and Highly Selective Inhibitor of INOS Reduces Experimental Renal Ischemia/Reperfusion Injury</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">853</span>– <span class="NLM_lpage">865</span>, <span class="refDoi"> DOI: 10.1046/j.1523-1755.2003.00802.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1046%2Fj.1523-1755.2003.00802.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=12631066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivV2jsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=853-865&issue=3&author=P.+K.+Chatterjeeauthor=N.+S.+A.+Patelauthor=A.+Sivarajahauthor=E.+O.+Kvaleauthor=L.+Dugoauthor=S.+Cuzzocreaauthor=P.+A.+J.+Brownauthor=K.+N.+Stewartauthor=H.+Mota-Filipeauthor=D.+Brittiauthor=M.+M.+Yaqoobauthor=C.+Thiemermann&title=GW274150%2C+a+Potent+and+Highly+Selective+Inhibitor+of+INOS+Reduces+Experimental+Renal+Ischemia%2FReperfusion+Injury&doi=10.1046%2Fj.1523-1755.2003.00802.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury</span></div><div class="casAuthors">Chatterjee, Prabal K.; Patel, Nimesh S. A.; Sivarajah, Ahila; Kvale, Espen O.; Dugo, Laura; Cuzzocrea, Salvatore; Brown, Paul A. J.; Stewart, Keith N.; Mota-Filipe, Helder; Britti, Domenico; Yaqoob, Muhammad M.; Thiemermann, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">853-865</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Generation of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) may contribute to renal ischemia/reperfusion (I/R) injury.  The aim of this study was to investigate the effects of GW274150, a novel, highly selective, potent and long-acting inhibitor of iNOS activity in rat and mouse models of renal I/R.  Rats were administered GW274150 (5 mg/kg i.v. bolus administered 30 min prior to I/R) and subjected to bilateral renal ischemia (45 min) followed by reperfusion (6 h).  Serum and urinary indicators of renal dysfunction, tubular and reperfusion injury were measured, specifically, serum urea, creatinine, aspartate aminotransferase (AST) and N-acetyl-β-D-glucosaminidase (NAG) enzymuria.  In addn., renal sections were used for histol. scoring of renal injury and for immunol. evidence of nitrotyrosine formation and poly [ADP (ADP)-ribose] (PAR).  Nitrate levels were measured in rat plasma using the Griess assay.  Mice (wild-type, administered 5 mg/kg GW274150, and iNOS-/-) were subjected to bilateral renal ischemia (30 min) followed by reperfusion (24 h) after which renal dysfunction (serum urea, creatinine), renal myeloperoxidase (MPO) activity and malondialdehyde (MDA) levels were measured.  GW274150, administered prior to I/R, significantly reduced serum urea, serum creatinine, AST, and NAG indicating redn. of renal dysfunction and injury caused by I/R.  GW274150 reduced histol. evidence of tubular injury and markedly reduced immunohistochem. evidence of nitrotyrosine and PAR formation, indicating reduced peroxynitrite formation and poly (ADP-ribose) polymerase (PARP) activation, resp.  GW274150 abolished the rise in the plasma levels of nitrate (indicating reduced NO prodn.).  GW274150 also reduced the renal dysfunction in wild-type mice to levels similar to that obsd. in iNOS-/- mice subjected to I/R.  Renal MPO activity and MDA levels were significantly reduced in wild-type mice administered GW274150 and iNOS-/- mice subjected to renal I/R, indicating reduced polymorphonuclear leukocyte (PMN) infiltration and lipid peroxidn.  These results suggest that (1) an enhanced formation of NO by iNOS contributes to the pathophysiol. of renal I/R injury and (2) GW274150 reduces I/R injury of the kidney.  We propose that selective inhibitors of iNOS activity may be useful against renal dysfunction and injury assocd. with I/R of the kidney.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0w-sSU2WM27Vg90H21EOLACvtfcHk0ljAqtPEsgGaIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivV2jsLs%253D&md5=feb716102c805d6d315f0d1a5a7268a5</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.2003.00802.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.2003.00802.x%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DP.%2BK.%26aulast%3DPatel%26aufirst%3DN.%2BS.%2BA.%26aulast%3DSivarajah%26aufirst%3DA.%26aulast%3DKvale%26aufirst%3DE.%2BO.%26aulast%3DDugo%26aufirst%3DL.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DStewart%26aufirst%3DK.%2BN.%26aulast%3DMota-Filipe%26aufirst%3DH.%26aulast%3DBritti%26aufirst%3DD.%26aulast%3DYaqoob%26aufirst%3DM.%2BM.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DGW274150%252C%2520a%2520Potent%2520and%2520Highly%2520Selective%2520Inhibitor%2520of%2520INOS%2520Reduces%2520Experimental%2520Renal%2520Ischemia%252FReperfusion%2520Injury%26jtitle%3DKidney%2520Int.%26date%3D2003%26volume%3D63%26issue%3D3%26spage%3D853%26epage%3D865%26doi%3D10.1046%2Fj.1523-1755.2003.00802.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serraino, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputi, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">Beneficial Effects of GW274150, a Novel, Potent and Selective Inhibitor of INOS Activity, in a Rodent Model of Collagen-Induced Arthritis</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>453</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(02)02338-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2FS0014-2999%2802%2902338-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=12393067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVChurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2002&pages=119-129&issue=1&author=S.+Cuzzocreaauthor=P.+K.+Chatterjeeauthor=E.+Mazzonauthor=M.+C.+McDonaldauthor=L.+Dugoauthor=R.+Di+Paolaauthor=I.+Serrainoauthor=D.+Brittiauthor=A.+P.+Caputiauthor=C.+Thiemermann&title=Beneficial+Effects+of+GW274150%2C+a+Novel%2C+Potent+and+Selective+Inhibitor+of+INOS+Activity%2C+in+a+Rodent+Model+of+Collagen-Induced+Arthritis&doi=10.1016%2FS0014-2999%2802%2902338-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis</span></div><div class="casAuthors">Cuzzocrea, Salvatore; Chatterjee, Prabal K.; Mazzon, Emanuela; McDonald, Michelle C.; Dugo, Laura; Di Paola, Rosanna; Serraino, Ivana; Britti, Domenico; Caputi, Achille P.; Thiemermann, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-129</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The aim of this study was to investigate the role of inducible nitric oxide synthase (iNOS) on the modulation of the inflammatory response in mice subjected to collagen-induced arthritis.  Collagen-induced arthritis was induced in wild-type mice (iNOS-WT) treated with GW274150, a novel, potent and selective inhibitor of iNOS activity, and in mice lacking the gene for iNOS (iNOS knock-out', iNOS-KO), by an intradermal injection of 100 μl of emulsion contg. 100 μg of bovine type II collagen and complete Freund's adjuvant at the base of the tail.  After 21 days, a second injection of type II collagen in complete Freund's adjuvant was administered. iNOS-WT mice developed erosive hind paw arthritis when immunized with type II collagen in complete Freund's adjuvant.  Over a 35-day period, macroscopic clin. evidence of collagen-induced arthritis first appeared as periarticular erythema and edema in the hind paws.  By day 28, the incidence of collagen-induced arthritis was 100% in type II collagen-challenged iNOS-WT mice and the severity of collagen-induced arthritis progressed with radiog. evaluation revealing resorption of bone.  Histopathol. of collagen-induced arthritis mice demonstrated erosion of the cartilage at the joint margins. iNOS-WT mice treated with GW274150 (5 mg/kg, i.p. daily) starting at the onset of arthritis (day 23), and iNOS-KO mice showed a delay of the development of the clin. signs at days 24-35 and an improvement of the histol. status in the knee and paw.  Immunohistochem. anal. for nitrotyrosine and for poly(ADP-ribose) polymerase revealed pos. staining in inflamed joints from type II collagen-treated iNOS-WT mice.  The degree of staining for nitrotyrosine and poly(ADP-ribose) polymerase were markedly reduced in tissue sections obtained from type II collagen-treated iNOS-WT mice, who had received GW274150 and from iNOS-KO mice.  Furthermore, radiog. signs of protection against bone resorption were present in the joints of iNOS-WT mice treated with GW274150 as well as in the joint from iNOS-KO mice.  This study provides the first evidence that GW274150, a novel, potent and selective inhibitor of iNOS activity, attenuates the degree of chronic inflammation and tissue damage assocd. with collagen-induced arthritis in mice.  Furthermore, these results suggest that the induction of iNOS and NO prodn. are essential for the up-regulation of the inflammatory response during exptl. collagen-induced arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDrF5GboEExLVg90H21EOLACvtfcHk0ljAqtPEsgGaIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVChurs%253D&md5=570e371daec34b34c8f9eb04ba7112b7</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902338-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902338-5%26sid%3Dliteratum%253Aachs%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DChatterjee%26aufirst%3DP.%2BK.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DMcDonald%26aufirst%3DM.%2BC.%26aulast%3DDugo%26aufirst%3DL.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DSerraino%26aufirst%3DI.%26aulast%3DBritti%26aufirst%3DD.%26aulast%3DCaputi%26aufirst%3DA.%2BP.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DBeneficial%2520Effects%2520of%2520GW274150%252C%2520a%2520Novel%252C%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520INOS%2520Activity%252C%2520in%2520a%2520Rodent%2520Model%2520of%2520Collagen-Induced%2520Arthritis%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D453%26issue%3D1%26spage%3D119%26epage%3D129%26doi%3D10.1016%2FS0014-2999%2802%2902338-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvale, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">GW274150 Inhibits Nitric Oxide Production by Primary Cultures of Rat Proximal Tubular Cells</span>. <i>Med. Sci. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">BR357</span>– <span class="NLM_lpage">BR362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=14523323" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=BR357-BR362&issue=10&author=P.+K.+Chatterjeeauthor=E.+O.+Kvaleauthor=N.+S.+A.+Patelauthor=C.+Thiemermann&title=GW274150+Inhibits+Nitric+Oxide+Production+by+Primary+Cultures+of+Rat+Proximal+Tubular+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DP.%2BK.%26aulast%3DKvale%26aufirst%3DE.%2BO.%26aulast%3DPatel%26aufirst%3DN.%2BS.%2BA.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DGW274150%2520Inhibits%2520Nitric%2520Oxide%2520Production%2520by%2520Primary%2520Cultures%2520of%2520Rat%2520Proximal%2520Tubular%2520Cells%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2003%26volume%3D9%26issue%3D10%26spage%3DBR357%26epage%3DBR362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Broom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinova-Mutafchieva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhurst, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexter, D. T.</span></span> <span> </span><span class="NLM_article-title">Neuroprotection by the Selective INOS Inhibitor GW274150 in a Model of Parkinson Disease</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2010.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2010.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=21185368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlejtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=633-640&issue=5&author=L.+Broomauthor=L.+Marinova-Mutafchievaauthor=M.+Sadeghianauthor=J.+B.+Davisauthor=A.+D.+Medhurstauthor=D.+T.+Dexter&title=Neuroprotection+by+the+Selective+INOS+Inhibitor+GW274150+in+a+Model+of+Parkinson+Disease&doi=10.1016%2Fj.freeradbiomed.2010.12.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease</span></div><div class="casAuthors">Broom, Lauren; Marinova-Mutafchieva, Lilia; Sadeghian, Mona; Davis, John B.; Medhurst, Andrew D.; Dexter, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">633-640</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neuroinflammation and the activation of inducible nitric oxide synthase (iNOS) have been proposed to play a role in the pathogenesis of Parkinson disease (PD).  In this study we investigated the effects of the selective iNOS inhibitor GW274150 in the 6-OHDA model of PD.  6-OHDA administration was assocd. with increased nos. of cells expressing iNOS.  Administration of the iNOS inhibitor twice daily for 7 days, beginning 2 days after the 6-OHDA lesioning, led to a significant neuroprotection as shown by assessment of the integrity of the nigrostriatal system by tyrosine hydroxylase immunocytochem. and HPLC assessment of striatal dopamine content.  However, GW274150 displayed a bell-shaped neuroprotective profile, being ineffective at high doses.  6-OHDA lesioning was assocd. with an increase in microglial activation as assessed by the MHC II antigen OX-6 and the no. of matrix metalloproteinase 9 (MMP-9)-immunopos. cells.  NO is a known modulator of MMP-9, and iNOS inhibition was assocd. with decreased nos. of MMP-9-immunopos. cells, culminating in a redn. in the nos. of reactive microglia.  Withdrawal of GW274150 for a further 7 days negated any neuroprotective effects of iNOS inhibition, suggesting that the damaging effects of inflammation last beyond 7 days in this model and the continued administration of the drug may be required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOlohkfL3bLVg90H21EOLACvtfcHk0ljUjdo34Xrd1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlejtbk%253D&md5=7ac55463ac877d6c20857c2d6a338569</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DBroom%26aufirst%3DL.%26aulast%3DMarinova-Mutafchieva%26aufirst%3DL.%26aulast%3DSadeghian%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DJ.%2BB.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DDexter%26aufirst%3DD.%2BT.%26atitle%3DNeuroprotection%2520by%2520the%2520Selective%2520INOS%2520Inhibitor%2520GW274150%2520in%2520a%2520Model%2520of%2520Parkinson%2520Disease%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2011%26volume%3D50%26issue%3D5%26spage%3D633%26epage%3D640%26doi%3D10.1016%2Fj.freeradbiomed.2010.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcin, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvai, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroeger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crane, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinder, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Gallay, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinker, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gensmantel, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mete, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheshire, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuehr, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tainer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getzoff, E. D.</span></span> <span> </span><span class="NLM_article-title">Anchored Plasticity Opens Doors for Selective Inhibitor Design in Nitric Oxide Synthase</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1038/nchembio.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fnchembio.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18849972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=700-707&issue=11&author=E.+D.+Garcinauthor=A.+S.+Arvaiauthor=R.+J.+Rosenfeldauthor=M.+D.+Kroegerauthor=B.+R.+Craneauthor=G.+Anderssonauthor=G.+Andrewsauthor=P.+J.+Hamleyauthor=P.+R.+Mallinderauthor=D.+J.+Nichollsauthor=S.+A.+St-Gallayauthor=A.+C.+Tinkerauthor=N.+P.+Gensmantelauthor=A.+Meteauthor=D.+R.+Cheshireauthor=S.+Connollyauthor=D.+J.+Stuehrauthor=A.+%C3%85bergauthor=A.+V.+Wallaceauthor=J.+A.+Tainerauthor=E.+D.+Getzoff&title=Anchored+Plasticity+Opens+Doors+for+Selective+Inhibitor+Design+in+Nitric+Oxide+Synthase&doi=10.1038%2Fnchembio.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase</span></div><div class="casAuthors">Garcin, Elsa D.; Arvai, Andrew S.; Rosenfeld, Robin J.; Kroeger, Matt D.; Crane, Brian R.; Andersson, Gunilla; Andrews, Glen; Hamley, Peter J.; Mallinder, Philip R.; Nicholls, David J.; St-Gallay, Stephen A.; Tinker, Alan C.; Gensmantel, Nigel P.; Mete, Antonio; Cheshire, David R.; Connolly, Stephen; Stuehr, Dennis J.; Aberg, Anders; Wallace, Alan V.; Tainer, John A.; Getzoff, Elizabeth D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">700-707</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nitric oxide synthase (NOS) enzymes synthesize nitric oxide, a signal for vasodilatation and neurotransmission at low concns. and a defensive cytotoxin at higher concns.  The high active site conservation among all three NOS isoenzymes hinders the design of selective NOS inhibitors to treat inflammation, arthritis, stroke, septic shock and cancer.  Our crystal structures and mutagenesis results identified an isoenzyme-specific induced-fit binding mode linking a cascade of conformational changes to a new specificity pocket.  Plasticity of an isoenzyme-specific triad of distant second- and third-shell residues modulates conformational changes of invariant first-shell residues to det. inhibitor selectivity.  To design potent and selective NOS inhibitors, we developed the anchored plasticity approach: anchor an inhibitor core in a conserved binding pocket, then extend rigid bulky substituents toward remote specificity pockets, which become accessible upon conformational changes of flexible residues.  This approach exemplifies general principles for the design of selective enzyme inhibitors that overcome strong active site conservation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolWKmmHvQjlbVg90H21EOLACvtfcHk0lhfD9Hva0Y96w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7nM&md5=838cf58525ee2f6fe85aaba9f3416536</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.115%26sid%3Dliteratum%253Aachs%26aulast%3DGarcin%26aufirst%3DE.%2BD.%26aulast%3DArvai%26aufirst%3DA.%2BS.%26aulast%3DRosenfeld%26aufirst%3DR.%2BJ.%26aulast%3DKroeger%26aufirst%3DM.%2BD.%26aulast%3DCrane%26aufirst%3DB.%2BR.%26aulast%3DAndersson%26aufirst%3DG.%26aulast%3DAndrews%26aufirst%3DG.%26aulast%3DHamley%26aufirst%3DP.%2BJ.%26aulast%3DMallinder%26aufirst%3DP.%2BR.%26aulast%3DNicholls%26aufirst%3DD.%2BJ.%26aulast%3DSt-Gallay%26aufirst%3DS.%2BA.%26aulast%3DTinker%26aufirst%3DA.%2BC.%26aulast%3DGensmantel%26aufirst%3DN.%2BP.%26aulast%3DMete%26aufirst%3DA.%26aulast%3DCheshire%26aufirst%3DD.%2BR.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DStuehr%26aufirst%3DD.%2BJ.%26aulast%3D%25C3%2585berg%26aufirst%3DA.%26aulast%3DWallace%26aufirst%3DA.%2BV.%26aulast%3DTainer%26aufirst%3DJ.%2BA.%26aulast%3DGetzoff%26aufirst%3DE.%2BD.%26atitle%3DAnchored%2520Plasticity%2520Opens%2520Doors%2520for%2520Selective%2520Inhibitor%2520Design%2520in%2520Nitric%2520Oxide%2520Synthase%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26issue%3D11%26spage%3D700%26epage%3D707%26doi%3D10.1038%2Fnchembio.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagmann, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durette, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esser, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanza, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopka, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guthikonda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacCoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabin, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humes, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacholok, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. K.</span></span> <span> </span><span class="NLM_article-title">Substituted 2-Ammopyridines as Inhibitors of Nitric Oxide Synthases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">1975</span>– <span class="NLM_lpage">1978</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)00389-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2FS0960-894X%2800%2900389-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10987430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFGmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1975-1978&issue=17&author=W.+K.+Hagmannauthor=C.+G.+Caldwellauthor=P.+Chenauthor=P.+L.+Duretteauthor=C.+K.+Esserauthor=T.+J.+Lanzaauthor=I.+E.+Kopkaauthor=R.+Guthikondaauthor=S.+K.+Shahauthor=M.+MacCossauthor=R.+M.+Chabinauthor=D.+Fletcherauthor=S.+K.+Grantauthor=B.+G.+Greenauthor=J.+L.+Humesauthor=T.+M.+Kellyauthor=S.+Luellauthor=R.+Meurerauthor=V.+Mooreauthor=S.+G.+Pacholokauthor=T.+Paviaauthor=H.+R.+Williamsauthor=K.+K.+Wong&title=Substituted+2-Ammopyridines+as+Inhibitors+of+Nitric+Oxide+Synthases&doi=10.1016%2FS0960-894X%2800%2900389-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 2-aminopyridines as inhibitors of nitric oxide synthases</span></div><div class="casAuthors">Hagmann, W. K.; Caldwell, C. G.; Chen, P.; Durette, P. L.; Esser, C. K.; Lanza, T. J.; Kopka, I. E.; Guthikonda, R.; Shah, S. K.; MacCoss, M.; Chabin, R. M.; Fletcher, D.; Grant, S. K.; Green, B. G.; Humes, J. L.; Kelly, T. M.; Luell, S.; Meurer, R.; Moore, V.; Pacholok, S. G.; Pavia, T.; Williams, H. R.; Wong, K. K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1975-1978</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of substituted 2-aminopyridines was prepd. and evaluated as inhibitors of human nitric oxide synthases.  4,6-Disubstitution enhanced both potency and specificity for the inducible NOS with the most potent compd. having an IC50 of 28 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonjuqmZk5vBLVg90H21EOLACvtfcHk0lhfD9Hva0Y96w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFGmsrY%253D&md5=b1455d89a1a49afece3f0898a02f575b</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900389-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900389-9%26sid%3Dliteratum%253Aachs%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26aulast%3DCaldwell%26aufirst%3DC.%2BG.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDurette%26aufirst%3DP.%2BL.%26aulast%3DEsser%26aufirst%3DC.%2BK.%26aulast%3DLanza%26aufirst%3DT.%2BJ.%26aulast%3DKopka%26aufirst%3DI.%2BE.%26aulast%3DGuthikonda%26aufirst%3DR.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DChabin%26aufirst%3DR.%2BM.%26aulast%3DFletcher%26aufirst%3DD.%26aulast%3DGrant%26aufirst%3DS.%2BK.%26aulast%3DGreen%26aufirst%3DB.%2BG.%26aulast%3DHumes%26aufirst%3DJ.%2BL.%26aulast%3DKelly%26aufirst%3DT.%2BM.%26aulast%3DLuell%26aufirst%3DS.%26aulast%3DMeurer%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DV.%26aulast%3DPacholok%26aufirst%3DS.%2BG.%26aulast%3DPavia%26aufirst%3DT.%26aulast%3DWilliams%26aufirst%3DH.%2BR.%26aulast%3DWong%26aufirst%3DK.%2BK.%26atitle%3DSubstituted%25202-Ammopyridines%2520as%2520Inhibitors%2520of%2520Nitric%2520Oxide%2520Synthases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26issue%3D17%26spage%3D1975%26epage%3D1978%26doi%3D10.1016%2FS0960-894X%2800%2900389-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinelli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Development of Nitric Oxide Synthase Inhibitors for Neurodegeneration and Neuropathic Pain</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6814</span>– <span class="NLM_lpage">6838</span>, <span class="refDoi"> DOI: 10.1039/C3CS60467E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1039%2FC3CS60467E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24549364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6814-6838&issue=19&author=P.+Mukherjeeauthor=M.+A.+Cinelliauthor=S.+Kangauthor=R.+B.+Silverman&title=Development+of+Nitric+Oxide+Synthase+Inhibitors+for+Neurodegeneration+and+Neuropathic+Pain&doi=10.1039%2FC3CS60467E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain</span></div><div class="casAuthors">Mukherjee, Paramita; Cinelli, Maris A.; Kang, Soosung; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6814-6838</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Nitric oxide (NO) is an important signaling mol. in the human body, playing a crucial role in cell and neuronal communication, regulation of blood pressure, and in immune activation.  However, overprodn. of NO by the neuronal isoform of nitric oxide synthase (nNOS) is one of the fundamental causes underlying neurodegenerative disorders and neuropathic pain.  Therefore, developing small mols. for selective inhibition of nNOS over related isoforms (eNOS and iNOS) is therapeutically desirable.  The aims of this review focus on the regulation and dysregulation of NO signaling, the role of NO in neurodegeneration and pain, the structure and mechanism of nNOS, and the use of this information to design selective inhibitors of this enzyme.  Structure-based drug design, the bioavailability and pharmacokinetics of these inhibitors, and extensive target validation through animal studies are addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT9LfBn3EJE7Vg90H21EOLACvtfcHk0lhSVMdIkQBO_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nK&md5=8c022181f136a666c0fd240735d742ca</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1039%2FC3CS60467E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60467E%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DP.%26aulast%3DCinelli%26aufirst%3DM.%2BA.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DDevelopment%2520of%2520Nitric%2520Oxide%2520Synthase%2520Inhibitors%2520for%2520Neurodegeneration%2520and%2520Neuropathic%2520Pain%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26issue%3D19%26spage%3D6814%26epage%3D6838%26doi%3D10.1039%2FC3CS60467E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevrioukova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulos, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Novel 2,4-Disubstituted Pyrimidines as Potent, Selective, and Cell- Permeable Inhibitors of Neuronal Nitric Oxide Synthase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.1021/jm501719e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501719e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVGmsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1067-1088&issue=3&author=P.+Mukherjeeauthor=H.+Liauthor=I.+Sevrioukovaauthor=G.+Chreiauthor=P.+Martaauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Novel+2%2C4-Disubstituted+Pyrimidines+as+Potent%2C+Selective%2C+and+Cell-+Permeable+Inhibitors+of+Neuronal+Nitric+Oxide+Synthase&doi=10.1021%2Fjm501719e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 2,4-Disubstituted Pyrimidines as Potent, Selective, and Cell-Permeable Inhibitors of Neuronal Nitric Oxide Synthase</span></div><div class="casAuthors">Mukherjee, Paramita; Li, Huiying; Sevrioukova, Irina; Chreifi, Georges; Martasek, Pavel; Roman, Linda J.; Poulos, Thomas L.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1067-1088</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibition of neuronal nitric oxide synthase (nNOS) is an important therapeutic approach to target neurodegenerative disorders.  However, the majority of the nNOS inhibitors developed are arginine mimetics and, therefore, suffer from poor bioavailability.  The authors designed a novel strategy to combine a more pharmacokinetically favorable 2-imidazolylpyrimidine head with promising structural components from previous inhibitors.  In conjunction with extensive structure-activity studies, several highly potent and selective inhibitors of nNOS were discovered.  X-ray crystallog. anal. reveals that these type II inhibitors utilize the same hydrophobic pocket to gain strong inhibitory potency I, as well as high isoform selectivity.  Interestingly, select compds. from this series II showed good permeability and low efflux in a Caco-2 assay, suggesting potential oral bioavailability, and exhibited minimal off-target binding to 50 central nervous system receptors.  Furthermore, even with heme-coordinating groups in the mol., modifying other pharmacophoric fragments minimized undesirable inhibition of cytochrome P450s from human liver microsomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3PMQyEmfT4rVg90H21EOLACvtfcHk0lhSVMdIkQBO_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVGmsLjL&md5=68139ff962657f7a02628da088d131ef</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Fjm501719e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501719e%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSevrioukova%26aufirst%3DI.%26aulast%3DChrei%26aufirst%3DG.%26aulast%3DMarta%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DNovel%25202%252C4-Disubstituted%2520Pyrimidines%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Cell-%2520Permeable%2520Inhibitors%2520of%2520Neuronal%2520Nitric%2520Oxide%2520Synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D3%26spage%3D1067%26epage%3D1088%26doi%3D10.1021%2Fjm501719e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davey, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaiz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eagen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilford, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrissey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paradkar, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polokoff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saionz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergona, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devlin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Activity of 2-Imidazol-1-Ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1146</span>– <span class="NLM_lpage">1157</span>, <span class="refDoi"> DOI: 10.1021/jm061319i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061319i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvF2rs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1146-1157&issue=6&author=D.+D.+Daveyauthor=M.+Adlerauthor=D.+Arnaizauthor=K.+Eagenauthor=S.+Ericksonauthor=W.+Guilfordauthor=M.+Kenrickauthor=M.+M.+Morrisseyauthor=M.+Ohlmeyerauthor=G.+Panauthor=V.+M.+Paradkarauthor=J.+Parkinsonauthor=M.+Polokoffauthor=K.+Saionzauthor=C.+Santosauthor=B.+Subramanyamauthor=R.+Vergonaauthor=R.+G.+Weiauthor=M.+Whitlowauthor=B.+Yeauthor=Z.+Zhaoauthor=J.+J.+Devlinauthor=G.+Phillips&title=Design%2C+Synthesis%2C+and+Activity+of+2-Imidazol-1-Ylpyrimidine+Derived+Inducible+Nitric+Oxide+Synthase+Dimerization+Inhibitors&doi=10.1021%2Fjm061319i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors</span></div><div class="casAuthors">Davey, David D.; Adler, Marc; Arnaiz, Damian; Eagen, Keith; Erickson, Shawn; Guilford, William; Kenrick, Margaret; Morrissey, Michael M.; Ohlmeyer, Mike; Pan, Gonghua; Paradkar, Vidyadhar M.; Parkinson, John; Polokoff, Mark; Saionz, Kurt; Santos, Cecile; Subramanyam, Babu; Vergona, Ron; Wei, Robert G.; Whitlow, Marc; Ye, Bin; Zhao, Zuchun; Devlin, James J.; Phillips, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1146-1157</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By the screening of a combinatorial library for inhibitors of nitric oxide (NO) formation by the inducible isoform of nitric oxide synthase (iNOS) using a whole-cell assay, 2-(imidazol-1-yl)pyrimidines were identified.  Compds. were found to inhibit the dimerization of iNOS monomers, thus preventing the formation of the dimeric, active form of the enzyme.  Optimization led to the selection of the potent, selective, and orally available iNOS dimerization inhibitor I, which significantly ameliorated adjuvant-induced arthritis in a rat model.  Anal. of the crystal structure of the I-iNOS monomer complex provided a rationalization for both the SAR and the mechanism by which compd. I blocks the formation of the protein-protein interaction present in the dimeric form of iNOS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw6TEIPjLF1LVg90H21EOLACvtfcHk0lh9e382twQwqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvF2rs70%253D&md5=5b280ba9f397094bb34fa15299898b6b</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1021%2Fjm061319i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061319i%26sid%3Dliteratum%253Aachs%26aulast%3DDavey%26aufirst%3DD.%2BD.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DArnaiz%26aufirst%3DD.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DErickson%26aufirst%3DS.%26aulast%3DGuilford%26aufirst%3DW.%26aulast%3DKenrick%26aufirst%3DM.%26aulast%3DMorrissey%26aufirst%3DM.%2BM.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DParadkar%26aufirst%3DV.%2BM.%26aulast%3DParkinson%26aufirst%3DJ.%26aulast%3DPolokoff%26aufirst%3DM.%26aulast%3DSaionz%26aufirst%3DK.%26aulast%3DSantos%26aufirst%3DC.%26aulast%3DSubramanyam%26aufirst%3DB.%26aulast%3DVergona%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DR.%2BG.%26aulast%3DWhitlow%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DDevlin%26aufirst%3DJ.%2BJ.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Activity%2520of%25202-Imidazol-1-Ylpyrimidine%2520Derived%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520Dimerization%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D6%26spage%3D1146%26epage%3D1157%26doi%3D10.1021%2Fjm061319i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martásek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulos, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Exploration of the Active Site of Neuronal Nitric Oxide Synthase by the Design and Synthesis of Pyrrolidinomethyl 2- Aminopyridine Derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7804</span>– <span class="NLM_lpage">7824</span>, <span class="refDoi"> DOI: 10.1021/jm100947x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100947x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7804-7824&issue=21&author=H.+Jiauthor=S.+L.+Delkerauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Exploration+of+the+Active+Site+of+Neuronal+Nitric+Oxide+Synthase+by+the+Design+and+Synthesis+of+Pyrrolidinomethyl+2-+Aminopyridine+Derivatives&doi=10.1021%2Fjm100947x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the Active Site of Neuronal Nitric Oxide Synthase by the Design and Synthesis of Pyrrolidinomethyl 2-Aminopyridine Derivatives</span></div><div class="casAuthors">Ji, Haitao; Delker, Silvia L.; Li, Huiying; Martasek, Pavel; Roman, Linda J.; Poulos, Thomas L.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7804-7824</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neuronal nitric oxide synthase (nNOS) represents an important therapeutic target for the prevention of brain injury and the treatment of various neurodegenerative disorders.  A series of trans-substituted amino pyrrolidinomethyl 2-aminopyridine derivs. (8-34) was designed and synthesized.  A structure-activity relationship anal. led to the discovery of low nanomolar nNOS inhibitors ((±)-32 and (±)-34) with more than 1000-fold selectivity for nNOS over eNOS.  Four enantiomerically pure isomers of 3'-[2''-(3'''-fluorophenethylamino)ethoxy]pyrrolidin-4'-ylmethyl-4-methylpyridin-2-amine (4) also were synthesized.  It was found that (3'R,4'R)-4 can induce enzyme elasticity to generate a new "hot spot" for ligand binding.  The inhibitor adopts a unique binding mode, the same as that obsd. for (3'R,4'R)-3'-[2''-(3'''-fluorophenethylamino)ethylamino]pyrrolidin-4'-ylmethyl-4-methylpyridin-2-amine ((3'R,4'R)-3).  On the basis of structure-activity relationships of 8-34 and different binding conformations of the cis and trans isomers of 3 and 4, crit. structural requirements of the NOS active site for ligand binding are revealed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8qg3dLeUcYrVg90H21EOLACvtfcHk0liSghsdxTF3Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjE&md5=0326c82eabceb9ceb8604ae5796b6436</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1021%2Fjm100947x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100947x%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DExploration%2520of%2520the%2520Active%2520Site%2520of%2520Neuronal%2520Nitric%2520Oxide%2520Synthase%2520by%2520the%2520Design%2520and%2520Synthesis%2520of%2520Pyrrolidinomethyl%25202-%2520Aminopyridine%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D21%26spage%3D7804%26epage%3D7824%26doi%3D10.1021%2Fjm100947x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span> <span> </span><span class="NLM_article-title">The Chemical Basis of Ferroptosis</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1137</span>– <span class="NLM_lpage">1147</span>, <span class="refDoi"> DOI: 10.1038/s41589-019-0408-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41589-019-0408-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31740834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFOqsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=1137-1147&issue=12&author=M.+Conradauthor=D.+A.+Pratt&title=The+Chemical+Basis+of+Ferroptosis&doi=10.1038%2Fs41589-019-0408-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">The chemical basis of ferroptosis</span></div><div class="casAuthors">Conrad, Marcus; Pratt, Derek A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1137-1147</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Lipid peroxidn. underlies the mechanism of oxidative cell death now known as ferroptosis.  This modality, distinct from other forms of cell death, has been intensely researched in recent years owing to its relevance in both degenerative disease and cancer.  The demonstration that it can be modulated by small mols. in multiple pathophysiol. contexts offers exciting opportunities for novel pharmacol. interventions.  Herein, we introduce the salient features of lipid peroxidn., how it can be modulated by small mols. and what principal aspects require urgent investigation by researchers in the field.  The central role of non-enzymic reactions in the execution of ferroptosis will be emphasized, as these processes have hitherto not been generally considered 'druggable'.  Moreover, we provide a crit. perspective on the biochem. mechanisms that contribute to cell vulnerability to ferroptosis and discuss how they can be exploited in the design of novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmBGqyaJ8WHrVg90H21EOLACvtfcHk0liSghsdxTF3Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFOqsrbN&md5=fa194bef13bea806e2412c679fb20307</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1038%2Fs41589-019-0408-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-019-0408-1%26sid%3Dliteratum%253Aachs%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Chemical%2520Basis%2520of%2520Ferroptosis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D15%26issue%3D12%26spage%3D1137%26epage%3D1147%26doi%3D10.1038%2Fs41589-019-0408-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossetto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venerando, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roveri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vučković, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosello
Travain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaccarin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zennaro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toppo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span> <span> </span><span class="NLM_article-title">Insight into the Mechanism of Ferroptosis Inhibition by Ferrostatin-1</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">101328</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.redox.2019.101328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31574461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVylt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=101328&author=G.+Miottoauthor=M.+Rossettoauthor=M.+L.+Di+Paoloauthor=L.+Orianauthor=R.+Venerandoauthor=A.+Roveriauthor=A.+M.+Vu%C4%8Dkovi%C4%87author=V.+Bosello%0ATravainauthor=M.+Zaccarinauthor=L.+Zennaroauthor=M.+Maiorinoauthor=S.+Toppoauthor=F.+Ursiniauthor=G.+Cozza&title=Insight+into+the+Mechanism+of+Ferroptosis+Inhibition+by+Ferrostatin-1&doi=10.1016%2Fj.redox.2019.101328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into the mechanism of ferroptosis inhibition by ferrostatin-1</span></div><div class="casAuthors">Miotto, Giovanni; Rossetto, Monica; Di Paolo, Maria Luisa; Orian, Laura; Venerando, Rina; Roveri, Antonella; Vuckovic, Ana-Marija; Bosello Travain, Valentina; Zaccarin, Mattia; Zennaro, Lucio; Maiorino, Matilde; Toppo, Stefano; Ursini, Fulvio; Cozza, Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101328</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ferroptosis is a form of cell death primed by iron and lipid hydroperoxides and prevented by GPx4.  Ferrostatin-1 (fer-1) inhibits ferroptosis much more efficiently than phenolic antioxidants.  Previous studies on the antioxidant efficiency of fer-1 adopted kinetic tests where a diazo compd. generates the hydroperoxyl radical scavenged by the antioxidant.  However, this reaction, accounting for a chain breaking effect, is only minimally useful for the description of the inhibition of ferrous iron and lipid hydroperoxide dependent peroxidn.  Scavenging lipid hydroperoxyl radicals, indeed, generates lipid hydroperoxides from which ferrous iron initiates a new peroxidative chain reaction.  We show that when fer-1 inhibits peroxidn., initiated by iron and traces of lipid hydroperoxides in liposomes, the pattern of oxidized species produced from traces of pre-existing hydroperoxides is practically identical to that obsd. following exhaustive peroxidn. in the absence of the antioxidant.  This supported the notion that the anti-ferroptotic activity of fer-1 is actually due to the scavenging of initiating alkoxyl radicals produced, together with other rearrangement products, by ferrous iron from lipid hydroperoxides.  Notably, fer-1 is not consumed while inhibiting iron dependent lipid peroxidn.  The emerging concept is that it is ferrous iron itself that reduces fer-1 radical.  This was supported by electroanal. evidence that fer-1 forms a complex with iron and further confirmed in cells by fluorescence of calcein, indicating a decrease of labile iron in the presence of fer-1.  The notion of such as pseudo-catalytic cycle of the ferrostatin-iron complex was also investigated by means of quantum mechanics calcns., which confirmed the redn. of an alkoxyl radical model by fer-1 and the redn. of fer-1 radical by ferrous iron.  In summary, GPx4 and fer-1 in the presence of ferrous iron, produces, by distinct mechanism, the most relevant anti-ferroptotic effect, i.e the disappearance of initiating lipid hydroperoxides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiu-QjvbUUI7Vg90H21EOLACvtfcHk0lgVmIuvQaDzKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVylt7%252FF&md5=3df8c36917ae41504caeeda0d3249835</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101328%26sid%3Dliteratum%253Aachs%26aulast%3DMiotto%26aufirst%3DG.%26aulast%3DRossetto%26aufirst%3DM.%26aulast%3DDi%2BPaolo%26aufirst%3DM.%2BL.%26aulast%3DOrian%26aufirst%3DL.%26aulast%3DVenerando%26aufirst%3DR.%26aulast%3DRoveri%26aufirst%3DA.%26aulast%3DVu%25C4%258Dkovi%25C4%2587%26aufirst%3DA.%2BM.%26aulast%3DBosello%2BTravain%26aufirst%3DV.%26aulast%3DZaccarin%26aufirst%3DM.%26aulast%3DZennaro%26aufirst%3DL.%26aulast%3DMaiorino%26aufirst%3DM.%26aulast%3DToppo%26aufirst%3DS.%26aulast%3DUrsini%26aufirst%3DF.%26aulast%3DCozza%26aufirst%3DG.%26atitle%3DInsight%2520into%2520the%2520Mechanism%2520of%2520Ferroptosis%2520Inhibition%2520by%2520Ferrostatin-1%26jtitle%3DRedox%2520Biol.%26date%3D2020%26volume%3D28%26spage%3D101328%26doi%3D10.1016%2Fj.redox.2019.101328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devisscher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Coillie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Rompaey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Winter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Veken, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">10126</span>– <span class="NLM_lpage">10140</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01299</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01299" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvF2mtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10126-10140&issue=22&author=L.+Devisscherauthor=S.+Van+Coillieauthor=S.+Hofmansauthor=D.+Van+Rompaeyauthor=K.+Goossensauthor=E.+Meulauthor=L.+Maesauthor=H.+De+Winterauthor=P.+Van+Der+Vekenauthor=P.+Vandenabeeleauthor=T.+Bergheauthor=K.+Augustyns&title=Discovery+of+Novel%2C+Drug-Like+Ferroptosis+Inhibitors+with+in+Vivo+Efficacy&doi=10.1021%2Facs.jmedchem.8b01299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy</span></div><div class="casAuthors">Devisscher, Lars; Van Coillie, Samya; Hofmans, Sam; Van Rompaey, Dries; Goossens, Kenneth; Meul, Eline; Maes, Louis; De Winter, Hans; Van Der Veken, Pieter; Vandenabeele, Peter; Berghe, Tom Vanden; Augustyns, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10126-10140</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ferroptosis is an iron-catalyzed, nonapoptotic form of regulated necrosis that results in oxidative lipid damage in cell membranes that can be inhibited by the radical-trapping antioxidant Ferrostatin-1 (Fer-1).  Novel inhibitors derived from the Fer-1 scaffold inhibited ferroptosis potently but suffered from soly. issues.  In this paper, the authors report the synthesis of a more stable and readily sol. series of Fer-1 analogs that potently inhibit ferroptosis.  The most promising compds. showed an improved protection compared to Fer-1 against multi-organ injury in mice.  No toxicity was obsd. in mice after daily injection of (I, UAMC-3203) for 4 wk.  UAMC-3203 inserts rapidly in a phospholipid bilayer in silico, which aligns with the current understanding of the mechanism of action of these compds.  In conclusion, these analogs have superior properties compared to Fer-1, show in vivo efficacy, and represent novel lead compds. with therapeutic potential in relevant ferroptosis-driven disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8FyW_G-tjd7Vg90H21EOLACvtfcHk0lgVmIuvQaDzKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvF2mtL3F&md5=db58889e5b5fc0794a13b5665d35364f</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01299%26sid%3Dliteratum%253Aachs%26aulast%3DDevisscher%26aufirst%3DL.%26aulast%3DVan%2BCoillie%26aufirst%3DS.%26aulast%3DHofmans%26aufirst%3DS.%26aulast%3DVan%2BRompaey%26aufirst%3DD.%26aulast%3DGoossens%26aufirst%3DK.%26aulast%3DMeul%26aufirst%3DE.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DDe%2BWinter%26aufirst%3DH.%26aulast%3DVan%2BDer%2BVeken%26aufirst%3DP.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DBerghe%26aufirst%3DT.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520Novel%252C%2520Drug-Like%2520Ferroptosis%2520Inhibitors%2520with%2520in%2520Vivo%2520Efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D22%26spage%3D10126%26epage%3D10140%26doi%3D10.1021%2Facs.jmedchem.8b01299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zilka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedmann
Angeli, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griesser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span> <span> </span><span class="NLM_article-title">On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1021/acscentsci.7b00028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.7b00028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjslaht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=232-243&issue=3&author=O.+Zilkaauthor=R.+Shahauthor=B.+Liauthor=J.+P.+Friedmann%0AAngeliauthor=M.+Griesserauthor=M.+Conradauthor=D.+A.+Pratt&title=On+the+Mechanism+of+Cytoprotection+by+Ferrostatin-1+and+Liproxstatin-1+and+the+Role+of+Lipid+Peroxidation+in+Ferroptotic+Cell+Death&doi=10.1021%2Facscentsci.7b00028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death</span></div><div class="casAuthors">Zilka, Omkar; Shah, Ron; Li, Bo; Friedmann Angeli, Jose Pedro; Griesser, Markus; Conrad, Marcus; Pratt, Derek A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">232-243</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ferroptosis is a form of regulated necrosis assocd. with the iron-dependent accumulation of lipid hydroperoxides that may play a key role in the pathogenesis of degenerative diseases in which lipid peroxidn. has been implicated.  High-throughput screening efforts have identified ferrostatin-1 (Fer-1) and liproxstatin-1 (Lip-1) as potent inhibitors of ferroptosis - an activity that has been ascribed to their ability to slow the accumulation of lipid hydroperoxides.  Herein we demonstrate that this activity likely derives from their reactivity as radical-trapping antioxidants (RTAs) rather than their potency as inhibitors of lipoxygenases.  Although inhibited autoxidns. of styrene revealed that Fer-1 and Lip-1 react roughly 10-fold more slowly with peroxyl radicals than reactions of α-tocopherol (α-TOH), they were significantly more reactive than α-TOH in phosphatidylcholine lipid bilayers - consistent with the greater potency of Fer-1 and Lip-1 relative to α-TOH as inhibitors of ferroptosis.  None of Fer-1, Lip-1, and α-TOH inhibited human 15-lipoxygenase-1 (15-LOX-1) overexpressed in HEK-293 cells when assayed at concns. where they inhibited ferroptosis.  These results stand in stark contrast to those obtained with a known 15-LOX-1 inhibitor (PD146176), which was able to inhibit the enzyme at concns. where it was effective in inhibiting ferroptosis.  Given the likelihood that Fer-1 and Lip-1 subvert ferroptosis by inhibiting lipid peroxidn. as RTAs, we evaluated the antiferroptotic potential of 1,8-tetrahydronaphthyridinols (hereafter THNs): rationally designed radical-trapping antioxidants of unparalleled reactivity.  We show for the first time that the inherent reactivity of the THNs translates to cell culture, where lipophilic THNs were similarly effective to Fer-1 and Lip-1 at subverting ferroptosis induced by either pharmacol. or genetic inhibition of the hydroperoxide-detoxifying enzyme Gpx4 in mouse fibroblasts, and glutamate-induced death of mouse hippocampal cells.  These results demonstrate that potent RTAs subvert ferroptosis and suggest that lipid peroxidn. (autoxidn.) may play a central role in the process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtKDxv_-zshrVg90H21EOLACvtfcHk0ljLdIvJi_7b1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjslaht7w%253D&md5=1f59e7fdb3ab17e78f4192f8366ad1f0</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.7b00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.7b00028%26sid%3Dliteratum%253Aachs%26aulast%3DZilka%26aufirst%3DO.%26aulast%3DShah%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DFriedmann%2BAngeli%26aufirst%3DJ.%2BP.%26aulast%3DGriesser%26aufirst%3DM.%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DOn%2520the%2520Mechanism%2520of%2520Cytoprotection%2520by%2520Ferrostatin-1%2520and%2520Liproxstatin-1%2520and%2520the%2520Role%2520of%2520Lipid%2520Peroxidation%2520in%2520Ferroptotic%2520Cell%2520Death%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2017%26volume%3D3%26issue%3D3%26spage%3D232%26epage%3D243%26doi%3D10.1021%2Facscentsci.7b00028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedmann Angeli, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proneth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurina, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurin, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aichler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggenhofer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basavarajappa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rådmark, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yefremova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornkamm, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odonnell, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span> <span> </span><span class="NLM_article-title">Inactivation of the Ferroptosis Regulator Gpx4 Triggers Acute Renal Failure in Mice</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1191</span>, <span class="refDoi"> DOI: 10.1038/ncb3064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fncb3064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=25402683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=1180-1191&issue=12&author=J.+P.+Friedmann+Angeliauthor=M.+Schneiderauthor=B.+Pronethauthor=Y.+Y.+Tyurinaauthor=V.+A.+Tyurinauthor=V.+J.+Hammondauthor=N.+Herbachauthor=M.+Aichlerauthor=A.+Walchauthor=E.+Eggenhoferauthor=D.+Basavarajappaauthor=O.+R%C3%A5dmarkauthor=S.+Kobayashiauthor=T.+Seibtauthor=H.+Beckauthor=F.+Neffauthor=I.+Espositoauthor=R.+Wankeauthor=H.+F%C3%B6rsterauthor=O.+Yefremovaauthor=M.+Heinrichmeyerauthor=G.+W.+Bornkammauthor=E.+K.+Geisslerauthor=S.+B.+Thomasauthor=B.+R.+Stockwellauthor=V.+B.+Odonnellauthor=V.+E.+Kaganauthor=J.+A.+Schickauthor=M.+Conrad&title=Inactivation+of+the+Ferroptosis+Regulator+Gpx4+Triggers+Acute+Renal+Failure+in+Mice&doi=10.1038%2Fncb3064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice</span></div><div class="casAuthors">Friedmann Angeli, Jose Pedro; Schneider, Manuela; Proneth, Bettina; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Hammond, Victoria J.; Herbach, Nadja; Aichler, Michaela; Walch, Axel; Eggenhofer, Elke; Basavarajappa, Devaraj; Radmark, Olof; Kobayashi, Sho; Seibt, Tobias; Beck, Heike; Neff, Frauke; Esposito, Irene; Wanke, Ruediger; Foerster, Heidi; Yefremova, Olena; Heinrichmeyer, Marc; Bornkamm, Georg W.; Geissler, Edward K.; Thomas, Stephen B.; Stockwell, Brent R.; O'Donnell, Valerie B.; Kagan, Valerian E.; Schick, Joel A.; Conrad, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1180-1191</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a non-apoptotic form of cell death induced by small mols. in specific tumor types, and in engineered cells overexpressing oncogenic RAS.  Yet, its relevance in non-transformed cells and tissues is unexplored and remains enigmatic.  Here, we provide direct genetic evidence that the knockout of glutathione peroxidase 4 (Gpx4) causes cell death in a pathol. relevant form of ferroptosis.  Using inducible Gpx4-/- mice, we elucidate an essential role for the glutathione/Gpx4 axis in preventing lipid-oxidn.-induced acute renal failure and assocd. death.  We furthermore systematically evaluated a library of small mols. for possible ferroptosis inhibitors, leading to the discovery of a potent spiroquinoxalinamine deriv. called Liproxstatin-1, which is able to suppress ferroptosis in cells, in Gpx4-/- mice, and in a pre-clin. model of ischemia/reperfusion-induced hepatic damage.  In sum, we demonstrate that ferroptosis is a pervasive and dynamic form of cell death, which, when impeded, promises substantial cytoprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuBNbniop_ibVg90H21EOLACvtfcHk0ljLdIvJi_7b1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrrF&md5=0d095f1a6206ab1dae7e04089847becf</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1038%2Fncb3064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3064%26sid%3Dliteratum%253Aachs%26aulast%3DFriedmann%2BAngeli%26aufirst%3DJ.%2BP.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DProneth%26aufirst%3DB.%26aulast%3DTyurina%26aufirst%3DY.%2BY.%26aulast%3DTyurin%26aufirst%3DV.%2BA.%26aulast%3DHammond%26aufirst%3DV.%2BJ.%26aulast%3DHerbach%26aufirst%3DN.%26aulast%3DAichler%26aufirst%3DM.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DEggenhofer%26aufirst%3DE.%26aulast%3DBasavarajappa%26aufirst%3DD.%26aulast%3DR%25C3%25A5dmark%26aufirst%3DO.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DSeibt%26aufirst%3DT.%26aulast%3DBeck%26aufirst%3DH.%26aulast%3DNeff%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DI.%26aulast%3DWanke%26aufirst%3DR.%26aulast%3DF%25C3%25B6rster%26aufirst%3DH.%26aulast%3DYefremova%26aufirst%3DO.%26aulast%3DHeinrichmeyer%26aufirst%3DM.%26aulast%3DBornkamm%26aufirst%3DG.%2BW.%26aulast%3DGeissler%26aufirst%3DE.%2BK.%26aulast%3DThomas%26aufirst%3DS.%2BB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DOdonnell%26aufirst%3DV.%2BB.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DSchick%26aufirst%3DJ.%2BA.%26aulast%3DConrad%26aufirst%3DM.%26atitle%3DInactivation%2520of%2520the%2520Ferroptosis%2520Regulator%2520Gpx4%2520Triggers%2520Acute%2520Renal%2520Failure%2520in%2520Mice%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26issue%3D12%26spage%3D1180%26epage%3D1191%26doi%3D10.1038%2Fncb3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span> <span> </span><span class="NLM_article-title">The Potency of Diarylamine Radical-Trapping Antioxidants as Inhibitors of Ferroptosis Underscores the Role of Autoxidation in the Mechanism of Cell Death</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2538</span>– <span class="NLM_lpage">2545</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00730</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00730" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlOksLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2538-2545&issue=10&author=R.+Shahauthor=K.+Margisonauthor=D.+A.+Pratt&title=The+Potency+of+Diarylamine+Radical-Trapping+Antioxidants+as+Inhibitors+of+Ferroptosis+Underscores+the+Role+of+Autoxidation+in+the+Mechanism+of+Cell+Death&doi=10.1021%2Facschembio.7b00730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">The Potency of Diarylamine Radical-Trapping Antioxidants as Inhibitors of Ferroptosis Underscores the Role of Autoxidation in the Mechanism of Cell Death</span></div><div class="casAuthors">Shah, Ron; Margison, Kaitlyn; Pratt, Derek A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2538-2545</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two arom. amines (ferrostatin-1 and liproxstatin-1) were recently identified from high-throughput screening efforts to uncover potent inhibitors of ferroptosis, the necrotic-like cell death induced by inhibition of glutathione peroxidase 4 (GPX4), deletion of the corresponding gpx4 gene, or starvation of GPX4 of its reducing cosubstrate, glutathione (GSH).  We have since demonstrated that these two arom. amines are highly effective radical-trapping antioxidants (RTAs) in lipid bilayers, suggesting that they subvert ferroptosis by inhibiting lipid peroxidn. (autoxidn.) and, thus, that this process drives the execution of ferroptosis.  Herein, we show that diarylamine RTAs used to protect petroleum-derived products from autoxidn. can be potent inhibitors of ferroptosis.  The diarylamines investigated include representative examples of additives to engine oils, greases and rubber (4,4'-dialkyldiphenylamines), core structures of dyes and pharmaceuticals (phenoxazines and phenothiazines), and aza-analogs of these three classes of compds. that we have recently shown can be modified to achieve much greater reactivity.  We find that regardless of how ferroptosis is induced (GPX4 inhibition, gpx4 deletion or GSH depletion), compds. which possess good RTA activity in org. soln. (kinh > 105 M-1 s-1) and lipid bilayers (kinh > 104 M-1 s-1) are generally potent inhibitors of ferroptosis (in mouse embryonic fibroblasts).  Likewise, structural analogs that do not possess RTA activity are devoid of antiferroptotic activity.  These results further support the argument that lipid peroxidn. (autoxidn.) plays a major role in the mechanism of cell death induced by either GPX4 inhibition, gpx4 deletion, or GSH depletion.  Moreover, it offers clear direction that ongoing medicinal chem. efforts on liproxstatin and ferrostatin derivs., which have been proposed as lead compds. for the treatment and/or prevention of ischemia/reperfusion injury, renal failure, and neurodegeneration, can be widened to include other aminic RTAs.  To aid in these efforts, some relevant structure-reactivity relationships are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGray_NCtHIr-bVg90H21EOLACvtfcHk0ljZ_xRH5vZ5UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOksLnM&md5=fefdd6246359c57145f57e52148d8449</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00730%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DR.%26aulast%3DMargison%26aufirst%3DK.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Potency%2520of%2520Diarylamine%2520Radical-Trapping%2520Antioxidants%2520as%2520Inhibitors%2520of%2520Ferroptosis%2520Underscores%2520the%2520Role%2520of%2520Autoxidation%2520in%2520the%2520Mechanism%2520of%2520Cell%2520Death%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26issue%3D10%26spage%3D2538%26epage%3D2545%26doi%3D10.1021%2Facschembio.7b00730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zilka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span> <span> </span><span class="NLM_article-title">Potent Ferroptosis Inhibitors Can Catalyze the Cross-Dismutation of Phospholipid-Derived Peroxyl Radicals and Hydroperoxyl Radicals</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">14331</span>– <span class="NLM_lpage">14342</span>, <span class="refDoi"> DOI: 10.1021/jacs.0c06379</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.0c06379" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVCmsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2020&pages=14331-14342&issue=33&author=J.+F.+Poonauthor=O.+Zilkaauthor=D.+A.+Pratt&title=Potent+Ferroptosis+Inhibitors+Can+Catalyze+the+Cross-Dismutation+of+Phospholipid-Derived+Peroxyl+Radicals+and+Hydroperoxyl+Radicals&doi=10.1021%2Fjacs.0c06379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Ferroptosis Inhibitors Can Catalyze the Cross-Dismutation of Phospholipid-Derived Peroxyl Radicals and Hydroperoxyl Radicals</span></div><div class="casAuthors">Poon, Jia-Fei; Zilka, Omkar; Pratt, Derek A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">14331-14342</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nitroxides were recently shown to catalyze the cross-dismutation of alkylperoxyl and hydroperoxyl radicals, making them uniquely effective radical-trapping antioxidants (RTAs) in unsatd. hydrocarbons where both species are formed.  Given the abundance of unsatd. lipids in biol. membranes, the continuous generation of hydroperoxyl (superoxide) as a byproduct of aerobic respiration, and the demonstrated cytoprotective properties of some nitroxides, we probed if cross-dismutation operates in phospholipid bilayers and cell culture.  Interestingly, only nitroxides that were efficiently converted to amines in situ were effective, with their activity paralleling the stability of the incipient aminyl radicals.  The ether-linked diarylamine phenoxazine, one of the most potent RTAs known, was particularly effective as a cross-dismutation catalyst.  In contrast, phenolic RTAs such as α-tocopherol (α-TOH), the most potent form of vitamin E, were found to be inefficient due to the preference for the combination of hydroperoxyl and phenoxyl radicals over H-atom transfer between them.  Expts. carried out in mouse embryonic fibroblasts corroborated these findings.  Cells cotreated with phenoxazine (or its nitroxide) and a superoxide source were better protected from ferroptosis than those treated with phenoxazine (or its nitroxide) alone.  No such synergy was obsd. for cells treated with α-TOH.  Live cell imaging established that cytoprotection was assocd. with suppression of (phospho)lipid peroxidn.  These results highlight the remarkable capacity for select amines to act as effective phase-transfer catalysts for a reducing equiv. (an H atom), such that a water-sol. "reactive oxygen species" can be used to quench a lipid-sol. one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAFHhvqa7X0bVg90H21EOLACvtfcHk0ljZ_xRH5vZ5UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVCmsLvK&md5=6351e5f66df2bda089ca456a7d84fbdf</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Fjacs.0c06379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.0c06379%26sid%3Dliteratum%253Aachs%26aulast%3DPoon%26aufirst%3DJ.%2BF.%26aulast%3DZilka%26aufirst%3DO.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DPotent%2520Ferroptosis%2520Inhibitors%2520Can%2520Catalyze%2520the%2520Cross-Dismutation%2520of%2520Phospholipid-Derived%2520Peroxyl%2520Radicals%2520and%2520Hydroperoxyl%2520Radicals%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2020%26volume%3D142%26issue%3D33%26spage%3D14331%26epage%3D14342%26doi%3D10.1021%2Fjacs.0c06379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vejražka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Míček, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štípek, S.</span></span> <span> </span><span class="NLM_article-title">Apocynin Inhibits NADPH Oxidase in Phagocytes but Stimulates ROS Production in Non-Phagocytic Cells</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1722</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2004.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.bbagen.2004.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1722&publication_year=2005&pages=143-147&issue=2&author=M.+Vejra%C5%BEkaauthor=R.+M%C3%AD%C4%8Dekauthor=S.+%C5%A0t%C3%ADpek&title=Apocynin+Inhibits+NADPH+Oxidase+in+Phagocytes+but+Stimulates+ROS+Production+in+Non-Phagocytic+Cells&doi=10.1016%2Fj.bbagen.2004.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells</span></div><div class="casAuthors">Vejrazka, Martin; Micek, Radan; Stipek, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1722</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-147</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Apocynin is a naturally occurring methoxy-substituted catechol, exptl. used as an inhibitor of NADPH oxidase.  Since it acts as a potent inhibitor in studies with neutrophils and macrophages, no inhibitory effect can often be found in non-phagocyte cells.  In our expts., apocynin even stimulated reactive oxygen species (ROS) prodn. by vascular fibroblasts.  Even when added to macrophages, apocynin initially caused an increase in ROS prodn.  The inhibition of ROS formation followed, suggesting that in the presence of leukocyte myeloperoxidase and hydrogen peroxide, apocynin is converted to another compd.  Apocynin pre-activated with H2O2 and horseradish peroxidase (HRP) inhibited ROS prodn. immediately.  In non-phagocytes, apocynin stimulated ROS prodn. and no inhibition was obsd. even after 60 min.  Apocynin treated with H2O2 and HRP, however, decreased ROS prodn. in the same manner as in macrophages.  The stimulatory effect on ROS prodn. can be abolished by tiron and superoxide dismutase (SOD), suggesting that superoxide was the produced species.  The effect of apocynin was inhibited by diphenylene iodinium (DPI), a non-scavenging NADPH oxidase inhibitor.  It can be summarized that apocynin stimulates cell superoxide prodn.  In the presence of peroxidase and hydrogen peroxide, however, it is converted into another compd. that acts as an inhibitor of superoxide prodn.  It strongly suggests that under conditions in vivo, apocynin can have opposite effects on phagocytes and non-phagocyte cells.  It acts as an inhibitor of phagocyte NADPH oxidase but also as a ROS prodn. stimulator in non-phagocyte cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyaVqpMnKkVrVg90H21EOLACvtfcHk0li3a-79xN2cbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVShtLg%253D&md5=b1e3236cf4c5e28a532c6911f0067594</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2004.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2004.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DVejra%25C5%25BEka%26aufirst%3DM.%26aulast%3DM%25C3%25AD%25C4%258Dek%26aufirst%3DR.%26aulast%3D%25C5%25A0t%25C3%25ADpek%26aufirst%3DS.%26atitle%3DApocynin%2520Inhibits%2520NADPH%2520Oxidase%2520in%2520Phagocytes%2520but%2520Stimulates%2520ROS%2520Production%2520in%2520Non-Phagocytic%2520Cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2005%26volume%3D1722%26issue%3D2%26spage%3D143%26epage%3D147%26doi%3D10.1016%2Fj.bbagen.2004.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stolk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiltermann, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoeven, A. J.</span></span> <span> </span><span class="NLM_article-title">Characteristics of the Inhibition of NADPH Oxidase Activation in Neutrophils by Apocynin, a Methoxy-Substituted Catechol</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1165/ajrcmb.11.1.8018341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1165%2Fajrcmb.11.1.8018341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=8018341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFGmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1994&pages=95-102&issue=1&author=J.+Stolkauthor=T.+J.+Hiltermannauthor=J.+H.+Dijkmanauthor=A.+J.+Verhoeven&title=Characteristics+of+the+Inhibition+of+NADPH+Oxidase+Activation+in+Neutrophils+by+Apocynin%2C+a+Methoxy-Substituted+Catechol&doi=10.1165%2Fajrcmb.11.1.8018341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol</span></div><div class="casAuthors">Stolk, J.; Hiltermann, T. J. N.; Dijkman, J. H.; Verhoeven, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-102</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    </div><div class="casAbstract">Phagocytes are able to generate reactive oxygen species by an activatable NADPH oxidase system.  We investigated the inhibition of NADPH oxidase activation by a methoxy-substituted catechol, apocynin.  Oxygen uptake by neutrophils incubated with 300 μM apocynin was completely inhibited at 7 min after addn. of serum-treated zymosan (STZ), with a lag-time of inhibition of 2 to 3 min.  The lag-time of effect of apocynin in neutrophils relatively deficient of myeloperoxidase was about 50% longer when compared with normal cells.  Inhibition of the STZ-induced respiratory burst by apocynin was also obsd. in human eosinophils but not in human alveolar macrophages.  Immunoblots of neutrophils membranes, isolated at 2 and 7 min after STZ stimulation of neutrophils, demonstrated translocation of the cytosolic oxidase components p47-phox and p67-phox to the membrane fraction.  Translocation at 7 min after STZ stimulation was markedly reduced when the neutrophils had been incubated with 300 μM apocynin, but translocation was normal after 2 min of stimulation.  These properties suggest that apocynin is an intracellular inhibitor of the assembly of NADPH oxidase in neutrophils and eosinophils and that apocynin requires conversion by peroxidases to exert its inhibitory effect.  The capacity of neutrophils for intracellular killing of Staphylococcus aureus was not affected by apocynin.  The potential therapeutic value of apocynin was demonstrated in vitro by its ability to protect secretory leukocyte proteinase inhibitor from oxidative inactivation by neutrophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1-_5U8QcKrrVg90H21EOLACvtfcHk0li3a-79xN2cbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFGmsL8%253D&md5=2ccd7bad5239b50dcf39b756f8d0c887</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.11.1.8018341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.11.1.8018341%26sid%3Dliteratum%253Aachs%26aulast%3DStolk%26aufirst%3DJ.%26aulast%3DHiltermann%26aufirst%3DT.%2BJ.%26aulast%3DDijkman%26aufirst%3DJ.%2BH.%26aulast%3DVerhoeven%26aufirst%3DA.%2BJ.%26atitle%3DCharacteristics%2520of%2520the%2520Inhibition%2520of%2520NADPH%2520Oxidase%2520Activation%2520in%2520Neutrophils%2520by%2520Apocynin%252C%2520a%2520Methoxy-Substituted%2520Catechol%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D1994%26volume%3D11%26issue%3D1%26spage%3D95%26epage%3D102%26doi%3D10.1165%2Fajrcmb.11.1.8018341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heumüller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wind, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa-Sicard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. H. H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandes, R. P.</span></span> <span> </span><span class="NLM_article-title">Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.107.100214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1161%2FHYPERTENSIONAHA.107.100214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18086956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=211-217&issue=2&author=S.+Heum%C3%BCllerauthor=S.+Windauthor=E.+Barbosa-Sicardauthor=H.+H.+H.+W.+Schmidtauthor=R.+Busseauthor=K.+Schr%C3%B6derauthor=R.+P.+Brandes&title=Apocynin+Is+Not+an+Inhibitor+of+Vascular+NADPH+Oxidases+but+an+Antioxidant&doi=10.1161%2FHYPERTENSIONAHA.107.100214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant</span></div><div class="casAuthors">Heumueller, Sabine; Wind, Sven; Barbosa-Sicard, Eduardo; Schmidt, Harald H. H. W.; Busse, Rudi; Schroeder, Katrin; Brandes, Ralf P.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-217</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A large body of literature suggest that vascular reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases are important sources of reactive oxygen species.  Many studies, however, relied on data obtained with the inhibitor apocynin (4'-hydroxy-3'methoxyacetophenone).  Because the mode of action of apocynin, however, is elusive, we detd. its mechanism of inhibition on vascular NADPH oxidases.  In HEK293 cells overexpressing NADPH oxidase isoforms (Nox1, Nox2, or Nox4), apocynin failed to inhibit superoxide anion generation detected by lucigenin chemiluminescence.  In contrast, apocynin interfered with the detection of reactive oxygen species in assay systems selective for hydrogen peroxide or hydroxyl radicals.  Importantly, apocynin interfered directly with the detection of peroxides but not superoxide, if generated by xanthine/xanthine oxidase or nonenzymic systems.  In leukocytes, apocynin is a prodrug that is activated by myeloperoxidase, a process that results in the formation of apocynin dimers.  Endothelial cells and smooth muscle cells failed to form these dimers and, therefore, are not able to activate apocynin.  Dimer formation was, however, obsd. in Nox-overexpressing HEK293 cells when myeloperoxidase was supplemented.  As a consequence, apocynin should only inhibit NADPH oxidase in leukocytes, whereas in vascular cells, the compd. could act as an antioxidant.  Indeed, in vascular smooth muscle cells, the activation of the redox-sensitive kinases p38-mitogen-activated protein kinase, Akt, and extracellular signal-regulated kinase 1/2 by hydrogen peroxide and by the intracellular radical generator menadione was prevented in the presence of apocynin.  These observations indicate that apocynin predominantly acts as an antioxidant in endothelial cells and vascular smooth muscle cells and should not be used as an NADPH oxidase inhibitor in vascular systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfYewBKMZgWrVg90H21EOLACvtfcHk0liwiGFi3qPNsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojsg%253D%253D&md5=8d489f78fca22a17cef17b5b264aa281</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.107.100214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.107.100214%26sid%3Dliteratum%253Aachs%26aulast%3DHeum%25C3%25BCller%26aufirst%3DS.%26aulast%3DWind%26aufirst%3DS.%26aulast%3DBarbosa-Sicard%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DH.%2BH.%2BH.%2BW.%26aulast%3DBusse%26aufirst%3DR.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DK.%26aulast%3DBrandes%26aufirst%3DR.%2BP.%26atitle%3DApocynin%2520Is%2520Not%2520an%2520Inhibitor%2520of%2520Vascular%2520NADPH%2520Oxidases%2520but%2520an%2520Antioxidant%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26issue%3D2%26spage%3D211%26epage%3D217%26doi%3D10.1161%2FHYPERTENSIONAHA.107.100214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kearse, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goserud, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harpel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, D. G.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase-Dependent and -Independent Mechanisms of Reported Inhibitors of Reactive Oxygen Generation</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.3109/14756366.2011.636360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3109%2F14756366.2011.636360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22136506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=95-104&issue=1&author=G.+J.+Gattoauthor=Z.+Aoauthor=M.+G.+Kearseauthor=M.+Zhouauthor=C.+R.+Moralesauthor=E.+Danielsauthor=B.+T.+Bradleyauthor=M.+T.+Goserudauthor=K.+B.+Goodmanauthor=S.+A.+Douglasauthor=M.+R.+Harpelauthor=D.+G.+Johns&title=NADPH+Oxidase-Dependent+and+-Independent+Mechanisms+of+Reported+Inhibitors+of+Reactive+Oxygen+Generation&doi=10.3109%2F14756366.2011.636360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation</span></div><div class="casAuthors">Gatto, Gregory J., Jr.; Ao, Zhaohui; Kearse, Michael G.; Zhou, Mei; Morales, Cyndi R.; Daniels, Erin; Bradley, Benjamin T.; Goserud, Matthew T.; Goodman, Krista B.; Douglas, Stephen A.; Harpel, Mark R.; Johns, Douglas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-104</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">NADPH oxidase isoform-2 (NOX2) generates reactive oxygen species (ROS) that contribute to neurodegenerative and cardiovascular pathologies.  However, validation of NOX2 as a pharmacotherapeutic target has been hampered by a lack of mechanistically-defined inhibitors.  Using cellular and biochem. assays, we explored previously reported inhibitors of ROS prodn. (perhexiline, suramin, VAS2870 and two Shionogi patent compds.) as direct NOX2 inhibitors.  All but suramin, which presumably lacks cell penetrance, inhibit cellular ROS prodn.  However, only perhexiline and suramin inhibit biochem. NOX2 activity.  Indeed, our data suggest that NOX2 inhibition by perhexiline may contribute significantly to its demonstrated cardioprotective effects.  Inhibition of protein kinase CβII explains the cellular activity of the Shionogi compds., whereas VAS2870 inhibits by an as-yet unidentified mechanism unrelated to direct NOX2 function or subunit assembly.  These data delineate the mechanisms of action of these compds. and highlight their strengths and limitations for use in future target validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPBEpSEtUqDLVg90H21EOLACvtfcHk0liwiGFi3qPNsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslajsw%253D%253D&md5=e509a2b7fd22c6ce23dcd8703c3e1ed7</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.3109%2F14756366.2011.636360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2011.636360%26sid%3Dliteratum%253Aachs%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DAo%26aufirst%3DZ.%26aulast%3DKearse%26aufirst%3DM.%2BG.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DMorales%26aufirst%3DC.%2BR.%26aulast%3DDaniels%26aufirst%3DE.%26aulast%3DBradley%26aufirst%3DB.%2BT.%26aulast%3DGoserud%26aufirst%3DM.%2BT.%26aulast%3DGoodman%26aufirst%3DK.%2BB.%26aulast%3DDouglas%26aufirst%3DS.%2BA.%26aulast%3DHarpel%26aufirst%3DM.%2BR.%26aulast%3DJohns%26aufirst%3DD.%2BG.%26atitle%3DNADPH%2520Oxidase-Dependent%2520and%2520-Independent%2520Mechanisms%2520of%2520Reported%2520Inhibitors%2520of%2520Reactive%2520Oxygen%2520Generation%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2013%26volume%3D28%26issue%3D1%26spage%3D95%26epage%3D104%26doi%3D10.3109%2F14756366.2011.636360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solbak, S. M. Ø.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Høj, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucciarelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Softley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langkilde, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotfredsen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">Developing Inhibitors of the P47phox–p22phox Protein–Protein Interaction by Fragment-Based Drug Discovery.Pdf</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1156</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01492</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01492" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvVWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=1156-1177&issue=3&author=S.+M.+%C3%98.+Solbakauthor=J.+Zangauthor=D.+Narayananauthor=L.+J.+H%C3%B8jauthor=S.+Bucciarelliauthor=C.+Softleyauthor=S.+Meierauthor=A.+E.+Langkildeauthor=C.+H.+Gotfredsenauthor=M.+Sattlerauthor=A.+Bach&title=Developing+Inhibitors+of+the+P47phox%E2%80%93p22phox+Protein%E2%80%93Protein+Interaction+by+Fragment-Based+Drug+Discovery.Pdf&doi=10.1021%2Facs.jmedchem.9b01492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Inhibitors of the p47phox-p22phox Protein-Protein Interaction by Fragment-Based Drug Discovery</span></div><div class="casAuthors">Solbak, Sara Marie Oeie; Zang, Jie; Narayanan, Dilip; Hoej, Lars Jakobsen; Bucciarelli, Saskia; Softley, Charlotte; Meier, Sebastian; Langkilde, Annette Eva; Gotfredsen, Charlotte Held; Sattler, Michael; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1156-1177</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NADP oxidase isoform 2 is an enzyme complex, which generates reactive oxygen species and contributes to oxidative stress.  The p47phox-p22phox interaction is crit. for the activation of the catalytical NOX2 domain, and p47phox is a potential target for therapeutic intervention.  By screening 2500 fragments using fluorescence polarization and a thermal shift assay and validation by surface plasmon resonance, we found eight hits toward the tandem SH3 domain of p47phox (p47phoxSH3A-B) with KD values of 400-600 μM.  Structural studies revealed that fragments 1 and 2 bound two sep. binding sites in the elongated conformation of p47phoxSH3A-B and these competed with p22phox for binding to p47phoxSH3A-B.  Chem. optimization led to a dimeric compd. with the ability to potently inhibit the p47phoxSH3A-B-p22phox interaction (Ki of 20 μM).  Thereby, we reveal a new way of targeting p47phox and present the first report of drug-like mols. with the ability to bind p47phox and inhibit its interaction with p22phox.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKsTGuYjZwNbVg90H21EOLACvtfcHk0liW2kePikP0fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvVWhsg%253D%253D&md5=2a0d529e136f236d3424d1cc2e723de5</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01492%26sid%3Dliteratum%253Aachs%26aulast%3DSolbak%26aufirst%3DS.%2BM.%2B%25C3%2598.%26aulast%3DZang%26aufirst%3DJ.%26aulast%3DNarayanan%26aufirst%3DD.%26aulast%3DH%25C3%25B8j%26aufirst%3DL.%2BJ.%26aulast%3DBucciarelli%26aufirst%3DS.%26aulast%3DSoftley%26aufirst%3DC.%26aulast%3DMeier%26aufirst%3DS.%26aulast%3DLangkilde%26aufirst%3DA.%2BE.%26aulast%3DGotfredsen%26aufirst%3DC.%2BH.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DDeveloping%2520Inhibitors%2520of%2520the%2520P47phox%25E2%2580%2593p22phox%2520Protein%25E2%2580%2593Protein%2520Interaction%2520by%2520Fragment-Based%2520Drug%2520Discovery.Pdf%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D3%26spage%3D1156%26epage%3D1177%26doi%3D10.1021%2Facs.jmedchem.9b01492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, R.</span></span> <span> </span><span class="NLM_article-title">Lactoflavin (Vitamin B2)</span>. <i>Angew. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1936</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1002/ange.19360490103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fange.19360490103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaA28Xhs12rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1936&pages=6-10&issue=1&author=R.+Kuhn&title=Lactoflavin+%28Vitamin+B2%29&doi=10.1002%2Fange.19360490103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Lactoflavin (vitamin B2)</span></div><div class="casAuthors">Kuhn, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie</span>
        (<span class="NLM_cas:date">1936</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6-10</span>CODEN:
                <span class="NLM_cas:coden">ANCEAD</span>;
        ISSN:<span class="NLM_cas:issn">0044-8249</span>.
    </div><div class="casAbstract">cf. C. A. 29, 6616.1.  The following subjects are discussed: (1) isolation, growth action, (2) decompn., primary stage of an enzyme (proenzyme), (3) synthesis of lumiflavin, (4) the OH-contg. side chain, (5) synthesis of lactoflavin, (6) intermediary products, boric acid method, (7) specificity, (8) flavin glucoside, (9) phosphoric acid ester and (10) bios, vitamin, proenzyme, coenzyme, enzyme.  Forty-one references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphXBFGpELGbLVg90H21EOLACvtfcHk0liW2kePikP0fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA28Xhs12rtQ%253D%253D&md5=88867e6d50899f96dbe4a4cefed2b9b5</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1002%2Fange.19360490103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fange.19360490103%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DR.%26atitle%3DLactoflavin%2520%2528Vitamin%2520B2%2529%26jtitle%3DAngew.%2520Chem.%26date%3D1936%26volume%3D49%26issue%3D1%26spage%3D6%26epage%3D10%26doi%3D10.1002%2Fange.19360490103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schramm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schramm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluschko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utermöhlen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krönke, M.</span></span> <span> </span><span class="NLM_article-title">Riboflavin (Vitamin B 2) Deficiency Impairs NADPH Oxidase 2 (Nox2) Priming and Defense against Listeria Monocytogenes</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1002/eji.201343940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Feji.201343940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24272050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWisrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=728-741&issue=3&author=M.+Schrammauthor=K.+Wiegmannauthor=S.+Schrammauthor=A.+Gluschkoauthor=M.+Herbauthor=O.+Uterm%C3%B6hlenauthor=M.+Kr%C3%B6nke&title=Riboflavin+%28Vitamin+B+2%29+Deficiency+Impairs+NADPH+Oxidase+2+%28Nox2%29+Priming+and+Defense+against+Listeria+Monocytogenes&doi=10.1002%2Feji.201343940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Riboflavin (vitamin B2) deficiency impairs NADPH oxidase 2 (Nox2) priming and defense against Listeria monocytogenes</span></div><div class="casAuthors">Schramm, Michael; Wiegmann, Katja; Schramm, Sandra; Gluschko, Alexander; Herb, Marc; Utermoehlen, Olaf; Kroenke, Martin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">728-741</span>CODEN:
                <span class="NLM_cas:coden">EJIMAF</span>;
        ISSN:<span class="NLM_cas:issn">0014-2980</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Riboflavin, also known as vitamin B2, is converted by riboflavin kinase (RFK) into FMN (FMN) and FAD (FAD), which are essential cofactors of dehydrogenases, reductases, and oxidases including the phagocytic NADPH oxidase 2 (Nox2).  Riboflavin deficiency is common in young adults and elderly individuals, who are at the coincidental risk for listeriosis.  To address the impact of acute riboflavin deficiency on host defense against Listeria monocytogenes (L.m.), we generated conditional RFK knockout (KO) strains of mice.  Phagocyte-specific RFK KO impaired the capability of phagocytes to control intracellular L.m., which corresponded to a greater susceptibility of mice to in vivo challenge with L.m.  The oxidative burst of RFK-deficient phagocytes in response to L.m. infection was significantly reduced.  Mechanistically, TNF-induced priming of Nox2, which is needed for oxidative burst, was defective in RFK-deficient phagocytes.  Lack of riboflavin in wild-type macrophages for only 6 h shut down TNF-induced, RFK-mediated de novo FMN/FAD generation, which was accompanied by diminished ROS prodn. and impaired anti-listerial activity.  Vice versa, ROS prodn. by riboflavin-deprived macrophages was rapidly restored by riboflavin supplementation.  Our results suggest that acute riboflavin deficiency immediately impairs priming of Nox2, which is of crucial relevance for an effective phagocytic immune response in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9JYAk_Wks47Vg90H21EOLACvtfcHk0liov-In5XGe-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWisrbF&md5=327bada69324b1103f6aaf6b9b5fbc05</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1002%2Feji.201343940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.201343940%26sid%3Dliteratum%253Aachs%26aulast%3DSchramm%26aufirst%3DM.%26aulast%3DWiegmann%26aufirst%3DK.%26aulast%3DSchramm%26aufirst%3DS.%26aulast%3DGluschko%26aufirst%3DA.%26aulast%3DHerb%26aufirst%3DM.%26aulast%3DUterm%25C3%25B6hlen%26aufirst%3DO.%26aulast%3DKr%25C3%25B6nke%26aufirst%3DM.%26atitle%3DRiboflavin%2520%2528Vitamin%2520B%25202%2529%2520Deficiency%2520Impairs%2520NADPH%2520Oxidase%25202%2520%2528Nox2%2529%2520Priming%2520and%2520Defense%2520against%2520Listeria%2520Monocytogenes%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2014%26volume%3D44%26issue%3D3%26spage%3D728%26epage%3D741%26doi%3D10.1002%2Feji.201343940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span> <span> </span><span class="NLM_article-title">Vitamin B2 Blocks Development of Alzheimer ’ s Disease in APP/PS1 Transgenic Mice via Anti-Oxidative Mechanism</span>. <i>Trop. J. Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1054</span>, <span class="refDoi"> DOI: 10.4314/tjpr.v17i6.10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.4314%2Ftjpr.v17i6.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlymtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1049-1054&issue=6&author=R.+Zhaoauthor=H.+Wangauthor=C.+Qiaoauthor=K.+Zhao&title=Vitamin+B2+Blocks+Development+of+Alzheimer+%E2%80%99+s+Disease+in+APP%2FPS1+Transgenic+Mice+via+Anti-Oxidative+Mechanism&doi=10.4314%2Ftjpr.v17i6.10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Vitamin B2 blocks development of Alzheimer's disease in APP/PS1 transgenic mice via anti-oxidative mechanism</span></div><div class="casAuthors">Zhao, Rong; Wang, Huajun; Qiao, Chen; Zhao, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Tropical Journal of Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1049-1054</span>CODEN:
                <span class="NLM_cas:coden">TJPRAQ</span>;
        ISSN:<span class="NLM_cas:issn">1596-9827</span>.
    
            (<span class="NLM_cas:orgname">Pharmacotherapy Group</span>)
        </div><div class="casAbstract">Purpose: To study the effect of vitamin B2 (VB2) on the development of Alzheimer's disease (AD).  Methods: Memory and learning abilities were assessed in amyloid precursor protein/presenilin-1 (APP/PSI) transgenic mice aged 3 mo, and C57BL/6 mice, using Morris water maze test.  Brain tissue levels of key antioxidant enzymes, malondialdehyde (MDA), and reactive oxygen species (ROS) were assayed using ELISA kits.  Western blot assay was used to monitor the expressions of Nrf2 and Keap1 proteins.  Results: Treatment with VB 2 significantly improved cognitive function of APP/PS1 mice with respect to no. of crossings, duration of stay in target quadrant (TQ), and escape latency time (p < 0.01).  Moreover, VB2 also significantly reduced the levels of MDA and ROS.  It also brought about significant increases in brain activities of CAT, SOD, and GSH-Px in APP/PS1 mice, relative to the control group (p < 0.01).  Moreover, VB2 up-regulated Nrf2 expression but down-regulated the expression of Keap1 in brain tissue of transgenic mice.  Conclusion: These results indicate that VB2 protects the brain from ROS-induced AD damage, most likely due to its potential anti-oxidant property and activation of the Nrf2 pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Kks30ugefrVg90H21EOLACvtfcHk0liov-In5XGe-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlymtbo%253D&md5=8e5da253448cf946eff225299ce5f173</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.4314%2Ftjpr.v17i6.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4314%252Ftjpr.v17i6.10%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DQiao%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DK.%26atitle%3DVitamin%2520B2%2520Blocks%2520Development%2520of%2520Alzheimer%2520%25E2%2580%2599%2520s%2520Disease%2520in%2520APP%252FPS1%2520Transgenic%2520Mice%2520via%2520Anti-Oxidative%2520Mechanism%26jtitle%3DTrop.%2520J.%2520Pharm.%2520Res.%26date%3D2018%26volume%3D17%26issue%3D6%26spage%3D1049%26epage%3D1054%26doi%3D10.4314%2Ftjpr.v17i6.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Torres, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarner-Lans, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio-Ruiz, M. E.</span></span> <span> </span><span class="NLM_article-title">Reductive Stress in Inflammation-Associated Diseases and the pro-Oxidant Effect of Antioxidant Agents</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2098</span>, <span class="refDoi"> DOI: 10.3390/ijms18102098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3390%2Fijms18102098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOjtrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=2098&issue=10&author=I.+P%C3%A9rez-Torresauthor=V.+Guarner-Lansauthor=M.+E.+Rubio-Ruiz&title=Reductive+Stress+in+Inflammation-Associated+Diseases+and+the+pro-Oxidant+Effect+of+Antioxidant+Agents&doi=10.3390%2Fijms18102098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive stress in inflammation-associated diseases and the pro-oxidant effect of antioxidant agents</span></div><div class="casAuthors">Perez-Torres, Israel; Guarner-Lans, Veronica; Rubio-Ruiz, Maria Esther</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2098/1-2098/26</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Reductive stress (RS) is the counterpart oxidative stress (OS), and can occur in response to conditions that shift the redox balance of important biol. redox couples, such as the NAD+/NADH, NADP+/NADPH, and GSH/GSSG, to a more reducing state.  Overexpression of antioxidant enzymic systems leads to excess reducing equiv. that can deplete reactive oxidative species, driving the cells to RS.  A feedback regulation is established in which chronic RS induces OS, which in turn, stimulates again RS.  Excess reducing equiv. may regulate cellular signaling pathways, modify transcriptional activity, induce alterations in the formation of disulfide bonds in proteins, reduce mitochondrial function, decrease cellular metab., and thus, contribute to the development of some diseases in which NF-κB, a redox-sensitive transcription factor, participates.  Here, we described the diseases in which an inflammatory condition is assocd. to RS, and where delayed folding, disordered transport, failed oxidn., and aggregation are found.  Some of these diseases are aggregation protein cardiomyopathy, hypertrophic cardiomyopathy, muscular dystrophy, pulmonary hypertension, rheumatoid arthritis, Alzheimer's disease, and metabolic syndrome, among others.  Moreover, chronic consumption of antioxidant supplements, such as vitamins and/or flavonoids, may have pro-oxidant effects that may alter the redox cellular equil. and contribute to RS, even diminishing life expectancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs4JNUGpcAQLVg90H21EOLACvtfcHk0lhDBYyIpClfLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOjtrrF&md5=a121085197df30ca0124558817fbd6b0</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.3390%2Fijms18102098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18102098%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Torres%26aufirst%3DI.%26aulast%3DGuarner-Lans%26aufirst%3DV.%26aulast%3DRubio-Ruiz%26aufirst%3DM.%2BE.%26atitle%3DReductive%2520Stress%2520in%2520Inflammation-Associated%2520Diseases%2520and%2520the%2520pro-Oxidant%2520Effect%2520of%2520Antioxidant%2520Agents%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26issue%3D10%26spage%3D2098%26doi%3D10.3390%2Fijms18102098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Concentration-dependent physiological and pathological conditions correlated to intracellular ROS levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lewis structures of ROS divided by free radical ROS (left) and nonradical ROS (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overview of the main sites of endogenous ROS production. Bilayer: NADPH oxidases (NOX). Within the mitochondria: electron transport chain (ETC) complexes I–V and monoamine oxidases (MAOs). Within peroxisomes: nitric oxide synthase (NOS), urate oxidase (UO), xanthine oxidases (XO), acyl-CoA (ACO), <span class="smallcaps smallerCapital">d</span>-aspartate (DDO), and <span class="smallcaps smallerCapital">d</span>-amino acid (DAAO) oxidases. Within the endoplasmic reticulum (ER): ER oxidoreductin 1 (Ero1) and protein disulfide isomerase family (PDI). The inlays describe the following: (a) Structure and ROS forming processes of mitochondrial ETC (Q = ubiquinone, C = cytochrome c). (b) Structure and ROS forming process of NADPH oxidase 2 (NOX2) with all associated subunits (B = cytochrome <i>b</i>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Small-molecule scavengers of ROS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mode-of-action of α-tocopherol with radical species. ROO<sup>•</sup> = lipid-peroxyl radical; ROOH = lipid hydroperoxide; R<sub>1</sub> = 4,8,12-trimethyltridecyl; LOOH = lipid-peroxyl radical.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mechanism-of-action of nitrone ROS scavengers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Hypothetical mode-of-action of edaravone. RO<sup>•</sup> = radical species; RO<sup>–</sup> = anion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Melatonin and its ring-opened oxidation products.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of NOX inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of inhibitors of mitochondrial ROS production.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Inhibitors of monoamine oxidases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Cocrystal structure of safinamide in the active site of MAO-B (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a>). The α-sheet and β-barrel of the protein are shown in cyan and active site residues in gray. H-bonds are the orange dotted lines. Safinamide is represented in yellow, and water molecules are represented as red spheres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of XO inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Cocrystal structure of topiroxostat in the active site of XO (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AM9">3AM9</a>). The α-sheet and β-barrel of the protein are shown in cyan. Active site residues are in gray. H-bonds are displayed as orange dotted lines. Topiroxostat is represented in yellow. Water molecules are represented as red spheres, and molybdenum cofactor is represented as green spheres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of NOS inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Cocrystal structure of <b>54</b> in the active site of nNOS (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V3U">4V3U</a>). The α-sheet and β-barrel of the protein are shown in cyan. Active site residues are in gray. H-bonds are displayed as orange dotted lines. Compound <b>54</b> is represented in yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Mechanism and structures of radical trapping antioxidants. (a) Scavenging of peroxyl radicals by hindered secondary amines; (b) structures of ferroptosis inhibitors that act as RTAs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structure and activity of phenoxazine-derived ferroptosis inhibitors. (a) Structure of phenoxazine <b>12</b> and phenoxazine-derived nitroxide; (b) suggested mechanism of superoxide and peroxyl radical quenching by PHOXNO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/medium/jm0c01914_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of ROS inhibitors with other modes-of-action.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c01914/20210506/images/large/jm0c01914_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01914&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74068" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74068" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 219 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halliwell, B.</span>; <span class="NLM_string-name">Gutteridge, J. M. C.</span></span> <i>Free Radicals in Biology and Medicine</i>; <span class="NLM_publisher-name">Oxford University Press</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2015</span>.<span class="refDoi"> DOI: 10.1093/acprof:oso/9780198717478.001.0001</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1093%2Facprof%3Aoso%2F9780198717478.001.0001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+Halliwell&author=J.+M.+C.+Gutteridge&title=Free+Radicals+in+Biology+and+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Facprof%3Aoso%2F9780198717478.001.0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1093%252Facprof%253Aoso%252F9780198717478.001.0001%26sid%3Dliteratum%253Aachs%26aulast%3DHalliwell%26aufirst%3DB.%26btitle%3DFree%2520Radicals%2520in%2520Biology%2520and%2520Medicine%26pub%3DOxford%2520University%2520Press%26date%3D2015%26doi%3D10.1093%2Facprof%3Aoso%2F9780198717478.001.0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ray, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, Y.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species (ROS) Homeostasis and Redox Regulation in Cellular Signaling</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">990</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2012.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cellsig.2012.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22286106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1alu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=981-990&issue=5&author=P.+D.+Rayauthor=B.-W.+Huangauthor=Y.+Tsuji&title=Reactive+Oxygen+Species+%28ROS%29+Homeostasis+and+Redox+Regulation+in+Cellular+Signaling&doi=10.1016%2Fj.cellsig.2012.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling</span></div><div class="casAuthors">Ray, Paul D.; Huang, Bo-Wen; Tsuji, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">981-990</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are generated during mitochondrial oxidative metab. as well as in cellular response to xenobiotics, cytokines, and bacterial invasion.  Oxidative stress refers to the imbalance due to excess ROS or oxidants over the capability of the cell to mount an effective antioxidant response.  Oxidative stress results in macromol. damage and is implicated in various disease states such as atherosclerosis, diabetes, cancer, neurodegeneration, and aging.  Paradoxically, accumulating evidence indicates that ROS also serve as crit. signaling mols. in cell proliferation and survival.  While there is a large body of research demonstrating the general effect of oxidative stress on signaling pathways, less is known about the initial and direct regulation of signaling mols. by ROS, or what we term the "oxidative interface.  " Cellular ROS sensing and metab. are tightly regulated by a variety of proteins involved in the redox (redn./oxidn.) mechanism.  This review focuses on the mol. mechanisms through which ROS directly interact with crit. signaling mols. to initiate signaling in a broad variety of cellular processes, such as proliferation and survival (MAP kinases, PI3 kinase, PTEN, and protein tyrosine phosphatases), ROS homeostasis and antioxidant gene regulation (thioredoxin, peroxiredoxin, Ref-1, and Nrf-2), mitochondrial oxidative stress, apoptosis, and aging (p66Shc), iron homeostasis through iron-sulfur cluster proteins (IRE-IRP), and ATM-regulated DNA damage response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUbrGINEaS57Vg90H21EOLACvtfcHk0ljSKHXDmQayWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1alu70%253D&md5=955f09c6b25d37d5548711a716902ddb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2012.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2012.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DRay%26aufirst%3DP.%2BD.%26aulast%3DHuang%26aufirst%3DB.-W.%26aulast%3DTsuji%26aufirst%3DY.%26atitle%3DReactive%2520Oxygen%2520Species%2520%2528ROS%2529%2520Homeostasis%2520and%2520Redox%2520Regulation%2520in%2520Cellular%2520Signaling%26jtitle%3DCell.%2520Signalling%26date%3D2012%26volume%3D24%26issue%3D5%26spage%3D981%26epage%3D990%26doi%3D10.1016%2Fj.cellsig.2012.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brieger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiavone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, F. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, K.-H.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species: From Health to Disease</span>. <i>Swiss Med. Wkly.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.4414/smw.2012.13659</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.4414%2Fsmw.2012.13659" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=1-14&author=K.+Briegerauthor=S.+Schiavoneauthor=F.+J.+Millerauthor=K.-H.+Krause&title=Reactive+Oxygen+Species%3A+From+Health+to+Disease&doi=10.4414%2Fsmw.2012.13659"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4414%2Fsmw.2012.13659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4414%252Fsmw.2012.13659%26sid%3Dliteratum%253Aachs%26aulast%3DBrieger%26aufirst%3DK.%26aulast%3DSchiavone%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DF.%2BJ.%26aulast%3DKrause%26aufirst%3DK.-H.%26atitle%3DReactive%2520Oxygen%2520Species%253A%2520From%2520Health%2520to%2520Disease%26jtitle%3DSwiss%2520Med.%2520Wkly.%26date%3D2012%26volume%3D142%26spage%3D1%26epage%3D14%26doi%3D10.4414%2Fsmw.2012.13659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mauch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Gorman, M. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zychlinsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oelschlägel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rösen-Wolff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesler, J.</span></span> <span> </span><span class="NLM_article-title">Chronic Granulomatous Disease (CGD) and Complete Myeloperoxidase Deficiency Both Yield Strongly Reduced Dihydrorhodamine 123 Test Signals but Can Be Easily Discerned in Routine Testing for CGD</span>. <i>Clin. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">896</span>, <span class="refDoi"> DOI: 10.1373/clinchem.2006.083444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1373%2Fclinchem.2006.083444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=17384005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFyqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2007&pages=890-896&issue=5&author=L.+Mauchauthor=A.+Lunauthor=M.+R.+G.+O%E2%80%99Gormanauthor=J.+S.+Harrisauthor=I.+Schulzeauthor=A.+Zychlinskyauthor=T.+Fuchsauthor=U.+Oelschl%C3%A4gelauthor=S.+Brennerauthor=D.+Kutterauthor=A.+R%C3%B6sen-Wolffauthor=J.+Roesler&title=Chronic+Granulomatous+Disease+%28CGD%29+and+Complete+Myeloperoxidase+Deficiency+Both+Yield+Strongly+Reduced+Dihydrorhodamine+123+Test+Signals+but+Can+Be+Easily+Discerned+in+Routine+Testing+for+CGD&doi=10.1373%2Fclinchem.2006.083444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD</span></div><div class="casAuthors">Mauch, Lysann; Lun, Andreas; O'Gorman, Maurice R. G.; Harris, John S.; Schulze, Ilka; Zychlinsky, Arturo; Fuchs, Tobias; Oelschlaegel, Uta; Brenner, Sebastian; Kutter, Dolphe; Roesen-Wolff, Angela; Roesler, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">890-896</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">The flow cytometric dihydrorhodamine 123 (DHR) assay is used as a screening test for chronic granulomatous disease (CGD), but complete myeloperoxidase (MPO) deficiency can also lead to a strongly decreased DHR signal.  The authors' aim was to devise simple lab. methods to differentiate MPO deficiency (false pos. for CGD) and NADPH oxidase abnormalities (true CGD).  The authors measured NADPH-oxidase and MPO activity in neutrophils from MPO-deficient patients, CGD patients, NADPH-oxidase-transfected K562 cells and cells with inhibited and substituted MPO.  Eosinophils from MPO-deficient individuals retain eosinophilic peroxidase and therefore generate a normal DHR signal.  The addn. of recombinant human MPO enhances the DHR signal when simply added to a suspension of MPO-deficient cells but not when added to NADPH-oxidase-deficient (CGD) cells.  Lucigenin-enhanced chemiluminescence (LCL) is increased in neutrophils from MPO-deficient patients, whereas neutrophils from patients with CGD show a decreased response.  A false-pos. result caused by MPO deficiency can be easily ascertained because, unlike cells from a CGD patient, cells from MPO-deficient patients (a) contain functionally normal eosinophils, (b) show a significant enhancement of the DHR signal following addn. of rhMPO, and (c) generate a strong LCL signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS2HaXZOA_jbVg90H21EOLACvtfcHk0lgNeEPudERtjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFyqtrc%253D&md5=23d61cc7d4317f0d2bee2e72cb7859cd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2006.083444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2006.083444%26sid%3Dliteratum%253Aachs%26aulast%3DMauch%26aufirst%3DL.%26aulast%3DLun%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Gorman%26aufirst%3DM.%2BR.%2BG.%26aulast%3DHarris%26aufirst%3DJ.%2BS.%26aulast%3DSchulze%26aufirst%3DI.%26aulast%3DZychlinsky%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DT.%26aulast%3DOelschl%25C3%25A4gel%26aufirst%3DU.%26aulast%3DBrenner%26aufirst%3DS.%26aulast%3DKutter%26aufirst%3DD.%26aulast%3DR%25C3%25B6sen-Wolff%26aufirst%3DA.%26aulast%3DRoesler%26aufirst%3DJ.%26atitle%3DChronic%2520Granulomatous%2520Disease%2520%2528CGD%2529%2520and%2520Complete%2520Myeloperoxidase%2520Deficiency%2520Both%2520Yield%2520Strongly%2520Reduced%2520Dihydrorhodamine%2520123%2520Test%2520Signals%2520but%2520Can%2520Be%2520Easily%2520Discerned%2520in%2520Routine%2520Testing%2520for%2520CGD%26jtitle%3DClin.%2520Chem.%26date%3D2007%26volume%3D53%26issue%3D5%26spage%3D890%26epage%3D896%26doi%3D10.1373%2Fclinchem.2006.083444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordgren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apanasets, O.</span></span> <span> </span><span class="NLM_article-title">Role of Peroxisomes in ROS/RNS-Metabolism: Implications for Human Disease</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1822</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1373</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2011.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.bbadis.2011.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOqt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1822&publication_year=2012&pages=1363-1373&issue=9&author=M.+Fransenauthor=M.+Nordgrenauthor=B.+Wangauthor=O.+Apanasets&title=Role+of+Peroxisomes+in+ROS%2FRNS-Metabolism%3A+Implications+for+Human+Disease&doi=10.1016%2Fj.bbadis.2011.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Role of peroxisomes in ROS/RNS-metabolism: Implications for human disease</span></div><div class="casAuthors">Fransen, Marc; Nordgren, Marcus; Wang, Bo; Apanasets, Oksana</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1822</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1363-1373</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Peroxisomes are cell organelles that play a central role in lipid metab.  At the same time, these organelles generate reactive oxygen and nitrogen species as byproducts.  Peroxisomes also possess intricate protective mechanisms to counteract oxidative stress and maintain redox balance.  An imbalance between peroxisomal reactive oxygen species/reactive nitrogen species prodn. and removal may possibly damage biomols., perturb cellular thiol levels, and deregulate cellular signaling pathways implicated in a variety of human diseases.  Somewhat surprisingly, the potential role of peroxisomes in cellular redox metab. has been underestimated for a long time.  However, in recent years, peroxisomal reactive oxygen species/reactive nitrogen species metab. and signaling have become the focus of a rapidly evolving and multidisciplinary research field with great prospects.  This review is mainly devoted to discuss evidence supporting the notion that peroxisomal metab. and oxidative stress are intimately interconnected and assocd. with age-related diseases.  We focus on several key aspects of how peroxisomes contribute to cellular reactive oxygen species/reactive nitrogen species levels in mammalian cells and how these cells cope with peroxisome-derived oxidative stress.  We also provide a brief overview of recent strategies that have been successfully employed to detect and modulate the peroxisomal redox status.  Finally, we highlight some gaps in our knowledge and propose potential avenues for further research.  This article is part of a Special Issue entitled: Metabolic Functions and Biogenesis of peroxisomes in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALzBYCdGlObVg90H21EOLACvtfcHk0lgNeEPudERtjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOqt7rJ&md5=8bedcd893e452de42037078173b68b6c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2011.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2011.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DFransen%26aufirst%3DM.%26aulast%3DNordgren%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DApanasets%26aufirst%3DO.%26atitle%3DRole%2520of%2520Peroxisomes%2520in%2520ROS%252FRNS-Metabolism%253A%2520Implications%2520for%2520Human%2520Disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2012%26volume%3D1822%26issue%3D9%26spage%3D1363%26epage%3D1373%26doi%3D10.1016%2Fj.bbadis.2011.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schieber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">ROS Function in Redox Signaling and Oxidative Stress</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">R453</span>– <span class="NLM_lpage">R462</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2014.03.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cub.2014.03.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24845678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVWktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=R453-R462&issue=10&author=M.+Schieberauthor=N.+S.+Chandel&title=ROS+Function+in+Redox+Signaling+and+Oxidative+Stress&doi=10.1016%2Fj.cub.2014.03.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">ROS Function in Redox Signaling and Oxidative Stress</span></div><div class="casAuthors">Schieber, Michael; Chandel, Navdeep S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">R453-R462</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Oxidative stress refers to elevated intracellular levels of reactive oxygen species (ROS) that cause damage to lipids, proteins and DNA.  Oxidative stress has been linked to a myriad of pathologies.  However, elevated ROS also act as signaling mols. in the maintenance of physiol. functions - a process termed redox biol.  In this review we discuss the two faces of ROS - redox biol. and oxidative stress - and their contribution to both physiol. and pathol. conditions.  Redox biol. involves a small increase in ROS levels that activates signaling pathways to initiate biol. processes, while oxidative stress denotes high levels of ROS that result in damage to DNA, protein or lipids.  Thus, the response to ROS displays hormesis, given that the opposite effect is obsd. at low levels compared with that seen at high levels.  Here, we argue that redox biol., rather than oxidative stress, underlies physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQKHDL4BvUHLVg90H21EOLACvtfcHk0lgNeEPudERtjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVWktL4%253D&md5=04979c81b50c4aefc5d19152d832febc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2014.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2014.03.034%26sid%3Dliteratum%253Aachs%26aulast%3DSchieber%26aufirst%3DM.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DROS%2520Function%2520in%2520Redox%2520Signaling%2520and%2520Oxidative%2520Stress%26jtitle%3DCurr.%2520Biol.%26date%3D2014%26volume%3D24%26issue%3D10%26spage%3DR453%26epage%3DR462%26doi%3D10.1016%2Fj.cub.2014.03.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mittler, R.</span></span> <span> </span><span class="NLM_article-title">ROS Are Good</span>. <i>Trends Plant Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.tplants.2016.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.tplants.2016.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27666517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKru7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=11-19&issue=1&author=R.+Mittler&title=ROS+Are+Good&doi=10.1016%2Fj.tplants.2016.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">ROS Are Good</span></div><div class="casAuthors">Mittler, Ron</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Plant Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-19</span>CODEN:
                <span class="NLM_cas:coden">TPSCF9</span>;
        ISSN:<span class="NLM_cas:issn">1360-1385</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are thought to play a dual role in plant biol.  They are required for many important signaling reactions, but are also toxic byproducts of aerobic metab.  Recent studies revealed that ROS are necessary for the progression of several basic biol. processes including cellular proliferation and differentiation.  Moreover, cell death-that was previously thought to be the outcome of ROS directly killing cells by oxidn., in other words via oxidative stress-is now considered to be the result of ROS triggering a physiol. or programmed pathway for cell death.  This Opinion focuses on the possibility that ROS are beneficial to plants, supporting cellular proliferation, physiol. function, and viability, and that maintaining a basal level of ROS in cells is essential for life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVUKReyEz3IrVg90H21EOLACvtfcHk0li8QGeAEmrapw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKru7nF&md5=f857bb204a4f7876206ed99ffb46ed95</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tplants.2016.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tplants.2016.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DMittler%26aufirst%3DR.%26atitle%3DROS%2520Are%2520Good%26jtitle%3DTrends%2520Plant%2520Sci.%26date%3D2017%26volume%3D22%26issue%3D1%26spage%3D11%26epage%3D19%26doi%3D10.1016%2Fj.tplants.2016.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhie, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S.</span></span> <span> </span><span class="NLM_article-title">The Role of Oxidative Stress in Neurodegenerative Diseases</span>. <i>Exp. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.5607/en.2015.24.4.325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.5607%2Fen.2015.24.4.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26713080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC28rls12hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=325-340&issue=4&author=G.+H.+Kimauthor=J.+E.+Kimauthor=S.+J.+Rhieauthor=S.+Yoon&title=The+Role+of+Oxidative+Stress+in+Neurodegenerative+Diseases&doi=10.5607%2Fen.2015.24.4.325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Oxidative Stress in Neurodegenerative Diseases</span></div><div class="casAuthors">Kim Geon Ha; Kim Jieun E; Rhie Sandy Jeong; Yoon Sujung</div><div class="citationInfo"><span class="NLM_cas:title">Experimental neurobiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">325-40</span>
        ISSN:<span class="NLM_cas:issn">1226-2560</span>.
    </div><div class="casAbstract">Oxidative stress is induced by an imbalanced redox states, involving either excessive generation of reactive oxygen species (ROS) or dysfunction of the antioxidant system.  The brain is one of organs especially vulnerable to the effects of ROS because of its high oxygen demand and its abundance of peroxidation-susceptible lipid cells.  Previous studies have demonstrated that oxidative stress plays a central role in a common pathophysiology of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.  Antioxidant therapy has been suggested for the prevention and treatment of neurodegenerative diseases, although the results with regard to their efficacy of treating neurodegenerative disease have been inconsistent.  In this review, we will discuss the role of oxidative stress in the pathophysiology of neurodegenerative diseases and in vivo measurement of an index of damage by oxidative stress.  Moreover, the present knowledge on antioxidant in the treatment of neurodegenerative diseases and future directions will be outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrttl-His737JzI8owOhpDfW6udTcc2eZ5Km3Lid3qrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rls12hsw%253D%253D&md5=0bab8c703855f561b023730c2c4d9447</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.5607%2Fen.2015.24.4.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5607%252Fen.2015.24.4.325%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DG.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DRhie%26aufirst%3DS.%2BJ.%26aulast%3DYoon%26aufirst%3DS.%26atitle%3DThe%2520Role%2520of%2520Oxidative%2520Stress%2520in%2520Neurodegenerative%2520Diseases%26jtitle%3DExp.%2520Neurobiol.%26date%3D2015%26volume%3D24%26issue%3D4%26spage%3D325%26epage%3D340%26doi%3D10.5607%2Fen.2015.24.4.325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayyan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashim, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">AlNashef, I. M.</span></span> <span> </span><span class="NLM_article-title">Superoxide Ion : Generation and Chemical Implications</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">3029</span>– <span class="NLM_lpage">3085</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVGqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=3029-3085&author=M.+Hayyanauthor=M.+A.+Hashimauthor=I.+M.+AlNashef&title=Superoxide+Ion%E2%80%AF%3A+Generation+and+Chemical+Implications&doi=10.1021%2Facs.chemrev.5b00407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Superoxide Ion: Generation and Chemical Implications</span></div><div class="casAuthors">Hayyan, Maan; Hashim, Mohd Ali; AlNashef, Inas M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3029-3085</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Superoxide ion (O2•-) is of great significance as a radical species implicated in diverse chem. and biol. systems.  However, the chem. knowledge of O2•- is rather scarce.  In addn., numerous studies on O2•- were conducted within the latter half of the 20th century.  Therefore, the current advancement in technol. and instrumentation will certainly provide better insights into mechanisms and products of O2•- reactions and thus will result in new findings.  This review emphasizes the state-of-the-art research on O2•- so as to enable researchers to venture into future research.  It comprises the main characteristics of O2•- followed by generation methods.  The reaction types of O2•- are reviewed, and its potential applications including the destruction of hazardous chems., synthesis of org. compds., and many other applications are highlighted.  The O2•- environmental chem. is also discussed.  The detection methods of O2•- are categorized and elaborated.  Special attention is given to the feasibility of using ionic liqs. as media for O2•-, addressing the latest progress of generation and applications.  The effect of electrodes on the O2•- electrochem. generation is reviewed.  Finally, some remarks and future perspectives are concluded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_icrPI8mpLVg90H21EOLACvtfcHk0li8QGeAEmrapw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVGqsrw%253D&md5=ad9278a28e8776ce6b2fcb40c062c70c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00407%26sid%3Dliteratum%253Aachs%26aulast%3DHayyan%26aufirst%3DM.%26aulast%3DHashim%26aufirst%3DM.%2BA.%26aulast%3DAlNashef%26aufirst%3DI.%2BM.%26atitle%3DSuperoxide%2520Ion%25E2%2580%25AF%253A%2520Generation%2520and%2520Chemical%2520Implications%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D3029%26epage%3D3085%26doi%3D10.1021%2Facs.chemrev.5b00407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zorov, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juhaszova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollott, S. J.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">950</span>, <span class="refDoi"> DOI: 10.1152/physrev.00026.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1152%2Fphysrev.00026.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24987008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtl2qurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2014&pages=909-950&issue=3&author=D.+B.+Zorovauthor=M.+Juhaszovaauthor=S.+J.+Sollott&title=Mitochondrial+Reactive+Oxygen+Species+%28ROS%29+and+ROS-Induced+ROS+Release&doi=10.1152%2Fphysrev.00026.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release</span></div><div class="casAuthors">Zorov, Dmitry B.; Juhaszova, Magdalena; Sollott, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">909-950</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Byproducts of normal mitochondrial metab. and homeostasis include the buildup of potentially damaging levels of reactive oxygen species (ROS), Ca2+, etc., which must be normalized.  Evidence suggests that brief mitochondrial permeability transition pore (mPTP) openings play an important physiol. role maintaining healthy mitochondria homeostasis.  Adaptive and maladaptive responses to redox stress may involve mitochondrial channels such as mPTP and inner membrane anion channel (IMAC).  Their activation causes intra- and intermitochondrial redox-environment changes leading to ROS release.  This regenerative cycle of mitochondrial ROS formation and release was named ROS-induced ROS release (RIRR).  Brief, reversible mPTP opening-assocd. ROS release apparently constitutes an adaptive housekeeping function by the timely release from mitochondria of accumulated potentially toxic levels of ROS (and Ca2+).  At higher ROS levels, longer mPTP openings may release a ROS burst leading to destruction of mitochondria, and if propagated from mitochondrion to mitochondrion, of the cell itself.  The destructive function of RIRR may serve a physiol. role by removal of unwanted cells or damaged mitochondria, or cause the pathol. elimination of vital and essential mitochondria and cells.  The adaptive release of sufficient ROS into the vicinity of mitochondria may also activate local pools of redox-sensitive enzymes involved in protective signaling pathways that limit ischemic damage to mitochondria and cells in that area.  Maladaptive mPTP- or IMAC-related RIRR may also be playing a role in aging.  Because the mechanism of mitochondrial RIRR highlights the central role of mitochondria-formed ROS, we discuss all of the known ROS-producing sites (shown in vitro) and their relevance to the mitochondrial ROS prodn. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopLjJhfOUWnrVg90H21EOLACvtfcHk0liaGMeyqIahJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtl2qurbL&md5=78757beddebdedbf4d131a338ebd0d76</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00026.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00026.2013%26sid%3Dliteratum%253Aachs%26aulast%3DZorov%26aufirst%3DD.%2BB.%26aulast%3DJuhaszova%26aufirst%3DM.%26aulast%3DSollott%26aufirst%3DS.%2BJ.%26atitle%3DMitochondrial%2520Reactive%2520Oxygen%2520Species%2520%2528ROS%2529%2520and%2520ROS-Induced%2520ROS%2520Release%26jtitle%3DPhysiol.%2520Rev.%26date%3D2014%26volume%3D94%26issue%3D3%26spage%3D909%26epage%3D950%26doi%3D10.1152%2Fphysrev.00026.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, M. N.</span></span> <span> </span><span class="NLM_article-title">Chemistry of Nitric Oxide and Related Species</span>. In  <i>Methods in Enzymology. Globins and Other Nitric Oxide-Reactive Proteins, Part A</i>; <span class="NLM_publisher-name">Elsevier Inc.</span>: <span class="NLM_publisher-loc">San Diego</span>, <span class="NLM_year">2008</span>; Vol.  <span class="NLM_volume">436</span>, pp  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">19</span>.<span class="refDoi"> DOI: 10.1016/S0076-6879(08)36001-7</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2FS0076-6879%2808%2936001-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=3-19&author=M.+N.+Hughes&title=Methods+in+Enzymology.+Globins+and+Other+Nitric+Oxide-Reactive+Proteins%2C+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2808%2936001-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252808%252936001-7%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DM.%2BN.%26atitle%3DChemistry%2520of%2520Nitric%2520Oxide%2520and%2520Related%2520Species%26btitle%3DMethods%2520in%2520Enzymology.%2520Globins%2520and%2520Other%2520Nitric%2520Oxide-Reactive%2520Proteins%252C%2520Part%2520A%26pub%3DElsevier%2520Inc%26date%3D2008%26volume%3D436%26spage%3D3%26epage%3D19%26doi%3D10.1016%2FS0076-6879%2808%2936001-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muntean, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dǎnilǎ, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duicu, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mornoş, C.</span></span> <span> </span><span class="NLM_article-title">The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1155/2016/8254942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2016%2F8254942" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1&author=D.+M.+Munteanauthor=A.+Sturzaauthor=M.+D.+D%C7%8Enil%C7%8Eauthor=C.+Borzaauthor=O.+M.+Duicuauthor=C.+Morno%C5%9F&title=The+Role+of+Mitochondrial+Reactive+Oxygen+Species+in+Cardiovascular+Injury+and+Protective+Strategies&doi=10.1155%2F2016%2F8254942"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1155%2F2016%2F8254942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F8254942%26sid%3Dliteratum%253Aachs%26aulast%3DMuntean%26aufirst%3DD.%2BM.%26aulast%3DSturza%26aufirst%3DA.%26aulast%3DD%25C7%258Enil%25C7%258E%26aufirst%3DM.%2BD.%26aulast%3DBorza%26aufirst%3DC.%26aulast%3DDuicu%26aufirst%3DO.%2BM.%26aulast%3DMorno%25C5%259F%26aufirst%3DC.%26atitle%3DThe%2520Role%2520of%2520Mitochondrial%2520Reactive%2520Oxygen%2520Species%2520in%2520Cardiovascular%2520Injury%2520and%2520Protective%2520Strategies%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2016%26volume%3D2016%26spage%3D1%26doi%3D10.1155%2F2016%2F8254942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. F.</span></span> <span> </span><span class="NLM_article-title">Targeting Mitochondrial Reactive Oxygen Species as Novel Therapy for Inflammatory Diseases and Cancers</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">19</span>, <span class="refDoi"> DOI: 10.1186/1756-8722-6-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1186%2F1756-8722-6-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=23442817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=19&issue=1&author=X.+Liauthor=P.+Fangauthor=J.+Maiauthor=E.+T.+Choiauthor=H.+Wangauthor=X.+F.+Yang&title=Targeting+Mitochondrial+Reactive+Oxygen+Species+as+Novel+Therapy+for+Inflammatory+Diseases+and+Cancers&doi=10.1186%2F1756-8722-6-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span></div><div class="casAuthors">Li, Xinyuan; Fang, Pu; Mai, Jietang; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  There are multiple sources of reactive oxygen species (ROS) in the cell.  As a major site of ROS prodn., mitochondria have drawn considerable interest because it was recently discovered that mitochondrial ROS (mtROS) directly stimulate the prodn. of proinflammatory cytokines and pathol. conditions as diverse as malignancies, autoimmune diseases, and cardiovascular diseases all share common phenotype of increased mtROS prodn. above basal levels.  Several excellent reviews on this topic have been published, but ever-changing new discoveries mandated a more up-to-date and comprehensive review on this topic.  Therefore, we update recent understanding of how mitochondria generate and regulate the prodn. of mtROS and the function of mtROS both in physiol. and pathol. conditions.  In addn., we describe newly developed methods to probe or scavenge mtROS and compare these methods in detail.  Thorough understanding of this topic and the application of mtROS-targeting drugs in the research is significant towards development of better therapies to combat inflammatory diseases and inflammatory malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdw7mjnRfUbVg90H21EOLACvtfcHk0liaGMeyqIahJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D&md5=d041a496a1ede846460023f0cc54885a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-19%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DE.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%2BF.%26atitle%3DTargeting%2520Mitochondrial%2520Reactive%2520Oxygen%2520Species%2520as%2520Novel%2520Therapy%2520for%2520Inflammatory%2520Diseases%2520and%2520Cancers%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26issue%3D1%26spage%3D19%26doi%3D10.1186%2F1756-8722-6-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, K.-H.</span></span> <span> </span><span class="NLM_article-title">The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1152/physrev.00044.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1152%2Fphysrev.00044.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=17237347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVagsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2007&pages=245-313&author=K.+Bedardauthor=K.-H.+Krause&title=The+NOX+Family+of+ROS-Generating+NADPH+Oxidases%3A+Physiology+and+Pathophysiology&doi=10.1152%2Fphysrev.00044.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology</span></div><div class="casAuthors">Bedard, Karen; Krause, Karl-Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">245-313</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  For a long time, superoxide generation by an NADPH oxidase was considered as an oddity only found in professional phagocytes.  Over the last years, six homologs of the cytochrome subunit of the phagocyte NADPH oxidase were found: NOX1, NOX3, NOX4, NOX5, DUOX1, and DUOX2.  Together with the phagocyte NADPH oxidase itself (NOX2/gp91phox), the homologs are now referred to as the NOX family of NADPH oxidases.  These enzymes share the capacity to transport electrons across the plasma membrane and to generate superoxide and other downstream reactive oxygen species (ROS).  Activation mechanisms and tissue distribution of the different members of the family are markedly different.  The physiol. functions of NOX family enzymes include host defense, posttranslational processing of proteins, cellular signaling, regulation of gene expression, and cell differentiation.  NOX enzymes also contribute to a wide range of pathol. processes.  NOX deficiency may lead to immunosuppression, lack of otoconogenesis, or hypothyroidism.  Increased NOX activity also contributes to a large no. or pathologies, in particular cardiovascular diseases and neurodegeneration.  This review summarizes the current state of knowledge of the functions of NOX enzymes in physiol. and pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotquVpFu29UrVg90H21EOLACvtfcHk0lgc06b3gPhRKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVagsr4%253D&md5=515b5e86696b85d933b8226f4fe6ce59</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00044.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00044.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBedard%26aufirst%3DK.%26aulast%3DKrause%26aufirst%3DK.-H.%26atitle%3DThe%2520NOX%2520Family%2520of%2520ROS-Generating%2520NADPH%2520Oxidases%253A%2520Physiology%2520and%2520Pathophysiology%26jtitle%3DPhysiol.%2520Rev.%26date%3D2007%26volume%3D87%26spage%3D245%26epage%3D313%26doi%3D10.1152%2Fphysrev.00044.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panday, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osorio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidases: An Overview from Structure to Innate Immunity-Associated Pathologies</span>. <i>Cell. Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1038/cmi.2014.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fcmi.2014.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=25263488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFKksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=5-23&author=A.+Pandayauthor=M.+K.+Sahooauthor=D.+Osorioauthor=S.+Batra&title=NADPH+Oxidases%3A+An+Overview+from+Structure+to+Innate+Immunity-Associated+Pathologies&doi=10.1038%2Fcmi.2014.89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH oxidases: an overview from structure to innate immunity-associated pathologies</span></div><div class="casAuthors">Panday, Arvind; Sahoo, Malaya K.; Osorio, Diana; Batra, Sanjay</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-23</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">A review.  Oxygen-derived free radicals, collectively termed reactive oxygen species (ROS), play important roles in immunity, cell growth, and cell signaling.  In excess, however, ROS are lethal to cells, and the overprodn. of these mols. leads to a myriad of devastating diseases.  The key producers of ROS in many cells are the NOX family of NADPH oxidases, of which there are seven members, with various tissue distributions and activation mechanisms.  NADPH oxidase is a multisubunit enzyme comprising membrane and cytosolic components, which actively communicate during the host responses to a wide variety of stimuli, including viral and bacterial infections.  This enzymic complex has been implicated in many functions ranging from host defense to cellular signaling and the regulation of gene expression.  NOX deficiency might lead to immunosuppression, while the intracellular accumulation of ROS results in the inhibition of viral propagation and apoptosis.  However, excess ROS prodn. causes cellular stress, leading to various lethal diseases, including autoimmune diseases and cancer.  During the later stages of injury, NOX promotes tissue repair through the induction of angiogenesis and cell proliferation.  Therefore, a complete understanding of the function of NOX is important to direct the role of this enzyme towards host defense and tissue repair or increase resistance to stress in a timely and disease-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovoR8UTxBXK7Vg90H21EOLACvtfcHk0lgc06b3gPhRKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFKksg%253D%253D&md5=d0fad1541df4f25ca279394c210e5442</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fcmi.2014.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcmi.2014.89%26sid%3Dliteratum%253Aachs%26aulast%3DPanday%26aufirst%3DA.%26aulast%3DSahoo%26aufirst%3DM.%2BK.%26aulast%3DOsorio%26aufirst%3DD.%26aulast%3DBatra%26aufirst%3DS.%26atitle%3DNADPH%2520Oxidases%253A%2520An%2520Overview%2520from%2520Structure%2520to%2520Innate%2520Immunity-Associated%2520Pathologies%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2015%26volume%3D12%26spage%3D5%26epage%3D23%26doi%3D10.1038%2Fcmi.2014.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forrester, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandes, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griendling, K. K.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in Metabolic and Inflammatory Signaling</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">902</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.117.311401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1161%2FCIRCRESAHA.117.311401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29700084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksFWlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2018&pages=877-902&issue=6&author=S.+J.+Forresterauthor=D.+S.+Kikuchiauthor=M.+S.+Hernandesauthor=Q.+Xuauthor=K.+K.+Griendling&title=Reactive+Oxygen+Species+in+Metabolic+and+Inflammatory+Signaling&doi=10.1161%2FCIRCRESAHA.117.311401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species in Metabolic and Inflammatory Signaling</span></div><div class="casAuthors">Forrester, Steven J.; Kikuchi, Daniel S.; Hernandes, Marina S.; Xu, Qian; Griendling, Kathy K.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">877-902</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are well known for their role in mediating both physiol. and pathophysiol. signal transduction.  Enzymes and subcellular compartments that typically produce ROS are assocd. with metabolic regulation, and diseases assocd. with metabolic dysfunction may be influenced by changes in redox balance.  In this review, we summarize the current literature surrounding ROS and their role in metabolic and inflammatory regulation, focusing on ROS signal transduction and its relationship to disease progression.  In particular, we examine ROS prodn. in compartments such as the cytoplasm, mitochondria, peroxisome, and endoplasmic reticulum and discuss how ROS influence metabolic processes such as proteasome function, autophagy, and general inflammatory signaling.  We also summarize and highlight the role of ROS in the regulation metabolic/inflammatory diseases including atherosclerosis, diabetes mellitus, and stroke.  In order to develop therapies that target oxidative signaling, it is vital to understand the balance ROS signaling plays in both physiol. and pathophysiol., and how manipulation of this balance and the identity of the ROS may influence cellular and tissue homeostasis.  An increased understanding of specific sources of ROS prodn. and an appreciation for how ROS influence cellular metab. may help guide us in the effort to treat cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoohVEWPXhla7Vg90H21EOLACvtfcHk0lgc06b3gPhRKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksFWlsbg%253D&md5=c12d63316b8720b61ccc7d841725a798</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.117.311401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.117.311401%26sid%3Dliteratum%253Aachs%26aulast%3DForrester%26aufirst%3DS.%2BJ.%26aulast%3DKikuchi%26aufirst%3DD.%2BS.%26aulast%3DHernandes%26aufirst%3DM.%2BS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DGriendling%26aufirst%3DK.%2BK.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520Metabolic%2520and%2520Inflammatory%2520Signaling%26jtitle%3DCirc.%2520Res.%26date%3D2018%26volume%3D122%26issue%3D6%26spage%3D877%26epage%3D902%26doi%3D10.1161%2FCIRCRESAHA.117.311401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maggiorani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mialet-Perez, J.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidases, Oxidative Stress, and Altered Mitochondrial Dynamics in Cardiac Ageing</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1155/2017/3017947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2017%2F3017947" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1-8&author=D.+Maggioraniauthor=N.+Manzellaauthor=D.+E.+Edmondsonauthor=A.+Matteviauthor=A.+Pariniauthor=C.+Bindaauthor=J.+Mialet-Perez&title=Monoamine+Oxidases%2C+Oxidative+Stress%2C+and+Altered+Mitochondrial+Dynamics+in+Cardiac+Ageing&doi=10.1155%2F2017%2F3017947"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1155%2F2017%2F3017947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F3017947%26sid%3Dliteratum%253Aachs%26aulast%3DMaggiorani%26aufirst%3DD.%26aulast%3DManzella%26aufirst%3DN.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DParini%26aufirst%3DA.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DMialet-Perez%26aufirst%3DJ.%26atitle%3DMonoamine%2520Oxidases%252C%2520Oxidative%2520Stress%252C%2520and%2520Altered%2520Mitochondrial%2520Dynamics%2520in%2520Cardiac%2520Ageing%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D8%26doi%3D10.1155%2F2017%2F3017947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaludercic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivakumaran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedja, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mario, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Lisa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolocci, N.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase b Prompts Mitochondrial and Cardiac Dysfunction in Pressure Overloaded Hearts</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1089/ars.2012.4616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fars.2012.4616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=23581564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislOrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=267-280&issue=2&author=N.+Kaludercicauthor=A.+Carpiauthor=T.+Nagayamaauthor=V.+Sivakumaranauthor=G.+Zhuauthor=E.+W.+Laiauthor=D.+Bedjaauthor=A.+De+Marioauthor=K.+Chenauthor=K.+L.+Gabrielsonauthor=M.+L.+Lindseyauthor=K.+Pacakauthor=E.+Takimotoauthor=J.+C.+Shihauthor=D.+A.+Kassauthor=F.+Di+Lisaauthor=N.+Paolocci&title=Monoamine+Oxidase+b+Prompts+Mitochondrial+and+Cardiac+Dysfunction+in+Pressure+Overloaded+Hearts&doi=10.1089%2Fars.2012.4616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine Oxidase B Prompts Mitochondrial and Cardiac Dysfunction in Pressure Overloaded Hearts</span></div><div class="casAuthors">Kaludercic, Nina; Carpi, Andrea; Nagayama, Takahiro; Sivakumaran, Vidhya; Zhu, Guangshuo; Lai, Edwin W.; Bedja, Djahida; De Mario, Agnese; Chen, Kevin; Gabrielson, Kathleen L.; Lindsey, Merry L.; Pacak, Karel; Takimoto, Eiki; Shih, Jean C.; Kass, David A.; Di Lisa, Fabio; Paolocci, Nazareno</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-280</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: Monoamine oxidases (MAOs) are mitochondrial flavoenzymes responsible for neurotransmitter and biogenic amines catabolism.  MAO-A contributes to heart failure progression via enhanced norepinephrine catabolism and oxidative stress.  The potential pathogenetic role of the isoenzyme MAO-B in cardiac diseases is currently unknown.  Moreover, it is has not been detd. yet whether MAO activation can directly affect mitochondrial function.  Results: In wild type mice, pressure overload induced by transverse aortic constriction (TAC) resulted in enhanced dopamine catabolism, left ventricular (LV) remodeling, and dysfunction.  Conversely, mice lacking MAO-B (MAO-B-/-) subjected to TAC maintained concentric hypertrophy accompanied by extracellular signal regulated kinase (ERK)1/2 activation, and preserved LV function, both at early (3 wk) and late stages (9 wk).  Enhanced MAO activation triggered oxidative stress, and dropped mitochondrial membrane potential in the presence of ATP synthase inhibitor oligomycin both in neonatal and adult cardiomyocytes.  The MAO-B inhibitor pargyline completely offset this change, suggesting that MAO activation induces a latent mitochondrial dysfunction, causing these organelles to hydrolyze ATP.  Moreover, MAO-dependent aldehyde formation due to inhibition of aldehyde dehydrogenase 2 activity also contributed to alter mitochondrial bioenergetics.  Innovation: Our study unravels a novel role for MAO-B in the pathogenesis of heart failure, showing that both MAO-driven reactive oxygen species prodn. and impaired aldehyde metab. affect mitochondrial function.  Conclusion: Under conditions of chronic hemodynamic stress, enhanced MAO-B activity is a major determinant of cardiac structural and functional disarrangement.  Both increased oxidative stress and the accumulation of aldehyde intermediates are likely liable for these adverse morphol. and mech. changes by directly targeting mitochondria.  Antioxid. Redox Signal. 20, 267-280.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JiMLBoVkHLVg90H21EOLACvtfcHk0lgYB72ajzEJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislOrsg%253D%253D&md5=c4291634416e80c5daa1b0f18f8bc6ae</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.4616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.4616%26sid%3Dliteratum%253Aachs%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DCarpi%26aufirst%3DA.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DSivakumaran%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DLai%26aufirst%3DE.%2BW.%26aulast%3DBedja%26aufirst%3DD.%26aulast%3DDe%2BMario%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DK.%2BL.%26aulast%3DLindsey%26aufirst%3DM.%2BL.%26aulast%3DPacak%26aufirst%3DK.%26aulast%3DTakimoto%26aufirst%3DE.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26aulast%3DKass%26aufirst%3DD.%2BA.%26aulast%3DDi%2BLisa%26aufirst%3DF.%26aulast%3DPaolocci%26aufirst%3DN.%26atitle%3DMonoamine%2520Oxidase%2520b%2520Prompts%2520Mitochondrial%2520and%2520Cardiac%2520Dysfunction%2520in%2520Pressure%2520Overloaded%2520Hearts%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D20%26issue%3D2%26spage%3D267%26epage%3D280%26doi%3D10.1089%2Fars.2012.4616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battelli, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, A.</span></span> <span> </span><span class="NLM_article-title">Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1155/2016/3527579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2016%2F3527579" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1&author=M.+G.+Battelliauthor=L.+Politoauthor=M.+Bortolottiauthor=A.+Bolognesi&title=Xanthine+Oxidoreductase-Derived+Reactive+Species%3A+Physiological+and+Pathological+Effects&doi=10.1155%2F2016%2F3527579"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1155%2F2016%2F3527579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F3527579%26sid%3Dliteratum%253Aachs%26aulast%3DBattelli%26aufirst%3DM.%2BG.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DBortolotti%26aufirst%3DM.%26aulast%3DBolognesi%26aufirst%3DA.%26atitle%3DXanthine%2520Oxidoreductase-Derived%2520Reactive%2520Species%253A%2520Physiological%2520and%2520Pathological%2520Effects%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2016%26volume%3D2016%26spage%3D1%26doi%3D10.1155%2F2016%2F3527579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, E. I.</span>; <span class="NLM_string-name">Serafim, R. A. M.</span></span> <span> </span><span class="NLM_article-title">Nitric Oxide Synthase Inhibitors</span>. In  <i>Nitric Oxide Synthase - Simple Enzyme-Complex Roles</i>; <span class="NLM_publisher-name">IntechOpen</span>: <span class="NLM_publisher-loc">Rijeka</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">237</span>.<span class="refDoi"> DOI: 10.5772/67027</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.5772%2F67027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=217-237&author=E.+I.+Ferreira&author=R.+A.+M.+Serafim&title=Nitric+Oxide+Synthase+-+Simple+Enzyme-Complex+Roles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.5772%2F67027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F67027%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DE.%2BI.%26atitle%3DNitric%2520Oxide%2520Synthase%2520Inhibitors%26btitle%3DNitric%2520Oxide%2520Synthase%2520-%2520Simple%2520Enzyme-Complex%2520Roles%26pub%3DIntechOpen%26date%3D2017%26spage%3D217%26epage%3D237%26doi%3D10.5772%2F67027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span> <span> </span><span class="NLM_article-title">The Dual Role of Inducible Nitric Oxide Synthase in Myocardial Ischemia/Reperfusion Injury: Friend or Foe?</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1155/2018/8364848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2018%2F8364848" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=1-7&author=X.+Yuauthor=L.+Geauthor=L.+Niuauthor=X.+Lianauthor=H.+Maauthor=L.+Pang&title=The+Dual+Role+of+Inducible+Nitric+Oxide+Synthase+in+Myocardial+Ischemia%2FReperfusion+Injury%3A+Friend+or+Foe%3F&doi=10.1155%2F2018%2F8364848"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1155%2F2018%2F8364848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F8364848%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DLian%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DL.%26atitle%3DThe%2520Dual%2520Role%2520of%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520in%2520Myocardial%2520Ischemia%252FReperfusion%2520Injury%253A%2520Friend%2520or%2520Foe%253F%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D7%26doi%3D10.1155%2F2018%2F8364848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Förstermann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sessa, W. C.</span></span> <span> </span><span class="NLM_article-title">Nitric Oxide Synthases: Regulation and Function</span>. <i>Eur. Heart J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1093/eurheartj/ehr304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1093%2Feurheartj%2Fehr304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=21890489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC38zlsFOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=829-837&issue=7&author=U.+F%C3%B6rstermannauthor=W.+C.+Sessa&title=Nitric+Oxide+Synthases%3A+Regulation+and+Function&doi=10.1093%2Feurheartj%2Fehr304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide synthases: regulation and function</span></div><div class="casAuthors">Forstermann Ulrich; Sessa William C</div><div class="citationInfo"><span class="NLM_cas:title">European heart journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">829-37, 837a-837d</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nitric oxide (NO), the smallest signalling molecule known, is produced by three isoforms of NO synthase (NOS; EC 1.14.13.39).  They all utilize l-arginine and molecular oxygen as substrates and require the cofactors reduced nicotinamide-adenine-dinucleotide phosphate (NADPH), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), and (6R-)5,6,7,8-tetrahydrobiopterin (BH(4)).  All NOS bind calmodulin and contain haem.  Neuronal NOS (nNOS, NOS I) is constitutively expressed in central and peripheral neurons and some other cell types.  Its functions include synaptic plasticity in the central nervous system (CNS), central regulation of blood pressure, smooth muscle relaxation, and vasodilatation via peripheral nitrergic nerves.  Nitrergic nerves are of particular importance in the relaxation of corpus cavernosum and penile erection.  Phosphodiesterase 5 inhibitors (sildenafil, vardenafil, and tadalafil) require at least a residual nNOS activity for their action.  Inducible NOS (NOS II) can be expressed in many cell types in response to lipopolysaccharide, cytokines, or other agents.  Inducible NOS generates large amounts of NO that have cytostatic effects on parasitic target cells.  Inducible NOS contributes to the pathophysiology of inflammatory diseases and septic shock.  Endothelial NOS (eNOS, NOS III) is mostly expressed in endothelial cells.  It keeps blood vessels dilated, controls blood pressure, and has numerous other vasoprotective and anti-atherosclerotic effects.  Many cardiovascular risk factors lead to oxidative stress, eNOS uncoupling, and endothelial dysfunction in the vasculature.  Pharmacologically, vascular oxidative stress can be reduced and eNOS functionality restored with renin- and angiotensin-converting enzyme-inhibitors, with angiotensin receptor blockers, and with statins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRK_7rA0a-WP2yYR5VtavbzfW6udTcc2eblvaGY2Z3mxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zlsFOltA%253D%253D&md5=5fa266fb718dd4b068fe6a86f4db7836</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehr304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehr304%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25B6rstermann%26aufirst%3DU.%26aulast%3DSessa%26aufirst%3DW.%2BC.%26atitle%3DNitric%2520Oxide%2520Synthases%253A%2520Regulation%2520and%2520Function%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2012%26volume%3D33%26issue%3D7%26spage%3D829%26epage%3D837%26doi%3D10.1093%2Feurheartj%2Fehr304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaube, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werstuck, G. H.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial ROS versus ER ROS: Which Comes First in Myocardial Calcium Dysregulation?</span>. <i>Front. Cardiovasc. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.3389/fcvm.2016.00036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3389%2Ffcvm.2016.00036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=1-5&author=R.+Chaubeauthor=G.+H.+Werstuck&title=Mitochondrial+ROS+versus+ER+ROS%3A+Which+Comes+First+in+Myocardial+Calcium+Dysregulation%3F&doi=10.3389%2Ffcvm.2016.00036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3389%2Ffcvm.2016.00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcvm.2016.00036%26sid%3Dliteratum%253Aachs%26aulast%3DChaube%26aufirst%3DR.%26aulast%3DWerstuck%26aufirst%3DG.%2BH.%26atitle%3DMitochondrial%2520ROS%2520versus%2520ER%2520ROS%253A%2520Which%2520Comes%2520First%2520in%2520Myocardial%2520Calcium%2520Dysregulation%253F%26jtitle%3DFront.%2520Cardiovasc.%2520Med.%26date%3D2016%26volume%3D3%26spage%3D1%26epage%3D5%26doi%3D10.3389%2Ffcvm.2016.00036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoboue, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, T.</span></span> <span> </span><span class="NLM_article-title">Redox Crosstalk at Endoplasmic Reticulum (ER) Membrane Contact Sites (MCS) Uses Toxic Waste to Deliver Messages</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1038/s41419-017-0033-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41419-017-0033-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29298988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVSksL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1-14&issue=3&author=E.+D.+Yoboueauthor=R.+Sitiaauthor=T.+Simmen&title=Redox+Crosstalk+at+Endoplasmic+Reticulum+%28ER%29+Membrane+Contact+Sites+%28MCS%29+Uses+Toxic+Waste+to+Deliver+Messages&doi=10.1038%2Fs41419-017-0033-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Redox crosstalk at endoplasmic reticulum (ER) membrane contact sites (MCS) uses toxic waste to deliver messages</span></div><div class="casAuthors">Yoboue, Edgar Djaha; Sitia, Roberto; Simmen, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Many cellular redox reactions housed within mitochondria, peroxisomes and the endoplasmic reticulum (ER) generate hydrogen peroxide (H2O2) and other reactive oxygen species (ROS).  The contribution of each organelle to the total cellular ROS prodn. is considerable, but varies between cell types and also over time.  Redox-regulatory enzymes are thought to assemble at a "redox triangle" formed by mitochondria, peroxisomes and the ER, assembling "redoxosomes" that sense ROS accumulations and redox imbalances.  The redoxosome enzymes use ROS, potentially toxic byproducts made by some redoxosome members themselves, to transmit inter-compartmental signals via chem. modifications of downstream proteins and lipids.  Interestingly, important components of the redoxosome are ER chaperones and oxidoreductases, identifying ER oxidative protein folding as a key ROS producer and controller of the tri-organellar membrane contact sites (MCS) formed at the redox triangle.  At these MCS, ROS accumulations could directly facilitate inter-organellar signal transmission, using ROS transporters.  In addn., ROS influence the flux of Ca2+ ions, since many Ca2+ handling proteins, including inositol 1,4,5 trisphosphate receptors (IP3Rs), SERCA pumps or regulators of the mitochondrial Ca2+ uniporter (MCU) are redox-sensitive.  Fine-tuning of these redox and ion signaling pathways might be difficult in older organisms, suggesting a dysfunctional redox triangle may accompany the aging process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2uytu_Vp8p7Vg90H21EOLACvtfcHk0lgguiB8eoyisg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVSksL7K&md5=ad2718a5b6999d6735994c962d0b1954</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fs41419-017-0033-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-017-0033-4%26sid%3Dliteratum%253Aachs%26aulast%3DYoboue%26aufirst%3DE.%2BD.%26aulast%3DSitia%26aufirst%3DR.%26aulast%3DSimmen%26aufirst%3DT.%26atitle%3DRedox%2520Crosstalk%2520at%2520Endoplasmic%2520Reticulum%2520%2528ER%2529%2520Membrane%2520Contact%2520Sites%2520%2528MCS%2529%2520Uses%2520Toxic%2520Waste%2520to%2520Deliver%2520Messages%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3D1%26epage%3D14%26doi%3D10.1038%2Fs41419-017-0033-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanburg, B. L.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in Cell Signaling</span>. <i>Am. J. lung cell Mol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">L1005</span>– <span class="NLM_lpage">L1028</span>, <span class="refDoi"> DOI: 10.1152/ajplung.2000.279.6.L1005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1152%2Fajplung.2000.279.6.L1005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11076791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptFSksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2000&pages=L1005-L1028&issue=6&author=V.+J.+Thannickalauthor=B.+L.+Fanburg&title=Reactive+Oxygen+Species+in+Cell+Signaling&doi=10.1152%2Fajplung.2000.279.6.L1005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species in cell signaling</span></div><div class="casAuthors">Thannickal, Victor J.; Fanburg, Barry L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">6, Pt. 1</span>),
    <span class="NLM_cas:pages">L1005-L1028</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review with 325 refs.  Reactive oxygen species (ROS) are generated as byproducts of cellular metab., primarily in the mitochondria.  When cellular prodn. of ROS overwhelms its antioxidant capacity, damage to cellular macromols. such as lipids, protein, and DNA may ensue.  Such a state of "oxidative stress" is thought to contribute to the pathogenesis of a no. of human diseases including those of the lung.  Recent studies have also implicated ROS that are generated by specialized plasma membrane oxidases in normal physiol. signaling by growth factors and cytokines.  In this review, we examine the evidence for ligand-induced generation of ROS, its cellular sources, and the signaling pathways that are activated.  Emerging concepts on the mechanisms of signal transduction by ROS that involve alterations in cellular redox state and oxidative modifications of proteins are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEH4w6eWY_ZLVg90H21EOLACvtfcHk0lhsC35v1Eu0fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptFSksbg%253D&md5=ae6d8f77b43dcd22a5d41afa7ffba4c5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1152%2Fajplung.2000.279.6.L1005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.2000.279.6.L1005%26sid%3Dliteratum%253Aachs%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26aulast%3DFanburg%26aufirst%3DB.%2BL.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520Cell%2520Signaling%26jtitle%3DAm.%2520J.%2520lung%2520cell%2520Mol.%2520Physiol.%26date%3D2000%26volume%3D279%26issue%3D6%26spage%3DL1005%26epage%3DL1028%26doi%3D10.1152%2Fajplung.2000.279.6.L1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Autréaux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledano, M. B.</span></span> <span> </span><span class="NLM_article-title">ROS as Signalling Molecules: Mechanisms That Generate Specificity in ROS Homeostasis</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">824</span>, <span class="refDoi"> DOI: 10.1038/nrm2256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fnrm2256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=17848967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=813-824&issue=10&author=B.+D%E2%80%99Autr%C3%A9auxauthor=M.+B.+Toledano&title=ROS+as+Signalling+Molecules%3A+Mechanisms+That+Generate+Specificity+in+ROS+Homeostasis&doi=10.1038%2Fnrm2256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">ROS as signaling molecules: mechanisms that generate specificity in ROS homeostasis</span></div><div class="casAuthors">D'Autreaux, Benoit; Toledano, Michel B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">813-824</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Reactive O species (ROS) have been shown to be toxic but also to function as signaling mols.  This biol. paradox underlies mechanisms that are important for the integrity and fitness of living organisms and their aging.  The pathways that regulate ROS homeostasis are crucial for mitigating the toxicity of ROS and provide strong evidence about specificity in ROS signaling.  By taking advantage of the chem. of ROS, highly specific mechanisms have evolved that form the basis of oxidant scavenging and ROS signaling systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR5hZl87z2WLVg90H21EOLACvtfcHk0lhsC35v1Eu0fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7rF&md5=5302fd59fdfaf8636793ea768f188219</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrm2256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2256%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Autr%25C3%25A9aux%26aufirst%3DB.%26aulast%3DToledano%26aufirst%3DM.%2BB.%26atitle%3DROS%2520as%2520Signalling%2520Molecules%253A%2520Mechanisms%2520That%2520Generate%2520Specificity%2520in%2520ROS%2520Homeostasis%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26issue%3D10%26spage%3D813%26epage%3D824%26doi%3D10.1038%2Fnrm2256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calamita, G.</span></span> <span> </span><span class="NLM_article-title">Aquaporin Membrane Channels in Oxidative Stress, Cell Signaling, and Aging: Recent Advances and Research Trends</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1155/2018/1501847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2018%2F1501847" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=1-14&author=G.+Tammaauthor=G.+Valentiauthor=E.+Grossiniauthor=S.+Donniniauthor=A.+Marinoauthor=R.+A.+Marinelliauthor=G.+Calamita&title=Aquaporin+Membrane+Channels+in+Oxidative+Stress%2C+Cell+Signaling%2C+and+Aging%3A+Recent+Advances+and+Research+Trends&doi=10.1155%2F2018%2F1501847"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1155%2F2018%2F1501847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F1501847%26sid%3Dliteratum%253Aachs%26aulast%3DTamma%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DG.%26aulast%3DGrossini%26aufirst%3DE.%26aulast%3DDonnini%26aufirst%3DS.%26aulast%3DMarino%26aufirst%3DA.%26aulast%3DMarinelli%26aufirst%3DR.%2BA.%26aulast%3DCalamita%26aufirst%3DG.%26atitle%3DAquaporin%2520Membrane%2520Channels%2520in%2520Oxidative%2520Stress%252C%2520Cell%2520Signaling%252C%2520and%2520Aging%253A%2520Recent%2520Advances%2520and%2520Research%2520Trends%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D14%26doi%3D10.1155%2F2018%2F1501847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvin, J. L.</span></span> <span> </span><span class="NLM_article-title">Aquaporin-1 Transports NO across Cell Membranes</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.0000223652.29338.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1161%2F01.HYP.0000223652.29338.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16682607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVSmtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2006&pages=157-164&issue=1&author=M.+Herreraauthor=N.+J.+Hongauthor=J.+L.+Garvin&title=Aquaporin-1+Transports+NO+across+Cell+Membranes&doi=10.1161%2F01.HYP.0000223652.29338.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aquaporin-1 Transports NO Across Cell Membranes</span></div><div class="casAuthors">Herrera, Marcela; Hong, Nancy J.; Garvin, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-164</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">NO plays a role in the regulation of blood pressure through its effects on renal, cardiovascular, and central nervous system function.  It is generally thought to freely diffuse through cell membranes without need for a specific transporter.  The water channel aquaporin-1 transports low mol. wt. gases in addn. to water and is expressed in cells that produce or are the targets of NO.  Consequently, we tested the hypothesis that aquaporin-1 transports NO.  In cells expressing aquaporin-1, NO permeability correlated with water permeability.  NO transport was reduced by 71% by HgCl2, an inhibitor of aquaporin-1.  Transport of NO by aquaporin-1 satd. at 3 μmol/L NO and displayed a K1/2 (the concn. of NO that produces half of the max. transport rate) of 0.54 μmol/L.  Reconstitution of purified aquaporin-1 into lipid vesicles increased NO influx by 316%.  In endothelial cells, lowering aquaporin-1 expression with a small interfering RNA (siRNA) blunted aquaporin-1 expression by 54% and NO release by 44%.  We conclude that NO transport by aquaporin-1 may allow cells to control intracellular NO levels and effects.  NO transport by aquaporin-1 may play a role in central nervous system, vascular and renal function, and consequently blood pressure.  Disruption of NO transport by aquaporin-1 offers an alternate cause for diseases currently explained by inadequate NO bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkb2viIRAdRLVg90H21EOLACvtfcHk0lhxtVKenhPnjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVSmtr4%253D&md5=3e9136d4fba3f6f1c2870b0f0ea17d73</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000223652.29338.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000223652.29338.77%26sid%3Dliteratum%253Aachs%26aulast%3DHerrera%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DN.%2BJ.%26aulast%3DGarvin%26aufirst%3DJ.%2BL.%26atitle%3DAquaporin-1%2520Transports%2520NO%2520across%2520Cell%2520Membranes%26jtitle%3DHypertension%26date%3D2006%26volume%3D48%26issue%3D1%26spage%3D157%26epage%3D164%26doi%3D10.1161%2F01.HYP.0000223652.29338.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chauvigné, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerdà, J.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Aquaporin-8-Mediated Hydrogen Peroxide Transport Is Essential for Teleost Spermatozoon Motility</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1038/srep07789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fsrep07789" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=2-11&author=F.+Chauvign%C3%A9author=M.+Bojauthor=R.+N.+Finnauthor=J.+Cerd%C3%A0&title=Mitochondrial+Aquaporin-8-Mediated+Hydrogen+Peroxide+Transport+Is+Essential+for+Teleost+Spermatozoon+Motility&doi=10.1038%2Fsrep07789"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep07789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep07789%26sid%3Dliteratum%253Aachs%26aulast%3DChauvign%25C3%25A9%26aufirst%3DF.%26aulast%3DBoj%26aufirst%3DM.%26aulast%3DFinn%26aufirst%3DR.%2BN.%26aulast%3DCerd%25C3%25A0%26aufirst%3DJ.%26atitle%3DMitochondrial%2520Aquaporin-8-Mediated%2520Hydrogen%2520Peroxide%2520Transport%2520Is%2520Essential%2520for%2520Teleost%2520Spermatozoon%2520Motility%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D2%26epage%3D11%26doi%3D10.1038%2Fsrep07789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchissio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francés, D. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnovale, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, R. A.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Aquaporin-8 Knockdown in Human Hepatoma HepG2 Cells Causes ROS-Induced Mitochondrial Depolarization and Loss of Viability</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>264</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2012.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.taap.2012.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22910329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GksrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=2012&pages=246-254&issue=2&author=M.+J.+Marchissioauthor=D.+E.+A.+Franc%C3%A9sauthor=C.+E.+Carnovaleauthor=R.+A.+Marinelli&title=Mitochondrial+Aquaporin-8+Knockdown+in+Human+Hepatoma+HepG2+Cells+Causes+ROS-Induced+Mitochondrial+Depolarization+and+Loss+of+Viability&doi=10.1016%2Fj.taap.2012.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial aquaporin-8 knockdown in human hepatoma HepG2 cells causes ROS-induced mitochondrial depolarization and loss of viability</span></div><div class="casAuthors">Marchissio, Maria Julia; Frances, Daniel Eleazar Antonio; Carnovale, Cristina Ester; Marinelli, Raul Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-254</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Human aquaporin-8 (AQP8) channels facilitate the diffusional transport of H2O2 across membranes.  Since AQP8 is expressed in hepatic inner mitochondrial membranes, we studied whether mitochondrial AQP8 (mtAQP8) knockdown in human hepatoma HepG2 cells impairs mitochondrial H2O2 release, which may lead to organelle dysfunction and cell death.  We confirmed AQP8 expression in HepG2 inner mitochondrial membranes and found that 72 h after cell transfection with siRNAs targeting two different regions of the human AQP8 mol., mtAQP8 protein specifically decreased by around 60% (p < 0.05).  Studies in isolated mtAQP8-knockdown mitochondria showed that H2O2 release, assessed by Amplex Red, was reduced by about 45% (p < 0.05), an effect not obsd. in digitonin-permeabilized mitochondria. mtAQP8-knockdown cells showed an increase in mitochondrial ROS, assessed by dichlorodihydrofluorescein diacetate (+ 120%, p < 0.05) and loss of mitochondrial membrane potential (- 80%, p < 0.05), assessed by tetramethylrhodamine-coupled quant. fluorescence microscopy.  The mitochondria-targeted antioxidant MitoTempol prevented ROS accumulation and dissipation of mitochondrial membrane potential.  Cyclosporin A, a mitochondrial permeability transition pore blocker, also abolished the mtAQP8 knockdown-induced mitochondrial depolarization.  Besides, the loss of viability in mtAQP8 knockdown cells verified by MTT assay, LDH leakage, and trypan blue exclusion test could be prevented by cyclosporin A.  Our data on human hepatoma HepG2 cells suggest that mtAQP8 facilitates mitochondrial H2O2 release and that its defective expression causes ROS-induced mitochondrial depolarization via the mitochondrial permeability transition mechanism, and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtFDoMK1W8bLVg90H21EOLACvtfcHk0lhxtVKenhPnjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GksrzK&md5=7ba731781edffd821c076e860f67e60e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2012.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2012.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DMarchissio%26aufirst%3DM.%2BJ.%26aulast%3DFranc%25C3%25A9s%26aufirst%3DD.%2BE.%2BA.%26aulast%3DCarnovale%26aufirst%3DC.%2BE.%26aulast%3DMarinelli%26aufirst%3DR.%2BA.%26atitle%3DMitochondrial%2520Aquaporin-8%2520Knockdown%2520in%2520Human%2520Hepatoma%2520HepG2%2520Cells%2520Causes%2520ROS-Induced%2520Mitochondrial%2520Depolarization%2520and%2520Loss%2520of%2520Viability%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2012%26volume%3D264%26issue%3D2%26spage%3D246%26epage%3D254%26doi%3D10.1016%2Fj.taap.2012.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pietro, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcón-Pérez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenza, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setty, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dell’Angelica, E. C.</span></span> <span> </span><span class="NLM_article-title">BLOC-1 Interacts with BLOC-2 and the AP-3 Complex to Facilitate Protein Trafficking on Endosomes</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4027</span>– <span class="NLM_lpage">4038</span>, <span class="refDoi"> DOI: 10.1091/mbc.e06-05-0379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1091%2Fmbc.e06-05-0379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16837549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1aksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=4027-4038&author=S.+M.+Di%0APietroauthor=J.+M.+Falc%C3%B3n-P%C3%A9rezauthor=D.+Tenzaauthor=S.+R.+G.+Settyauthor=M.+S.+Marksauthor=G.+Raposoauthor=E.+C.+Dell%E2%80%99Angelica&title=BLOC-1+Interacts+with+BLOC-2+and+the+AP-3+Complex+to+Facilitate+Protein+Trafficking+on+Endosomes&doi=10.1091%2Fmbc.e06-05-0379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate protein trafficking on endosomes</span></div><div class="casAuthors">Di Pietro, Santiago M.; Falcon-Perez, Juan M.; Tenza, Daniele; Setty, Subba R. G.; Marks, Michael S.; Raposo, Graca; Dell'Angelica, Esteban C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4027-4038</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The adaptor protein (AP)-3 complex is a component of the cellular machinery that controls protein sorting from endosomes to lysosomes and specialized related organelles such as melanosomes.  Mutations in an AP-3 subunit underlie a form of Hermansky-Pudlak syndrome (HPS), a disorder characterized by abnormalities in lysosome-related organelles.  HPS in humans can also be caused by mutations in genes encoding subunits of three complexes of unclear function, named biogenesis of lysosome-related organelles complex (BLOC)-1, -2, and -3.  Here, the authors report that BLOC-1 interacts phys. and functionally with AP-3 to facilitate the trafficking of a known AP-3 cargo, CD63, and of tyrosinase-related protein 1 (Tyrp1), a melanosomal membrane protein previously thought to traffic only independently of AP-3.  BLOC-1 also interacts with BLOC-2 to facilitate Tyrp1 trafficking by a mechanism apparently independent of AP-3 function.  Both BLOC-1 and -2 localize mainly to early endosome-assocd. tubules as detd. by immunoelectron microscopy.  These findings support the idea that BLOC-1 and -2 represent hitherto unknown components of the endosomal protein trafficking machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIAfnWuujIArVg90H21EOLACvtfcHk0lhiMdzPvtpWKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1aksr0%253D&md5=fbc596269cab6a837b0f797ade7a1dd1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e06-05-0379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e06-05-0379%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DS.%2BM.%26aulast%3DFalc%25C3%25B3n-P%25C3%25A9rez%26aufirst%3DJ.%2BM.%26aulast%3DTenza%26aufirst%3DD.%26aulast%3DSetty%26aufirst%3DS.%2BR.%2BG.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3DDell%25E2%2580%2599Angelica%26aufirst%3DE.%2BC.%26atitle%3DBLOC-1%2520Interacts%2520with%2520BLOC-2%2520and%2520the%2520AP-3%2520Complex%2520to%2520Facilitate%2520Protein%2520Trafficking%2520on%2520Endosomes%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2006%26volume%3D17%26spage%3D4027%26epage%3D4038%26doi%3D10.1091%2Fmbc.e06-05-0379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species (ROS) as Pleiotropic Physiological Signalling Agents</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1038/s41580-020-0230-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41580-020-0230-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32231263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=363-383&issue=7&author=H.+Siesauthor=D.+P.+Jones&title=Reactive+Oxygen+Species+%28ROS%29+as+Pleiotropic+Physiological+Signalling+Agents&doi=10.1038%2Fs41580-020-0230-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species (ROS) as pleiotropic physiological signalling agents</span></div><div class="casAuthors">Sies, Helmut; Jones, Dean P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">363-383</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: 'Reactive oxygen species' (ROS) is an umbrella term for an array of derivs. of mol. oxygen that occur as a normal attribute of aerobic life.  Elevated formation of the different ROS leads to mol. damage, denoted as 'oxidative distress'.  Here we focus on ROS at physiol. levels and their central role in redox signalling via different post-translational modifications, denoted as 'oxidative eustress'.  Two species, hydrogen peroxide (H2O2) and the superoxide anion radical (O2·-), are key redox signalling agents generated under the control of growth factors and cytokines by more than 40 enzymes, prominently including NADPH oxidases and the mitochondrial electron transport chain.  At the low physiol. levels in the nanomolar range, H2O2 is the major agent signalling through specific protein targets, which engage in metabolic regulation and stress responses to support cellular adaptation to a changing environment and stress.  In addn., several other reactive species are involved in redox signalling, for instance nitric oxide, hydrogen sulfide and oxidized lipids.  Recent methodol. advances permit the assessment of mol. interactions of specific ROS mols. with specific targets in redox signalling pathways.  Accordingly, major advances have occurred in understanding the role of these oxidants in physiol. and disease, including the nervous, cardiovascular and immune systems, skeletal muscle and metabolic regulation as well as ageing and cancer.  In the past, unspecific elimination of ROS by use of low mol. mass antioxidant compds. was not successful in counteracting disease initiation and progression in clin. trials.  However, controlling specific ROS-mediated signalling pathways by selective targeting offers a perspective for a future of more refined redox medicine.  This includes enzymic defense systems such as those controlled by the stress-response transcription factors NRF2 and nuclear factor-κB, the role of trace elements such as selenium, the use of redox drugs and the modulation of environmental factors collectively known as the exposome (for example, nutrition, lifestyle and irradn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUOGVldjysxrVg90H21EOLACvtfcHk0lhiMdzPvtpWKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtrY%253D&md5=52e3327385f2c2910d1ffc5f4062eb77</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41580-020-0230-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41580-020-0230-3%26sid%3Dliteratum%253Aachs%26aulast%3DSies%26aufirst%3DH.%26aulast%3DJones%26aufirst%3DD.%2BP.%26atitle%3DReactive%2520Oxygen%2520Species%2520%2528ROS%2529%2520as%2520Pleiotropic%2520Physiological%2520Signalling%2520Agents%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2020%26volume%3D21%26issue%3D7%26spage%3D363%26epage%3D383%26doi%3D10.1038%2Fs41580-020-0230-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chio, I. I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span> <span> </span><span class="NLM_article-title">ROS in Cancer: The Burning Question</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2017.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.molmed.2017.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28427863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1WiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=411-429&issue=5&author=I.+I.+C.+Chioauthor=D.+A.+Tuveson&title=ROS+in+Cancer%3A+The+Burning+Question&doi=10.1016%2Fj.molmed.2017.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">ROS in Cancer: The Burning Question</span></div><div class="casAuthors">Chio, Iok In Christine; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-429</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">An unanswered question in human health is whether antioxidn. prevents or promotes cancer.  Antioxidn. has historically been viewed as chemopreventive, but emerging evidence suggests that antioxidants may be supportive of neoplasia.  We posit this contention to be rooted in the fact that ROS do not operate as one single biochem. entity, but as diverse secondary messengers in cancer cells.  This cautions against therapeutic strategies to increase ROS at a global level.  To leverage redox alterations towards the development of effective therapies necessitates the application of biophys. and biochem. approaches to define redox dynamics and to functionally elucidate specific oxidative modifications in cancer vs. normal cells.  An improved understanding of the sophisticated workings of redox biol. is imperative to defeating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0BkT0gWhumrVg90H21EOLACvtfcHk0lh7i41fq3Qm2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1WiurY%253D&md5=74ce7fb3d8db3718d6c97b9030deb0da</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2017.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2017.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DChio%26aufirst%3DI.%2BI.%2BC.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DROS%2520in%2520Cancer%253A%2520The%2520Burning%2520Question%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2017%26volume%3D23%26issue%3D5%26spage%3D411%26epage%3D429%26doi%3D10.1016%2Fj.molmed.2017.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hariharan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaraj, S.</span></span> <span> </span><span class="NLM_article-title">Selenium and Selenoproteins: It’s Role in Regulation of Inflammation</span>. <i>Inflammopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1007/s10787-020-00690-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs10787-020-00690-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32144521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslGjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=667-695&issue=3&author=S.+Hariharanauthor=S.+Dharmaraj&title=Selenium+and+Selenoproteins%3A+It%E2%80%99s+Role+in+Regulation+of+Inflammation&doi=10.1007%2Fs10787-020-00690-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium and selenoproteins: it's role in regulation of inflammation</span></div><div class="casAuthors">Hariharan, Sneha; Dharmaraj, Selvakumar</div><div class="citationInfo"><span class="NLM_cas:title">Inflammopharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">667-695</span>CODEN:
                <span class="NLM_cas:coden">IAOAES</span>;
        ISSN:<span class="NLM_cas:issn">0925-4692</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Abstr.: Selenium is an essential immunonutrient which holds the human's metabolic activity with its chem. bonds.  Glutathione peroxidase (GPX) is the major selenoprotein present in the human body, which assists in the control of excessive prodn. of free radical at the site of inflammation.  Other than GPX, other selenoproteins include selenoprotein-S that regulates the inflammatory cytokines and selenoprotein-P that serves as an inducer of homeostasis.  Previously, reports were mainly focused on the cellular and mol. mechanism of wound healing with ref. to various animal models and cell lines.  In this review, the role of selenium and its possible routes in translational decoding of selenocysteine, synthesis of selenoproteins, systemic action of selenoproteins and their indirect assimilation in the process of wound healing are explained in detail.  Some of the selenium contg. compds. which can acts as cancer preventive and therapeutics are also discussed.  These compds. directly or indirectly exhibit antioxidant properties which can sustain the intracellular redox status and these activities protect the healthy cells from reactive oxygen species induced oxidative damage.  Although the review covers the importance of selenium/selenoproteins in wound healing process, still some unresolved mystery persists which may be resolved in near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8NUS50S5hw7Vg90H21EOLACvtfcHk0lh7i41fq3Qm2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslGjsr0%253D&md5=fec080fb12b68dddba303e4e5b8f0ee6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs10787-020-00690-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10787-020-00690-x%26sid%3Dliteratum%253Aachs%26aulast%3DHariharan%26aufirst%3DS.%26aulast%3DDharmaraj%26aufirst%3DS.%26atitle%3DSelenium%2520and%2520Selenoproteins%253A%2520It%25E2%2580%2599s%2520Role%2520in%2520Regulation%2520of%2520Inflammation%26jtitle%3DInflammopharmacology%26date%3D2020%26volume%3D28%26issue%3D3%26spage%3D667%26epage%3D695%26doi%3D10.1007%2Fs10787-020-00690-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arbogast, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreiro, A.</span></span> <span> </span><span class="NLM_article-title">Selenoproteins and Protection against Oxidative Stress: Selenoprotein N as a Novel Player at the Crossroads of Redox Signaling and Calcium Homeostasis</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1089/ars.2009.2890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fars.2009.2890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=19769461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFOjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=893-904&issue=7&author=S.+Arbogastauthor=A.+Ferreiro&title=Selenoproteins+and+Protection+against+Oxidative+Stress%3A+Selenoprotein+N+as+a+Novel+Player+at+the+Crossroads+of+Redox+Signaling+and+Calcium+Homeostasis&doi=10.1089%2Fars.2009.2890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Selenoproteins and protection against oxidative stress: selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis</span></div><div class="casAuthors">Arbogast, Sandrine; Ferreiro, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">893-904</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Healthy cells continually produce low levels of reactive oxygen species (ROS), which are buffered by multiple antioxidant systems.  Imbalance between ROS prodn. and elimination results in oxidative stress, which has been implicated in aging and in numerous human diseases, including cancer and diabetes.  Selenoproteins are a family of proteins that contain the amino acid selenocysteine, encoded by an in-frame UGA.  Those selenoproteins whose function is identified are catalytically active in redox processes, representing one of the main enzymic antioxidant systems and important mediators of the beneficial role of selenium in human health.  Nevertheless, the function of most selenoproteins remains unknown; this included Selenoprotein N (SelN), the only selenoprotein directly assocd. with a human genetic disease.  Mutations of the SelN gene cause SEPN1-related myopathy, a particular early-onset muscle disorder.  Recent studies have identified SelN as a key protein in cell protection against oxidative stress and redox-related calcium homeostasis.  Furthermore, an effective ex vivo treatment of SelN deficiency has been identified, paving the way to a clin. therapy.  In this review we discuss the physiol. and pathophysiol. role of SelN and the interest of SEPN1-related myopathy as a model paradigm to understand and target therapeutically other selenoproteins involved in human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0FTiUZMy73LVg90H21EOLACvtfcHk0lh7i41fq3Qm2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFOjsbo%253D&md5=55556e3ebbb8a09f3a07cb92c3339d8b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1089%2Fars.2009.2890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2009.2890%26sid%3Dliteratum%253Aachs%26aulast%3DArbogast%26aufirst%3DS.%26aulast%3DFerreiro%26aufirst%3DA.%26atitle%3DSelenoproteins%2520and%2520Protection%2520against%2520Oxidative%2520Stress%253A%2520Selenoprotein%2520N%2520as%2520a%2520Novel%2520Player%2520at%2520the%2520Crossroads%2520of%2520Redox%2520Signaling%2520and%2520Calcium%2520Homeostasis%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D12%26issue%3D7%26spage%3D893%26epage%3D904%26doi%3D10.1089%2Fars.2009.2890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maiorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aumann, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigelius-Flohe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den
Heuvel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohé, L.</span></span> <span> </span><span class="NLM_article-title">Probing the Presumed Catalytic Triad of Selenium-Containing Peroxidases by Mutational Analysis of Phospholipid Hydroperoxide Glutathione Peroxidase (PHGPx)</span>. <i>Biol. Chem. Hoppe-Seyler</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>376</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1515/bchm3.1995.376.11.651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1515%2Fbchm3.1995.376.11.651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=8962674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2MXpvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=651-660&issue=11&author=M.+Maiorinoauthor=K.+D.+Aumannauthor=R.+Brigelius-Floheauthor=F.+Ursiniauthor=J.+van+den%0AHeuvelauthor=J.+McCarthyauthor=L.+Floh%C3%A9&title=Probing+the+Presumed+Catalytic+Triad+of+Selenium-Containing+Peroxidases+by+Mutational+Analysis+of+Phospholipid+Hydroperoxide+Glutathione+Peroxidase+%28PHGPx%29&doi=10.1515%2Fbchm3.1995.376.11.651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the presumed catalytic triad of selenium-containing peroxidases by mutational analysis of phospholipid hydroperoxide glutathione peroxidase (PHGPx)</span></div><div class="casAuthors">Maiorino, Matilde; Aumann, Klaus-Dieter; Brigelius-Flohe, Regina; Doria, Denise; van den Heuvel, Joop; McCarthy, John; Roveri, Antonella; Ursini, Fulvio; Flohe, Leopold</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry Hoppe-Seyler</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">651-60</span>CODEN:
                <span class="NLM_cas:coden">BCHSEI</span>;
        ISSN:<span class="NLM_cas:issn">0177-3593</span>.
    
            (<span class="NLM_cas:orgname">de Gruyter</span>)
        </div><div class="casAbstract">Single and double site mutants affecting the presumed catalytic center of the selenoenzyme PHGPx were subjected to functional anal.  The rate consts. k+1 and k'+2, for the oxidn. and the regeneration of the ground state enzyme were estd., resp.  Moreover, the alkylation rate of the reactive center by iodoacetate (kinact.) was also analyzed.  The substitution of the catalytically competent selenocysteine 46 by cysteine (PHGPxcys46) decreased k+1 and k'+2 by about three orders of magnitude, although leaving unaffected kinact.  Furthermore, mutations of PHGPxcys46 involving the other residues of the triad decreased both kinact. and k+1, thus highlighting the involvement of Gln 81 and Trp 136 in the dissocn./activation of the nucleophilic cysteine thiol.  In general, substitutions of Gln 81 or Trp 136 by acidic residues in PHGPxcys46 most dramatically depressed the k+1 values, because they practically prevented the dissocn. of the thiol group, while neutral or pos. charged residues in these positions allowed an intermediate dissocn. and induced a corresponding reactivity of the thiol.  The data, for the first time, reveal that the presumed triad of selenocysteine, glutamine and tryptophan residues represents a novel type of catalytic center, whose integrity is essential for the full catalytic function of glutathione peroxidases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqytuVxqIvurLVg90H21EOLACvtfcHk0liENl7uLE2XSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpvVClsbo%253D&md5=09e0d5acc0fcc1ac99d4b3cf875977d4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1515%2Fbchm3.1995.376.11.651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbchm3.1995.376.11.651%26sid%3Dliteratum%253Aachs%26aulast%3DMaiorino%26aufirst%3DM.%26aulast%3DAumann%26aufirst%3DK.%2BD.%26aulast%3DBrigelius-Flohe%26aufirst%3DR.%26aulast%3DUrsini%26aufirst%3DF.%26aulast%3Dvan%2Bden%2BHeuvel%26aufirst%3DJ.%26aulast%3DMcCarthy%26aufirst%3DJ.%26aulast%3DFloh%25C3%25A9%26aufirst%3DL.%26atitle%3DProbing%2520the%2520Presumed%2520Catalytic%2520Triad%2520of%2520Selenium-Containing%2520Peroxidases%2520by%2520Mutational%2520Analysis%2520of%2520Phospholipid%2520Hydroperoxide%2520Glutathione%2520Peroxidase%2520%2528PHGPx%2529%26jtitle%3DBiol.%2520Chem.%2520Hoppe-Seyler%26date%3D1995%26volume%3D376%26issue%3D11%26spage%3D651%26epage%3D660%26doi%3D10.1515%2Fbchm3.1995.376.11.651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">Non-Covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8088</span>– <span class="NLM_lpage">8103</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00358</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00358" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8088-8103&author=J.+S.+Pallesenauthor=K.+T.+Tranauthor=A.+Bach&title=Non-Covalent+Small-Molecule+Kelch-like+ECH-Associated+Protein+1%E2%80%93Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Keap1%E2%80%93Nrf2%29+Inhibitors+and+Their+Potential+for+Targeting+Central+Nervous+System+Diseases&doi=10.1021%2Facs.jmedchem.8b00358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases</span></div><div class="casAuthors">Pallesen, Jakob S.; Tran, Kim T.; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8088-8103</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) diseases.  Inhibition of the protein-protein interaction (PPI) between Nrf2 and its repressor protein, Kelch-like ECH-assocd. protein 1 (Keap1), leads to translocation of Nrf2 from the cytosol to the nucleus and expression of detoxifying antioxidant enzymes.  To date, several non-covalent small-mol. Keap1-Nrf2 inhibitors have been identified; however, many of them contain carboxylic acids and are rather large in size, which likely prevents or decreases CNS permeability.  This Perspective describes current small-mol. Keap1-Nrf2 inhibitors with exptl. evidence for the ability to inhibit the Keap1-Nrf2 interaction by binding to Keap1 in a non-covalent manner.  Binding data, biostructural studies, and biol. activity are summarized for the inhibitors, and their potential as CNS tool compds. is discussed by analyzing physicochem. properties, including CNS multiparameter optimization (MPO) scoring algorithms.  Finally, several strategies for identifying CNS-targeting Keap1 inhibitors are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAnObBnG8ca7Vg90H21EOLACvtfcHk0liENl7uLE2XSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D&md5=0492259af2532169001a1d4ef532fdbb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00358%26sid%3Dliteratum%253Aachs%26aulast%3DPallesen%26aufirst%3DJ.%2BS.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DNon-Covalent%2520Small-Molecule%2520Kelch-like%2520ECH-Associated%2520Protein%25201%25E2%2580%2593Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Keap1%25E2%2580%2593Nrf2%2529%2520Inhibitors%2520and%2520Their%2520Potential%2520for%2520Targeting%2520Central%2520Nervous%2520System%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8088%26epage%3D8103%26doi%3D10.1021%2Facs.jmedchem.8b00358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azad, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, S. B.</span></span> <span> </span><span class="NLM_article-title">Regulation of Autophagy by Reactive OxygenSpecies (ROS): Implications for Cancer Progression and Treatment</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">777</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1089/ars.2008.2270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fars.2008.2270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18828708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlWiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=777-790&issue=4&author=M.+B.+Azadauthor=Y.+Chenauthor=S.+B.+Gibson&title=Regulation+of+Autophagy+by+Reactive+OxygenSpecies+%28ROS%29%3A+Implications+for+Cancer+Progression+and+Treatment&doi=10.1089%2Fars.2008.2270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Autophagy by Reactive Oxygen Species (ROS): Implications for Cancer Progression and Treatment</span></div><div class="casAuthors">Azad, Meghan B.; Chen, Yongqiang; Gibson, Spencer B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">777-790</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) have been identified as signaling mols. in various pathways regulating both cell survival and cell death.  Autophagy, a self-digestion process that degrades intracellular structures in response to stress, such as nutrient starvation, is also involved in both cell survival and cell death.  Alterations in both ROS and autophagy regulation contribute to cancer initiation and progression, and both are targets for developing therapies to induce cell death selectively in cancer cells.  Many stimuli that induce ROS generation also induce autophagy, including nutrient starvation, mitochondrial toxins, hypoxia, and oxidative stress.  Some of these stimuli are under clin. investigation as cancer treatments, such as 2-methoxyestrodial and arsenic trioxide.  Recently, it was demonstrated that ROS can induce autophagy through several distinct mechanisms involving Atg4, catalase, and the mitochondrial electron transport chain (mETC).  This leads to both cell-survival and cell-death responses and could be selective toward cancer cells.  In this review, we give an overview of the roles ROS and autophagy play in cell survival and cell death, and their importance to cancer.  Furthermore, we describe how autophagy is mediated by ROS and the implications of this regulation to cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxdbKzM77o-bVg90H21EOLACvtfcHk0lil01KYzZMWUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlWiu7Y%253D&md5=44f69c5abd553fd0e4914b49a4346fc9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1089%2Fars.2008.2270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2008.2270%26sid%3Dliteratum%253Aachs%26aulast%3DAzad%26aufirst%3DM.%2BB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGibson%26aufirst%3DS.%2BB.%26atitle%3DRegulation%2520of%2520Autophagy%2520by%2520Reactive%2520OxygenSpecies%2520%2528ROS%2529%253A%2520Implications%2520for%2520Cancer%2520Progression%2520and%2520Treatment%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2009%26volume%3D11%26issue%3D4%26spage%3D777%26epage%3D790%26doi%3D10.1089%2Fars.2008.2270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scherz-shouval, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elazar, Z.</span></span> <span> </span><span class="NLM_article-title">Regulation of Autophagy by ROS : Physiology and Pathology</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2010.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.tibs.2010.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=20728362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=30-38&issue=1&author=R.+Scherz-shouvalauthor=Z.+Elazar&title=Regulation+of+Autophagy+by+ROS%E2%80%AF%3A+Physiology+and+Pathology&doi=10.1016%2Fj.tibs.2010.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of autophagy by ROS: physiology and pathology</span></div><div class="casAuthors">Scherz-Shouval, Ruth; Elazar, Zvulun</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-38</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are small and highly reactive mols. that can oxidize proteins, lipids and DNA.  When tightly controlled, ROS serve as signaling mols. by modulating the activity of the oxidized targets.  Accumulating data point to an essential role for ROS in the activation of autophagy.  Be the outcome of autophagy survival or death and the initiation conditions starvation, pathogens or death receptors, ROS are invariably involved.  The nature of this involvement, however, remains unclear.  Moreover, although connections between ROS and autophagy are obsd. in diverse pathol. conditions, the mode of activation of autophagy and its potential protective role remain incompletely understood.  Notably, recent advances in the field of redox regulation of autophagy focus on the role of mitochondria as a source of ROS and on mitophagy as a means for clearance of ROS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptRenFq2B6YbVg90H21EOLACvtfcHk0lil01KYzZMWUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFKgtw%253D%253D&md5=249d7f7c7ac185d457044121e80d880a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2010.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2010.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DScherz-shouval%26aufirst%3DR.%26aulast%3DElazar%26aufirst%3DZ.%26atitle%3DRegulation%2520of%2520Autophagy%2520by%2520ROS%25E2%2580%25AF%253A%2520Physiology%2520and%2520Pathology%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2011%26volume%3D36%26issue%3D1%26spage%3D30%26epage%3D38%26doi%3D10.1016%2Fj.tibs.2010.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filomeni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Zio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecconi, F.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress and Autophagy : The Clash between Damage and Metabolic Needs</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1038/cdd.2014.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fcdd.2014.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=25257172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ChsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=377-388&issue=3&author=G.+Filomeniauthor=D.+De+Zioauthor=F.+Cecconi&title=Oxidative+Stress+and+Autophagy%E2%80%AF%3A+The+Clash+between+Damage+and+Metabolic+Needs&doi=10.1038%2Fcdd.2014.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and autophagy: the clash between damage and metabolic needs</span></div><div class="casAuthors">Filomeni, G.; De Zio, D.; Cecconi, F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-388</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autophagy is a catabolic process aimed at recycling cellular components and damaged organelles in response to diverse conditions of stress, such as nutrient deprivation, viral infection and genotoxic stress.  A growing amt. of evidence in recent years argues for oxidative stress acting as the converging point of these stimuli, with reactive oxygen species (ROS) and reactive nitrogen species (RNS) being among the main intracellular signal transducers sustaining autophagy.  This review aims at providing novel insight into the regulatory pathways of autophagy in response to glucose and amino acid deprivation, as well as their tight interconnection with metabolic networks and redox homeostasis.  The role of oxidative and nitrosative stress in autophagy is also discussed in the light of its being harmful for both cellular biomols. and signal mediator through reversible posttranslational modifications of thiol-contg. proteins.  The redox-independent relationship between autophagy and antioxidant response, occurring through the p62/Keap1/Nrf2 pathway, is also addressed in order to provide a wide perspective upon the interconnection between autophagy and oxidative stress.  Herein, we also attempt to afford an overview of the complex crosstalk between autophagy and DNA damage response (DDR), focusing on the main pathways activated upon ROS and RNS overprodn.  Along these lines, the direct and indirect role of autophagy in DDR is dissected in depth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwn5KtqIqiJrVg90H21EOLACvtfcHk0lhWwgBRtix9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ChsbbN&md5=54ea9102602e513e1b3877599a4b1865</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2014.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2014.150%26sid%3Dliteratum%253Aachs%26aulast%3DFilomeni%26aufirst%3DG.%26aulast%3DDe%2BZio%26aufirst%3DD.%26aulast%3DCecconi%26aufirst%3DF.%26atitle%3DOxidative%2520Stress%2520and%2520Autophagy%25E2%2580%25AF%253A%2520The%2520Clash%2520between%2520Damage%2520and%2520Metabolic%2520Needs%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2015%26volume%3D22%26issue%3D3%26spage%3D377%26epage%3D388%26doi%3D10.1038%2Fcdd.2014.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundaresan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrans, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkel, T.</span></span> <span> </span><span class="NLM_article-title">Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span> (<span class="NLM_issue">5234</span>),  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1126/science.270.5234.296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1126%2Fscience.270.5234.296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=7569979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2MXoslehs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=296-299&issue=5234&author=M.+Sundaresanauthor=Z.+Yuauthor=V.+J.+Ferransauthor=K.+Iraniauthor=T.+Finkel&title=Requirement+for+Generation+of+H2O2+for+Platelet-Derived+Growth+Factor+Signal+Transduction&doi=10.1126%2Fscience.270.5234.296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for generation of H2O2 for platelet-derived growth factor signal transduction</span></div><div class="casAuthors">Sundaresan, Maitrayee; Yu, Zu-Xi; Ferrans, Victor J.; Irani, Kaikobad; Finkel, Toren</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">5234</span>),
    <span class="NLM_cas:pages">296-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Stimulation of rat vascular smooth muscle cells (VSMCs) by platelet-derived growth factor (PDGF) transiently increased the intracellular concn. of hydrogen peroxide (H2O2).  This increase could be blunted by increasing the intracellular concn. of the scavenging enzyme catalase or by the chem. antioxidant N-acetylcysteine.  The response of VSMCs to PDGF, which includes tyrosine phosphorylation, mitogen-activated protein kinase stimulation, DNA synthesis, and chemotaxis, was inhibited when the growth factor-stimulated rise in H2O2 concn. was blocked.  These results suggest that H2O2 may act as a signal-transducing mol., and they suggest a potential mechanism for the cardioprotective effects of antioxidants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY7kya9xgydLVg90H21EOLACvtfcHk0lhWwgBRtix9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslehs7c%253D&md5=d5c8c7d54f0cbecbe855883fe50d03e6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscience.270.5234.296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.270.5234.296%26sid%3Dliteratum%253Aachs%26aulast%3DSundaresan%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DFerrans%26aufirst%3DV.%2BJ.%26aulast%3DIrani%26aufirst%3DK.%26aulast%3DFinkel%26aufirst%3DT.%26atitle%3DRequirement%2520for%2520Generation%2520of%2520H2O2%2520for%2520Platelet-Derived%2520Growth%2520Factor%2520Signal%2520Transduction%26jtitle%3DScience%26date%3D1995%26volume%3D270%26issue%3D5234%26spage%3D296%26epage%3D299%26doi%3D10.1126%2Fscience.270.5234.296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in Vascular Formation and Development</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1155/2013/374963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2013%2F374963" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=1-14&author=Y.+Zhouauthor=H.+Yanauthor=M.+Guoauthor=J.+Zhuauthor=Q.+Xiaoauthor=L.+Zhang&title=Reactive+Oxygen+Species+in+Vascular+Formation+and+Development&doi=10.1155%2F2013%2F374963"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1155%2F2013%2F374963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F374963%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520Vascular%2520Formation%2520and%2520Development%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D14%26doi%3D10.1155%2F2013%2F374963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazhin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakhanova, S.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in the Immune System</span>. <i>Int. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.3109/08830185.2012.755176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3109%2F08830185.2012.755176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=23617726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslCnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=249-270&issue=3&author=Y.+Yangauthor=A.+V.+Bazhinauthor=J.+Wernerauthor=S.+Karakhanova&title=Reactive+Oxygen+Species+in+the+Immune+System&doi=10.3109%2F08830185.2012.755176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species in the Immune System</span></div><div class="casAuthors">Yang, Yuhui; Bazhin, Alexandr V.; Werner, Jens; Karakhanova, Svetlana</div><div class="citationInfo"><span class="NLM_cas:title">International Reviews of Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-270</span>CODEN:
                <span class="NLM_cas:coden">IRIMEH</span>;
        ISSN:<span class="NLM_cas:issn">0883-0185</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are a group of highly reactive chems. contg. oxygen produced either exogenously or endogenously.  ROS are related to a wide variety of human disorders, such as chronic inflammation, age-related diseases and cancers.  Besides, ROS are also essential for various biol. functions, including cell survival, cell growth, proliferation and differentiation, and immune response.  At present there are a no. of excellent publications including some reviews about functions of these mols. either in normal cell biol. or in pathophysiol.  In this work, we reviewed available information and recent advances about ROS in the main immune cell types and gave summary about functions of these highly reactive mols. both in innate immunity as conservative defense mechanisms and in essential immune cells involved in adaptive immunity, and particularly in immune suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhUSJEYJjbcLVg90H21EOLACvtfcHk0lhWwgBRtix9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslCnsL4%253D&md5=97ddf4d53073235ea70337eaf25b05ad</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3109%2F08830185.2012.755176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08830185.2012.755176%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBazhin%26aufirst%3DA.%2BV.%26aulast%3DWerner%26aufirst%3DJ.%26aulast%3DKarakhanova%26aufirst%3DS.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520the%2520Immune%2520System%26jtitle%3DInt.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D32%26issue%3D3%26spage%3D249%26epage%3D270%26doi%3D10.3109%2F08830185.2012.755176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selemidis, S.</span></span> <span> </span><span class="NLM_article-title">Targeting Reactive Oxygen Species for Respiratory Infection: Fact or Fancy?</span>. <i>Respirology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1111/resp.13417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fresp.13417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30295360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BB3czmslOhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=15-16&issue=1&author=S.+Selemidis&title=Targeting+Reactive+Oxygen+Species+for+Respiratory+Infection%3A+Fact+or+Fancy%3F&doi=10.1111%2Fresp.13417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting reactive oxygen species for respiratory infection: Fact or fancy?</span></div><div class="casAuthors">Selemidis Stavros; Selemidis Stavros</div><div class="citationInfo"><span class="NLM_cas:title">Respirology (Carlton, Vic.)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDhdgDcof-FZw7prLlxLOzfW6udTcc2eahpQlK12M45Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czmslOhtQ%253D%253D&md5=2aded28d9d2a0b8d543819d9d63af870</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fresp.13417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fresp.13417%26sid%3Dliteratum%253Aachs%26aulast%3DSelemidis%26aufirst%3DS.%26atitle%3DTargeting%2520Reactive%2520Oxygen%2520Species%2520for%2520Respiratory%2520Infection%253A%2520Fact%2520or%2520Fancy%253F%26jtitle%3DRespirology%26date%3D2019%26volume%3D24%26issue%3D1%26spage%3D15%26epage%3D16%26doi%3D10.1111%2Fresp.13417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1155/2016/1580967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2016%2F1580967" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1-10&author=X.+Chenauthor=M.+Songauthor=B.+Zhangauthor=Y.+Zhang&title=Reactive+Oxygen+Species+Regulate+T+Cell+Immune+Response+in+the+Tumor+Microenvironment&doi=10.1155%2F2016%2F1580967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1155%2F2016%2F1580967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F1580967%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DReactive%2520Oxygen%2520Species%2520Regulate%2520T%2520Cell%2520Immune%2520Response%2520in%2520the%2520Tumor%2520Microenvironment%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2016%26volume%3D2016%26spage%3D1%26epage%3D10%26doi%3D10.1155%2F2016%2F1580967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">To, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlahos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halls, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reading, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobey, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broughton, B. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starkey, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Sluis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozinovski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, L. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, C. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selemidis, S.</span></span> <span> </span><span class="NLM_article-title">Endosomal NOX2 Oxidase Exacerbates Virus Pathogenicity and Is a Target for Antiviral Therapy</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">69</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-00057-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41467-017-00057-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28701733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC1cjmvFOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=69&issue=1&author=E.+E.+Toauthor=R.+Vlahosauthor=R.+Luongauthor=M.+L.+Hallsauthor=P.+C.+Readingauthor=P.+T.+Kingauthor=C.+Chanauthor=G.+R.+Drummondauthor=C.+G.+Sobeyauthor=B.+R.+S.+Broughtonauthor=M.+R.+Starkeyauthor=R.+Van+Der+Sluisauthor=S.+R.+Lewinauthor=S.+Bozinovskiauthor=L.+A.+J.+O%E2%80%99Neillauthor=T.+Quachauthor=C.+J.+H.+Porterauthor=D.+A.+Brooksauthor=J.+J.+O%E2%80%99Learyauthor=S.+Selemidis&title=Endosomal+NOX2+Oxidase+Exacerbates+Virus+Pathogenicity+and+Is+a+Target+for+Antiviral+Therapy&doi=10.1038%2Fs41467-017-00057-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy</span></div><div class="casAuthors">To Eunice E; Vlahos Ross; Bozinovski Steven; Selemidis Stavros; To Eunice E; Luong Raymond; Chan Christopher; Broughton Brad R S; Selemidis Stavros; Halls Michelle L; Reading Patrick C; King Paul T; Chan Christopher; Drummond Grant R; Sobey Christopher G; Starkey Malcolm R; van der Sluis Renee; Lewin Sharon R; Lewin Sharon R; O'Neill Luke A J; Quach Tim; Porter Christopher J H; Quach Tim; Quach Tim; Porter Christopher J H; Brooks Doug A; O'Leary John J; O'Leary John J; O'Leary John J</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The imminent threat of viral epidemics and pandemics dictates a need for therapeutic approaches that target viral pathology irrespective of the infecting strain.  Reactive oxygen species are ancient processes that protect plants, fungi and animals against invading pathogens including bacteria.  However, in mammals reactive oxygen species production paradoxically promotes virus pathogenicity by mechanisms not yet defined.  Here we identify that the primary enzymatic source of reactive oxygen species, NOX2 oxidase, is activated by single stranded RNA and DNA viruses in endocytic compartments resulting in endosomal hydrogen peroxide generation, which suppresses antiviral and humoral signaling networks via modification of a unique, highly conserved cysteine residue (Cys98) on Toll-like receptor-7.  Accordingly, targeted inhibition of endosomal reactive oxygen species production abrogates influenza A virus pathogenicity.  We conclude that endosomal reactive oxygen species promote fundamental molecular mechanisms of viral pathogenicity, and the specific targeting of this pathogenic process with endosomal-targeted reactive oxygen species inhibitors has implications for the treatment of viral disease.Production of reactive oxygen species is an ancient antimicrobial mechanism, but its role in antiviral defense in mammals is unclear.  Here, To et al. show that virus infection activates endosomal NOX2 oxidase and restricts TLR7 signaling, and that an endosomal NOX2 inhibitor decreases viral pathogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgOfKItXMUyUBuFdjgVNKSfW6udTcc2eahpQlK12M45Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjmvFOhtg%253D%253D&md5=3d4eda2676922e6705101745500849ba</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-00057-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-00057-x%26sid%3Dliteratum%253Aachs%26aulast%3DTo%26aufirst%3DE.%2BE.%26aulast%3DVlahos%26aufirst%3DR.%26aulast%3DLuong%26aufirst%3DR.%26aulast%3DHalls%26aufirst%3DM.%2BL.%26aulast%3DReading%26aufirst%3DP.%2BC.%26aulast%3DKing%26aufirst%3DP.%2BT.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DDrummond%26aufirst%3DG.%2BR.%26aulast%3DSobey%26aufirst%3DC.%2BG.%26aulast%3DBroughton%26aufirst%3DB.%2BR.%2BS.%26aulast%3DStarkey%26aufirst%3DM.%2BR.%26aulast%3DVan%2BDer%2BSluis%26aufirst%3DR.%26aulast%3DLewin%26aufirst%3DS.%2BR.%26aulast%3DBozinovski%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26aulast%3DQuach%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DC.%2BJ.%2BH.%26aulast%3DBrooks%26aufirst%3DD.%2BA.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DJ.%2BJ.%26aulast%3DSelemidis%26aufirst%3DS.%26atitle%3DEndosomal%2520NOX2%2520Oxidase%2520Exacerbates%2520Virus%2520Pathogenicity%2520and%2520Is%2520a%2520Target%2520for%2520Antiviral%2520Therapy%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D69%26doi%3D10.1038%2Fs41467-017-00057-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laforge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frère, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hémadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massaad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoliel, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span> <span> </span><span class="NLM_article-title">Tissue Damage from Neutrophil-Induced Oxidative Stress in COVID-19</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1038/s41577-020-0407-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41577-020-0407-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32728221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVygtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2020&pages=515-516&issue=9&author=M.+Laforgeauthor=C.+Elbimauthor=C.+Fr%C3%A8reauthor=M.+H%C3%A9madiauthor=C.+Massaadauthor=P.+Nussauthor=J.+J.+Benolielauthor=C.+Becker&title=Tissue+Damage+from+Neutrophil-Induced+Oxidative+Stress+in+COVID-19&doi=10.1038%2Fs41577-020-0407-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue damage from neutrophil-induced oxidative stress in COVID-19</span></div><div class="casAuthors">Laforge, Mireille; Elbim, Carole; Frere, Corinne; Hemadi, Miryana; Massaad, Charbel; Nuss, Philippe; Benoliel, Jean-Jacques; Becker, Chrystel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">515-516</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The high neutrophil to lymphocyte ratio obsd. in critically ill patients with COVID-19 is assocd. with excessive levels of reactive oxygen species (ROS), which promote a cascade of biol. events that drive pathol. host responses.  ROS induce tissue damage, thrombosis and red blood cell dysfunction, which contribute to COVID-19 disease severity.  We suggest that free radical scavengers could be beneficial for the most vulnerable patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoacJYd-pg1irVg90H21EOLACvtfcHk0ljBYsZM3m9WRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVygtLvO&md5=20d4ed56aad2a7f1971c7325aea76ad8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fs41577-020-0407-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41577-020-0407-1%26sid%3Dliteratum%253Aachs%26aulast%3DLaforge%26aufirst%3DM.%26aulast%3DElbim%26aufirst%3DC.%26aulast%3DFr%25C3%25A8re%26aufirst%3DC.%26aulast%3DH%25C3%25A9madi%26aufirst%3DM.%26aulast%3DMassaad%26aufirst%3DC.%26aulast%3DNuss%26aufirst%3DP.%26aulast%3DBenoliel%26aufirst%3DJ.%2BJ.%26aulast%3DBecker%26aufirst%3DC.%26atitle%3DTissue%2520Damage%2520from%2520Neutrophil-Induced%2520Oxidative%2520Stress%2520in%2520COVID-19%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2020%26volume%3D20%26issue%3D9%26spage%3D515%26epage%3D516%26doi%3D10.1038%2Fs41577-020-0407-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beckhauser, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis-Oliveira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pasquale, R.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species : Physiological and Physiopathological Effects on Synaptic Plasticity</span>. <i>J. Exp. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">S1</span>),  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.4137/JEN.S39887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.4137%2FJEN.S39887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27625575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotl2ns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=23-48&issue=S1&author=T.+F.+Beckhauserauthor=J.+Francis-Oliveiraauthor=R.+De+Pasquale&title=Reactive+Oxygen+Species%E2%80%AF%3A+Physiological+and+Physiopathological+Effects+on+Synaptic+Plasticity&doi=10.4137%2FJEN.S39887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species: physiological and physiopathological effects on synaptic plasticity</span></div><div class="casAuthors">Beckhauser, Thiago Fernando; Francis-Oliveira, Jose; De Pasquale, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">Suppl.1</span>),
    <span class="NLM_cas:pages">23-48</span>CODEN:
                <span class="NLM_cas:coden">JENOCY</span>;
        ISSN:<span class="NLM_cas:issn">1179-0695</span>.
    
            (<span class="NLM_cas:orgname">Libertas Academica Ltd.</span>)
        </div><div class="casAbstract">In the mammalian central nervous system, reactive oxygen species (ROS) generation is counterbalanced by antioxidant defenses.  When large amts. of ROS accumulate, antioxidant mechanisms become overwhelmed and oxidative cellular stress may occur.  Therefore, ROS are typically characterized as toxic mols., oxidizing membrane lipids, changing the conformation of proteins, damaging nucleic acids, and causing deficits in synaptic plasticity.  High ROS concns. are assocd. with a decline in cognitive functions, as obsd. in some neurodegenerative disorders and agedependent decay of neuroplasticity.  Nevertheless, controlled ROS prodn. provides the optimal redox state for the activation of transductional pathways involved in synaptic changes.  Since ROS may regulate neuronal activity and elicit neg. effects at the same time, the distinction between beneficial and deleterious consequences is unclear.  In this regard, this review assesses current research and describes the main sources of ROS in neurons, specifying their involvement in synaptic plasticity and distinguishing between physiol. and pathol. processes implicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR5VWPv5dTH7Vg90H21EOLACvtfcHk0ljBYsZM3m9WRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotl2ns74%253D&md5=f6279d31e5aacf3f9b3943135c507990</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.4137%2FJEN.S39887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4137%252FJEN.S39887%26sid%3Dliteratum%253Aachs%26aulast%3DBeckhauser%26aufirst%3DT.%2BF.%26aulast%3DFrancis-Oliveira%26aufirst%3DJ.%26aulast%3DDe%2BPasquale%26aufirst%3DR.%26atitle%3DReactive%2520Oxygen%2520Species%25E2%2580%25AF%253A%2520Physiological%2520and%2520Physiopathological%2520Effects%2520on%2520Synaptic%2520Plasticity%26jtitle%3DJ.%2520Exp.%2520Neurosci.%26date%3D2016%26volume%3D10%26issue%3DS1%26spage%3D23%26epage%3D48%26doi%3D10.4137%2FJEN.S39887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liou, G.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storz, P.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in Cancer</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.3109/10715761003667554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3109%2F10715761003667554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=20370557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVyhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=479-496&issue=5&author=G.-Y.+Liouauthor=P.+Storz&title=Reactive+Oxygen+Species+in+Cancer&doi=10.3109%2F10715761003667554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species in cancer</span></div><div class="casAuthors">Liou, Geou-Yarh; Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">479-496</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Elevated rates of reactive oxygen species (ROS) have been detected in almost all cancers, where they promote many aspects of tumor development and progression.  However, tumor cells also express increased levels of antioxidant proteins to detoxify from ROS, suggesting that a delicate balance of intracellular ROS levels is required for cancer cell function.  Further, the radical generated, the location of its generation, as well as the local concn. is important for the cellular functions of ROS in cancer.  A challenge for novel therapeutic strategies will be the fine tuning of intracellular ROS signalling to effectively deprive cells from ROS-induced tumor promoting events, towards tipping the balance to ROS-induced apoptotic signalling.  Alternatively, therapeutic antioxidants may prevent early events in tumor development, where ROS are important.  However, to effectively target cancer cells specific ROS-sensing signalling pathways that mediate the diverse stress-regulated cellular functions need to be identified.  This review discusses the generation of ROS within tumor cells, their detoxification, their cellular effects, as well as the major signalling cascades they utilize, but also provides an outlook on their modulation in therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwtVSe56knA7Vg90H21EOLACvtfcHk0ljBYsZM3m9WRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVyhu78%253D&md5=74d17b013387120ba165302bd7c282df</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3109%2F10715761003667554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715761003667554%26sid%3Dliteratum%253Aachs%26aulast%3DLiou%26aufirst%3DG.-Y.%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520Cancer%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2010%26volume%3D44%26issue%3D5%26spage%3D479%26epage%3D496%26doi%3D10.3109%2F10715761003667554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reczek, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">The Two Faces of Reactive Oxygen Species in Cancer</span>. <i>Annu. Rev. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1146/annurev-cancerbio-041916-065808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1146%2Fannurev-cancerbio-041916-065808" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2017&pages=79-98&author=C.+R.+Reczekauthor=N.+S.+Chandel&title=The+Two+Faces+of+Reactive+Oxygen+Species+in+Cancer&doi=10.1146%2Fannurev-cancerbio-041916-065808"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1146%2Fannurev-cancerbio-041916-065808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-cancerbio-041916-065808%26sid%3Dliteratum%253Aachs%26aulast%3DReczek%26aufirst%3DC.%2BR.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DThe%2520Two%2520Faces%2520of%2520Reactive%2520Oxygen%2520Species%2520in%2520Cancer%26jtitle%3DAnnu.%2520Rev.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D1%26spage%3D79%26epage%3D98%26doi%3D10.1146%2Fannurev-cancerbio-041916-065808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badana, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murali
Mohan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shailender, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malla, R. R.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species: A Key Constituent in Cancer Survival</span>. <i>Biomarker Insights</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1177/1177271918755391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1177%2F1177271918755391" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1-9&author=S.+Kumariauthor=A.+K.+Badanaauthor=G.+Murali%0AMohanauthor=G.+Shailenderauthor=R.+R.+Malla&title=Reactive+Oxygen+Species%3A+A+Key+Constituent+in+Cancer+Survival&doi=10.1177%2F1177271918755391"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1177%2F1177271918755391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1177271918755391%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DS.%26aulast%3DBadana%26aufirst%3DA.%2BK.%26aulast%3DMurali%2BMohan%26aufirst%3DG.%26aulast%3DShailender%26aufirst%3DG.%26aulast%3DMalla%26aufirst%3DR.%2BR.%26atitle%3DReactive%2520Oxygen%2520Species%253A%2520A%2520Key%2520Constituent%2520in%2520Cancer%2520Survival%26jtitle%3DBiomarker%2520Insights%26date%3D2018%26volume%3D13%26spage%3D1%26epage%3D9%26doi%3D10.1177%2F1177271918755391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanicka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotter, T. G.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase-Generated Hydrogen Peroxide Induces DNA Damage in Mutant FLT3-Expressing Leukemia Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">9348</span>– <span class="NLM_lpage">9361</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.510495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.M113.510495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=25697362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmt1Ohs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=9348-9361&issue=15&author=J.+Stanickaauthor=E.+G.+Russellauthor=J.+F.+Woolleyauthor=T.+G.+Cotter&title=NADPH+Oxidase-Generated+Hydrogen+Peroxide+Induces+DNA+Damage+in+Mutant+FLT3-Expressing+Leukemia+Cells&doi=10.1074%2Fjbc.M113.510495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH oxidase-generated hydrogen peroxide induces DNA damage in mutant FLT3-expressing leukemia cells</span></div><div class="casAuthors">Stanicka, Joanna; Russell, Eileen G.; Woolley, John F.; Cotter, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">9348-9361</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Internal tandem duplication of the FMS-like tyrosine kinase (FLT3-ITD) receptor is present in 20% of acute myeloid leukemia (AML) patients and it has been assocd. with an aggressive AML phenotype.  FLT3-ITD expressing cell lines have been shown to generate increased levels of reactive oxygen species (ROS) and DNA double strand breaks (DSBs).  However, the mol. basis of how FLT3-ITD-driven ROS leads to the aggressive form of AML is not clearly understood.  Our group has previously reported that inhibition of FLT3-ITD signaling results in post-translational down-regulation of p22phox, a small membrane-bound subunit of the NADPH oxidase (NOX) complex.  Here we demonstrated that 32D cells, a myeloblast-like cell line transfected with FLT3-ITD, have a higher protein level of p22phox and p22phox-interacting NOX isoforms than 32D cells transfected with the wild type FLT3 receptor (FLT3-WT).  The inhibition of NOX proteins, p22phox, and NOX protein knockdowns caused a redn. in ROS, as measured with a hydrogen peroxide (H2O2)-specific dye, peroxy orange 1 (PO1), and nuclear H2O2, as measured with nuclear peroxy emerald 1 (NucPE1).  These redns. in the level of H2O2 following the NOX knockdowns were accompanied by a decrease in the no. of DNA DSBs.  We showed that 32D cells that express FLT3-ITD have a higher level of both oxidized DNA and DNA DSBs than their wild type counterparts.  We also obsd. that NOX4 and p22phox localize to the nuclear membrane in MV4-11 cells expressing FLT3-ITD.  Taken together these data indicate that NOX and p22phox mediate the ROS prodn. from FLT3-ITD that signal to the nucleus causing genomic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW8UDk0nrMIrVg90H21EOLACvtfcHk0ljnChYuglVUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmt1Ohs74%253D&md5=da768d255b29d3d90cc65b4c0254d383</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.510495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.510495%26sid%3Dliteratum%253Aachs%26aulast%3DStanicka%26aufirst%3DJ.%26aulast%3DRussell%26aufirst%3DE.%2BG.%26aulast%3DWoolley%26aufirst%3DJ.%2BF.%26aulast%3DCotter%26aufirst%3DT.%2BG.%26atitle%3DNADPH%2520Oxidase-Generated%2520Hydrogen%2520Peroxide%2520Induces%2520DNA%2520Damage%2520in%2520Mutant%2520FLT3-Expressing%2520Leukemia%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D15%26spage%3D9348%26epage%3D9361%26doi%3D10.1074%2Fjbc.M113.510495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrion, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, L.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1155/2017/2525967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2017%2F2525967" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1-11&author=Z.+Liuauthor=T.+Zhouauthor=A.+C.+Zieglerauthor=P.+Dimitrionauthor=L.+Zuo&title=Oxidative+Stress+in+Neurodegenerative+Diseases%3A+From+Molecular+Mechanisms+to+Clinical+Applications&doi=10.1155%2F2017%2F2525967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1155%2F2017%2F2525967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F2525967%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DZiegler%26aufirst%3DA.%2BC.%26aulast%3DDimitrion%26aufirst%3DP.%26aulast%3DZuo%26aufirst%3DL.%26atitle%3DOxidative%2520Stress%2520in%2520Neurodegenerative%2520Diseases%253A%2520From%2520Molecular%2520Mechanisms%2520to%2520Clinical%2520Applications%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D11%26doi%3D10.1155%2F2017%2F2525967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paudel, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parajuli, K.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species : A Key Hallmark of Cardiovascullar Disease</span>. <i>Adv. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1155/2016/9152732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2016%2F9152732" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1-12&author=N.+Panthauthor=K.+R.+Paudelauthor=K.+Parajuli&title=Reactive+Oxygen+Species%E2%80%AF%3A+A+Key+Hallmark+of+Cardiovascullar+Disease&doi=10.1155%2F2016%2F9152732"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1155%2F2016%2F9152732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F9152732%26sid%3Dliteratum%253Aachs%26aulast%3DPanth%26aufirst%3DN.%26aulast%3DPaudel%26aufirst%3DK.%2BR.%26aulast%3DParajuli%26aufirst%3DK.%26atitle%3DReactive%2520Oxygen%2520Species%25E2%2580%25AF%253A%2520A%2520Key%2520Hallmark%2520of%2520Cardiovascullar%2520Disease%26jtitle%3DAdv.%2520Med.%26date%3D2016%26volume%3D2016%26spage%3D1%26epage%3D12%26doi%3D10.1155%2F2016%2F9152732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jha, J. C.</span>; <span class="NLM_string-name">Bose, M.</span>; <span class="NLM_string-name">Jandeleit-Dahm, M.</span></span> <span> </span><span class="NLM_article-title">Modulation of Oxidative Stress in Cardiovascular Diseases</span>. In  <i>Modulation of Oxidative Stress in Heart Disease</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Singapore</span>, <span class="NLM_year">2019</span>; pp  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">253</span>.<span class="refDoi"> DOI: 10.1007/978-981-13-8946-7_10</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2F978-981-13-8946-7_10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=237-253&author=J.+C.+Jha&author=M.+Bose&author=M.+Jandeleit-Dahm&title=Modulation+of+Oxidative+Stress+in+Heart+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2F978-981-13-8946-7_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-981-13-8946-7_10%26sid%3Dliteratum%253Aachs%26aulast%3DJha%26aufirst%3DJ.%2BC.%26atitle%3DModulation%2520of%2520Oxidative%2520Stress%2520in%2520Cardiovascular%2520Diseases%26btitle%3DModulation%2520of%2520Oxidative%2520Stress%2520in%2520Heart%2520Disease%26pub%3DSpringer%26date%3D2019%26spage%3D237%26epage%3D253%26doi%3D10.1007%2F978-981-13-8946-7_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrabi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parvez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabassum, H.</span></span> <span> </span><span class="NLM_article-title">Ischemic Stroke and Mitochondria: Mechanisms and Targets</span>. <i>Protoplasma</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>257</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1007/s00709-019-01439-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs00709-019-01439-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31612315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BB3MnnvVGntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=2020&pages=335-343&issue=2&author=S.+S.+Andrabiauthor=S.+Parvezauthor=H.+Tabassum&title=Ischemic+Stroke+and+Mitochondria%3A+Mechanisms+and+Targets&doi=10.1007%2Fs00709-019-01439-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Ischemic stroke and mitochondria: mechanisms and targets</span></div><div class="casAuthors">Andrabi Syed Suhail; Andrabi Syed Suhail; Parvez Suhel; Tabassum Heena</div><div class="citationInfo"><span class="NLM_cas:title">Protoplasma</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">335-343</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Stroke is one of the main causes of mortality and disability in most countries of the world.  The only way of managing patients with ischemic stroke is the use of intravenous tissue plasminogen activator and endovascular thrombectomy.  However, very few patients receive these treatments as the therapeutic time window is narrow after an ischemic stroke.  The paucity of stroke management approaches can only be addressed by identifying new possible therapeutic targets.  Mitochondria have been a rare target in the clinical management of stroke.  Previous studies have only investigated the bioenergetics and apoptotic roles of this organelle; however, the mitochondrion is now considered as a key organelle that participates in many cellular and molecular functions.  This review discusses the mitochondrial mechanisms in cerebral ischemia such as its role in reactive oxygen species (ROS) generation, apoptosis, and electron transport chain dysfunction.  Understanding the mechanisms of mitochondria in neural cell death during ischemic stroke might help to design new therapeutic targets for ischemic stroke as well as other neurological diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkp58BVUNu9GHOrQ6qeX-mfW6udTcc2eYBhSa42cZDirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnnvVGntQ%253D%253D&md5=361ab2bd0c146b064c3b42ebaadc57eb</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs00709-019-01439-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00709-019-01439-2%26sid%3Dliteratum%253Aachs%26aulast%3DAndrabi%26aufirst%3DS.%2BS.%26aulast%3DParvez%26aufirst%3DS.%26aulast%3DTabassum%26aufirst%3DH.%26atitle%3DIschemic%2520Stroke%2520and%2520Mitochondria%253A%2520Mechanisms%2520and%2520Targets%26jtitle%3DProtoplasma%26date%3D2020%26volume%3D257%26issue%3D2%26spage%3D335%26epage%3D343%26doi%3D10.1007%2Fs00709-019-01439-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Revuelta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elicegui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Cugnon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bührer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matheu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, T.</span></span> <span> </span><span class="NLM_article-title">Ischemic Stroke in Neonatal and Adult Astrocytes</span>. <i>Mech. Ageing Dev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">111147</span>, <span class="refDoi"> DOI: 10.1016/j.mad.2019.111147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.mad.2019.111147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31493435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVSru7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2019&pages=111147&author=M.+Revueltaauthor=A.+Eliceguiauthor=L.+Moreno-Cugnonauthor=C.+B%C3%BChrerauthor=A.+Matheuauthor=T.+Schmitz&title=Ischemic+Stroke+in+Neonatal+and+Adult+Astrocytes&doi=10.1016%2Fj.mad.2019.111147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Ischemic stroke in neonatal and adult astrocytes</span></div><div class="casAuthors">Revuelta, Miren; Elicegui, Amaia; Moreno-Cugnon, Leire; Buehrer, Christoph; Matheu, Ander; Schmitz, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Mechanisms of Ageing and Development</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111147</span>CODEN:
                <span class="NLM_cas:coden">MAGDA3</span>;
        ISSN:<span class="NLM_cas:issn">0047-6374</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The objective of this paper is to review current information regarding astrocytes function after a stroke in neonatal and adult brain.  Based on the current literature, there are some mol. differences related to blood brain barrier (BBB) homeostasis disruption, inflammation and reactive oxygen species (ROS) mediated injury between the immature and mature brain after an ischemic event.  In particular, astrocytes, the main glial cells in brain, play a different role in neonatal and adult brain after stroke, as time course of glial activation is strongly age dependent.  Moreover, the present review provides further insight into the therapeutic approaches of using neonatal and adult astrocytes after stroke.  More research will be needed in order to translate them into an effective treatment against stroke, the second main cause of death and disability worldwide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2z6Ucx4O1aLVg90H21EOLACvtfcHk0lhdXCYy5sdaHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVSru7vP&md5=b69f885b3aeedce7ac66768fac9891f4</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.mad.2019.111147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mad.2019.111147%26sid%3Dliteratum%253Aachs%26aulast%3DRevuelta%26aufirst%3DM.%26aulast%3DElicegui%26aufirst%3DA.%26aulast%3DMoreno-Cugnon%26aufirst%3DL.%26aulast%3DB%25C3%25BChrer%26aufirst%3DC.%26aulast%3DMatheu%26aufirst%3DA.%26aulast%3DSchmitz%26aufirst%3DT.%26atitle%3DIschemic%2520Stroke%2520in%2520Neonatal%2520and%2520Adult%2520Astrocytes%26jtitle%3DMech.%2520Ageing%2520Dev.%26date%3D2019%26volume%3D183%26spage%3D111147%26doi%3D10.1016%2Fj.mad.2019.111147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sims, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yew, W. P.</span></span> <span> </span><span class="NLM_article-title">Reactive Astrogliosis in Stroke: Contributions of Astrocytes to Recovery of Neurological Function</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2016.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.neuint.2016.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28057555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFant7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2017&pages=88-103&author=N.+R.+Simsauthor=W.+P.+Yew&title=Reactive+Astrogliosis+in+Stroke%3A+Contributions+of+Astrocytes+to+Recovery+of+Neurological+Function&doi=10.1016%2Fj.neuint.2016.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive astrogliosis in stroke: Contributions of astrocytes to recovery of neurological function</span></div><div class="casAuthors">Sims, Neil R.; Yew, Wai Ping</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-103</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alterations in neuronal connectivity, particularly in the "peri-infarct" tissue adjacent to the region of ischemic damage, are important contributors to the spontaneous recovery of function that commonly follows stroke.  Peri-infarct astrocytes undergo reactive astrogliosis and play key roles in modulating the adaptive responses in neurons.  This reactive astrogliosis shares many features with that induced by other forms of damage to the central nervous system but also differs in details that potentially influence neurol. recovery.  A subpopulation of astrocytes within a few hundred micrometers of the infarct proliferate and are centrally involved in the development of the glial scar that separates the damaged tissue in the infarct from surrounding normal brain.  The intertwined processes of astrocytes adjacent to the infarct provide the core structural component of the mature scar.  Interventions that cause early disruption of glial scar formation typically impede restoration of neurol. function.  Marked reactive astrogliosis also develops in cells more distant from the infarct but these cells largely remain in the spatial territories they occupied prior to stroke.  These cells play important roles in controlling the extracellular environment and release proteins and other mols. that are able to promote neuronal plasticity and improve functional recovery.  Treatments manipulating aspects of reactive astrogliosis can enhance neuronal plasticity following stroke.  Optimizing these treatments for use in human stroke would benefit from a more complete characterization of the specific responses of peri-infarct astrocytes to stroke as well as a better understanding of the influence of other factors including age, sex, comorbidities and reperfusion of the ischemic tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyrP_ujED1sLVg90H21EOLACvtfcHk0lhTcDOhwRp_7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFant7o%253D&md5=a86de3bdabf86c7af53efd93fd144dee</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2016.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2016.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DSims%26aufirst%3DN.%2BR.%26aulast%3DYew%26aufirst%3DW.%2BP.%26atitle%3DReactive%2520Astrogliosis%2520in%2520Stroke%253A%2520Contributions%2520of%2520Astrocytes%2520to%2520Recovery%2520of%2520Neurological%2520Function%26jtitle%3DNeurochem.%2520Int.%26date%3D2017%26volume%3D107%26spage%3D88%26epage%3D103%26doi%3D10.1016%2Fj.neuint.2016.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, W.</span></span> <span> </span><span class="NLM_article-title">Mitophagy, a Potential Therapeutic Target for Stroke</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">87</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1186/s12929-018-0487-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1186%2Fs12929-018-0487-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29295709" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=1-16&issue=87&author=R.+Guanauthor=W.+Zouauthor=X.+Daiauthor=X.+Yuauthor=H.+Liuauthor=Q.+Chenauthor=W.+Teng&title=Mitophagy%2C+a+Potential+Therapeutic+Target+for+Stroke&doi=10.1186%2Fs12929-018-0487-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1186%2Fs12929-018-0487-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12929-018-0487-4%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DTeng%26aufirst%3DW.%26atitle%3DMitophagy%252C%2520a%2520Potential%2520Therapeutic%2520Target%2520for%2520Stroke%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2018%26volume%3D25%26issue%3D87%26spage%3D1%26epage%3D16%26doi%3D10.1186%2Fs12929-018-0487-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhandapani, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brann, D. W.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase 2 Regulates NLRP3 Inflammasome Activation in the Brain after Traumatic Brain Injury</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1155/2017/6057609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2017%2F6057609" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1&author=M.+W.+Maauthor=J.+Wangauthor=K.+M.+Dhandapaniauthor=D.+W.+Brann&title=NADPH+Oxidase+2+Regulates+NLRP3+Inflammasome+Activation+in+the+Brain+after+Traumatic+Brain+Injury&doi=10.1155%2F2017%2F6057609"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1155%2F2017%2F6057609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F6057609%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DM.%2BW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDhandapani%26aufirst%3DK.%2BM.%26aulast%3DBrann%26aufirst%3DD.%2BW.%26atitle%3DNADPH%2520Oxidase%25202%2520Regulates%2520NLRP3%2520Inflammasome%2520Activation%2520in%2520the%2520Brain%2520after%2520Traumatic%2520Brain%2520Injury%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2017%26volume%3D2017%26spage%3D1%26doi%3D10.1155%2F2017%2F6057609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngarashi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferdaus, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahid, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabika, T.</span></span> <span> </span><span class="NLM_article-title">Dual Inhibition of NADPH Oxidases and Xanthine Oxidase Potently Prevents Salt-Induced Stroke in Stroke-Prone Spontaneously Hypertensive Rats</span>. <i>Hypertens. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1038/s41440-019-0246-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41440-019-0246-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30850755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2isLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2019&pages=981-989&issue=7&author=D.+Ngarashiauthor=K.+Fujikawaauthor=M.+Z.+Ferdausauthor=H.+M.+Zahidauthor=H.+Oharaauthor=T.+Nabika&title=Dual+Inhibition+of+NADPH+Oxidases+and+Xanthine+Oxidase+Potently+Prevents+Salt-Induced+Stroke+in+Stroke-Prone+Spontaneously+Hypertensive+Rats&doi=10.1038%2Fs41440-019-0246-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition of NADPH oxidases and xanthine oxidase potently prevents salt-induced stroke in stroke-prone spontaneously hypertensive rats</span></div><div class="casAuthors">Ngarashi, Davis; Fujikawa, Koichi; Ferdaus, Mohammed Zubaerul; Zahid, Hasan M.; Ohara, Hiroki; Nabika, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">981-989</span>CODEN:
                <span class="NLM_cas:coden">HRESE4</span>;
        ISSN:<span class="NLM_cas:issn">0916-9636</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Oxidative stress has been implicated in the pathophysiol. of cerebral stroke.  As NADPH oxidases (NOXs) play major roles in the regulation of oxidative stress, we hypothesized that redn. of NOX activity by depletion of p22phox, an essential subunit of NOX complexes, would prevent cerebral stroke.  To investigate this, we used the stroke-prone spontaneously hypertensive rat (SHRSP) and the p22phox-deleted congenic SHRSP.  Although p22phox depletion reduced blood pressure under salt loading, it did not ameliorate oxidative stress or reduce the incidence of salt-induced stroke in SHRSPs.  Addnl. pharmacol. redn. of oxidative stress using antioxidant reagents with different mechanisms of action was necessary to prevent stroke, indicating that NOX was not the major target in salt-induced stroke in SHRSPs.  On the other hand, oxidative stress measured based on urinary isoprostane levels showed significant correlations with blood pressure, stroke latency and urinary protein excretion under salt loading, suggesting an important role of oxidative stress per se in hypertension and hypertensive organ damage.  Overall, our results imply that oxidative stress from multiple sources influences stroke susceptibility and other hypertensive disorders in salt-loaded SHRSPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD9dnMA4JitLVg90H21EOLACvtfcHk0lhTcDOhwRp_7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2isLvJ&md5=54a5a57bb2cf697cff93f5076b10297c</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fs41440-019-0246-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41440-019-0246-2%26sid%3Dliteratum%253Aachs%26aulast%3DNgarashi%26aufirst%3DD.%26aulast%3DFujikawa%26aufirst%3DK.%26aulast%3DFerdaus%26aufirst%3DM.%2BZ.%26aulast%3DZahid%26aufirst%3DH.%2BM.%26aulast%3DOhara%26aufirst%3DH.%26aulast%3DNabika%26aufirst%3DT.%26atitle%3DDual%2520Inhibition%2520of%2520NADPH%2520Oxidases%2520and%2520Xanthine%2520Oxidase%2520Potently%2520Prevents%2520Salt-Induced%2520Stroke%2520in%2520Stroke-Prone%2520Spontaneously%2520Hypertensive%2520Rats%26jtitle%3DHypertens.%2520Res.%26date%3D2019%26volume%3D42%26issue%3D7%26spage%3D981%26epage%3D989%26doi%3D10.1038%2Fs41440-019-0246-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calmettes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, J. N.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species Production Induced by Pore Opening in Cardiac Mitochondria: The Role of Complex II</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">9896</span>– <span class="NLM_lpage">9905</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.768325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.M116.768325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28450394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVShtLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=9896-9905&issue=24&author=P.+Korgeauthor=S.+A.+Johnauthor=G.+Calmettesauthor=J.+N.+Weiss&title=Reactive+Oxygen+Species+Production+Induced+by+Pore+Opening+in+Cardiac+Mitochondria%3A+The+Role+of+Complex+II&doi=10.1074%2Fjbc.M116.768325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species production induced by pore opening in cardiac mitochondria: The role of complex II</span></div><div class="casAuthors">Korge, Paavo; John, Scott A.; Calmettes, Guillaume; Weiss, James N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9896-9905</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Succinate-driven reverse electron transport (RET) through complex I is hypothesized to be a major source of reactive oxygen species (ROS) that induces permeability transition pore (PTP) opening and damages the heart during ischemia/reperfusion.  Because RET can only generate ROS when mitochondria are fully polarized, this mechanism is self-limiting once PTP opens during reperfusion.  In an accompanying article, we showed that ROS prodn. after PTP opening could be sustained when complex III was damaged (simulated by antimycin).  Here, we show that complex II can also contribute to sustained ROS prodn. in isolated rabbit cardiac mitochondria following inner membrane pore formation induced by either alamethicin or Ca2+-induced PTP opening.  Two conditions were required to maximize malonate-sensitive ROS prodn. by complex II in isolated mitochondria: (1) complex II inhibition by atpenin A5 or complex III inhibition by stigmatellin that results in succinate-dependent redn. of the dicarboxylate-binding site of complex II (site IIf) and (2) pore opening in the inner membrane resulting in rapid efflux of succinate/fumarate and other dicarboxylates capable of competitively binding to site IIf.  The decrease in matrix [dicarboxylate] allowed O2 access to reduced site IIf, thereby making electron donation to O2 possible, explaining the rapid increase in ROS prodn. provided that site IIf was reduced.  Because ischemia is known to inhibit complexes II and III and increase matrix succinate/fumarate levels, we hypothesized that by allowing dicarboxylate efflux from the matrix, PTP opening during reperfusion may activate sustained ROS prodn. by this mechanism after RET-driven ROS prodn. has ceased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFSD3K9nl2_rVg90H21EOLACvtfcHk0lg7p7oqwEg4JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVShtLzP&md5=6b97ade06bf3f75f7a446a3a24b9be38</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.768325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.768325%26sid%3Dliteratum%253Aachs%26aulast%3DKorge%26aufirst%3DP.%26aulast%3DJohn%26aufirst%3DS.%2BA.%26aulast%3DCalmettes%26aufirst%3DG.%26aulast%3DWeiss%26aufirst%3DJ.%2BN.%26atitle%3DReactive%2520Oxygen%2520Species%2520Production%2520Induced%2520by%2520Pore%2520Opening%2520in%2520Cardiac%2520Mitochondria%253A%2520The%2520Role%2520of%2520Complex%2520II%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D24%26spage%3D9896%26epage%3D9905%26doi%3D10.1074%2Fjbc.M116.768325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaludercic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Lisa, F.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy</span>. <i>Front. Cardiovasc. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.3389/fcvm.2020.00012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3389%2Ffcvm.2020.00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32039241" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2020&pages=1-15&author=N.+Kaludercicauthor=F.+Di+Lisa&title=Mitochondrial+ROS+Formation+in+the+Pathogenesis+of+Diabetic+Cardiomyopathy&doi=10.3389%2Ffcvm.2020.00012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3389%2Ffcvm.2020.00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcvm.2020.00012%26sid%3Dliteratum%253Aachs%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DDi%2BLisa%26aufirst%3DF.%26atitle%3DMitochondrial%2520ROS%2520Formation%2520in%2520the%2520Pathogenesis%2520of%2520Diabetic%2520Cardiomyopathy%26jtitle%3DFront.%2520Cardiovasc.%2520Med.%26date%3D2020%26volume%3D7%26spage%3D1%26epage%3D15%26doi%3D10.3389%2Ffcvm.2020.00012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asmat, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismail, K.</span></span> <span> </span><span class="NLM_article-title">Diabetes Mellitus and Oxidative Stress-A Concise Review</span>. <i>Saudi Pharm. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1016/j.jsps.2015.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.jsps.2015.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27752226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC2srhsFOisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=547-553&issue=5&author=U.+Asmatauthor=K.+Abadauthor=K.+Ismail&title=Diabetes+Mellitus+and+Oxidative+Stress-A+Concise+Review&doi=10.1016%2Fj.jsps.2015.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Diabetes mellitus and oxidative stress-A concise review</span></div><div class="casAuthors">Asmat Ullah; Abad Khan; Ismail Khan</div><div class="citationInfo"><span class="NLM_cas:title">Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">547-553</span>
        ISSN:<span class="NLM_cas:issn">1319-0164</span>.
    </div><div class="casAbstract">Human body is continuously exposed to different types of agents that results in the production of reactive species called as free radicals (ROS/RNS) which by the transfer of their free unpaired electron causes the oxidation of cellular machinery.  In order to encounter the deleterious effects of such species, body has got endogenous antioxidant systems or it obtains exogenous antioxidants from diet that neutralizes such species and keeps the homeostasis of body.  Any imbalance between the RS and antioxidants leads to produce a condition known as "oxidative stress" that results in the development of pathological condition among which one is diabetes.  Most of the studies reveal the inference of oxidative stress in diabetes pathogenesis by the alteration in enzymatic systems, lipid peroxidation, impaired Glutathione metabolism and decreased Vitamin C levels.  Lipids, proteins, DNA damage, Glutathione, catalane and superoxide dismutase are various biomarkers of oxidative stress in diabetes mellitus.  Oxidative stress induced complications of diabetes may include stroke, neuropathy, retinopathy and nephropathy.  The basic aim of this review was to summarize the basics of oxidative stress in diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwn9gu9848Z5dYoSR9eyvsfW6udTcc2eYtn9QMKQtTnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srhsFOisQ%253D%253D&md5=5650d4a24d863ddeb5ab1dcb0a55601c</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.jsps.2015.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsps.2015.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DAsmat%26aufirst%3DU.%26aulast%3DAbad%26aufirst%3DK.%26aulast%3DIsmail%26aufirst%3DK.%26atitle%3DDiabetes%2520Mellitus%2520and%2520Oxidative%2520Stress-A%2520Concise%2520Review%26jtitle%3DSaudi%2520Pharm.%2520J.%26date%3D2016%26volume%3D24%26issue%3D5%26spage%3D547%26epage%3D553%26doi%3D10.1016%2Fj.jsps.2015.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fakhruddin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alanazi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, K. E.</span></span> <span> </span><span class="NLM_article-title">Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury</span>. <i>J. Diabetes Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1155/2017/8379327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1155%2F2017%2F8379327" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1-30&author=S.+Fakhruddinauthor=W.+Alanaziauthor=K.+E.+Jackson&title=Diabetes-Induced+Reactive+Oxygen+Species%3A+Mechanism+of+Their+Generation+and+Role+in+Renal+Injury&doi=10.1155%2F2017%2F8379327"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1155%2F2017%2F8379327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F8379327%26sid%3Dliteratum%253Aachs%26aulast%3DFakhruddin%26aufirst%3DS.%26aulast%3DAlanazi%26aufirst%3DW.%26aulast%3DJackson%26aufirst%3DK.%2BE.%26atitle%3DDiabetes-Induced%2520Reactive%2520Oxygen%2520Species%253A%2520Mechanism%2520of%2520Their%2520Generation%2520and%2520Role%2520in%2520Renal%2520Injury%26jtitle%3DJ.%2520Diabetes%2520Res.%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D30%26doi%3D10.1155%2F2017%2F8379327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemberg, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaitsev, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleason, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cell.2012.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22632970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1060-1072&issue=5&author=S.+J.+Dixonauthor=K.+M.+Lembergauthor=M.+R.+Lamprechtauthor=R.+Skoutaauthor=E.+M.+Zaitsevauthor=C.+E.+Gleasonauthor=D.+N.+Patelauthor=A.+J.+Bauerauthor=A.+M.+Cantleyauthor=W.+S.+Yangauthor=B.+Morrisonauthor=B.+R.+Stockwell&title=Ferroptosis%3A+An+Iron-Dependent+Form+of+Nonapoptotic+Cell+Death&doi=10.1016%2Fj.cell.2012.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death</span></div><div class="casAuthors">Dixon, Scott J.; Lemberg, Kathryn M.; Lamprecht, Michael R.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Morrison, Barclay; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathol. states.  The oncogenic RAS-selective lethal small mol. erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis.  Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphol., biochem., and genetically distinct from apoptosis, necrosis, and autophagy.  We identify the small mol. ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes.  Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system xc-), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death.  Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzDzMapViBQ7Vg90H21EOLACvtfcHk0ljIL9m_Qggxfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D&md5=5d3b8c55a053dfde7e758cc1701ef71b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DLemberg%26aufirst%3DK.%2BM.%26aulast%3DLamprecht%26aufirst%3DM.%2BR.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DZaitsev%26aufirst%3DE.%2BM.%26aulast%3DGleason%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DD.%2BN.%26aulast%3DBauer%26aufirst%3DA.%2BJ.%26aulast%3DCantley%26aufirst%3DA.%2BM.%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520An%2520Iron-Dependent%2520Form%2520of%2520Nonapoptotic%2520Cell%2520Death%26jtitle%3DCell%26date%3D2012%26volume%3D149%26issue%3D5%26spage%3D1060%26epage%3D1072%26doi%3D10.1016%2Fj.cell.2012.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Latunde-Dada, G. O.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: Role of Lipid Peroxidation, Iron and Ferritinophagy</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1861</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1893</span>– <span class="NLM_lpage">1900</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2017.05.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.bbagen.2017.05.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28552631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1ektrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1861&publication_year=2017&pages=1893-1900&issue=8&author=G.+O.+Latunde-Dada&title=Ferroptosis%3A+Role+of+Lipid+Peroxidation%2C+Iron+and+Ferritinophagy&doi=10.1016%2Fj.bbagen.2017.05.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy</span></div><div class="casAuthors">Latunde-Dada, Gladys O.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1861</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1893-1900</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ferroptosis is a form of regulated cell death that is dependent on iron and reactive oxygen species (ROS) and is characterized by lipid peroxidn.  It is morphol. and biochem. distinct and disparate from other processes of cell death.  As ferroptosis is induced by inhibition of cysteine uptake or inactivation of the lipid repair enzyme glutathione peroxidase 4 (GPX4), the process is favored by chem. or mutational inhibition of the cystine/glutamate antiporter and culminates in the accumulation of reactive oxygen species (ROS) in the form of lipid hydroperoxides.  Excessive lipid peroxidn. leads to death by ferroptosis and the phenotype is accentuated resp. by the repletion and depletion of iron and glutathione in cells.  Furthermore, oxidized phosphatidylethanolamines (PE) harboring arachidonoyl (AA) and adrenoyl moieties (AdA) have been shown as proximate executioners of ferroptosis.  Induction of ferroptosis due to cysteine depletion leads to the degrdn. of ferritin (i.e. ferritinophagy), which releases iron via the NCOA4-mediated autophagy pathway.  Evidence of the manifestation of ferroptosis in vivo in iron overload mice mutants is emerging.  Thus, a concerted synchronization of iron availability, ROS generation, glutamate excess and cysteine deficit leads to ferroptosis.  A no. of questions on the mol. mechanisms of some features of ferroptosis are highlighted as subjects for future investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9y7eDu1zclbVg90H21EOLACvtfcHk0ljIL9m_Qggxfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1ektrk%253D&md5=d7fee5296d4774497c55b610b0e85d58</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2017.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2017.05.019%26sid%3Dliteratum%253Aachs%26aulast%3DLatunde-Dada%26aufirst%3DG.%2BO.%26atitle%3DFerroptosis%253A%2520Role%2520of%2520Lipid%2520Peroxidation%252C%2520Iron%2520and%2520Ferritinophagy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2017%26volume%3D1861%26issue%3D8%26spage%3D1893%26epage%3D1900%26doi%3D10.1016%2Fj.bbagen.2017.05.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span> <span> </span><span class="NLM_article-title">The Metabolic Underpinnings of Ferroptosis</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2020.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cmet.2020.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=33217331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVyntLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2020&pages=920-937&issue=6&author=J.+Zhengauthor=M.+Conrad&title=The+Metabolic+Underpinnings+of+Ferroptosis&doi=10.1016%2Fj.cmet.2020.10.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">The Metabolic Underpinnings of Ferroptosis</span></div><div class="casAuthors">Zheng, Jiashuo; Conrad, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">920-937</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Acute or chronic cellular stress resulting from aberrant metabolic and biochem. processes may trigger a pervasive non-apoptotic form of cell death, generally known as ferroptosis.  Ferroptosis is unique among the different cell death modalities, as it has been mostly linked to pathophysiol. conditions and because several metabolic pathways, such as (seleno)thiol metab., fatty acid metab., iron handling, mevalonate pathway, and mitochondrial respiration, directly impinge on the cells' sensitivity toward lipid peroxidn. and ferroptosis.  Addnl., key cellular redox systems, such as selenium-dependent glutathione peroxidase 4 and the NAD(P)H/ferroptosis suppressor protein-1/ubiquinone axis, are at play that constantly surveil and neutralize oxidative damage to cellular membranes.  Since this form of cell death emerges to be the root cause of a no. of diseases and since it offers various pharmacol. tractable nodes for therapeutic intervention, there has been overwhelming interest in the last few years aiming for a better mol. understanding of the ferroptotic death process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUEuMthPCIOrVg90H21EOLACvtfcHk0ljYMVjg1I_mQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVyntLrK&md5=0e3fb5c87dead6d92537694393196aba</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2020.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2020.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DConrad%26aufirst%3DM.%26atitle%3DThe%2520Metabolic%2520Underpinnings%2520of%2520Ferroptosis%26jtitle%3DCell%2520Metab.%26date%3D2020%26volume%3D32%26issue%3D6%26spage%3D920%26epage%3D937%26doi%3D10.1016%2Fj.cmet.2020.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swarup, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwind, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seravalli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansing, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emma, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hondal, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cave, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagdullaev, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karuppagounder, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratan, R. R.</span></span> <span> </span><span class="NLM_article-title">Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>177</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1279.e25</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2019.03.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cell.2019.03.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31056284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovVOmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2019&pages=1262-1279.e25&issue=5&author=I.+Alimauthor=J.+T.+Caulfieldauthor=Y.+Chenauthor=V.+Swarupauthor=D.+H.+Geschwindauthor=E.+Ivanovaauthor=J.+Seravalliauthor=Y.+Aiauthor=L.+H.+Sansingauthor=E.+J.+Emmaauthor=R.+J.+Hondalauthor=S.+Mukherjeeauthor=J.+W.+Caveauthor=B.+T.+Sagdullaevauthor=S.+S.+Karuppagounderauthor=R.+R.+Ratan&title=Selenium+Drives+a+Transcriptional+Adaptive+Program+to+Block+Ferroptosis+and+Treat+Stroke&doi=10.1016%2Fj.cell.2019.03.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke</span></div><div class="casAuthors">Alim, Ishraq; Caulfield, Joseph T.; Chen, Yingxin; Swarup, Vivek; Geschwind, Daniel H.; Ivanova, Elena; Seravalli, Javier; Ai, Youxi; Sansing, Lauren H.; Ste. Marie, Emma J.; Hondal, Robert J.; Mukherjee, Sushmita; Cave, John W.; Sagdullaev, Botir T.; Karuppagounder, Saravanan S.; Ratan, Rajiv R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1262-1279.e25</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Ferroptosis, a non-apoptotic form of programmed cell death, is triggered by oxidative stress in cancer, heat stress in plants, and hemorrhagic stroke.  A homeostatic transcriptional response to ferroptotic stimuli is unknown.  We show that neurons respond to ferroptotic stimuli by induction of selenoproteins, including antioxidant glutathione peroxidase 4 (GPX4).  Pharmacol. selenium (Se) augments GPX4 and other genes in this transcriptional program, the selenome, via coordinated activation of the transcription factors TFAP2c and Sp1 to protect neurons.  Remarkably, a single dose of Se delivered into the brain drives antioxidant GPX4 expression, protects neurons, and improves behavior in a hemorrhagic stroke model.  Altogether, we show that pharmacol. Se supplementation effectively inhibits GPX4-dependent ferroptotic death as well as cell death induced by excitotoxicity or ER stress, which are GPX4 independent.  Systemic administration of a brain-penetrant selenopeptide activates homeostatic transcription to inhibit cell death and improves function when delivered after hemorrhagic or ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-L0sQKjjFEbVg90H21EOLACvtfcHk0ljYMVjg1I_mQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovVOmtr8%253D&md5=015bfffdefacade3893519cedf4cfa87</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2019.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2019.03.032%26sid%3Dliteratum%253Aachs%26aulast%3DAlim%26aufirst%3DI.%26aulast%3DCaulfield%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSwarup%26aufirst%3DV.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DIvanova%26aufirst%3DE.%26aulast%3DSeravalli%26aufirst%3DJ.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DSansing%26aufirst%3DL.%2BH.%26aulast%3DEmma%26aufirst%3DE.%2BJ.%26aulast%3DHondal%26aufirst%3DR.%2BJ.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DCave%26aufirst%3DJ.%2BW.%26aulast%3DSagdullaev%26aufirst%3DB.%2BT.%26aulast%3DKaruppagounder%26aufirst%3DS.%2BS.%26aulast%3DRatan%26aufirst%3DR.%2BR.%26atitle%3DSelenium%2520Drives%2520a%2520Transcriptional%2520Adaptive%2520Program%2520to%2520Block%2520Ferroptosis%2520and%2520Treat%2520Stroke%26jtitle%3DCell%26date%3D2019%26volume%3D177%26issue%3D5%26spage%3D1262%26epage%3D1279.e25%26doi%3D10.1016%2Fj.cell.2019.03.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belavgeni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornstein, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Mässenhausen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonnus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Othmar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanczkowski, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroiss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hantel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassnacht, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krone, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span> <span> </span><span class="NLM_article-title">Exquisite Sensitivity of Adrenocortical Carcinomas to Induction of Ferroptosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">22269</span>– <span class="NLM_lpage">22274</span>, <span class="refDoi"> DOI: 10.1073/pnas.1912700116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1073%2Fpnas.1912700116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31611400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVOhtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=22269-22274&issue=44&author=A.+Belavgeniauthor=S.+R.+Bornsteinauthor=A.+Von+M%C3%A4ssenhausenauthor=W.+Tonnusauthor=J.+Stumpfauthor=C.+Meyerauthor=E.+Othmarauthor=M.+Latkauthor=W.+Kanczkowskiauthor=M.+Kroissauthor=C.+Hantelauthor=C.+Hugoauthor=M.+Fassnachtauthor=C.+G.+Zieglerauthor=A.+V.+Schallyauthor=N.+P.+Kroneauthor=A.+Linkermann&title=Exquisite+Sensitivity+of+Adrenocortical+Carcinomas+to+Induction+of+Ferroptosis&doi=10.1073%2Fpnas.1912700116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis</span></div><div class="casAuthors">Belavgeni, Alexia; Bornstein, Stefan R.; von Massenhausen, Anne; Tonnus, Wulf; Stumpf, Julian; Meyer, Claudia; Othmar, Evelyn; Latk, Markus; Kanczkowski, Waldemar; Kroiss, Matthias; Hantel, Constanze; Hugo, Christian; Fassnacht, Martin; Ziegler, Christian G.; Schally, Andrew V.; Krone, Nils P.; Linkermann, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">22269-22274</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Adrenocortical carcinomas (ACCs) are rare and highly malignant cancers assocd. with poor survival of patients.  Currently, mitotane, a nonspecific deriv. of the pesticide DDT (1,1-(dichlorobiphenyl)-2,2-dichloroethane), is used as the std. treatment, but its mechanism of action in ACCs remains elusive.  Here we demonstrate that the human ACC NCI-H295R cell line is remarkably sensitive to induction of ferroptosis, while mitotane does not induce this iron-dependent mode of regulated necrosis.  Supplementation with insulin, transferrin, and selenium (ITS) is commonly used to keep NCI-H295R cells in cell culture.  We show that this supplementation prevents spontaneous ferroptosis, esp. when it contains polyunsatd. fatty acids (PUFAs), such as linoleic acid.  Inhibitors of apoptosis (zVAD, emricasan) do not prevent the mitotane-induced cell death but morphol. prevent membrane blebbing.  The expression of glutathione peroxidase 4 (GPX4) in H295R cells, however, is significantly higher when compared to HT1080 fibrosarcoma cells, suggesting a role for ferroptosis.  Direct inhibition of GPX4 in H295R cells led to high necrotic populations compared to control, while cotreatment with ferrostatin-1 (Fer-1) completely reverted ferroptosis.  Interestingly, the anal. of public databases revealed that several key players of the ferroptosis pathway are hypermethylated and/or mutated in human ACCs.  Finally, we also detected that growth hormone-releasing hormone (GHRH) antagonists, such as MIA602, kill H295R cells in a nonapoptotic manner.  In summary, we found elevated expression of GPX4 and higher sensitivity to ferroptosis in ACCs.  We hypothesize that instead of treatment with mitotane, human adrenocortical carcinomas may be much more sensitive to induction of ferroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9XsAECLe-BrVg90H21EOLACvtfcHk0ljYMVjg1I_mQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVOhtLbF&md5=2cfa61e0d4cc9b05d73217ae22ee53c3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1912700116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1912700116%26sid%3Dliteratum%253Aachs%26aulast%3DBelavgeni%26aufirst%3DA.%26aulast%3DBornstein%26aufirst%3DS.%2BR.%26aulast%3DVon%2BM%25C3%25A4ssenhausen%26aufirst%3DA.%26aulast%3DTonnus%26aufirst%3DW.%26aulast%3DStumpf%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DC.%26aulast%3DOthmar%26aufirst%3DE.%26aulast%3DLatk%26aufirst%3DM.%26aulast%3DKanczkowski%26aufirst%3DW.%26aulast%3DKroiss%26aufirst%3DM.%26aulast%3DHantel%26aufirst%3DC.%26aulast%3DHugo%26aufirst%3DC.%26aulast%3DFassnacht%26aufirst%3DM.%26aulast%3DZiegler%26aufirst%3DC.%2BG.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26aulast%3DKrone%26aufirst%3DN.%2BP.%26aulast%3DLinkermann%26aufirst%3DA.%26atitle%3DExquisite%2520Sensitivity%2520of%2520Adrenocortical%2520Carcinomas%2520to%2520Induction%2520of%2520Ferroptosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26issue%3D44%26spage%3D22269%26epage%3D22274%26doi%3D10.1073%2Fpnas.1912700116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gurevich, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurevich, V. V.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Potential of Small Molecules and Engineered Proteins</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>219</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1007/978-3-642-41199-1_1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2F978-3-642-41199-1_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24292822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFOhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=2014&pages=1-12&author=E.+V.+Gurevichauthor=V.+V.+Gurevich&title=Therapeutic+Potential+of+Small+Molecules+and+Engineered+Proteins&doi=10.1007%2F978-3-642-41199-1_1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Small Molecules and Engineered Proteins</span></div><div class="casAuthors">Gurevich, Eugenia V.; Gurevich, Vsevolod V.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">Arrestins</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Virtually all currently used therapeutic agents are small mols., largely because the development and delivery of small mol. drugs is relatively straightforward.  Small mols. have serious limitations: drugs of this type can be fairly good enzyme inhibitors, receptor ligands, or allosteric modulators.  However, most cellular functions are mediated by protein interactions with other proteins, and targeting protein-protein interactions by small mols. presents challenges that are unlikely to be overcome with these compds. as the only tools.  Recent advances in gene delivery techniques and characterization of cell type-specific promoters open the prospect of using reengineered signaling-biased proteins as next-generation therapeutics.  The first steps in targeted engineering of proteins with desired functional characteristics look very promising.  As quintessential scaffolds that act strictly via interactions with other proteins in the cell, arrestins represent a perfect model for the development of these novel therapeutic agents with enormous potential: custom-designed signaling proteins will allow us to tell the cell what to do and when to do it in a way it cannot disobey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBZ0F6zAOUM7Vg90H21EOLACvtfcHk0ljM9CNBixOX1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFOhu78%253D&md5=3aac593512d8fb34ec56c72c0f8b4ae9</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-41199-1_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-41199-1_1%26sid%3Dliteratum%253Aachs%26aulast%3DGurevich%26aufirst%3DE.%2BV.%26aulast%3DGurevich%26aufirst%3DV.%2BV.%26atitle%3DTherapeutic%2520Potential%2520of%2520Small%2520Molecules%2520and%2520Engineered%2520Proteins%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2014%26volume%3D219%26spage%3D1%26epage%3D12%26doi%3D10.1007%2F978-3-642-41199-1_1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chocry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leloup, L.</span></span> <span> </span><span class="NLM_article-title">The NADPH Oxidase Family and Its Inhibitors</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1089/ars.2019.7915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fars.2019.7915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31826639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFyitrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2020&pages=332-353&author=M.+Chocryauthor=L.+Leloup&title=The+NADPH+Oxidase+Family+and+Its+Inhibitors&doi=10.1089%2Fars.2019.7915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The NADPH Oxidase Family and Its Inhibitors</span></div><div class="casAuthors">Chocry, Mathieu; Leloup, Ludovic</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">332-353</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: The oxidative stress, resulting from an imbalance in the prodn. and scavenging of reactive oxygen species (ROS), is known to be involved in the development and progression of several pathologies.  The excess of ROS prodn. is often due to an overactivation of NADP (NADPH) oxidases (NOX) and for this reason these enzymes became promising therapeutic targets.  However, even if NOX are now well characterized, the development of new therapies is limited by the lack of highly isoform-specific inhibitors.  Recent Advances: In the past decade, several groups and labs. have screened thousands of mols. to identify new specific inhibitors with low off-target effects.  These works have led to the characterization of several new potent NOX inhibitors; however, their specificity varies a lot depending on the mols.  Crit. Issues: Here, we are reviewing more than 25 known NOX inhibitors, focusing mainly on the newly identified ones such as APX-115, NOS31, Phox-I1 and 2, GLX7013114, and GSK2795039.  To have a better overall view of these mols., the inhibitors were classified according to their specificity, from pan-NOX inhibitors to highly isoform-specific ones.  We are also presenting the use of these compds. both in vitro and in vivo.  Future Directions: Several of these new mols. are potent and very specific inhibitors that could be good candidates for the development of new drugs.  Even if the results are very promising, most of these compds. were only validated in vitro or in mice models and further investigations will be required before using them as potential therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_LEFSki4Kn7Vg90H21EOLACvtfcHk0ljM9CNBixOX1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFyitrzJ&md5=702fec90994e7bf4141b4c66dea8eb2d</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1089%2Fars.2019.7915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2019.7915%26sid%3Dliteratum%253Aachs%26aulast%3DChocry%26aufirst%3DM.%26aulast%3DLeloup%26aufirst%3DL.%26atitle%3DThe%2520NADPH%2520Oxidase%2520Family%2520and%2520Its%2520Inhibitors%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2020%26volume%3D33%26spage%3D332%26epage%3D353%26doi%3D10.1089%2Fars.2019.7915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haenen, G. R. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bast, A.</span></span> <span> </span><span class="NLM_article-title">Glutathione Revisited : A Better Scavenger than Previously Thought</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.3389/fphar.2014.00260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3389%2Ffphar.2014.00260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24478702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSjs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1-5&author=G.+R.+M.+M.+Haenenauthor=A.+Bast&title=Glutathione+Revisited%E2%80%AF%3A+A+Better+Scavenger+than+Previously+Thought&doi=10.3389%2Ffphar.2014.00260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione revisited: a better scavenger than previously thought</span></div><div class="casAuthors">Haenen, Guido R. M. M.; Bast, Aalt</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Glutathione (GSH) is the classical example of a scavenging antioxidant.  It forms the first line of defense and efficiently scavenges reactive species, e.g., hypochlorous acid (HOCl), before they inflict damage to biomols.  Scavenging antioxidant activity is best established in competition assays (that closely mimics mol. mechanism of the biol. effect).  In this type of assay, the antioxidant competes with a mol. that functions as an easy read-out detector for a reactive species.  It is generally assumed that the scavenging antioxidant activity reflects the reaction rate const. of the antioxidant with the reactive species (ka).  However, crit. appraisal of several competition assays of GSH with HOCl as reactive species, reveals that ka does not det. the scavenging antioxidant activity.  Assays using acetylcholine esterase, alpha1-antiprotease, methionine, and albumin as detector are compared.  The total no. of mols. of the reactive species scavenged by GSH plus that by partially oxidized forms of the GSH, reflect the scavenging activity of GSH.  The contribution of the partially oxidized forms of GSH depends on the reactivity of the competing mol.  In several assays the partially oxidized forms of GSH have a substantial contribution to the scavenging activity of GSH.  In contrast to the prevailing perception, not the reaction rate but rather the total no. of mols. of the reactive species scavenged reflects the true scavenging activity of an antioxidant like GSH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUJuGoXVC-aLVg90H21EOLACvtfcHk0liMTmS-uMyhQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSjs73N&md5=ccc6f762f951cc5afb7314b8b75efe8f</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2014.00260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2014.00260%26sid%3Dliteratum%253Aachs%26aulast%3DHaenen%26aufirst%3DG.%2BR.%2BM.%2BM.%26aulast%3DBast%26aufirst%3DA.%26atitle%3DGlutathione%2520Revisited%25E2%2580%25AF%253A%2520A%2520Better%2520Scavenger%2520than%2520Previously%2520Thought%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D5%26spage%3D1%26epage%3D5%26doi%3D10.3389%2Ffphar.2014.00260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Benedetto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varı, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filesi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, C.</span></span> <span> </span><span class="NLM_article-title">Novel Mechanisms of Natural Antioxidant Compounds in Biological Systems : Involvement of Glutathione and Glutathione-Related Enzymes</span>. <i>J. Nutr. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1016/j.jnutbio.2005.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.jnutbio.2005.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16111877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVegurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=577-586&issue=10&author=R.+Masellaauthor=R.+Di+Benedettoauthor=R.+Var%C4%B1author=C.+Filesiauthor=C.+Giovannini&title=Novel+Mechanisms+of+Natural+Antioxidant+Compounds+in+Biological+Systems%E2%80%AF%3A+Involvement+of+Glutathione+and+Glutathione-Related+Enzymes&doi=10.1016%2Fj.jnutbio.2005.05.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes</span></div><div class="casAuthors">Masella, Roberta; Di Benedetto, Roberta; Vari, Rosaria; Filesi, Carmela; Giovannini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutritional Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">577-586</span>CODEN:
                <span class="NLM_cas:coden">JNBIEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-2863</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Polyphenols are wide variety of compds. that occur in fruits and vegetables, wine, tea, extra virgin olive oil, chocolate and other cocoa products.  Several polyphenols have been demonstrated to have clear antioxidant properties in vitro, and many of their biol. actions have been attributed to their intrinsic reducing capabilities.  However, this concept appears now to be a simplistic way to conceive their activity.  Evidence is indeed accumulating that polyphenols might exert several other specific biol. effects that are as yet poorly understood.  In this article we review the most recent data on the subject and describe the addnl. functions that polyphenols can have in biol. systems, focusing on their effects on glutathione and its related enzymes.  Exptl. data indicate that polyphenols may offer an indirect protection by activating endogenous defense systems.  Several lines of evidence suggest a tight connection between exogenous and endogenous antioxidants that appear to act in a coordinated fashion.  It is reasonable to hypothesize that this is achieved, at least in part, through antioxidant responsive elements (AREs) present in the promoter regions of many of the genes inducible by oxidative and chem. stress.  The latest studies strongly suggest that dietary polyphenols can stimulate antioxidant transcription and detoxification defense systems through ARE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ7M3hcqTt_bVg90H21EOLACvtfcHk0liMTmS-uMyhQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVegurzN&md5=7cc613623b3e1cd8024c09af6336a273</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.jnutbio.2005.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jnutbio.2005.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DMasella%26aufirst%3DR.%26aulast%3DDi%2BBenedetto%26aufirst%3DR.%26aulast%3DVar%25C4%25B1%26aufirst%3DR.%26aulast%3DFilesi%26aufirst%3DC.%26aulast%3DGiovannini%26aufirst%3DC.%26atitle%3DNovel%2520Mechanisms%2520of%2520Natural%2520Antioxidant%2520Compounds%2520in%2520Biological%2520Systems%25E2%2580%25AF%253A%2520Involvement%2520of%2520Glutathione%2520and%2520Glutathione-Related%2520Enzymes%26jtitle%3DJ.%2520Nutr.%2520Biochem.%26date%3D2005%26volume%3D16%26issue%3D10%26spage%3D577%26epage%3D586%26doi%3D10.1016%2Fj.jnutbio.2005.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinauer, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irish, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecane, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrell, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peehl, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, S. J.</span></span> <span> </span><span class="NLM_article-title">Role of Glutathione Depletion and Reactive Oxygen Species Generation in Apoptotic Signaling in a Human B Lymphoma Cell Line</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4400959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fsj.cdd.4400959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11859408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVWmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=252-263&issue=3&author=J.+S.+Armstrongauthor=K.+K.+Steinauerauthor=B.+Hornungauthor=J.+M.+Irishauthor=P.+Lecaneauthor=G.+W.+Birrellauthor=D.+M.+Peehlauthor=S.+J.+Knox&title=Role+of+Glutathione+Depletion+and+Reactive+Oxygen+Species+Generation+in+Apoptotic+Signaling+in+a+Human+B+Lymphoma+Cell+Line&doi=10.1038%2Fsj.cdd.4400959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line</span></div><div class="casAuthors">Armstrong, J. S.; Steinauer, K. K.; Hornung, B.; Irish, J. M.; Lecane, P.; Birrell, G. W.; Peehl, D. M.; Knox, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-263</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The primary objective of this study was to det. the sequence of biochem. signaling events that occur after modulation of the cellular redox state in the B cell lymphoma line, PW, with emphasis on the role of mitochondrial signaling.  L-Buthionine sulfoximine (BSO), which inhibits gamma glutamyl cysteine synthetase (γGCS), was used to modulate the cellular redox status.  The sequence and role of mitochondrial events and downstream apoptotic signals and mediators was studied.  After BSO treatment, there was an early decline in cellular glutathione (GSH), followed by an increase in reactive oxygen species (ROS) prodn., which induced a variety of apoptotic signals (detectable at different time points) in the absence of any external apoptotic stimuli.  The sequence of biochem. events accompanying apoptosis included a 95% decrease in total GSH and a partial (25%) preservation of mitochondrial GSH, without a significant increase in ROS prodn. at 24 h.  Early activation and nuclear translocation of the nuclear factor kappa B subunit Rel A was obsd. at approx. 3 h after BSO treatment.  Cytochrome c release into the cytosol was also seen after 24 h of BSO treatment.  P53 protein expression was unchanged after redox modulation for up to 72 h, and p21waf1 independent loss of cellular proliferation was obsd.  Surprisingly, a truncated form of p53 was expressed in a time-dependent manner, beginning at 24 h after BSO incubation.  Irreversible commitment to apoptosis occurred between 48 and 72 h after BSO treatment when mitochondrial GSH was depleted, and there was an increase in ROS prodn.  Procaspase 3 protein levels showed a time-dependent redn. following incubation with BSO, notably after 48 h, that corresponded with increasing ROS levels.  At 96 h, caspase 3 cleavage products were detectable.  The pancaspase inhibitor zVADfmk, partially blocked the induction of apoptosis at 48 h, and was ineffective after 72 h.  PW cells could be rescued from apoptosis by removing them from BSO after up to 48, but not 72 h incubation with BSO.  Mitochondrial transmembrane potential (Δψm) remained intact in most of the cells during the 72 h observation period, indicating that Δψm dissipation is not an early signal for the induction of redox dependent apoptosis in PW cells.  These data suggest that a decrease in GSH alone can act as a potent early activator of apoptotic signaling.  Increased ROS prodn. following mitochondrial GSH depletion, represents a crucial event, which irreversibly commits PW cells to apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3wno4BN01b7Vg90H21EOLACvtfcHk0liMTmS-uMyhQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVWmsLg%253D&md5=e85925befc7a1b497d5bcbde1cb07fc2</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4400959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4400959%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DJ.%2BS.%26aulast%3DSteinauer%26aufirst%3DK.%2BK.%26aulast%3DHornung%26aufirst%3DB.%26aulast%3DIrish%26aufirst%3DJ.%2BM.%26aulast%3DLecane%26aufirst%3DP.%26aulast%3DBirrell%26aufirst%3DG.%2BW.%26aulast%3DPeehl%26aufirst%3DD.%2BM.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26atitle%3DRole%2520of%2520Glutathione%2520Depletion%2520and%2520Reactive%2520Oxygen%2520Species%2520Generation%2520in%2520Apoptotic%2520Signaling%2520in%2520a%2520Human%2520B%2520Lymphoma%2520Cell%2520Line%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2002%26volume%3D9%26issue%3D3%26spage%3D252%26epage%3D263%26doi%3D10.1038%2Fsj.cdd.4400959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swamy, S. M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huat, B. T. K.</span></span> <span> </span><span class="NLM_article-title">Intracellular Glutathione Depletion and Reactive Oxygen Species Generation Are Important in α-Hederin-Induced Apoptosis of P388 Cells</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>245</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1023/A:1022807207948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1023%2FA%3A1022807207948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=12708752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks12jsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=2003&pages=127-139&issue=1%E2%80%932&author=S.+M.+K.+Swamyauthor=B.+T.+K.+Huat&title=Intracellular+Glutathione+Depletion+and+Reactive+Oxygen+Species+Generation+Are+Important+in+%CE%B1-Hederin-Induced+Apoptosis+of+P388+Cells&doi=10.1023%2FA%3A1022807207948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular glutathione depletion and reactive oxygen species generation are important in α-hederin-induced apoptosis of P388 cells</span></div><div class="casAuthors">Huat, Benny Tan Kwong; Swamy, S. Muthu Kumara</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">1&2</span>),
    <span class="NLM_cas:pages">127-139</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">α-Hederin, a pentacyclic triterpene saponin isolated from the seeds of Nigella sativa, was recently reported to have potent in vivo antitumor activity against LL/2 (Lewis Lung carcinoma) in BDF1 mice.  In this study we obsd. that α-hederin caused a dose- and time-dependent increase in apoptosis of murine leukemia P388 cells.  In order to evaluate the possible mechanisms for apoptosis, the effects of α-hederin on intracellular thiol concn., including reduced glutathione (GSH), and protein thiols, and the effects of pretreatment with N-acetlycysteine (NAC), a precursor of intracellular GSH synthesis, or buthionine sulfoxime (BSO), a specific inhibitor of intracellular GSH synthesis, on α-hederin-induced apoptosis were investigated.  It was found that α-hederin rapidly depleted intracellular GSH and protein thiols prior to the occurrence of apoptosis.  NAC significantly alleviated α-hederin-induced apoptosis, while BSO augmented α-hederin-induced apoptosis significantly.  The depletion of cellular thiols obsd. after α-hederin treatment caused disruption of mitochondrial membrane potential (ΔΨm) and subsequently increased the prodn. of reactive oxygen species (ROS) in P388 cells at an early time point.  Bongkrekic acid (BA), a ligand of the mitochondrial adenine nucleotide translocator, and cyclosporin (CsA) attenuated the α-hederin-induced loss of ΔΨm, and ROS prodn.  Thus, oxidative stress after α-hederin treatment is an important event in α-hederin-induced apoptosis.  As obsd. in this study, permeability transition of mitochondrial membrane occurs after depletion of GSH and precedes a state of reactive oxygen species (ROS) generation.  Further, we obsd. that α-hederin caused the release of cytochrome c from the mitochondria to cytosol, leading to caspase-3 activation.  Our findings thus demonstrate that changes in intracellular thiols and redox status leading to perturbance of mitochondrial functions are important components in the mechanism of α-hederin-induced cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmXWcnQ8OgHLVg90H21EOLACvtfcHk0lgE2F46A-Q66Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks12jsbs%253D&md5=6abb92e48d452edf6c32e92a278417d2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022807207948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022807207948%26sid%3Dliteratum%253Aachs%26aulast%3DSwamy%26aufirst%3DS.%2BM.%2BK.%26aulast%3DHuat%26aufirst%3DB.%2BT.%2BK.%26atitle%3DIntracellular%2520Glutathione%2520Depletion%2520and%2520Reactive%2520Oxygen%2520Species%2520Generation%2520Are%2520Important%2520in%2520%25CE%25B1-Hederin-Induced%2520Apoptosis%2520of%2520P388%2520Cells%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2003%26volume%3D245%26issue%3D1%25E2%2580%25932%26spage%3D127%26epage%3D139%26doi%3D10.1023%2FA%3A1022807207948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, G. C.</span></span> <span> </span><span class="NLM_article-title">Hemoglobin Catabolism I. Glutathione Peroxidase, An Erythrocyte Enzyme Which Protects Hemoglobin From Oxidative Breakdown</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>229</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(18)70608-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2FS0021-9258%2818%2970608-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=13491573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaG1cXjsFKltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1957&pages=189-198&author=G.+C.+Mills&title=Hemoglobin+Catabolism+I.+Glutathione+Peroxidase%2C+An+Erythrocyte+Enzyme+Which+Protects+Hemoglobin+From+Oxidative+Breakdown&doi=10.1016%2FS0021-9258%2818%2970608-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown</span></div><div class="casAuthors">Mills, Gordon C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">189-97</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The presence was shown of a heat-labile, nondialyzable factor in erythrocytes which acts with glutathione to protect hemoglobin from oxidative breakdown.  Studies with H2O2 indicate that the enzyme catalyzes the oxidation of reduced glutathione by H2O2, and thus can be termed a glutathione peroxidase.  It is not inhibited by cyanide or azide, and is more effective than catalase in protecting hemoglobin from the oxidative breakdown brought about by low concns. of ascorbic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqky0RLY9ZAILVg90H21EOLACvtfcHk0lgE2F46A-Q66Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXjsFKltA%253D%253D&md5=d1d2bc6b265687a25b975e8833c4d63d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2970608-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252970608-X%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DG.%2BC.%26atitle%3DHemoglobin%2520Catabolism%2520I.%2520Glutathione%2520Peroxidase%252C%2520An%2520Erythrocyte%2520Enzyme%2520Which%2520Protects%2520Hemoglobin%2520From%2520Oxidative%2520Breakdown%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1957%26volume%3D229%26spage%3D189%26epage%3D198%26doi%3D10.1016%2FS0021-9258%2818%2970608-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quintana-Cabrera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Fernandez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobo-Jimenez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escobar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolaños, J. P.</span></span> <span> </span><span class="NLM_article-title">γ 3-Glutamylcysteine Detoxifies Reactive Oxygen Species by Acting as Glutathione Peroxidase-1 Cofactor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1722</span>, <span class="refDoi"> DOI: 10.1038/ncomms1722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fncomms1722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSntbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1722&author=R.+Quintana-Cabreraauthor=S.+Fernandez-Fernandezauthor=V.+Bobo-Jimenezauthor=J.+Escobarauthor=J.+Sastreauthor=A.+Almeidaauthor=J.+P.+Bola%C3%B1os&title=%CE%B3+3-Glutamylcysteine+Detoxifies+Reactive+Oxygen+Species+by+Acting+as+Glutathione+Peroxidase-1+Cofactor&doi=10.1038%2Fncomms1722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor</span></div><div class="casAuthors">Quintana-Cabrera, Ruben; Fernandez-Fernandez, Seila; Bob-Jimenez, Veronica; Escobar, Javier; Sastre, Juan; Almeida, Angeles; Bolanos, Juan P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">March</span>),
    <span class="NLM_cas:pages">1722/1-1722/8</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reactive oxygen species regulate redox-signaling processes, but in excess they can cause cell damage, hence underlying the etiol. of several neurol. diseases.  Through its ability to down modulate reactive oxygen species, glutathione is considered an essential thiol-antioxidant deriv., yet under certain circumstances it is dispensable for cell growth and redox control.  Here we show, by directing the biosynthesis of γ-glutamylcysteine - the immediate glutathione precursor - to mitochondria, that it efficiently detoxifies hydrogen peroxide and superoxide anion, regardless of cellular glutathione concns.  Knocking down glutathione peroxidase-1 drastically increases superoxide anion in cells synthesizing mitochondrial γ-glutamylcysteine.  In vitro, γ-glutamylcysteine is as efficient as glutathione in disposing of hydrogen peroxide by glutathione peroxidase-1.  In primary neurons, endogenously synthesized γ-glutamylcysteine fully prevents apoptotic death in several neurotoxic paradigms and, in an in vivo mouse model of neurodegeneration, γ-glutamylcysteine protects against neuronal loss and motor impairment.  Thus, γ-glutamylcysteine takes over the antioxidant and neuroprotective functions of glutathione by acting as glutathione peroxidase-1 cofactor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc-Kul25XaS7Vg90H21EOLACvtfcHk0liA0um5LJvnOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSntbvI&md5=c15df1736e948a1d805d33656a2c6368</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fncomms1722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1722%26sid%3Dliteratum%253Aachs%26aulast%3DQuintana-Cabrera%26aufirst%3DR.%26aulast%3DFernandez-Fernandez%26aufirst%3DS.%26aulast%3DBobo-Jimenez%26aufirst%3DV.%26aulast%3DEscobar%26aufirst%3DJ.%26aulast%3DSastre%26aufirst%3DJ.%26aulast%3DAlmeida%26aufirst%3DA.%26aulast%3DBola%25C3%25B1os%26aufirst%3DJ.%2BP.%26atitle%3D%25CE%25B3%25203-Glutamylcysteine%2520Detoxifies%2520Reactive%2520Oxygen%2520Species%2520by%2520Acting%2520as%2520Glutathione%2520Peroxidase-1%2520Cofactor%26jtitle%3DNat.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D1722%26doi%3D10.1038%2Fncomms1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Csallany, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draper, H. H.</span></span> <span> </span><span class="NLM_article-title">Oxidation Products of α-Tocopherol Formed in Autoxidizing Methyl Linoleate</span>. <i>Lipids</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1007/BF02531096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2FBF02531096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaE3cXhtFWlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1970&pages=63-70&author=A.+S.+Csallanyauthor=M.+Chiuauthor=H.+H.+Draper&title=Oxidation+Products+of+%CE%B1-Tocopherol+Formed+in+Autoxidizing+Methyl+Linoleate&doi=10.1007%2FBF02531096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation products of α-tocopherol formed in autoxidizing methyl linoleate</span></div><div class="casAuthors">Csallany, A. Saari; Chiu, Mei; Draper, H. H.</div><div class="citationInfo"><span class="NLM_cas:title">Lipids</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-70</span>CODEN:
                <span class="NLM_cas:coden">LPDSAP</span>;
        ISSN:<span class="NLM_cas:issn">0024-4201</span>.
    </div><div class="casAbstract">The oxidn. products of α-tocopherol-14C (I) formed by heating with Me linoleate in air at 60° or 100° were investigated.  The products included a dimer, trimer, and dihydroxy dimer, α-tocopherol quinone (II) and unidentified degradation compds.  The dimer and trimer were the major products present after heating for 70 hr at 60°.  After 70 hr at 100° most of the α-tocopherol-14C was converted to degradation products; part of the 14C originally present in the 5-Me group wa s recovered as 14CO2 and 14CH3OH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2VNzkSGpUVbVg90H21EOLACvtfcHk0liA0um5LJvnOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXhtFWlsbw%253D&md5=b82bb56ba5edb2c2e544b11fdb7f3ad9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2FBF02531096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02531096%26sid%3Dliteratum%253Aachs%26aulast%3DCsallany%26aufirst%3DA.%2BS.%26aulast%3DChiu%26aufirst%3DM.%26aulast%3DDraper%26aufirst%3DH.%2BH.%26atitle%3DOxidation%2520Products%2520of%2520%25CE%25B1-Tocopherol%2520Formed%2520in%2520Autoxidizing%2520Methyl%2520Linoleate%26jtitle%3DLipids%26date%3D1970%26volume%3D5%26spage%3D63%26epage%3D70%26doi%3D10.1007%2FBF02531096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, R.</span></span> <span> </span><span class="NLM_article-title">Vitamin E: Mechanism of Its Antioxidant Activity</span>. <i>Food Sci. Technol. Int., Tokyo</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.3136/fsti9596t9798.3.301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3136%2Ffsti9596t9798.3.301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK1cXhtVWls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=301-309&issue=4&author=R.+Yamauchi&title=Vitamin+E%3A+Mechanism+of+Its+Antioxidant+Activity&doi=10.3136%2Ffsti9596t9798.3.301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Vitamin E: mechanism of its antioxidant activity</span></div><div class="casAuthors">Yamauchi, Ryo</div><div class="citationInfo"><span class="NLM_cas:title">Food Science and Technology International, Tokyo</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-309</span>CODEN:
                <span class="NLM_cas:coden">FTINF2</span>;
        ISSN:<span class="NLM_cas:issn">1341-7592</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for Food Science and Technology</span>)
        </div><div class="casAbstract">A review with 67 refs.  The antioxidant activity of vitamin E (α-tocopherol) during the peroxidn. of unsatd. lipids has been reviewed based on its reaction products.  Free-radical scavenging reactions of α-tocopherol take place via the α-tocopheroxyl radical as an intermediate.  If a suitable free radical is present, a non-radical product can be formed from the coupling of the free radical with the α-tocopheroxyl radical.  The reaction products of α-tocopherol with lipid-peroxyl radicals are 8a-(lipid-dioxy)-α-tocopherones which are hydrolyzed to α-tocopherylquinone.  If the supply of oxygen is insufficient, α-tocopherol can trap the carbon-centered radicals of lipids to form 6-O-(lipid-alkyl)-α-tocopherols.  On the other hand, the dimer and trimer of α-tocopherol is formed by the bimol. self-reaction of the α-tocopheroxyl radical in a reaction mixt. contg. a large amt. of α-tocopherol.  The other product-forming pathway yields isomeric epoxy-α-tocopherylquinones and their precursors, epoxyhydroperoxy-α-tocopherones, but the mechanism of this pathway remains unknown.  The reaction products of other vitamin E compds. (γ- and δ-tocopherols) during lipid peroxidn. are almost the same as those formed from the α-tocopherol.  The tocopheroxyl radicals of γ- and δ-tocopherols prefer to react with each other to form dimeric products that are still effective as antioxidants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0FT2z8U_ZFbVg90H21EOLACvtfcHk0liA0um5LJvnOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtVWls74%253D&md5=4cbf15b5bb357b100baebc6936ddf33d</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.3136%2Ffsti9596t9798.3.301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3136%252Ffsti9596t9798.3.301%26sid%3Dliteratum%253Aachs%26aulast%3DYamauchi%26aufirst%3DR.%26atitle%3DVitamin%2520E%253A%2520Mechanism%2520of%2520Its%2520Antioxidant%2520Activity%26jtitle%3DFood%2520Sci.%2520Technol.%2520Int.%252C%2520Tokyo%26date%3D1997%26volume%3D3%26issue%3D4%26spage%3D301%26epage%3D309%26doi%3D10.3136%2Ffsti9596t9798.3.301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cancela, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canclini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourglia-Ettlin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlino, A.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective Effects of Novel Nitrones: In Vitro and in Silico Studies</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>871</i></span>,  <span class="NLM_fpage">172926</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2020.172926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.ejphar.2020.172926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31958456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFGjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=871&publication_year=2020&pages=172926&author=S.+Cancelaauthor=L.+Cancliniauthor=G.+Mourglia-Ettlinauthor=P.+Hern%C3%A1ndezauthor=A.+Merlino&title=Neuroprotective+Effects+of+Novel+Nitrones%3A+In+Vitro+and+in+Silico+Studies&doi=10.1016%2Fj.ejphar.2020.172926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective effects of novel nitrones: In vitro and in silico studies</span></div><div class="casAuthors">Cancela, Saira; Canclini, Lucia; Mourglia-Ettlin, Gustavo; Hernandez, Paola; Merlino, Alicia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">871</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">172926</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases affect millions of people around the world.  Several studies point out caspase-3 as a key player in the development and progression of neurol. disorders including amyotrophic lateral sclerosis, Alzheimer's, Parkinson's and Huntington's diseases.  Furthermore, oxidative stress and mitochondrial dysfunction plays an important role in neurodegenerative pathologies leading to neuronal damage and cell death.  Pharmacol. properties of nitrones such as free radical trapping and neuroprotection has been previously described.  In the present work, we have assessed ten non-cytotoxic nitrones for their ability to inhibit apoptosis plus their potential to reduce active caspase-3 and oxidative stress in the hippocampal neuronal cell line HT22.  Our results highlight the faculty of nitrones to inhibit apoptosis by a mechanism that involves active caspase-3 redn. and decrease of reactive oxygen species.  Moreover, docking and mol. dynamics approaches lead to a detailed anal. at the at. level of the nitrones binding mode to caspase-3 suggesting that compds. bind in a region close to the catalytic site.  All these data place these mols. as excellent hits for further efforts to redesign novel compds. in the search of a new therapy against neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-DqzsjqZlbVg90H21EOLACvtfcHk0li1_pi6p_lJSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFGjtrc%253D&md5=36e8eac32472aa6215cdd05e9743f525</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2020.172926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2020.172926%26sid%3Dliteratum%253Aachs%26aulast%3DCancela%26aufirst%3DS.%26aulast%3DCanclini%26aufirst%3DL.%26aulast%3DMourglia-Ettlin%26aufirst%3DG.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DP.%26aulast%3DMerlino%26aufirst%3DA.%26atitle%3DNeuroprotective%2520Effects%2520of%2520Novel%2520Nitrones%253A%2520In%2520Vitro%2520and%2520in%2520Silico%2520Studies%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2020%26volume%3D871%26spage%3D172926%26doi%3D10.1016%2Fj.ejphar.2020.172926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nash, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiefer, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Z. A.</span></span> <span> </span><span class="NLM_article-title">Development of a Reactive Oxygen Species-Sensitive Nitric Oxide Synthase Inhibitor for the Treatment of Ischemic Stroke</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2017.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2017.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29275014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVCkur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=395-404&author=K.+M.+Nashauthor=I.+T.+Schieferauthor=Z.+A.+Shah&title=Development+of+a+Reactive+Oxygen+Species-Sensitive+Nitric+Oxide+Synthase+Inhibitor+for+the+Treatment+of+Ischemic+Stroke&doi=10.1016%2Fj.freeradbiomed.2017.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a reactive oxygen species-sensitive nitric oxide synthase inhibitor for the treatment of ischemic stroke</span></div><div class="casAuthors">Nash, Kevin M.; Schiefer, Isaac T.; Shah, Zahoor A.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">395-404</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ischemic stroke is caused by a blockage of cerebral blood flow resulting in neuronal and glial hypoxia leading to inflammatory and reactive oxygen species (ROS)-mediated cell death.  Nitric oxide (NO) formed by NO synthase (NOS) is known to be protective in ischemic stroke, however NOS has been shown to 'uncouple' under oxidative conditions to instead produce ROS.  Nitrones are antioxidant mols. that are shown to trap ROS to then decomp. and release NO.  In this study, the nitrone 5 (N-tert-butyl-a-(3-[ethanimidamidomethyl]phenyl)nitrone) was designed such that its decompn. product is a NOS inhibitor, 6, effectively leading to NOS inhibition specifically at the site of ROS prodn.  The ability of 5 to spin-trap radicals and decomp. to 6 was obsd. using EPR and LC-MS/MS.  The pro-drug concept was tested in vitro by measuring cell viability and 6 formation in SH-SY5Y cells subjected to oxygen glucose deprivation (OGD).  5 Was found to be more efficacious and more potent than PBN, and was able to increase phospho-Akt while reducing nitrotyrosine and cleaved caspase-3 levels.  6 Treatment, but not 5, was found to decrease NO prodn. in LPS-stimulated microglia.  Doppler flowmetry on anesthetized mice showed increased cerebral blood flow upon i.v. administration of 1 mg/kg of 5, but a return to baseline upon administration of 10 mg/kg, likely due to its dual nature of antioxidant/NO-donor and NOS-inhibition.  Mice treated with 5 after permanent ischemia exhibited a >30% redn. in infarct vol., and higher formation of 6 in ischemic tissue resulting in region specific effects limited to the infarct area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo24ZADxBHaDLVg90H21EOLACvtfcHk0li1_pi6p_lJSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVCkur%252FP&md5=f6a2a5a377af35afb793e3fdcf830bf1</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2017.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2017.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DNash%26aufirst%3DK.%2BM.%26aulast%3DSchiefer%26aufirst%3DI.%2BT.%26aulast%3DShah%26aufirst%3DZ.%2BA.%26atitle%3DDevelopment%2520of%2520a%2520Reactive%2520Oxygen%2520Species-Sensitive%2520Nitric%2520Oxide%2520Synthase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Ischemic%2520Stroke%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2018%26volume%3D115%26spage%3D395%26epage%3D404%26doi%3D10.1016%2Fj.freeradbiomed.2017.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Recent Advances on Nitrones Design for Stroke Treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">13413</span>– <span class="NLM_lpage">13427</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00976</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00976" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslejs7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=13413-13427&issue=22&author=J.+Marco-Contelles&title=Recent+Advances+on+Nitrones+Design+for+Stroke+Treatment&doi=10.1021%2Facs.jmedchem.0c00976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances on Nitrones Design for Stroke Treatment</span></div><div class="casAuthors">Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">13413-13427</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The recent advances of tetramethylpyrazine nitrones and quinolylnitrones for the treatment of stroke have been reviewed and compared with other agents, showing promising therapeutic applications.  As a result of a functional transformation of natural product ligustrazine, (Z)-N-tert-butyl-1-(3,5,6-trimethylpyrazin-2-yl)methanimine oxide (6) is a multitarget small nitrone showing potent thrombolytic activity and free radicals scavenging power, in addn. to nontoxicity and blood-brain barrier permeability.  Similarly, antioxidant (Z)-N-tert-butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine oxide (17) is a novel agent for cerebral ischemia therapy as it is able to scavenge different types of free radical species, showing strong neuroprotection and reduced infarct size.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF_xOnJwnJBrVg90H21EOLACvtfcHk0lhD_JY-NhxUkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslejs7rO&md5=99aa3098f732879825b1f8861ba0d657</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00976%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520Advances%2520on%2520Nitrones%2520Design%2520for%2520Stroke%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D22%26spage%3D13413%26epage%3D13427%26doi%3D10.1021%2Facs.jmedchem.0c00976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marklund, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewén, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillered, L.</span></span> <span> </span><span class="NLM_article-title">The Nitrone Free Radical Scavenger NXY-059 Is Neuroprotective When Administered after Traumatic Brain Injury in the Rat</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1449</span>– <span class="NLM_lpage">1457</span>, <span class="refDoi"> DOI: 10.1089/neu.2008.0585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fneu.2008.0585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=19118455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BD1M3otlOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=1449-1457&issue=12&author=F.+Clausenauthor=N.+Marklundauthor=A.+Lew%C3%A9nauthor=L.+Hillered&title=The+Nitrone+Free+Radical+Scavenger+NXY-059+Is+Neuroprotective+When+Administered+after+Traumatic+Brain+Injury+in+the+Rat&doi=10.1089%2Fneu.2008.0585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">The nitrone free radical scavenger NXY-059 is neuroprotective when administered after traumatic brain injury in the rat</span></div><div class="casAuthors">Clausen Fredrik; Marklund Niklas; Lewen Anders; Hillered Lars</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1449-57</span>
        ISSN:<span class="NLM_cas:issn">0897-7151</span>.
    </div><div class="casAbstract">Reactive oxygen species (ROS) are important contributors to the secondary injury cascade following traumatic brain injury (TBI), and ROS inhibition has consistently been shown to be neuroprotective following experimental TBI.  NXY-059, a nitrone free radical trapping compound, has been shown to be neuroprotective in models of ischemic stroke but has not been evaluated in experimental TBI.  In the present study, a continuous 24-h intravenous infusion of NXY-059 or vehicle was initiated 30 min following a severe lateral fluid percussion brain injury (FPI) in adult rats (n=22), and histological and behavioral outcomes were evaluated.  Sham-injured animals (n=22) receiving identical drug infusion were used as controls.  Visuospatial learning was evaluated in the Morris water maze at post-injury days 11-14, followed by a probe trial (memory test) at day 18.  The animals were sacrificed at day 18, and loss of hemispheric brain tissue was measured in microtubule-associated protein (MAP)-2 stained sections.  Brain-injured, NXY-059-treated animals showed a significant reduction of visuospatial learning deficits when compared to the brain-injured, vehicle-treated control animals (p < 0.05).  NXY-059-treated animals significantly reduced the loss of hemispheric tissue compared to brain-injured controls (43.0 +/- 11 mm3 versus 74.4 +/- 19 mm3, respectively; p < 0.01).  The results show that post-injury treatment with NXY-059 significantly attenuated the loss of injured brain tissue and improved cognitive outcome, suggesting a major role for ROS in the pathophysiology of TBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSjMCLuN1s-_6AExegM5LLfW6udTcc2eZdn2Yr5pGoLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3otlOguw%253D%253D&md5=3bfe28cda55707504c14807603d28868</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1089%2Fneu.2008.0585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2008.0585%26sid%3Dliteratum%253Aachs%26aulast%3DClausen%26aufirst%3DF.%26aulast%3DMarklund%26aufirst%3DN.%26aulast%3DLew%25C3%25A9n%26aufirst%3DA.%26aulast%3DHillered%26aufirst%3DL.%26atitle%3DThe%2520Nitrone%2520Free%2520Radical%2520Scavenger%2520NXY-059%2520Is%2520Neuroprotective%2520When%2520Administered%2520after%2520Traumatic%2520Brain%2520Injury%2520in%2520the%2520Rat%26jtitle%3DJ.%2520Neurotrauma%26date%3D2008%26volume%3D25%26issue%3D12%26spage%3D1449%26epage%3D1457%26doi%3D10.1089%2Fneu.2008.0585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marklund, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewander, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillered, L.</span></span> <span> </span><span class="NLM_article-title">Effects of the Nitrone Radical Scavengers PBN and S-PBN on in Vivo Trapping of Reactive Oxygen Species after Traumatic Brain Injury in Rats</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1267</span>, <span class="refDoi"> DOI: 10.1097/00004647-200111000-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1097%2F00004647-200111000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11702041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1WktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=1259-1267&issue=11&author=N.+Marklundauthor=T.+Lewanderauthor=F.+Clausenauthor=L.+Hillered&title=Effects+of+the+Nitrone+Radical+Scavengers+PBN+and+S-PBN+on+in+Vivo+Trapping+of+Reactive+Oxygen+Species+after+Traumatic+Brain+Injury+in+Rats&doi=10.1097%2F00004647-200111000-00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the nitrone radical scavengers PBN and S-PBN on in vivo trapping of reactive oxygen species after traumatic brain injury in rats</span></div><div class="casAuthors">Marklund, Niklas; Lewander, Tommy; Clausen, Fredrik; Hillered, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1259-1267</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">In previous studies, the authors showed that the nitrone radical scavenger α-phenyl-N-tert-butylnitrone (PBN) and its sulfo-deriv., 2-sulfophenyl-N-tert-butylnitrone (S-PBN), attenuated cognitive disturbance and reduced tissue damage after traumatic brain injury (TBI) in rats.  In the current study, the prodn. of reactive oxygen species (ROS) after TBI was monitored with microdialysis and the 4-hydroxybenzoic acid (4-HBA) trapping method.  A single dose of PBN (30 mg/kg) or an equimolar dose of S-PBN (47 mg/kg) was administered i.v. 30 min before a controlled cortical contusion injury in rats.  Plasma and brain tissue drug concns. were analyzed at the end of the microdialysis expt. (3 h after injury) and, in a sep. expt. with S-PBN, at 30 and 60 min after injury.  Traumatic brain injury caused a significant increase in ROS formation that lasted for 60 min after the injury as evidenced by increased 3,4-dihydroxybenzoic acid (3,4-DHBA) concns. in the dialyzate.  PBN and S-PBN equally and significantly attenuated the posttraumatic increase in 3,4-DHBA formation.  High PBN concns. were found bilaterally in brain tissue up to 3 h after injury.  In contrast, S-PBN was rapidly cleared from the circulation and was not detectable in brain at 30 min after injury or at any later time point.  The results suggest that scavenging of ROS after TBI may contribute to the neuroprotective properties obsd. with nitrone spin-trapping agents.  S-PBN, which remained undetectable even in traumatized brain tissue, reduced ROS prodn. to the same extent as PBN that readily crossed the blood-brain barrier.  This finding supports an important role for ROS prodn. at the blood-endothelial interface in TBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjTghvGL7cSLVg90H21EOLACvtfcHk0li9OVnOXqRniw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1WktbY%253D&md5=ea0c7fad22081de4164eb6d0bb96b582</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1097%2F00004647-200111000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-200111000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DMarklund%26aufirst%3DN.%26aulast%3DLewander%26aufirst%3DT.%26aulast%3DClausen%26aufirst%3DF.%26aulast%3DHillered%26aufirst%3DL.%26atitle%3DEffects%2520of%2520the%2520Nitrone%2520Radical%2520Scavengers%2520PBN%2520and%2520S-PBN%2520on%2520in%2520Vivo%2520Trapping%2520of%2520Reactive%2520Oxygen%2520Species%2520after%2520Traumatic%2520Brain%2520Injury%2520in%2520Rats%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2001%26volume%3D21%26issue%3D11%26spage%3D1259%26epage%3D1267%26doi%3D10.1097%2F00004647-200111000-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villamena, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, K. M.</span></span> <span> </span><span class="NLM_article-title">Potential Implication of the Chemical Properties and Bioactivity of Nitrone Spin Traps for Therapeutics</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1171</span>– <span class="NLM_lpage">1207</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.74</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.4155%2Ffmc.12.74" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22709256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38Xoslaltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1171-1207&issue=9&author=F.+A.+Villamenaauthor=A.+Dasauthor=K.+M.+Nash&title=Potential+Implication+of+the+Chemical+Properties+and+Bioactivity+of+Nitrone+Spin+Traps+for+Therapeutics&doi=10.4155%2Ffmc.12.74"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Potential implication of the chemical properties and bioactivity of nitrone spin traps for therapeutics</span></div><div class="casAuthors">Villamena, Frederick A.; Das, Amlan; Nash, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1171-1207</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Nitrone therapeutics has been employed in the treatment of oxidative stress-related diseases such as neurodegeneration, cardiovascular disease and cancer.  The nitrone-based compd. NXY-059, which is the first drug to reach clin. trials for the treatment of acute ischemic stroke, has provided promise for the development of more robust pharmacol. agents.  However, the specific mechanism of nitrone bioactivity remains unclear.  In this review, we present a variety of nitrone chem. and biol. activity that could be implicated for the nitrone's pharmacol. activity.  The chemistries of spin trapping and spin adduct reveal insights on the possible roles of nitrones for altering cellular redox status through radical scavenging or nitric oxide donation, and their biol. effects are presented.  An interdisciplinary approach towards the development of novel synthetic antioxidants with improved pharmacol. properties encompassing theor., synthetic, biochem. and in vitro/in vivo studies is covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryiCxMpHZdtrVg90H21EOLACvtfcHk0li9OVnOXqRniw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xoslaltr8%253D&md5=0db6aee0517ae193ff15cb2ad280b8d3</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.74&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.74%26sid%3Dliteratum%253Aachs%26aulast%3DVillamena%26aufirst%3DF.%2BA.%26aulast%3DDas%26aufirst%3DA.%26aulast%3DNash%26aufirst%3DK.%2BM.%26atitle%3DPotential%2520Implication%2520of%2520the%2520Chemical%2520Properties%2520and%2520Bioactivity%2520of%2520Nitrone%2520Spin%2520Traps%2520for%2520Therapeutics%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26issue%3D9%26spage%3D1171%26epage%3D1207%26doi%3D10.4155%2Ffmc.12.74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Locigno, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweier, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villamena, F. A.</span></span> <span> </span><span class="NLM_article-title">Nitric Oxide Release from the Unimolecular Decomposition of the Superoxide Radical Anion Adduct of Cyclic Nitrones in Aqueous Medium</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">3220</span>– <span class="NLM_lpage">3227</span>, <span class="refDoi"> DOI: 10.1039/b507530k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1039%2Fb507530k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16106305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotVSmsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=3220-3227&issue=17&author=E.+J.+Locignoauthor=J.+L.+Zweierauthor=F.+A.+Villamena&title=Nitric+Oxide+Release+from+the+Unimolecular+Decomposition+of+the+Superoxide+Radical+Anion+Adduct+of+Cyclic+Nitrones+in+Aqueous+Medium&doi=10.1039%2Fb507530k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide release from the unimolecular decomposition of the superoxide radical anion adduct of cyclic nitrones in aqueous medium</span></div><div class="casAuthors">Locigno, Edward J.; Zweier, Jay L.; Villamena, Frederick A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3220-3227</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Nitrones such as 5,5-dimethyl-1-pyrroline N-oxide (DMPO), 5-diethoxyphosphoryl-5-methyl-1-pyrroline N-oxide (DEPMPO) and 5-ethoxycarbonyl-5-methyl-1-pyrroline N-oxide (EMPO) have become the spin-traps of choice for the detection of transient radical species in chem. and biol. systems using ESR spectroscopy.  The mechanism of decompn. of the superoxide radical anion (O2•-) adducts of DMPO, DEPMPO and EMPO in aq. solns. was investigated.  The authors' findings suggest that nitric oxide (NO) was formed during the decompn. of the O2•- adduct as detected by EPR spin trapping using Fe(II) N-methyl-D-glucamine dithiocarbamate (MGD).  Nitric oxide release was obsd. from the O2•- adduct formed from hypoxanthine-xanthine oxidase, PMA-activated human neutrophils, and DMSO soln. of KO2.  Nitric oxide formation was not obsd. from the independently generated hydroxyl radical adduct.  Formation of nitric oxide was also indirectly detected as nitrite (NO2-) utilizing the Griess assay.  Nitrite concn. increases with increasing O2•- concn. at const. DMPO concn., while NO2- formation is suppressed at anaerobic conditions.  Moreover, large excess of DMPO also inhibits NO2- formation which can be attributed to the oxidn. of DMPO to hydroxamic acid nitroxide (DMPO-X) by nitrogen dioxide (NO2), a precursor to NO2-.  Product anal. was also conducted to further elucidate the mechanism of adduct decay using gas chromatog.-mass spectrometry (GC-MS) technique.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG8JUExMIrnLVg90H21EOLACvtfcHk0ljZKKPPhFRlMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotVSmsrs%253D&md5=a14449facc380f99ba554e52e1dfe7eb</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1039%2Fb507530k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb507530k%26sid%3Dliteratum%253Aachs%26aulast%3DLocigno%26aufirst%3DE.%2BJ.%26aulast%3DZweier%26aufirst%3DJ.%2BL.%26aulast%3DVillamena%26aufirst%3DF.%2BA.%26atitle%3DNitric%2520Oxide%2520Release%2520from%2520the%2520Unimolecular%2520Decomposition%2520of%2520the%2520Superoxide%2520Radical%2520Anion%2520Adduct%2520of%2520Cyclic%2520Nitrones%2520in%2520Aqueous%2520Medium%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26issue%3D17%26spage%3D3220%26epage%3D3227%26doi%3D10.1039%2Fb507530k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shuaib, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lees, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davalos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashwood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasiewski, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emeribe, U.</span></span> <span> </span><span class="NLM_article-title">NXY-059 for the Treatment of Acute Ischemic Stroke</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>357</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa070240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1056%2FNEJMoa070240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=17687131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVSjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=562-571&issue=6&author=A.+Shuaibauthor=K.+R.+Leesauthor=P.+Lydenauthor=J.+Grottaauthor=A.+Davalosauthor=S.+M.+Davisauthor=H.-C.+Dienerauthor=T.+Ashwoodauthor=W.+W.+Wasiewskiauthor=U.+Emeribe&title=NXY-059+for+the+Treatment+of+Acute+Ischemic+Stroke&doi=10.1056%2FNEJMoa070240"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">NXY-059 for the treatment of acute ischemic stroke</span></div><div class="casAuthors">Shuaib, Ashfaq; Lees, Kennedy R.; Lyden, Patrick; Grotta, James; Davalos, Antonio; Davis, Stephen M.; Diener, Hans-Christoph; Ashwood, Tim; Wasiewski, Warren W.; Emeribe, Ugochi</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">562-571</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: The free-radical-trapping agent NXY-059 showed promise as a neuroprotectant in the Stroke-Acute Ischemic NXY Treatment I (SAINT I) trial, reducing disability when given to patients who had acute ischemic stroke.  We sought confirmation of efficacy in a second, larger trial.  Methods: We enrolled 3306 patients with acute ischemic stroke in a randomized, double-blind trial to receive a 72-h infusion of i.v. NXY-059 or placebo within 6 h after the. onset of stroke symptoms.  Our primary end point was the distribution of disability scores on the modified Rankin scale at 90 days.  We examd. scores on neurol. and activities-of-daily-living scales as secondary end points.  We also tested the hypothesis that NXY-059 would reduce alteplase-related intracranial hemorrhages.  Results: The efficacy anal. was based on 3195 patients.  Prognostic factors were well balanced between the treatment groups.  Mortality was equal in the two groups, and adverse-event rates were similar.  The distribution of scores on the modified Rankin scale did not differ between the group treated with NXY-059 (1588 patients) and the placebo group (1607 patients; P = 0.33 by the Cochran-Mantel-Haenszel test; odds ratio for limiting disability, 0.94; 95% confidence interval [CI], 0.83 to 1.06).  Anal. of categorized scores on the modified Rankin scale confirmed the lack of benefit: the odds ratio for trichotomization into modified Rankin scale scores of 0 to 1 vs. 2 to 3 vs. 4 to 6 was 0.92 (95% CI, 0.80 to 1.06).  There was no evidence of efficacy for any of the secondary end points.  Among patients treated with alteplase, there was no difference between the NXY-059 group and the placebo group in the frequency of symptomatic or asymptomatic hemorrhage.  Conclusions: NXY-059 is ineffective for the treatment of acute ischemic stroke within 6 h after the onset of symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF9Lz8mJUaG7Vg90H21EOLACvtfcHk0ljZKKPPhFRlMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVSjsLc%253D&md5=4a249bb6f8aa45b485496c9c91bede82</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa070240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa070240%26sid%3Dliteratum%253Aachs%26aulast%3DShuaib%26aufirst%3DA.%26aulast%3DLees%26aufirst%3DK.%2BR.%26aulast%3DLyden%26aufirst%3DP.%26aulast%3DGrotta%26aufirst%3DJ.%26aulast%3DDavalos%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DS.%2BM.%26aulast%3DDiener%26aufirst%3DH.-C.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DWasiewski%26aufirst%3DW.%2BW.%26aulast%3DEmeribe%26aufirst%3DU.%26atitle%3DNXY-059%2520for%2520the%2520Treatment%2520of%2520Acute%2520Ischemic%2520Stroke%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D357%26issue%3D6%26spage%3D562%26epage%3D571%26doi%3D10.1056%2FNEJMoa070240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Alonso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalo-Gobernado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayuso, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escobar-Peso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infantes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjipavlou-Litina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcázar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective (Z)- N- Tert-Butyl-1-(2-Chloro-6-Methoxyquinolin-3-Yl)Methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2184</span>– <span class="NLM_lpage">2201</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01987</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01987" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2184-2201&issue=4&author=M.+Chiouaauthor=E.+Mart%C3%ADnez-Alonsoauthor=R.+Gonzalo-Gobernadoauthor=M.+I.+Ayusoauthor=A.+Escobar-Pesoauthor=L.+Infantesauthor=D.+Hadjipavlou-Litinaauthor=J.+J.+Montoyaauthor=J.+Montanerauthor=A.+Alc%C3%A1zarauthor=J.+Marco-Contelles&title=New+Quinolylnitrones+for+Stroke+Therapy%3A+Antioxidant+and+Neuroprotective+%28Z%29-+N-+Tert-Butyl-1-%282-Chloro-6-Methoxyquinolin-3-Yl%29Methanimine+Oxide+as+a+New+Lead-Compound+for+Ischemic+Stroke+Treatment&doi=10.1021%2Facs.jmedchem.8b01987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective (Z)-N-tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment</span></div><div class="casAuthors">Chioua, Mourad; Martinez-Alonso, Emma; Gonzalo-Gobernado, Rafael; Ayuso, Maria I.; Escobar-Peso, Alejandro; Infantes, Lourdes; Hadjipavlou-Litina, Dimitra; Montoya, Juan J.; Montaner, Joan; Alcazar, Alberto; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2184-2201</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe herein the synthesis and neuroprotective capacity of an array of 31 compds. comprising quinolyloximes, quinolylhydrazones, quinolylimines, QNs, and related heterocyclic azolylnitrones.  Neuronal cultures subjected to oxygen-glucose deprivation (OGD), as exptl. model for ischemic conditions, were treated with our mols. at the onset of recovery period after OGD and showed that most of these QNs, but not the azo mols., improved neuronal viability 24 h after recovery.  Esp., QN (Z)-N-tert-butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine oxide (I) was shown as a very potent neuroprotective agent.  Antioxidant anal. based on the ability of I to trap different types of toxic radical oxygenated species supported and confirmed its strong neuroprotective capacity.  Finally, I showed also neuroprotection induction in two in vivo models of cerebral ischemia, decreasing neuronal death and reducing infarct size, allowing us to conclude that I can be considered as new lead-compd. for ischemic stroke treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCp1AW7e0XLVg90H21EOLACvtfcHk0liiduozK5sFVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWjtbs%253D&md5=0f23023ae2328f11dab4bf332442d636</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01987%26sid%3Dliteratum%253Aachs%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez-Alonso%26aufirst%3DE.%26aulast%3DGonzalo-Gobernado%26aufirst%3DR.%26aulast%3DAyuso%26aufirst%3DM.%2BI.%26aulast%3DEscobar-Peso%26aufirst%3DA.%26aulast%3DInfantes%26aufirst%3DL.%26aulast%3DHadjipavlou-Litina%26aufirst%3DD.%26aulast%3DMontoya%26aufirst%3DJ.%2BJ.%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DA.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DNew%2520Quinolylnitrones%2520for%2520Stroke%2520Therapy%253A%2520Antioxidant%2520and%2520Neuroprotective%2520%2528Z%2529-%2520N-%2520Tert-Butyl-1-%25282-Chloro-6-Methoxyquinolin-3-Yl%2529Methanimine%2520Oxide%2520as%2520a%2520New%2520Lead-Compound%2520for%2520Ischemic%2520Stroke%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D4%26spage%3D2184%26epage%3D2201%26doi%3D10.1021%2Facs.jmedchem.8b01987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quideau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deffieux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douat-Casassus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouységu, L.</span></span> <span> </span><span class="NLM_article-title">Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">586</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1002/anie.201000044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fanie.201000044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFGjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=586-621&author=S.+Quideauauthor=D.+Deffieuxauthor=C.+Douat-Casassusauthor=L.+Pouys%C3%A9gu&title=Plant+Polyphenols%3A+Chemical+Properties%2C+Biological+Activities%2C+and+Synthesis&doi=10.1002%2Fanie.201000044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Plant polyphenols: Chemical properties, biological activities, and synthesis</span></div><div class="casAuthors">Quideau, Stephane; Deffieux, Denis; Douat-Casassus, Celine; Pouysegu, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">586-621</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Eating five servings of fruits and vegetables per day!!This is what is highly recommended and heavily advertised nowadays to the general public to stay fit and healthy! Drinking green tea on a regular basis, eating chocolate from time to time, as well as savoring a couple of glasses of red wine per day have been claimed to increase life expectancy even further! Why The answer is in fact still under scientific scrutiny, but a particular class of compds. naturally occurring in fruits and vegetables is considered to be crucial for the expression of such human health benefits: the polyphenols! What are these plant products really What are their physicochem. properties How do they express their biol. activity Are they really valuable for disease prevention Can they be used to develop new pharmaceutical drugs What recent progress has been made toward their prepn. by org. synthesis This Review gives answers from a chem. perspective, summarizes the state of the art, and highlights the most significant advances in the field of polyphenol research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6yStrEg5Z0rVg90H21EOLACvtfcHk0liiduozK5sFVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFGjsw%253D%253D&md5=e1469df2ccba3b121680dff0b43b696a</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1002%2Fanie.201000044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201000044%26sid%3Dliteratum%253Aachs%26aulast%3DQuideau%26aufirst%3DS.%26aulast%3DDeffieux%26aufirst%3DD.%26aulast%3DDouat-Casassus%26aufirst%3DC.%26aulast%3DPouys%25C3%25A9gu%26aufirst%3DL.%26atitle%3DPlant%2520Polyphenols%253A%2520Chemical%2520Properties%252C%2520Biological%2520Activities%252C%2520and%2520Synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D586%26epage%3D621%26doi%3D10.1002%2Fanie.201000044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laraia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkitaraman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Profiling of Tellimagrandin I and Analogues Reveals That the Medium Ring Can Significantly Modulate Biological Activity</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2590</span>– <span class="NLM_lpage">2593</span>, <span class="refDoi"> DOI: 10.1039/c2ob25065a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1039%2Fc2ob25065a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22361895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFKls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=2590-2593&issue=13&author=S.+Zhengauthor=L.+Laraiaauthor=C.+J.+O%E2%80%99Connorauthor=D.+Sorrellauthor=Y.+S.+Tanauthor=Z.+Xuauthor=A.+R.+Venkitaramanauthor=W.+Wuauthor=D.+R.+Spring&title=Synthesis+and+Biological+Profiling+of+Tellimagrandin+I+and+Analogues+Reveals+That+the+Medium+Ring+Can+Significantly+Modulate+Biological+Activity&doi=10.1039%2Fc2ob25065a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological profiling of tellimagrandin I and analogues reveals that the medium ring can significantly modulate biological activity</span></div><div class="casAuthors">Zheng, Shaojun; Laraia, Luca; O'Connor, Cornelius J.; Sorrell, David; Tan, Yaw Sing; Xu, Zhaochao; Venkitaraman, Ashok R.; Wu, Wenjun; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2590-2593</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel synthesis of the ellagitannin natural product tellimagrandin I and a series of medium ring analogs is described.  These compds. were all subsequently screened for redox activity, ability to ppt. protein and cellular phenotype in HeLa cells.  From this we have shown that all properties can be modulated independently by varying ring size and by moving the ester out of conjugation with the biaryl ring system.  Increasing ring size increased redox activity and cytotoxicity, leading to the identification of a compd. I which was significantly more cytotoxic.  In addn. compds. identified with a redox active scaffold and low cytotoxicity may be employed as a new class of redox probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRjoF409LiY7Vg90H21EOLACvtfcHk0ljEYTzto7RStQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFKls7k%253D&md5=4ee784ca806b669e9e44526c31f62099</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25065a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25065a%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DLaraia%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DC.%2BJ.%26aulast%3DSorrell%26aufirst%3DD.%26aulast%3DTan%26aufirst%3DY.%2BS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DSynthesis%2520and%2520Biological%2520Profiling%2520of%2520Tellimagrandin%2520I%2520and%2520Analogues%2520Reveals%2520That%2520the%2520Medium%2520Ring%2520Can%2520Significantly%2520Modulate%2520Biological%2520Activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26issue%3D13%26spage%3D2590%26epage%3D2593%26doi%3D10.1039%2Fc2ob25065a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, E. S.</span></span> <span> </span><span class="NLM_article-title">High-Dose Nicotinamide Suppresses ROS Generation and Augments Population Expansion during CD8 + T Cell Activation</span>. <i>Mol. Cells</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.14348/molcells.2015.0168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.14348%2Fmolcells.2015.0168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26442863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFCjsbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2015&pages=918-924&issue=10&author=H.+J.+Choiauthor=S.+Jangauthor=E.+S.+Hwang&title=High-Dose+Nicotinamide+Suppresses+ROS+Generation+and+Augments+Population+Expansion+during+CD8+%2B+T+Cell+Activation&doi=10.14348%2Fmolcells.2015.0168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">High-dose nicotinamide suppresses reactive oxygen species (ROS) generation and augments population expansion during CD8+ T cell activation</span></div><div class="casAuthors">Choi, Ho Jin; Jang, So-Young; Hwang, Eun Seong</div><div class="citationInfo"><span class="NLM_cas:title">Molecules and Cells</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">918-924</span>CODEN:
                <span class="NLM_cas:coden">MOCEEK</span>;
        ISSN:<span class="NLM_cas:issn">1016-8478</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Molecular and Cellular Biology</span>)
        </div><div class="casAbstract">During T cell activation, mitochondrial content increases to meet the high energy demand of rapid cell proliferation.  With this increase, the level of reactive oxygen species (ROS) also increases and causes the rapid apoptotic death of activated cells, thereby facilitating T cell homeostasis.  Nicotinamide (NAM) has previously been shown to enhance mitochondria quality and extend the replicative life span of human fibroblasts.  In this study, the authors examd. the effect of NAM on CD8+ T cell activation.  NAM treatment attenuated the increase of mitochondrial content and ROS in T cells activated by CD3/CD28 antibodies.  This was accompanied by an accelerated and higher-level clonal expansion resulting from attenuated apoptotic death but not increased division of the activated cells.  Attenuation of ROS-triggered pro-apoptotic events and upregulation of Bcl-2 expression appeared to be involved.  Although cells activated in the presence of NAM exhibited compromised cytokine gene expression, the results suggest a means to augment the size of T cell expansion during activation without consuming their limited replicative potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZTDQ7kl77LVg90H21EOLACvtfcHk0ljEYTzto7RStQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFCjsbrF&md5=5891355837032c9b5dd09c8d1e6ccd06</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.14348%2Fmolcells.2015.0168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14348%252Fmolcells.2015.0168%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DJang%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DE.%2BS.%26atitle%3DHigh-Dose%2520Nicotinamide%2520Suppresses%2520ROS%2520Generation%2520and%2520Augments%2520Population%2520Expansion%2520during%2520CD8%2520%252B%2520T%2520Cell%2520Activation%26jtitle%3DMol.%2520Cells%26date%3D2015%26volume%3D38%26issue%3D10%26spage%3D918%26epage%3D924%26doi%3D10.14348%2Fmolcells.2015.0168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sikora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szajerski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piotrowski, Ł.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielonka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ã, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerzy, G.</span></span> <span> </span><span class="NLM_article-title">Radical Scavenging Properties of Nicotinamide and Its Metabolites</span>. <i>Radiat. Phys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/j.radphyschem.2007.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.radphyschem.2007.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKrs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2008&pages=259-266&issue=3&author=A.+Sikoraauthor=P.+Szajerskiauthor=%C5%81.+Piotrowskiauthor=J.+Zielonkaauthor=J.+Adamusauthor=A.+M.+%C3%83author=G.+Jerzy&title=Radical+Scavenging+Properties+of+Nicotinamide+and+Its+Metabolites&doi=10.1016%2Fj.radphyschem.2007.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Radical scavenging properties of nicotinamide and its metabolites</span></div><div class="casAuthors">Sikora, Adam; Szajerski, Piotr; Piotrowski, Lukasz; Zielonka, Jacek; Adamus, Jan; Marcinek, Andrzej; Gebicki, Jerzy</div><div class="citationInfo"><span class="NLM_cas:title">Radiation Physics and Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">259-266</span>CODEN:
                <span class="NLM_cas:coden">RPCHDM</span>;
        ISSN:<span class="NLM_cas:issn">0969-806X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">By means of pulse radiolysis the reactivity of nicotinamide, its metabolites and selected pyridinium salts towards reactive oxygen species was tested and compared with the pharmacol. efficacy of this group of compds.  It was found that pyridinium salts are poor radical scavengers but the pos. charge distribution enhances their interactions with immobilized heparin.  Thus, superior pharmacol. efficacy of 1-methylnicotinamide may be related to its ability to interact with biol. tissues rather than to its direct antioxidant properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBTYJgRId2ZbVg90H21EOLACvtfcHk0ljPIqqoz4P0WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKrs7rP&md5=c225e3c0dbea3f5ef98a1c2f5bf2af5b</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.radphyschem.2007.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.radphyschem.2007.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DSikora%26aufirst%3DA.%26aulast%3DSzajerski%26aufirst%3DP.%26aulast%3DPiotrowski%26aufirst%3D%25C5%2581.%26aulast%3DZielonka%26aufirst%3DJ.%26aulast%3DAdamus%26aufirst%3DJ.%26aulast%3D%25C3%2583%26aufirst%3DA.%2BM.%26aulast%3DJerzy%26aufirst%3DG.%26atitle%3DRadical%2520Scavenging%2520Properties%2520of%2520Nicotinamide%2520and%2520Its%2520Metabolites%26jtitle%3DRadiat.%2520Phys.%2520Chem.%26date%3D2008%26volume%3D77%26issue%3D3%26spage%3D259%26epage%3D266%26doi%3D10.1016%2Fj.radphyschem.2007.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeoun, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, E. S.</span></span> <span> </span><span class="NLM_article-title">Molecules and Cells Modulation of Mitochondrial Membrane Potential and ROS Generation by Nicotinamide in a Manner Independent of SIRT1 and Mitophagy</span>. <i>Mol. Cells</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">514</span>, <span class="refDoi"> DOI: 10.14348/molcells.2017.0081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.14348%2Fmolcells.2017.0081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28736426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOhu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2017&pages=503-514&issue=7&author=S.+B.+Songauthor=S.+Jangauthor=H.+T.+Kangauthor=B.+Weiauthor=U.+Jeounauthor=G.+S.+Yoonauthor=E.+S.+Hwang&title=Molecules+and+Cells+Modulation+of+Mitochondrial+Membrane+Potential+and+ROS+Generation+by+Nicotinamide+in+a+Manner+Independent+of+SIRT1+and+Mitophagy&doi=10.14348%2Fmolcells.2017.0081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of mitochondrial membrane potential and ROS generation by nicotinamide in a manner independent of SIRT1 and mitophagy</span></div><div class="casAuthors">Song, Seon Beom; Jang, So-Young; Kang, Hyun Tae; Wei, Bie; Jeoun, Un-woo; Yoon, Gye Soon; Hwang, Eun Seong</div><div class="citationInfo"><span class="NLM_cas:title">Molecules and Cells</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">503-514</span>CODEN:
                <span class="NLM_cas:coden">MOCEEK</span>;
        ISSN:<span class="NLM_cas:issn">1016-8478</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Molecular and Cellular Biology</span>)
        </div><div class="casAbstract">Nicotinamide (NAM) plays essential roles in physiol. through facilitating NAD+ redox homeostasis.  Importantly, at high doses, it protects cells under oxidative stresses, and has shown therapeutic effectiveness in a variety of disease conditions.  In our previous studies, NAM lowered reactive oxygen species (ROS) levels and extended cellular life span in primary human cells.  In the treated cells, levels of NAD+/NADH and SIRT1 activity increased, while mitochondrial content decreased through autophagy activation.  The remaining mitochondria were marked with low superoxide levels and high membrane potentials (Δψm); we posited that the treatment of NAM induced an activation of mitophagy that is selective for depolarized mitochondria, which produce high levels of ROS.  However, evidence for the selective mitophagy that is mediated by SIRT1 has never been provided.  This study sought to explain the mechanisms by which NAM lowers ROS levels and increases Δψm.  Our results showed that NAM and SIRT1 activation exert quite different effects on mitochondrial physiol.  Furthermore, the changes in ROS and Δψm were not found to be mediated through autophagy or SIRT activation.  Rather, NAM suppressed superoxide generation via a direct redn. of electron transport, and increased Δψm via suppression of mitochondrial permeability transition pore formation.  Our results dissected the effects of cellular NAD+ redox modulation, and emphasized the importance of the NAD+/NADH ratio in the mitochondria as well as the cytosol in maintaining mitochondrial quality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw5qivlQwOIrVg90H21EOLACvtfcHk0ljPIqqoz4P0WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOhu7zK&md5=731eac70b949226a5035861c47bd12bc</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.14348%2Fmolcells.2017.0081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14348%252Fmolcells.2017.0081%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DS.%2BB.%26aulast%3DJang%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DH.%2BT.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DJeoun%26aufirst%3DU.%26aulast%3DYoon%26aufirst%3DG.%2BS.%26aulast%3DHwang%26aufirst%3DE.%2BS.%26atitle%3DMolecules%2520and%2520Cells%2520Modulation%2520of%2520Mitochondrial%2520Membrane%2520Potential%2520and%2520ROS%2520Generation%2520by%2520Nicotinamide%2520in%2520a%2520Manner%2520Independent%2520of%2520SIRT1%2520and%2520Mitophagy%26jtitle%3DMol.%2520Cells%26date%3D2017%26volume%3D40%26issue%3D7%26spage%3D503%26epage%3D514%26doi%3D10.14348%2Fmolcells.2017.0081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maoka, T.</span></span> <span> </span><span class="NLM_article-title">Reaction and Scavenging Mechanism of β -Carotene and Zeaxanthin with Reactive Oxygen Species</span>. <i>J. Oleo Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.5650/jos.ess16107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.5650%2Fjos.ess16107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27928140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosVCjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=77-84&issue=1&author=A.+Nishinoauthor=H.+Yasuiauthor=T.+Maoka&title=Reaction+and+Scavenging+Mechanism+of+%CE%B2+-Carotene+and+Zeaxanthin+with+Reactive+Oxygen+Species&doi=10.5650%2Fjos.ess16107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction and scavenging mechanism of β-carotene and zeaxanthin with reactive oxygen species</span></div><div class="casAuthors">Nishino, Azusa; Yasui, Hiroyuki; Maoka, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Oleo Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">JOSOAP</span>;
        ISSN:<span class="NLM_cas:issn">1345-8957</span>.
    
            (<span class="NLM_cas:orgname">Japan Oil Chemists' Society</span>)
        </div><div class="casAbstract">In order to investigate chem. scavenging mechanism of singlet oxygen, superoxide anion radical, and hydroxyl radical by carotenoids, reaction products obtained by reacting β-carotene or zeaxanthin with singlet oxygen, superoxide anion radical, and hydroxyl radical were analyzed by LC/PDA ESI-MS, and ESR spectrometry. β-Carotene endoperoxides were identified as the major reaction products of β-carotene and singlet oxygen, while β-carotene epoxides were the major reaction products of β-carotene and superoxide anion or hydroxyl radical.  Similar results to those for β-carotene were obtained with zeaxanthin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkHE3oy4J6qbVg90H21EOLACvtfcHk0li2-SrWTN8k1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosVCjtL8%253D&md5=73fe8d0d52aaf63eb00a09c39b46126b</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.5650%2Fjos.ess16107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5650%252Fjos.ess16107%26sid%3Dliteratum%253Aachs%26aulast%3DNishino%26aufirst%3DA.%26aulast%3DYasui%26aufirst%3DH.%26aulast%3DMaoka%26aufirst%3DT.%26atitle%3DReaction%2520and%2520Scavenging%2520Mechanism%2520of%2520%25CE%25B2%2520-Carotene%2520and%2520Zeaxanthin%2520with%2520Reactive%2520Oxygen%2520Species%26jtitle%3DJ.%2520Oleo%2520Sci.%26date%3D2017%26volume%3D66%26issue%3D1%26spage%3D77%26epage%3D84%26doi%3D10.5650%2Fjos.ess16107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, S.</span></span> <span> </span><span class="NLM_article-title">Anti-Inflammatory Activity of β-Carotene, Lycopene and Tri- n -Butylborane, a Scavenger of Reactive Oxygen Species</span>. <i>In Vivo (Brooklyn)</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.21873/invivo.11232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.21873%2Finvivo.11232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=255-264&author=A.+Kawataauthor=Y.+Murakamiauthor=S.+Suzukiauthor=S.+Fujisawa&title=Anti-Inflammatory+Activity+of+%CE%B2-Carotene%2C+Lycopene+and+Tri-+n+-Butylborane%2C+a+Scavenger+of+Reactive+Oxygen+Species&doi=10.21873%2Finvivo.11232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.21873%2Finvivo.11232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Finvivo.11232%26sid%3Dliteratum%253Aachs%26aulast%3DKawata%26aufirst%3DA.%26aulast%3DMurakami%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DFujisawa%26aufirst%3DS.%26atitle%3DAnti-Inflammatory%2520Activity%2520of%2520%25CE%25B2-Carotene%252C%2520Lycopene%2520and%2520Tri-%2520n%2520-Butylborane%252C%2520a%2520Scavenger%2520of%2520Reactive%2520Oxygen%2520Species%26jtitle%3DIn%2520Vivo%2520%2528Brooklyn%2529%26date%3D2018%26volume%3D32%26spage%3D255%26epage%3D264%26doi%3D10.21873%2Finvivo.11232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varma, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devamanoharan, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A. H.</span></span> <span> </span><span class="NLM_article-title">Prevention of Intracellular Oxidative Stress to Lens by Pyruvate and Its Ester</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.3109/10715769809065799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3109%2F10715769809065799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=9645390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFemu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1998&pages=131-135&issue=2&author=S.+D.+Varmaauthor=P.+S.+Devamanoharanauthor=A.+H.+Ali&title=Prevention+of+Intracellular+Oxidative+Stress+to+Lens+by+Pyruvate+and+Its+Ester&doi=10.3109%2F10715769809065799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of intracellular oxidative stress to lens by pyruvate and its ester</span></div><div class="casAuthors">Varma, S. D.; Devamanoharan, P. S.; Ali, A. H.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-135</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">Pyruvate is a well-known scavenger of hydrogen peroxide (H2O2).  In addn., it scavenges superoxide radical (O2•-).  However, evidence on its intracellular antioxidant function is meager at present.  Hence, we have examd. the effectiveness of this metabolite and its Et ester against intracellular oxidative damage to the lens under organ culture.  Menadione, a redoxcycling quinone, was used to generate the reactive oxygen species (ROS).  It was found to inhibit lens metab. as evidenced by a decrease of ATP.  Addnl., tissue oxidn. was apparent by loss of glutathione (GSH), and increase in the level of oxidized glutathione (GSSG), coupled with increase of the urea sol. proteins (water insol.).  The overall-physiol. damage was apparent by the inhibition of the Na+-K+-ATPase dependent cation pump, as evidenced by a decreased rubidium transport.  These deleterious effects were attenuated by pyruvate and ethyl-pyruvate.  The later was found to be more effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlliR_5xl66rVg90H21EOLACvtfcHk0li2-SrWTN8k1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFemu78%253D&md5=ebbfd3a28f9c2a0845a4cab9e0c41c05</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.3109%2F10715769809065799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715769809065799%26sid%3Dliteratum%253Aachs%26aulast%3DVarma%26aufirst%3DS.%2BD.%26aulast%3DDevamanoharan%26aufirst%3DP.%2BS.%26aulast%3DAli%26aufirst%3DA.%2BH.%26atitle%3DPrevention%2520of%2520Intracellular%2520Oxidative%2520Stress%2520to%2520Lens%2520by%2520Pyruvate%2520and%2520Its%2520Ester%26jtitle%3DFree%2520Radical%2520Res.%26date%3D1998%26volume%3D28%26issue%3D2%26spage%3D131%26epage%3D135%26doi%3D10.3109%2F10715769809065799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crestanello, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamelgard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitman, G. J. R.</span></span> <span> </span><span class="NLM_article-title">The Cumulative Nature of Pyruvate’s Dual Mechanism for Myocardial Protection</span>. <i>J. Surg. Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1006/jsre.1995.1154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1006%2Fjsre.1995.1154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=7630128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2MXotFGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1995&pages=198-204&author=J.+A.+Crestanelloauthor=J.+Kamelgardauthor=G.+J.+R.+Whitman&title=The+Cumulative+Nature+of+Pyruvate%E2%80%99s+Dual+Mechanism+for+Myocardial+Protection&doi=10.1006%2Fjsre.1995.1154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">The cumulative nature of pyruvate's dual mechanism for myocardial protection</span></div><div class="casAuthors">Crestanello, Juan A.; Kamelgard, Joseph; Whitman, Glenn J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Surgical Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">JSGRA2</span>;
        ISSN:<span class="NLM_cas:issn">0022-4804</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Pyruvate (PYR) supplementation protects myocardium from ischemia reperfusion injury.  This study was designed to characterize and quantify the mechanism underlying this protection: specifically whether this ability resides in PYR's metabolic effect or in its antioxidant effect.  Isolated perfused rat hearts (/group) were subjected to 15 min of equilibration (EQ), 25 min of ischemia, and 10 min of reperfusion (RP).  Glucose was the sole metabolic substrate (Control) or was supplemented with PYR (5 mM) during (a) EQ only (PYREQ group), (b) RP only (PYRRP group), or (c) EQ and RP (PYREQ-RP group).  Left ventricular developed pressure (DP) and ± dP/dt were recorded throughout the expt.  ATP concns. and intracellular pH were detd. by 31P NMR spectroscopy.  Myocardial creatine kinase (CK) activity was assayed at end EQ and end RP.  In vitro, purified CK was assayed and, after exposure to H2O2 (200 μM) and increasing concns. of PYR (0-6 mM) for 10 min, reassayed to det. the antioxidant effect of PYR.  In all cases PYR improved recovery of mech. function at end RP (DP: Control, 11%; PYRRP, 23%; PYREQ, 34%; PYREQ-RP, 53%; between all groups and Control).  Ischemic contracture was delayed in hearts that received PYR during EQ (PYREQ and PYREQ-RP: 17.8 vs 12.5 min).  PYR during EQ (PYREQ and PYREQ-RP) led to higher end ischemic ATP levels (32% vs 14%) and a more acidic end ischemic pH (5.92 vs 5.98 in Control and PYRRP).  PYREQ-RP showed the highest end reperfusion ATP levels (55% vs 38%, vs other groups).  PYR during reperfusion (PYREQ-RP and PYRRP) showed more end reperfusion CK activity (501 IU/gV vs 446 IU/gV).  In vitro, CK exposure to H2O2 abolished 65% of its activity, while in the presence of PYR 6 mM it abolished only 9%.  The authors conclude that PYR given during EQ stimulates anaerobic glycolysis during ischemia as seen by the lower pH and higher end ischemic ATP with a correlative delay in onset of contracture and improvement in DP at end RP.  PYR during RP protects CK from hydrogen peroxide-induced inactivation and improves recovery of function.  PYR given during EQ and RP has a cumulative effect leading to an even greater recovery of function.  PYR must be present both prior to ischemia and during reperfusion for best utilization of its metabolic and antioxidant effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6pKgNmE6VILVg90H21EOLACvtfcHk0lgg4NveYpeoEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotFGntL8%253D&md5=dfae633e6c5882493e1cec6fa5fe6e80</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1006%2Fjsre.1995.1154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjsre.1995.1154%26sid%3Dliteratum%253Aachs%26aulast%3DCrestanello%26aufirst%3DJ.%2BA.%26aulast%3DKamelgard%26aufirst%3DJ.%26aulast%3DWhitman%26aufirst%3DG.%2BJ.%2BR.%26atitle%3DThe%2520Cumulative%2520Nature%2520of%2520Pyruvate%25E2%2580%2599s%2520Dual%2520Mechanism%2520for%2520Myocardial%2520Protection%26jtitle%3DJ.%2520Surg.%2520Res.%26date%3D1995%26volume%3D59%26spage%3D198%26epage%3D204%26doi%3D10.1006%2Fjsre.1995.1154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavallini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigobello, M. P.</span></span> <span> </span><span class="NLM_article-title">The Protective Action of Pyruvate on Recovery of Ischemic Rat Heart: Comparison with Other Oxidizable Substrates</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/0022-2828(90)91111-J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2F0022-2828%2890%2991111-J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=2182887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK3cXktFOlt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1990&pages=143-154&issue=2&author=L.+Cavalliniauthor=M.+Valenteauthor=M.+P.+Rigobello&title=The+Protective+Action+of+Pyruvate+on+Recovery+of+Ischemic+Rat+Heart%3A+Comparison+with+Other+Oxidizable+Substrates&doi=10.1016%2F0022-2828%2890%2991111-J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The protective action of pyruvate on recovery of ischemic rat heart:  comparison with other oxidizable substrates</span></div><div class="casAuthors">Cavallini, Lucia; Valente, Marina; Rigobello, Maria Pia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-54</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    </div><div class="casAbstract">The recovery of both contractile performance and metabolic response of rat heart following 1 h of ischemia after equil. with glucose + insulin (glucose-ischemia) or with pyruvate (pyruvate-ischemia), was tested in nontoxic reperfusion in the presence of glucose + insulin, pyruvate, lactate, or acetate.  In glucose-ischemia only reperfusion with pyruvate results in a complete recovery of the contractile force (left ventricular pressure, LVP) (170%) and good recovery of high-energy phosphate compds.  Lower LVP and tissue energy charge were found in glucose reperfusion and even less in lactate and acetate reperfusion.  Disappearance of the IMP accumulated during ischemia is evident only in the pyruvate reperfusion indicating a higher metabolic recovery.  On the contrary, in pyruvate-ischemia all types of reperfusion tested were effective in reactivating the contractile force (acetate to a lesser extent); the contractile activity was accompanied by a good recovery of phosphocreatine, ATP, energy charge and by the decrease of IMP.  Large decreases of adenine nucleotides and NADP and lower decreases of NAD are obsd. during ischemia/reperfusion in both systems.  Pyruvate-ischemia is quite similar to, if not worse than glucose-ischemia, for all the metabolic parameters considered, but not worse for the possibility of recovery.  Some specific effect of pyruvate should be exerted during the ischemic phase.  The mechanism of pyruvate protection is discussed in relationship to: (i) the possible activation of pyruvate dehydrogenase, (ii) the activation of NADPH-dependent peroxide scavenging systems, and (iii) the direct scavenging action of pyruvate on H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQUSPZ0fUTZrVg90H21EOLACvtfcHk0lgg4NveYpeoEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktFOlt7c%253D&md5=4612a230405485d9570a1cfba1f7b7a8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2F0022-2828%2890%2991111-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2828%252890%252991111-J%26sid%3Dliteratum%253Aachs%26aulast%3DCavallini%26aufirst%3DL.%26aulast%3DValente%26aufirst%3DM.%26aulast%3DRigobello%26aufirst%3DM.%2BP.%26atitle%3DThe%2520Protective%2520Action%2520of%2520Pyruvate%2520on%2520Recovery%2520of%2520Ischemic%2520Rat%2520Heart%253A%2520Comparison%2520with%2520Other%2520Oxidizable%2520Substrates%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D1990%26volume%3D22%26issue%3D2%26spage%3D143%26epage%3D154%26doi%3D10.1016%2F0022-2828%2890%2991111-J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, K.</span></span> <span> </span><span class="NLM_article-title">Free-Radical Scavenger Edaravone Inhibits Both Formation and Development of Abdominal Aortic Aneurysm in Rats</span>. <i>J. Vasc. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1749</span>– <span class="NLM_lpage">1758</span>, <span class="refDoi"> DOI: 10.1016/j.jvs.2011.11.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.jvs.2011.11.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22341578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC38vjt1KhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1749-1758&issue=6&author=K.+Morimotoauthor=T.+Hasegawaauthor=A.+Tanakaauthor=B.+Wulanauthor=N.+Morimotoauthor=Y.+Okitaauthor=K.+Okada&title=Free-Radical+Scavenger+Edaravone+Inhibits+Both+Formation+and+Development+of+Abdominal+Aortic+Aneurysm+in+Rats&doi=10.1016%2Fj.jvs.2011.11.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats</span></div><div class="casAuthors">Morimoto Keisuke; Hasegawa Tomomi; Tanaka Akiko; Wulan Bao; Yu Jie; Morimoto Naoto; Okita Yutaka; Okada Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of vascular surgery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1749-58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  An ideal pharmaceutical treatment for abdominal aortic aneurysm (AAA) is to prevent aneurysm formation and development (further dilatation of pre-existing aneurysm).  Recent studies have reported that oxidative stress with reactive oxygen species (ROS) is crucial in aneurysm formation.  We hypothesized that edaravone, a free-radical scavenger, would attenuate vascular oxidative stress and inhibit AAA formation and development.  METHODS:  An AAA model induced with intraluminal elastase and extraluminal calcium chloride was created in 42 rats.  Thirty-six rats were divided three groups: a low-dose (group LD; 1 mg/kg/d), high-dose (group HD; 5 mg/kg/d), and control (group C, saline).  Edaravone or saline was intraperitoneally injected twice daily, starting 30 minutes before aneurysm preparation.  The remaining six rats (group DA) received a delayed edaravone injection (5 mg/kg/d) intraperitoneally, starting 7 days after aneurysm preparation to 28 days.  AAA dilatation ratio was calculated.  Pathologic examination was performed.  ROS expression was semi-quantified by dihydroethidium staining and the oxidative product of DNA induced by ROS, 8-hydroxydeoxyguanosine (8-OHdG), by immunohistochemical staining.  RESULTS:  At day 7, ROS expression and 8-OHdG-positive cells in aneurysm walls were decreased by edaravone treatment (ROS expression: 3.0 ± 0.5 in group LD, 1.7 ± 0.3 in group HD, and 4.8 ± 0.7 in group C; 8-OHdG-positive cells: 106.2 ± 7.8 cells in group LD, 64.5 ± 7.7 cells in group HD, and 136.6 ± 7.4 cells in group C; P < .0001), compared with group C.  Edaravone treatment significantly reduced messenger RNA expressions of cytokines and matrix metalloproteinases (MMPs) in aneurysm walls (MMP-2: 1.1 ± 0.5 in group LD, 0.6 ± 0.1 in group HD, and 2.3 ± 0.4 in group C; P < .001; MMP-9: 1.2 ± 0.1 in group LD, 0.2 ± 0.6 in group HD, and 2.4 ± 0.2 in group C; P < .001).  At day 28, aortic walls in groups LD and HD were less dilated, with increased wall thickness and elastin content than those in group C (dilatation ratio: 204.7% ± 16.0% in group C, 156.5% ± 6.6% in group LD, 136.7% ± 2.0% in group HD; P < .0001).  Delayed edaravone administration significantly prevented further aneurysm dilatation, with increased elastin content (155.2% ± 2.9% at day 7, 153.1% ± 11.6% at day 28; not significant).  CONCLUSIONS:  Edaravone inhibition of ROS can prevent aneurysm formation and expansion in the rat AAA model.  Free-radical scavenger edaravone might be an effective pharmaceutical agent for AAA in clinical practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVTCC_7r7pdr5XHngOXiV_fW6udTcc2ebTaO_NxrUNNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vjt1KhsQ%253D%253D&md5=34990b19b8ccc121d05d966c38cb45ac</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.jvs.2011.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jvs.2011.11.059%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DWulan%26aufirst%3DB.%26aulast%3DMorimoto%26aufirst%3DN.%26aulast%3DOkita%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DK.%26atitle%3DFree-Radical%2520Scavenger%2520Edaravone%2520Inhibits%2520Both%2520Formation%2520and%2520Development%2520of%2520Abdominal%2520Aortic%2520Aneurysm%2520in%2520Rats%26jtitle%3DJ.%2520Vasc.%2520Surg.%26date%3D2012%26volume%3D55%26issue%3D6%26spage%3D1749%26epage%3D1758%26doi%3D10.1016%2Fj.jvs.2011.11.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inokuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimazawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, H.</span></span> <span> </span><span class="NLM_article-title">Edaravone, a Free Radical Scavenger, Protects against Retinal Damage in Vitro and in Vivo</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>329</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.148676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1124%2Fjpet.108.148676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=19201991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Ols7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=687-698&issue=2&author=Y.+Inokuchiauthor=S.+Imaiauthor=Y.+Nakajimaauthor=M.+Shimazawaauthor=M.+Aiharaauthor=M.+Araieauthor=H.+Hara&title=Edaravone%2C+a+Free+Radical+Scavenger%2C+Protects+against+Retinal+Damage+in+Vitro+and+in+Vivo&doi=10.1124%2Fjpet.108.148676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo</span></div><div class="casAuthors">Inokuchi, Yuta; Imai, Shunsuke; Nakajima, Yoshimi; Shimazawa, Masamitsu; Aihara, Makoto; Araie, Makoto; Hara, Hideaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">687-698</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a free radical scavenger, is used for the treatment of acute cerebral infarction.  In this study, we investigated whether edaravone is neuroprotective against retinal damage.  In vitro, we used a radical-scavenging capacity assay using reactive oxygen species-sensitive probes to investigate the effects of edaravone on H2O2, superoxide anion (O-·2), and hydroxyl radical (·OH) prodn. in a rat retinal ganglion cell line (RGC-5).  The effect of edaravone on oxygen-glucose deprivation (OGD)-induced RGC-5 damage was evaluated using a 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt assay of cell viability.  Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) significantly decreased radical generation and reduced the cell death induced by OGD stress.  In vivo, retinal damage was induced by intravitreous injection of N-methyl-D-aspartate (NMDA; 5 nmol) and was evaluated by examg. ganglion cell layer cell loss, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining, and the expressions of two oxidant-stress markers [4-hydroxy-2-nonenal (4-HNE) and 8-hydroxy-2-deoxyguanosine (8-OHdG)].  In addn., activations of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated protein kinases (ERK), c-Jun N-terminal kinases (JNK), and p38 MAPK], as downstream signal pathways after NMDA receptor activation, were measured using immunoblotting and immunostaining.  Edaravone at 5 and 50 nmol intravitreous injection or at 1 and 3 mg/kg i.v. significantly protected against NMDA-induced retinal cell death.  At 50 nmol intravitreous injection, it (1) decreased the retinal expressions of TUNEL-pos. cells, 4-HNE, and 8-OHdG and (2) reduced the retinal expressions of NMDA-induced phosphorylated JNK and phosphorylated p38 but not that of phosphorylated ERK.  These findings suggest that oxidative stress plays a pivotal role in retinal damage and that edaravone may be a candidate for the effective treatment of retinal diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZo0jj-UiqXbVg90H21EOLACvtfcHk0lhPaITy5K_hDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Ols7s%253D&md5=3e52d4762a0395cb3411fb646e0435d6</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.148676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.148676%26sid%3Dliteratum%253Aachs%26aulast%3DInokuchi%26aufirst%3DY.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DShimazawa%26aufirst%3DM.%26aulast%3DAihara%26aufirst%3DM.%26aulast%3DAraie%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DH.%26atitle%3DEdaravone%252C%2520a%2520Free%2520Radical%2520Scavenger%252C%2520Protects%2520against%2520Retinal%2520Damage%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26issue%3D2%26spage%3D687%26epage%3D698%26doi%3D10.1124%2Fjpet.108.148676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todo, S.</span></span> <span> </span><span class="NLM_article-title">The Novel Antioxidant Edaravone: From Bench to Bedside</span>. <i>Cardiovasc. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1111/j.1527-3466.2008.00041.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fj.1527-3466.2008.00041.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18485133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFGnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=101-114&issue=2&author=T.+Watanabeauthor=M.+Taharaauthor=S.+Todo&title=The+Novel+Antioxidant+Edaravone%3A+From+Bench+to+Bedside&doi=10.1111%2Fj.1527-3466.2008.00041.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">The novel antioxidant edaravone: from bench to bedside</span></div><div class="casAuthors">Watanabe, Toshiaki; Tahara, Munenori; Todo, Satoru</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-114</span>CODEN:
                <span class="NLM_cas:coden">CTAHCA</span>;
        ISSN:<span class="NLM_cas:issn">1755-5914</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Over the last decade, important advances have been made to support the fact that reactive oxygen species (ROS) are generated and play a harmful role during the acute and late stages of cerebral ischemia.  Several drugs, such as radical scavengers and antioxidants, have been evaluated in preclin. and clin. studies.  Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one; Radicut, Mitsubishi Tanabe Pharma Corporation) is a novel antioxidant that is currently used in Japan for the treatment of patients in the acute stage of cerebral infarction.  Edaravone scavenges ROS and inhibits proinflammatory responses after brain ischemia in animals and humans.  In particular, postischemic inflammation, leading to brain edema and infarction due to neuronal damage and endothelial cell death, can be ameliorated by edaravone.  In addn. to these antistroke effects, edaravone has also been shown to prevent oxidative damage to various extracerebral organs.  Therefore, in addn. to its usefulness in the treatment of stroke, edaravone is expected to play an integral role in the treatment of many oxidative stress-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGors8VWWQ0eL7Vg90H21EOLACvtfcHk0lhPaITy5K_hDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFGnsbs%253D&md5=f755fd3e59771a75e91140707738f6af</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3466.2008.00041.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3466.2008.00041.x%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DTahara%26aufirst%3DM.%26aulast%3DTodo%26aufirst%3DS.%26atitle%3DThe%2520Novel%2520Antioxidant%2520Edaravone%253A%2520From%2520Bench%2520to%2520Bedside%26jtitle%3DCardiovasc.%2520Ther.%26date%3D2008%26volume%3D26%26issue%3D2%26spage%3D101%26epage%3D114%26doi%3D10.1111%2Fj.1527-3466.2008.00041.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwahara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span> <span> </span><span class="NLM_article-title">Antioxidant Activity of 3-Methyl-1-Phenyl-2-Pyrazolin-5-One</span>. <i>Redox Rep.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">338</span>, <span class="refDoi"> DOI: 10.1080/13510002.1996.11747069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1080%2F13510002.1996.11747069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27406414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2sXjsl2qtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=333-338&issue=5&author=Y.+Yamamotoauthor=T.+Kuwaharaauthor=K.+Watanabeauthor=K.+Watanabe&title=Antioxidant+Activity+of+3-Methyl-1-Phenyl-2-Pyrazolin-5-One&doi=10.1080%2F13510002.1996.11747069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one</span></div><div class="casAuthors">Yamamoto, Y.; Kuwahara, T.; Watanabe, K.; Watanabe, K.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Report</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">333-338</span>CODEN:
                <span class="NLM_cas:coden">RDRPE4</span>;
        ISSN:<span class="NLM_cas:issn">1351-0002</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">The antioxidant activity of an anti-ischemic agent, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), was examd.  The pKa value of MCI-186 is 7.0 and the rate of oxidn. of MCI-186 initiated with an azo compd. increased with increasing pH, suggesting that the anionic from of MCI-186 is much more reactive than the non-ionic form.  The major products were 3-methyl-1-phenyl-2-pyrazolin-4,5-dione and 2-oxo-3-(phenylhydrazono)-butanoic acid (OPB).  Hydrolysis of 4,5-dione gave OPB.  The minor intermediate product was 4-hydroxy-4-(3-methyl-1-phenyl-1H-pyrazolin-5-on-4-yl)-3-methyl-1-phenyl-1H-pyrazolin-5-one (BPOH).  The nucleophilic attack of the anionic form of MCI-186 to 4,5-dione is likely to give BPOH.  MCI-186 (50 μM) inhibited the aerobic oxidn. at 37° of 5.2 mM unilamellar soybean phosphatidylcholine (PC) liposomal membranes, initiated with a water-sol. initiator, as efficiently as did ascorbate (100 μM).  MCI-186 (50 μM) also inhibited the oxidn. of the same PC liposomal membranes, this time initiated with a lipid-sol. initiator, almost as efficiently as did α-tocopherol (2 μM).  Furthermore, the combination of MCI-186 with ascorbate or α-tocopherol showed almost complete inhibition of PC oxidn. induced by both initiators.  These data suggest that MCI-186 may work as a good antioxidant in cellular systems as well as in cell-free systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPVPWkUubv07Vg90H21EOLACvtfcHk0lhPaITy5K_hDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsl2qtg%253D%253D&md5=83089f672dfc8b58e5c406f3f9fd4510</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1080%2F13510002.1996.11747069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13510002.1996.11747069%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuwahara%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DK.%26atitle%3DAntioxidant%2520Activity%2520of%25203-Methyl-1-Phenyl-2-Pyrazolin-5-One%26jtitle%3DRedox%2520Rep.%26date%3D1996%26volume%3D2%26issue%3D5%26spage%3D333%26epage%3D338%26doi%3D10.1080%2F13510002.1996.11747069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ezerina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezerin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T. P.</span></span> <span> </span><span class="NLM_article-title">N-Acetyl Cysteine Functions as a Fast-Acting Antioxidant by Triggering Intracellular H2S and Sulfane Sulfur Production</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2018.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.chembiol.2018.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29429900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFehtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=447-459&issue=4&author=D.+Ezerinaauthor=Y.+Takanoauthor=K.+Hanaokaauthor=Y.+Uranoauthor=T.+P.+Dickauthor=D.+Ezerinauthor=Y.+Takanoauthor=K.+Hanaokaauthor=Y.+Uranoauthor=T.+P.+Dick&title=N-Acetyl+Cysteine+Functions+as+a+Fast-Acting+Antioxidant+by+Triggering+Intracellular+H2S+and+Sulfane+Sulfur+Production&doi=10.1016%2Fj.chembiol.2018.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">N-Acetyl Cysteine Functions as a Fast-Acting Antioxidant by Triggering Intracellular H2S and Sulfane Sulfur Production</span></div><div class="casAuthors">Ezerina, Daria; Takano, Yoko; Hanaoka, Kenjiro; Urano, Yasuteru; Dick, Tobias P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">447-459.e4</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The cysteine prodrug N-acetyl cysteine (NAC) is widely used as a pharmacol. antioxidant and cytoprotectant.  It has been reported to lower endogenous oxidant levels and to protect cells against a wide range of pro-oxidative insults.  As NAC itself is a poor scavenger of oxidants, the mol. mechanisms behind the antioxidative effects of NAC have remained uncertain.  Here we show that NAC-derived cysteine is desulfurated to generate hydrogen sulfide, which in turn is oxidized to sulfane sulfur species, predominantly within mitochondria.  We provide evidence suggesting the possibility that sulfane sulfur species produced by 3-mercaptopyruvate sulfurtransferase and sulfide:quinone oxidoreductase are the actual mediators of the immediate antioxidative and cytoprotective effects provided by NAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptxutwGdwRO7Vg90H21EOLACvtfcHk0ljrIka3tlffew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFehtbs%253D&md5=6b3a5d867fcdd84fd3dfce2af4fb86bd</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2018.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2018.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DEzerina%26aufirst%3DD.%26aulast%3DTakano%26aufirst%3DY.%26aulast%3DHanaoka%26aufirst%3DK.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DDick%26aufirst%3DT.%2BP.%26aulast%3DEzerin%26aufirst%3DD.%26aulast%3DTakano%26aufirst%3DY.%26aulast%3DHanaoka%26aufirst%3DK.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DDick%26aufirst%3DT.%2BP.%26atitle%3DN-Acetyl%2520Cysteine%2520Functions%2520as%2520a%2520Fast-Acting%2520Antioxidant%2520by%2520Triggering%2520Intracellular%2520H2S%2520and%2520Sulfane%2520Sulfur%2520Production%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2018%26volume%3D25%26issue%3D4%26spage%3D447%26epage%3D459%26doi%3D10.1016%2Fj.chembiol.2018.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monks, T. J.</span></span> <span> </span><span class="NLM_article-title">The Cytoprotective Effect of N-Acetyl- L -Cysteine against ROS-Induced Cytotoxicity Is Independent of Its Ability to Enhance Glutathione Synthesis</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>120</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfq364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1093%2Ftoxsci%2Fkfq364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=21135414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1eksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2011&pages=87-97&issue=1&author=F.+Zhangauthor=S.+S.+Lauauthor=T.+J.+Monks&title=The+Cytoprotective+Effect+of+N-Acetyl-+L+-Cysteine+against+ROS-Induced+Cytotoxicity+Is+Independent+of+Its+Ability+to+Enhance+Glutathione+Synthesis&doi=10.1093%2Ftoxsci%2Fkfq364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">The Cytoprotective Effect of N-acetyl-L-cysteine against ROS-Induced Cytotoxicity Is Independent of Its Ability to Enhance Glutathione Synthesis</span></div><div class="casAuthors">Zhang, Fengjiao; Lau, Serrine S.; Monks, Terrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-97</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">2,3,5-Tris(glutathion-S-yl)-hydroquinone (TGHQ), a metabolite of hydroquinone, is toxic to renal proximal tubule epithelial cells.  TGHQ retains the ability to redox cycle and create an oxidative stress.  To assist in elucidating the contribution of reactive oxygen species (ROS) to TGHQ-induced toxicity, we detd. whether the antioxidant, N-acetyl-L-cysteine (NAC), could protect human kidney proximal tubule epithelial cells (HK-2 cell line) against TGHQ-induced toxicity.  NAC provided remarkable protection against TGHQ-induced toxicity to HK-2 cells.  NAC almost completely inhibited TGHQ-induced cell death, mitochondrial membrane potential collapse, as well as ROS prodn.  NAC also attenuated TGHQ-induced DNA damage and the subsequent activation of poly (ADP-ribose) polymerase and ATP depletion.  Moreover, NAC significantly attenuated c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase phosphorylation induced by TGHQ.  In contrast, NAC itself markedly increased extracellular regulated kinase 1/2 (ERK1/2) activation, and the upstream mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor, PD-98059, only partially inhibited this activation, suggesting that NAC can directly activate ERK1/2 activity.  However, although NAC is frequently utilized as a glutathione (GSH) precursor, the cytoprotection afforded by NAC in HK-2 cells was not a consequence of increased GSH levels.  We speculate that NAC exerts its protective effect in part by directly scavenging ROS and in part via ERK1/2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWva1NiCpBObVg90H21EOLACvtfcHk0ljrIka3tlffew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1eksb0%253D&md5=dbc9e747382de8570cb883ce2cbf87ff</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq364%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLau%26aufirst%3DS.%2BS.%26aulast%3DMonks%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520Cytoprotective%2520Effect%2520of%2520N-Acetyl-%2520L%2520-Cysteine%2520against%2520ROS-Induced%2520Cytotoxicity%2520Is%2520Independent%2520of%2520Its%2520Ability%2520to%2520Enhance%2520Glutathione%2520Synthesis%26jtitle%3DToxicol.%2520Sci.%26date%3D2011%26volume%3D120%26issue%3D1%26spage%3D87%26epage%3D97%26doi%3D10.1093%2Ftoxsci%2Fkfq364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhim, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-S.</span></span> <span> </span><span class="NLM_article-title">N-Acetylcysteine Induces Cell Cycle Arrest in Hepatic Stellate Cells through Its Reducing Activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">40591</span>– <span class="NLM_lpage">40598</span>, <span class="refDoi"> DOI: 10.1074/jbc.M100975200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.M100975200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11509553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVKhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=40591-40598&issue=44&author=K.-Y.+Kimauthor=T.+Y.+Rhimauthor=I.+Choiauthor=S.-S.+Kim&title=N-Acetylcysteine+Induces+Cell+Cycle+Arrest+in+Hepatic+Stellate+Cells+through+Its+Reducing+Activity&doi=10.1074%2Fjbc.M100975200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">N-Acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity</span></div><div class="casAuthors">Kim, Ki-Yong; Rhim, TaiYoun; Choi, Inpyo; Kim, Soung-Soo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">40591-40598</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Activation of hepatic stellate cells (HSC) has been identified as a crit. step in hepatic fibrogenesis and is regulated by several factors including cytokines and oxidative stress.  However, the mol. mechanism for HSC inactivation is not well understood.  We investigated an N-acetyl-L-cysteine (NAC)-mediated signaling pathway involved in HSC inactivation.  NAC, which acting through its reducing activity, induced cell arrest at G1 via the mitogen-activated protein kinase (MAPK) kinase (MEK)/MAPK pathway in a Ras-independent manner.  The sustained activation of this extracellular signal-regulated kinase induced the expression of p21Cip1/WAF1, a cell cycle-dependent kinase inhibitor, and mediated cell growth arrest through the Sp1 transcription activator-dependent mechanism.  These effects of NAC were all reversed by treatment of HSC with MEK inhibitor PD98059 followed by culturing HSC on type I collagen-coated flasks.  The collagen-mediated suppression of NAC-induced arrest may be due to an overriding of the cell cycle arrest through an acceleration of integrin-induced cell growth.  NAC action is actually dependent on modulating the redox states of cysteine residues of target proteins such as Raf-1, MEK, and ERK.  In conclusion, an understanding of the NAC signaling pathway in HSC should provide the theor. basis for clin. approaches using antioxidant therapies in liver fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS-B_6XF2wArVg90H21EOLACvtfcHk0lgz_hzXmoOq2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVKhtL8%253D&md5=c1c48fffb7845c68e9d584e31dfed1bf</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M100975200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M100975200%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.-Y.%26aulast%3DRhim%26aufirst%3DT.%2BY.%26aulast%3DChoi%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DS.-S.%26atitle%3DN-Acetylcysteine%2520Induces%2520Cell%2520Cycle%2520Arrest%2520in%2520Hepatic%2520Stellate%2520Cells%2520through%2520Its%2520Reducing%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D44%26spage%3D40591%26epage%3D40598%26doi%3D10.1074%2Fjbc.M100975200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hacışevki, A.</span>; <span class="NLM_string-name">Baba, B.</span></span> <span> </span><span class="NLM_article-title">An Overview of Melatonin as an Antioxidant Molecule: A Biochemical Approach</span>. In  <i>Melatonin-molecular biology, clinical and pharmaceutical approaches</i>; <span class="NLM_publisher-name">IntechOpen</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2018</span>; pp  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">88</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.5772%2Fintechopen.79421" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=59-88&author=A.+Hac%C4%B1%C5%9Fevki&author=B.+Baba&title=Melatonin-molecular+biology%2C+clinical+and+pharmaceutical+approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.5772%2Fintechopen.79421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252Fintechopen.79421%26sid%3Dliteratum%253Aachs%26aulast%3DHac%25C4%25B1%25C5%259Fevki%26aufirst%3DA.%26atitle%3DAn%2520Overview%2520of%2520Melatonin%2520as%2520an%2520Antioxidant%2520Molecule%253A%2520A%2520Biochemical%2520Approach%26btitle%3DMelatonin-molecular%2520biology%252C%2520clinical%2520and%2520pharmaceutical%2520approaches%26pub%3DIntechOpen%26date%3D2018%26spage%3D59%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chainy, G. B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, D. K.</span></span> <span> </span><span class="NLM_article-title">Hormones and Oxidative Stress: An Overview</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1080/10715762.2019.1702656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1080%2F10715762.2019.1702656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31868060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGju7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2020&pages=1-26&issue=1&author=G.+B.+N.+Chainyauthor=D.+K.+Sahoo&title=Hormones+and+Oxidative+Stress%3A+An+Overview&doi=10.1080%2F10715762.2019.1702656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Hormones and oxidative stress: an overview</span></div><div class="casAuthors">Chainy, Gagan B. N.; Sahoo, Dipak Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1029-2470</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  In aerobes, oxygen is essential for maintenance of life.  However, incomplete redn. of oxygen leads to generation of reactive oxygen species.  These oxidants oxidise biol. macromols. present in their vicinity and thereby impair cellular functions causing oxidative stress (OS).  Aerobes have evolved both enzymic and nonenzymic antioxidant defences to protect themselves from OS.  Although hormones as means of biol. coordination involve in regulation of physiol. activities of tissues by regulating metab., any change in their normal titer leads to pathophysiol. states.  While, hormones such as melatonin, insulin, estrogen, progesterone display antioxidant features, thyroid hormone, corticosteroids and catecholamines elicit free radical generation and OS, and the role of testosterone in inducing OS is debateable.  This review is an attempt to understand the impact of free radical generation and cross talk between the hormones modulating antioxidant defense system under various pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphorHBm69KfLVg90H21EOLACvtfcHk0liA__tkk3JY6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGju7jJ&md5=5e7e60d2ccab5370939555147907f86f</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1080%2F10715762.2019.1702656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715762.2019.1702656%26sid%3Dliteratum%253Aachs%26aulast%3DChainy%26aufirst%3DG.%2BB.%2BN.%26aulast%3DSahoo%26aufirst%3DD.%2BK.%26atitle%3DHormones%2520and%2520Oxidative%2520Stress%253A%2520An%2520Overview%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2020%26volume%3D54%26issue%3D1%26spage%3D1%26epage%3D26%26doi%3D10.1080%2F10715762.2019.1702656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klitzke, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onuki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prado, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, M. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di
Mascio, P.</span></span> <span> </span><span class="NLM_article-title">Measurement of Melatonin and Its Metabolites: Importance for the Evaluation of Their Biological Roles</span>. <i>Endocr. J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1385/ENDO:27:2:111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1385%2FENDO%3A27%3A2%3A111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=111-118&issue=2&author=G.+R.+Martinezauthor=E.+A.+Almeidaauthor=C.+F.+Klitzkeauthor=J.+Onukiauthor=F.+M.+Pradoauthor=M.+H.+G.+Medeirosauthor=P.+Di%0AMascio&title=Measurement+of+Melatonin+and+Its+Metabolites%3A+Importance+for+the+Evaluation+of+Their+Biological+Roles&doi=10.1385%2FENDO%3A27%3A2%3A111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1385%2FENDO%3A27%3A2%3A111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FENDO%253A27%253A2%253A111%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DG.%2BR.%26aulast%3DAlmeida%26aufirst%3DE.%2BA.%26aulast%3DKlitzke%26aufirst%3DC.%2BF.%26aulast%3DOnuki%26aufirst%3DJ.%26aulast%3DPrado%26aufirst%3DF.%2BM.%26aulast%3DMedeiros%26aufirst%3DM.%2BH.%2BG.%26aulast%3DDi%2BMascio%26aufirst%3DP.%26atitle%3DMeasurement%2520of%2520Melatonin%2520and%2520Its%2520Metabolites%253A%2520Importance%2520for%2520the%2520Evaluation%2520of%2520Their%2520Biological%2520Roles%26jtitle%3DEndocr.%2520J.%26date%3D2005%26volume%3D27%26issue%3D2%26spage%3D111%26epage%3D118%26doi%3D10.1385%2FENDO%3A27%3A2%3A111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krausz, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceraulo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">Urinary Metabolites and Antioxidant Products of Exogenous Melatonin in the Mouse</span>. <i>J. Pineal Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1111/j.1600-079X.2006.00321.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fj.1600-079X.2006.00321.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16635022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Oitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2006&pages=343-349&issue=4&author=X.+Maauthor=J.+R.+Idleauthor=K.+W.+Krauszauthor=D.+X.+Tanauthor=L.+Cerauloauthor=F.+J.+Gonzalez&title=Urinary+Metabolites+and+Antioxidant+Products+of+Exogenous+Melatonin+in+the+Mouse&doi=10.1111%2Fj.1600-079X.2006.00321.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary metabolites and antioxidant products of exogenous melatonin in the mouse</span></div><div class="casAuthors">Ma, Xiaochao; Idle, Jeffrey R.; Krausz, Kristopher W.; Tan, Dun-Xian; Ceraulo, Leopoldo; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pineal Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">JPRSE9</span>;
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Exogenous melatonin is widely used for sleep disorders and has potential value in neuroprotection, cardioprotection and as an antioxidant.  Here, a novel method is described for the detn. of melatonin and six metabolites in mouse urine by use of LC-MS/MS and GC-MS.  LC-MS/MS is used for the measurement of melatonin, N1-acetyl-5-methoxykynuramine (AMK), N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and 6-hydroxymelatonin (6-HMEL), while GC/MS is used for the detn. of N-[2-(5-methoxy-2-oxo-2,3-dihydro-1H-indol-3-yl)-ethyl]-acetamide (2-OMEL) and cyclic 3-hydroxymelatonin (3-HMEL) with detection limits on column of 0.02-0.5 pmol, depending on the metabolite.  Following oral administration of melatonin to mice, a 0-24 h urine collection revealed the presence of melatonin (0.2% dose), 6-HMEL (37.1%) and NAS (3.1%) comprising >90% of the total metabolites; AMK and AFMK were also detected at 0.01% each; 2-OMEL was found at 2.2% of the dose, which is >100 times more than the AMK/AFMK pathway, and comprises >5% of the melatonin-related material detected in mouse urine.  3-HMEL was largely found as a sulfate conjugate.  These studies establish sensitive assays for detn. of six melatonin metabolites in mouse urine and confirm the potential for antioxidant activity of melatonin through the identification in vivo of AMK and AFMK, ring-opened metabolites with a high capacity for scavenging reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuz5gNusD4OLVg90H21EOLACvtfcHk0liA__tkk3JY6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Oitbg%253D&md5=ea39643e832ad3a856660662c7c1d139</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-079X.2006.00321.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-079X.2006.00321.x%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DIdle%26aufirst%3DJ.%2BR.%26aulast%3DKrausz%26aufirst%3DK.%2BW.%26aulast%3DTan%26aufirst%3DD.%2BX.%26aulast%3DCeraulo%26aufirst%3DL.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DUrinary%2520Metabolites%2520and%2520Antioxidant%2520Products%2520of%2520Exogenous%2520Melatonin%2520in%2520the%2520Mouse%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2006%26volume%3D40%26issue%3D4%26spage%3D343%26epage%3D349%26doi%3D10.1111%2Fj.1600-079X.2006.00321.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antolín, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáinz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uría, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotler, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Colunga, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolivia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menéndez-Peláez, A.</span></span> <span> </span><span class="NLM_article-title">Neurohormone Melatonin Prevents Cell Damage: Effect on Gene Expression for Antioxidant Enzymes</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">882</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1096/fasebj.10.8.8666165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1096%2Ffasebj.10.8.8666165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=8666165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK28XjslSrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=882-890&issue=8&author=I.+Antol%C3%ADnauthor=C.+Rodr%C3%ADguezauthor=R.+M.+S%C3%A1inzauthor=J.+C.+Mayoauthor=H.+Ur%C3%ADaauthor=M.+L.+Kotlerauthor=M.+J.+Rodr%C3%ADguez-Colungaauthor=D.+Toliviaauthor=A.+Men%C3%A9ndez-Pel%C3%A1ez&title=Neurohormone+Melatonin+Prevents+Cell+Damage%3A+Effect+on+Gene+Expression+for+Antioxidant+Enzymes&doi=10.1096%2Ffasebj.10.8.8666165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes</span></div><div class="casAuthors">Antolin, Isaac; Rodriguez, Carmen; Sainz, Rosa M.; Mayo, Juan C.; Uria, Higinio; Kotler, Monica L.; Rodriguez-Colunga, Maria J.; Tolivia, Delio; Menendez-Pelaez, Armando</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">882-890</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">It is well known that porphyrins cause a toxic light-mediated effect due to their capability to generate free radicals.  Several reports have proved that melatonin is a potent free radical scavenger.  The aim of this work has been to study the ability of melatonin to prevent the cell damage caused by porphyrins in the Harderian gland of female Syrian hamsters.  Cell injury was evaluated estg. the percentage of damaged cells found in the gland and analyzing the degree of this damage at ultrastructural level.  To explain the mechanism by which this hormone could prevent the cell damage caused by porphyrins, its capability to both decrease porphyrins, its capability to both decrease porphyrin synthesis and increase the mRNA levels for antioxidant enzymes was evaluated.  Our results demonstrate that melatonin administration decreases the percentage of damaged cells, porphyrin synthesis, and aminolevulinate synthase (ALA-S) mRNA levels and increases the mRNA levels for manganese superoxide-dismutase and copper-zinc superoxide dismutase.  When obsd. under an electron microscope, the lesions in the clear cells of the treated females were much less severe than in the corresponding cells of the control animals.  Melatonin exerts a cytoprotective effect by inhibiting the ALA-S gene expression (and so porphyrin synthesis) and by raising the mRNA levels for several antioxidant enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT58i8cjuKvbVg90H21EOLACvtfcHk0lgX0dLCvXPelQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjslSrsLc%253D&md5=d32d8d848dc8a9c71bb5634801b47182</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.10.8.8666165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.10.8.8666165%26sid%3Dliteratum%253Aachs%26aulast%3DAntol%25C3%25ADn%26aufirst%3DI.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DC.%26aulast%3DS%25C3%25A1inz%26aufirst%3DR.%2BM.%26aulast%3DMayo%26aufirst%3DJ.%2BC.%26aulast%3DUr%25C3%25ADa%26aufirst%3DH.%26aulast%3DKotler%26aufirst%3DM.%2BL.%26aulast%3DRodr%25C3%25ADguez-Colunga%26aufirst%3DM.%2BJ.%26aulast%3DTolivia%26aufirst%3DD.%26aulast%3DMen%25C3%25A9ndez-Pel%25C3%25A1ez%26aufirst%3DA.%26atitle%3DNeurohormone%2520Melatonin%2520Prevents%2520Cell%2520Damage%253A%2520Effect%2520on%2520Gene%2520Expression%2520for%2520Antioxidant%2520Enzymes%26jtitle%3DFASEB%2520J.%26date%3D1996%26volume%3D10%26issue%3D8%26spage%3D882%26epage%3D890%26doi%3D10.1096%2Ffasebj.10.8.8666165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patiño, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-Martín, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parada, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">los Rios, C. de</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span> <span> </span><span class="NLM_article-title">Ischemic Brain Injury: New Insights on the Protective Role of Melatonin</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">2016</span>),  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2017.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2017.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28065781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2017&pages=32-53&issue=2016&author=E.+Ramosauthor=P.+Pati%C3%B1oauthor=R.+J.+Reiterauthor=E.+Gil-Mart%C3%ADnauthor=J.+Marco-Contellesauthor=E.+Paradaauthor=C.+de+los+Riosauthor=A.+Romeroauthor=J.+Egea&title=Ischemic+Brain+Injury%3A+New+Insights+on+the+Protective+Role+of+Melatonin&doi=10.1016%2Fj.freeradbiomed.2017.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Ischemic brain injury: New insights on the protective role of melatonin</span></div><div class="casAuthors">Ramos, Eva; Patino, Paloma; Reiter, Russel J.; Gil-Martin, Emilio; Marco-Contelles, Jose; Parada, Esther; los Rios, Cristobal de; Romero, Alejandro; Egea, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-53</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Stroke represents one of the most common causes of brain's vulnerability for many millions of people worldwide.  The plethora of physiopathol. events assocd. with brain ischemia are regulate through multiple signaling pathways leading to the activation of oxidative stress process, Ca2+ dyshomeostasis, mitochondrial dysfunction, proinflammatory mediators, excitotoxicity and/or programmed neuronal cell death.  Understanding this cascade of mol. events is mandatory in order to develop new therapeutic strategies for stroke.  In this review article, we have highlighted the pleiotropic effects of melatonin to counteract the multiple processes of the ischemic cascade.  Addnl., exptl. evidence supports its actions to ameliorate ischemic long-term behavioral and neuronal deficits, preserving the functional integrity of the blood-brain barrier, inducing neurogenesis and cell proliferation through receptor-dependent mechanism, as well as improving synaptic transmission.  Consequently, the synthesis of melatonin derivs. designed as new multitarget-directed products has focused a great interest in this area.  This latter has been reinforced by the low cost of melatonin and its reduced toxicity.  Furthermore, its spectrum of usages seems to be wide and with the potential for improving human health.  Nevertheless, the mol. and cellular mechanisms underlying melatonin's actions need to be further exploration and accordingly, new clin. studies should be conducted in human patients with ischemic brain pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo9ZaHk9KREbVg90H21EOLACvtfcHk0lgFw9roXHgcyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlyjtA%253D%253D&md5=b1d6a17a6c50b8f7e17f50e49a778815</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2017.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2017.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DRamos%26aufirst%3DE.%26aulast%3DPati%25C3%25B1o%26aufirst%3DP.%26aulast%3DReiter%26aufirst%3DR.%2BJ.%26aulast%3DGil-Mart%25C3%25ADn%26aufirst%3DE.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DParada%26aufirst%3DE.%26aulast%3Dlos%2BRios%26aufirst%3DC.%2Bde%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DEgea%26aufirst%3DJ.%26atitle%3DIschemic%2520Brain%2520Injury%253A%2520New%2520Insights%2520on%2520the%2520Protective%2520Role%2520of%2520Melatonin%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2017%26volume%3D104%26issue%3D2016%26spage%3D32%26epage%3D53%26doi%3D10.1016%2Fj.freeradbiomed.2017.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Özdemir, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keleştimur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalkara, T.</span></span> <span> </span><span class="NLM_article-title">Pinealectomy Aggravates and Melatonin Administration Attenuates Brain Damage in Focal Ischemia</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1097/00004647-199905000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1097%2F00004647-199905000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10326718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVCqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=511-516&issue=5&author=E.+Kilicauthor=Y.+G.+%C3%96zdemirauthor=H.+Bolayauthor=H.+Kele%C5%9Ftimurauthor=T.+Dalkara&title=Pinealectomy+Aggravates+and+Melatonin+Administration+Attenuates+Brain+Damage+in+Focal+Ischemia&doi=10.1097%2F00004647-199905000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia</span></div><div class="casAuthors">Kilic, Ertugrul; Ozdemir, Yasemin Gursoy; Bolay, Hayrunnisa; Kelestimur, Haluk; Dalkara, Turgay</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-516</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Large infarcts develop in pinealectomized rats subjected to middle cerebral artery occlusion, which was attributed to loss of antioxidant action of melatonin.  However, melatonin also has vascular actions, and pinealectomy may induce hypertension.  The authors investigated whether hemodynamic factors contribute to infarct development in pinealectomized rats, whether melatonin administration can reverse the unfavorable effect of pinealectomy on infarct formation, and whether melatonin can reduce the infarct vol. in nonpinealectomized rats subjected to focal transient ischemia (2 h middle cerebral artery occlusion, 22 h reperfusion).  Rats were pinealectomized 3 mo before ischemia to eliminate any possible action of pinealectomy-induced hypertension on stroke.  Blood pressure and regional CBF values during ischemia and reperfusion were not significantly different between pinealectomized and sham-operated rats, suggesting that pinealectomy-induced increase in infarct was not related to hemodynamic factors.  The infarct vol. resumed to the level of sham-operated rats on melatonin administration.  Injection of melatonin (4 mg/kg) before both ischemia and reperfusion reduced infarct vol. by 40% and significantly improved neurol. deficit scores in pinealectomized as well as sham-operated rats subjected to middle cerebral artery occlusion.  These data suggest that physiol. melatonin release as well as exogenously given melatonin has a neuroprotective action in focal cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG3jpFq1CZ9LVg90H21EOLACvtfcHk0lgFw9roXHgcyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVCqtro%253D&md5=cdc560a7edcce9a5bebe9a120af31b4e</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1097%2F00004647-199905000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-199905000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DKilic%26aufirst%3DE.%26aulast%3D%25C3%2596zdemir%26aufirst%3DY.%2BG.%26aulast%3DBolay%26aufirst%3DH.%26aulast%3DKele%25C5%259Ftimur%26aufirst%3DH.%26aulast%3DDalkara%26aufirst%3DT.%26atitle%3DPinealectomy%2520Aggravates%2520and%2520Melatonin%2520Administration%2520Attenuates%2520Brain%2520Damage%2520in%2520Focal%2520Ischemia%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1999%26volume%3D19%26issue%3D5%26spage%3D511%26epage%3D516%26doi%3D10.1097%2F00004647-199905000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laleu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaggini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orchard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioraso-Cartier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houngninou-Molango, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duboux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szyndralewiez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, P.</span></span> <span> </span><span class="NLM_article-title">First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7715</span>– <span class="NLM_lpage">7730</span>, <span class="refDoi"> DOI: 10.1021/jm100773e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100773e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1OqtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7715-7730&issue=21&author=B.+Laleuauthor=F.+Gagginiauthor=M.+Orchardauthor=L.+Fioraso-Cartierauthor=L.+Cagnonauthor=S.+Houngninou-Molangoauthor=A.+Gradiaauthor=G.+Dubouxauthor=C.+Merlotauthor=F.+Heitzauthor=C.+Szyndralewiezauthor=P.+Page&title=First+in+Class%2C+Potent%2C+and+Orally+Bioavailable+NADPH+Oxidase+Isoform+4+%28Nox4%29+Inhibitors+for+the+Treatment+of+Idiopathic+Pulmonary+Fibrosis&doi=10.1021%2Fjm100773e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Laleu, Benoit; Gaggini, Francesca; Orchard, Mike; Fioraso-Cartier, Laetitia; Cagnon, Laurene; Houngninou-Molango, Sophie; Gradia, Angelo; Duboux, Guillaume; Merlot, Cedric; Heitz, Freddy; Szyndralewiez, Cedric; Page, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7715-7730</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design, synthesis, and optimization of first-in-class series of inhibitors I (R1 = H, MeCO, 4-FC6H4CH2, etc.; R2 = Ph, 2-ClC6H4, 2-benzothiazolyl, etc.; R3 = Me, 2-FC6H4, 1-pyrrolidinylmethyl, PhCH2NMeCH2, etc.; R4 = MeOCH2CH2, 3-pyridylmethyl, 4-morpholinyl, etc.) of NADPH oxidase isoform 4 (Nox4), an enzyme implicated in several pathologies, in particular idiopathic pulmonary fibrosis, a life-threatening and orphan disease, is described.  Initially, several moderately potent pyrazolopyridine dione derivs. were found during a high-throughput screening campaign.  SAR investigation around the pyrazolopyridine dione core led to the discovery of several double-digit nanomolar inhibitors in cell free assays of reactive oxygen species (ROS) prodn., showing high potency on Nox4 and Nox1.  The compds. have little affinity for Nox2 isoform and are selective for Nox4/1 isoforms.  The specificity of these compds. was confirmed in an extensive in vitro pharmacol. profile, as well as in a counterscreening assay for potential ROS scavenging.  Concomitant benefits are good oral bioavailability and high plasma concns. in vivo, allowing further clin. trials for the potential treatment of fibrotic diseases, cancers, and cardiovascular and metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNSPjijoh4dLVg90H21EOLACvtfcHk0liXffWTOozyEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1OqtbzI&md5=39f3be6bed0d02fce6693e626788f125</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fjm100773e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100773e%26sid%3Dliteratum%253Aachs%26aulast%3DLaleu%26aufirst%3DB.%26aulast%3DGaggini%26aufirst%3DF.%26aulast%3DOrchard%26aufirst%3DM.%26aulast%3DFioraso-Cartier%26aufirst%3DL.%26aulast%3DCagnon%26aufirst%3DL.%26aulast%3DHoungninou-Molango%26aufirst%3DS.%26aulast%3DGradia%26aufirst%3DA.%26aulast%3DDuboux%26aufirst%3DG.%26aulast%3DMerlot%26aufirst%3DC.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DSzyndralewiez%26aufirst%3DC.%26aulast%3DPage%26aufirst%3DP.%26atitle%3DFirst%2520in%2520Class%252C%2520Potent%252C%2520and%2520Orally%2520Bioavailable%2520NADPH%2520Oxidase%2520Isoform%25204%2520%2528Nox4%2529%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Idiopathic%2520Pulmonary%2520Fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D21%26spage%3D7715%26epage%3D7730%26doi%3D10.1021%2Fjm100773e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Augsburger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seredenina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maghzal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahiout, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen-Dürr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, U. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroshow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaquet, V.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Characterization of the Seven Human NOX Isoforms and Their Inhibitors</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">101272</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.redox.2019.101272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31330481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVWksbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=101272&author=F.+Augsburgerauthor=A.+Filippovaauthor=D.+Rastiauthor=T.+Seredeninaauthor=M.+Lamauthor=G.+Maghzalauthor=Z.+Mahioutauthor=P.+Jansen-D%C3%BCrrauthor=U.+G.+Knausauthor=J.+Doroshowauthor=R.+Stockerauthor=K.+H.+Krauseauthor=V.+Jaquet&title=Pharmacological+Characterization+of+the+Seven+Human+NOX+Isoforms+and+Their+Inhibitors&doi=10.1016%2Fj.redox.2019.101272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the seven human NOX isoforms and their inhibitors</span></div><div class="casAuthors">Augsburger, Fiona; Filippova, Aleksandra; Rasti, Delphine; Seredenina, Tamara; Lam, Magdalena; Maghzal, Ghassan; Mahiout, Zahia; Jansen-Durr, Pidder; Knaus, Ulla G.; Doroshow, James; Stocker, Roland; Krause, Karl-Heinz; Jaquet, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101272</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NADPH oxidases (NOX) are a family of flavoenzymes that catalyze the formation of superoxide anion radical (O-2) and/or hydrogen peroxide (H2/O2).  As major oxidant generators, NOX are assocd. with oxidative damage in numerous diseases and represent promising drug targets for several pathologies.  Various small mol. NOX inhibitors are used in the literature, but their pharmacol. characterization is often incomplete in terms of potency, specificity and mode of action.  We used cell lines expressing high levels of human NOX isoforms (NOX1-5, DUOX1 and 2) to detect NOX-derived O-2/or H2O2 using a variety of specific probes.  NOX inhibitory activity of diphenylene iodonium (DPI), apocynin, diapocynin, ebselen, GKT136901 and VAS2870 was tested on NOX isoforms in cellular and membrane assays.  Addnl. assays were used to identify potential off target effects, such as antioxidant activity, interference with assays or acute cytotoxicity.  Cells expressing active NOX isoforms formed O/2, except for DUOX1 and 2, and in all cases activation of NOX isoforms was assocd. with the detection of extracellular H2O2.  Among all mols. tested, DPI elicited dose-dependent inhibition of all isoforms in all assays, however all other mols. tested displayed interesting pharmacol. characteristics, but did not meet criteria for bona fide NOX inhibitors.  Our findings indicate that exptl. results obtained with widely used NOX inhibitors must be carefully interpreted and highlight the challenge of developing reliable pharmacol. inhibitors of these key mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxV_rnN-nPA7Vg90H21EOLACvtfcHk0liXffWTOozyEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVWksbrJ&md5=a963942896468f59f1464c41ff0505ff</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101272%26sid%3Dliteratum%253Aachs%26aulast%3DAugsburger%26aufirst%3DF.%26aulast%3DFilippova%26aufirst%3DA.%26aulast%3DRasti%26aufirst%3DD.%26aulast%3DSeredenina%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DM.%26aulast%3DMaghzal%26aufirst%3DG.%26aulast%3DMahiout%26aufirst%3DZ.%26aulast%3DJansen-D%25C3%25BCrr%26aufirst%3DP.%26aulast%3DKnaus%26aufirst%3DU.%2BG.%26aulast%3DDoroshow%26aufirst%3DJ.%26aulast%3DStocker%26aufirst%3DR.%26aulast%3DKrause%26aufirst%3DK.%2BH.%26aulast%3DJaquet%26aufirst%3DV.%26atitle%3DPharmacological%2520Characterization%2520of%2520the%2520Seven%2520Human%2520NOX%2520Isoforms%2520and%2520Their%2520Inhibitors%26jtitle%3DRedox%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D101272%26doi%3D10.1016%2Fj.redox.2019.101272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aalbers, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">A Closer Look into NADPH Oxidase Inhibitors: Validation and Insight into Their Mechanism of Action</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">101466</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2020.101466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.redox.2020.101466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32105983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjvVKgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2020&pages=101466&author=J.+Reisauthor=M.+Massariauthor=S.+Marcheseauthor=M.+Cecconauthor=F.+S.+Aalbersauthor=F.+Coranaauthor=S.+Valenteauthor=A.+Maiauthor=F.+Magnaniauthor=A.+Mattevi&title=A+Closer+Look+into+NADPH+Oxidase+Inhibitors%3A+Validation+and+Insight+into+Their+Mechanism+of+Action&doi=10.1016%2Fj.redox.2020.101466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">A closer look into NADPH oxidase inhibitors: Validation and insight into their mechanism of action</span></div><div class="casAuthors">Reis, Joana; Massari, Marta; Marchese, Sara; Ceccon, Marta; Aalbers, Friso S.; Corana, Federica; Valente, Sergio; Mai, Antonello; Magnani, Francesca; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101466</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NADPH-oxidases (NOXs) purposefully produce reactive-oxygen-species (ROS) and are found in most kingdoms of life.  The seven human NOXs are each characterized by a specific expression profile and a fine regulation to spatio-temporally tune ROS concn. in cells and tissues.  One of the best known roles for NOXs is in host protection against pathogens but ROS themselves are important second messengers involved in tissue regeneration and the modulation of pathways that induce and sustain cell proliferation.  As such, NOXs are attractive pharmacol. targets in immunomodulation, fibrosis and cancer.  We have studied an extensive no. of available NOX inhibitors, with the specific aim to identify bona fide ligands vs. ROS-scavenging mols.  Accordingly, we have established a comprehensive platform of biochem. and biophys. assays.  Most of the investigated small mols. revealed ROS-scavenging and/or assay-interfering properties to various degrees.  A few compds., however, were also demonstrated to directly engage one or more NOX enzymes.  Diphenylene iodonium was found to react with the NOXs' flavin and heme prosthetic groups to form stable adducts.  We also discovered that two compds., VAS2870 and VAS3947, inhibit NOXs through the covalent alkylation of a cysteine residue.  Importantly, the amino acid involved in covalent binding was found to reside in the dehydrogenase domain, where the nicotinamide ring of NADPH is bound.  This work can serve as a springboard to guide further development of bona fide ligands with either agonistic or antagonistic properties toward NOXs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5KH3K8WuaeLVg90H21EOLACvtfcHk0ljh0MBCEYdlsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjvVKgs74%253D&md5=6251e232aa3b02be3497e3e3ad8b8b41</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2020.101466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2020.101466%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DMassari%26aufirst%3DM.%26aulast%3DMarchese%26aufirst%3DS.%26aulast%3DCeccon%26aufirst%3DM.%26aulast%3DAalbers%26aufirst%3DF.%2BS.%26aulast%3DCorana%26aufirst%3DF.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DMagnani%26aufirst%3DF.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DA%2520Closer%2520Look%2520into%2520NADPH%2520Oxidase%2520Inhibitors%253A%2520Validation%2520and%2520Insight%2520into%2520Their%2520Mechanism%2520of%2520Action%26jtitle%3DRedox%2520Biol.%26date%3D2020%26volume%3D32%26spage%3D101466%26doi%3D10.1016%2Fj.redox.2020.101466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szilagyi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleksunes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heindel, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laskin, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laskin, J. D.</span></span> <span> </span><span class="NLM_article-title">Selective Targeting of Heme Protein in Cytochrome P450 and Nitric Oxide Synthase by Diphenyleneiodonium</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>151</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfw031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1093%2Ftoxsci%2Fkfw031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26880746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSisbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2016&pages=150-159&issue=1&author=J.+T.+Szilagyiauthor=V.+Mishinauthor=D.+E.+Heckauthor=Y.+H.+Janauthor=L.+M.+Aleksunesauthor=J.+R.+Richardsonauthor=N.+D.+Heindelauthor=D.+L.+Laskinauthor=J.+D.+Laskin&title=Selective+Targeting+of+Heme+Protein+in+Cytochrome+P450+and+Nitric+Oxide+Synthase+by+Diphenyleneiodonium&doi=10.1093%2Ftoxsci%2Fkfw031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Selective targeting of heme protein in cytochrome P450 and nitric oxide synthase by diphenyleneiodonium</span></div><div class="casAuthors">Szilagyi, John T.; Mishin, Vladimir; Heck, Diane E.; Jan, Yi-Hua; Aleksunes, Lauren M.; Richardson, Jason R.; Heindel, Ned D.; Laskin, Debra L.; Laskin, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-159</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Cytochrome P 450 (CYP) enzymes mediate mixed-function oxidn. reactions important in drug metab.  The arom. heterocyclic cation, diphenyleneiodonium (DPI), binds flavin in cytochrome P 450 reductase and inhibits CYP-mediated activity.  DPI also inhibits CYP by directly interacting with heme.  Herein, we report that DPI effectively inhibits a no. of CYP-related monooxygenase reactions including NADPH oxidase, a microsomal enzyme activity that generates hydrogen peroxide in the absence of metabolizing substrates.  Inhibition of monooxygenase by DPI was time and concn. dependent with IC50's ranging from 0.06 to 1.9 μM.  Higher (4.6-23.9 μM), but not lower (0.06-1.9 μM), concns. of DPI inhibited electron flow via cytochrome P 450 reductase, as measured by its ability to reduce cytochrome c and mediate quinone redox cycling.  Similar results were obsd. with inducible nitric oxide synthase (iNOS), an enzyme contg. a C-terminal reductase domain homologous to cytochrome P 450 reductase that mediates redn. of cytochrome c, and an N-terminal heme-thiolate oxygenase domain mediating nitric oxide prodn.  Significantly greater concns. of DPI were required to inhibit cytochrome c redn. by iNOS (IC50=3.5 μM) than nitric oxide prodn. (IC50=0.16 μM).  Difference spectra of liver microsomes, recombinant CYPs, and iNOS demonstrated that DPI altered heme-carbon monoxide interactions.  In the presence of NADPH, DPI treatment of microsomes and iNOS yielded a type II spectral shift.  These data indicate that DPI interacts with both flavin and heme in CYPs and iNOS.  Increased sensitivity for inhibition of CYP-mediated metab. and nitric oxide prodn. by iNOS indicates that DPI targets heme moieties within the enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK3MwmIS0zzbVg90H21EOLACvtfcHk0liTqt3r6zLIYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSisbrO&md5=d7482e5b058e90a784db594a2e5ee529</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfw031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfw031%26sid%3Dliteratum%253Aachs%26aulast%3DSzilagyi%26aufirst%3DJ.%2BT.%26aulast%3DMishin%26aufirst%3DV.%26aulast%3DHeck%26aufirst%3DD.%2BE.%26aulast%3DJan%26aufirst%3DY.%2BH.%26aulast%3DAleksunes%26aufirst%3DL.%2BM.%26aulast%3DRichardson%26aufirst%3DJ.%2BR.%26aulast%3DHeindel%26aufirst%3DN.%2BD.%26aulast%3DLaskin%26aufirst%3DD.%2BL.%26aulast%3DLaskin%26aufirst%3DJ.%2BD.%26atitle%3DSelective%2520Targeting%2520of%2520Heme%2520Protein%2520in%2520Cytochrome%2520P450%2520and%2520Nitric%2520Oxide%2520Synthase%2520by%2520Diphenyleneiodonium%26jtitle%3DToxicol.%2520Sci.%26date%3D2016%26volume%3D151%26issue%3D1%26spage%3D150%26epage%3D159%26doi%3D10.1093%2Ftoxsci%2Fkfw031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stuehr, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasehun, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C. F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Macrophage and Endothelial Cell Nitric Synthase by Diphenyleneiodonium and Its Analogs</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1096/fasebj.5.1.1703974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1096%2Ffasebj.5.1.1703974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1703974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK3MXhtFOmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1991&pages=98-103&issue=1&author=D.+J.+Stuehrauthor=O.+A.+Fasehunauthor=N.+S.+Kwonauthor=S.+Grossauthor=J.+A.+Gonzalezauthor=R.+Leviauthor=C.+F.+Nathan&title=Inhibition+of+Macrophage+and+Endothelial+Cell+Nitric+Synthase+by+Diphenyleneiodonium+and+Its+Analogs&doi=10.1096%2Ffasebj.5.1.1703974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs</span></div><div class="casAuthors">Stuehr, Dennis J.; Fasehun, Olufunmilayo A.; Kwon, Nyoun Soo; Gross, Steven S.; Gonzalez, Jose A.; Levi, Roberto; Nathan, Carl F.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-103</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    </div><div class="casAbstract">The cofactor requirements of macrophage nitric oxide (NO) synthase suggest involvement of an NADPH-dependent flavoprotein.  Therefore the effect of the flavoprotein inhibitors diphenyleneiodonium (DPI), di-2-thienyliodonium (DTI), and iodoniumdiphenyl (ID) on the NO synthases of macrophages and endothelium was tested.  DPI, DTI, and ID completely inhibited NO synthesis by mouse macrophages, their lysates, and partially purified macrophage NO synthase.  Inhibition of NO synthase by these agents was potent (IC50's 50-150 nM), irreversible, dependent on time and temp., and independent of enzyme catalysis.  The inhibition by DPI was blocked by NADPH, NADP, or 2',5'-ADP, but not by NADH.  Likewise, FAD or FMN, but not riboflavin or adenosine 5'-diphosphoribose, protected NO synthase from inhibition by DPI.  Neither NADPH nor FAD reacted with DPI.  Once NO synthase was inhibited by DPI, neither NADPH nor FAD could restore its activity.  DPI also inhibited acetylcholine-induced relaxation of norepinephrine-preconstricted rabbit aortic rings (IC50 300 nM).  Inhibition of acetylcholine-induced relaxation persisted for at least 2 h after DPI was washed out.  In contrast, DPI had no effect on norepinephrine-induced vasoconstriction itself nor on vasorelaxation induced by the NO-generating agent sodium nitroprusside.  These results suggest that NO synthesis in both macrophages and endothelial cells depends on an NADPH-utilizing flavoprotein.  As a new class of NO synthase inhibitors, DPI and its analogs are likely to prove useful in analyzing the physiol. and pathophysiol. roles of NO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwou5S41-mY7Vg90H21EOLACvtfcHk0liTqt3r6zLIYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtFOmsL8%253D&md5=726ee653d19952b1a3886ecbaebcd8eb</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.5.1.1703974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.5.1.1703974%26sid%3Dliteratum%253Aachs%26aulast%3DStuehr%26aufirst%3DD.%2BJ.%26aulast%3DFasehun%26aufirst%3DO.%2BA.%26aulast%3DKwon%26aufirst%3DN.%2BS.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DGonzalez%26aufirst%3DJ.%2BA.%26aulast%3DLevi%26aufirst%3DR.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26atitle%3DInhibition%2520of%2520Macrophage%2520and%2520Endothelial%2520Cell%2520Nitric%2520Synthase%2520by%2520Diphenyleneiodonium%2520and%2520Its%2520Analogs%26jtitle%3DFASEB%2520J.%26date%3D1991%26volume%3D5%26issue%3D1%26spage%3D98%26epage%3D103%26doi%3D10.1096%2Ffasebj.5.1.1703974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laleu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaggini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioraso-Cartier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molango, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szyndralewiez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D. D.</span></span> <span> </span><span class="NLM_article-title">Nicotinamide Adenine Dinucleotide Phosphate Oxidase (NOX) in Experimental Liver Fibrosis: GKT137831 as a Novel Potential Therapeutic Agent</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2316</span>– <span class="NLM_lpage">2327</span>, <span class="refDoi"> DOI: 10.1002/hep.25938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fhep.25938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22806357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSmtb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=2316-2327&issue=6&author=T.+Aoyamaauthor=Y.-H.+Paikauthor=S.+Watanabeauthor=B.+Laleuauthor=F.+Gagginiauthor=L.+Fioraso-Cartierauthor=S.+Molangoauthor=F.+Heitzauthor=C.+Merlotauthor=C.+Szyndralewiezauthor=P.+Pageauthor=D.+D.+Brenner&title=Nicotinamide+Adenine+Dinucleotide+Phosphate+Oxidase+%28NOX%29+in+Experimental+Liver+Fibrosis%3A+GKT137831+as+a+Novel+Potential+Therapeutic+Agent&doi=10.1002%2Fhep.25938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent</span></div><div class="casAuthors">Aoyama, Tomonori; Paik, Yong-Han; Watanabe, Sumio; Laleu, Benoit; Gaggini, Francesca; Fioraso-Cartier, Laetitia; Molango, Sophie; Heitz, Freddy; Merlot, Cedric; Szyndralewiez, Cedric; Page, Patrick; Brenner, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2316-2327</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">NADP (NADPH) oxidase (NOX) generates reactive oxygen species (ROS) in hepatic stellate cells (HSCs) during liver fibrosis.  In response to fibrogenic agonists, such as angiotensin II (Ang II), the NOX1 components form an active complex, including Ras-related botulinum toxin substrate 1 (Rac1).  Superoxide dismutase 1 (SOD1) interacts with the NOX-Rac1 complex to stimulate NOX activity.  NOX4 is also induced in activated HSCs/myofibroblast by increased gene expression.  Here, we investigate the role of an enhanced activity SOD1 G37R mutation (SODmu) and the effects of GKT137831, a dual NOX1/4 inhibitor, on HSCs and liver fibrosis.  To induce liver fibrosis, wild-type (WT) and SOD1mu mice were treated with CCl4 or bile duct ligation (BDL).  Then, to address the role of NOX-SOD1-mediated ROS prodn. in HSC activation and liver fibrosis, mice were treated with a NOX1/4 inhibitor.  Fibrosis and ROS generation was assessed by histol. and measurement of thiobarbituric acid reactive substances and NOX-related genes.  Primary cultured HSCs isolated from WT, SODmu, and NOX1 knockout (KO) mice were assessed for ROS prodn., Rac1 activity, and NOX gene expression.  Liver fibrosis was increased in SOD1mu mice, and ROS prodn. and Rac1 activity were increased in SOD1mu HSCs.  The NOX1/4 inhibitor, GKT137831, attenuated liver fibrosis and ROS prodn. in both SOD1mu and WT mice as well as mRNA expression of fibrotic and NOX genes.  Treatment with GKT137831 suppressed ROS prodn. and NOX and fibrotic gene expression, but not Rac1 activity, in SOD1mut and WT HSCs.  Both Ang II and tumor growth factor beta up-regulated NOX4, but Ang II required NOX1.  Conclusions: SOD1mu induces excessive NOX1 activation through Rac1 in HSCs, causing enhanced NOX4 up-regulation, ROS generation, and liver fibrosis.  Treatment targeting NOX1/4 may be a new therapy for liver fibrosis. (HEPATOl. 2012).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBHJRPuQUHUrVg90H21EOLACvtfcHk0lirPhkKYkCZDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSmtb3F&md5=993f393975771b613669a8624d06d6cc</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1002%2Fhep.25938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.25938%26sid%3Dliteratum%253Aachs%26aulast%3DAoyama%26aufirst%3DT.%26aulast%3DPaik%26aufirst%3DY.-H.%26aulast%3DWatanabe%26aufirst%3DS.%26aulast%3DLaleu%26aufirst%3DB.%26aulast%3DGaggini%26aufirst%3DF.%26aulast%3DFioraso-Cartier%26aufirst%3DL.%26aulast%3DMolango%26aufirst%3DS.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DMerlot%26aufirst%3DC.%26aulast%3DSzyndralewiez%26aufirst%3DC.%26aulast%3DPage%26aufirst%3DP.%26aulast%3DBrenner%26aufirst%3DD.%2BD.%26atitle%3DNicotinamide%2520Adenine%2520Dinucleotide%2520Phosphate%2520Oxidase%2520%2528NOX%2529%2520in%2520Experimental%2520Liver%2520Fibrosis%253A%2520GKT137831%2520as%2520a%2520Novel%2520Potential%2520Therapeutic%2520Agent%26jtitle%3DHepatology%26date%3D2012%26volume%3D56%26issue%3D6%26spage%3D2316%26epage%3D2327%26doi%3D10.1002%2Fhep.25938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Q.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.-k.</span></span> <span> </span><span class="NLM_article-title">Nox1/4 Dual Inhibitor GKT137831 Attenuates Hypertensive Cardiac Remodelling Associating with the Inhibition of ADAM17-Dependent Proinflammatory Cytokines-Induced Signalling Pathways in the Rats with Abdominal Artery Constriction</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">1907</span>– <span class="NLM_lpage">1914</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.11.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.biopha.2018.11.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30551445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGgtLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2019&pages=1907-1914&author=S.-y.+Zengauthor=L.+Yangauthor=Q.-j.+Yanauthor=L.+Gaoauthor=H.-q.+Luauthor=P.-k.+Yan&title=Nox1%2F4+Dual+Inhibitor+GKT137831+Attenuates+Hypertensive+Cardiac+Remodelling+Associating+with+the+Inhibition+of+ADAM17-Dependent+Proinflammatory+Cytokines-Induced+Signalling+Pathways+in+the+Rats+with+Abdominal+Artery+Constriction&doi=10.1016%2Fj.biopha.2018.11.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Nox1/4 dual inhibitor GKT137831 attenuates hypertensive cardiac remodelling associating with the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways in the rats with abdominal artery constriction</span></div><div class="casAuthors">Zeng, Si-yu; Yang, Li; Yan, Qiu-jiang; Gao, Ling; Lu, Hui-qin; Yan, Peng-ke</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1907-1914</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">NADPH oxidases (Noxs) 1/4 dual inhibitor GKT137831 prevents hypertensive cardiac remodelling in angiotensin II-infused transgenic mice with cardiomyocyte-specific human Nox4 (c-hNo x 4 Tg); however, further research is still required to det. the beneficial role of GKT137831 in hypertensive cardiac remodelling in other types of hypertensive models because this hypertensive model is insufficient to mimic the complicated pathol. mechanisms of hypertension.  A disintegrin and metalloprotease 17 (ADAM17) promotes the shedding of tumor necrosis factor α (TNF-α), TNF-α receptor, interleukin 1 receptor-II and interleukin 6 (IL-6) receptor from cells, thereby mediating the signalling pathways induced by corresponding proinflammatory cytokines.  This study aimed to det. whether GKT137831 prevents hypertensive cardiac remodelling and its mechanisms of action in the rats with abdominal artery coarctation (AAC).  The rats subjected to AAC were orally given GKT137831 for a consecutive period of 28 days.  Echocardiog. and histol. anal. were performed to evaluate cardiac remodelling; and immunohistochem. and real-time PCR were used to detect the expression of proinflammatory cytokines.  GKT137831 significantly suppressed hypertensive cardiac remodelling in AAC-induced hypertensive rats.  Concurrently, Nox1/4 dual inhibitor GKT137831 reduced the protein and mRNA levels of proinflammatory cytokines interleukin 1β (IL-1β), IL-6, and TNF-α in the left ventricle of AAC-induced hypertensive rats.  Moreover, the treatment with GKT137831 markedly diminished the protein and mRNA levels of ADAM17 in the left ventricle of AAC-induced hypertensive rats.  In summary, Nox1/4 dual inhibitor GKT137831 protects against hypertensive cardiac remodelling in AAC-induced hypertensive rats, and the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways are related to its beneficial effect on hypertensive cardiac remodelling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorgsTJlb4fP7Vg90H21EOLACvtfcHk0lirPhkKYkCZDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGgtLvM&md5=8bdf8cd7fd889cca72ecbb2631511acb</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.11.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.11.077%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DS.-y.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DQ.-j.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DH.-q.%26aulast%3DYan%26aufirst%3DP.-k.%26atitle%3DNox1%252F4%2520Dual%2520Inhibitor%2520GKT137831%2520Attenuates%2520Hypertensive%2520Cardiac%2520Remodelling%2520Associating%2520with%2520the%2520Inhibition%2520of%2520ADAM17-Dependent%2520Proinflammatory%2520Cytokines-Induced%2520Signalling%2520Pathways%2520in%2520the%2520Rats%2520with%2520Abdominal%2520Artery%2520Constriction%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D109%26spage%3D1907%26epage%3D1914%26doi%3D10.1016%2Fj.biopha.2018.11.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedeek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutsol, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montezano, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen Dinh Cat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, C. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jandeleit-Dahm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szyndralewiez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebert, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touyz, R. M.</span></span> <span> </span><span class="NLM_article-title">Renoprotective Effects of a Novel Nox1/4 Inhibitor in a Mouse Model of Type 2 Diabetes</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1042/CS20120330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1042%2FCS20120330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WqsL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2013&pages=191-202&issue=3&author=M.+Sedeekauthor=A.+Gutsolauthor=A.+C.+Montezanoauthor=D.+Burgerauthor=A.+Nguyen+Dinh+Catauthor=C.+R.+J.+Kennedyauthor=K.+D.+Burnsauthor=M.+E.+Cooperauthor=K.+Jandeleit-Dahmauthor=P.+Pageauthor=C.+Szyndralewiezauthor=F.+Heitzauthor=R.+L.+Hebertauthor=R.+M.+Touyz&title=Renoprotective+Effects+of+a+Novel+Nox1%2F4+Inhibitor+in+a+Mouse+Model+of+Type+2+Diabetes&doi=10.1042%2FCS20120330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes</span></div><div class="casAuthors">Sedeek, Mona; Gutsol, Alex; Montezano, Augusto C.; Burger, Dylan; Nguyen, Dinh Cat Aurelie; Kennedy, Chris R. J.; Burns, Kevin D.; Cooper, Mark E.; Jandeleit-Dahm, Karin; Page, Patrick; Szyndralewiez, Cedric; Heitz, Freddy; Hebert, Richard L.; Touyz, Rhian M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-202</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Nox (NADPH oxidase)-derived ROS (reactive oxygen species) have been implicated in the development of diabetic nephropathy.  Of the Nox isoforms in the kidney, Nox4 is important because of its renal abundance.  In the present study, we tested the hypothesis that GKT136901, a Nox1/4 inhibitor, prevents the development of nephropathy in db/db (diabetic) mice.  Six groups of male mice (8-wk-old) were studied: (i) untreated control db/m, (ii) low-dose GKT136901-treated db/m (30 mg/kg of body wt. per day), (iii) high-dose GKT136901-treated db/m (90 mg/kg of body wt. per day), (iv) untreated db/db; (v) low dose GKT136901-treated db/db; and (vi) high-dose GKT136901-treated db/db.  GKT136901, in chow, was administered for 16 wk. db/db mice developed diabetes and nephropathy as evidenced by hyperglycemia, albuminuria and renal injury (mesangial expansion, tubular dystrophy and glomerulosclerosis).  GKT136901 treatment had no effect on plasma glucose or BP (blood pressure) in any of the groups.  Plasma and urine TBARSs (thiobarbituric acid-reacting substances) levels, markers of systemic and renal oxidative stress, resp., were increased in diabetic mice.  Renal mRNA expression of Nox4, but not of Nox2, increased, Nox1 was barely detectable in db/db.  Expression of the antioxidant enzyme SOD-1 (superoxide dismutase 1) decreased in db/db mice.  Renal content of fibronectin, pro-collagen, TGFβ (transforming growth factor β) and VCAM-1 (vascular cell adhesion mol. 1) and phosphorylation of ERK1/2 (extracellular-signal-regulated kinase 1/2) were augmented in db/db kidneys, with no change in p38 MAPK (mitogen-activated protein kinase) and JNK (c-Jun N-terminal kinase).  Treatment reduced albuminuria, TBARS and renal ERK1/2 phosphorylation and preserved renal structure in diabetic mice.  Our findings suggest a renoprotective effect of the Nox1/4 inhibitor, possibly through reduced oxidative damage and decreased ERK1/2 activation.  These phenomena occur independently of improved glucose control, suggesting GKT136901-sensitive targets are involved in complications of diabetes rather than in the disease process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6mu_O0B-J2LVg90H21EOLACvtfcHk0lhTNZOeSZXBjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WqsL3F&md5=8386e4df0677405bbe29a264ab61086c</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1042%2FCS20120330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20120330%26sid%3Dliteratum%253Aachs%26aulast%3DSedeek%26aufirst%3DM.%26aulast%3DGutsol%26aufirst%3DA.%26aulast%3DMontezano%26aufirst%3DA.%2BC.%26aulast%3DBurger%26aufirst%3DD.%26aulast%3DNguyen%2BDinh%2BCat%26aufirst%3DA.%26aulast%3DKennedy%26aufirst%3DC.%2BR.%2BJ.%26aulast%3DBurns%26aufirst%3DK.%2BD.%26aulast%3DCooper%26aufirst%3DM.%2BE.%26aulast%3DJandeleit-Dahm%26aufirst%3DK.%26aulast%3DPage%26aufirst%3DP.%26aulast%3DSzyndralewiez%26aufirst%3DC.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DHebert%26aufirst%3DR.%2BL.%26aulast%3DTouyz%26aufirst%3DR.%2BM.%26atitle%3DRenoprotective%2520Effects%2520of%2520a%2520Novel%2520Nox1%252F4%2520Inhibitor%2520in%2520a%2520Mouse%2520Model%2520of%2520Type%25202%2520Diabetes%26jtitle%3DClin.%2520Sci.%26date%3D2013%26volume%3D124%26issue%3D3%26spage%3D191%26epage%3D202%26doi%3D10.1042%2FCS20120330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schildknecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robotta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drescher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquardt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daiber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leist, M.</span></span> <span> </span><span class="NLM_article-title">The NOX1/4 Inhibitor GKT136901 as Selective and Direct Scavenger of Peroxynitrite</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.2174/09298673113209990179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.2174%2F09298673113209990179" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=365-376&issue=3&author=S.+Schildknechtauthor=A.+Weberauthor=H.+Gerdingauthor=R.+Papeauthor=M.+Robottaauthor=M.+Drescherauthor=A.+Marquardtauthor=A.+Daiberauthor=B.+Fergerauthor=M.+Leist&title=The+NOX1%2F4+Inhibitor+GKT136901+as+Selective+and+Direct+Scavenger+of+Peroxynitrite&doi=10.2174%2F09298673113209990179"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990179%26sid%3Dliteratum%253Aachs%26aulast%3DSchildknecht%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DGerding%26aufirst%3DH.%26aulast%3DPape%26aufirst%3DR.%26aulast%3DRobotta%26aufirst%3DM.%26aulast%3DDrescher%26aufirst%3DM.%26aulast%3DMarquardt%26aufirst%3DA.%26aulast%3DDaiber%26aufirst%3DA.%26aulast%3DFerger%26aufirst%3DB.%26aulast%3DLeist%26aufirst%3DM.%26atitle%3DThe%2520NOX1%252F4%2520Inhibitor%2520GKT136901%2520as%2520Selective%2520and%2520Direct%2520Scavenger%2520of%2520Peroxynitrite%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D3%26spage%3D365%26epage%3D376%26doi%3D10.2174%2F09298673113209990179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dao, V. T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbatreek, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altenhöfer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachado, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neullens, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, U. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. H. H. W.</span></span> <span> </span><span class="NLM_article-title">Isoform-Selective NADPH Oxidase Inhibitor Panel for Pharmacological Target Validation</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2019.12.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2019.12.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31883469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFCnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2020&pages=60-69&author=V.+T.+V.+Daoauthor=M.+H.+Elbatreekauthor=S.+Altenh%C3%B6ferauthor=A.+I.+Casasauthor=M.+P.+Pachadoauthor=C.+T.+Neullensauthor=U.+G.+Knausauthor=H.+H.+H.+W.+Schmidt&title=Isoform-Selective+NADPH+Oxidase+Inhibitor+Panel+for+Pharmacological+Target+Validation&doi=10.1016%2Fj.freeradbiomed.2019.12.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation</span></div><div class="casAuthors">Dao, Vu Thao-Vi; Elbatreek, Mahmoud H.; Altenhofer, Sebastian; Casas, Ana I.; Pachado, Mayra P.; Neullens, Christopher T.; Knaus, Ulla G.; Schmidt, Harald H. H. W.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60-69</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dysfunctional reactive oxygen species (ROS) signaling is considered an important disease mechanism.  Therapeutically, non-selective scavenging of ROS by antioxidants, however, has failed in multiple clin. trials to provide patient benefit.  Instead, pharmacol. modulation of disease-relevant, enzymic sources of ROS appears to be an alternative, more promising and meanwhile successfully validated approach.  With respect to targets, the family of NADPH oxidases (NOX) stands out as main and dedicated ROS sources.  Validation of the different NOX isoforms has been mainly through genetically modified rodent models and is lagging behind in other species.  It is unclear whether the different NOX isoforms are sufficiently distinct to allow selective pharmacol. modulation.  Here we show for five widely used NOX inhibitors that isoform selectivity can be achieved, although individual compd. specificity is as yet insufficient.  NOX1 was most potently (IC50) targeted by ML171 (0.1μM); NOX2, by VAS2870 (0.7μM); NOX4, by M13 (0.01μM) and NOX5, by ML090 (0.01μM).  In addn., some non-specific antioxidant and assay artifacts may limit the interpretation of data, which included, surprisingly, the clin. advanced NOX inhibitor, GKT136901.  In a human ischemic blood-brain barrier hyperpermeability model where genetic target validation is not an option, we provide proof-of-principle that pharmacol. target validation for different NOX isoforms is possible by applying an inhibitor panel at IC50 concns.  Moreover, our findings encourage further lead optimization and development efforts for isoform-selective NOX inhibitors in different indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHoebSJGneMrVg90H21EOLACvtfcHk0lhDiRiRS6lkIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFCnt7Y%253D&md5=0ce490f236e5053d5680c304cef203e8</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2019.12.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2019.12.038%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DV.%2BT.%2BV.%26aulast%3DElbatreek%26aufirst%3DM.%2BH.%26aulast%3DAltenh%25C3%25B6fer%26aufirst%3DS.%26aulast%3DCasas%26aufirst%3DA.%2BI.%26aulast%3DPachado%26aufirst%3DM.%2BP.%26aulast%3DNeullens%26aufirst%3DC.%2BT.%26aulast%3DKnaus%26aufirst%3DU.%2BG.%26aulast%3DSchmidt%26aufirst%3DH.%2BH.%2BH.%2BW.%26atitle%3DIsoform-Selective%2520NADPH%2520Oxidase%2520Inhibitor%2520Panel%2520for%2520Pharmacological%2520Target%2520Validation%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2020%26volume%3D148%26spage%3D60%26epage%3D69%26doi%3D10.1016%2Fj.freeradbiomed.2019.12.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stalin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido-Urbani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szyndralewiez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemelin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coquoz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruegg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, B. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Host NOX1 Blocks Tumor Growth and Enhances Checkpoint Inhibitor–Based Immunotherapy</span>. <i>Life Sci. Alliance</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">e201800265</span>, <span class="refDoi"> DOI: 10.26508/lsa.201800265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.26508%2Flsa.201800265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31249132" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2019&pages=e201800265&issue=4&author=J.+Stalinauthor=S.+Garrido-Urbaniauthor=F.+Heitzauthor=C.+Szyndralewiezauthor=S.+Jemelinauthor=O.+Coquozauthor=C.+Rueggauthor=B.+A.+Imhof&title=Inhibition+of+Host+NOX1+Blocks+Tumor+Growth+and+Enhances+Checkpoint+Inhibitor%E2%80%93Based+Immunotherapy&doi=10.26508%2Flsa.201800265"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.26508%2Flsa.201800265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26508%252Flsa.201800265%26sid%3Dliteratum%253Aachs%26aulast%3DStalin%26aufirst%3DJ.%26aulast%3DGarrido-Urbani%26aufirst%3DS.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DSzyndralewiez%26aufirst%3DC.%26aulast%3DJemelin%26aufirst%3DS.%26aulast%3DCoquoz%26aufirst%3DO.%26aulast%3DRuegg%26aufirst%3DC.%26aulast%3DImhof%26aufirst%3DB.%2BA.%26atitle%3DInhibition%2520of%2520Host%2520NOX1%2520Blocks%2520Tumor%2520Growth%2520and%2520Enhances%2520Checkpoint%2520Inhibitor%25E2%2580%2593Based%2520Immunotherapy%26jtitle%3DLife%2520Sci.%2520Alliance%26date%3D2019%26volume%3D2%26issue%3D4%26spage%3De201800265%26doi%3D10.26508%2Flsa.201800265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschnitz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grund, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armitage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barthel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmann, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meuth, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrewe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gailus-Durner, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klopstock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Angelis, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jandeleit-Dahm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. H. H. W.</span></span> <span> </span><span class="NLM_article-title">Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">e1000479</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1000479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1371%2Fjournal.pbio.1000479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=20877715" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=e1000479&issue=9&author=C.+Kleinschnitzauthor=H.+Grundauthor=K.+Winglerauthor=M.+E.+Armitageauthor=E.+Jonesauthor=M.+Mittalauthor=D.+Baritauthor=T.+Schwarzauthor=C.+Geisauthor=P.+Kraftauthor=K.+Barthelauthor=M.+K.+Schuhmannauthor=A.+M.+Herrmannauthor=S.+G.+Meuthauthor=G.+Stollauthor=S.+Meurerauthor=A.+Schreweauthor=L.+Beckerauthor=V.+Gailus-Durnerauthor=H.+Fuchsauthor=T.+Klopstockauthor=M.+H.+de+Angelisauthor=K.+Jandeleit-Dahmauthor=A.+M.+Shahauthor=N.+Weissmannauthor=H.+H.+H.+W.+Schmidt&title=Post-Stroke+Inhibition+of+Induced+NADPH+Oxidase+Type+4+Prevents+Oxidative+Stress+and+Neurodegeneration&doi=10.1371%2Fjournal.pbio.1000479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1000479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1000479%26sid%3Dliteratum%253Aachs%26aulast%3DKleinschnitz%26aufirst%3DC.%26aulast%3DGrund%26aufirst%3DH.%26aulast%3DWingler%26aufirst%3DK.%26aulast%3DArmitage%26aufirst%3DM.%2BE.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DMittal%26aufirst%3DM.%26aulast%3DBarit%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DT.%26aulast%3DGeis%26aufirst%3DC.%26aulast%3DKraft%26aufirst%3DP.%26aulast%3DBarthel%26aufirst%3DK.%26aulast%3DSchuhmann%26aufirst%3DM.%2BK.%26aulast%3DHerrmann%26aufirst%3DA.%2BM.%26aulast%3DMeuth%26aufirst%3DS.%2BG.%26aulast%3DStoll%26aufirst%3DG.%26aulast%3DMeurer%26aufirst%3DS.%26aulast%3DSchrewe%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DL.%26aulast%3DGailus-Durner%26aufirst%3DV.%26aulast%3DFuchs%26aufirst%3DH.%26aulast%3DKlopstock%26aufirst%3DT.%26aulast%3Dde%2BAngelis%26aufirst%3DM.%2BH.%26aulast%3DJandeleit-Dahm%26aufirst%3DK.%26aulast%3DShah%26aufirst%3DA.%2BM.%26aulast%3DWeissmann%26aufirst%3DN.%26aulast%3DSchmidt%26aufirst%3DH.%2BH.%2BH.%2BW.%26atitle%3DPost-Stroke%2520Inhibition%2520of%2520Induced%2520NADPH%2520Oxidase%2520Type%25204%2520Prevents%2520Oxidative%2520Stress%2520and%2520Neurodegeneration%26jtitle%3DPLoS%2520Biol.%26date%3D2010%26volume%3D8%26issue%3D9%26spage%3De1000479%26doi%3D10.1371%2Fjournal.pbio.1000479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuo, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z. S.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase Inhibitor Regulates MicroRNAs with Improved Outcome after Mechanical Reperfusion</span>. <i>J. Neurointerv. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">702</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1136/neurintsurg-2016-012463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1136%2Fneurintsurg-2016-012463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27325364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC2s7hvV2quw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=702-706&issue=7&author=Z.+Liuauthor=Y.+H.+Tuoauthor=J.+W.+Chenauthor=Q.+Y.+Wangauthor=S.+Liauthor=M.+C.+Liauthor=G.+Daiauthor=J.+S.+Wangauthor=Y.+L.+Zhangauthor=L.+Fengauthor=Z.+S.+Shi&title=NADPH+Oxidase+Inhibitor+Regulates+MicroRNAs+with+Improved+Outcome+after+Mechanical+Reperfusion&doi=10.1136%2Fneurintsurg-2016-012463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH oxidase inhibitor regulates microRNAs with improved outcome after mechanical reperfusion</span></div><div class="casAuthors">Liu Zhong; Tuo Yong-Hua; Wang Qing-Yuan; Wang Jin-Shan; Shi Zhong-Song; Chen Jian-Wen; Li Songlin; Li Ming-Chang; Dai Gang; Zhang Yong-Li; Feng Lei; Shi Zhong-Song</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurointerventional surgery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">702-706</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Inhibition of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) pathway improves the neurological outcome in the transient middle cerebral artery occlusion (tMCAO) animal model.  In this study we analyzed the microRNAs profile targeting NOX2 and NOX4 genes and its response to NOX2/4 inhibitor VAS2870 to understand the mechanisms of this protective effect.  METHODS:  The intraluminal filament tMCAO model was established in hyperglycemic rats (n=106) with 5 hours ischemia followed by 19 hours reperfusion.  NOX inhibitor VAS2870 was delivered intravenously before reperfusion.  Infarct volume, hemorrhagic transformation, and mortality were determined at 24 hours after cerebral ischemia.  MicroRNAs profile targeting NOX2 and NOX4 genes were predicted by microRNA databases and further evaluated by microRNA microarray and quantitative RT-PCR.  RESULTS:  Ten microRNAs potentially targeting NOX2 and NOX4 genes (including microRNA-29a, microRNA-29c, microRNA-126a, microRNA-132, microRNA-136, microRNA-138, microRNA-139, microRNA-153, microRNA-337, and microRNA-376a) were significantly downregulated in the ischemic hemisphere in the tMCAO group compared with the sham-operated group, as shown by microRNA microarray and quantitative RT-PCR (all p<0.05).  Intravenous treatment with NOX inhibitor VAS2870 before reperfusion increased the expression of microRNA-29a, microRNA-29c, microRNA-126a, and microRNA-132 compared with the tMCAO group (all p<0.05).  CONCLUSIONS:  Several microRNAs potentially targeting NOX2 and NOX4 genes displayed altered levels in hyperglycemic rats with the tMCAO model, suggesting their regulatory roles and targeting potentials for acute ischemic stroke treatment.  Targeting specific microRNAs may represent a novel intervention opportunity to improve outcome and reduce hemorrhagic transformation after mechanical reperfusion for acute ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIGso_NfqkwJPlX7E30qdzfW6udTcc2eZ-Uv3DXfzKv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7hvV2quw%253D%253D&md5=01fe1f3159c1f8cf317a40ee387c33f9</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1136%2Fneurintsurg-2016-012463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fneurintsurg-2016-012463%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DTuo%26aufirst%3DY.%2BH.%26aulast%3DChen%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DM.%2BC.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DJ.%2BS.%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DZ.%2BS.%26atitle%3DNADPH%2520Oxidase%2520Inhibitor%2520Regulates%2520MicroRNAs%2520with%2520Improved%2520Outcome%2520after%2520Mechanical%2520Reperfusion%26jtitle%3DJ.%2520Neurointerv.%2520Surg.%26date%3D2017%26volume%3D9%26issue%3D7%26spage%3D702%26epage%3D706%26doi%3D10.1136%2Fneurintsurg-2016-012463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sancho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabregat, I.</span></span> <span> </span><span class="NLM_article-title">The NADPH Oxidase Inhibitor VAS2870 Impairs Cell Growth and Enhances TGF-β-Induced Apoptosis of Liver Tumor Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.bcp.2011.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=21276422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFGkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=917-924&issue=7&author=P.+Sanchoauthor=I.+Fabregat&title=The+NADPH+Oxidase+Inhibitor+VAS2870+Impairs+Cell+Growth+and+Enhances+TGF-%CE%B2-Induced+Apoptosis+of+Liver+Tumor+Cells&doi=10.1016%2Fj.bcp.2011.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-β-induced apoptosis of liver tumor cells</span></div><div class="casAuthors">Sancho, Patricia; Fabregat, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">917-924</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Liver tumor cells show several mol. alterations which favor pro-survival signaling.  Among those, we have proposed the NADPH oxidase NOX1 as a prosurvival signal for liver tumor cells.  On the one side, we have described that FaO rat hepatoma cells show NOX1-dependent partial resistance to apoptosis induced by Transforming Growth Factor beta (TGF-β).  On the other side, we have shown that FaO cells, as well as different human hepatocellular carcinoma (HCC) cell lines, are able to proliferate in the absence of serum through the activation of a NOX1-dependent signaling pathway.  The aim of this work was to analyze the effects of NADPH oxidase pharmacol. inhibition in liver tumor cells using the inhibitor VAS2870.  This compd. inhibits dose-dependently autocrine increase of cell no. in FaO rat hepatoma cells, and almost completely blocked ROS prodn. and thymidine incorporation when used at 25 μM.  Such inhibitory effect on autocrine growth is coincident with lower mRNA levels of EGFR (Epidermal Growth Factor Receptor) and its ligand TGF-α (Transforming Growth Factor-alpha), and decreased phosphorylation of the EGFR itself and other downstream targets, such as SRC or AKT.  Moreover, NADPH oxidase pharmacol. inhibition also effectively attenuates serum-dependent growth and phosphorylation of AKT and ERK.  Importantly, these inhibitory effects on either autocrine or serum-dependent cell growth are obsd. in several human HCC cell lines.  Finally, we have obsd. that VAS2870 is also effective in enhancing apoptosis induced by a physiol. stimulus, such as TGF-β.  In summary, NADPH oxidase pharmacol. inhibition could be considered a promising tool in the treatment of liver cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqd6eXEeGTfbVg90H21EOLACvtfcHk0lggOepld1x_fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFGkt78%253D&md5=571095e0ee96d9fec66b96fc7ca51e2f</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DSancho%26aufirst%3DP.%26aulast%3DFabregat%26aufirst%3DI.%26atitle%3DThe%2520NADPH%2520Oxidase%2520Inhibitor%2520VAS2870%2520Impairs%2520Cell%2520Growth%2520and%2520Enhances%2520TGF-%25CE%25B2-Induced%2520Apoptosis%2520of%2520Liver%2520Tumor%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26issue%3D7%26spage%3D917%26epage%3D924%26doi%3D10.1016%2Fj.bcp.2011.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamler, J. S.</span></span> <span> </span><span class="NLM_article-title">Off-Target Thiol Alkylation by the NADPH Oxidase Inhibitor 3- Benzyl-7-(2-Benzoxazolyl)Thio-1,2,3-Triazolo[4,5-d]Pyrimidine (VAS2870)</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1897</span>– <span class="NLM_lpage">1902</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2012.02.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2012.02.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22406319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlWmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1897-1902&issue=9&author=Q.-A.+Sunauthor=D.+T.+Hessauthor=B.+Wangauthor=M.+Miyagiauthor=J.+S.+Stamler&title=Off-Target+Thiol+Alkylation+by+the+NADPH+Oxidase+Inhibitor+3-+Benzyl-7-%282-Benzoxazolyl%29Thio-1%2C2%2C3-Triazolo%5B4%2C5-d%5DPyrimidine+%28VAS2870%29&doi=10.1016%2Fj.freeradbiomed.2012.02.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine (VAS2870)</span></div><div class="casAuthors">Sun, Qi-An; Hess, Douglas T.; Wang, Benlian; Miyagi, Masaru; Stamler, Jonathan S.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1897-1902</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Specific inhibitors of the prodn. of reactive oxygen species (ROS) by the NADPH oxidases (Nox's) are potentially important therapeutic agents in the wide range of human diseases that are characterized by excessive ROS prodn.  It has been proposed that VAS2870 (3-benzyl-7-(2-benzoxazolyl)thio-1,2,3- triazolo[4,5-d]pyrimidine), identified as an inhibitor of Nox2 by small-mol. screening, may serve as an example of such an agent.  Here we show that VAS2870 inhibits ROS prodn. in the sarcoplasmic reticulum (SR) of mammalian skeletal muscle, previously identified with Nox4, and thereby abrogates O2-coupled redox regulation of the ryanodine receptor-Ca2+ channel (RyR1).  However, we also find that VAS2870 modifies directly identified cysteine thiols within RyR1.  Mass spectrometric anal. of RyR1 exposed in situ to VAS2870 and of VAS2870-treated glutathione indicated that thiol modification is through alkylation by the benzyltriazolopyrimidine moiety of VAS2870.  Thus, VAS2870 exerts significant off-target effects, and thiol alkylation by VAS2870 (and closely related Nox inhibitors) may in fact replicate some of the effects of ROS on cellular thiol redox status.  In addn., we show that SR-localized Nox4 is inhibited by other thiol-alkylating agents, consistent with a causal role for cysteine modification in the inhibition of ROS prodn. by VAS2870.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSMAxkJX1GbbVg90H21EOLACvtfcHk0lggOepld1x_fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlWmsLs%253D&md5=43dae8c22f646bd49a41392cf6d092f9</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2012.02.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2012.02.046%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.-A.%26aulast%3DHess%26aufirst%3DD.%2BT.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMiyagi%26aufirst%3DM.%26aulast%3DStamler%26aufirst%3DJ.%2BS.%26atitle%3DOff-Target%2520Thiol%2520Alkylation%2520by%2520the%2520NADPH%2520Oxidase%2520Inhibitor%25203-%2520Benzyl-7-%25282-Benzoxazolyl%2529Thio-1%252C2%252C3-Triazolo%255B4%252C5-d%255DPyrimidine%2520%2528VAS2870%2529%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26issue%3D9%26spage%3D1897%26epage%3D1902%26doi%3D10.1016%2Fj.freeradbiomed.2012.02.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wind, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuerlein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eucker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armitage, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingler, K.</span></span> <span> </span><span class="NLM_article-title">Comparative Pharmacology of Chemically Distinct NADPH Oxidase Inhibitors</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>161</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00920.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fj.1476-5381.2010.00920.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=20860666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kju7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=885-898&issue=4&author=S.+Windauthor=K.+Beuerleinauthor=T.+Euckerauthor=H.+M%C3%BCllerauthor=P.+Scheurerauthor=M.+Armitageauthor=H.+Hoauthor=H.+Schmidtauthor=K.+Wingler&title=Comparative+Pharmacology+of+Chemically+Distinct+NADPH+Oxidase+Inhibitors&doi=10.1111%2Fj.1476-5381.2010.00920.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative pharmacology of chemically distinct NADPH oxidase inhibitors</span></div><div class="casAuthors">Wind, S.; Beuerlein, K.; Eucker, T.; Mueller, H.; Scheurer, P.; Armitage, M. E.; Ho, H.; Schmidt, H. H. H. W.; Wingler, K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">885-898</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Oxidative stress [i.e. increased levels of reactive oxygen species (ROS)] was suggested as a pathomechanism of different diseases, although the disease-relevant sources of ROS remain to be identified.  One of these sources may be NADPH oxidases.  However, due to increasing concerns about the specificity of the compds. commonly used as NADPH oxidase inhibitors, data obtained with these compds. may have to be re-interpreted.  We compared the pharmacol. profiles of the commonly used NADPH oxidase inhibitors, diphenylene iodonium (DPI), apocynin and 4-(2-amino-ethyl)-benzolsulfonyl-fluoride (AEBSF), as well as the novel triazolo pyrimidine VAS3947.  We used several assays for detecting cellular and tissue ROS, as none of them is specific and artifact free.  DPI abolished NADPH oxidase-mediated ROS formation, but also inhibited other flavo-enzymes such as NO synthase (NOS) and xanthine oxidase (XOD).  Apocynin interfered with ROS detection and varied considerably in efficacy and potency, as did AEBSF.  Conversely, the novel NADPH oxidase inhibitor, VAS3947, consistently inhibited NADPH oxidase activity in low micromolar concns., and interfered neither with ROS detection nor with XOD or eNOS activities.  VAS3947 attenuated ROS formation in aortas of spontaneously hypertensive rats (SHRs), where NOS or XOD inhibitors were without effect.  These data suggest that triazolo pyrimidines such as VAS3947 are specific NADPH oxidase inhibitors, while DPI and apocynin can no longer be recommended.  Based on the effects of VAS3947, NADPH oxidases appear to be a major source of ROS in aortas of SHRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0O304hImDGbVg90H21EOLACvtfcHk0liUB7WnxEcxjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kju7zN&md5=c8f1238e49b693771df03b590ed524b8</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00920.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00920.x%26sid%3Dliteratum%253Aachs%26aulast%3DWind%26aufirst%3DS.%26aulast%3DBeuerlein%26aufirst%3DK.%26aulast%3DEucker%26aufirst%3DT.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DScheurer%26aufirst%3DP.%26aulast%3DArmitage%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DSchmidt%26aufirst%3DH.%26aulast%3DWingler%26aufirst%3DK.%26atitle%3DComparative%2520Pharmacology%2520of%2520Chemically%2520Distinct%2520NADPH%2520Oxidase%2520Inhibitors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26issue%3D4%26spage%3D885%26epage%3D898%26doi%3D10.1111%2Fj.1476-5381.2010.00920.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cha, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y. S.</span></span> <span> </span><span class="NLM_article-title">APX-115, a First-in-Class Pan-NADPH Oxidase (Nox) Inhibitor, Protects Db/Db Mice from Renal Injury</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1038/labinvest.2017.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Flabinvest.2017.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28165467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFGltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2017&pages=419-431&issue=4&author=D.+R.+Chaauthor=J.+J.+Chaauthor=H.+S.+Minauthor=K.+T.+Kimauthor=J.+E.+Kimauthor=J.+Y.+Gheeauthor=H.+W.+Kimauthor=J.+E.+Leeauthor=J.+Y.+Hanauthor=G.+Leeauthor=H.+J.+Haauthor=Y.+S.+Baeauthor=S.+R.+Leeauthor=S.+H.+Moonauthor=S.+C.+Leeauthor=G.+Kimauthor=Y.+S.+Kang&title=APX-115%2C+a+First-in-Class+Pan-NADPH+Oxidase+%28Nox%29+Inhibitor%2C+Protects+Db%2FDb+Mice+from+Renal+Injury&doi=10.1038%2Flabinvest.2017.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury</span></div><div class="casAuthors">Cha, Jin Joo; Min, Hye Sook; Kim, Ki Tae; Kim, Jung Eun; Ghee, Jung Yeon; Kim, Hyun Wook; Lee, Ji Eun; Han, Jee Young; Lee, Gayoung; Ha, Hun Joo; Bae, Yun Soo; Lee, Sae Rom; Moon, Sung Hwan; Lee, Sung Chan; Kim, Ganghyun; Kang, Young Sun; Cha, Dae Ryong</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory Investigation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-431</span>CODEN:
                <span class="NLM_cas:coden">LAINAW</span>;
        ISSN:<span class="NLM_cas:issn">0023-6837</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recent studies have suggested that renal Nox is important in the progression of diabetic nephropathy.  Therefore, we investigated the effect of a novel pan-NOX-inhibitor, APX-115, on diabetic nephropathy in type 2 diabetic mice.  Eight- week-old db/m and db/db mice were treated with APX-115 for 12 wk.  APX-115 was administered by oral gavage at a dose of 60 mg/kg per day.  To compare the effects of APX-115 with a dual Nox1/Nox4 inhibitor, db/db mice were treated with GKT137831 according to the same protocol.  APX-115 significantly improved insulin resistance in diabetic mice, similar to GKT137831.  Oxidative stress as measured by plasma 8-isoprostane level was decreased in the APX-115 group compared with diabetic controls.  All lipid profiles, both in plasma and tissues improved with Nox inhibition.  APX-115 treatment decreased Nox1, Nox2, and Nox4 protein expression in the kidney.  APX-115 decreased urinary albumin excretion and preserved creatinine level.  In diabetic kidneys, APX-115 significantly improved mesangial expansion, but GKT137831 did not.  In addn., F4/80 infiltration in the adipose tissue and kidney decreased with APX-115 treatment.  We also found that TGF-β stimulated ROS generation in primary mouse mesangial cells (pMMCs) from wild-type, Nox1 KO, and Duox1 KO mice, but did not induce Nox activity in pMMCs from Nox2 knockout (KO), Nox4 KO, or Duox2 KO mice.  These results indicate that activating Nox2, Nox4, or Duox2 in pMMCs is essential for TGF-β-mediated ROS generation.  Our findings suggest that APX-115 may be as effective or may provide better protection than the dual Nox1/Nox4 inhibitor, and pan-Nox inhibition with APX-115 might be a promising therapy for diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvE3keDiQgirVg90H21EOLACvtfcHk0liUB7WnxEcxjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFGltLo%253D&md5=1228945e1a6780e9b68a46695d3fa4e3</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.2017.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.2017.2%26sid%3Dliteratum%253Aachs%26aulast%3DCha%26aufirst%3DD.%2BR.%26aulast%3DCha%26aufirst%3DJ.%2BJ.%26aulast%3DMin%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DK.%2BT.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DGhee%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DHan%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DBae%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BR.%26aulast%3DMoon%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DKim%26aufirst%3DG.%26aulast%3DKang%26aufirst%3DY.%2BS.%26atitle%3DAPX-115%252C%2520a%2520First-in-Class%2520Pan-NADPH%2520Oxidase%2520%2528Nox%2529%2520Inhibitor%252C%2520Protects%2520Db%252FDb%2520Mice%2520from%2520Renal%2520Injury%26jtitle%3DLab.%2520Invest.%26date%3D2017%26volume%3D97%26issue%3D4%26spage%3D419%26epage%3D431%26doi%3D10.1038%2Flabinvest.2017.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goo, J. Il</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baek, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. S.</span></span> <span> </span><span class="NLM_article-title">A Novel Pyrazole Derivative Protects from Ovariectomy-Induced Osteoporosis through the Inhibition of NADPH Oxidase</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1038/srep22389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fsrep22389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28442746" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=1-14&author=J.+H.+Jooauthor=J.+E.+Huhauthor=J.+H.+Leeauthor=D.+R.+Parkauthor=Y.+Leeauthor=S.+G.+Leeauthor=S.+Choiauthor=H.+J.+Leeauthor=S.+W.+Songauthor=Y.+Jeongauthor=J.+Il+Gooauthor=Y.+Choiauthor=H.+K.+Baekauthor=S.+S.+Yiauthor=S.+J.+Parkauthor=J.+E.+Leeauthor=S.+K.+Kuauthor=W.+J.+Leeauthor=K.+I.+Leeauthor=S.+Y.+Leeauthor=Y.+S.+Bae&title=A+Novel+Pyrazole+Derivative+Protects+from+Ovariectomy-Induced+Osteoporosis+through+the+Inhibition+of+NADPH+Oxidase&doi=10.1038%2Fsrep22389"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1038%2Fsrep22389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22389%26sid%3Dliteratum%253Aachs%26aulast%3DJoo%26aufirst%3DJ.%2BH.%26aulast%3DHuh%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DD.%2BR.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%2BG.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DSong%26aufirst%3DS.%2BW.%26aulast%3DJeong%26aufirst%3DY.%26aulast%3DGoo%26aufirst%3DJ.%2BIl%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DBaek%26aufirst%3DH.%2BK.%26aulast%3DYi%26aufirst%3DS.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DKu%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BI.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DBae%26aufirst%3DY.%2BS.%26atitle%3DA%2520Novel%2520Pyrazole%2520Derivative%2520Protects%2520from%2520Ovariectomy-Induced%2520Osteoporosis%2520through%2520the%2520Inhibition%2520of%2520NADPH%2520Oxidase%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D1%26epage%3D14%26doi%3D10.1038%2Fsrep22389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic Study of NADPH Oxidase Inhibitor Ewha-18278, a Pyrazole Derivative</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">482</span>, <span class="refDoi"> DOI: 10.3390/pharmaceutics11090482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3390%2Fpharmaceutics11090482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmvF2lurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=482&issue=9&author=S.+G.+Leeauthor=J.+Leeauthor=K.+M.+Kimauthor=K.+I.+Leeauthor=Y.+S.+Baeauthor=H.+J.+Lee&title=Pharmacokinetic+Study+of+NADPH+Oxidase+Inhibitor+Ewha-18278%2C+a+Pyrazole+Derivative&doi=10.3390%2Fpharmaceutics11090482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic study of NADPH oxidase inhibitor Ewha-18278, a pyrazole derivative</span></div><div class="casAuthors">Lee, Seul Gee; Lee, Jaeok; Kim, Kyung Min; Lee, Kee-In; Bae, Yun Soo; Lee, Hwa Jeong</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">482</span>CODEN:
                <span class="NLM_cas:coden">PHARK5</span>;
        ISSN:<span class="NLM_cas:issn">1999-4923</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In a previous study, the specific NOX1/2/4 inhibitor Ewha-18278 was confirmed as a possible treatment for osteoporosis both in vitro and in vivo.  Here, we investigated the pharmacokinetics (PK) of the compd. by i.v. (IV) and oral administrations to rats.  Di-Me sulfoxide (DMSO)-based and diazepam injection-based formulations were used to dissolve the compd.  In the latter formulation applicable to humans, the changes in PK parameters were monitored at two different concns. (1 mg/mL and 2 mg/mL).  The area under the plasma concn.-time curve from zero time to infinity (AUCinf) of Ewha-18278 was highest in the DMSO-based formulation (2 mg/mL).  Also, the concn. was increased 1.6-fold at the low concn. of the diazepam injection-based formulation compared to the high concn.  There was no statistical significance in the AUCinf of the compd. between DMSO-based formulation (2 mg/mL) and diazepam injection-based formulation (1 mg/mL).  These results suggest that Ewha-18278 can be delivered to humans by both IV and oral routes.  In addn., the diazepam injection-based formulation of Ewha-18278 appears to be a suitable candidate for dosage development for future toxicity test and clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCVlezw2qPlLVg90H21EOLACvtfcHk0liTKdG6TSkjXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmvF2lurk%253D&md5=7d6440d5548eab81903d8656adcc8728</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics11090482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics11090482%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BG.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%2BM.%26aulast%3DLee%26aufirst%3DK.%2BI.%26aulast%3DBae%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26atitle%3DPharmacokinetic%2520Study%2520of%2520NADPH%2520Oxidase%2520Inhibitor%2520Ewha-18278%252C%2520a%2520Pyrazole%2520Derivative%26jtitle%3DPharmaceutics%26date%3D2019%26volume%3D11%26issue%3D9%26spage%3D482%26doi%3D10.3390%2Fpharmaceutics11090482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorotea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H.</span></span> <span> </span><span class="NLM_article-title">A Pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats</span>. <i>Pharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1159/000491398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1159%2F000491398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30099457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslaqt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2018&pages=180-189&issue=3%E2%80%934&author=D.+Doroteaauthor=G.+Kwonauthor=J.+H.+Leeauthor=E.+Saundersauthor=Y.+S.+Baeauthor=S.+H.+Moonauthor=S.+J.+Leeauthor=D.+R.+Chaauthor=H.+Ha&title=A+Pan-NADPH+Oxidase+Inhibitor+Ameliorates+Kidney+Injury+in+Type+1+Diabetic+Rats&doi=10.1159%2F000491398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">A pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats</span></div><div class="casAuthors">Dorotea, Debra; Kwon, Guideock; Lee, Jung Hwa; Saunders, Erika; Bae, Yun Soo; Moon, Sung Hwan; Lee, Soo Jin; Cha, Dae Ryong; Ha, Hunjoo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">180-189</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: NADPH oxidases (Nox) is a major enzyme system contributing to oxidative stress, which plays an important role in the pathogenesis of diabetic kidney disease (DKD).  We have shown an elevation of renal Nox1, Nox2, and Nox4 in diabetic mice.  APX-115, a pan-Nox inhibitor, attenuated the progression of DKD in mice.  As the std. diabetic mice cannot fully mimic human DKD, the present study was aimed to show the dose-dependent effect and to provide a confirmatory evidence of APX-115 in attenuating DKD in diabetic rats.  Method: Type 1 diabetes was induced by a single 60 mg/kg i.p. injection of streptozotocin in Sprague-Dawley rats. 0.5, 5, or 30 mg APX-115/kg/day or losartan 1 mg/kg/day were administered orally to diabetic rats for 8 wk.  Results: APX-115 treatment showed an improvement in kidney function and tubular and podocyte -injury, as well as attenuation of inflammation, fibrosis, and oxidative stress as much as losartan, a comparative drug and mainstay treatment in DKD.  Therapeutic effect of APX-115 was exhibited in a dose-dependent manner; a dose of 30 mg/kg displayed a superior efficacy.  Conclusion: This finding verified the pre-clin. data of APX-115 in protecting against DKD, which is important to bring APX-115 toward the next stage of drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_DemfCK7hD7Vg90H21EOLACvtfcHk0lh0OxznTgwm2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslaqt7vO&md5=6db3af54eb5aebf07d3a96db68a9971d</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1159%2F000491398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000491398%26sid%3Dliteratum%253Aachs%26aulast%3DDorotea%26aufirst%3DD.%26aulast%3DKwon%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DSaunders%26aufirst%3DE.%26aulast%3DBae%26aufirst%3DY.%2BS.%26aulast%3DMoon%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DCha%26aufirst%3DD.%2BR.%26aulast%3DHa%26aufirst%3DH.%26atitle%3DA%2520Pan-NADPH%2520Oxidase%2520Inhibitor%2520Ameliorates%2520Kidney%2520Injury%2520in%2520Type%25201%2520Diabetic%2520Rats%26jtitle%3DPharmacology%26date%3D2018%26volume%3D102%26issue%3D3%25E2%2580%25934%26spage%3D180%26epage%3D189%26doi%3D10.1159%2F000491398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiomi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanibuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamata, T.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of a Novel NADPH Oxidase 1 (Nox1) Inhibitor That Suppresses Proliferation of Colon and Stomach Cancer Cells</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1248/bpb.b17-00804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1248%2Fbpb.b17-00804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29269607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWhsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=419-426&issue=3&author=T.+Yamamotoauthor=H.+Nakanoauthor=K.+Shiomiauthor=K.+Wanibuchiauthor=H.+Masuiauthor=T.+Takahashiauthor=Y.+Uranoauthor=T.+Kamata&title=Identification+and+Characterization+of+a+Novel+NADPH+Oxidase+1+%28Nox1%29+Inhibitor+That+Suppresses+Proliferation+of+Colon+and+Stomach+Cancer+Cells&doi=10.1248%2Fbpb.b17-00804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a novel NADPH oxidase 1 (noxl) inhibitor that suppresses proliferation of colon and stomach cancer cells</span></div><div class="casAuthors">Yamamoto, Tsuyoshi; Nakano, Hirofumi; Shiomi, Kazuro; Wanibuchi, Kiyofumi; Masui, Hisashi; Takahashi, Takashi; Urano, Yasuteru; Kamata, Tohru</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">419-426</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) generated by reduced NADP (NADPH) oxidase (Nox)l mediate cellular signalings i.m. oh ed in normal physiol. processes, and aberrant control of Noxl has been implicated in the pathogenesis of various diseases.  Therefore, Noxl could have great potential as a therapeutic target.  Here, we identified a novel Nox1 inhibitor.  NOS31 secreted from Stretomyces sp. and analyzed its chem. structure.  Furthermore, NOS31 was found to selectively inhibit Noxl-mediated ROS generation, with only a marginal effect on other Nox isoforms (Nox2-5) and no ROS scavenging activity.  This compd. blocked both Nox organizer I (NOXOI)/Nox activator I (NOXA1)-dependent and phorbol 12-myristatc 13-acetate-stimulated Noxl-mediatcd ROS prodn. in colon cancer cells.  NOS31 inhibited the proliferation of several colon carcinoma and gastric cancer cell lines that uprcgulate the Noxl system, whereas it had no appreciable effect on normal cells with low levels or Nox1.  The finding suggests that NOS331 is a unique, potent Noxl inhibitor of microbial origin and raises its possibility as a therapeutic agent for inhibiting gastrointestinal cancer cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN-FOsZej6MLVg90H21EOLACvtfcHk0lh0OxznTgwm2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWhsb3J&md5=dc104452d63f966ee58d9b2ae7443e0c</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b17-00804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b17-00804%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DShiomi%26aufirst%3DK.%26aulast%3DWanibuchi%26aufirst%3DK.%26aulast%3DMasui%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DKamata%26aufirst%3DT.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520Novel%2520NADPH%2520Oxidase%25201%2520%2528Nox1%2529%2520Inhibitor%2520That%2520Suppresses%2520Proliferation%2520of%2520Colon%2520and%2520Stomach%2520Cancer%2520Cells%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2018%26volume%3D41%26issue%3D3%26spage%3D419%26epage%3D426%26doi%3D10.1248%2Fbpb.b17-00804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chueng, A. L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunne, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seredenina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulyanidewi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aw, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oon, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaquet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutter, A. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1089/ars.2014.6202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1089%2Fars.2014.6202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26135714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWmurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=358-374&issue=5&author=K.+Hiranoauthor=W.+S.+Chenauthor=A.+L.+W.+Chuengauthor=A.+A.+Dunneauthor=T.+Seredeninaauthor=A.+Filippovaauthor=S.+Ramachandranauthor=A.+Bridgesauthor=L.+Chaudryauthor=G.+Pettmanauthor=C.+Allanauthor=S.+Duncanauthor=K.+C.+Leeauthor=J.+Limauthor=M.+T.+Maauthor=A.+B.+Ongauthor=N.+Y.+Yeauthor=S.+Nasirauthor=S.+Mulyanidewiauthor=C.+C.+Awauthor=P.+P.+Oonauthor=S.+Liaoauthor=D.+Liauthor=D.+G.+Johnsauthor=N.+D.+Millerauthor=C.+H.+Daviesauthor=E.+R.+Browneauthor=Y.+Matsuokaauthor=D.+W.+Chenauthor=V.+Jaquetauthor=A.+R.+Rutter&title=Discovery+of+GSK2795039%2C+a+Novel+Small+Molecule+NADPH+Oxidase+2+Inhibitor&doi=10.1089%2Fars.2014.6202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor</span></div><div class="casAuthors">Hirano, Kazufumi; Chen, Woei Shin; Chueng, Adeline L. W.; Dunne, Angela A.; Seredenina, Tamara; Filippova, Aleksandra; Ramachandran, Sumitra; Bridges, Angela; Chaudry, Laiq; Pettman, Gary; Allan, Craig; Duncan, Sarah; Lee, Kiew Ching; Lim, Jean; Ma, May Thu; Ong, Agnes B.; Ye, Nicole Y.; Nasir, Shabina; Mulyanidewi, Sri; Aw, Chiu Cheong; Oon, Pamela P.; Liao, Shihua; Li, Dizheng; Johns, Douglas G.; Miller, Neil D.; Davies, Ceri H.; Browne, Edward R.; Matsuoka, Yasuji; Chen, Deborah W.; Jaquet, Vincent; Rutter, A. Richard</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">358-374</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: The NADPH oxidase (NOX) family of enzymes catalyzes the formation of reactive oxygen species (ROS).  NOX enzymes not only have a key role in a variety of physiol. processes but also contribute to oxidative stress in certain disease states.  To date, while numerous small mol. inhibitors have been reported (in particular for NOX2), none have demonstrated inhibitory activity in vivo.  As such, there is a need for the identification of improved NOX inhibitors to enable further evaluation of the biol. functions of NOX enzymes in vivo as well as the therapeutic potential of NOX inhibition.  In this study, both the in vitro and in vivo pharmacol. profiles of GSK2795039, a novel NOX2 inhibitor, were characterized in comparison with other published NOX inhibitors.  Results: GSK2795039 inhibited both the formation of ROS and the utilization of the enzyme substrates, NADPH and oxygen, in a variety of semirecombinant cell-free and cell-based NOX2 assays.  It inhibited NOX2 in an NADPH competitive manner and was selective over other NOX isoforms, xanthine oxidase, and endothelial nitric oxide synthase enzymes.  Following systemic administration in mice, GSK2795039 abolished the prodn. of ROS by activated NOX2 enzyme in a paw inflammation model.  Furthermore, GSK2795039 showed activity in a murine model of acute pancreatitis, reducing the levels of serum amylase triggered by systemic injection of caerulein.  Innovation and Conclusions: GSK2795039 is a novel NOX2 inhibitor that is the first small mol. to demonstrate inhibition of the NOX2 enzyme in vivo.  Antioxid. Redox Signal. 23, 358-374.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfXOnm82DryrVg90H21EOLACvtfcHk0liozTBkVyuNBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWmurvO&md5=5a33ec778532e641db86dcda7c65e6a3</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1089%2Fars.2014.6202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2014.6202%26sid%3Dliteratum%253Aachs%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DW.%2BS.%26aulast%3DChueng%26aufirst%3DA.%2BL.%2BW.%26aulast%3DDunne%26aufirst%3DA.%2BA.%26aulast%3DSeredenina%26aufirst%3DT.%26aulast%3DFilippova%26aufirst%3DA.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DBridges%26aufirst%3DA.%26aulast%3DChaudry%26aufirst%3DL.%26aulast%3DPettman%26aufirst%3DG.%26aulast%3DAllan%26aufirst%3DC.%26aulast%3DDuncan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DK.%2BC.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DM.%2BT.%26aulast%3DOng%26aufirst%3DA.%2BB.%26aulast%3DYe%26aufirst%3DN.%2BY.%26aulast%3DNasir%26aufirst%3DS.%26aulast%3DMulyanidewi%26aufirst%3DS.%26aulast%3DAw%26aufirst%3DC.%2BC.%26aulast%3DOon%26aufirst%3DP.%2BP.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DJohns%26aufirst%3DD.%2BG.%26aulast%3DMiller%26aufirst%3DN.%2BD.%26aulast%3DDavies%26aufirst%3DC.%2BH.%26aulast%3DBrowne%26aufirst%3DE.%2BR.%26aulast%3DMatsuoka%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DD.%2BW.%26aulast%3DJaquet%26aufirst%3DV.%26aulast%3DRutter%26aufirst%3DA.%2BR.%26atitle%3DDiscovery%2520of%2520GSK2795039%252C%2520a%2520Novel%2520Small%2520Molecule%2520NADPH%2520Oxidase%25202%2520Inhibitor%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2015%26volume%3D23%26issue%3D5%26spage%3D358%26epage%3D374%26doi%3D10.1089%2Fars.2014.6202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yauger, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermudez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoica, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrnes, K. R.</span></span> <span> </span><span class="NLM_article-title">Iron Accentuated Reactive Oxygen Species Release by NADPH Oxidase in Activated Microglia Contributes to Oxidative Stress in Vitro</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1186/s12974-019-1430-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1186%2Fs12974-019-1430-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30606213" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=1-15&issue=1&author=Y.+J.+Yaugerauthor=S.+Bermudezauthor=K.+E.+Moritzauthor=E.+Glaserauthor=B.+Stoicaauthor=K.+R.+Byrnes&title=Iron+Accentuated+Reactive+Oxygen+Species+Release+by+NADPH+Oxidase+in+Activated+Microglia+Contributes+to+Oxidative+Stress+in+Vitro&doi=10.1186%2Fs12974-019-1430-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1186%2Fs12974-019-1430-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-019-1430-7%26sid%3Dliteratum%253Aachs%26aulast%3DYauger%26aufirst%3DY.%2BJ.%26aulast%3DBermudez%26aufirst%3DS.%26aulast%3DMoritz%26aufirst%3DK.%2BE.%26aulast%3DGlaser%26aufirst%3DE.%26aulast%3DStoica%26aufirst%3DB.%26aulast%3DByrnes%26aufirst%3DK.%2BR.%26atitle%3DIron%2520Accentuated%2520Reactive%2520Oxygen%2520Species%2520Release%2520by%2520NADPH%2520Oxidase%2520in%2520Activated%2520Microglia%2520Contributes%2520to%2520Oxidative%2520Stress%2520in%2520Vitro%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2019%26volume%3D16%26issue%3D1%26spage%3D1%26epage%3D15%26doi%3D10.1186%2Fs12974-019-1430-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span> <span> </span><span class="NLM_article-title">An Effective NADPH Oxidase 2 Inhibitor Provides Neuroprotection and Improves Functional Outcomes in Animal Model of Traumatic Brain Injury</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1097</span>– <span class="NLM_lpage">1106</span>, <span class="refDoi"> DOI: 10.1007/s11064-020-02987-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs11064-020-02987-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32072445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtlagtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2020&pages=1097-1106&issue=5&author=M.+Wangauthor=L.+Luo&title=An+Effective+NADPH+Oxidase+2+Inhibitor+Provides+Neuroprotection+and+Improves+Functional+Outcomes+in+Animal+Model+of+Traumatic+Brain+Injury&doi=10.1007%2Fs11064-020-02987-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">An Effective NADPH Oxidase 2 Inhibitor Provides Neuroprotection and Improves Functional Outcomes in Animal Model of Traumatic Brain Injury</span></div><div class="casAuthors">Wang, Mengwei; Luo, Le</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1097-1106</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: Traumatic brain injury (TBI) has become a leading cause of death and disability all over the world.  Pharmacol. suppression of NADP (NADPH) oxidase 2 (NOX2) can inhibit oxidative stress which is implicated in the pathol. of TBI.  GSK2795039 was reported to target NOX2 to inhibit O.-2 and ROS prodn.  The present study aimed to investigate the effect of GSK2795039 on NOX2 activity and neurol. deficits in a TBI mouse model.  TBI mouse model was established by a wt.-drop to mouse skull.  GSK2795039 at a dose of 100 mg/kg was administrated to mice 30 min before TBI.  NOX2 expression and activity were detected by Western blot and biochem. method.  Neurol. damage and apoptosis were detected by behavioral test and terminal deoxynucleotidyl transferase dUTP nick end labeling staining.  GSK2795039 significantly inhibited NOX2 expression and activity in the TBI mouse model.  It also attenuated TBI-induced neurol. deficits, apoptosis, and neurol. recovery.  The results indicate that GSK2795039 can be used as a potential drug for TBI treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGSeJFnsKck7Vg90H21EOLACvtfcHk0li_IKh1sHjrsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtlagtLo%253D&md5=0179d06e17ee7bff26773e5063c62bd0</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1007%2Fs11064-020-02987-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-020-02987-3%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DL.%26atitle%3DAn%2520Effective%2520NADPH%2520Oxidase%25202%2520Inhibitor%2520Provides%2520Neuroprotection%2520and%2520Improves%2520Functional%2520Outcomes%2520in%2520Animal%2520Model%2520of%2520Traumatic%2520Brain%2520Injury%26jtitle%3DNeurochem.%2520Res.%26date%3D2020%26volume%3D45%26issue%3D5%26spage%3D1097%26epage%3D1106%26doi%3D10.1007%2Fs11064-020-02987-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cifuentes-Pagano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csányi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Ghouleh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrıguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wipf, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skoda, E. M.</span></span> <span> </span><span class="NLM_article-title">Bridged Tetrahydroisoquinolines as Selective NADPH Oxidase 2 (Nox2) Inhibitors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1039/c3md00061c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1039%2Fc3md00061c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24466406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSiu77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1085-1092&issue=7&author=E.+Cifuentes-Paganoauthor=J.+Sahaauthor=G.+Cs%C3%A1nyiauthor=I.+Al+Ghoulehauthor=S.+Sahooauthor=A.+Rodr%C4%B1guezauthor=P.+Wipfauthor=P.+J.+Paganoauthor=E.+M.+Skoda&title=Bridged+Tetrahydroisoquinolines+as+Selective+NADPH+Oxidase+2+%28Nox2%29+Inhibitors&doi=10.1039%2Fc3md00061c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors</span></div><div class="casAuthors">Cifuentes-Pagano, Eugenia; Saha, Jaideep; Csanyi, Gabor; Al Ghouleh, Imad; Sahoo, Sanghamitra; Rodriguez, Andres; Wipf, Peter; Pagano, Patrick J.; Skoda, Erin M.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1085-1092</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">(1SR,4RS)-3,3-Dimethyl-1,2,3,4-tetrahydro-1,4-(epiminomethano)naphthalenes were synthesized in 2-3 steps from com. available materials and assessed for specificity and effectiveness across a range of Nox isoforms.  The N-pentyl and N-methylenethiophene substituted analogs 11g and 11h emerged as selective Nox2 inhibitors with cellular IC50 values of 20 and 32 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHNPDpo6oc5LVg90H21EOLACvtfcHk0lj6Re5f4oGgsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSiu77J&md5=22132923bdf946990bac6a67c8699b5a</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1039%2Fc3md00061c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00061c%26sid%3Dliteratum%253Aachs%26aulast%3DCifuentes-Pagano%26aufirst%3DE.%26aulast%3DSaha%26aufirst%3DJ.%26aulast%3DCs%25C3%25A1nyi%26aufirst%3DG.%26aulast%3DAl%2BGhouleh%26aufirst%3DI.%26aulast%3DSahoo%26aufirst%3DS.%26aulast%3DRodr%25C4%25B1guez%26aufirst%3DA.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DPagano%26aufirst%3DP.%2BJ.%26aulast%3DSkoda%26aufirst%3DE.%2BM.%26atitle%3DBridged%2520Tetrahydroisoquinolines%2520as%2520Selective%2520NADPH%2520Oxidase%25202%2520%2528Nox2%2529%2520Inhibitors%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26issue%3D7%26spage%3D1085%26epage%3D1092%26doi%3D10.1039%2Fc3md00061c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cifuentes-Pagano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVallance, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jesus, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijles, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croix, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, P. J.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase 2 Inhibitors CPP11G and CPP11H Attenuate Endothelial Cell Inflammation & Vessel Dysfunction and Restore Mouse Hind-Limb Flow</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">101143</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.redox.2019.101143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30897521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltFygsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2019&pages=101143&author=Y.+Liauthor=E.+Cifuentes-Paganoauthor=E.+R.+DeVallanceauthor=D.+S.+de+Jesusauthor=S.+Sahooauthor=D.+N.+Meijlesauthor=D.+Koesauthor=C.+J.+Camachoauthor=M.+Rossauthor=C.+Croixauthor=P.+J.+Pagano&title=NADPH+Oxidase+2+Inhibitors+CPP11G+and+CPP11H+Attenuate+Endothelial+Cell+Inflammation+%26+Vessel+Dysfunction+and+Restore+Mouse+Hind-Limb+Flow&doi=10.1016%2Fj.redox.2019.101143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH oxidase 2 inhibitors CPP11G and CPP11H attenuate endothelial cell inflammation & vessel dysfunction and restore mouse hind-limb flow</span></div><div class="casAuthors">Li, Y.; Cifuentes-Pagano, E.; DeVallance, E. R.; de Jesus, D. S.; Sahoo, S.; Meijles, D. N.; Koes, D.; Camacho, C. J.; Ross, M.; St Croix, C.; Pagano, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101143</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">First described as essential to the phagocytic activity of leukocytes, Nox2-derived ROS have emerged as mediators of a range of cellular and tissue responses across species from salubrious to deleterious consequences.  Knowledge of their role in inflammation is limited, however.  We postulated that TNFα-induced endothelial reactive oxygen species (ROS) generation and pro-inflammatory signaling would be ameliorated by targeting Nox2.  Herein, we in silico-modelled two first-in-class Nox2 inhibitors developed in our lab., explored their cellular mechanism of action and tested their efficacy in in vitro and mouse in vivo models of inflammation.  Our data show that these inhibitors (CPP11G and CPP11H) disrupted canonical Nox2 organizing factor, p47phox, translocation to Nox2 in the plasma membrane; and abolished ROS prodn., markedly attenuated stress-responsive MAPK signaling and downstream AP-1 and NFκB nuclear translocation in human cells.  Consequently, cell adhesion mol. expression and monocyte adherence were significantly inhibited by both inhibitors.  In vivo, TNFα-induced ROS and inflammation were ameliorated by targeted Nox2 inhibition, which, in turn, improved hind-limb blood flow.  These studies identify a proximal role for Nox2 in propagated inflammatory signaling and support therapeutic value of Nox2 inhibitors in inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFWFzZYP-Zn7Vg90H21EOLACvtfcHk0lj6Re5f4oGgsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltFygsLs%253D&md5=98d54bb8d0e14ec2333c9829e1fa3952</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101143%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCifuentes-Pagano%26aufirst%3DE.%26aulast%3DDeVallance%26aufirst%3DE.%2BR.%26aulast%3Dde%2BJesus%26aufirst%3DD.%2BS.%26aulast%3DSahoo%26aufirst%3DS.%26aulast%3DMeijles%26aufirst%3DD.%2BN.%26aulast%3DKoes%26aufirst%3DD.%26aulast%3DCamacho%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DM.%26aulast%3DCroix%26aufirst%3DC.%26aulast%3DPagano%26aufirst%3DP.%2BJ.%26atitle%3DNADPH%2520Oxidase%25202%2520Inhibitors%2520CPP11G%2520and%2520CPP11H%2520Attenuate%2520Endothelial%2520Cell%2520Inflammation%2520%2526%2520Vessel%2520Dysfunction%2520and%2520Restore%2520Mouse%2520Hind-Limb%2520Flow%26jtitle%3DRedox%2520Biol.%26date%3D2019%26volume%3D22%26spage%3D101143%26doi%3D10.1016%2Fj.redox.2019.101143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anvari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikström, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walum, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, N.</span></span> <span> </span><span class="NLM_article-title">The Novel NADPH Oxidase 4 Inhibitor GLX351322 Counteracts Glucose Intolerance in High-Fat Diet-Treated C57BL/6 Mice</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1318</span>, <span class="refDoi"> DOI: 10.3109/10715762.2015.1067697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3109%2F10715762.2015.1067697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26118714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCqtb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2015&pages=1308-1318&issue=11&author=E.+Anvariauthor=P.+Wikstr%C3%B6mauthor=E.+Walumauthor=N.+Welsh&title=The+Novel+NADPH+Oxidase+4+Inhibitor+GLX351322+Counteracts+Glucose+Intolerance+in+High-Fat+Diet-Treated+C57BL%2F6+Mice&doi=10.3109%2F10715762.2015.1067697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice</span></div><div class="casAuthors">Anvari, E.; Wikstroem, P.; Walum, E.; Welsh, N.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1308-1318</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1029-2470</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">In type 2 diabetes, it has been proposed that pancreatic beta-cell dysfunction is promoted by oxidative stress caused by NADPH oxidase (NOX) overactivity.  Five different NOX enzymes (NOX1-5) have been characterized, among which NOX1 and NOX2 have been proposed to neg. affect beta-cells, but the putative role of NOX4 in type 2 diabetes-assocd. beta-cell dysfunction and glucose intolerance is largely unknown.  Therefore, we presently investigated the importance of NOX4 for high-fat diet or HFD-induced glucose intolerance using male C57BL/6 mice using the new NOX4 inhibitor GLX351322, which has relative NOX4 selectivity over NOX2.  In HFD-treated male C57BL/6 mice a two-week treatment with GLX351322 counteracted non-fasting hyperglycemia and impaired glucose tolerance.  This effect occurred without any change in peripheral insulin sensitivity.  To ascertain that NOX4 also plays a role for the function of human beta-cells, we obsd. that glucose- and sodium palmitate-induced insulin release from human islets in vitro was increased in response to NOX4 inhibitors.  In long-term expts. (1-3 days), high-glucose-induced human islet cell reactive oxygen species (ROS) prodn. and death were prevented by GLX351322.  We propose that while short-term NOX4-generated ROS prodn. is a physiol. requirement for beta-cell function, persistent NOX4 activity, for example, during conditions of high-fat feeding, promotes ROS-mediated beta-cell dysfunction.  Thus, selective NOX inhibition may be a therapeutic strategy in type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZjFHOAuFikrVg90H21EOLACvtfcHk0lhzn9zba6KKNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCqtb%252FJ&md5=7cdc414d304b79261c621c63c91a16dd</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.3109%2F10715762.2015.1067697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715762.2015.1067697%26sid%3Dliteratum%253Aachs%26aulast%3DAnvari%26aufirst%3DE.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DP.%26aulast%3DWalum%26aufirst%3DE.%26aulast%3DWelsh%26aufirst%3DN.%26atitle%3DThe%2520Novel%2520NADPH%2520Oxidase%25204%2520Inhibitor%2520GLX351322%2520Counteracts%2520Glucose%2520Intolerance%2520in%2520High-Fat%2520Diet-Treated%2520C57BL%252F6%2520Mice%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2015%26volume%3D49%26issue%3D11%26spage%3D1308%26epage%3D1318%26doi%3D10.3109%2F10715762.2015.1067697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elksnis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikström, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walum, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, P. O.</span></span> <span> </span><span class="NLM_article-title">The Novel NADPH Oxidase 4 Selective Inhibitor GLX7013114 Counteracts Human Islet Cell Death in Vitro</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">e0204271</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0204271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1371%2Fjournal.pone.0204271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30265686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlais77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=e0204271&issue=9&author=X.+Wangauthor=A.+Elksnisauthor=P.+Wikstr%C3%B6mauthor=E.+Walumauthor=N.+Welshauthor=P.+O.+Carlsson&title=The+Novel+NADPH+Oxidase+4+Selective+Inhibitor+GLX7013114+Counteracts+Human+Islet+Cell+Death+in+Vitro&doi=10.1371%2Fjournal.pone.0204271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro</span></div><div class="casAuthors">Wang, Xuan; Elksnis, Andris; Wikstroem, Per; Walum, Erik; Welsh, Nils; Carlsson, Per-Ola</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0204271/1-e0204271/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The aim of the present study was to evaluate the efficacy of novel Nox inhibitors as protective agents against cytokine- or high glucose + palmitate-induced human beta-cell death.  The Nox2 protein was present mainly in the cytoplasm and was induced by cytokines.  Nox4 protein immunoreactivity, with some nuclear accumulation, was obsd. in human islet cells, and was not affected by islet culture in the presence of cytokines or high glucose + palmitate.  Nox inhibitors with partial or no isoform selectivity (DPI, dapsone, GLX351322, and GLX481372) all reduced ROS prodn. of human islet cells exposed to high glucose + palmitate.  The Nox1 selective inhibitor ML171 failed to reduce human islet cell death in response to both cytokines and high glucose + palmitate.  The selective Nox2 inhibitor Phox-I2 also failed to protect against cytokines, but protected partially against high glucose + palmitate-induced cellular death.  The highly selective Nox4 inhibitor GLX7013114 protected islet cells against both cytokines and high glucose + palmitate.  However, as no osmotic control for high glucose was used, we cannot exclude the possibility that the high glucose effect was due to osmosis.  It is concluded that Nox4 may participate in stress-induced islet cell death in human islets in vitro.  We propose that Nox4 mediates pro-apoptotic effects in intact islets under stressful conditions and that selective Nox4-inhibition may be a therapeutic strategy in type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryI4sqraHD_bVg90H21EOLACvtfcHk0lioT7esOlUlTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlais77I&md5=964257d9fb03458d4eea5f626d2313fe</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0204271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0204271%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DElksnis%26aufirst%3DA.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DP.%26aulast%3DWalum%26aufirst%3DE.%26aulast%3DWelsh%26aufirst%3DN.%26aulast%3DCarlsson%26aufirst%3DP.%2BO.%26atitle%3DThe%2520Novel%2520NADPH%2520Oxidase%25204%2520Selective%2520Inhibitor%2520GLX7013114%2520Counteracts%2520Human%2520Islet%2520Cell%2520Death%2520in%2520Vitro%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26issue%3D9%26spage%3De0204271%26doi%3D10.1371%2Fjournal.pone.0204271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikström, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walum, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovicu, F. J.</span></span> <span> </span><span class="NLM_article-title">A Novel NADPH Oxidase Inhibitor Targeting Nox4 in TGFβ-Induced Lens Epithelial to Mesenchymal Transition</span>. <i>Exp. Eye Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">107692</span>, <span class="refDoi"> DOI: 10.1016/j.exer.2019.107692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.exer.2019.107692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31189078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtF2nsbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2019&pages=107692&author=S.+Dasauthor=P.+Wikstr%C3%B6mauthor=E.+Walumauthor=F.+J.+Lovicu&title=A+Novel+NADPH+Oxidase+Inhibitor+Targeting+Nox4+in+TGF%CE%B2-Induced+Lens+Epithelial+to+Mesenchymal+Transition&doi=10.1016%2Fj.exer.2019.107692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">A novel NADPH oxidase inhibitor targeting Nox4 in TGFβ-induced lens epithelial to mesenchymal transition</span></div><div class="casAuthors">Das, Shannon; Wikstrom, Per; Walum, Erik; Lovicu, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107692</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In the present study, we use a newly developed highly selective Nox4 inhibitor, GLX7013114, to modulate TGFβ-induced lens epithelial to mesenchymal transition (EMT).  Rat lens epithelial explants were pre-treated with 0.3μM of GLX7013114, and then treated with 200 pg/mL of TGF-β2 to induce lens EMT.  ROS prodn. was visualized microscopically using the superoxide fluorogenic probe, DHE.  The EMT process was documented using phase-contrast microscopy, and mol. EMT markers were immunolabeled. qPCR was also performed to observe changes in EMT-assocd. genes.  TGFβ-induced ROS was evident at 8 h of culture and its intensity was found to be significantly reduced when GLX7013114 was applied, comparable to ROS levels measured in untreated explants.  Using phase-contrast microscopy to follow TGFβ-induced EMT over 5 days in the presence of the inhibitor, lens epithelial cells in explants became myofibroblastic by day 2 and underwent progressive apoptosis to reveal a bare lens capsule by day 5.  Explants treated with TGFβ and GLX7013114 had some increased cell survival; however, these differences were not significant.  For the first time, Nox4 inhibition by GLX7013114 was shown to reduce the TGFβ-induced gene expression of α-SMA, collagen 1a and fibronectin.  GLX7013114, given that it appears to block aspects of TGFβ-induced EMT, including ROS prodn., may be a new useful Nox4-selective inhibitor for further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWUXQ3FQty1rVg90H21EOLACvtfcHk0lioT7esOlUlTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtF2nsbfK&md5=32e4193a16132b2d5edcd2bb37b751ec</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2019.107692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2019.107692%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DS.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DP.%26aulast%3DWalum%26aufirst%3DE.%26aulast%3DLovicu%26aufirst%3DF.%2BJ.%26atitle%3DA%2520Novel%2520NADPH%2520Oxidase%2520Inhibitor%2520Targeting%2520Nox4%2520in%2520TGF%25CE%25B2-Induced%2520Lens%2520Epithelial%2520to%2520Mesenchymal%2520Transition%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2019%26volume%3D185%26spage%3D107692%26doi%3D10.1016%2Fj.exer.2019.107692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelso, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porteous, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulter, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porteous, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledgerwood, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span> <span> </span><span class="NLM_article-title">Selective Targeting of a Redox-Active Ubiquinone to Mitochondria within Cells: Antioxidant and Antiapoptotic Properties</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">4588</span>– <span class="NLM_lpage">4596</span>, <span class="refDoi"> DOI: 10.1074/jbc.M009093200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.M009093200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11092892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlOqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=4588-4596&issue=7&author=G.+F.+Kelsoauthor=C.+M.+Porteousauthor=C.+V.+Coulterauthor=G.+Hughesauthor=W.+K.+Porteousauthor=E.+C.+Ledgerwoodauthor=R.+A.+J.+Smithauthor=M.+P.+Murphy&title=Selective+Targeting+of+a+Redox-Active+Ubiquinone+to+Mitochondria+within+Cells%3A+Antioxidant+and+Antiapoptotic+Properties&doi=10.1074%2Fjbc.M009093200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Selective targeting of a redox-active ubiquinone to mitochondria within cells. Antioxidant and antiapoptotic properties</span></div><div class="casAuthors">Kelso, Geoffrey F.; Porteous, Carolyn M.; Coulter, Carolyn V.; Hughes, Gillian; Porteous, William K.; Ledgerwood, Elizabeth C.; Smith, Robin A. J.; Murphy, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4588-4596</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">With the recognition of the central role of mitochondria in apoptosis, there is a need to develop specific tools to manipulate mitochondrial function within cells.  Here we report on the development of a novel antioxidant that selectively blocks mitochondrial oxidative damage, enabling the roles of mitochondrial oxidative stress in different types of cell death to be inferred.  This antioxidant, named mitoQ, is a ubiquinone deriv. targeted to mitochondria by covalent attachment to a lipophilic triphenylphosphonium cation through an aliph. carbon chain.  Due to the large mitochondrial membrane potential, the cation was accumulated within mitochondria inside cells, where the ubiquinone moiety inserted into the lipid bilayer and was reduced by the respiratory chain.  The ubiquinol deriv. thus formed was an effective antioxidant that prevented lipid peroxidn. and protected mitochondria from oxidative damage.  After detoxifying the reactive oxygen species peroxynitrite, the ubiquinol moiety was regenerated by the respiratory chain enabling its antioxidant activity to be recycled.  In cell culture studies, the mitochondrially localized antioxidant protected mammalian cells from hydrogen peroxide-induced apoptosis but not from apoptosis induced by staurosporine or tumor necrosis factor-α.  This was compared with untargeted ubiquinone analogs, which were ineffective in preventing apoptosis.  These results suggest that mitochondrial oxidative stress may be a crit. step in apoptosis induced by hydrogen peroxide but not for apoptosis induced by staurosporine or tumor necrosis factor-α.  We have shown that selectively manipulating mitochondrial antioxidant status with targeted and recyclable antioxidants is a feasible approach to investigate the role of mitochondrial oxidative damage in apoptotic cell death.  This approach will have further applications in investigating mitochondrial dysfunction in a range of exptl. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphRgJVKubqmLVg90H21EOLACvtfcHk0lgJQ1kGvULlnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlOqsb0%253D&md5=15c370855eea13a79a56073e464e71c2</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M009093200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M009093200%26sid%3Dliteratum%253Aachs%26aulast%3DKelso%26aufirst%3DG.%2BF.%26aulast%3DPorteous%26aufirst%3DC.%2BM.%26aulast%3DCoulter%26aufirst%3DC.%2BV.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DPorteous%26aufirst%3DW.%2BK.%26aulast%3DLedgerwood%26aufirst%3DE.%2BC.%26aulast%3DSmith%26aufirst%3DR.%2BA.%2BJ.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26atitle%3DSelective%2520Targeting%2520of%2520a%2520Redox-Active%2520Ubiquinone%2520to%2520Mitochondria%2520within%2520Cells%253A%2520Antioxidant%2520and%2520Antiapoptotic%2520Properties%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D7%26spage%3D4588%26epage%3D4596%26doi%3D10.1074%2Fjbc.M009093200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dashdorj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KR, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. S.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-Targeted Antioxidant MitoQ Ameliorates Experimental Mouse Colitis by Suppressing NLRP3 Inflammasome-Mediated Inflammatory Cytokines</span>. <i>BMC Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1186/1741-7015-11-178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1186%2F1741-7015-11-178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=23281898" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=1-13&author=A.+Dashdorjauthor=J.+KRauthor=S.+Limauthor=A.+Joauthor=M.+N.+Nguyenauthor=J.+Haauthor=K.+S.+Yoonauthor=H.+J.+Kimauthor=J.+H.+Parkauthor=M.+P.+Murphyauthor=S.+S.+Kim&title=Mitochondria-Targeted+Antioxidant+MitoQ+Ameliorates+Experimental+Mouse+Colitis+by+Suppressing+NLRP3+Inflammasome-Mediated+Inflammatory+Cytokines&doi=10.1186%2F1741-7015-11-178"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-11-178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-11-178%26sid%3Dliteratum%253Aachs%26aulast%3DDashdorj%26aufirst%3DA.%26aulast%3DKR%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DJo%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DM.%2BN.%26aulast%3DHa%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DKim%26aufirst%3DS.%2BS.%26atitle%3DMitochondria-Targeted%2520Antioxidant%2520MitoQ%2520Ameliorates%2520Experimental%2520Mouse%2520Colitis%2520by%2520Suppressing%2520NLRP3%2520Inflammasome-Mediated%2520Inflammatory%2520Cytokines%26jtitle%3DBMC%2520Med.%26date%3D2013%26volume%3D11%26spage%3D1%26epage%3D13%26doi%3D10.1186%2F1741-7015-11-178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottwald, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugarski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haenni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuh, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landau, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A. M.</span></span> <span> </span><span class="NLM_article-title">The Targeted Anti-Oxidant MitoQ Causes Mitochondrial Swelling and Depolarization in Kidney Tissue</span>. <i>Physiol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">e13667</span>, <span class="refDoi"> DOI: 10.14814/phy2.13667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.14814%2Fphy2.13667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29611340" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=e13667&issue=7&author=E.+M.+Gottwaldauthor=M.+Dussauthor=M.+Bugarskiauthor=D.+Haenniauthor=C.+D.+Schuhauthor=E.+M.+Landauauthor=A.+M.+Hall&title=The+Targeted+Anti-Oxidant+MitoQ+Causes+Mitochondrial+Swelling+and+Depolarization+in+Kidney+Tissue&doi=10.14814%2Fphy2.13667"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.14814%2Fphy2.13667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14814%252Fphy2.13667%26sid%3Dliteratum%253Aachs%26aulast%3DGottwald%26aufirst%3DE.%2BM.%26aulast%3DDuss%26aufirst%3DM.%26aulast%3DBugarski%26aufirst%3DM.%26aulast%3DHaenni%26aufirst%3DD.%26aulast%3DSchuh%26aufirst%3DC.%2BD.%26aulast%3DLandau%26aufirst%3DE.%2BM.%26aulast%3DHall%26aufirst%3DA.%2BM.%26atitle%3DThe%2520Targeted%2520Anti-Oxidant%2520MitoQ%2520Causes%2520Mitochondrial%2520Swelling%2520and%2520Depolarization%2520in%2520Kidney%2520Tissue%26jtitle%3DPhysiol.%2520Rep.%26date%3D2018%26volume%3D6%26issue%3D7%26spage%3De13667%26doi%3D10.14814%2Fphy2.13667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farhood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, H.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-Targeted Antioxidant Mito-Tempo Protects against Acetaminophen Hepatotoxicity</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">773</span>, <span class="refDoi"> DOI: 10.1007/s00204-016-1692-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs00204-016-1692-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27002509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1CksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2017&pages=761-773&issue=2&author=K.+Duauthor=A.+Farhoodauthor=H.+Jaeschke&title=Mitochondria-Targeted+Antioxidant+Mito-Tempo+Protects+against+Acetaminophen+Hepatotoxicity&doi=10.1007%2Fs00204-016-1692-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity</span></div><div class="casAuthors">Du, Kuo; Farhood, Anwar; Jaeschke, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">761-773</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Acetaminophen (APAP) hepatotoxicity is characterized by an extensive mitochondrial oxidant stress.  However, its importance as a drug target has not been clarified.  To investigate this, fasted C57BL/6J mice were treated with 300 mg/kg APAP and the mitochondria-targeted antioxidant Mito-Tempo (MT) was given 1.5 h later.  APAP caused severe liver injury in mice, as indicated by the increase in plasma ALT activities and centrilobular necrosis.  MT dose-dependently reduced the injury.  Importantly, MT did not affect APAP-protein adducts formation, glutathione depletion or c-jun N-terminal kinase activation and its mitochondrial translocation.  In contrast, hepatic glutathione disulfide and peroxynitrite formation were dose-dependently reduced by MT, indicating its effective mitochondrial oxidant stress scavenging capacity.  Consequently, mitochondrial translocation of Bax and release of mitochondrial intermembrane proteins such as apoptosis-inducing factor were prevented, and nuclear DNA fragmentation was eliminated.  To demonstrate the importance of mitochondria-specific antioxidant property of MT, we compared its efficacy with Tempo, which has the same pharmacol. mode of action as MT but lacks the mitochondria targeting moiety.  In contrast to the dramatic protection by MT, the same molar dose of Tempo did not significantly reduce APAP hepatotoxicity.  In contrast, even a 3 h post-treatment with MT reduced 70 % of the injury, and the combination of MT with N-acetylcysteine (NAC) provided superior protection than NAC alone.  We conclude that MT protects against APAP overdose in mice by attenuating the mitochondrial oxidant stress and preventing peroxynitrite formation and the subsequent mitochondrial dysfunction.  MT is a promising therapeutic agent for APAP overdose patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkdu8xQ6kSLVg90H21EOLACvtfcHk0lihqsbN4SWiLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1CksLo%253D&md5=24cc176d47d5867b8dceda3735e8ba83</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs00204-016-1692-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-016-1692-0%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DK.%26aulast%3DFarhood%26aufirst%3DA.%26aulast%3DJaeschke%26aufirst%3DH.%26atitle%3DMitochondria-Targeted%2520Antioxidant%2520Mito-Tempo%2520Protects%2520against%2520Acetaminophen%2520Hepatotoxicity%26jtitle%3DArch.%2520Toxicol.%26date%3D2017%26volume%3D91%26issue%3D2%26spage%3D761%26epage%3D773%26doi%3D10.1007%2Fs00204-016-1692-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trnka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaikie, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span> <span> </span><span class="NLM_article-title">A Mitochondria-Targeted Nitroxide Is Reduced to Its Hydroxylamine by Ubiquinol in Mitochondria</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1406</span>– <span class="NLM_lpage">1419</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2007.12.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2007.12.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18206669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktV2gt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2008&pages=1406-1419&issue=7&author=J.+Trnkaauthor=F.+H.+Blaikieauthor=R.+A.+J.+Smithauthor=M.+P.+Murphy&title=A+Mitochondria-Targeted+Nitroxide+Is+Reduced+to+Its+Hydroxylamine+by+Ubiquinol+in+Mitochondria&doi=10.1016%2Fj.freeradbiomed.2007.12.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria</span></div><div class="casAuthors">Trnka, Jan; Blaikie, Frances H.; Smith, Robin A. J.; Murphy, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1406-1419</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Piperidine nitroxides such as TEMPOL act as antioxidants in vivo due to their interconversion among nitroxide, hydroxylamine, and oxoammonium derivs., but the mechanistic details of these reactions are unclear.  As mitochondria are a significant site of piperidine nitroxide metab. and action, we synthesized a mitochondria-targeted nitroxide, MitoTEMPOL, by conjugating TEMPOL to the lipophilic triphenylphosphonium cation.  MitoTEMPOL was accumulated several hundred-fold into energized mitochondria where it was reduced to the hydroxylamine by direct reaction with ubiquinol.  This reaction occurred by transfer of H· from ubiquinol to the nitroxide, with the ubisemiquinone radical product predominantly dismutating to ubiquinone and ubiquinol, together with a small amt. reacting with oxygen to form superoxide.  The piperidine nitroxides TEMPOL, TEMPO, and butylTEMPOL reacted similarly with ubiquinol in org. solvents but in mitochondrial membranes the rates varied in the order: MitoTEMPOL > butylTEMPOL > TEMPO > TEMPOL, which correlated with the extent of access of the nitroxide moiety to ubiquinol within the membrane.  These findings suggest ways of using mitochondria-targeted compds. to modulate the coenzyme Q pool within mitochondria in vivo, and indicate that the antioxidant effects of mitochondria-targeted piperidine nitroxides can be ascribed to their corresponding hydroxylamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnMKwk46GgQLVg90H21EOLACvtfcHk0lj010pmrfYKNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktV2gt74%253D&md5=0602de5ab5c90283b05183a2eec565f0</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2007.12.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2007.12.036%26sid%3Dliteratum%253Aachs%26aulast%3DTrnka%26aufirst%3DJ.%26aulast%3DBlaikie%26aufirst%3DF.%2BH.%26aulast%3DSmith%26aufirst%3DR.%2BA.%2BJ.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26atitle%3DA%2520Mitochondria-Targeted%2520Nitroxide%2520Is%2520Reduced%2520to%2520Its%2520Hydroxylamine%2520by%2520Ubiquinol%2520in%2520Mitochondria%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2008%26volume%3D44%26issue%3D7%26spage%3D1406%26epage%3D1419%26doi%3D10.1016%2Fj.freeradbiomed.2007.12.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brand, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, R. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerencser, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borch Jensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardov, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrassi, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeusen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perevoshchikova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasper, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookes, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ainscow, E. K.</span></span> <span> </span><span class="NLM_article-title">Suppressors of Superoxide-H2O2 Production at Site IQ of Mitochondrial Complex I Protect against Stem Cell Hyperplasia and Ischemia-Reperfusion Injury</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2016.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.cmet.2016.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27667666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGru7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=582-592&issue=4&author=M.+D.+Brandauthor=R.+L.+S.+Goncalvesauthor=A.+L.+Orrauthor=L.+Vargasauthor=A.+A.+Gerencserauthor=M.+Borch+Jensenauthor=Y.+T.+Wangauthor=S.+Melovauthor=C.+N.+Turkauthor=J.+T.+Matzenauthor=V.+J.+Dardovauthor=H.+M.+Petrassiauthor=S.+L.+Meeusenauthor=I.+V.+Perevoshchikovaauthor=H.+Jasperauthor=P.+S.+Brookesauthor=E.+K.+Ainscow&title=Suppressors+of+Superoxide-H2O2+Production+at+Site+IQ+of+Mitochondrial+Complex+I+Protect+against+Stem+Cell+Hyperplasia+and+Ischemia-Reperfusion+Injury&doi=10.1016%2Fj.cmet.2016.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Suppressors of Superoxide-H2O2 Production at Site IQ of Mitochondrial Complex I Protect against Stem Cell Hyperplasia and Ischemia-Reperfusion Injury</span></div><div class="casAuthors">Brand, Martin D.; Goncalves, Renata L. S.; Orr, Adam L.; Vargas, Leonardo; Gerencser, Akos A.; Borch Jensen, Martin; Wang, Yves T.; Melov, Simon; Turk, Carolina N.; Matzen, Jason T.; Dardov, Victoria J.; Petrassi, H. Michael; Meeusen, Shelly L.; Perevoshchikova, Irina V.; Jasper, Heinrich; Brookes, Paul S.; Ainscow, Edward K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">582-592</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Using high-throughput screening we identified small mols. that suppress superoxide and/or H2O2 prodn. during reverse electron transport through mitochondrial respiratory complex I (site IQ) without affecting oxidative phosphorylation (suppressors of site IQ electron leak, "S1QELs").  S1QELs diminished endogenous oxidative damage in primary astrocytes cultured at ambient or low oxygen tension, showing that site IQ is a normal contributor to mitochondrial superoxide-H2O2 prodn. in cells.  They diminished stem cell hyperplasia in Drosophila intestine in vivo and caspase activation in a cardiomyocyte cell model driven by endoplasmic reticulum stress, showing that superoxide-H2O2 prodn. by site IQ is involved in cellular stress signaling.  They protected against ischemia-reperfusion injury in perfused mouse heart, showing directly that superoxide-H2O2 prodn. by site IQ is a major contributor to this pathol.  S1QELs are tools for assessing the contribution of site IQ to cell physiol. and pathol. and have great potential as therapeutic leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS7_SIYiA6r7Vg90H21EOLACvtfcHk0lj010pmrfYKNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGru7%252FL&md5=a4dc498852fcb85c3e741fd378a6158f</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2016.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2016.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DM.%2BD.%26aulast%3DGoncalves%26aufirst%3DR.%2BL.%2BS.%26aulast%3DOrr%26aufirst%3DA.%2BL.%26aulast%3DVargas%26aufirst%3DL.%26aulast%3DGerencser%26aufirst%3DA.%2BA.%26aulast%3DBorch%2BJensen%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DMelov%26aufirst%3DS.%26aulast%3DTurk%26aufirst%3DC.%2BN.%26aulast%3DMatzen%26aufirst%3DJ.%2BT.%26aulast%3DDardov%26aufirst%3DV.%2BJ.%26aulast%3DPetrassi%26aufirst%3DH.%2BM.%26aulast%3DMeeusen%26aufirst%3DS.%2BL.%26aulast%3DPerevoshchikova%26aufirst%3DI.%2BV.%26aulast%3DJasper%26aufirst%3DH.%26aulast%3DBrookes%26aufirst%3DP.%2BS.%26aulast%3DAinscow%26aufirst%3DE.%2BK.%26atitle%3DSuppressors%2520of%2520Superoxide-H2O2%2520Production%2520at%2520Site%2520IQ%2520of%2520Mitochondrial%2520Complex%2520I%2520Protect%2520against%2520Stem%2520Cell%2520Hyperplasia%2520and%2520Ischemia-Reperfusion%2520Injury%26jtitle%3DCell%2520Metab.%26date%3D2016%26volume%3D24%26issue%3D4%26spage%3D582%26epage%3D592%26doi%3D10.1016%2Fj.cmet.2016.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monternier, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, M. D.</span></span> <span> </span><span class="NLM_article-title">S1QELs Suppress Mitochondrial Superoxide/Hydrogen Peroxide Production from Site IQ without Inhibiting Reverse Electron Flow through Complex I</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2019.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2019.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31518685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVSrtrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2019&pages=545-559&author=H.+S.+Wongauthor=P.+A.+Monternierauthor=M.+D.+Brand&title=S1QELs+Suppress+Mitochondrial+Superoxide%2FHydrogen+Peroxide+Production+from+Site+IQ+without+Inhibiting+Reverse+Electron+Flow+through+Complex+I&doi=10.1016%2Fj.freeradbiomed.2019.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">S1QELs suppress mitochondrial superoxide/hydrogen peroxide production from site IQ without inhibiting reverse electron flow through Complex I</span></div><div class="casAuthors">Wong, Hoi-Shan; Monternier, Pierre-Axel; Brand, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">545-559</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mitochondria are important sources of superoxide and hydrogen peroxide in cell signaling and disease.  In particular, superoxide/hydrogen peroxide prodn. during reverse electron transport from ubiquinol to NAD+ though Complex I is implicated in several physiol. and pathol. processes.  S1QELs are small mols. that suppress superoxide/hydrogen peroxide prodn. at Complex I without affecting forward electron transport.  Their mechanism of action is disputed.  To test different mechanistic models, we compared the effects of two inhibitors of Complex I electron transport (piericidin A and rotenone) and two S1QELs from different chem. families on superoxide/hydrogen peroxide prodn. and electron transport by Complex I in isolated mitochondria.  Piericidin A and rotenone (and S1QEL1.1 at higher concns.) prevented superoxide/hydrogen peroxide prodn. from sites IQ and IF in Complex I by inhibiting reverse electron transport into the complex.  S1QELs decreased the potency of electron transport inhibition by piericidin A and rotenone, suggesting that S1QELs bind directly to Complex I.  S1QEL2.1 (and S1QEL1.1 at lower concns.) suppressed site IQ without affecting reverse electron transport or site IF, showing that sites IQ and IF are distinct, and that S1QELs do not work simply by decreasing reverse electron transport to site IF (or site IQ).  S1QELs did not affect the redn. of NAD+ or the rate of site IF driven by reverse electron transport, therefore they do not alter the driving forces for reverse electron transport and that is not how they suppress site IQ.  We conclude that S1QELs bind to Complex I to influence the conformation of the piericidin A and rotenone binding sites and directly suppress superoxide/hydrogen peroxide prodn. at site IQ, which is a sep. site from site IF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlNvqJ_wqcrVg90H21EOLACvtfcHk0ljRbIVD88c0CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVSrtrfM&md5=34459a70d21e2fa459401798dd302c03</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2019.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2019.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DMonternier%26aufirst%3DP.%2BA.%26aulast%3DBrand%26aufirst%3DM.%2BD.%26atitle%3DS1QELs%2520Suppress%2520Mitochondrial%2520Superoxide%252FHydrogen%2520Peroxide%2520Production%2520from%2520Site%2520IQ%2520without%2520Inhibiting%2520Reverse%2520Electron%2520Flow%2520through%2520Complex%2520I%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2019%26volume%3D143%26spage%3D545%26epage%3D559%26doi%3D10.1016%2Fj.freeradbiomed.2019.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyoshi, H.</span></span> <span> </span><span class="NLM_article-title">Defining the Mechanism of Action of S1QELs, Specific Suppressors of Superoxide Production in the Quinone-Reaction Site in Mitochondrial Complex I</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">6550</span>– <span class="NLM_lpage">6561</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA119.007687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.RA119.007687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30824536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1Oju7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=6550-6561&issue=16&author=A.+Banbaauthor=A.+Tsujiauthor=H.+Kimuraauthor=M.+Muraiauthor=H.+Miyoshi&title=Defining+the+Mechanism+of+Action+of+S1QELs%2C+Specific+Suppressors+of+Superoxide+Production+in+the+Quinone-Reaction+Site+in+Mitochondrial+Complex+I&doi=10.1074%2Fjbc.RA119.007687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the mechanism of action of S1QELs, specific suppressors of superoxide production in the quinone-reaction site in mitochondrial complex I</span></div><div class="casAuthors">Banba, Atsushi; Tsuji, Atsuhito; Kimura, Hironori; Murai, Masatoshi; Miyoshi, Hideto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6550-6562</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Site-specific suppressors of superoxide prodn. (named S1QELs) in the quinone-reaction site in mitochondrial respiratory complex I during reverse electron transfer have been previously reported; however, their mechanism of action remains elusive.  Using bovine heart submitochondrial particles, we herein investigated the effects of S1QELs on complex I functions.  We found that the inhibitory effects of S1QELs on complex I are distinctly different from those of other known quinone-site inhibitors.  For example, the inhibitory potencies of S1QELs significantly varied depending on the direction of electron transfer (forward or reverse).  S1QELs marginally suppressed the specific chem. modification of Asp160 in the 49-kDa subunit, located deep in the quinone-binding pocket, by the tosyl chem. reagent AL1.  S1QELs also failed to suppress the binding of a photoreactive quinazoline-type inhibitor ([125I]AzQ) to the 49-kDa subunit.  Moreover, a photoaffinity labeling expt. with photoreactive S1QEL derivs. indicated that they bind to a segment in the ND1 subunit that is not considered to make up the binding pocket for quinone or inhibitors.  These results indicate that unlike known quinone-site inhibitors, S1QELs do not occupy the quinone- or inhibitor-binding pocket; rather, they may indirectly modulate the quinone-redox reactions by inducing structural changes of the pocket through binding to ND1.  We conclude that this indirect effect may be a prerequisite for S1QELs' direction-dependent modulation of electron transfer.  This, in turn, may be responsible for the suppression of superoxide prodn. during reverse electron transfer without significantly interfering with forward electron transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomYxrR9X_lkLVg90H21EOLACvtfcHk0lgMYwBDYzNt5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1Oju7fN&md5=13b1780e7672fc8c86f48f04003d8c95</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.007687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.007687%26sid%3Dliteratum%253Aachs%26aulast%3DBanba%26aufirst%3DA.%26aulast%3DTsuji%26aufirst%3DA.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DMurai%26aufirst%3DM.%26aulast%3DMiyoshi%26aufirst%3DH.%26atitle%3DDefining%2520the%2520Mechanism%2520of%2520Action%2520of%2520S1QELs%252C%2520Specific%2520Suppressors%2520of%2520Superoxide%2520Production%2520in%2520the%2520Quinone-Reaction%2520Site%2520in%2520Mitochondrial%2520Complex%2520I%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26issue%3D16%26spage%3D6550%26epage%3D6561%26doi%3D10.1074%2Fjbc.RA119.007687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orr, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baaten, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardov, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attle, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quackenbush, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, R. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perevoshchikova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrassi, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeusen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ainscow, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, M. D.</span></span> <span> </span><span class="NLM_article-title">Suppressors of Superoxide Production from Mitochondrial Complex III</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fnchembio.1910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26368590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2ltrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=834-836&issue=11&author=A.+L.+Orrauthor=L.+Vargasauthor=C.+N.+Turkauthor=J.+E.+Baatenauthor=J.+T.+Matzenauthor=V.+J.+Dardovauthor=S.+J.+Attleauthor=J.+Liauthor=D.+C.+Quackenbushauthor=R.+L.+S.+Goncalvesauthor=I.+V.+Perevoshchikovaauthor=H.+M.+Petrassiauthor=S.+L.+Meeusenauthor=E.+K.+Ainscowauthor=M.+D.+Brand&title=Suppressors+of+Superoxide+Production+from+Mitochondrial+Complex+III&doi=10.1038%2Fnchembio.1910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Suppressors of superoxide production from mitochondrial complex III</span></div><div class="casAuthors">Orr, Adam L.; Vargas, Leonardo; Turk, Carolina N.; Baaten, Janine E.; Matzen, Jason T.; Dardov, Victoria J.; Attle, Stephen J.; Li, Jing; Quackenbush, Douglas C.; Goncalves, Renata L. S.; Perevoshchikova, Irina V.; Petrassi, H. Michael; Meeusen, Shelly L.; Ainscow, Edward K.; Brand, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">834-836</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mitochondrial electron transport drives ATP synthesis but also generates reactive oxygen species, which are both cellular signals and damaging oxidants.  Superoxide prodn. by respiratory complex III is implicated in diverse signaling events and pathologies, but its role remains controversial.  Using high-throughput screening, we identified compds. that selectively eliminate superoxide prodn. by complex III without altering oxidative phosphorylation; they modulate retrograde signaling including cellular responses to hypoxic and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4G_jKAOfBC7Vg90H21EOLACvtfcHk0lgMYwBDYzNt5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2ltrrL&md5=3837c206c33c8a051409893a63019a7b</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1910%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%26aufirst%3DA.%2BL.%26aulast%3DVargas%26aufirst%3DL.%26aulast%3DTurk%26aufirst%3DC.%2BN.%26aulast%3DBaaten%26aufirst%3DJ.%2BE.%26aulast%3DMatzen%26aufirst%3DJ.%2BT.%26aulast%3DDardov%26aufirst%3DV.%2BJ.%26aulast%3DAttle%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DD.%2BC.%26aulast%3DGoncalves%26aufirst%3DR.%2BL.%2BS.%26aulast%3DPerevoshchikova%26aufirst%3DI.%2BV.%26aulast%3DPetrassi%26aufirst%3DH.%2BM.%26aulast%3DMeeusen%26aufirst%3DS.%2BL.%26aulast%3DAinscow%26aufirst%3DE.%2BK.%26aulast%3DBrand%26aufirst%3DM.%2BD.%26atitle%3DSuppressors%2520of%2520Superoxide%2520Production%2520from%2520Mitochondrial%2520Complex%2520III%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D11%26spage%3D834%26epage%3D836%26doi%3D10.1038%2Fnchembio.1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manzoor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoda, N.</span></span> <span> </span><span class="NLM_article-title">A Comprehensive Review of Monoamine Oxidase Inhibitors as Anti-Alzheimer’s Disease Agents: A Review</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">112787</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.ejmech.2020.112787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=32942081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVymsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2020&pages=112787&author=S.+Manzoorauthor=N.+Hoda&title=A+Comprehensive+Review+of+Monoamine+Oxidase+Inhibitors+as+Anti-Alzheimer%E2%80%99s+Disease+Agents%3A+A+Review&doi=10.1016%2Fj.ejmech.2020.112787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review</span></div><div class="casAuthors">Manzoor, Shoaib; Hoda, Nasimul</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112787</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidases (MAO-A and MAO-B) are mammalian flavoenzyme, which catalyze the oxidative deamination of several neurotransmitters like norepinephrine, dopamine, tyramine, serotonin, and some other amines.  The oxidative deamination produces several harmful side products like ammonia, peroxides, and aldehydes during the biochem. reaction.  The concn. of biochem. neurotransmitter alteration in the brain by MAO is directly related with several neurol. disorders like Alzheimer's disease and Parkinson's disease (PD).  Activated MAO also contributes to the amyloid beta (Aβ) aggregation by two successive cleft β-secretase and γ-secretase of amyloid precursor protein (APP).  Addnl., activated MAO is also involved in aggregation of neurofibrillary tangles and cognitive destruction through the cholinergic neuronal damage and disorder of the cholinergic system.  MAO inhibition has general anti-Alzheimer's disease effect as a consequence of oxidative stress redn. prompted by MAO enzymes.  In this review, we outlined and addressed recent understanding on MAO enzymes such as their structure, physiol. function, catalytic mechanism, and possible therapeutic goals in AD.  In addn., it also highlights the current development and discovery of potential MAO inhibitors (MAOIs) from various chem. scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBQku5jXLi7bVg90H21EOLACvtfcHk0liDT4IcNpGOeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVymsr%252FF&md5=b8f8f175d700bb36dd0aab708f197b4d</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112787%26sid%3Dliteratum%253Aachs%26aulast%3DManzoor%26aufirst%3DS.%26aulast%3DHoda%26aufirst%3DN.%26atitle%3DA%2520Comprehensive%2520Review%2520of%2520Monoamine%2520Oxidase%2520Inhibitors%2520as%2520Anti-Alzheimer%25E2%2580%2599s%2520Disease%2520Agents%253A%2520A%2520Review%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D206%26spage%3D112787%26doi%3D10.1016%2Fj.ejmech.2020.112787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B. H.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase Inhibitors, and Iron Chelators in Depressive Illness and Neurodegenerative Diseases</span>. <i>J. Neural Transm.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1719</span>– <span class="NLM_lpage">1733</span>, <span class="refDoi"> DOI: 10.1007/s00702-018-1942-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs00702-018-1942-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30341696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvF2murjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2018&pages=1719-1733&issue=11&author=M.+B.+H.+Youdim&title=Monoamine+Oxidase+Inhibitors%2C+and+Iron+Chelators+in+Depressive+Illness+and+Neurodegenerative+Diseases&doi=10.1007%2Fs00702-018-1942-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases</span></div><div class="casAuthors">Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1719-1733</span>CODEN:
                <span class="NLM_cas:coden">JNTRF3</span>;
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag GmbH</span>)
        </div><div class="casAbstract">In early 1920s, tyramine oxidase was discovered that metabolized tyramine and in 1933 Blaschko demonstrated that this enzyme also metabolized adrenaline, noradrenaline and dopamine.  Zeller gave it the name monoamine oxidase (MAO) to distinguish it from the enzyme that oxidatively deaminated diamines.  MAO was recognized as an enzyme of crucial interest to pharmacologists because it catalyzed the major inactivation pathway for the catecholamines (and, later, 5-hydroxytryptamine, as well).  Within the few decade, the inhibitors of MAO were discovered and introduced for the treatment of depressive illness which was established clin.  However, the first clin. use exposed serious side effects, pharmacol. interest in, and investigation of, MAO continued, resulting in the characterization of two forms, distinct forms, MAO-A and -B, and selective inhibitors for them.  Selective inhibitors of MAO-B (selegiline, rasagiline and safinamide) have found a therapeutic role in the treatment of Parkinson's disease and reversible inhibitors of MAO-A offered antidepressant activity without the serious side effects of the earlier nonselective MAO inhibitors.  Subsequent mol. pharmacol. have also generated the concept of neuroprotection, reflecting the possibility of slowing, halting and maybe reversing, neurodegeneration in Parkinson's or Alzheimer's diseases.  Increased levels of oxidative stress through the accumulation of iron in the Parkinsonian and Alzheimer brains has been suggested to be crit. for the initiation and progress of neurodegeneration.  Selective inhibition of brain MAO could contribute importantly to lowering such stress, preventing the formation of hydrogen peroxide.  Interaction of Iron with hydrogen peroxide and lead to Fenton reaction and prodn. of the most reactive radical, namely hydroxyl radical.  There are complex interactions between free iron levels in brain and MAO, and cascade of neurotoxic events may have practical outcomes for depressive disorders and neurodegenerative diseases.  As consequence recent novel therapeutic drugs for neurodegenerative diseases has led to the development of multi target drugs, that possess selective brain MAO A and B inhibitory moiety, iron chelating and antioxidant activities and the ability to increase brain levels of endogenous neurotrophins, such as BDNF, GDNF VEGF and erythropoietin and induce mitochondrial biogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgtDqxCd-iILVg90H21EOLACvtfcHk0liDT4IcNpGOeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvF2murjO&md5=23e9c21513fbe64a91d0d7e1d38c78db</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1007%2Fs00702-018-1942-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-018-1942-9%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DMonoamine%2520Oxidase%2520Inhibitors%252C%2520and%2520Iron%2520Chelators%2520in%2520Depressive%2520Illness%2520and%2520Neurodegenerative%2520Diseases%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2018%26volume%3D125%26issue%3D11%26spage%3D1719%26epage%3D1733%26doi%3D10.1007%2Fs00702-018-1942-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aminoff, Michael J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christine, Chadwick W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhall, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umeh, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stover, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leehey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweig, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholas, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodis-Wollner</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivan Willis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieburtz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, B. C.</span></span> <span> </span><span class="NLM_article-title">Longer Duration of MAO-b Inhibitor Exposure Is Associated with Less Clinical Decline in Parkinson’s Disease: An Analysis of NETPD LS1</span>. <i>J. Parkinson's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.3233/JPD-160965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3233%2FJPD-160965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27911341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1ehsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=117-127&issue=1&author=R.+A.+Hauserauthor=R.+Liauthor=A.+P%C3%A9rezauthor=X.+Renauthor=D.+Weintraubauthor=J.+Elmauthor=J.+L.+Goudreauauthor=J.+C.+Morganauthor=J.+Y.+Fangauthor=Michael+J.+Aminoffauthor=Chadwick+W.+Christineauthor=R.+Dhallauthor=C.+C.+Umehauthor=J.+T.+Boydauthor=N.+Stoverauthor=M.+Leeheyauthor=R.+M.+Zweigauthor=A.+P.+Nicholasauthor=+Bodis-Wollnerauthor=A.+Ivan+Willisauthor=K.+Kieburtzauthor=B.+C.+Tilley&title=Longer+Duration+of+MAO-b+Inhibitor+Exposure+Is+Associated+with+Less+Clinical+Decline+in+Parkinson%E2%80%99s+Disease%3A+An+Analysis+of+NETPD+LS1&doi=10.3233%2FJPD-160965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1</span></div><div class="casAuthors">Hauser, Robert A.; Li, Ruosha; Perez, Adriana; Ren, Xuehan; Weintraub, Dan; Elm, Jordan; Goudreau, John L.; Morgan, John C.; Fang, John Y.; Aminoff, Michael J.; Christine, Chadwick W.; Dhall, Rohit; Umeh, Chizoba C.; Boyd, James T.; Stover, Natividad; Leehey, Maureen; Zweig, Richard M.; Nicholas, Anthony P.; Bodis-Wollner, Ivan; Willis, Allison; Kieburtz, Karl; Tilley, Barbara C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Parkinson's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-127</span>CODEN:
                <span class="NLM_cas:coden">JPDOAP</span>;
        ISSN:<span class="NLM_cas:issn">1877-7171</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Monoamine oxidase type B (MAO-B) inhibitors exhibit neuroprotective effects in preclin. models of PD but clin. trials have failed to convincingly demonstrate disease modifying benefits in PD patients.  To perform a secondary anal. of NET-PD LS1 to det. if longer duration of MAO-B inhibitor exposure was assocd. with less clin. decline.  The primary outcome measure was the Global Outcome (GO), comprised of 5 measures: change from baseline in the Schwab and England (ADL) scale, the 39-item Parkinson's Disease Questionnaire (PDQ-39), the UPDRS Ambulatory Capacity Scale, the Symbol Digit Modalities Test, and the most recent Modified Rankin Scale.  A linear mixed model was used to explore the assocn. between the cumulative duration of MAO-B inhibitor exposure and the GO, adjusting for necessary factors and confounders.  Assocns. between MAO-B inhibitor exposure and each of the five GO components were then studied individually.  A 1616 participants comprised the analytic sample.  Mean observation was 4.1 (SD = 1.4) years, and 784 (48.5%) participants received an MAO-B inhibitor.  The regression coeff. of cumulative duration of MAO-B inhibitor exposure (in years) on the GO was - 0.0064 (SE = 0.002, p = 0.001).  Significant assocns. between duration of MAO-B inhibitor exposure and less progression were obsd. for ADL (p < 0.001), Ambulatory Capacity (p < 0.001), and the Rankin (p = 0.002).  Our anal. identified a significant assocn. between longer duration of MAO-B inhibitor exposure and less clin. decline.  These findings support the possibility that MAO-B inhibitors slow clin. disease progression and suggest that a definitive prospective trial should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV12MdI0aLkLVg90H21EOLACvtfcHk0lilTBeAXeJyqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1ehsLo%253D&md5=b8479eaa9608eb8368e736609a4585a5</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.3233%2FJPD-160965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJPD-160965%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DP%25C3%25A9rez%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DWeintraub%26aufirst%3DD.%26aulast%3DElm%26aufirst%3DJ.%26aulast%3DGoudreau%26aufirst%3DJ.%2BL.%26aulast%3DMorgan%26aufirst%3DJ.%2BC.%26aulast%3DFang%26aufirst%3DJ.%2BY.%26aulast%3DAminoff%26aufirst%3DMichael%2BJ.%26aulast%3DChristine%26aufirst%3DChadwick%2BW.%26aulast%3DDhall%26aufirst%3DR.%26aulast%3DUmeh%26aufirst%3DC.%2BC.%26aulast%3DBoyd%26aufirst%3DJ.%2BT.%26aulast%3DStover%26aufirst%3DN.%26aulast%3DLeehey%26aufirst%3DM.%26aulast%3DZweig%26aufirst%3DR.%2BM.%26aulast%3DNicholas%26aufirst%3DA.%2BP.%26aulast%3DBodis-Wollner%26aulast%3DIvan%2BWillis%26aufirst%3DA.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DTilley%26aufirst%3DB.%2BC.%26atitle%3DLonger%2520Duration%2520of%2520MAO-b%2520Inhibitor%2520Exposure%2520Is%2520Associated%2520with%2520Less%2520Clinical%2520Decline%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520An%2520Analysis%2520of%2520NETPD%2520LS1%26jtitle%3DJ.%2520Parkinson%2527s%2520Dis.%26date%3D2017%26volume%3D7%26issue%3D1%26spage%3D117%26epage%3D127%26doi%3D10.3233%2FJPD-160965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binde, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tvete, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gåsemyr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natvig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemp, M.</span></span> <span> </span><span class="NLM_article-title">A Multiple Treatment Comparison Meta-Analysis of Monoamine Oxidase Type B Inhibitors for Parkinson’s Disease</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1917</span>– <span class="NLM_lpage">1927</span>, <span class="refDoi"> DOI: 10.1111/bcp.13651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fbcp.13651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29847694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFSqs7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2018&pages=1917-1927&issue=9&author=C.+D.+Bindeauthor=I.+F.+Tveteauthor=J.+G%C3%A5semyrauthor=B.+Natvigauthor=M.+Klemp&title=A+Multiple+Treatment+Comparison+Meta-Analysis+of+Monoamine+Oxidase+Type+B+Inhibitors+for+Parkinson%E2%80%99s+Disease&doi=10.1111%2Fbcp.13651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson's disease</span></div><div class="casAuthors">Binde, C. D.; Tvete, I. F.; Gasemyr, J.; Natvig, B.; Klemp, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1917-1927</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : To the best of our knowledge, there are no systematic reviews or meta-analyses that compare rasagiline, selegiline and safinamide.  Therefore, we aimed to perform a drug class review comparing all available monoamine oxidase type B (MAO-B) inhibitors in a multiple treatment comparison.  Methods : We performed a systematic literature search to identify randomized controlled trials assessing the efficacy of MAO-B inhibitors in patients with Parkinson's disease.  MAO-B inhibitors were evaluated either as monotherapy or in combination with levodopa or dopamine agonists.  Endpoints of interest were change in the Unified Parkinson's Disease Rating Scale (UPDRS) score and serious adverse events.  We estd. the relative effect of each MAO-B inhibitor vs. the comparator drug by creating three networks of direct and indirect comparisons.  For each of the networks, we considered a joint model.  Results : The systematic literature search and study selection process identified 27 publications eligible for our three network analyses.  We found the relative effects of rasagiline, safinamide and selegiline treatment given alone and compared to placebo in a model without explanatory variables to be 1.560 (1.409, 1.734), 1.449 (0.873, 2.413) and 1.532 (1.337, 1.757) resp.  We also found all MAO-B inhibitors to be efficient when given together with levodopa.  When ranking the MAO-B inhibitors given in combination with levodopa, selegiline was the most effective and rasagiline was the second best.  Conclusions : All of the included MAO-B inhibitors were effective compared to placebo when given as monotherapy.  Combination therapy with MAO-B inhibitors and levodopa showed that all three MAO-B inhibitors were effective compared to placebo, but selegiline was the most effective drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMvwb5upOqhLVg90H21EOLACvtfcHk0lgP30sm8IC7-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFSqs7fF&md5=47cee0ca410f382f9ac829d46848fe03</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13651%26sid%3Dliteratum%253Aachs%26aulast%3DBinde%26aufirst%3DC.%2BD.%26aulast%3DTvete%26aufirst%3DI.%2BF.%26aulast%3DG%25C3%25A5semyr%26aufirst%3DJ.%26aulast%3DNatvig%26aufirst%3DB.%26aulast%3DKlemp%26aufirst%3DM.%26atitle%3DA%2520Multiple%2520Treatment%2520Comparison%2520Meta-Analysis%2520of%2520Monoamine%2520Oxidase%2520Type%2520B%2520Inhibitors%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2018%26volume%3D84%26issue%3D9%26spage%3D1917%26epage%3D1927%26doi%3D10.1111%2Fbcp.13651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birkmayer, W.</span></span> <span> </span><span class="NLM_article-title">Deprenyl (Selegiline) in the Treatment of Parkinson ’ s Disease</span>. <i>Acta Neurol. Scand.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">S95</span>),  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0404.1983.tb01522.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1111%2Fj.1600-0404.1983.tb01522.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1983&pages=103-106&issue=S95&author=W.+Birkmayer&title=Deprenyl+%28Selegiline%29+in+the+Treatment+of+Parkinson+%E2%80%99+s+Disease&doi=10.1111%2Fj.1600-0404.1983.tb01522.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0404.1983.tb01522.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0404.1983.tb01522.x%26sid%3Dliteratum%253Aachs%26aulast%3DBirkmayer%26aufirst%3DW.%26atitle%3DDeprenyl%2520%2528Selegiline%2529%2520in%2520the%2520Treatment%2520of%2520Parkinson%2520%25E2%2580%2599%2520s%2520Disease%26jtitle%3DActa%2520Neurol.%2520Scand.%26date%3D1983%26volume%3D68%26issue%3DS95%26spage%3D103%26epage%3D106%26doi%3D10.1111%2Fj.1600-0404.1983.tb01522.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D. R. P.</span></span> <span> </span><span class="NLM_article-title">Rasagiline (TVP-1012): A New Selective Monoamine Oxidase Inhibitor for Parkinson’s Disease</span>. <i>Am. J. Geriatr. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1016/j.amjopharm.2006.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.amjopharm.2006.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=17296539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFequr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=330-346&issue=4&author=D.+R.+P.+Guay&title=Rasagiline+%28TVP-1012%29%3A+A+New+Selective+Monoamine+Oxidase+Inhibitor+for+Parkinson%E2%80%99s+Disease&doi=10.1016%2Fj.amjopharm.2006.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease</span></div><div class="casAuthors">Guay, David R. P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Geriatric Pharmacotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">330-346</span>CODEN:
                <span class="NLM_cas:coden">AJGPB5</span>;
        ISSN:<span class="NLM_cas:issn">1543-5946</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Objective: This article reviews the chem., pharmacodynamics, pharmacokinetics, clin. efficacy, tolerability, drug-interaction potential, indications, dosing, and potential role of rasagiline mesylate, a new selective monoamine oxidase (MAO) type B (MAO-B) inhibitor, in the treatment of Parkinson's disease.  Methods: A MEDLINE/PUBMED search (1986 through Sept. 2006) was conducted to identify studies involving rasagiline written in English.  Addnl. refs. were obtained from the bibliogs. of these studies.  All studies evaluating any aspect of rasagiline, including in vitro, in vivo (animal), and human studies, were reviewed.  Results: Rasagiline mesylate was developed with the goal of producing a selective MAO-B inhibitor that is not metabolized to (presumed) toxic metabolites (eg, amphetamine and methamphetamine, which are byproducts of the metab. of selegiline, another selective MAO-B inhibitor).  In vitro and in vivo data have confirmed the drug's selectivity for MAO-B.  Rasagiline is almost completely eliminated by oxidative metab. (catalyzed by cytochrome P 450 [CYP] isoenzyme 1A2) followed by renal excretion of conjugated parent compd. and metabolites.  Drug clearance is sufficiently slow to allow once-daily dosing.  Several studies have documented its efficacy as monotherapy for early-stage disease and as adjunctive therapy in L-dopa recipients with motor fluctuations.  As monotherapy, rasagiline is well tolerated with an adverse-effect profile similar to that of placebo.  As adjunctive therapy, it exhibits the expected adverse effects of dopamine excess, which can be ameliorated by reducing the L-dopa dosage.  CYP1A2 inhibitors slow the elimination of rasagiline and mandate dosage redn.  Hepatic impairment has an analogous effect.  The recommended dosage regimens for monotherapy and adjunctive therapy are 1 and 0.5 mg PO QD, resp.  Conclusions: Despite the well-documented selectivity of rasagiline, the manufacturer recommends virtually all of the dietary (vis-a-vis tyramine) and drug restrictions of the nonselective MAO inhibitors.  Although useful, selective MAO-B inhibitors have a limited role in Parkinson's disease.  Of greater interest is the potential neuroprotective effect of rasagiline and its major metabolite, 1(R)-aminoindan, which may have great utility in a wide variety of neurodegenerative disorders of aging.  In addn., bifunctional mols. combining selective MAO-B inhibition (based on the active moiety of rasagiline) with acetylcholinesterase inhibition or iron chelation may eventually be useful in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcnBFh20xisrVg90H21EOLACvtfcHk0lhzjUefF2BVVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFequr8%253D&md5=222d796493466e8fad7f46e59ce04e85</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.amjopharm.2006.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjopharm.2006.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DGuay%26aufirst%3DD.%2BR.%2BP.%26atitle%3DRasagiline%2520%2528TVP-1012%2529%253A%2520A%2520New%2520Selective%2520Monoamine%2520Oxidase%2520Inhibitor%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Pharmacother.%26date%3D2006%26volume%3D4%26issue%3D4%26spage%3D330%26epage%3D346%26doi%3D10.1016%2Fj.amjopharm.2006.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filip, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolibás, E.</span></span> <span> </span><span class="NLM_article-title">Selegiline in the Treatment of Alzheimer’s Disease: A Long-Term Randomized Placebo-Controlled Trial</span>. <i>J. Psychiatry Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10354658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADyaK1M3otlSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1999&pages=234-243&issue=3&author=V.+Filipauthor=E.+Kolib%C3%A1s&title=Selegiline+in+the+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+A+Long-Term+Randomized+Placebo-Controlled+Trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group</span></div><div class="casAuthors">Filip V; Kolibas E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">234-43</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the efficacy and adverse effects of the type B monoamine oxidase inhibitor selegiline (also known as I-deprenyl) in the treatment of Alzheimer's disease.  DESIGN:  Long-term, double-blind, placebo-controlled trial.  SETTING:  Seven cities (1 or 2 nursing homes in each city) in the Czech and Slovak Republics.  PATIENTS:  A total of 173 nursing-home residents fulfilling the DSM-III criteria for mild to moderate Alzheimer's disease.  INTERVENTIONS:  Selegiline (10 mg per day) or placebo (both including 50 mg ascorbic acid) administered for 24 weeks.  OUTCOME MEASURES:  Clinical Global Impressions scale and Nurses Observation Scale for Inpatient Evaluation at baseline and at weeks 6, 12 and 24; Clock Drawing Test at baseline and 24 weeks, results of which were evaluated as normal or pathologic, and quantitatively on a modified 6-point scale; Sternberg's Memory Scanning test at baseline and at weeks 6, 12 and 24; Mini Mental State Examination, and electroencephalogram at baseline and 24 weeks; Structured Adverse Effects Rating Scale; physical, laboratory, hematological and electrocardiographic examinations at baseline and weeks 12 and 24.  RESULTS:  A total of 143 subjects completed enough of the trial to be entered in the analysis.  Subjects were analyzed by 2 subgroups depending on whether they had a normal or pathologic result of the Clock Drawing Test.  Analysis of variance showed significant improvement with selegiline versus placebo among those with a normal result of the Clock Drawing Test on the Mini Mental Status Examination (total score and orientation-place subscale) and among those with a pathologic result of the Clock Drawing Test of Sternberg's Memory Scanning test (for both speed and accuracy), on the Clinical Global Impressions scale as well as in terms of the dominant frequency on electroencephalograms.  CONCLUSION:  Selegiline has a long-term beneficial effect in Alzheimer's disease on memory modalities that reflect the function of the prefrontal areas of the brain, which are rich in dopamine receptors.  The delayed appearance of differences between selegiline and placebo supports the notion that the mechanism of action is through neuronal rescue or neuroprotection.  The differential response of patients with normal and pathologic results of the Clock Drawing Test may reflect the fact that the evaluation methods' sensitivity to change depends on the severity of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVoSjqXqI3-5w7prLlxLOzfW6udTcc2ebQchxc2ccsMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3otlSmtw%253D%253D&md5=6b09940e9f47d21c45dd440df17b91bd</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFilip%26aufirst%3DV.%26aulast%3DKolib%25C3%25A1s%26aufirst%3DE.%26atitle%3DSelegiline%2520in%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Long-Term%2520Randomized%2520Placebo-Controlled%2520Trial%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D1999%26volume%3D24%26issue%3D3%26spage%3D234%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kweon, G. R.</span></span> <span> </span><span class="NLM_article-title">L-Deprenyl Exerts Cytotoxicity towards Acute Myeloid Leukemia through Inhibition of Mitochondrial Respiration</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">3869</span>– <span class="NLM_lpage">3878</span>, <span class="refDoi"> DOI: 10.3892/or.2018.6753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3892%2For.2018.6753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=30272370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFahu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=3869-3878&author=I.+Ryuauthor=M.+J.+Ryuauthor=J.+Hanauthor=S.+J.+Kimauthor=M.+J.+Leeauthor=X.+Juauthor=B.+H.+Yooauthor=Y.+L.+Leeauthor=Y.+Jangauthor=I.+C.+Songauthor=W.+Chungauthor=E.+Ohauthor=J.+Y.+Heoauthor=G.+R.+Kweon&title=L-Deprenyl+Exerts+Cytotoxicity+towards+Acute+Myeloid+Leukemia+through+Inhibition+of+Mitochondrial+Respiration&doi=10.3892%2For.2018.6753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">L-Deprenyl exerts cytotoxicity towards acute myeloid leukemia through inhibition of mitochondrial respiration</span></div><div class="casAuthors">Ryu, Ilhwan; Ryu, Min Jeong; Han, Jeongsu; Kim, Soo Jeong; Lee, Min Joung; Ju, Xianshu; Yoo, Byeong Hyeon; Lee, Yu Lim; Jang, Yunseon; Song, Ik-Chan; Chung, Woosuk; Oh, Eungseok; Heo, Jun Young; Kweon, Gi Ryang</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3869-3878</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The identification of large nos. of genetic mutations in immature myeloid cells has made it difficult to identify specific targets for acute myeloid leukemia (AML) therapy.  Although current pharmacol. targets for controlling cancer are focused on identifying genetic mutations, it is hard to develop the specific drugs to achieve complete remission due to complex and variable genetic mutations.  To overcome the failure of the genetic mutation theory, the present study targeted mitochondrial metab. as a strategy for inducing anti.leukemic activity, based on evidence that AML cells have an abnormally high amt. of mitochondria and that somatic mutations can alter metabolic flux in cancer.  It was found that L.deprenyl, which is clin. available for the treatment of Parkinson's disease, exerts anti.mitochondria activity in KG.1α cells, as assessed by detection of oxygen consumption rate (OCR) and extracellular acidification (ECAR) using XF analyzer, resp.  Using a luciferase assay for detecting ATP (ATP) content, it was found that suppression of mitochondrial activity led to ATP depletion and was assocd. with potent cytotoxic activity.  Consistent with the aforementioned results, treatment with L-deprenyl reduced the mRNA level of mitochondrial respiration. and glycolysis.related genes.  Collectively, the present results identify L-deprenyl as a novel candidate for the treatment of AML through inhibition of mitochondrial respiration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxO4qJeJrAJ7Vg90H21EOLACvtfcHk0ligMraiRGvoJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFahu73M&md5=5fb5f18450cbc7a25b85117e536dfb1c</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.3892%2For.2018.6753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2018.6753%26sid%3Dliteratum%253Aachs%26aulast%3DRyu%26aufirst%3DI.%26aulast%3DRyu%26aufirst%3DM.%2BJ.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DJu%26aufirst%3DX.%26aulast%3DYoo%26aufirst%3DB.%2BH.%26aulast%3DLee%26aufirst%3DY.%2BL.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DI.%2BC.%26aulast%3DChung%26aufirst%3DW.%26aulast%3DOh%26aufirst%3DE.%26aulast%3DHeo%26aufirst%3DJ.%2BY.%26aulast%3DKweon%26aufirst%3DG.%2BR.%26atitle%3DL-Deprenyl%2520Exerts%2520Cytotoxicity%2520towards%2520Acute%2520Myeloid%2520Leukemia%2520through%2520Inhibition%2520of%2520Mitochondrial%2520Respiration%26jtitle%3DOncol.%2520Rep.%26date%3D2018%26spage%3D3869%26epage%3D3878%26doi%3D10.3892%2For.2018.6753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lighezan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duicu, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceausu, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaduva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feier, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lighezan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muntean, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mornos, C.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase Inhibition Improves Vascular Function in Mammary Arteries from Nondiabetic and Diabetic Patients with Coronary Heart Disease</span>. <i>Can. J. Physiol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1040</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1139/cjpp-2015-0580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1139%2Fcjpp-2015-0580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27322151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVClu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2016&pages=1040-1047&issue=10&author=R.+Lighezanauthor=A.+Sturzaauthor=O.+M.+Duicuauthor=R.+A.+Ceausuauthor=A.+Vaduvaauthor=M.+Gasparauthor=H.+Feierauthor=M.+Vaidaauthor=V.+Ivanauthor=D.+Lighezanauthor=D.+M.+Munteanauthor=C.+Mornos&title=Monoamine+Oxidase+Inhibition+Improves+Vascular+Function+in+Mammary+Arteries+from+Nondiabetic+and+Diabetic+Patients+with+Coronary+Heart+Disease&doi=10.1139%2Fcjpp-2015-0580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase inhibition improves vascular function in mammary arteries from nondiabetic and diabetic patients with coronary heart disease1</span></div><div class="casAuthors">Lighezan, Rodica; Sturza, Adrian; Duicu, Oana M.; Ceausu, Raluca A.; Vaduva, Adrian; Gaspar, Marian; Feier, Horea; Vaida, Monica; Ivan, Viviana; Lighezan, Daniel; Muntean, Danina M.; Mornos, Cristian</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1040-1047</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    
            (<span class="NLM_cas:orgname">Canadian Science Publishing</span>)
        </div><div class="casAbstract">Monoamine oxidases (MAOs) are mitochondrial enzymes with 2 isoforms that have emerged as important contributors to cardiovascular oxidative stress via the const. generation of hydrogen peroxide.  The present study was purported to assess whether MAO-derived H2O2 contributes to the endothelial dysfunction in mammary arteries harvested from coronary heart disease patients with and without diabetes mellitus subjected to coronary artery bypass grafting.  To this aim, the effects of MAO inhibition on vascular contractility to phenylephrine and endothelial-dependent relaxation (EDR) in response to acetylcholine were studied in vascular segments.  Clorgyline (irreversible MAO-A inhibitor), selegiline (irreversible MAO-B inhibitor), and moclobemide (reversible MAO-A inhibitor) were applied in the organ bath (10 μmol/L).  MAO expression was assessed by immunohistochem.  We found a const. impairment of EDR that has been significantly attenuated in the presence of the MAO-A and MAO-B inhibitors in both groups of coronary heart disease patients.  MAO-B was the dominant isoform in all human diseased vessels.  In conclusion, in vitro inhibition of MAO significantly improved EDR in human mammary arteries, regardless of the presence of diabetes.  These data suggest that MAO inhibitors might be useful in restoring endothelial response in clin. conditions assocd. with increased oxidative stress, such as coronary artery disease and diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFvITuv3YxZ7Vg90H21EOLACvtfcHk0ligMraiRGvoJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVClu73N&md5=162ab83d05c60f7e7d5a0fdb26fbc5af</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1139%2Fcjpp-2015-0580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fcjpp-2015-0580%26sid%3Dliteratum%253Aachs%26aulast%3DLighezan%26aufirst%3DR.%26aulast%3DSturza%26aufirst%3DA.%26aulast%3DDuicu%26aufirst%3DO.%2BM.%26aulast%3DCeausu%26aufirst%3DR.%2BA.%26aulast%3DVaduva%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DM.%26aulast%3DFeier%26aufirst%3DH.%26aulast%3DVaida%26aufirst%3DM.%26aulast%3DIvan%26aufirst%3DV.%26aulast%3DLighezan%26aufirst%3DD.%26aulast%3DMuntean%26aufirst%3DD.%2BM.%26aulast%3DMornos%26aufirst%3DC.%26atitle%3DMonoamine%2520Oxidase%2520Inhibition%2520Improves%2520Vascular%2520Function%2520in%2520Mammary%2520Arteries%2520from%2520Nondiabetic%2520and%2520Diabetic%2520Patients%2520with%2520Coronary%2520Heart%2520Disease%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D2016%26volume%3D94%26issue%3D10%26spage%3D1040%26epage%3D1047%26doi%3D10.1139%2Fcjpp-2015-0580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tábi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vécsei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riederer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szökő, É.</span></span> <span> </span><span class="NLM_article-title">Selegiline: A Molecule with Innovative Potential</span>. <i>J. Neural Transm.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1007/s00702-019-02082-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs00702-019-02082-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31562557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BB3MnivV2lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2020&pages=831-842&issue=5&author=T.+T%C3%A1biauthor=L.+V%C3%A9cseiauthor=M.+B.+Youdimauthor=P.+Riedererauthor=%C3%89.+Sz%C3%B6k%C5%91&title=Selegiline%3A+A+Molecule+with+Innovative+Potential&doi=10.1007%2Fs00702-019-02082-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Selegiline: a molecule with innovative potential</span></div><div class="casAuthors">Tabi Tamas; Szoko Eva; Vecsei Laszlo; Youdim Moussa B; Riederer Peter; Riederer Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission (Vienna, Austria : 1996)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">831-842</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Monoamine oxidase B (MAO-B) inhibitors have an established role in the treatment of Parkinson's disease as monotherapy or adjuvant to levodopa.  Two major recognitions were required for their introduction into this therapeutic field.  The first was the elucidation of the novel pharmacological properties of selegiline as a selective MAO-B inhibitor by Knoll and Magyar and the original idea of Riederer and Youdim, supported by Birkmayer, to explore its effect in parkinsonian patients with on-off phases.  In the 1960s, MAO inhibitors were mainly studied as potential antidepressants, but Birkmayer found that combined use of levodopa and various MAO inhibitors improved akinesia in Parkinson's disease.  However, the serious side effects of the first non-selective MAO inhibitors prevented their further use.  Later studies demonstrated that MAO-B, mainly located in glial cells, is important for dopamine metabolism in the brain.  Recently, cell and molecular studies revealed interesting properties of selegiline opening new possibilities for neuroprotective mechanisms and a disease-modifying effect of MAO-B inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCmt7Ed9RBS1m8bhe6roZYfW6udTcc2ebnC5LCPyWTbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnivV2lsg%253D%253D&md5=66071187e7bbde6e9f565793a90be63b</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1007%2Fs00702-019-02082-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-019-02082-0%26sid%3Dliteratum%253Aachs%26aulast%3DT%25C3%25A1bi%26aufirst%3DT.%26aulast%3DV%25C3%25A9csei%26aufirst%3DL.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DSz%25C3%25B6k%25C5%2591%26aufirst%3D%25C3%2589.%26atitle%3DSelegiline%253A%2520A%2520Molecule%2520with%2520Innovative%2520Potential%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2020%26volume%3D127%26issue%3D5%26spage%3D831%26epage%3D842%26doi%3D10.1007%2Fs00702-019-02082-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroutiunian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarovici, P.</span></span> <span> </span><span class="NLM_article-title">Rasagiline - A Novel MAO B Inhibitor in Parkinson’s Disease Therapy</span>. <i>Ther. Clin. Risk Manag.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18488080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1Cqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=467-474&issue=3&author=S.+Lechtauthor=S.+Haroutiunianauthor=A.+Hoffmanauthor=P.+Lazarovici&title=Rasagiline+-+A+Novel+MAO+B+Inhibitor+in+Parkinson%E2%80%99s+Disease+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy</span></div><div class="casAuthors">Lecht, Shimon; Haroutiunian, Simon; Hoffman, Amnon; Lazarovici, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutics and Clinical Risk Management</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">467-474</span>CODEN:
                <span class="NLM_cas:coden">TCRMA6</span>;
        ISSN:<span class="NLM_cas:issn">1176-6336</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a progressive neurodegenerative, dopamine deficiency disorder.  The main therapeutic strategies for PD treatment relies on dopamine precursors (levodopa), inhibition of dopamine metab. (monoamine oxidase [MAO] B and catechol-O-Me transferase inhibitors), and dopamine receptor agonists.  Recently, a novel selective and irreversible MAO B propargylamine inhibitor rasagiline (N-propargyl-1-R-aminoindan, Azilect) was approved for PD therapy.  In contrast to selegiline, the prototype of MAO B inhibitors, rasagiline is not metabolized to potentially toxic amphetamine metabolites.  The oral bioavailability of rasagiline is 35%, it reaches Tmax after 0.5-1 h and its half-life is 1.5-3.5 h.  Rasagiline undergoes extensive hepatic metab. primarily by cytochrome P 450 type 1A2 (CYP1A2).  Rasagiline is initiated at 1 mg once-daily dosage as monotherapy in early PD patients and at 0.5-1 mg once-daily as adjunctive to levodopa in advanced PD patients.  Rasagiline treatment was not assocd. with "cheese effect" and up to 20 mg per day was well tolerated.  In PD patients with hepatic impairment, rasagiline dosage should be carefully adjusted.  Rasagiline should not be administered with other MAO inhibitors and co-administration with certain antidepressants and opioids should be avoided.  Although further clin. evidence is needed on the neuroprotective effects of rasagiline in PD patients, this drug provides an addnl. tool for PD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUhIhJ2-qIxrVg90H21EOLACvtfcHk0lhoByJcCLUS7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1Cqtro%253D&md5=946444380187310c2fb8925676cd8376</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLecht%26aufirst%3DS.%26aulast%3DHaroutiunian%26aufirst%3DS.%26aulast%3DHoffman%26aufirst%3DA.%26aulast%3DLazarovici%26aufirst%3DP.%26atitle%3DRasagiline%2520-%2520A%2520Novel%2520MAO%2520B%2520Inhibitor%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%2520Therapy%26jtitle%3DTher.%2520Clin.%2520Risk%2520Manag.%26date%3D2007%26volume%3D3%26issue%3D3%26spage%3D467%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sieradzan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Channon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramponi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lees, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span> <span> </span><span class="NLM_article-title">The Therapeutic Potential of Moclobemide, a Reversible Selective Monoamine Oxidase A Inhibitor in Parkinson’s Disease</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">51S</span>– <span class="NLM_lpage">59S</span>, <span class="refDoi"> DOI: 10.1097/00004714-199508001-00010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1097%2F00004714-199508001-00010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=7593732" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=51S-59S&issue=4&author=K.+Sieradzanauthor=S.+Channonauthor=C.+Ramponiauthor=G.+M.+Sternauthor=A.+J.+Leesauthor=M.+B.+Youdim&title=The+Therapeutic+Potential+of+Moclobemide%2C+a+Reversible+Selective+Monoamine+Oxidase+A+Inhibitor+in+Parkinson%E2%80%99s+Disease&doi=10.1097%2F00004714-199508001-00010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1097%2F00004714-199508001-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199508001-00010%26sid%3Dliteratum%253Aachs%26aulast%3DSieradzan%26aufirst%3DK.%26aulast%3DChannon%26aufirst%3DS.%26aulast%3DRamponi%26aufirst%3DC.%26aulast%3DStern%26aufirst%3DG.%2BM.%26aulast%3DLees%26aufirst%3DA.%2BJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DThe%2520Therapeutic%2520Potential%2520of%2520Moclobemide%252C%2520a%2520Reversible%2520Selective%2520Monoamine%2520Oxidase%2520A%2520Inhibitor%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1995%26volume%3D15%26issue%3D4%26spage%3D51S%26epage%3D59S%26doi%3D10.1097%2F00004714-199508001-00010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vuohelainen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hämäläinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paavonen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moilanen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennander, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Monoamine Oxidase A Increases Recovery after Experimental Cardiac Arrest</span>. <i>Interact. Cardiovasc. Thorac. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1093/icvts/ivv175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1093%2Ficvts%2Fivv175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=26116370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC2MbnsF2ntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=441-449&issue=4&author=V.+Vuohelainenauthor=M.+H%C3%A4m%C3%A4l%C3%A4inenauthor=T.+Paavonenauthor=S.+Karlssonauthor=E.+Moilanenauthor=A.+Mennander&title=Inhibition+of+Monoamine+Oxidase+A+Increases+Recovery+after+Experimental+Cardiac+Arrest&doi=10.1093%2Ficvts%2Fivv175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase A increases recovery after experimental cardiac arrest</span></div><div class="casAuthors">Vuohelainen Vilma; Mennander Ari; Hamalainen Mari; Moilanen Eeva; Paavonen Timo; Karlsson Sari</div><div class="citationInfo"><span class="NLM_cas:title">Interactive cardiovascular and thoracic surgery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Perioperative myocardial infarction (MI) with ischaemia-reperfusion injury (IRI) is a devastating entity occurring in 1-2% of patients after cardiac surgery.  The molecular pathway leading to myocardial cellular destruction after MI may include monoamine oxidases.  We experimentally investigated whether moclobemide, a monoamine oxidase inhibitor, enhances myocardial recovery after cardiac arrest and MI.  METHODS:  Fifty-six syngeneic Fischer rats underwent heterotopic cardiac transplantation to induce reversible IRI after cardiac arrest.  Twenty-eight rats also underwent permanent ligation of the left anterior descending coronary artery to induce MI after cardiac arrest.  Twenty-eight rats with or without MI were treated with subcutaneous moclobemide 10 mg/kg/day.  Methods used to study myocardial recovery were microdialysis for intramyocardial metabolism, histology and quantitative reverse-transcription polymerase chain reaction for high-mobility group box-1 (HMGB1), haeme oxygenase-1 (HO-1), interleukin-6, hypoxia-inducible factor 1α and macrophages (CD68).  RESULTS:  Pyruvate increased in MI treated with moclobemide versus IRI with moclobemide (29.19 ± 7.64 vs 13.86 ± 8.49 μM, P = 0.028), reflecting metabolic activity after cardiac arrest and reperfusion.  Myocardial inflammation increased in MI compared with IRI after 1 h (0.80 ± 0.56 vs 0, point score units [PSUs], P = 0.003), but decreased after 5 days in MI treated with moclobemide versus MI alone (0.80 ± 0.83 vs 2.00 ± 0.70, PSU, P = 0.033).  Expressions of HMGB1, CD68 and HO-1 decreased in MI treated with moclobemide versus MI alone (1.33 ± 0.20 vs 1.75 ± 0.24, fold changes [FCs], P = 0.028; 5.15 ± 1.10 vs 9.59 ± 2.75, FC, P = 0.050; 10.41 ± 4.17 vs 21.28 ± 10.01, FC, P = 0.047), indicating myocardial recovery and increased cellularity of remote intramyocardial arteries.  CONCLUSIONS:  Moclobemide enhances myocardial recovery after cardiac arrest and MI; inhibition of remote myocardial changes may be achieved by targeting treatment against monoamine oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1_KCoddCWLq-9TkgmBqTqfW6udTcc2eaWBdi_t6ElqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbnsF2ntA%253D%253D&md5=4e63d058aed5ded8c0634665d537f3b6</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1093%2Ficvts%2Fivv175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ficvts%252Fivv175%26sid%3Dliteratum%253Aachs%26aulast%3DVuohelainen%26aufirst%3DV.%26aulast%3DH%25C3%25A4m%25C3%25A4l%25C3%25A4inen%26aufirst%3DM.%26aulast%3DPaavonen%26aufirst%3DT.%26aulast%3DKarlsson%26aufirst%3DS.%26aulast%3DMoilanen%26aufirst%3DE.%26aulast%3DMennander%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520Monoamine%2520Oxidase%2520A%2520Increases%2520Recovery%2520after%2520Experimental%2520Cardiac%2520Arrest%26jtitle%3DInteract.%2520Cardiovasc.%2520Thorac.%2520Surg.%26date%3D2015%26volume%3D21%26issue%3D4%26spage%3D441%26epage%3D449%26doi%3D10.1093%2Ficvts%2Fivv175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-x.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-k.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S.-n.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-d.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel Propargylamine-Modified 4-Aminoalkyl Imidazole Substituted Pyrimidinylthiourea Derivatives as Multifunctional Agents for the Treatment of Alzheimer’s Disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.ejmech.2017.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29172081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKhsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=33-47&author=Y.-x.+Xuauthor=H.+Wangauthor=X.-k.+Liauthor=S.-n.+Dongauthor=W.-w.+Liuauthor=Q.+Gongauthor=T.-d.-y.+Wangauthor=Y.+Tangauthor=J.+Zhuauthor=J.+Liauthor=H.-y.+Zhangauthor=F.+Mao&title=Discovery+of+Novel+Propargylamine-Modified+4-Aminoalkyl+Imidazole+Substituted+Pyrimidinylthiourea+Derivatives+as+Multifunctional+Agents+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.ejmech.2017.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Xu, Yi-xiang; Wang, Huan; Li, Xiao-kang; Dong, Sheng-nan; Liu, Wen-wen; Gong, Qi; Wang, Tian-duan-yi; Tang, Yun; Zhu, Jin; Li, Jian; Zhang, Hai-yan; Mao, Fei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33-47</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel propargylamine-modified pyrimidinylthiourea derivs. were designed and synthesized as multifunctional agents for Alzheimer's disease (AD) therapy, and their potential was evaluated through various biol. expts.  Among these derivs., compd. 1b (I) displayed good selective inhibitory activity against AChE (vs BuChE, IC50 = 0.324 μM, SI > 123) and MAO-B (vs MAO-A, IC50 = 1.427 μM, SI > 35).  Mol. docking study showed that the pyrimidinylthiourea moiety of 1b could bind to the catalytic active site (CAS) of AChE, and the propargylamine moiety interacted directly with the FAD of MAO-B.  Moreover, 1b demonstrated mild antioxidant ability, good copper chelating property, effective inhibitory activity against Cu2+-induced Aβ1-42 aggregation, moderate neuroprotection, low cytotoxicity, and appropriate blood-brain barrier (BBB) permeability in vitro and was capable of ameliorating scopolamine-induced cognitive impairment in mice.  These results indicated that 1b has the potential to be a multifunctional candidate for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB7tdzpIhKRbVg90H21EOLACvtfcHk0lgeF1rIzyp6AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKhsLjP&md5=d16df6d9494814e95096f04d50cc35b8</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.-x.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.-k.%26aulast%3DDong%26aufirst%3DS.-n.%26aulast%3DLiu%26aufirst%3DW.-w.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DT.-d.-y.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.-y.%26aulast%3DMao%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520Novel%2520Propargylamine-Modified%25204-Aminoalkyl%2520Imidazole%2520Substituted%2520Pyrimidinylthiourea%2520Derivatives%2520as%2520Multifunctional%2520Agents%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D33%26epage%3D47%26doi%3D10.1016%2Fj.ejmech.2017.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Basis of Neuroprotective Activities of Rasagiline and the Anti-Alzheimer Drug TV3326 [(N-Propargyl-(3R)Aminoindan-5-YL)-Ethyl Methyl Carbamate]</span>. <i>Cell. Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1023/A:1015131516649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1023%2FA%3A1015131516649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=12043833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BD38zgt12ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=555-573&issue=6&author=M.+B.+H.+Youdimauthor=M.+Weinstock&title=Molecular+Basis+of+Neuroprotective+Activities+of+Rasagiline+and+the+Anti-Alzheimer+Drug+TV3326+%5B%28N-Propargyl-%283R%29Aminoindan-5-YL%29-Ethyl+Methyl+Carbamate%5D&doi=10.1023%2FA%3A1015131516649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]</span></div><div class="casAuthors">Youdim M B; Weinstock M</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and molecular neurobiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">555-73</span>
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    </div><div class="casAbstract">Rasagiline (N-propargyl-1-(R)-aminoindan) is a selective, irreversible monoamine oxidase B (MAO B) inhibitor which has been developed as an anti-Parkinson drug.  In controlled monotherapy and as adjunct to L-dopa it has shown anti-Parkinson activity.  In cell culture (PC-12 and neuroblastoma SH-SY5Y cells) it exhibits neuroprotective and anti-apoptotic activity against several neurotoxins (SIN-1, MPTP, 6-hydroxydopamine and N-methyl-(R)-salsolinol) and ischemia.  In vivo, it reduces the sequelae of traumatic brain injury in mice and speeds their recovery.  The neuroprotective activity of rasagaline does not result from MAO B inhibition, since its S-enantiomer, TVP1022, which has 1000-fold weaker MAO inhibitory activity, exhibits similar neuroprotective properties.  Introduction of a carbamate moiety into the rasagiline molecule to confer cholinesterase inhibitory activity for the treatment of Alzheimer's disease, resulted in compounds TV3326 [(N-Propargyl-(3R)Aminoindan-5-YL)-Ethyl Methyl Carbamate] and its S-enantiomer TV3279 [(N-Propargyl-(3S)Aminoindan-5-YL)-Ethyl Methyl Carbamate], which retain the neuroprotective activities of rasagiline and TVP1022.  They also antagonize scopolamine-induced impairments in spatial memory.  In addition, TV3326 exhibits brain-selective MAO A and B inhibitory activity after chronic administration and has antidepressant-like activity in the forced swim test.  This is associated with an increase in brain levels of serotonin.  The anti-apoptotic activity of these propargylamine-containing derivatives may be related to their ability to delay the opening of voltage-dependent anion channels (VDAC), which are part of the mitochondrial permeability transition pore.  The propargylamine moiety is responsible for the increase in the mitochondrial family of Bcl-2 proteins, prevention in the fall in mitochondrial membrane potential, prevention of the activation of caspase 3, and of translocation of glyceraldehyde-3-phosphate dehydrogenase from the cytoplasm to the nucleus.  The latter processes are closely associated with neurotoxin-induced apoptosis.  Rasagiline interacts with and prevents the binding of PKI 1195 to the pro-apoptotic peripheral benzodiazepine receptor, which together with Bcl-2, hexokinase, porin, and adenine nucleotide translocator constitutes part of the VDAC.  Furthermore, rasagiline, TV3326 and TV3279 are able to influence the processing of amyloid precursor protein by activation of alpha-secretase and increasing the release of soluble alpha APP in rat PC-12 and human neuroblastoma SH-SY5Y cells and in rat and mice cortex and hippocampus.  This process has been shown to involve the upregulation of PKC and MAP kinase.  It is quite likely that the induction of Bcl-2 and activation of PKC by rasagiline and TV3326 is closely linked to the anti-apoptotic action of these drugs and their ability to process APP by activation of alpha-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQR3CdWC5jGOz0SWnHPWbmmfW6udTcc2eZiIBJKOQG1dbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zgt12ksQ%253D%253D&md5=0909d8e1af5f7cbdcd55ad7d48ebfc15</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015131516649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015131516649%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DMolecular%2520Basis%2520of%2520Neuroprotective%2520Activities%2520of%2520Rasagiline%2520and%2520the%2520Anti-Alzheimer%2520Drug%2520TV3326%2520%255B%2528N-Propargyl-%25283R%2529Aminoindan-5-YL%2529-Ethyl%2520Methyl%2520Carbamate%255D%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2001%26volume%3D21%26issue%3D6%26spage%3D555%26epage%3D573%26doi%3D10.1023%2FA%3A1015131516649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, Ó. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino-Antolin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farré-Alins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joffrin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimeno, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janočková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwed, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero Martínez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Muñoz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">12765</span>– <span class="NLM_lpage">12769</span>, <span class="refDoi"> DOI: 10.1002/anie.201706072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fanie.201706072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVekt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=12765-12769&issue=41&author=%C3%93.+M.+Bautista-Aguileraauthor=S.+Hagenowauthor=A.+Palomino-Antolinauthor=V.+Farr%C3%A9-Alinsauthor=L.+Ismailiauthor=P.+L.+Joffrinauthor=M.+L.+Jimenoauthor=O.+Soukupauthor=J.+Jano%C4%8Dkov%C3%A1author=L.+Kalinowskyauthor=E.+Proschakauthor=I.+Iriepaauthor=I.+Moraledaauthor=J.+S.+Schwedauthor=A.+Romero+Mart%C3%ADnezauthor=F.+L%C3%B3pez-Mu%C3%B1ozauthor=M.+Chiouaauthor=J.+Egeaauthor=R.+R.+Ramsayauthor=J.+Marco-Contellesauthor=H.+Stark&title=Multitarget-Directed+Ligands+Combining+Cholinesterase+and+Monoamine+Oxidase+Inhibition+with+Histamine+H3R+Antagonism+for+Neurodegenerative+Diseases&doi=10.1002%2Fanie.201706072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases</span></div><div class="casAuthors">Bautista-Aguilera, Oscar M.; Hagenow, Stefanie; Palomino-Antolin, Alejandra; Farre-Alins, Victor; Ismaili, Lhassane; Joffrin, Pierre-Louis; Jimeno, Maria L.; Soukup, Ondrej; Janockova, Jana; Kalinowsky, Lena; Proschak, Ewgenij; Iriepa, Isabel; Moraleda, Ignacio; Schwed, Johannes S.; Romero Martinez, Alejandro; Lopez-Munoz, Francisco; Chioua, Mourad; Egea, Javier; Ramsay, Rona R.; Marco-Contelles, Jose; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12765-12769</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The therapy of complex neurodegenerative diseases requires the development of multitarget-directed drugs (MTDs).  Novel indole derivs. with inhibitory activity towards acetyl/butyrylcholinesterases and monoamine oxidases A/B as well as the histamine H3 receptor (H3R) were obtained by optimization of the neuroprotectant ASS234 by incorporating generally accepted H3R pharmacophore motifs.  These small-mol. hits demonstrated balanced activities at the targets, mostly in the nanomolar concn. range.  Addnl. in vitro studies showed antioxidative neuroprotective effects as well as the ability to penetrate the blood-brain barrier.  With this promising in vitro profile, contilisant (at 1 mg kg-1 i.p.) also significantly improved lipopolysaccharide-induced cognitive deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2wNLAClUFULVg90H21EOLACvtfcHk0liOUbvLipiQEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVekt73L&md5=4a962ad1ada3f5b8e8102add09cd4e60</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706072%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3D%25C3%2593.%2BM.%26aulast%3DHagenow%26aufirst%3DS.%26aulast%3DPalomino-Antolin%26aufirst%3DA.%26aulast%3DFarr%25C3%25A9-Alins%26aufirst%3DV.%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3DJoffrin%26aufirst%3DP.%2BL.%26aulast%3DJimeno%26aufirst%3DM.%2BL.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DJano%25C4%258Dkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DKalinowsky%26aufirst%3DL.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DSchwed%26aufirst%3DJ.%2BS.%26aulast%3DRomero%2BMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez-Mu%25C3%25B1oz%26aufirst%3DF.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DMultitarget-Directed%2520Ligands%2520Combining%2520Cholinesterase%2520and%2520Monoamine%2520Oxidase%2520Inhibition%2520with%2520Histamine%2520H3R%2520Antagonism%2520for%2520Neurodegenerative%2520Diseases%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D41%26spage%3D12765%26epage%3D12769%26doi%3D10.1002%2Fanie.201706072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, Ó. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Muñoz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Contilisant, a Tetratarget Small Molecule for Alzheimer’s Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6937</span>– <span class="NLM_lpage">6943</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00848</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00848" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Cqu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6937-6943&issue=15&author=%C3%93.+M.+Bautista-Aguileraauthor=J.+Budniauthor=F.+Minaauthor=E.+B.+Medeirosauthor=W.+Deuther-Conradauthor=J.+M.+Entrenaauthor=I.+Moraledaauthor=I.+Iriepaauthor=F.+L%C3%B3pez-Mu%C3%B1ozauthor=J.+Marco-Contelles&title=Contilisant%2C+a+Tetratarget+Small+Molecule+for+Alzheimer%E2%80%99s+Disease+Therapy+Combining+Cholinesterase%2C+Monoamine+Oxidase+Inhibition%2C+and+H3R+Antagonism+with+S1R+Agonism+Profile&doi=10.1021%2Facs.jmedchem.8b00848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile</span></div><div class="casAuthors">Bautista-Aguilera, Oscar M.; Budni, Josiane; Mina, Francielle; Medeiros, Eduarda Behenck; Deuther-Conrad, Winnie; Entrena, Jose M.; Moraleda, Ignacio; Iriepa, Isabel; Lopez-Munoz, Francisco; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6937-6943</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Contilisant, a permeable, antioxidant, and neuroprotectant agent, showing high nM affinity at H3R and excellent inhibition of the monoamine oxidases and cholinesterases, is an affine and selective S1R agonist in the nanomolar range, based on the binding affinity and functional expt., a result confirmed by mol. modeling.  In addn., contilisant significantly restores the cognitive deficit induced by Aβ1-42 in the radial maze assay in an in vivo Alzheimer's disease test, comparing very favorably with donepezil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRam68D-99zLVg90H21EOLACvtfcHk0liOUbvLipiQEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Cqu7nM&md5=526d2eedfb4f6ae6f69a4116f87a633a</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00848%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3D%25C3%2593.%2BM.%26aulast%3DBudni%26aufirst%3DJ.%26aulast%3DMina%26aufirst%3DF.%26aulast%3DMedeiros%26aufirst%3DE.%2BB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DL%25C3%25B3pez-Mu%25C3%25B1oz%26aufirst%3DF.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DContilisant%252C%2520a%2520Tetratarget%2520Small%2520Molecule%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Therapy%2520Combining%2520Cholinesterase%252C%2520Monoamine%2520Oxidase%2520Inhibition%252C%2520and%2520H3R%2520Antagonism%2520with%2520S1R%2520Agonism%2520Profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D15%26spage%3D6937%26epage%3D6943%26doi%3D10.1021%2Facs.jmedchem.8b00848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blair, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhillon, S.</span></span> <span> </span><span class="NLM_article-title">Safinamide: A Review in Parkinson’s Disease</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1007/s40263-017-0408-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs40263-017-0408-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=28110399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=169-176&issue=2&author=H.+A.+Blairauthor=S.+Dhillon&title=Safinamide%3A+A+Review+in+Parkinson%E2%80%99s+Disease&doi=10.1007%2Fs40263-017-0408-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Safinamide: A Review in Parkinson's Disease</span></div><div class="casAuthors">Blair, Hannah A.; Dhillon, Sohita</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-176</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Safinamide (Xadago) is an orally active, selective, reversible monoamine oxidase-B inhibitor with both dopaminergic and non-dopaminergic (glutamatergic) properties.  In the EU, safinamide is approved for the treatment of mid- to late-stage fluctuating Parkinson's disease (PD) as add-on therapy to a stable dose of levodopa alone or in combination with other PD medications.  Safinamide 50-100 mg/day administered as a fixed or flexible dose significantly increased daily 'on' time without dyskinesia (primary endpoint) in patients with mid- to late-stage PD with motor fluctuations in 24-wk, placebo-controlled clin. trials.  Other outcomes, including motor function, overall clin. status and health-related quality of life, were also generally improved with safinamide.  Furthermore, in an 18-mo extension of one study, although dyskinesia (primary endpoint) was not significantly improved with safinamide relative to placebo, treatment benefits in other outcomes were generally sustained over 24 mo of treatment.  Safinamide was generally well tolerated in clin. trials; dyskinesia was the most common adverse event.  Although further studies are needed, including comparative and long-term studies, current evidence indicates that safinamide extends the treatment options available for use as add-on therapy to levodopa and other PD medications in patients with mid- to late-stage PD experiencing motor fluctuations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsl8UyUX-7XrVg90H21EOLACvtfcHk0liS0vNNPOFwew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeisrc%253D&md5=7adc3525326e5274c2f9fac22d39cb28</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1007%2Fs40263-017-0408-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-017-0408-1%26sid%3Dliteratum%253Aachs%26aulast%3DBlair%26aufirst%3DH.%2BA.%26aulast%3DDhillon%26aufirst%3DS.%26atitle%3DSafinamide%253A%2520A%2520Review%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCNS%2520Drugs%26date%3D2017%26volume%3D31%26issue%3D2%26spage%3D169%26epage%3D176%26doi%3D10.1007%2Fs40263-017-0408-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">5848</span>– <span class="NLM_lpage">5852</span>, <span class="refDoi"> DOI: 10.1021/jm070677y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&issue=23&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+of+Human+Monoamine+Oxidase+B+Complexes+with+Selective+Noncovalent+Inhibitors%3A+Safinamide+and+Coumarin+Analogs&doi=10.1021%2Fjm070677y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span></div><div class="casAuthors">Binda, Claudia; Wang, Jin; Pisani, Leonardo; Caccia, Carla; Carotti, Angelo; Salvati, Patricia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5848-5852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivs., all sharing a common benzyloxy substituent, were detd. by x-ray crystallog.  These compds. competitively inhibit MAO B with Ki values in the 0.1-0.5 μM range that are 30-700-fold lower than those obsd. with MAO A.  The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPIubufo89bVg90H21EOLACvtfcHk0liS0vNNPOFwew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI&md5=448f65696f4870e2301f46a6f015e35c</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%2520Complexes%2520with%2520Selective%2520Noncovalent%2520Inhibitors%253A%2520Safinamide%2520and%2520Coumarin%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D23%26spage%3D5848%26epage%3D5852%26doi%3D10.1021%2Fjm070677y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fariello, R. G.</span></span> <span> </span><span class="NLM_article-title">Pressor Response to Intravenous Tyramine in Healthy Subjects after Safinamide, a Novel Neuroprotectant with Selective, Reversible Monoamine Oxidase B Inhibition</span>. <i>Clin. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1097/00002826-200307000-00012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1097%2F00002826-200307000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=12897643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFars7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=213-217&issue=4&author=C.+Cattaneoauthor=C.+Cacciaauthor=A.+Marzoauthor=R.+Majauthor=R.+G.+Fariello&title=Pressor+Response+to+Intravenous+Tyramine+in+Healthy+Subjects+after+Safinamide%2C+a+Novel+Neuroprotectant+with+Selective%2C+Reversible+Monoamine+Oxidase+B+Inhibition&doi=10.1097%2F00002826-200307000-00012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition</span></div><div class="casAuthors">Cattaneo, Carlo; Caccia, Carla; Marzo, Antonio; Maj, Roberto; Fariello, Ruggero G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Neuropharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">213-217</span>CODEN:
                <span class="NLM_cas:coden">CLNEDB</span>;
        ISSN:<span class="NLM_cas:issn">0362-5664</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Safinamide is a novel neuroprotectant combining Na and Ca channel blocking properties with selective, reversible monoamine oxidase type B (MAO B) inhibition.  Phase 1 studies have demonstrated that in healthy volunteers, the ED50 (a dose that inhibits enzyme activity by 50% in 50% of treated subjects) for MAO B inhibition is 87.5 μg/kg/day orally, and that no MAO A inhibition occurs after 10-mg/kg oral dosing.  To assess the risk of inducing the "cheese effect," the effect of safinamide and placebo on the pressor response to tyramine was investigated in a group of healthy male volunteers.  The study was an open, single-dose placebo-controlled trial with the 2 treatments in sequence.  An increase of 30 mm Hg systolic blood pressure was obtained by i.v. tyramine administered by 0.5-mg incremental boluses injected at 15-min intervals.  The amt. of tyramine necessary to achieve such a blood pressure increase was the same after the safinamide 2-mg/kg oral load compared with placebo.  These results suggest that dietary restrictions for food with high tyramine content should not be required under safinamide treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8o0I5Vj9N0LVg90H21EOLACvtfcHk0ljcEc7CSOXTBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFars7k%253D&md5=4a017f58f984638d43b15bdcea466c35</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1097%2F00002826-200307000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002826-200307000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DCattaneo%26aufirst%3DC.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DMarzo%26aufirst%3DA.%26aulast%3DMaj%26aufirst%3DR.%26aulast%3DFariello%26aufirst%3DR.%2BG.%26atitle%3DPressor%2520Response%2520to%2520Intravenous%2520Tyramine%2520in%2520Healthy%2520Subjects%2520after%2520Safinamide%252C%2520a%2520Novel%2520Neuroprotectant%2520with%2520Selective%252C%2520Reversible%2520Monoamine%2520Oxidase%2520B%2520Inhibition%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2003%26volume%3D26%26issue%3D4%26spage%3D213%26epage%3D217%26doi%3D10.1097%2F00002826-200307000-00012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mialet-Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span> <span> </span><span class="NLM_article-title">Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4203</span>– <span class="NLM_lpage">4212</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00357</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00357" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFSnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4203-4212&issue=9&author=J.+Reisauthor=N.+Manzellaauthor=F.+Cagideauthor=J.+Mialet-Perezauthor=E.+Uriarteauthor=A.+Pariniauthor=F.+Borgesauthor=C.+Binda&title=Tight-Binding+Inhibition+of+Human+Monoamine+Oxidase+B+by+Chromone+Analogs%3A+A+Kinetic%2C+Crystallographic%2C+and+Biological+Analysis&doi=10.1021%2Facs.jmedchem.8b00357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis</span></div><div class="casAuthors">Reis, Joana; Manzella, Nicola; Cagide, Fernando; Mialet-Perez, Jeanne; Uriarte, Eugenio; Parini, Angelo; Borges, Fernanda; Binda, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4203-4212</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO-B) is a validated drug target for Parkinson's disease.  Chromone derivs. were identified as novel potent and reversible MAO-B inhibitors, and herewith we report on a crystallog. and biochem. anal. to investigate their inhibition mechanism.  The crystal structures of human MAO-B in complex with three chromone analogs bearing different substituents on the exocyclic arom. ring (detd. at 1.6-1.8 Å resoln.) showed that they all bind in the active site cavity of the protein with the chromone moiety located in front of the FAD cofactor.  These inhibitors form two hydrogen bonds with Tyr435 and Cys172 and perfectly fit the hydrophobic flat active site of human MAO-B.  This is reflected in their tight-binding mechanism of inhibition with Ki values of 55, 17, and 31 nM for N-(3',4'-dimethylphenyl)-4-oxo-4H-chromene-3-carboxamide (1), N-(3'-chlorophenyl)-4-oxo-4H-chromene-3-carboxamide (2), and N-(3'-fluorophenyl)-4-oxo-4H-chromene-3-carboxamide (3), resp.  These compds. were also 1000-fold more effective than L-deprenyl in reducing the cellular levels of reactive oxygen species (ROS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4_ZAaYfpTbVg90H21EOLACvtfcHk0ljcEc7CSOXTBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsFSnsrw%253D&md5=129e0b5bbd744bc3ef74a75bda97a550</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00357%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DManzella%26aufirst%3DN.%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DMialet-Perez%26aufirst%3DJ.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DParini%26aufirst%3DA.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DBinda%26aufirst%3DC.%26atitle%3DTight-Binding%2520Inhibition%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%2520by%2520Chromone%2520Analogs%253A%2520A%2520Kinetic%252C%2520Crystallographic%252C%2520and%2520Biological%2520Analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D9%26spage%3D4203%26epage%3D4212%26doi%3D10.1021%2Facs.jmedchem.8b00357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remião, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5879</span>– <span class="NLM_lpage">5893</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00527</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00527" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC28XovVWksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5879-5893&issue=12&author=J.+Reisauthor=F.+Cagideauthor=D.+Chavarriaauthor=T.+Silvaauthor=C.+Fernandesauthor=A.+Gasparauthor=E.+Uriarteauthor=F.+Remi%C3%A3oauthor=S.+Alcaroauthor=F.+Ortusoauthor=F.+Borges&title=Discovery+of+New+Chemical+Entities+for+Old+Targets%3A+Insights+on+the+Lead+Optimization+of+Chromone-Based+Monoamine+Oxidase+B+%28MAO-B%29+Inhibitors&doi=10.1021%2Facs.jmedchem.6b00527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors</span></div><div class="casAuthors">Reis, Joana; Cagide, Fernando; Chavarria, Daniel; Silva, Tiago; Fernandes, Carlos; Gaspar, Alexandra; Uriarte, Eugenio; Remiao, Fernando; Alcaro, Stefano; Ortuso, Francesco; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5879-5893</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of new chem. entities endowed with potent, selective, and reversible monoamine oxidase B inhibitory activity is a clin. relevant subject.  Therefore, a small library of chromone derivs. was synthesized and screened toward human monoamine oxidase isoforms (hMAO-A and hMAO-B).  The structure-activity relationships studies strengthen the importance of the amide spacer and the direct linkage of carbonyl group to the γ-pyrone ring, along with the presence of meta and para substituents in the exocyclic ring.  The most potent MAO-B inhibitors were N-(3'-chlorophenyl)-4-oxo-4H-chromene-3-carboxamide (20) (IC50 = 403 pM) and N-(3',4'-dimethylphenyl)-4-oxo-4H-chromene-3-carboxamide (27) (IC50 = 669 pM), acting as competitive and noncompetitive reversible inhibitors, resp.  Computational docking studies provided insights into enzyme-inhibitor interactions and a rationale for the obsd. selectivity and potency.  Compd. 27 stands out due to its favorable toxicol. profile and physicochem. properties, which pointed toward blood-brain barrier permeability, thus being a valid candidate for subsequent animal studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWONk5yTkyN7Vg90H21EOLACvtfcHk0lj4vrLeIYtBsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovVWksb8%253D&md5=361d3dde07c197e2bdc41d08746a35f6</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00527%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DRemi%25C3%25A3o%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520New%2520Chemical%2520Entities%2520for%2520Old%2520Targets%253A%2520Insights%2520on%2520the%2520Lead%2520Optimization%2520of%2520Chromone-Based%2520Monoamine%2520Oxidase%2520B%2520%2528MAO-B%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D12%26spage%3D5879%26epage%3D5893%26doi%3D10.1021%2Facs.jmedchem.6b00527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tzvetkov, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Küppers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastreich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Indazole-and Indole-5-Carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6679</span>– <span class="NLM_lpage">6703</span>, <span class="refDoi"> DOI: 10.1021/jm500729a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500729a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVentLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6679-6703&issue=15&author=N.+T.+Tzvetkovauthor=S.+Hinzauthor=P.+K%C3%BCppersauthor=M.+Gastreichauthor=C.+E.+M%C3%BCller&title=Indazole-and+Indole-5-Carboxamides%3A+Selective+and+Reversible+Monoamine+Oxidase+B+Inhibitors+with+Subnanomolar+Potency&doi=10.1021%2Fjm500729a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Indazole- and Indole-5-carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency</span></div><div class="casAuthors">Tzvetkov, Nikolay T.; Hinz, Sonja; Kueppers, Petra; Gastreich, Marcus; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6679-6703</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indazole- and indole-carboxamides were discovered as highly potent, selective, competitive, and reversible inhibitors of monoamine oxidase B (MAO-B).  The compds. are easily accessible by std. synthetic procedures with high overall yields.  The most potent derivs. were N-(3,4-dichlorophenyl)-1-methyl-1H-indazole-5-carboxamide (38a, PSB-1491, IC50 human MAO-B 0.386 nM, >25000-fold selective vs. MAO-A) and N-(3,4-dichlorophenyl)-1H-indole-5-carboxamide (53, PSB-1410, IC50 human MAO-B 0.227 nM, >5700-fold selective vs. MAO-A).  Replacement of the carboxamide linker with a methanimine spacer leading to (E)-N-(3,4-dichlorophenyl)-1-(1H-indazol-5-yl)methanimine (58) represents a further novel class of highly potent and selective MAO-B inhibitors (IC50 human MAO-B 0.612 nM, >16000-fold selective vs. MAO-A).  In N-3,4-difluorophenyl-1H-indazole-5-carboxamide (30, PSB-1434, IC50 human MAO-B 1.59 nM, selectivity vs. MAO-A >6000-fold), high potency and selectivity are optimally combined with superior physicochem. properties.  Computational docking studies provided insights into the inhibitors' interaction with the enzyme binding site and a rationale for their high potency despite their small mol. size.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx38ZSIgn0B7Vg90H21EOLACvtfcHk0lj4vrLeIYtBsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVentLzO&md5=dc379b26fd57276ac41fe7a1331dd4c6</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Fjm500729a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500729a%26sid%3Dliteratum%253Aachs%26aulast%3DTzvetkov%26aufirst%3DN.%2BT.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DK%25C3%25BCppers%26aufirst%3DP.%26aulast%3DGastreich%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DIndazole-and%2520Indole-5-Carboxamides%253A%2520Selective%2520and%2520Reversible%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%2520with%2520Subnanomolar%2520Potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D15%26spage%3D6679%26epage%3D6703%26doi%3D10.1021%2Fjm500729a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gealageas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devineau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, P. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surendradoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwalder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebeler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dullaghan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grierson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putnins, E. E.</span></span> <span> </span><span class="NLM_article-title">Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7043</span>– <span class="NLM_lpage">7064</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01588</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01588" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCns7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7043-7064&issue=16&author=R.+Gealageasauthor=A.+Devineauauthor=P.+P.+L.+Soauthor=C.+M.+J.+Kimauthor=J.+Surendradossauthor=C.+Buchwalderauthor=M.+Hellerauthor=V.+Goebelerauthor=E.+M.+Dullaghanauthor=D.+S.+Griersonauthor=E.+E.+Putnins&title=Development+of+Novel+Monoamine+Oxidase-B+%28MAO-B%29+Inhibitors+with+Reduced+Blood-Brain+Barrier+Permeability+for+the+Potential+Management+of+Noncentral+Nervous+System+%28CNS%29+Diseases&doi=10.1021%2Facs.jmedchem.7b01588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases</span></div><div class="casAuthors">Gealageas, Ronan; Devineau, Alice; So, Pauline P. L.; Kim, Catrina M. J.; Surendradoss, Jayakumar; Buchwalder, Christian; Heller, Markus; Goebeler, Verena; Dullaghan, Edith M.; Grierson, David S.; Putnins, Edward E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7043-7064</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Studies indicate that MAO-B is induced in peripheral inflammatory diseases.  To target peripheral tissues using MAO-B inhibitors that do not permeate the blood-brain barrier (BBB) the MAO-B-selective inhibitor deprenyl was remodeled by replacing the terminal acetylene with a CO2H function, and incorporating a para-OCH2Ar motif (compds. 10a-s).  Further, in compd. 32 ((S)-N-[1-cyano-3-[4-[(3,4-dichlorobenzyl)oxy]phenyl]propan-2-yl]-N-methylglycine hydrochloride) the C-2 side chain corresponded to CH2CN.  In vitro, 10c (N-[(R)-[1-[4-(3-chlorobenzyloxy)phenyl]propan-2-yl](methyl)]glycine hydrochloride), 10j, 10k, and 32 were identified as potent reversible MAO-B inhibitors, and all four compds. were more stable than deprenyl in plasma, liver microsomal, and hepatocyte stability assays.  In vivo, they demonstrated greater plasma bioavailability.  Assessment of in vitro BBB permeability showed that compd. 10k is a P-glycoprotein (P-gp) substrate and 10j displayed mild interaction.  Importantly, compds. 10c, 10j, 10k, and 32 displayed significantly reduced BBB permeability after i.v., s.c., and oral administration.  These polar MAO-B inhibitors are pertinent leads for evaluation of efficacy in noncentral nervous system (CNS) inflammatory disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxwJVafqtiYrVg90H21EOLACvtfcHk0lhuYvkVvanLEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCns7bL&md5=46d24762b2205d7e1fef6543ff26997b</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01588%26sid%3Dliteratum%253Aachs%26aulast%3DGealageas%26aufirst%3DR.%26aulast%3DDevineau%26aufirst%3DA.%26aulast%3DSo%26aufirst%3DP.%2BP.%2BL.%26aulast%3DKim%26aufirst%3DC.%2BM.%2BJ.%26aulast%3DSurendradoss%26aufirst%3DJ.%26aulast%3DBuchwalder%26aufirst%3DC.%26aulast%3DHeller%26aufirst%3DM.%26aulast%3DGoebeler%26aufirst%3DV.%26aulast%3DDullaghan%26aufirst%3DE.%2BM.%26aulast%3DGrierson%26aufirst%3DD.%2BS.%26aulast%3DPutnins%26aufirst%3DE.%2BE.%26atitle%3DDevelopment%2520of%2520Novel%2520Monoamine%2520Oxidase-B%2520%2528MAO-B%2529%2520Inhibitors%2520with%2520Reduced%2520Blood-Brain%2520Barrier%2520Permeability%2520for%2520the%2520Potential%2520Management%2520of%2520Noncentral%2520Nervous%2520System%2520%2528CNS%2529%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D16%26spage%3D7043%26epage%3D7064%26doi%3D10.1021%2Facs.jmedchem.7b01588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bredemeier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenreich, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bongiorno, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Avila, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morsch, A. L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva Stein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, G. G. D.</span></span> <span> </span><span class="NLM_article-title">Xanthine Oxidase Inhibitors for Prevention of Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials</span>. <i>BMC Cardiovasc. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1186/s12872-018-0757-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1186%2Fs12872-018-0757-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=29301486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKksbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=1-11&issue=1&author=M.+Bredemeierauthor=L.+M.+Lopesauthor=M.+A.+Eisenreichauthor=S.+Hickmannauthor=G.+K.+Bongiornoauthor=R.+d%E2%80%99Avilaauthor=A.+L.+B.+Morschauthor=F.+da+Silva+Steinauthor=G.+G.+D.+Campos&title=Xanthine+Oxidase+Inhibitors+for+Prevention+of+Cardiovascular+Events%3A+A+Systematic+Review+and+Meta-Analysis+of+Randomized+Controlled+Trials&doi=10.1186%2Fs12872-018-0757-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials</span></div><div class="casAuthors">Bredemeier, Markus; Lopes, Lediane Moreira; Eisenreich, Matheus Augusto; Hickmann, Sheila; Bongiorno, Guilherme Kopik; D'Avila, Rui; Morsch, Andre Luis Bittencourt; Da Silva Stein, Fernando; Campos, Guilherme Gomes Dias</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cardiovascular Disorders</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">BCDMBB</span>;
        ISSN:<span class="NLM_cas:issn">1471-2261</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Xanthine oxidase inhibitors (XOI), classified as purine-like (allopurinol and oxypurinol) and non-purine (febuxostat and topiroxostat) XOI, present antioxidant properties by reducing the prodn. of reactive oxygen species derived from purine metab.  Oxidative stress is an important factor related to endothelial dysfunction and ischemia-reperfusion injury, and may be implicated in the pathogenesis of heart failure, hypertension, and ischemic heart disease.  However, there is contradictory evidence regarding the possible cardiovascular (CV) protective effect exerted by XOI.  Our objective is to compare the incidence of major adverse cardiovascular events (MACE), mortality, total (TCE) and specific CV events in randomized controlled trials (RCTs) testing XOI against placebo or no treatment.  Methods: PubMed, EMBASE, Web of Science, Cochrane Central, Lilacs databases were searched from inception to Dec 30 2016, along with hand searching.  RCTs including exclusively adult individuals, lasting ≥4 wk, with no language restriction, were eligible.  Independent paired researchers selected studies and extd. data.  Considering the expected rarity of events, Peto and DerSimonian/Laird odds ratios (OR), the latter in case of heterogeneity, were used for anal.  Random-effects meta-regression was used to explore heterogeneity.  Results: The anal. of MACE included 81 articles (10,684 patients, 6434 patient-years).  XOI did not significantly reduce risk of MACE (ORP = 0.71, 95% CI 0.46-1.09) and death (0.89, 0.59-1.33), but reduced risk of TCE (0.60, 0.44-0.82; serious TCE: 0.64, 0.46 to 0.89), and hypertension (0.54, 0.37 to 0.80).  There was protection for MACE in patients with previous ischemic events (0.42, 0.23-0.76).  Allopurinol protected for myocardial infarction (0.38, 0.17-0.83), hypertension (0.32, 0.18-0.58), TCE (0.48, 0.31 to 0.75, I2 = 55%) and serious TCE (0.56, 0.36 to 0.86, I2 = 44%).  Meta-regression assocd. increasing dose of allopurinol with higher risk of TCE and serious TCE (P < 0.05).  Accordingly, lower doses (≤ 300 mg/day) of allopurinol reduced the risk of TCE, unlike higher doses.  Non-purine-like XOI did not significantly reduce or increase the risk of adverse CV events, but confidence intervals were wide.  Quality of evidence was generally low to moderate.  Conclusions: Purine-like XOI may reduce the incidence of adverse CV outcomes.  However, higher doses of allopurinol (> 300 mg/day) may be assocd. with loss of CV protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr73GYoHbb2ZLVg90H21EOLACvtfcHk0lhuYvkVvanLEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKksbzP&md5=eadf4605be5c48c26ccf9a36574fada9</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1186%2Fs12872-018-0757-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12872-018-0757-9%26sid%3Dliteratum%253Aachs%26aulast%3DBredemeier%26aufirst%3DM.%26aulast%3DLopes%26aufirst%3DL.%2BM.%26aulast%3DEisenreich%26aufirst%3DM.%2BA.%26aulast%3DHickmann%26aufirst%3DS.%26aulast%3DBongiorno%26aufirst%3DG.%2BK.%26aulast%3Dd%25E2%2580%2599Avila%26aufirst%3DR.%26aulast%3DMorsch%26aufirst%3DA.%2BL.%2BB.%26aulast%3Dda%2BSilva%2BStein%26aufirst%3DF.%26aulast%3DCampos%26aufirst%3DG.%2BG.%2BD.%26atitle%3DXanthine%2520Oxidase%2520Inhibitors%2520for%2520Prevention%2520of%2520Cardiovascular%2520Events%253A%2520A%2520Systematic%2520Review%2520and%2520Meta-Analysis%2520of%2520Randomized%2520Controlled%2520Trials%26jtitle%3DBMC%2520Cardiovasc.%2520Disord.%26date%3D2018%26volume%3D18%26issue%3D1%26spage%3D1%26epage%3D11%26doi%3D10.1186%2Fs12872-018-0757-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nivorozhkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabó, C.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1124/pr.58.1.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1124%2Fpr.58.1.6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16507884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlCqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=87-114&issue=1&author=P.+Pacherauthor=A.+Nivorozhkinauthor=C.+Szab%C3%B3&title=Therapeutic+Effects+of+Xanthine+Oxidase+Inhibitors%3A+Renaissance+Half+a+Century+after+the+Discovery+of+Allopurinol&doi=10.1124%2Fpr.58.1.6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol</span></div><div class="casAuthors">Pacher, Pal; Nivorozhkin, Alex; Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-114</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The prototypical xanthine oxidase (XO) inhibitor allopurinol, has been the cornerstone of the clin. management of gout and conditions assocd. with hyperuricemia for several decades.  More recent data indicate that XO also plays an important role in various forms of ischemic and other types of tissue and vascular injuries, inflammatory diseases, and chronic heart failure.  Allopurinol and its active metabolite oxypurinol showed considerable promise in the treatment of these conditions both in exptl. animals and in small-scale human clin. trials.  Although some of the beneficial effects of these compds. may be unrelated to the inhibition of the XO, the encouraging findings rekindled significant interest in the development of addnl., novel series of XO inhibitors for various therapeutic indications.  Here we present a crit. overview of the effects of XO inhibitors in various pathophysiol. conditions and also review the various emerging therapeutic strategies offered by this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoshSwZZNciVrVg90H21EOLACvtfcHk0lhtBT3emSzyjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlCqsLs%253D&md5=8dfe2e35a22c02431fdaf561ef494f5e</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.1.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.1.6%26sid%3Dliteratum%253Aachs%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DNivorozhkin%26aufirst%3DA.%26aulast%3DSzab%25C3%25B3%26aufirst%3DC.%26atitle%3DTherapeutic%2520Effects%2520of%2520Xanthine%2520Oxidase%2520Inhibitors%253A%2520Renaissance%2520Half%2520a%2520Century%2520after%2520the%2520Discovery%2520of%2520Allopurinol%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26issue%3D1%26spage%3D87%26epage%3D114%26doi%3D10.1124%2Fpr.58.1.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robins, R. K.</span></span> <span> </span><span class="NLM_article-title">Potential Purine Antagonists. I. Synthesis of Some 4,6-Substituted Pyrazolo [3,4-d] Pyrimidines</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1021/ja01585a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01585a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaG28XmvFCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1956&pages=784-790&issue=4&author=R.+K.+Robins&title=Potential+Purine+Antagonists.+I.+Synthesis+of+Some+4%2C6-Substituted+Pyrazolo+%5B3%2C4-d%5D+Pyrimidines&doi=10.1021%2Fja01585a023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Potential purine antagonists. I. Synthesis of some 4,6-substituted pyrazolo[3,4-d]pyrimidines</span></div><div class="casAuthors">Robins, Roland K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">784-90</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">EtOCH2CH(CN)2 (150 g.) added in 3-5-g. portions to 100 g. 85% N2H4.H2O with slight cooling, the mixt. heated 1 hr. on the steam bath, dild. with 100 cc. H2O, and refrigerated overnight, the mushy soln. filtered, and the solid washed with cold H2O yielded 97 g. 3-amino-4-cyanopyrazole (I), m. 174-5° (from H2O).  I (0.5 g.) refluxed 8 hrs. with 100 cc. AcCl and evapd. to dryness on the steam bath, and the residue dissolved in 25 cc. boiling H2O, neutralized with NH4OH, and cooled gave 0.4 g. Ac deriv. of I, m. 221-2° (from H2O).  Finely powd. I (50 g.) added with stirring below 40° to 170 cc. concd. H2SO4 (cooled to 20°) during 0.5 hr., and the soln. stirred 1 hr. at room temp., poured with stirring into 500 cc. H2O and 250 cc. ice, refrigerated overnight, and filtered yielded 67.0 g. 3-amino-4-pyrazolecarboxamide-0.5H2SO4 (II) (II.0.5H2SO4), m. 222-5° (from H2O).  II.0.5H2SO4 (3 g.) in 50 cc. H2O adjusted with NH4OH to pH 9 and allowed to stand 3 days deposited 1.1 g. II, m. 187-9° (from H2O).  II.0.5H2SO4 (75 g.) and 200 cc. HCONH2 heated 45 min. at 180-90°, cooled, dild. with 1 l. cold H2O, and filtered yielded 48.0 g. 4-hydroxypyrazolo[3,4-d]pyrimidine (III).  II.0.5H2SO4 (100 g.) and 200 g. urea heated 20 min. at 160° and then 20 min. at 190° and dissolved in hot dil. aq. NaOH, the boiling basic soln. carefully acidified with AcOH and filtered after 10 min. yielded 74 g. 90-5% pure 4,6-di-OH analog (IIIa) of III.  I (35 g.) and 70 g. CS(NH2)2 heated 0.5 hr. at 180° and 10 min. at 200°, cooled, and dissolved in hot dil. aq. NaOH, the hot soln. treated with C, and the boiling filtrate carefully acidified with glacial AcOH yielded 26.0 g. 4-amino-6-mercaptopyrazolo[3,4-d]pyrimidine (IV), light tan material.  II.0.5H2SO4 (50 g.) with 100 g. CS(NH2)2 gave similarly 24.0 g. 4-OH analog (V) of IV.  Dry III (10 g.) added to 300 cc. POCl3, the mixt. refluxed 1.5 hrs. with 30 cc. PhNMe2, the excess POCl3 removed in vacuo, the sirupy residue poured with stirring into 100 cc. H2O and 400 g. crushed ice and extd. with Et2O, and the ext. worked up gave 9.8 g. 4-chloropyrazolo[3,4-d]pyrimidine (VI), decompd. at 130-5° (from C6H6).  III (10 g.) finely powd. and mixt. with 50 g. P2S5, the mixt. added in small portions with stirring to 300 cc. Tetralin at 165° during 0.5 hr., the mixt. heated 4 hrs. with stirring at 190-5°, cooled, and filtered, the filter residue washed with petr. ether, dried, added carefully to 1 l. H2O at 80°, boiled 10 min., and treated with enough KOH to effect soln., the soln. stirred with C and filtered, and the hot filtrate acidified with AcOH gave 10.1 g. 4-mercaptopyrazolo[3,4-d]pyrimidine (VII), white crystals, m. above 360° (from 30% EtOH).  VI (2 g.) and 2 g. CS(NH2)2 refluxed 2 hrs. with 100 cc. abs. EtOH cooled and filtered gave 1.6 g. crude VII.  VI (3 g.) in 150 cc. concd. NH4OH concd. on the steam bath to 50 cc., dild. with 200 cc. concd. NH4OH, concd. on the steam bath to 150 cc., boiled with C, filtered, and cooled gave 0.85 g. 4-aminopyrazolo[3,4-d]pyrimidine (VIII), colorless needles.  I (30 g.) boiled 0.5 hr. with 60 cc. HCONH2, cooled, dild. with 100 cc. cold H2O, and filtered, the residue suspended in 400 cc. hot H2O, treated with 50 cc. concd. HCl, boiled 15 min. with C, and the hot filtrate adjusted to pH 8 with concd. NH4OH and cooled to room temp. gave 21.0 g. VIII, colorless solid.  VI (5.0 g.) and alc. NH3 heated 12 hrs. at 100° in a bomb and filtered, and the crude residue dissolved in dil. HCl and repptd. with NH4OH gave 3.9 g. VIII.  IIIa (10 g.) and 30 cc. PhNMe2 refluxed 1 hr. with 250 cc. POCl3, the mixt. worked up in the usual manner, and the product isolated with Et2O gave 2.4 g. compd. C12H10ClN4(sic), light yellow needles, m. 225-7° (from xylene).  V (14 g.) and 10 g. NaOH in 300 cc. H2O shaken 10 min. at 5° with 12 g. MeI, charcoaled, filtered, and acidified with AcOH yielded 12.0 g. 4-hydroxy-6-methylmercaptopyrazolo[3,4-d]pyrimidine (IX).  I (10 g.) heated 20 min. with 20 g. urea at 180-200°, the cooled solid dissolved in 2N NaOH, the soln. boiled gently 10 min. with C, and the boiling filtrate acidified with glacial AcOH gave 4-amino-6-hydroxypyrazolo[3,4-d]-pyrimidine which was purified by repptn.  IX (22.0 g.), 400 cc. POCl3, and 30 cc. PhNMe2 refluxed 0.5 hr. gave 16 g. 4-Cl analog of IX, m. 178-9° (decompn.) (from heptane).  VII (5 g.) in 65 cc. 0.8N NaOH shaken 15 min. at 20° with 5.0 g. MeI, treated with C, filtered, and acidified with AcOH, the crude ppt. suspended in 100 cc. H2O and adjusted with NH4OH to pH 9 and filtered, and the residue washed and recrystd. from H2O yielded 4.1 g. 4-MeS analog of VII, m. 193°.  IIIa (15 g.) and 80 g. P2S5 refluxed 4 hrs. with 900 cc. dry pyridine and evapd. in vacuo on the steam bath, the residue dild. with 600 cc. ice H2O, allowed to stand 0.5 hr. at room temp., heated 2 hrs. on the steam bath, the soln. refrigerated overnight, and the crude ppt. repptd. with AcOH from boiling aq. alkali gave 12.6 g. 4-mercapto-6-hydroxypyrazolo[3,4-d]pyrimidine, light green needles.  V (15 g.) and 65 g. P2S5 in 900 cc. dry pyridine gave similarly 12.0 g. 4,6-dimercaptopyrazolo[3,4-d]pyrimidine, light green solid.  Finely powd. VI (4.5 g.) in 150 cc. H2O and 4 cc. concd. NH4OH hydrogenated about 6 hrs. at 20 lb. pressure over 1.0 g. 10% Pd-C and filtered, the residue extd. with 100 cc. boiling H2O, the combined filtrates evapd. to dryness on the steam bath, the residue extd. 18 hrs. with 200 cc. PhMe in a Soxhlet app., the ext. evapd., and the residue sublimed at 180-200° and 15 mm. yielded 2.65 g. pyrazolo[3,4-d]pyrimidine (X), colorless needles, m. 213-14°.  VI (3.0 g.) heated 1 hr. on the steam bath with 0.6 g. Na dissolved in 30 cc. abs. EtOH, dild. with 20 cc. H2O, and neutralized with AcOH gave 1.3 g. 4-EtO deriv. of X, m. 168-9°.  4-Cl analog (XI) of X (7.0 g.) in 150 cc. EtOH and 10 cc. concd. NH4OH hydrogenated 24 hrs. over 2.7 g. Pd-C at 20 lb. pressure, filtered, and evapd. to dryness on the steam bath yielded 1.7 g. 6-methylmercaptopyrazolo[3,4-d]pyrimidine, white crystals, m. 210-12° (from 80% EtOH).  XI (4.0 g.) heated 4 hrs. on the steam bath with 1.0 g. Na in 75 cc. abs. MeOH, neutralized with glacial AcOH, and cooled gave 3.1 g. 4-MeO analog of IX, m. 193-4° (from aq. MeOH).  VI (5-10 g.) added to 50-100 cc. of a 25-40% aq. soln. of a primary or secondary amine, heated 4 hrs. on the steam bath, refrigerated overnight, and filtered, and the residue washed with a little ice water and recrystd. gave the corresponding N-substituted-4-aminopyrazolo[3,4-d]pyrimidines (XII) (method A); VI (5-10 g.) added to about 0.15 mole primary or secondary amine in 150 cc. abs. EtOH, heated 4 hrs. on the steam bath, cooled overnight and filtered, and the crude product recrystd. gave the corresponding XII (method B) (N-substituents, m.p., % yield, and method given): H, Me, 227-8° (from H2O), 83, A; Me, Me, 233-4° (from C6H6-EtOH), 61, A; Et, Et, 186-7° (from aq. EtOH), 85, A; H, iso-Pr, 253-4° (from H2O), 70, A; H, Ph, 263-4° (from EtOH), 55, B; H, PhCH2, 215-17° (from aq. EtOH), 78, B; H, Et, 259-60° (from aq. EtOH), 77, A; H, 1-furylmethyl, 223-5° (from EtOH), 82, B; Me, Ph, 234-6° (from EtOH), 63, B; H, Bu, 205-6° (from aq. EtOH), 75, B; H, o-MeC6H4, 260-1° (from EtOH), 85, B.  XI gave similarly the 6-MeS derivs. of XII (N-substituents, m.p., % yield, and method given): H, H, above 300° (from H2O), 58, A; Me, Me, 263-5° (aq. EtOH), 45, A; H, NH2, above 300° (from H2O), 30, A; H, (CH2)2NEt2, 130-2° (from EtOH), 35, B.  The solubilities of a no. of 4,6-disubstituted-pyrazolo[3,4-d]pyrimidines (XIII) are tabulated (4 and 6-substituents, and soly. in H2O at 100° in parts of H2O necessary to dissolve 1 part XIII given): OH, H, 190; OH, OH, 800; NH2, H, 1000; MeNH, H, 10; Me2N, H, 10; SH, H, 500; H, MeS, 350; MeS, H, 300; H, H, 200 (at 30°).  The ultraviolet absorption max. of the various XIII described at pH 1 and 11 are listed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYvGReip6s2rVg90H21EOLACvtfcHk0lhtBT3emSzyjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG28XmvFCmsA%253D%253D&md5=eae2de5e3fe6c85303a32fb1af2a8868</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1021%2Fja01585a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01585a023%26sid%3Dliteratum%253Aachs%26aulast%3DRobins%26aufirst%3DR.%2BK.%26atitle%3DPotential%2520Purine%2520Antagonists.%2520I.%2520Synthesis%2520of%2520Some%25204%252C6-Substituted%2520Pyrazolo%2520%255B3%252C4-d%255D%2520Pyrimidines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1956%26volume%3D78%26issue%3D4%26spage%3D784%26epage%3D790%26doi%3D10.1021%2Fja01585a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, T.</span></span> <span> </span><span class="NLM_article-title">Clinical Efficacy and Safety of Topiroxostat in Japanese Hyperuricemic Patients with or without Gout: A Randomized, Double-Blinded, Controlled Phase 2b Study</span>. <i>Clin. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1007/s10067-016-3474-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1007%2Fs10067-016-3474-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=27832384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A280%3ADC%252BC2snkvFWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=649-656&issue=3&author=T.+Hosoyaauthor=T.+Sasakiauthor=T.+Ohashi&title=Clinical+Efficacy+and+Safety+of+Topiroxostat+in+Japanese+Hyperuricemic+Patients+with+or+without+Gout%3A+A+Randomized%2C+Double-Blinded%2C+Controlled+Phase+2b+Study&doi=10.1007%2Fs10067-016-3474-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study</span></div><div class="casAuthors">Hosoya Tatsuo; Sasaki Tomomitsu; Ohashi Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical rheumatology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-656</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Topiroxostat, a selective xanthine oxidoreductase inhibitor, is used in Japan for the treatment of hyperuricemic patients with or without gout.  In terms of the effectiveness of topiroxostat in lowering serum urate levels, the dose-response relationship has been evaluated; however, it remains to be verified.  A randomized, multi-center, double-blinded study of topiroxostat was performed for Japanese hyperuricemic patients with or without gout.  During the 16-week study, 157 Japanese hyperuricemic patients with or without gout were randomly assigned to receive a placebo, topiroxostat at 120 or 160 mg/day, or allopurinol at 200 mg/day.  The primary endpoint of this study was to determine the lowering rate of serum uric acid levels compared to those of baseline at the end of administration.  A dose-response relationship (regarding decreases in the serum urate levels) was confirmed for the placebo and topiroxostat at 120 and at 160 mg/day.  Moreover, at the end of administration, the lowering rate of serum urate levels was determined to be -44.8% in the topiroxostat 160-mg/day group.  No significant difference in the incidence of adverse events was observed among all groups, including the allopurinol group.  The serum urate-lowering effect of topiroxostat was found to have a dose-response relationship in Japanese hyperuricemic patients with or without gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5pG6DwTHCNPxQvRxYU81tfW6udTcc2eZwCkXo6CToNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snkvFWqtQ%253D%253D&md5=0592ff206f65665041b853d5eb27fa11</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1007%2Fs10067-016-3474-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10067-016-3474-8%26sid%3Dliteratum%253Aachs%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DOhashi%26aufirst%3DT.%26atitle%3DClinical%2520Efficacy%2520and%2520Safety%2520of%2520Topiroxostat%2520in%2520Japanese%2520Hyperuricemic%2520Patients%2520with%2520or%2520without%2520Gout%253A%2520A%2520Randomized%252C%2520Double-Blinded%252C%2520Controlled%2520Phase%25202b%2520Study%26jtitle%3DClin.%2520Rheumatol.%26date%3D2017%26volume%3D36%26issue%3D3%26spage%3D649%26epage%3D656%26doi%3D10.1007%2Fs10067-016-3474-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palo, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eustace, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernillet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph-Ridge, N.</span></span> <span> </span><span class="NLM_article-title">Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase: A Twenty-Eight-Day, Multicenter, Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Response Clinical Trial Examining Safety and Efficacy in Patients with Gout</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.1002/art.20935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fart.20935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=15751090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVGjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=916-923&issue=3&author=M.+A.+Beckerauthor=H.+R.+Schumacherauthor=R.+L.+Wortmannauthor=P.+A.+MacDonaldauthor=W.+A.+Paloauthor=D.+Eustaceauthor=L.+Vernilletauthor=N.+Joseph-Ridge&title=Febuxostat%2C+a+Novel+Nonpurine+Selective+Inhibitor+of+Xanthine+Oxidase%3A+A+Twenty-Eight-Day%2C+Multicenter%2C+Phase+II%2C+Randomized%2C+Double-Blind%2C+Placebo-Controlled%2C+Dose-Response+Clinical+Trial+Examining+Safety+and+Efficacy+in+Patients+with+Gout&doi=10.1002%2Fart.20935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout</span></div><div class="casAuthors">Becker, Michael A.; Schumacher, H. Ralph, Jr.; Wortmann, Robert L.; MacDonald, Patricia A.; Palo, William A.; Eustace, Denise; Vernillet, Laurent; Joseph-Ridge, Nancy</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">916-923</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Gout affects ∼1-2% of the American population.  Current options for treating hyperuricemia in chronic gout are limited.  The purpose of this study was to assess the safety and efficacy of febuxostat, a nonpurine selective inhibitor of xanthine oxidase, in establishing normal serum urate (sUA) concns. in gout patients with hyperuricemia (≥8.0 mg/dL).  We conducted a phase II, randomized, double-blind, placebo-controlled trial in 153 patients (ages 23-80 years).  Subjects received febuxostat (40 mg, 80 mg, 120 mg) or placebo once daily for 28 days and colchicine prophylaxis for 14 days prior to and 14 days after randomization.  The primary end point was the proportion of subjects with sUA levels <6.0 mg/dL on day 28.  Greater proportions of febuxostat-treated patients than placebo-treated patients achieved an sUA level <6.0 mg/dL at each visit (P < 0.001 for each comparison).  The targeted sUA level was attained on day 28 in 0% of those taking placebo and in 56% of those taking 40 mg, 76% taking 80 mg, and 94% taking 120 mg of febuxostat.  The mean sUA redn. from baseline to day 28 was 2% in the placebo group and 37% in the 40-mg, 44% in the 80-mg, and 59% in the 120-mg febuxostat groups.  Gout flares occurred with similar frequency in the placebo (37%) and 40-mg febuxostat (35%) groups and with increased frequency in the higher dosage febuxostat groups (43% taking 80 mg; 55% taking 120 mg).  During colchicine prophylaxis, gout flares occurred less frequently (8-13%).  Incidences of treatment-related adverse events were similar in the febuxostat and placebo groups.  Treatment with febuxostat resulted in a significant redn. of sUA levels at all dosages.  Febuxostat therapy was safe and well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWFODs8VOwZLVg90H21EOLACvtfcHk0lhmEDcskjT3NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVGjtbo%253D&md5=b1cc068ac997158b0775268a411e0983</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1002%2Fart.20935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.20935%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DM.%2BA.%26aulast%3DSchumacher%26aufirst%3DH.%2BR.%26aulast%3DWortmann%26aufirst%3DR.%2BL.%26aulast%3DMacDonald%26aufirst%3DP.%2BA.%26aulast%3DPalo%26aufirst%3DW.%2BA.%26aulast%3DEustace%26aufirst%3DD.%26aulast%3DVernillet%26aufirst%3DL.%26aulast%3DJoseph-Ridge%26aufirst%3DN.%26atitle%3DFebuxostat%252C%2520a%2520Novel%2520Nonpurine%2520Selective%2520Inhibitor%2520of%2520Xanthine%2520Oxidase%253A%2520A%2520Twenty-Eight-Day%252C%2520Multicenter%252C%2520Phase%2520II%252C%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%252C%2520Dose-Response%2520Clinical%2520Trial%2520Examining%2520Safety%2520and%2520Efficacy%2520in%2520Patients%2520with%2520Gout%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26issue%3D3%26spage%3D916%26epage%3D923%26doi%3D10.1002%2Fart.20935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beardmore, T. D.</span></span> <span> </span><span class="NLM_article-title">Allopurinol : Alteration in Pyrimidine Metabolism in Man</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>169</i></span> (<span class="NLM_issue">3943</span>),  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1126/science.169.3943.388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1126%2Fscience.169.3943.388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=5450375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaE3cXkvVKnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=1970&pages=388-390&issue=3943&author=W.+N.+Kelleyauthor=T.+D.+Beardmore&title=Allopurinol%E2%80%AF%3A+Alteration+in+Pyrimidine+Metabolism+in+Man&doi=10.1126%2Fscience.169.3943.388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Allopurinol:  alteration in pyrimidine metabolism in man</span></div><div class="casAuthors">Kelley, William N.; Beardmore, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3943</span>),
    <span class="NLM_cas:pages">388-90</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">In addn. to its well-established inhibitory effect on uric acid synthesis, allopurinol appears to alter substantially pyrimidine metabolism, as evidenced by a striking increase in the urinary excretion of orotidine and orotic acid.  Allopurinol ribonucleotide and xanthosine 5'-monophosphate are potent inhibitors of human erythrocyte orotidylic decarboxylase and provide a possible mechanism for this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0joHQgN9qmLVg90H21EOLACvtfcHk0lgceHOetie7KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXkvVKnt7g%253D&md5=9d7f04953ef1e77381d4a069f8f8f349</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1126%2Fscience.169.3943.388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.169.3943.388%26sid%3Dliteratum%253Aachs%26aulast%3DKelley%26aufirst%3DW.%2BN.%26aulast%3DBeardmore%26aufirst%3DT.%2BD.%26atitle%3DAllopurinol%25E2%2580%25AF%253A%2520Alteration%2520in%2520Pyrimidine%2520Metabolism%2520in%2520Man%26jtitle%3DScience%26date%3D1970%26volume%3D169%26issue%3D3943%26spage%3D388%26epage%3D390%26doi%3D10.1126%2Fscience.169.3943.388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Royse-Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, W. J.</span></span> <span> </span><span class="NLM_article-title">Orotidinuria Induced by Allopurinol</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>168</i></span> (<span class="NLM_issue">3933</span>),  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1126/science.168.3933.861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1126%2Fscience.168.3933.861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=5444063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaE3cXksVersLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=1970&pages=861-862&issue=3933&author=R.+M.+Foxauthor=D.+Royse-Smithauthor=W.+J.+O%E2%80%99Sullivan&title=Orotidinuria+Induced+by+Allopurinol&doi=10.1126%2Fscience.168.3933.861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Orotidinuria induced by allopurinol</span></div><div class="casAuthors">Fox, R. M.; Royse-Smith, D.; O'Sullivan, William James</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3933</span>),
    <span class="NLM_cas:pages">861-2</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The administration of allopurinol to patients suffering from hyperuricemia and to normal subjects results in increased excretion of the pyrimidine nucleoside orotidine.  Evidence is presented for the interference by allopurinol of the de novo biosynthesis of uridine 5'-phosphate in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW9gPE0GHzrLVg90H21EOLACvtfcHk0lgceHOetie7KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXksVersLg%253D&md5=dd4078bc405afaf386d45f39ef348635</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1126%2Fscience.168.3933.861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.168.3933.861%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DR.%2BM.%26aulast%3DRoyse-Smith%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DW.%2BJ.%26atitle%3DOrotidinuria%2520Induced%2520by%2520Allopurinol%26jtitle%3DScience%26date%3D1970%26volume%3D168%26issue%3D3933%26spage%3D861%26epage%3D862%26doi%3D10.1126%2Fscience.168.3933.861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span> <span> </span><span class="NLM_article-title">A Facile One-Pot Synthesis Of 4-Alkoxy-1,3. Benzenedicarbonitrile</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.3987/COM-97-S(N)89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3987%2FCOM-97-S%28N%2989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK1cXit1yhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=857-864&issue=2&author=M.+Hasegawa&title=A+Facile+One-Pot+Synthesis+Of+4-Alkoxy-1%2C3.+Benzenedicarbonitrile&doi=10.3987%2FCOM-97-S%28N%2989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">A facile one-pot synthesis of 4-alkoxy-1,3-benzenedicarbonitriles</span></div><div class="casAuthors">Hasegawa, Masaichi</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">857-864</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">The introduction of cyano group to 4-nitrobenzonitrile with KCN in dry DMSO followed by quenching with alkyl halides afforded 4-alkoxy-1,3-benzenedicarbonitriles in good yield.  The reaction was completed in dry DMSO, while no reaction occurred in dry DMF.  This observation can be suggested by the participation of DMSO in the reaction.  2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxlic acid (TEI-6720) was prepd. from 4-nitrobenzonitrile via 4-isobutoxy-1,3-benzenedicarbonitrile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAyj3aRtZd7Vg90H21EOLACvtfcHk0liIFWWDt7uQqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1yhs74%253D&md5=5d5de4cc3295ff62c9921292d10903a0</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.3987%2FCOM-97-S%28N%2989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-97-S%2528N%252989%26sid%3Dliteratum%253Aachs%26aulast%3DHasegawa%26aufirst%3DM.%26atitle%3DA%2520Facile%2520One-Pot%2520Synthesis%2520Of%25204-Alkoxy-1%252C3.%2520Benzenedicarbonitrile%26jtitle%3DHeterocycles%26date%3D1998%26volume%3D47%26issue%3D2%26spage%3D857%26epage%3D864%26doi%3D10.3987%2FCOM-97-S%28N%2989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase-Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, M. A.</span></span> <span> </span><span class="NLM_article-title">Selectivity of Febuxostat, a Novel Non-Purine Inhibitor of Xanthine Oxidase/Xanthine Dehydrogenase</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">1835</span>– <span class="NLM_lpage">1847</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2004.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.lfs.2004.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=15698861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2005&pages=1835-1847&issue=16&author=Y.+Takanoauthor=K.+Hase-Aokiauthor=H.+Horiuchiauthor=L.+Zhaoauthor=Y.+Kasaharaauthor=S.+Kondoauthor=M.+A.+Becker&title=Selectivity+of+Febuxostat%2C+a+Novel+Non-Purine+Inhibitor+of+Xanthine+Oxidase%2FXanthine+Dehydrogenase&doi=10.1016%2Fj.lfs.2004.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase</span></div><div class="casAuthors">Takano, Yasuhiro; Hase-Aoki, Kumiko; Horiuchi, Hideki; Zhao, Lin; Kasahara, Yoshinori; Kondo, Shiro; Becker, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1835-1847</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purine analog, allopurinol, has been in clin. use for more than 30 years as an inhibitor of xanthine oxidase (XO) in the treatment of hyperuricemia and gout.  As consequences of structural similarities to purine compds., however, allopurinol, its major active product, oxypurinol, and their resp. metabolites inhibit other enzymes involved in purine and pyrimidine metab.  Febuxostat (TEI-6720, TMX-67) is a potent, non-purine inhibitor of XO, currently under clin. evaluation for the treatment of hyperuricemia and gout.  In this study, we investigated the effects of febuxostat on several enzymes in purine and pyrimidine metab. and characterized the mechanism of febuxostat inhibition of XO activity.  Febuxostat displayed potent mixed-type inhibition of the activity of purified bovine milk XO, with Ki and Ki' values of 0.6 and 3.1 nM resp., indicating inhibition of both the oxidized and reduced forms of XO.  In contrast, at concns. up to 100 μM, febuxostat had no significant effects on the activities of the following enzymes of purine and pyrimidine metab.: guanine deaminase, hypoxanthine-guanine phosphoribosyltransferase, purine nucleoside phosphorylase, orotate phosphoribosyltransferase and orotidine-5'-monophosphate decarboxylase.  These results demonstrate that febuxostat is a potent non-purine, selective inhibitor of XO, and could be useful for the treatment of hyperuricemia and gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt94NMipTWUbVg90H21EOLACvtfcHk0liIFWWDt7uQqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGrt7s%253D&md5=d425eb40e5605c943e2d9a0b7c0794f7</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2004.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2004.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DY.%26aulast%3DHase-Aoki%26aufirst%3DK.%26aulast%3DHoriuchi%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DM.%2BA.%26atitle%3DSelectivity%2520of%2520Febuxostat%252C%2520a%2520Novel%2520Non-Purine%2520Inhibitor%2520of%2520Xanthine%2520Oxidase%252FXanthine%2520Dehydrogenase%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D76%26issue%3D16%26spage%3D1835%26epage%3D1847%26doi%3D10.1016%2Fj.lfs.2004.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hille, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eger, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, T.</span></span> <span> </span><span class="NLM_article-title">The Crystal Structure of Xanthine Oxidoreductase during Catalysis: Implications for Reaction Mechanism and Enzyme Inhibition</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7931</span>– <span class="NLM_lpage">7936</span>, <span class="refDoi"> DOI: 10.1073/pnas.0400973101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1073%2Fpnas.0400973101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=15148401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkslCis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=7931-7936&issue=21&author=K.+Okamotoauthor=K.+Matsumotoauthor=R.+Hilleauthor=B.+T.+Egerauthor=E.+F.+Paiauthor=T.+Nishino&title=The+Crystal+Structure+of+Xanthine+Oxidoreductase+during+Catalysis%3A+Implications+for+Reaction+Mechanism+and+Enzyme+Inhibition&doi=10.1073%2Fpnas.0400973101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of xanthine oxidoreductase during catalysis: Implications for reaction mechanism and enzyme inhibition</span></div><div class="casAuthors">Okamoto, Ken; Matsumoto, Koji; Hille, Russ; Eger, Bryan T.; Pai, Emil F.; Nishino, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7931-7936</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Molybdenum is widely distributed in biol. and is usually found as a mononuclear metal center in the active sites of many enzymes catalyzing oxygen atom transfer.  The molybdenum hydroxylases are distinct from other biol. systems catalyzing hydroxylation reactions in that the oxygen atom incorporated into the product is derived from water rather than mol. oxygen.  Here, we present the crystal structure of the key intermediate in the hydroxylation reaction of xanthine oxidoreductase with a slow substrate, in which the carbon-oxygen bond of the product is formed, yet the product remains complexed to the molybdenum.  This intermediate displays a stable broad charge-transfer band at ≈640 nm.  The crystal structure of the complex indicates that the catalytically labile Mo-OH oxygen has formed a bond with a carbon atom of the substrate.  In addn., the Mo=S group of the oxidized enzyme has become protonated to afford Mo-SH on redn. of the molybdenum center.  In contrast to previous assignments, we find this last ligand at an equatorial position in the square-pyramidal metal coordination sphere, not the apical position.  A water mol. usually seen in the active site of the enzyme is absent in the present structure, which probably accounts for the stability of this intermediate toward ligand displacement by hydroxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6sp0ZWs19-rVg90H21EOLACvtfcHk0lizrdZ9Y0ljig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkslCis7k%253D&md5=c1454067285fc6cdd4e7b847b3d09c9e</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0400973101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0400973101%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DHille%26aufirst%3DR.%26aulast%3DEger%26aufirst%3DB.%2BT.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DNishino%26aufirst%3DT.%26atitle%3DThe%2520Crystal%2520Structure%2520of%2520Xanthine%2520Oxidoreductase%2520during%2520Catalysis%253A%2520Implications%2520for%2520Reaction%2520Mechanism%2520and%2520Enzyme%2520Inhibition%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D21%26spage%3D7931%26epage%3D7936%26doi%3D10.1073%2Fpnas.0400973101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashizawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwanaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, O.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3-(3-Cyano-4-Pyridyl)-5-(4-Pyridyl)-1,2,4-Triazole, FYX-051-a Xanthine Oxidoreductase Inhibitor for the Treatment of Hyperuricemia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6225</span>– <span class="NLM_lpage">6229</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.bmcl.2009.08.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=19783139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GmurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6225-6229&issue=21&author=T.+Satoauthor=N.+Ashizawaauthor=K.+Matsumotoauthor=T.+Iwanagaauthor=H.+Nakamuraauthor=T.+Inoueauthor=O.+Nagata&title=Discovery+of+3-%283-Cyano-4-Pyridyl%29-5-%284-Pyridyl%29-1%2C2%2C4-Triazole%2C+FYX-051-a+Xanthine+Oxidoreductase+Inhibitor+for+the+Treatment+of+Hyperuricemia&doi=10.1016%2Fj.bmcl.2009.08.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia</span></div><div class="casAuthors">Sato, Takahiro; Ashizawa, Naoki; Matsumoto, Koji; Iwanaga, Takashi; Nakamura, Hiroshi; Inoue, Tsutomu; Nagata, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6225-6229</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A previous study identified 2-[2-(2-methoxy-ethoxy)-ethoxy]-5-[5-(2-methyl-4-pyridyl)-1H-[1,2,4]triazol-3-yl]-benzonitrile as a safe and potent xanthine oxidoreductase (XOR) inhibitor for the treatment of hyperuricemia.  A series of 3,5-dipyridyl-1,2,4-triazole derivs. were synthesized and their in vivo activity in lowering the serum uric acid levels in rats was examd.  As a result, 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole (FYX-051) to be one of the most potent XOR inhibitors; it exhibited an extremely potent in vivo activity, weak CYP3A4-inhibitory activity and a better pharmacokinetic profile than the previously identified compd.  FYX-051 is currently being evaluated in a phase 2 clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBzt8AQ13SK7Vg90H21EOLACvtfcHk0lizrdZ9Y0ljig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GmurjK&md5=515ed8e433aca32b3e8e1b199963c160</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.091%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DT.%26aulast%3DAshizawa%26aufirst%3DN.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DIwanaga%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DO.%26atitle%3DDiscovery%2520of%25203-%25283-Cyano-4-Pyridyl%2529-5-%25284-Pyridyl%2529-1%252C2%252C4-Triazole%252C%2520FYX-051-a%2520Xanthine%2520Oxidoreductase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hyperuricemia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D21%26spage%3D6225%26epage%3D6229%26doi%3D10.1016%2Fj.bmcl.2009.08.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashizawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, T.</span></span> <span> </span><span class="NLM_article-title">FYX-051: A Novel and Potent Hybrid-Type Inhibitor of Xanthine Oxidoreductase</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>336</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.174540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1124%2Fjpet.110.174540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=20952484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1ersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=95-103&issue=1&author=K.+Matsumotoauthor=K.+Okamotoauthor=N.+Ashizawaauthor=T.+Nishino&title=FYX-051%3A+A+Novel+and+Potent+Hybrid-Type+Inhibitor+of+Xanthine+Oxidoreductase&doi=10.1124%2Fjpet.110.174540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">FYX-051: a novel and potent hybrid-type inhibitor of xanthine oxidoreductase</span></div><div class="casAuthors">Matsumoto, Koji; Okamoto, Ken; Ashizawa, Naoki; Nishino, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-103</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">4-[5-(Pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile (FYX-051) is a potent inhibitor of bovine milk xanthine oxidoreductase (XOR).  Steady-state kinetics study showed that it initially behaved as a competitive-type inhibitor with a Ki value of 5.7 × 10-9 M, then after a few minutes it formed a tight complex with XOR via a Mo-oxygen-carbon atom covalent linkage, as reported previously.  Thus, FYX-051 is a hybrid-type inhibitor exhibiting both structure- and mechanism-based inhibition.  The FYX-051-XOR complex decompd. with a half-life of 20.4 h, but the enzyme activity did not fully recover.  This was found to be caused by XOR-mediated conversion of FYX-051 to 4-[5-(2-hydroxypyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile (2-hydroxy-FYX-051), as well as formation of 6-hydroxy-4-[5-(2-hydroxypyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile (dihydroxy-FYX-051) and 4-[5-(2,6-dihydroxypyridin-4-yl)-1H-1,2,4-triazol-3-yl]-6-hydroxypyridine-2-carbonitrile (trihydroxy-FYX-051) during prolonged incubation for up to 72 h.  A distinct charge-transfer band was obsd. concomitantly with the formation of the trihydroxy-FYX-051-XOR complex.  Crystallog. anal. of the charge-transfer complex indicated that a Mo-nitrogen-carbon bond was formed between molybdenum of XOR and the nitrile group of trihydroxy-FYX-051.  FYX-051 showed a potent and long-lasting hypouricemic effect in a rat model of potassium oxonate-induced hyperuricemia, and it seems to be a promising candidate for the clin. treatment of hyperuricemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8aMcZkNAFgLVg90H21EOLACvtfcHk0lgwYIbED0bVrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1ersw%253D%253D&md5=39aacb2b3979a17f58a425680ddd6091</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.174540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.174540%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DAshizawa%26aufirst%3DN.%26aulast%3DNishino%26aufirst%3DT.%26atitle%3DFYX-051%253A%2520A%2520Novel%2520and%2520Potent%2520Hybrid-Type%2520Inhibitor%2520of%2520Xanthine%2520Oxidoreductase%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26issue%3D1%26spage%3D95%26epage%3D103%26doi%3D10.1124%2Fjpet.110.174540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minhas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, G.</span></span> <span> </span><span class="NLM_article-title">Inducible Nitric Oxide Synthase Inhibitors: A Comprehensive Update</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">855</span>, <span class="refDoi"> DOI: 10.1002/med.21636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fmed.21636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31502681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlantbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&pages=823-855&issue=3&author=R.+Minhasauthor=Y.+Bansalauthor=G.+Bansal&title=Inducible+Nitric+Oxide+Synthase+Inhibitors%3A+A+Comprehensive+Update&doi=10.1002%2Fmed.21636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Inducible nitric oxide synthase inhibitors: A comprehensive update</span></div><div class="casAuthors">Minhas, Richa; Bansal, Yogita; Bansal, Gulshan</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">823-855</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Inducible nitric oxide synthase (iNOS), which is expressed in response to bacterial/proinflammatory stimuli, generates nitric oxide (NO) that provides cytoprotection.  Overexpression of iNOS increases the levels of NO, and this increased NO level is implicated in pathophysiol. of complex multifactorial diseases like Parkinson's disease, Alzheimer's disease, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease.  Selective inhibition of iNOS is an effective approach in treatment of such complex diseases.  -Arginine, being a substrate for iNOS, is the natural lead to develop iNOS inhibitors.  More than 200 research reports on development of nitric oxide synthase inhibitors by different research groups across the globe have appeared in literature so far.  In the present review, all reports on both natural and synthetic iNOS inhibitors, published 2002 onwards, are studied, classified, and discussed to provide comprehensive information on iNOS inhibitors.  The latter are further classified into amidines, five- or six-membered heterocyclics, fused cyclics, steroidal type, and chalcones analogs.  Structures of the most/significantly potent compds. from each report are provided to know the functional groups important for incurring iNOS inhibitory activity and selectivity.  This review is aimed to provide a comprehensive view to the medicinal chemists for rational designing of novel and potent iNOS inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUTlomCGpTELVg90H21EOLACvtfcHk0lgwYIbED0bVrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlantbo%253D&md5=54fe69326cbeb700ae5592beaf7fa702</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1002%2Fmed.21636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21636%26sid%3Dliteratum%253Aachs%26aulast%3DMinhas%26aufirst%3DR.%26aulast%3DBansal%26aufirst%3DY.%26aulast%3DBansal%26aufirst%3DG.%26atitle%3DInducible%2520Nitric%2520Oxide%2520Synthase%2520Inhibitors%253A%2520A%2520Comprehensive%2520Update%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2020%26volume%3D40%26issue%3D3%26spage%3D823%26epage%3D855%26doi%3D10.1002%2Fmed.21636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alderton, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angell, A. D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moncada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monkhouse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waslidge, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowles, R. G.</span></span> <span> </span><span class="NLM_article-title">GW274150 and GW273629 Are Potent and Highly Selective Inhibitors of Inducible Nitric Oxide Synthase in Vitro and in Vivo</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>145</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0706168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fsj.bjp.0706168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=15778742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Gntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2005&pages=301-312&issue=3&author=W.+K.+Aldertonauthor=A.+D.+R.+Angellauthor=C.+Craigauthor=J.+Dawsonauthor=E.+Garveyauthor=S.+Moncadaauthor=J.+Monkhouseauthor=D.+Reesauthor=L.+J.+Russellauthor=R.+J.+Russellauthor=S.+Schwartzauthor=N.+Waslidgeauthor=R.+G.+Knowles&title=GW274150+and+GW273629+Are+Potent+and+Highly+Selective+Inhibitors+of+Inducible+Nitric+Oxide+Synthase+in+Vitro+and+in+Vivo&doi=10.1038%2Fsj.bjp.0706168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo</span></div><div class="casAuthors">Alderton, Wendy K.; Angell, Anthony D. R.; Craig, Caroline; Dawson, John; Garvey, Edward; Moncada, Salvador; Monkhouse, Jayne; Rees, Daryl; Russell, Linda J.; Russell, Rachel J.; Schwartz, Sheila; Waslidge, Neil; Knowles, Richard G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-312</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">GW274150 ([2-[(1-iminoethyl) amino]ethyl]-L-homocysteine) and GW273629 (3-[[2-[(1-iminoethyl)amino]ethyl]sulfonyl]-L-alanine) are potent, time-dependent, highly selective inhibitors of human inducible nitric oxide synthase (iNOS) vs. endothelial NOS (eNOS) (>100-fold) or neuronal NOS (nNOS) (>80-fold).  GW274150 and GW273629 are arginine competitive, NADPH-dependent inhibitors of human iNOS with steady state Kd values of <40 and <90 nM, resp.  GW274150 and GW273629 inhibited intracellular iNOS in J774 cells in a time-dependent manner, reaching IC50 values of 0.2±0.04 and 1.3±0.16 μM, resp.  They were also acutely selective in intact rat tissues: GW274150 was >260-fold and 219-fold selective for iNOS against eNOS and nNOS, resp., while GW273629 was >150-fold and 365-fold selective for iNOS against eNOS and nNOS, resp.  The pharmacokinetic profile of GW274150 was biphasic in healthy rats and mice with a terminal half-life of ∼6 h.  That of GW273629 was also biphasic in rats, producing a terminal half-life of ∼3 h.  In mice however, elimination of GW273629 appeared monophasic and more rapid (∼10 min).  Both compds. show a high oral bioavailability (>90%) in rats and mice.  GW274150 was effective in inhibiting LPS-induced plasma NOx levels in mice with an ED50 of 3.2±0.7 mg kg-1 after 14 h i.p. and 3.8±1.5 mg kg-1 after 14 h when administered orally.  GW274150 was effective in inhibiting LPS-induced plasma NOx levels in mice with an ED50 of 3.2±0.7 mg kg-1 after 14 h i.p. and 3.8±1.5 mg kg-1 after 14 h when administered orally.  GW273629 showed shorter-lived effects on plasma NOx and an ED50 of 9±2 mg kg-1 after 2 h when administered i.p.  The effects of GW274150 and GW273629 in vivo were consistent with high selectivity for iNOS, as these inhibitors were of low potency against nNOS in the rat cerebellum and did not cause significant effects on blood pressure in instrumented mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquFYuHFmJTFLVg90H21EOLACvtfcHk0lhu3aBDIQ1D2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Gntbs%253D&md5=15b026f9a4e0cff55024719c98e55f85</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706168%26sid%3Dliteratum%253Aachs%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAngell%26aufirst%3DA.%2BD.%2BR.%26aulast%3DCraig%26aufirst%3DC.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DGarvey%26aufirst%3DE.%26aulast%3DMoncada%26aufirst%3DS.%26aulast%3DMonkhouse%26aufirst%3DJ.%26aulast%3DRees%26aufirst%3DD.%26aulast%3DRussell%26aufirst%3DL.%2BJ.%26aulast%3DRussell%26aufirst%3DR.%2BJ.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DWaslidge%26aufirst%3DN.%26aulast%3DKnowles%26aufirst%3DR.%2BG.%26atitle%3DGW274150%2520and%2520GW273629%2520Are%2520Potent%2520and%2520Highly%2520Selective%2520Inhibitors%2520of%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D145%26issue%3D3%26spage%3D301%26epage%3D312%26doi%3D10.1038%2Fsj.bjp.0706168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strub, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, W.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesslinger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltze, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchß, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strassner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehner, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boer, R.</span></span> <span> </span><span class="NLM_article-title">The Novel Imidazopyridine 2- [ 2- (4-Methoxy-Pyridin-2-Yl) -Ethyl ] - 3 H -Imidazo [ 4, 5- b ] Pyridine (BYK191023) Is a Highly Selective Inhibitor of the Inducible Nitric-Oxide Synthase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1124/mol.105.017087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1124%2Fmol.105.017087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=16223957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD28XktlWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=328-337&issue=1&author=A.+Strubauthor=W.-R.+Ulrichauthor=C.+Hesslingerauthor=M.+Eltzeauthor=T.+Fuch%C3%9Fauthor=J.+Strassnerauthor=S.+Strandauthor=M.+D.+Lehnerauthor=R.+Boer&title=The+Novel+Imidazopyridine+2-+%5B+2-+%284-Methoxy-Pyridin-2-Yl%29+-Ethyl+%5D+-+3+H+-Imidazo+%5B+4%2C+5-+b+%5D+Pyridine+%28BYK191023%29+Is+a+Highly+Selective+Inhibitor+of+the+Inducible+Nitric-Oxide+Synthase&doi=10.1124%2Fmol.105.017087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">The novel imidazopyridine 2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase</span></div><div class="casAuthors">Strub, Andreas; Ulrich, Wolf-Ruediger; Hesslinger, Christian; Eltze, Manfrid; Fuchss, Thomas; Strassner, Jochen; Strand, Susanne; Lehner, Martin D.; Boer, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">328-337</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have identified imidazopyridine derivs. as a novel class of NO synthase inhibitors with high selectivity for the inducible isoform.  2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) showed half-maximal inhibition of crudely purified human inducible (iNOS), neuronal (nNOS), and endothelial (eNOS) NO synthases at 86 nM, 17 μM, and 162 μM, resp.  Inhibition of inducible NO synthase was competitive with L-arginine, pointing to an interaction of BYK191023 with the catalytic center of the enzyme.  In radioligand and surface plasmon resonance expts., BYK191023 exhibited an affinity for iNOS, nNOS, and eNOS of 450 nM, 30 μM, and >500 μM, resp.  Inhibition of cellular nitrate/nitrite synthesis in RAW, rat mesangium, and human embryonic kidney 293 cells after iNOS induction showed 40- to 100-fold higher IC50 values than at the isolated enzyme, in agreement with the much higher L-arginine concns. in cell culture media and inside intact cells.  BYK191023 did not show any toxicity in various rodent and human cell lines up to high micromolar concns.  The inhibitory potency of BYK191023 was tested in isolated organ models of iNOS (lipopolysaccharide-treated and phenylephrine-precontracted rat aorta; IC50 = 7 μM), eNOS (arecaidine propargyl ester-induced relaxation of phenylephrine-precontracted rat aorta; IC50 > 100 μM), and nNOS (field-stimulated relaxation of phenylephrine-precontracted rabbit corpus cavernosum; IC50 > 100 μM).  These data confirm the high selectivity of BYK191023 for iNOS over eNOS and nNOS found at isolated enzymes.  In summary, we have identified a new highly selective iNOS inhibitor structurally unrelated to known compds. and L-arginine.  BYK191023 is a valuable tool for the investigation of iNOS-mediated effects in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmoCXREGVIZrVg90H21EOLACvtfcHk0lhu3aBDIQ1D2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktlWmtA%253D%253D&md5=ac863b02e078326c40b0212d1c78970d</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.017087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.017087%26sid%3Dliteratum%253Aachs%26aulast%3DStrub%26aufirst%3DA.%26aulast%3DUlrich%26aufirst%3DW.-R.%26aulast%3DHesslinger%26aufirst%3DC.%26aulast%3DEltze%26aufirst%3DM.%26aulast%3DFuch%25C3%259F%26aufirst%3DT.%26aulast%3DStrassner%26aufirst%3DJ.%26aulast%3DStrand%26aufirst%3DS.%26aulast%3DLehner%26aufirst%3DM.%2BD.%26aulast%3DBoer%26aufirst%3DR.%26atitle%3DThe%2520Novel%2520Imidazopyridine%25202-%2520%255B%25202-%2520%25284-Methoxy-Pyridin-2-Yl%2529%2520-Ethyl%2520%255D%2520-%25203%2520H%2520-Imidazo%2520%255B%25204%252C%25205-%2520b%2520%255D%2520Pyridine%2520%2528BYK191023%2529%2520Is%2520a%2520Highly%2520Selective%2520Inhibitor%2520of%2520the%2520Inducible%2520Nitric-Oxide%2520Synthase%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26issue%3D1%26spage%3D328%26epage%3D337%26doi%3D10.1124%2Fmol.105.017087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oplinger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furfine, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiff, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittle, B. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowles, R. G.</span></span> <span> </span><span class="NLM_article-title">1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-Oxide Synthase in Vitro and in Vivo</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4959</span>– <span class="NLM_lpage">4963</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.8.4959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1074%2Fjbc.272.8.4959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=9030556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2sXhsValtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=4959-4963&issue=8&author=E.+P.+Garveyauthor=J.+A.+Oplingerauthor=E.+S.+Furfineauthor=R.+J.+Kiffauthor=F.+Laszloauthor=B.+J.+R.+Whittleauthor=R.+G.+Knowles&title=1400W+Is+a+Slow%2C+Tight+Binding%2C+and+Highly+Selective+Inhibitor+of+Inducible+Nitric-Oxide+Synthase+in+Vitro+and+in+Vivo&doi=10.1074%2Fjbc.272.8.4959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo</span></div><div class="casAuthors">Garvey, Edward P.; Oplinger, Jeffrey A.; Furfine, Eric S.; Kiff, Rachel J.; Laszlo, Ferenc; Whittle, Brenden J. R.; Knowles, Richard G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4959-4963</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-(3-(aminomethyl)benzyl)acetamidine (1400W) was a slow, tight binding inhibitor of human inducible nitric oxide synthase (iNOS).  The slow onset of inhibition by 1400W showed satn. kinetics with a maximal rate const. of 0.028 s-1 and a binding const. of 2.0 μM.  Inhibition was dependent on the cofactor NADPH.  L-Arginine was a competitive inhibitor of 1400W binding with a Ks value of 3.0 μM.  Inhibited enzyme did not recover activity after 2 h.  Thus, 1400W was either an irreversible inhibitor or an extremely slowly reversible inhibitor of human iNOS with a Kd value ≤ 7 nM.  In contrast, inhibition of human neuronal NOS and endothelial NOS (eNOS) was relatively weaker, rapidly reversible, and competitive with L-arginine, with Ki values of 2 μM and 50 μM, resp.  Thus, 1400W was at least 5000-fold selective for iNOS vs. eNOS.  This selectivity was similar to that obsd. in rat aortic rings, in which 1400W was greater than 1000-fold more potent against rat iNOS than eNOS.  Finally, 1400W was greater than 50-fold more potent against iNOS than eNOS in a rat model of endotoxin-induced vascular injury.  Thus, the potency and selectivity of 1400W inhibition of iNOS both in vitro and in vivo were far greater than of any previously described iNOS inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe5tgzssWloLVg90H21EOLACvtfcHk0lj3owGtsYZXQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsValtLY%253D&md5=c6c9d901c810e1ab4e8817c63995b9c8</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.8.4959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.8.4959%26sid%3Dliteratum%253Aachs%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DOplinger%26aufirst%3DJ.%2BA.%26aulast%3DFurfine%26aufirst%3DE.%2BS.%26aulast%3DKiff%26aufirst%3DR.%2BJ.%26aulast%3DLaszlo%26aufirst%3DF.%26aulast%3DWhittle%26aufirst%3DB.%2BJ.%2BR.%26aulast%3DKnowles%26aufirst%3DR.%2BG.%26atitle%3D1400W%2520Is%2520a%2520Slow%252C%2520Tight%2520Binding%252C%2520and%2520Highly%2520Selective%2520Inhibitor%2520of%2520Inducible%2520Nitric-Oxide%2520Synthase%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D8%26spage%3D4959%26epage%3D4963%26doi%3D10.1074%2Fjbc.272.8.4959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjoeng, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misko, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, M. G.</span></span> <span> </span><span class="NLM_article-title">L-N6-(1-Iminoethyl)Lysine: Selective Inhibitor of Inducible Nitric Oxide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">3886</span>– <span class="NLM_lpage">3888</span>, <span class="refDoi"> DOI: 10.1021/jm00049a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00049a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2MXhs12htr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3886-3888&author=W.+M.+Mooreauthor=R.+K.+Webberauthor=G.+M.+Jeromeauthor=F.+S.+Tjoengauthor=T.+P.+Miskoauthor=M.+G.+Currie&title=L-N6-%281-Iminoethyl%29Lysine%3A+Selective+Inhibitor+of+Inducible+Nitric+Oxide&doi=10.1021%2Fjm00049a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">L-N6-(1-Iminoethyl)lysine: A Selective Inhibitor of Inducible Nitric Oxide Synthase</span></div><div class="casAuthors">Moore, William M.; Webber, R. Keith; Jerome, Gina M.; Tjoeng, Foe S.; Misko, Thomas P.; Currie, Mark G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3886-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">L-N6-(1-iminoethyl)lysine (L-NIL) has been synthesized and is shown to be both a potent and selective inhibitor of mouse-inducible nitric oxide synthase (miNOS).  L-NIL has an IC50 of 3.3 μM for miNOS compared to an IC50 of 92 μM for rat brain constitutive NOS indicating that L-NIL is 28-fold more selective for inducible NOS.  L-N5-(1-iminoethyl)ornithine (L-NIO), which differes from L-NIL by having one less methylene group, has very similar potency for inducible NOS, but lacks selectivity.  DL-N7-(1-iminoethyl)homolysine was also synthesized and found to be substantially less potent than L-NIL or L-NIO, with intermediate selectivity for inducible NOS.  These data suggest that L-NIL may be useful as a selective inhibitor of inducible NOS for detg. the role of this enzyme in disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3m3-Er1JDnbVg90H21EOLACvtfcHk0lj3owGtsYZXQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhs12htr8%253D&md5=34710a372ba204cc1f8f3211822fbc5f</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Fjm00049a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00049a007%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DW.%2BM.%26aulast%3DWebber%26aufirst%3DR.%2BK.%26aulast%3DJerome%26aufirst%3DG.%2BM.%26aulast%3DTjoeng%26aufirst%3DF.%2BS.%26aulast%3DMisko%26aufirst%3DT.%2BP.%26aulast%3DCurrie%26aufirst%3DM.%2BG.%26atitle%3DL-N6-%25281-Iminoethyl%2529Lysine%253A%2520Selective%2520Inhibitor%2520of%2520Inducible%2520Nitric%2520Oxide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3886%26epage%3D3888%26doi%3D10.1021%2Fjm00049a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvale, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota-Filipe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Inducible Nitric Oxide Synthase Reduces Renal Ischemia/Reperfusion Injury</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">862</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1046/j.1523-1755.2002.00234.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1046%2Fj.1523-1755.2002.00234.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=11849439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1agur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=862-871&issue=3&author=P.+K.+Chatterjeeauthor=N.+S.+A.+Patelauthor=E.+O.+Kvaleauthor=S.+Cuzzocreaauthor=P.+A.+J.+Brownauthor=K.+N.+Stewartauthor=H.+Mota-Filipeauthor=C.+Thiemermann&title=Inhibition+of+Inducible+Nitric+Oxide+Synthase+Reduces+Renal+Ischemia%2FReperfusion+Injury&doi=10.1046%2Fj.1523-1755.2002.00234.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury</span></div><div class="casAuthors">Chatterjee, Prabal K.; Patel, Nimesh S. A.; Kvale, Espen O.; Cuzzocrea, Salvatore; Brown, Paul A. J.; Stewart, Keith N.; Mota-Filipe, Helder; Thiemermann, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-871</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">NO (NO), produced via inducible NO synthase (iNOS), is implicated in the pathophysiol. of renal ischemia/reperfusion (I/R) injury.  The aim of this study was to investigate the effects of the iNOS inhibitors L-N6-(1-iminoethyl)lysine (L-NIL) and aminoethyl-isothiourea (AE-ITU) on (a) renal dysfunction and injury mediated by bilateral I/R of rat kidneys in vivo and (b) cytokine-stimulated NO prodn. by primary cultures of rat proximal tubule (PT) cells.  Male Wistar rats subjected to bilateral renal ischemia (45 min) followed by reperfusion (6 h).  Rats were administered either L-NIL (3 mg/kg IV bolus 15 min prior to I/R followed by 1 mg/kg/h throughout I/R) or AE-ITU (1 mg/kg IV bolus 15 min prior to I/R followed by 1 mg/kg/h throughout I/R).  Blood serum and urinary biochem. indicators of renal dysfunction and injury were measured; serum creatinine (SCr, glomerular dysfunction), fractional excretion of Na+ (FENa, tubular dysfunction), serum Asp aminotransferase (sAST, I/R injury) and urinary N-acetyl-β-D-glucosaminidase (uNAG, tubular injury).  Addnl., renal sections were used for histol. grading of renal injury and for immunol. evidence of nitrotyrosine formation.  Nitrate/nitrate levels in plasma were measured using the Griess assay and used as an indicator of NO prodn.  Primary cultures of rat PT cells were incubated with interferon-γ (IFN-γ, 100 IU/mL) and lipopolysaccharide (LPS, 10 μg/mL) for 24 h, either in the absence or presence of increasing concns. of L-NIL or AE-ITU (0.001 to 1 mmol/L) after which nitrite/nitrate levels were measured using the Griess assay.  L-NIL and AE-ITU significantly reduced the I/R-mediated increases in SCr, FENa, sAST, and uNAG, indicating attenuation of I/R-mediated renal dysfunction and injury.  Specifically, L-NIL and AE-ITU reduced the I/R-mediated glomerular and tubular dysfunction and biochem. and histol. evidence of tubular injury.  Both L-NIL and AE-ITU attenuated the plasma levels of nitrate (indicating reduced NO prodn.) and the immunohistochem. evidence of the formation of nitrotyrosine.  In vitro, L-NIL and AE-ITU both significantly reduced cytokine-stimulated NO prodn. by primary cultures of rat PT cells in a dose-dependent manner.  These results suggest that L-NIL and AE-ITU reduce the renal dysfunction and injury assocd. with I/R of the kidney, via inhibition of iNOS activity and subsequent redn. of NO (and peroxynitrite) generation.  The authors propose that selective and specific inhibitors of iNOS activity may be useful against the NO-mediated renal dysfunction and injury assocd. with I/R of the kidney.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ckx8dxSJ47Vg90H21EOLACvtfcHk0lgyMQXs29Ugiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1agur4%253D&md5=78ad771fd687a37367cc870c2694df33</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.2002.00234.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.2002.00234.x%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DP.%2BK.%26aulast%3DPatel%26aufirst%3DN.%2BS.%2BA.%26aulast%3DKvale%26aufirst%3DE.%2BO.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DStewart%26aufirst%3DK.%2BN.%26aulast%3DMota-Filipe%26aufirst%3DH.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DInhibition%2520of%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520Reduces%2520Renal%2520Ischemia%252FReperfusion%2520Injury%26jtitle%3DKidney%2520Int.%26date%3D2002%26volume%3D61%26issue%3D3%26spage%3D862%26epage%3D871%26doi%3D10.1046%2Fj.1523-1755.2002.00234.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivarajah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvale, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota-Filipe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaqoob, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">GW274150, a Potent and Highly Selective Inhibitor of INOS Reduces Experimental Renal Ischemia/Reperfusion Injury</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">853</span>– <span class="NLM_lpage">865</span>, <span class="refDoi"> DOI: 10.1046/j.1523-1755.2003.00802.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1046%2Fj.1523-1755.2003.00802.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=12631066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivV2jsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=853-865&issue=3&author=P.+K.+Chatterjeeauthor=N.+S.+A.+Patelauthor=A.+Sivarajahauthor=E.+O.+Kvaleauthor=L.+Dugoauthor=S.+Cuzzocreaauthor=P.+A.+J.+Brownauthor=K.+N.+Stewartauthor=H.+Mota-Filipeauthor=D.+Brittiauthor=M.+M.+Yaqoobauthor=C.+Thiemermann&title=GW274150%2C+a+Potent+and+Highly+Selective+Inhibitor+of+INOS+Reduces+Experimental+Renal+Ischemia%2FReperfusion+Injury&doi=10.1046%2Fj.1523-1755.2003.00802.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury</span></div><div class="casAuthors">Chatterjee, Prabal K.; Patel, Nimesh S. A.; Sivarajah, Ahila; Kvale, Espen O.; Dugo, Laura; Cuzzocrea, Salvatore; Brown, Paul A. J.; Stewart, Keith N.; Mota-Filipe, Helder; Britti, Domenico; Yaqoob, Muhammad M.; Thiemermann, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">853-865</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Generation of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) may contribute to renal ischemia/reperfusion (I/R) injury.  The aim of this study was to investigate the effects of GW274150, a novel, highly selective, potent and long-acting inhibitor of iNOS activity in rat and mouse models of renal I/R.  Rats were administered GW274150 (5 mg/kg i.v. bolus administered 30 min prior to I/R) and subjected to bilateral renal ischemia (45 min) followed by reperfusion (6 h).  Serum and urinary indicators of renal dysfunction, tubular and reperfusion injury were measured, specifically, serum urea, creatinine, aspartate aminotransferase (AST) and N-acetyl-β-D-glucosaminidase (NAG) enzymuria.  In addn., renal sections were used for histol. scoring of renal injury and for immunol. evidence of nitrotyrosine formation and poly [ADP (ADP)-ribose] (PAR).  Nitrate levels were measured in rat plasma using the Griess assay.  Mice (wild-type, administered 5 mg/kg GW274150, and iNOS-/-) were subjected to bilateral renal ischemia (30 min) followed by reperfusion (24 h) after which renal dysfunction (serum urea, creatinine), renal myeloperoxidase (MPO) activity and malondialdehyde (MDA) levels were measured.  GW274150, administered prior to I/R, significantly reduced serum urea, serum creatinine, AST, and NAG indicating redn. of renal dysfunction and injury caused by I/R.  GW274150 reduced histol. evidence of tubular injury and markedly reduced immunohistochem. evidence of nitrotyrosine and PAR formation, indicating reduced peroxynitrite formation and poly (ADP-ribose) polymerase (PARP) activation, resp.  GW274150 abolished the rise in the plasma levels of nitrate (indicating reduced NO prodn.).  GW274150 also reduced the renal dysfunction in wild-type mice to levels similar to that obsd. in iNOS-/- mice subjected to I/R.  Renal MPO activity and MDA levels were significantly reduced in wild-type mice administered GW274150 and iNOS-/- mice subjected to renal I/R, indicating reduced polymorphonuclear leukocyte (PMN) infiltration and lipid peroxidn.  These results suggest that (1) an enhanced formation of NO by iNOS contributes to the pathophysiol. of renal I/R injury and (2) GW274150 reduces I/R injury of the kidney.  We propose that selective inhibitors of iNOS activity may be useful against renal dysfunction and injury assocd. with I/R of the kidney.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0w-sSU2WM27Vg90H21EOLACvtfcHk0lijW05srSaLuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivV2jsLs%253D&md5=feb716102c805d6d315f0d1a5a7268a5</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.2003.00802.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.2003.00802.x%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DP.%2BK.%26aulast%3DPatel%26aufirst%3DN.%2BS.%2BA.%26aulast%3DSivarajah%26aufirst%3DA.%26aulast%3DKvale%26aufirst%3DE.%2BO.%26aulast%3DDugo%26aufirst%3DL.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DStewart%26aufirst%3DK.%2BN.%26aulast%3DMota-Filipe%26aufirst%3DH.%26aulast%3DBritti%26aufirst%3DD.%26aulast%3DYaqoob%26aufirst%3DM.%2BM.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DGW274150%252C%2520a%2520Potent%2520and%2520Highly%2520Selective%2520Inhibitor%2520of%2520INOS%2520Reduces%2520Experimental%2520Renal%2520Ischemia%252FReperfusion%2520Injury%26jtitle%3DKidney%2520Int.%26date%3D2003%26volume%3D63%26issue%3D3%26spage%3D853%26epage%3D865%26doi%3D10.1046%2Fj.1523-1755.2003.00802.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serraino, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputi, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">Beneficial Effects of GW274150, a Novel, Potent and Selective Inhibitor of INOS Activity, in a Rodent Model of Collagen-Induced Arthritis</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>453</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(02)02338-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2FS0014-2999%2802%2902338-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=12393067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVChurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2002&pages=119-129&issue=1&author=S.+Cuzzocreaauthor=P.+K.+Chatterjeeauthor=E.+Mazzonauthor=M.+C.+McDonaldauthor=L.+Dugoauthor=R.+Di+Paolaauthor=I.+Serrainoauthor=D.+Brittiauthor=A.+P.+Caputiauthor=C.+Thiemermann&title=Beneficial+Effects+of+GW274150%2C+a+Novel%2C+Potent+and+Selective+Inhibitor+of+INOS+Activity%2C+in+a+Rodent+Model+of+Collagen-Induced+Arthritis&doi=10.1016%2FS0014-2999%2802%2902338-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis</span></div><div class="casAuthors">Cuzzocrea, Salvatore; Chatterjee, Prabal K.; Mazzon, Emanuela; McDonald, Michelle C.; Dugo, Laura; Di Paola, Rosanna; Serraino, Ivana; Britti, Domenico; Caputi, Achille P.; Thiemermann, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-129</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The aim of this study was to investigate the role of inducible nitric oxide synthase (iNOS) on the modulation of the inflammatory response in mice subjected to collagen-induced arthritis.  Collagen-induced arthritis was induced in wild-type mice (iNOS-WT) treated with GW274150, a novel, potent and selective inhibitor of iNOS activity, and in mice lacking the gene for iNOS (iNOS knock-out', iNOS-KO), by an intradermal injection of 100 μl of emulsion contg. 100 μg of bovine type II collagen and complete Freund's adjuvant at the base of the tail.  After 21 days, a second injection of type II collagen in complete Freund's adjuvant was administered. iNOS-WT mice developed erosive hind paw arthritis when immunized with type II collagen in complete Freund's adjuvant.  Over a 35-day period, macroscopic clin. evidence of collagen-induced arthritis first appeared as periarticular erythema and edema in the hind paws.  By day 28, the incidence of collagen-induced arthritis was 100% in type II collagen-challenged iNOS-WT mice and the severity of collagen-induced arthritis progressed with radiog. evaluation revealing resorption of bone.  Histopathol. of collagen-induced arthritis mice demonstrated erosion of the cartilage at the joint margins. iNOS-WT mice treated with GW274150 (5 mg/kg, i.p. daily) starting at the onset of arthritis (day 23), and iNOS-KO mice showed a delay of the development of the clin. signs at days 24-35 and an improvement of the histol. status in the knee and paw.  Immunohistochem. anal. for nitrotyrosine and for poly(ADP-ribose) polymerase revealed pos. staining in inflamed joints from type II collagen-treated iNOS-WT mice.  The degree of staining for nitrotyrosine and poly(ADP-ribose) polymerase were markedly reduced in tissue sections obtained from type II collagen-treated iNOS-WT mice, who had received GW274150 and from iNOS-KO mice.  Furthermore, radiog. signs of protection against bone resorption were present in the joints of iNOS-WT mice treated with GW274150 as well as in the joint from iNOS-KO mice.  This study provides the first evidence that GW274150, a novel, potent and selective inhibitor of iNOS activity, attenuates the degree of chronic inflammation and tissue damage assocd. with collagen-induced arthritis in mice.  Furthermore, these results suggest that the induction of iNOS and NO prodn. are essential for the up-regulation of the inflammatory response during exptl. collagen-induced arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDrF5GboEExLVg90H21EOLACvtfcHk0lijW05srSaLuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVChurs%253D&md5=570e371daec34b34c8f9eb04ba7112b7</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902338-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902338-5%26sid%3Dliteratum%253Aachs%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DChatterjee%26aufirst%3DP.%2BK.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DMcDonald%26aufirst%3DM.%2BC.%26aulast%3DDugo%26aufirst%3DL.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DSerraino%26aufirst%3DI.%26aulast%3DBritti%26aufirst%3DD.%26aulast%3DCaputi%26aufirst%3DA.%2BP.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DBeneficial%2520Effects%2520of%2520GW274150%252C%2520a%2520Novel%252C%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520INOS%2520Activity%252C%2520in%2520a%2520Rodent%2520Model%2520of%2520Collagen-Induced%2520Arthritis%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D453%26issue%3D1%26spage%3D119%26epage%3D129%26doi%3D10.1016%2FS0014-2999%2802%2902338-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvale, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">GW274150 Inhibits Nitric Oxide Production by Primary Cultures of Rat Proximal Tubular Cells</span>. <i>Med. Sci. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">BR357</span>– <span class="NLM_lpage">BR362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=14523323" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=BR357-BR362&issue=10&author=P.+K.+Chatterjeeauthor=E.+O.+Kvaleauthor=N.+S.+A.+Patelauthor=C.+Thiemermann&title=GW274150+Inhibits+Nitric+Oxide+Production+by+Primary+Cultures+of+Rat+Proximal+Tubular+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DP.%2BK.%26aulast%3DKvale%26aufirst%3DE.%2BO.%26aulast%3DPatel%26aufirst%3DN.%2BS.%2BA.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DGW274150%2520Inhibits%2520Nitric%2520Oxide%2520Production%2520by%2520Primary%2520Cultures%2520of%2520Rat%2520Proximal%2520Tubular%2520Cells%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2003%26volume%3D9%26issue%3D10%26spage%3DBR357%26epage%3DBR362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Broom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinova-Mutafchieva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhurst, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexter, D. T.</span></span> <span> </span><span class="NLM_article-title">Neuroprotection by the Selective INOS Inhibitor GW274150 in a Model of Parkinson Disease</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2010.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.freeradbiomed.2010.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=21185368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlejtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=633-640&issue=5&author=L.+Broomauthor=L.+Marinova-Mutafchievaauthor=M.+Sadeghianauthor=J.+B.+Davisauthor=A.+D.+Medhurstauthor=D.+T.+Dexter&title=Neuroprotection+by+the+Selective+INOS+Inhibitor+GW274150+in+a+Model+of+Parkinson+Disease&doi=10.1016%2Fj.freeradbiomed.2010.12.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease</span></div><div class="casAuthors">Broom, Lauren; Marinova-Mutafchieva, Lilia; Sadeghian, Mona; Davis, John B.; Medhurst, Andrew D.; Dexter, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">633-640</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neuroinflammation and the activation of inducible nitric oxide synthase (iNOS) have been proposed to play a role in the pathogenesis of Parkinson disease (PD).  In this study we investigated the effects of the selective iNOS inhibitor GW274150 in the 6-OHDA model of PD.  6-OHDA administration was assocd. with increased nos. of cells expressing iNOS.  Administration of the iNOS inhibitor twice daily for 7 days, beginning 2 days after the 6-OHDA lesioning, led to a significant neuroprotection as shown by assessment of the integrity of the nigrostriatal system by tyrosine hydroxylase immunocytochem. and HPLC assessment of striatal dopamine content.  However, GW274150 displayed a bell-shaped neuroprotective profile, being ineffective at high doses.  6-OHDA lesioning was assocd. with an increase in microglial activation as assessed by the MHC II antigen OX-6 and the no. of matrix metalloproteinase 9 (MMP-9)-immunopos. cells.  NO is a known modulator of MMP-9, and iNOS inhibition was assocd. with decreased nos. of MMP-9-immunopos. cells, culminating in a redn. in the nos. of reactive microglia.  Withdrawal of GW274150 for a further 7 days negated any neuroprotective effects of iNOS inhibition, suggesting that the damaging effects of inflammation last beyond 7 days in this model and the continued administration of the drug may be required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOlohkfL3bLVg90H21EOLACvtfcHk0ljT79y0SaNQLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlejtbk%253D&md5=7ac55463ac877d6c20857c2d6a338569</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DBroom%26aufirst%3DL.%26aulast%3DMarinova-Mutafchieva%26aufirst%3DL.%26aulast%3DSadeghian%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DJ.%2BB.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DDexter%26aufirst%3DD.%2BT.%26atitle%3DNeuroprotection%2520by%2520the%2520Selective%2520INOS%2520Inhibitor%2520GW274150%2520in%2520a%2520Model%2520of%2520Parkinson%2520Disease%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2011%26volume%3D50%26issue%3D5%26spage%3D633%26epage%3D640%26doi%3D10.1016%2Fj.freeradbiomed.2010.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcin, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvai, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroeger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crane, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinder, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Gallay, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinker, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gensmantel, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mete, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheshire, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuehr, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tainer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getzoff, E. D.</span></span> <span> </span><span class="NLM_article-title">Anchored Plasticity Opens Doors for Selective Inhibitor Design in Nitric Oxide Synthase</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1038/nchembio.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fnchembio.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18849972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=700-707&issue=11&author=E.+D.+Garcinauthor=A.+S.+Arvaiauthor=R.+J.+Rosenfeldauthor=M.+D.+Kroegerauthor=B.+R.+Craneauthor=G.+Anderssonauthor=G.+Andrewsauthor=P.+J.+Hamleyauthor=P.+R.+Mallinderauthor=D.+J.+Nichollsauthor=S.+A.+St-Gallayauthor=A.+C.+Tinkerauthor=N.+P.+Gensmantelauthor=A.+Meteauthor=D.+R.+Cheshireauthor=S.+Connollyauthor=D.+J.+Stuehrauthor=A.+%C3%85bergauthor=A.+V.+Wallaceauthor=J.+A.+Tainerauthor=E.+D.+Getzoff&title=Anchored+Plasticity+Opens+Doors+for+Selective+Inhibitor+Design+in+Nitric+Oxide+Synthase&doi=10.1038%2Fnchembio.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase</span></div><div class="casAuthors">Garcin, Elsa D.; Arvai, Andrew S.; Rosenfeld, Robin J.; Kroeger, Matt D.; Crane, Brian R.; Andersson, Gunilla; Andrews, Glen; Hamley, Peter J.; Mallinder, Philip R.; Nicholls, David J.; St-Gallay, Stephen A.; Tinker, Alan C.; Gensmantel, Nigel P.; Mete, Antonio; Cheshire, David R.; Connolly, Stephen; Stuehr, Dennis J.; Aberg, Anders; Wallace, Alan V.; Tainer, John A.; Getzoff, Elizabeth D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">700-707</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nitric oxide synthase (NOS) enzymes synthesize nitric oxide, a signal for vasodilatation and neurotransmission at low concns. and a defensive cytotoxin at higher concns.  The high active site conservation among all three NOS isoenzymes hinders the design of selective NOS inhibitors to treat inflammation, arthritis, stroke, septic shock and cancer.  Our crystal structures and mutagenesis results identified an isoenzyme-specific induced-fit binding mode linking a cascade of conformational changes to a new specificity pocket.  Plasticity of an isoenzyme-specific triad of distant second- and third-shell residues modulates conformational changes of invariant first-shell residues to det. inhibitor selectivity.  To design potent and selective NOS inhibitors, we developed the anchored plasticity approach: anchor an inhibitor core in a conserved binding pocket, then extend rigid bulky substituents toward remote specificity pockets, which become accessible upon conformational changes of flexible residues.  This approach exemplifies general principles for the design of selective enzyme inhibitors that overcome strong active site conservation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolWKmmHvQjlbVg90H21EOLACvtfcHk0li4aClivq5wug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7nM&md5=838cf58525ee2f6fe85aaba9f3416536</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.115%26sid%3Dliteratum%253Aachs%26aulast%3DGarcin%26aufirst%3DE.%2BD.%26aulast%3DArvai%26aufirst%3DA.%2BS.%26aulast%3DRosenfeld%26aufirst%3DR.%2BJ.%26aulast%3DKroeger%26aufirst%3DM.%2BD.%26aulast%3DCrane%26aufirst%3DB.%2BR.%26aulast%3DAndersson%26aufirst%3DG.%26aulast%3DAndrews%26aufirst%3DG.%26aulast%3DHamley%26aufirst%3DP.%2BJ.%26aulast%3DMallinder%26aufirst%3DP.%2BR.%26aulast%3DNicholls%26aufirst%3DD.%2BJ.%26aulast%3DSt-Gallay%26aufirst%3DS.%2BA.%26aulast%3DTinker%26aufirst%3DA.%2BC.%26aulast%3DGensmantel%26aufirst%3DN.%2BP.%26aulast%3DMete%26aufirst%3DA.%26aulast%3DCheshire%26aufirst%3DD.%2BR.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DStuehr%26aufirst%3DD.%2BJ.%26aulast%3D%25C3%2585berg%26aufirst%3DA.%26aulast%3DWallace%26aufirst%3DA.%2BV.%26aulast%3DTainer%26aufirst%3DJ.%2BA.%26aulast%3DGetzoff%26aufirst%3DE.%2BD.%26atitle%3DAnchored%2520Plasticity%2520Opens%2520Doors%2520for%2520Selective%2520Inhibitor%2520Design%2520in%2520Nitric%2520Oxide%2520Synthase%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26issue%3D11%26spage%3D700%26epage%3D707%26doi%3D10.1038%2Fnchembio.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagmann, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durette, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esser, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanza, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopka, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guthikonda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacCoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabin, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humes, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacholok, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. K.</span></span> <span> </span><span class="NLM_article-title">Substituted 2-Ammopyridines as Inhibitors of Nitric Oxide Synthases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">1975</span>– <span class="NLM_lpage">1978</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)00389-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2FS0960-894X%2800%2900389-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10987430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFGmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1975-1978&issue=17&author=W.+K.+Hagmannauthor=C.+G.+Caldwellauthor=P.+Chenauthor=P.+L.+Duretteauthor=C.+K.+Esserauthor=T.+J.+Lanzaauthor=I.+E.+Kopkaauthor=R.+Guthikondaauthor=S.+K.+Shahauthor=M.+MacCossauthor=R.+M.+Chabinauthor=D.+Fletcherauthor=S.+K.+Grantauthor=B.+G.+Greenauthor=J.+L.+Humesauthor=T.+M.+Kellyauthor=S.+Luellauthor=R.+Meurerauthor=V.+Mooreauthor=S.+G.+Pacholokauthor=T.+Paviaauthor=H.+R.+Williamsauthor=K.+K.+Wong&title=Substituted+2-Ammopyridines+as+Inhibitors+of+Nitric+Oxide+Synthases&doi=10.1016%2FS0960-894X%2800%2900389-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 2-aminopyridines as inhibitors of nitric oxide synthases</span></div><div class="casAuthors">Hagmann, W. K.; Caldwell, C. G.; Chen, P.; Durette, P. L.; Esser, C. K.; Lanza, T. J.; Kopka, I. E.; Guthikonda, R.; Shah, S. K.; MacCoss, M.; Chabin, R. M.; Fletcher, D.; Grant, S. K.; Green, B. G.; Humes, J. L.; Kelly, T. M.; Luell, S.; Meurer, R.; Moore, V.; Pacholok, S. G.; Pavia, T.; Williams, H. R.; Wong, K. K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1975-1978</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of substituted 2-aminopyridines was prepd. and evaluated as inhibitors of human nitric oxide synthases.  4,6-Disubstitution enhanced both potency and specificity for the inducible NOS with the most potent compd. having an IC50 of 28 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonjuqmZk5vBLVg90H21EOLACvtfcHk0lhAGbj6nxB2Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFGmsrY%253D&md5=b1455d89a1a49afece3f0898a02f575b</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900389-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900389-9%26sid%3Dliteratum%253Aachs%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26aulast%3DCaldwell%26aufirst%3DC.%2BG.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDurette%26aufirst%3DP.%2BL.%26aulast%3DEsser%26aufirst%3DC.%2BK.%26aulast%3DLanza%26aufirst%3DT.%2BJ.%26aulast%3DKopka%26aufirst%3DI.%2BE.%26aulast%3DGuthikonda%26aufirst%3DR.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DChabin%26aufirst%3DR.%2BM.%26aulast%3DFletcher%26aufirst%3DD.%26aulast%3DGrant%26aufirst%3DS.%2BK.%26aulast%3DGreen%26aufirst%3DB.%2BG.%26aulast%3DHumes%26aufirst%3DJ.%2BL.%26aulast%3DKelly%26aufirst%3DT.%2BM.%26aulast%3DLuell%26aufirst%3DS.%26aulast%3DMeurer%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DV.%26aulast%3DPacholok%26aufirst%3DS.%2BG.%26aulast%3DPavia%26aufirst%3DT.%26aulast%3DWilliams%26aufirst%3DH.%2BR.%26aulast%3DWong%26aufirst%3DK.%2BK.%26atitle%3DSubstituted%25202-Ammopyridines%2520as%2520Inhibitors%2520of%2520Nitric%2520Oxide%2520Synthases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26issue%3D17%26spage%3D1975%26epage%3D1978%26doi%3D10.1016%2FS0960-894X%2800%2900389-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinelli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Development of Nitric Oxide Synthase Inhibitors for Neurodegeneration and Neuropathic Pain</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6814</span>– <span class="NLM_lpage">6838</span>, <span class="refDoi"> DOI: 10.1039/C3CS60467E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1039%2FC3CS60467E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24549364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6814-6838&issue=19&author=P.+Mukherjeeauthor=M.+A.+Cinelliauthor=S.+Kangauthor=R.+B.+Silverman&title=Development+of+Nitric+Oxide+Synthase+Inhibitors+for+Neurodegeneration+and+Neuropathic+Pain&doi=10.1039%2FC3CS60467E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain</span></div><div class="casAuthors">Mukherjee, Paramita; Cinelli, Maris A.; Kang, Soosung; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6814-6838</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Nitric oxide (NO) is an important signaling mol. in the human body, playing a crucial role in cell and neuronal communication, regulation of blood pressure, and in immune activation.  However, overprodn. of NO by the neuronal isoform of nitric oxide synthase (nNOS) is one of the fundamental causes underlying neurodegenerative disorders and neuropathic pain.  Therefore, developing small mols. for selective inhibition of nNOS over related isoforms (eNOS and iNOS) is therapeutically desirable.  The aims of this review focus on the regulation and dysregulation of NO signaling, the role of NO in neurodegeneration and pain, the structure and mechanism of nNOS, and the use of this information to design selective inhibitors of this enzyme.  Structure-based drug design, the bioavailability and pharmacokinetics of these inhibitors, and extensive target validation through animal studies are addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT9LfBn3EJE7Vg90H21EOLACvtfcHk0lhAGbj6nxB2Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nK&md5=8c022181f136a666c0fd240735d742ca</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1039%2FC3CS60467E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60467E%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DP.%26aulast%3DCinelli%26aufirst%3DM.%2BA.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DDevelopment%2520of%2520Nitric%2520Oxide%2520Synthase%2520Inhibitors%2520for%2520Neurodegeneration%2520and%2520Neuropathic%2520Pain%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26issue%3D19%26spage%3D6814%26epage%3D6838%26doi%3D10.1039%2FC3CS60467E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevrioukova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulos, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Novel 2,4-Disubstituted Pyrimidines as Potent, Selective, and Cell- Permeable Inhibitors of Neuronal Nitric Oxide Synthase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.1021/jm501719e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501719e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVGmsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1067-1088&issue=3&author=P.+Mukherjeeauthor=H.+Liauthor=I.+Sevrioukovaauthor=G.+Chreiauthor=P.+Martaauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Novel+2%2C4-Disubstituted+Pyrimidines+as+Potent%2C+Selective%2C+and+Cell-+Permeable+Inhibitors+of+Neuronal+Nitric+Oxide+Synthase&doi=10.1021%2Fjm501719e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 2,4-Disubstituted Pyrimidines as Potent, Selective, and Cell-Permeable Inhibitors of Neuronal Nitric Oxide Synthase</span></div><div class="casAuthors">Mukherjee, Paramita; Li, Huiying; Sevrioukova, Irina; Chreifi, Georges; Martasek, Pavel; Roman, Linda J.; Poulos, Thomas L.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1067-1088</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibition of neuronal nitric oxide synthase (nNOS) is an important therapeutic approach to target neurodegenerative disorders.  However, the majority of the nNOS inhibitors developed are arginine mimetics and, therefore, suffer from poor bioavailability.  The authors designed a novel strategy to combine a more pharmacokinetically favorable 2-imidazolylpyrimidine head with promising structural components from previous inhibitors.  In conjunction with extensive structure-activity studies, several highly potent and selective inhibitors of nNOS were discovered.  X-ray crystallog. anal. reveals that these type II inhibitors utilize the same hydrophobic pocket to gain strong inhibitory potency I, as well as high isoform selectivity.  Interestingly, select compds. from this series II showed good permeability and low efflux in a Caco-2 assay, suggesting potential oral bioavailability, and exhibited minimal off-target binding to 50 central nervous system receptors.  Furthermore, even with heme-coordinating groups in the mol., modifying other pharmacophoric fragments minimized undesirable inhibition of cytochrome P450s from human liver microsomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3PMQyEmfT4rVg90H21EOLACvtfcHk0lhxp040tNYz5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVGmsLjL&md5=68139ff962657f7a02628da088d131ef</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Fjm501719e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501719e%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSevrioukova%26aufirst%3DI.%26aulast%3DChrei%26aufirst%3DG.%26aulast%3DMarta%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DNovel%25202%252C4-Disubstituted%2520Pyrimidines%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Cell-%2520Permeable%2520Inhibitors%2520of%2520Neuronal%2520Nitric%2520Oxide%2520Synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D3%26spage%3D1067%26epage%3D1088%26doi%3D10.1021%2Fjm501719e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davey, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaiz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eagen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilford, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrissey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paradkar, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polokoff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saionz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergona, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devlin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Activity of 2-Imidazol-1-Ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1146</span>– <span class="NLM_lpage">1157</span>, <span class="refDoi"> DOI: 10.1021/jm061319i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061319i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvF2rs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1146-1157&issue=6&author=D.+D.+Daveyauthor=M.+Adlerauthor=D.+Arnaizauthor=K.+Eagenauthor=S.+Ericksonauthor=W.+Guilfordauthor=M.+Kenrickauthor=M.+M.+Morrisseyauthor=M.+Ohlmeyerauthor=G.+Panauthor=V.+M.+Paradkarauthor=J.+Parkinsonauthor=M.+Polokoffauthor=K.+Saionzauthor=C.+Santosauthor=B.+Subramanyamauthor=R.+Vergonaauthor=R.+G.+Weiauthor=M.+Whitlowauthor=B.+Yeauthor=Z.+Zhaoauthor=J.+J.+Devlinauthor=G.+Phillips&title=Design%2C+Synthesis%2C+and+Activity+of+2-Imidazol-1-Ylpyrimidine+Derived+Inducible+Nitric+Oxide+Synthase+Dimerization+Inhibitors&doi=10.1021%2Fjm061319i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors</span></div><div class="casAuthors">Davey, David D.; Adler, Marc; Arnaiz, Damian; Eagen, Keith; Erickson, Shawn; Guilford, William; Kenrick, Margaret; Morrissey, Michael M.; Ohlmeyer, Mike; Pan, Gonghua; Paradkar, Vidyadhar M.; Parkinson, John; Polokoff, Mark; Saionz, Kurt; Santos, Cecile; Subramanyam, Babu; Vergona, Ron; Wei, Robert G.; Whitlow, Marc; Ye, Bin; Zhao, Zuchun; Devlin, James J.; Phillips, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1146-1157</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By the screening of a combinatorial library for inhibitors of nitric oxide (NO) formation by the inducible isoform of nitric oxide synthase (iNOS) using a whole-cell assay, 2-(imidazol-1-yl)pyrimidines were identified.  Compds. were found to inhibit the dimerization of iNOS monomers, thus preventing the formation of the dimeric, active form of the enzyme.  Optimization led to the selection of the potent, selective, and orally available iNOS dimerization inhibitor I, which significantly ameliorated adjuvant-induced arthritis in a rat model.  Anal. of the crystal structure of the I-iNOS monomer complex provided a rationalization for both the SAR and the mechanism by which compd. I blocks the formation of the protein-protein interaction present in the dimeric form of iNOS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw6TEIPjLF1LVg90H21EOLACvtfcHk0lhxp040tNYz5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvF2rs70%253D&md5=5b280ba9f397094bb34fa15299898b6b</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1021%2Fjm061319i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061319i%26sid%3Dliteratum%253Aachs%26aulast%3DDavey%26aufirst%3DD.%2BD.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DArnaiz%26aufirst%3DD.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DErickson%26aufirst%3DS.%26aulast%3DGuilford%26aufirst%3DW.%26aulast%3DKenrick%26aufirst%3DM.%26aulast%3DMorrissey%26aufirst%3DM.%2BM.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DParadkar%26aufirst%3DV.%2BM.%26aulast%3DParkinson%26aufirst%3DJ.%26aulast%3DPolokoff%26aufirst%3DM.%26aulast%3DSaionz%26aufirst%3DK.%26aulast%3DSantos%26aufirst%3DC.%26aulast%3DSubramanyam%26aufirst%3DB.%26aulast%3DVergona%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DR.%2BG.%26aulast%3DWhitlow%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DDevlin%26aufirst%3DJ.%2BJ.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Activity%2520of%25202-Imidazol-1-Ylpyrimidine%2520Derived%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520Dimerization%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D6%26spage%3D1146%26epage%3D1157%26doi%3D10.1021%2Fjm061319i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martásek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulos, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Exploration of the Active Site of Neuronal Nitric Oxide Synthase by the Design and Synthesis of Pyrrolidinomethyl 2- Aminopyridine Derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7804</span>– <span class="NLM_lpage">7824</span>, <span class="refDoi"> DOI: 10.1021/jm100947x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100947x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7804-7824&issue=21&author=H.+Jiauthor=S.+L.+Delkerauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Exploration+of+the+Active+Site+of+Neuronal+Nitric+Oxide+Synthase+by+the+Design+and+Synthesis+of+Pyrrolidinomethyl+2-+Aminopyridine+Derivatives&doi=10.1021%2Fjm100947x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the Active Site of Neuronal Nitric Oxide Synthase by the Design and Synthesis of Pyrrolidinomethyl 2-Aminopyridine Derivatives</span></div><div class="casAuthors">Ji, Haitao; Delker, Silvia L.; Li, Huiying; Martasek, Pavel; Roman, Linda J.; Poulos, Thomas L.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7804-7824</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neuronal nitric oxide synthase (nNOS) represents an important therapeutic target for the prevention of brain injury and the treatment of various neurodegenerative disorders.  A series of trans-substituted amino pyrrolidinomethyl 2-aminopyridine derivs. (8-34) was designed and synthesized.  A structure-activity relationship anal. led to the discovery of low nanomolar nNOS inhibitors ((±)-32 and (±)-34) with more than 1000-fold selectivity for nNOS over eNOS.  Four enantiomerically pure isomers of 3'-[2''-(3'''-fluorophenethylamino)ethoxy]pyrrolidin-4'-ylmethyl-4-methylpyridin-2-amine (4) also were synthesized.  It was found that (3'R,4'R)-4 can induce enzyme elasticity to generate a new "hot spot" for ligand binding.  The inhibitor adopts a unique binding mode, the same as that obsd. for (3'R,4'R)-3'-[2''-(3'''-fluorophenethylamino)ethylamino]pyrrolidin-4'-ylmethyl-4-methylpyridin-2-amine ((3'R,4'R)-3).  On the basis of structure-activity relationships of 8-34 and different binding conformations of the cis and trans isomers of 3 and 4, crit. structural requirements of the NOS active site for ligand binding are revealed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8qg3dLeUcYrVg90H21EOLACvtfcHk0lgEksZpos8q0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjE&md5=0326c82eabceb9ceb8604ae5796b6436</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1021%2Fjm100947x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100947x%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DExploration%2520of%2520the%2520Active%2520Site%2520of%2520Neuronal%2520Nitric%2520Oxide%2520Synthase%2520by%2520the%2520Design%2520and%2520Synthesis%2520of%2520Pyrrolidinomethyl%25202-%2520Aminopyridine%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D21%26spage%3D7804%26epage%3D7824%26doi%3D10.1021%2Fjm100947x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span> <span> </span><span class="NLM_article-title">The Chemical Basis of Ferroptosis</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1137</span>– <span class="NLM_lpage">1147</span>, <span class="refDoi"> DOI: 10.1038/s41589-019-0408-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fs41589-019-0408-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31740834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFOqsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=1137-1147&issue=12&author=M.+Conradauthor=D.+A.+Pratt&title=The+Chemical+Basis+of+Ferroptosis&doi=10.1038%2Fs41589-019-0408-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">The chemical basis of ferroptosis</span></div><div class="casAuthors">Conrad, Marcus; Pratt, Derek A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1137-1147</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Lipid peroxidn. underlies the mechanism of oxidative cell death now known as ferroptosis.  This modality, distinct from other forms of cell death, has been intensely researched in recent years owing to its relevance in both degenerative disease and cancer.  The demonstration that it can be modulated by small mols. in multiple pathophysiol. contexts offers exciting opportunities for novel pharmacol. interventions.  Herein, we introduce the salient features of lipid peroxidn., how it can be modulated by small mols. and what principal aspects require urgent investigation by researchers in the field.  The central role of non-enzymic reactions in the execution of ferroptosis will be emphasized, as these processes have hitherto not been generally considered 'druggable'.  Moreover, we provide a crit. perspective on the biochem. mechanisms that contribute to cell vulnerability to ferroptosis and discuss how they can be exploited in the design of novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmBGqyaJ8WHrVg90H21EOLACvtfcHk0lizBuE-s2LntQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFOqsrbN&md5=fa194bef13bea806e2412c679fb20307</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1038%2Fs41589-019-0408-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-019-0408-1%26sid%3Dliteratum%253Aachs%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Chemical%2520Basis%2520of%2520Ferroptosis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D15%26issue%3D12%26spage%3D1137%26epage%3D1147%26doi%3D10.1038%2Fs41589-019-0408-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossetto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venerando, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roveri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vučković, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosello
Travain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaccarin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zennaro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toppo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span> <span> </span><span class="NLM_article-title">Insight into the Mechanism of Ferroptosis Inhibition by Ferrostatin-1</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">101328</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.redox.2019.101328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=31574461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVylt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=101328&author=G.+Miottoauthor=M.+Rossettoauthor=M.+L.+Di+Paoloauthor=L.+Orianauthor=R.+Venerandoauthor=A.+Roveriauthor=A.+M.+Vu%C4%8Dkovi%C4%87author=V.+Bosello%0ATravainauthor=M.+Zaccarinauthor=L.+Zennaroauthor=M.+Maiorinoauthor=S.+Toppoauthor=F.+Ursiniauthor=G.+Cozza&title=Insight+into+the+Mechanism+of+Ferroptosis+Inhibition+by+Ferrostatin-1&doi=10.1016%2Fj.redox.2019.101328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into the mechanism of ferroptosis inhibition by ferrostatin-1</span></div><div class="casAuthors">Miotto, Giovanni; Rossetto, Monica; Di Paolo, Maria Luisa; Orian, Laura; Venerando, Rina; Roveri, Antonella; Vuckovic, Ana-Marija; Bosello Travain, Valentina; Zaccarin, Mattia; Zennaro, Lucio; Maiorino, Matilde; Toppo, Stefano; Ursini, Fulvio; Cozza, Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101328</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ferroptosis is a form of cell death primed by iron and lipid hydroperoxides and prevented by GPx4.  Ferrostatin-1 (fer-1) inhibits ferroptosis much more efficiently than phenolic antioxidants.  Previous studies on the antioxidant efficiency of fer-1 adopted kinetic tests where a diazo compd. generates the hydroperoxyl radical scavenged by the antioxidant.  However, this reaction, accounting for a chain breaking effect, is only minimally useful for the description of the inhibition of ferrous iron and lipid hydroperoxide dependent peroxidn.  Scavenging lipid hydroperoxyl radicals, indeed, generates lipid hydroperoxides from which ferrous iron initiates a new peroxidative chain reaction.  We show that when fer-1 inhibits peroxidn., initiated by iron and traces of lipid hydroperoxides in liposomes, the pattern of oxidized species produced from traces of pre-existing hydroperoxides is practically identical to that obsd. following exhaustive peroxidn. in the absence of the antioxidant.  This supported the notion that the anti-ferroptotic activity of fer-1 is actually due to the scavenging of initiating alkoxyl radicals produced, together with other rearrangement products, by ferrous iron from lipid hydroperoxides.  Notably, fer-1 is not consumed while inhibiting iron dependent lipid peroxidn.  The emerging concept is that it is ferrous iron itself that reduces fer-1 radical.  This was supported by electroanal. evidence that fer-1 forms a complex with iron and further confirmed in cells by fluorescence of calcein, indicating a decrease of labile iron in the presence of fer-1.  The notion of such as pseudo-catalytic cycle of the ferrostatin-iron complex was also investigated by means of quantum mechanics calcns., which confirmed the redn. of an alkoxyl radical model by fer-1 and the redn. of fer-1 radical by ferrous iron.  In summary, GPx4 and fer-1 in the presence of ferrous iron, produces, by distinct mechanism, the most relevant anti-ferroptotic effect, i.e the disappearance of initiating lipid hydroperoxides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiu-QjvbUUI7Vg90H21EOLACvtfcHk0lizBuE-s2LntQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVylt7%252FF&md5=3df8c36917ae41504caeeda0d3249835</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101328%26sid%3Dliteratum%253Aachs%26aulast%3DMiotto%26aufirst%3DG.%26aulast%3DRossetto%26aufirst%3DM.%26aulast%3DDi%2BPaolo%26aufirst%3DM.%2BL.%26aulast%3DOrian%26aufirst%3DL.%26aulast%3DVenerando%26aufirst%3DR.%26aulast%3DRoveri%26aufirst%3DA.%26aulast%3DVu%25C4%258Dkovi%25C4%2587%26aufirst%3DA.%2BM.%26aulast%3DBosello%2BTravain%26aufirst%3DV.%26aulast%3DZaccarin%26aufirst%3DM.%26aulast%3DZennaro%26aufirst%3DL.%26aulast%3DMaiorino%26aufirst%3DM.%26aulast%3DToppo%26aufirst%3DS.%26aulast%3DUrsini%26aufirst%3DF.%26aulast%3DCozza%26aufirst%3DG.%26atitle%3DInsight%2520into%2520the%2520Mechanism%2520of%2520Ferroptosis%2520Inhibition%2520by%2520Ferrostatin-1%26jtitle%3DRedox%2520Biol.%26date%3D2020%26volume%3D28%26spage%3D101328%26doi%3D10.1016%2Fj.redox.2019.101328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devisscher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Coillie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Rompaey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Winter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Veken, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">10126</span>– <span class="NLM_lpage">10140</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01299</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01299" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvF2mtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10126-10140&issue=22&author=L.+Devisscherauthor=S.+Van+Coillieauthor=S.+Hofmansauthor=D.+Van+Rompaeyauthor=K.+Goossensauthor=E.+Meulauthor=L.+Maesauthor=H.+De+Winterauthor=P.+Van+Der+Vekenauthor=P.+Vandenabeeleauthor=T.+Bergheauthor=K.+Augustyns&title=Discovery+of+Novel%2C+Drug-Like+Ferroptosis+Inhibitors+with+in+Vivo+Efficacy&doi=10.1021%2Facs.jmedchem.8b01299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy</span></div><div class="casAuthors">Devisscher, Lars; Van Coillie, Samya; Hofmans, Sam; Van Rompaey, Dries; Goossens, Kenneth; Meul, Eline; Maes, Louis; De Winter, Hans; Van Der Veken, Pieter; Vandenabeele, Peter; Berghe, Tom Vanden; Augustyns, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10126-10140</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ferroptosis is an iron-catalyzed, nonapoptotic form of regulated necrosis that results in oxidative lipid damage in cell membranes that can be inhibited by the radical-trapping antioxidant Ferrostatin-1 (Fer-1).  Novel inhibitors derived from the Fer-1 scaffold inhibited ferroptosis potently but suffered from soly. issues.  In this paper, the authors report the synthesis of a more stable and readily sol. series of Fer-1 analogs that potently inhibit ferroptosis.  The most promising compds. showed an improved protection compared to Fer-1 against multi-organ injury in mice.  No toxicity was obsd. in mice after daily injection of (I, UAMC-3203) for 4 wk.  UAMC-3203 inserts rapidly in a phospholipid bilayer in silico, which aligns with the current understanding of the mechanism of action of these compds.  In conclusion, these analogs have superior properties compared to Fer-1, show in vivo efficacy, and represent novel lead compds. with therapeutic potential in relevant ferroptosis-driven disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8FyW_G-tjd7Vg90H21EOLACvtfcHk0ljtjeg-tZpx3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvF2mtL3F&md5=db58889e5b5fc0794a13b5665d35364f</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01299%26sid%3Dliteratum%253Aachs%26aulast%3DDevisscher%26aufirst%3DL.%26aulast%3DVan%2BCoillie%26aufirst%3DS.%26aulast%3DHofmans%26aufirst%3DS.%26aulast%3DVan%2BRompaey%26aufirst%3DD.%26aulast%3DGoossens%26aufirst%3DK.%26aulast%3DMeul%26aufirst%3DE.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DDe%2BWinter%26aufirst%3DH.%26aulast%3DVan%2BDer%2BVeken%26aufirst%3DP.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DBerghe%26aufirst%3DT.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520Novel%252C%2520Drug-Like%2520Ferroptosis%2520Inhibitors%2520with%2520in%2520Vivo%2520Efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D22%26spage%3D10126%26epage%3D10140%26doi%3D10.1021%2Facs.jmedchem.8b01299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zilka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedmann
Angeli, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griesser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span> <span> </span><span class="NLM_article-title">On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1021/acscentsci.7b00028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.7b00028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjslaht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=232-243&issue=3&author=O.+Zilkaauthor=R.+Shahauthor=B.+Liauthor=J.+P.+Friedmann%0AAngeliauthor=M.+Griesserauthor=M.+Conradauthor=D.+A.+Pratt&title=On+the+Mechanism+of+Cytoprotection+by+Ferrostatin-1+and+Liproxstatin-1+and+the+Role+of+Lipid+Peroxidation+in+Ferroptotic+Cell+Death&doi=10.1021%2Facscentsci.7b00028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death</span></div><div class="casAuthors">Zilka, Omkar; Shah, Ron; Li, Bo; Friedmann Angeli, Jose Pedro; Griesser, Markus; Conrad, Marcus; Pratt, Derek A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">232-243</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ferroptosis is a form of regulated necrosis assocd. with the iron-dependent accumulation of lipid hydroperoxides that may play a key role in the pathogenesis of degenerative diseases in which lipid peroxidn. has been implicated.  High-throughput screening efforts have identified ferrostatin-1 (Fer-1) and liproxstatin-1 (Lip-1) as potent inhibitors of ferroptosis - an activity that has been ascribed to their ability to slow the accumulation of lipid hydroperoxides.  Herein we demonstrate that this activity likely derives from their reactivity as radical-trapping antioxidants (RTAs) rather than their potency as inhibitors of lipoxygenases.  Although inhibited autoxidns. of styrene revealed that Fer-1 and Lip-1 react roughly 10-fold more slowly with peroxyl radicals than reactions of α-tocopherol (α-TOH), they were significantly more reactive than α-TOH in phosphatidylcholine lipid bilayers - consistent with the greater potency of Fer-1 and Lip-1 relative to α-TOH as inhibitors of ferroptosis.  None of Fer-1, Lip-1, and α-TOH inhibited human 15-lipoxygenase-1 (15-LOX-1) overexpressed in HEK-293 cells when assayed at concns. where they inhibited ferroptosis.  These results stand in stark contrast to those obtained with a known 15-LOX-1 inhibitor (PD146176), which was able to inhibit the enzyme at concns. where it was effective in inhibiting ferroptosis.  Given the likelihood that Fer-1 and Lip-1 subvert ferroptosis by inhibiting lipid peroxidn. as RTAs, we evaluated the antiferroptotic potential of 1,8-tetrahydronaphthyridinols (hereafter THNs): rationally designed radical-trapping antioxidants of unparalleled reactivity.  We show for the first time that the inherent reactivity of the THNs translates to cell culture, where lipophilic THNs were similarly effective to Fer-1 and Lip-1 at subverting ferroptosis induced by either pharmacol. or genetic inhibition of the hydroperoxide-detoxifying enzyme Gpx4 in mouse fibroblasts, and glutamate-induced death of mouse hippocampal cells.  These results demonstrate that potent RTAs subvert ferroptosis and suggest that lipid peroxidn. (autoxidn.) may play a central role in the process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtKDxv_-zshrVg90H21EOLACvtfcHk0lgSn6eIfPbrBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjslaht7w%253D&md5=1f59e7fdb3ab17e78f4192f8366ad1f0</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.7b00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.7b00028%26sid%3Dliteratum%253Aachs%26aulast%3DZilka%26aufirst%3DO.%26aulast%3DShah%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DFriedmann%2BAngeli%26aufirst%3DJ.%2BP.%26aulast%3DGriesser%26aufirst%3DM.%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DOn%2520the%2520Mechanism%2520of%2520Cytoprotection%2520by%2520Ferrostatin-1%2520and%2520Liproxstatin-1%2520and%2520the%2520Role%2520of%2520Lipid%2520Peroxidation%2520in%2520Ferroptotic%2520Cell%2520Death%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2017%26volume%3D3%26issue%3D3%26spage%3D232%26epage%3D243%26doi%3D10.1021%2Facscentsci.7b00028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedmann Angeli, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proneth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurina, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyurin, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aichler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggenhofer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basavarajappa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rådmark, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yefremova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornkamm, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odonnell, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span> <span> </span><span class="NLM_article-title">Inactivation of the Ferroptosis Regulator Gpx4 Triggers Acute Renal Failure in Mice</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1191</span>, <span class="refDoi"> DOI: 10.1038/ncb3064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1038%2Fncb3064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=25402683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=1180-1191&issue=12&author=J.+P.+Friedmann+Angeliauthor=M.+Schneiderauthor=B.+Pronethauthor=Y.+Y.+Tyurinaauthor=V.+A.+Tyurinauthor=V.+J.+Hammondauthor=N.+Herbachauthor=M.+Aichlerauthor=A.+Walchauthor=E.+Eggenhoferauthor=D.+Basavarajappaauthor=O.+R%C3%A5dmarkauthor=S.+Kobayashiauthor=T.+Seibtauthor=H.+Beckauthor=F.+Neffauthor=I.+Espositoauthor=R.+Wankeauthor=H.+F%C3%B6rsterauthor=O.+Yefremovaauthor=M.+Heinrichmeyerauthor=G.+W.+Bornkammauthor=E.+K.+Geisslerauthor=S.+B.+Thomasauthor=B.+R.+Stockwellauthor=V.+B.+Odonnellauthor=V.+E.+Kaganauthor=J.+A.+Schickauthor=M.+Conrad&title=Inactivation+of+the+Ferroptosis+Regulator+Gpx4+Triggers+Acute+Renal+Failure+in+Mice&doi=10.1038%2Fncb3064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice</span></div><div class="casAuthors">Friedmann Angeli, Jose Pedro; Schneider, Manuela; Proneth, Bettina; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Hammond, Victoria J.; Herbach, Nadja; Aichler, Michaela; Walch, Axel; Eggenhofer, Elke; Basavarajappa, Devaraj; Radmark, Olof; Kobayashi, Sho; Seibt, Tobias; Beck, Heike; Neff, Frauke; Esposito, Irene; Wanke, Ruediger; Foerster, Heidi; Yefremova, Olena; Heinrichmeyer, Marc; Bornkamm, Georg W.; Geissler, Edward K.; Thomas, Stephen B.; Stockwell, Brent R.; O'Donnell, Valerie B.; Kagan, Valerian E.; Schick, Joel A.; Conrad, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1180-1191</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a non-apoptotic form of cell death induced by small mols. in specific tumor types, and in engineered cells overexpressing oncogenic RAS.  Yet, its relevance in non-transformed cells and tissues is unexplored and remains enigmatic.  Here, we provide direct genetic evidence that the knockout of glutathione peroxidase 4 (Gpx4) causes cell death in a pathol. relevant form of ferroptosis.  Using inducible Gpx4-/- mice, we elucidate an essential role for the glutathione/Gpx4 axis in preventing lipid-oxidn.-induced acute renal failure and assocd. death.  We furthermore systematically evaluated a library of small mols. for possible ferroptosis inhibitors, leading to the discovery of a potent spiroquinoxalinamine deriv. called Liproxstatin-1, which is able to suppress ferroptosis in cells, in Gpx4-/- mice, and in a pre-clin. model of ischemia/reperfusion-induced hepatic damage.  In sum, we demonstrate that ferroptosis is a pervasive and dynamic form of cell death, which, when impeded, promises substantial cytoprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuBNbniop_ibVg90H21EOLACvtfcHk0lgSn6eIfPbrBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrrF&md5=0d095f1a6206ab1dae7e04089847becf</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1038%2Fncb3064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3064%26sid%3Dliteratum%253Aachs%26aulast%3DFriedmann%2BAngeli%26aufirst%3DJ.%2BP.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DProneth%26aufirst%3DB.%26aulast%3DTyurina%26aufirst%3DY.%2BY.%26aulast%3DTyurin%26aufirst%3DV.%2BA.%26aulast%3DHammond%26aufirst%3DV.%2BJ.%26aulast%3DHerbach%26aufirst%3DN.%26aulast%3DAichler%26aufirst%3DM.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DEggenhofer%26aufirst%3DE.%26aulast%3DBasavarajappa%26aufirst%3DD.%26aulast%3DR%25C3%25A5dmark%26aufirst%3DO.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DSeibt%26aufirst%3DT.%26aulast%3DBeck%26aufirst%3DH.%26aulast%3DNeff%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DI.%26aulast%3DWanke%26aufirst%3DR.%26aulast%3DF%25C3%25B6rster%26aufirst%3DH.%26aulast%3DYefremova%26aufirst%3DO.%26aulast%3DHeinrichmeyer%26aufirst%3DM.%26aulast%3DBornkamm%26aufirst%3DG.%2BW.%26aulast%3DGeissler%26aufirst%3DE.%2BK.%26aulast%3DThomas%26aufirst%3DS.%2BB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DOdonnell%26aufirst%3DV.%2BB.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DSchick%26aufirst%3DJ.%2BA.%26aulast%3DConrad%26aufirst%3DM.%26atitle%3DInactivation%2520of%2520the%2520Ferroptosis%2520Regulator%2520Gpx4%2520Triggers%2520Acute%2520Renal%2520Failure%2520in%2520Mice%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26issue%3D12%26spage%3D1180%26epage%3D1191%26doi%3D10.1038%2Fncb3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span> <span> </span><span class="NLM_article-title">The Potency of Diarylamine Radical-Trapping Antioxidants as Inhibitors of Ferroptosis Underscores the Role of Autoxidation in the Mechanism of Cell Death</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2538</span>– <span class="NLM_lpage">2545</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00730</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00730" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlOksLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2538-2545&issue=10&author=R.+Shahauthor=K.+Margisonauthor=D.+A.+Pratt&title=The+Potency+of+Diarylamine+Radical-Trapping+Antioxidants+as+Inhibitors+of+Ferroptosis+Underscores+the+Role+of+Autoxidation+in+the+Mechanism+of+Cell+Death&doi=10.1021%2Facschembio.7b00730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">The Potency of Diarylamine Radical-Trapping Antioxidants as Inhibitors of Ferroptosis Underscores the Role of Autoxidation in the Mechanism of Cell Death</span></div><div class="casAuthors">Shah, Ron; Margison, Kaitlyn; Pratt, Derek A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2538-2545</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two arom. amines (ferrostatin-1 and liproxstatin-1) were recently identified from high-throughput screening efforts to uncover potent inhibitors of ferroptosis, the necrotic-like cell death induced by inhibition of glutathione peroxidase 4 (GPX4), deletion of the corresponding gpx4 gene, or starvation of GPX4 of its reducing cosubstrate, glutathione (GSH).  We have since demonstrated that these two arom. amines are highly effective radical-trapping antioxidants (RTAs) in lipid bilayers, suggesting that they subvert ferroptosis by inhibiting lipid peroxidn. (autoxidn.) and, thus, that this process drives the execution of ferroptosis.  Herein, we show that diarylamine RTAs used to protect petroleum-derived products from autoxidn. can be potent inhibitors of ferroptosis.  The diarylamines investigated include representative examples of additives to engine oils, greases and rubber (4,4'-dialkyldiphenylamines), core structures of dyes and pharmaceuticals (phenoxazines and phenothiazines), and aza-analogs of these three classes of compds. that we have recently shown can be modified to achieve much greater reactivity.  We find that regardless of how ferroptosis is induced (GPX4 inhibition, gpx4 deletion or GSH depletion), compds. which possess good RTA activity in org. soln. (kinh > 105 M-1 s-1) and lipid bilayers (kinh > 104 M-1 s-1) are generally potent inhibitors of ferroptosis (in mouse embryonic fibroblasts).  Likewise, structural analogs that do not possess RTA activity are devoid of antiferroptotic activity.  These results further support the argument that lipid peroxidn. (autoxidn.) plays a major role in the mechanism of cell death induced by either GPX4 inhibition, gpx4 deletion, or GSH depletion.  Moreover, it offers clear direction that ongoing medicinal chem. efforts on liproxstatin and ferrostatin derivs., which have been proposed as lead compds. for the treatment and/or prevention of ischemia/reperfusion injury, renal failure, and neurodegeneration, can be widened to include other aminic RTAs.  To aid in these efforts, some relevant structure-reactivity relationships are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGray_NCtHIr-bVg90H21EOLACvtfcHk0lh49GyCGVi8mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOksLnM&md5=fefdd6246359c57145f57e52148d8449</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00730%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DR.%26aulast%3DMargison%26aufirst%3DK.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Potency%2520of%2520Diarylamine%2520Radical-Trapping%2520Antioxidants%2520as%2520Inhibitors%2520of%2520Ferroptosis%2520Underscores%2520the%2520Role%2520of%2520Autoxidation%2520in%2520the%2520Mechanism%2520of%2520Cell%2520Death%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26issue%3D10%26spage%3D2538%26epage%3D2545%26doi%3D10.1021%2Facschembio.7b00730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zilka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span> <span> </span><span class="NLM_article-title">Potent Ferroptosis Inhibitors Can Catalyze the Cross-Dismutation of Phospholipid-Derived Peroxyl Radicals and Hydroperoxyl Radicals</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">14331</span>– <span class="NLM_lpage">14342</span>, <span class="refDoi"> DOI: 10.1021/jacs.0c06379</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.0c06379" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVCmsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2020&pages=14331-14342&issue=33&author=J.+F.+Poonauthor=O.+Zilkaauthor=D.+A.+Pratt&title=Potent+Ferroptosis+Inhibitors+Can+Catalyze+the+Cross-Dismutation+of+Phospholipid-Derived+Peroxyl+Radicals+and+Hydroperoxyl+Radicals&doi=10.1021%2Fjacs.0c06379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Ferroptosis Inhibitors Can Catalyze the Cross-Dismutation of Phospholipid-Derived Peroxyl Radicals and Hydroperoxyl Radicals</span></div><div class="casAuthors">Poon, Jia-Fei; Zilka, Omkar; Pratt, Derek A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">14331-14342</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nitroxides were recently shown to catalyze the cross-dismutation of alkylperoxyl and hydroperoxyl radicals, making them uniquely effective radical-trapping antioxidants (RTAs) in unsatd. hydrocarbons where both species are formed.  Given the abundance of unsatd. lipids in biol. membranes, the continuous generation of hydroperoxyl (superoxide) as a byproduct of aerobic respiration, and the demonstrated cytoprotective properties of some nitroxides, we probed if cross-dismutation operates in phospholipid bilayers and cell culture.  Interestingly, only nitroxides that were efficiently converted to amines in situ were effective, with their activity paralleling the stability of the incipient aminyl radicals.  The ether-linked diarylamine phenoxazine, one of the most potent RTAs known, was particularly effective as a cross-dismutation catalyst.  In contrast, phenolic RTAs such as α-tocopherol (α-TOH), the most potent form of vitamin E, were found to be inefficient due to the preference for the combination of hydroperoxyl and phenoxyl radicals over H-atom transfer between them.  Expts. carried out in mouse embryonic fibroblasts corroborated these findings.  Cells cotreated with phenoxazine (or its nitroxide) and a superoxide source were better protected from ferroptosis than those treated with phenoxazine (or its nitroxide) alone.  No such synergy was obsd. for cells treated with α-TOH.  Live cell imaging established that cytoprotection was assocd. with suppression of (phospho)lipid peroxidn.  These results highlight the remarkable capacity for select amines to act as effective phase-transfer catalysts for a reducing equiv. (an H atom), such that a water-sol. "reactive oxygen species" can be used to quench a lipid-sol. one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAFHhvqa7X0bVg90H21EOLACvtfcHk0ljJEDwNEPadtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVCmsLvK&md5=6351e5f66df2bda089ca456a7d84fbdf</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Fjacs.0c06379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.0c06379%26sid%3Dliteratum%253Aachs%26aulast%3DPoon%26aufirst%3DJ.%2BF.%26aulast%3DZilka%26aufirst%3DO.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DPotent%2520Ferroptosis%2520Inhibitors%2520Can%2520Catalyze%2520the%2520Cross-Dismutation%2520of%2520Phospholipid-Derived%2520Peroxyl%2520Radicals%2520and%2520Hydroperoxyl%2520Radicals%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2020%26volume%3D142%26issue%3D33%26spage%3D14331%26epage%3D14342%26doi%3D10.1021%2Fjacs.0c06379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vejražka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Míček, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štípek, S.</span></span> <span> </span><span class="NLM_article-title">Apocynin Inhibits NADPH Oxidase in Phagocytes but Stimulates ROS Production in Non-Phagocytic Cells</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1722</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2004.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1016%2Fj.bbagen.2004.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1722&publication_year=2005&pages=143-147&issue=2&author=M.+Vejra%C5%BEkaauthor=R.+M%C3%AD%C4%8Dekauthor=S.+%C5%A0t%C3%ADpek&title=Apocynin+Inhibits+NADPH+Oxidase+in+Phagocytes+but+Stimulates+ROS+Production+in+Non-Phagocytic+Cells&doi=10.1016%2Fj.bbagen.2004.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells</span></div><div class="casAuthors">Vejrazka, Martin; Micek, Radan; Stipek, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1722</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-147</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Apocynin is a naturally occurring methoxy-substituted catechol, exptl. used as an inhibitor of NADPH oxidase.  Since it acts as a potent inhibitor in studies with neutrophils and macrophages, no inhibitory effect can often be found in non-phagocyte cells.  In our expts., apocynin even stimulated reactive oxygen species (ROS) prodn. by vascular fibroblasts.  Even when added to macrophages, apocynin initially caused an increase in ROS prodn.  The inhibition of ROS formation followed, suggesting that in the presence of leukocyte myeloperoxidase and hydrogen peroxide, apocynin is converted to another compd.  Apocynin pre-activated with H2O2 and horseradish peroxidase (HRP) inhibited ROS prodn. immediately.  In non-phagocytes, apocynin stimulated ROS prodn. and no inhibition was obsd. even after 60 min.  Apocynin treated with H2O2 and HRP, however, decreased ROS prodn. in the same manner as in macrophages.  The stimulatory effect on ROS prodn. can be abolished by tiron and superoxide dismutase (SOD), suggesting that superoxide was the produced species.  The effect of apocynin was inhibited by diphenylene iodinium (DPI), a non-scavenging NADPH oxidase inhibitor.  It can be summarized that apocynin stimulates cell superoxide prodn.  In the presence of peroxidase and hydrogen peroxide, however, it is converted into another compd. that acts as an inhibitor of superoxide prodn.  It strongly suggests that under conditions in vivo, apocynin can have opposite effects on phagocytes and non-phagocyte cells.  It acts as an inhibitor of phagocyte NADPH oxidase but also as a ROS prodn. stimulator in non-phagocyte cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyaVqpMnKkVrVg90H21EOLACvtfcHk0ljJEDwNEPadtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVShtLg%253D&md5=b1e3236cf4c5e28a532c6911f0067594</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2004.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2004.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DVejra%25C5%25BEka%26aufirst%3DM.%26aulast%3DM%25C3%25AD%25C4%258Dek%26aufirst%3DR.%26aulast%3D%25C5%25A0t%25C3%25ADpek%26aufirst%3DS.%26atitle%3DApocynin%2520Inhibits%2520NADPH%2520Oxidase%2520in%2520Phagocytes%2520but%2520Stimulates%2520ROS%2520Production%2520in%2520Non-Phagocytic%2520Cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2005%26volume%3D1722%26issue%3D2%26spage%3D143%26epage%3D147%26doi%3D10.1016%2Fj.bbagen.2004.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stolk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiltermann, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoeven, A. J.</span></span> <span> </span><span class="NLM_article-title">Characteristics of the Inhibition of NADPH Oxidase Activation in Neutrophils by Apocynin, a Methoxy-Substituted Catechol</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1165/ajrcmb.11.1.8018341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1165%2Fajrcmb.11.1.8018341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=8018341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFGmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1994&pages=95-102&issue=1&author=J.+Stolkauthor=T.+J.+Hiltermannauthor=J.+H.+Dijkmanauthor=A.+J.+Verhoeven&title=Characteristics+of+the+Inhibition+of+NADPH+Oxidase+Activation+in+Neutrophils+by+Apocynin%2C+a+Methoxy-Substituted+Catechol&doi=10.1165%2Fajrcmb.11.1.8018341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol</span></div><div class="casAuthors">Stolk, J.; Hiltermann, T. J. N.; Dijkman, J. H.; Verhoeven, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-102</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    </div><div class="casAbstract">Phagocytes are able to generate reactive oxygen species by an activatable NADPH oxidase system.  We investigated the inhibition of NADPH oxidase activation by a methoxy-substituted catechol, apocynin.  Oxygen uptake by neutrophils incubated with 300 μM apocynin was completely inhibited at 7 min after addn. of serum-treated zymosan (STZ), with a lag-time of inhibition of 2 to 3 min.  The lag-time of effect of apocynin in neutrophils relatively deficient of myeloperoxidase was about 50% longer when compared with normal cells.  Inhibition of the STZ-induced respiratory burst by apocynin was also obsd. in human eosinophils but not in human alveolar macrophages.  Immunoblots of neutrophils membranes, isolated at 2 and 7 min after STZ stimulation of neutrophils, demonstrated translocation of the cytosolic oxidase components p47-phox and p67-phox to the membrane fraction.  Translocation at 7 min after STZ stimulation was markedly reduced when the neutrophils had been incubated with 300 μM apocynin, but translocation was normal after 2 min of stimulation.  These properties suggest that apocynin is an intracellular inhibitor of the assembly of NADPH oxidase in neutrophils and eosinophils and that apocynin requires conversion by peroxidases to exert its inhibitory effect.  The capacity of neutrophils for intracellular killing of Staphylococcus aureus was not affected by apocynin.  The potential therapeutic value of apocynin was demonstrated in vitro by its ability to protect secretory leukocyte proteinase inhibitor from oxidative inactivation by neutrophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1-_5U8QcKrrVg90H21EOLACvtfcHk0lgb4StznPuaIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFGmsL8%253D&md5=2ccd7bad5239b50dcf39b756f8d0c887</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.11.1.8018341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.11.1.8018341%26sid%3Dliteratum%253Aachs%26aulast%3DStolk%26aufirst%3DJ.%26aulast%3DHiltermann%26aufirst%3DT.%2BJ.%26aulast%3DDijkman%26aufirst%3DJ.%2BH.%26aulast%3DVerhoeven%26aufirst%3DA.%2BJ.%26atitle%3DCharacteristics%2520of%2520the%2520Inhibition%2520of%2520NADPH%2520Oxidase%2520Activation%2520in%2520Neutrophils%2520by%2520Apocynin%252C%2520a%2520Methoxy-Substituted%2520Catechol%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D1994%26volume%3D11%26issue%3D1%26spage%3D95%26epage%3D102%26doi%3D10.1165%2Fajrcmb.11.1.8018341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heumüller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wind, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa-Sicard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H. H. H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandes, R. P.</span></span> <span> </span><span class="NLM_article-title">Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.107.100214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1161%2FHYPERTENSIONAHA.107.100214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=18086956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=211-217&issue=2&author=S.+Heum%C3%BCllerauthor=S.+Windauthor=E.+Barbosa-Sicardauthor=H.+H.+H.+W.+Schmidtauthor=R.+Busseauthor=K.+Schr%C3%B6derauthor=R.+P.+Brandes&title=Apocynin+Is+Not+an+Inhibitor+of+Vascular+NADPH+Oxidases+but+an+Antioxidant&doi=10.1161%2FHYPERTENSIONAHA.107.100214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant</span></div><div class="casAuthors">Heumueller, Sabine; Wind, Sven; Barbosa-Sicard, Eduardo; Schmidt, Harald H. H. W.; Busse, Rudi; Schroeder, Katrin; Brandes, Ralf P.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-217</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A large body of literature suggest that vascular reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases are important sources of reactive oxygen species.  Many studies, however, relied on data obtained with the inhibitor apocynin (4'-hydroxy-3'methoxyacetophenone).  Because the mode of action of apocynin, however, is elusive, we detd. its mechanism of inhibition on vascular NADPH oxidases.  In HEK293 cells overexpressing NADPH oxidase isoforms (Nox1, Nox2, or Nox4), apocynin failed to inhibit superoxide anion generation detected by lucigenin chemiluminescence.  In contrast, apocynin interfered with the detection of reactive oxygen species in assay systems selective for hydrogen peroxide or hydroxyl radicals.  Importantly, apocynin interfered directly with the detection of peroxides but not superoxide, if generated by xanthine/xanthine oxidase or nonenzymic systems.  In leukocytes, apocynin is a prodrug that is activated by myeloperoxidase, a process that results in the formation of apocynin dimers.  Endothelial cells and smooth muscle cells failed to form these dimers and, therefore, are not able to activate apocynin.  Dimer formation was, however, obsd. in Nox-overexpressing HEK293 cells when myeloperoxidase was supplemented.  As a consequence, apocynin should only inhibit NADPH oxidase in leukocytes, whereas in vascular cells, the compd. could act as an antioxidant.  Indeed, in vascular smooth muscle cells, the activation of the redox-sensitive kinases p38-mitogen-activated protein kinase, Akt, and extracellular signal-regulated kinase 1/2 by hydrogen peroxide and by the intracellular radical generator menadione was prevented in the presence of apocynin.  These observations indicate that apocynin predominantly acts as an antioxidant in endothelial cells and vascular smooth muscle cells and should not be used as an NADPH oxidase inhibitor in vascular systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfYewBKMZgWrVg90H21EOLACvtfcHk0lgb4StznPuaIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojsg%253D%253D&md5=8d489f78fca22a17cef17b5b264aa281</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.107.100214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.107.100214%26sid%3Dliteratum%253Aachs%26aulast%3DHeum%25C3%25BCller%26aufirst%3DS.%26aulast%3DWind%26aufirst%3DS.%26aulast%3DBarbosa-Sicard%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DH.%2BH.%2BH.%2BW.%26aulast%3DBusse%26aufirst%3DR.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DK.%26aulast%3DBrandes%26aufirst%3DR.%2BP.%26atitle%3DApocynin%2520Is%2520Not%2520an%2520Inhibitor%2520of%2520Vascular%2520NADPH%2520Oxidases%2520but%2520an%2520Antioxidant%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26issue%3D2%26spage%3D211%26epage%3D217%26doi%3D10.1161%2FHYPERTENSIONAHA.107.100214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kearse, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goserud, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harpel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, D. G.</span></span> <span> </span><span class="NLM_article-title">NADPH Oxidase-Dependent and -Independent Mechanisms of Reported Inhibitors of Reactive Oxygen Generation</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.3109/14756366.2011.636360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3109%2F14756366.2011.636360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=22136506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=95-104&issue=1&author=G.+J.+Gattoauthor=Z.+Aoauthor=M.+G.+Kearseauthor=M.+Zhouauthor=C.+R.+Moralesauthor=E.+Danielsauthor=B.+T.+Bradleyauthor=M.+T.+Goserudauthor=K.+B.+Goodmanauthor=S.+A.+Douglasauthor=M.+R.+Harpelauthor=D.+G.+Johns&title=NADPH+Oxidase-Dependent+and+-Independent+Mechanisms+of+Reported+Inhibitors+of+Reactive+Oxygen+Generation&doi=10.3109%2F14756366.2011.636360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation</span></div><div class="casAuthors">Gatto, Gregory J., Jr.; Ao, Zhaohui; Kearse, Michael G.; Zhou, Mei; Morales, Cyndi R.; Daniels, Erin; Bradley, Benjamin T.; Goserud, Matthew T.; Goodman, Krista B.; Douglas, Stephen A.; Harpel, Mark R.; Johns, Douglas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-104</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">NADPH oxidase isoform-2 (NOX2) generates reactive oxygen species (ROS) that contribute to neurodegenerative and cardiovascular pathologies.  However, validation of NOX2 as a pharmacotherapeutic target has been hampered by a lack of mechanistically-defined inhibitors.  Using cellular and biochem. assays, we explored previously reported inhibitors of ROS prodn. (perhexiline, suramin, VAS2870 and two Shionogi patent compds.) as direct NOX2 inhibitors.  All but suramin, which presumably lacks cell penetrance, inhibit cellular ROS prodn.  However, only perhexiline and suramin inhibit biochem. NOX2 activity.  Indeed, our data suggest that NOX2 inhibition by perhexiline may contribute significantly to its demonstrated cardioprotective effects.  Inhibition of protein kinase CβII explains the cellular activity of the Shionogi compds., whereas VAS2870 inhibits by an as-yet unidentified mechanism unrelated to direct NOX2 function or subunit assembly.  These data delineate the mechanisms of action of these compds. and highlight their strengths and limitations for use in future target validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPBEpSEtUqDLVg90H21EOLACvtfcHk0ljRbNTSm8SgnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslajsw%253D%253D&md5=e509a2b7fd22c6ce23dcd8703c3e1ed7</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.3109%2F14756366.2011.636360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2011.636360%26sid%3Dliteratum%253Aachs%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DAo%26aufirst%3DZ.%26aulast%3DKearse%26aufirst%3DM.%2BG.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DMorales%26aufirst%3DC.%2BR.%26aulast%3DDaniels%26aufirst%3DE.%26aulast%3DBradley%26aufirst%3DB.%2BT.%26aulast%3DGoserud%26aufirst%3DM.%2BT.%26aulast%3DGoodman%26aufirst%3DK.%2BB.%26aulast%3DDouglas%26aufirst%3DS.%2BA.%26aulast%3DHarpel%26aufirst%3DM.%2BR.%26aulast%3DJohns%26aufirst%3DD.%2BG.%26atitle%3DNADPH%2520Oxidase-Dependent%2520and%2520-Independent%2520Mechanisms%2520of%2520Reported%2520Inhibitors%2520of%2520Reactive%2520Oxygen%2520Generation%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2013%26volume%3D28%26issue%3D1%26spage%3D95%26epage%3D104%26doi%3D10.3109%2F14756366.2011.636360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solbak, S. M. Ø.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Høj, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucciarelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Softley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langkilde, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotfredsen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">Developing Inhibitors of the P47phox–p22phox Protein–Protein Interaction by Fragment-Based Drug Discovery.Pdf</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1156</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01492</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01492" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvVWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=1156-1177&issue=3&author=S.+M.+%C3%98.+Solbakauthor=J.+Zangauthor=D.+Narayananauthor=L.+J.+H%C3%B8jauthor=S.+Bucciarelliauthor=C.+Softleyauthor=S.+Meierauthor=A.+E.+Langkildeauthor=C.+H.+Gotfredsenauthor=M.+Sattlerauthor=A.+Bach&title=Developing+Inhibitors+of+the+P47phox%E2%80%93p22phox+Protein%E2%80%93Protein+Interaction+by+Fragment-Based+Drug+Discovery.Pdf&doi=10.1021%2Facs.jmedchem.9b01492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Inhibitors of the p47phox-p22phox Protein-Protein Interaction by Fragment-Based Drug Discovery</span></div><div class="casAuthors">Solbak, Sara Marie Oeie; Zang, Jie; Narayanan, Dilip; Hoej, Lars Jakobsen; Bucciarelli, Saskia; Softley, Charlotte; Meier, Sebastian; Langkilde, Annette Eva; Gotfredsen, Charlotte Held; Sattler, Michael; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1156-1177</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NADP oxidase isoform 2 is an enzyme complex, which generates reactive oxygen species and contributes to oxidative stress.  The p47phox-p22phox interaction is crit. for the activation of the catalytical NOX2 domain, and p47phox is a potential target for therapeutic intervention.  By screening 2500 fragments using fluorescence polarization and a thermal shift assay and validation by surface plasmon resonance, we found eight hits toward the tandem SH3 domain of p47phox (p47phoxSH3A-B) with KD values of 400-600 μM.  Structural studies revealed that fragments 1 and 2 bound two sep. binding sites in the elongated conformation of p47phoxSH3A-B and these competed with p22phox for binding to p47phoxSH3A-B.  Chem. optimization led to a dimeric compd. with the ability to potently inhibit the p47phoxSH3A-B-p22phox interaction (Ki of 20 μM).  Thereby, we reveal a new way of targeting p47phox and present the first report of drug-like mols. with the ability to bind p47phox and inhibit its interaction with p22phox.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKsTGuYjZwNbVg90H21EOLACvtfcHk0ljRbNTSm8SgnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvVWhsg%253D%253D&md5=2a0d529e136f236d3424d1cc2e723de5</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01492%26sid%3Dliteratum%253Aachs%26aulast%3DSolbak%26aufirst%3DS.%2BM.%2B%25C3%2598.%26aulast%3DZang%26aufirst%3DJ.%26aulast%3DNarayanan%26aufirst%3DD.%26aulast%3DH%25C3%25B8j%26aufirst%3DL.%2BJ.%26aulast%3DBucciarelli%26aufirst%3DS.%26aulast%3DSoftley%26aufirst%3DC.%26aulast%3DMeier%26aufirst%3DS.%26aulast%3DLangkilde%26aufirst%3DA.%2BE.%26aulast%3DGotfredsen%26aufirst%3DC.%2BH.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DDeveloping%2520Inhibitors%2520of%2520the%2520P47phox%25E2%2580%2593p22phox%2520Protein%25E2%2580%2593Protein%2520Interaction%2520by%2520Fragment-Based%2520Drug%2520Discovery.Pdf%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D3%26spage%3D1156%26epage%3D1177%26doi%3D10.1021%2Facs.jmedchem.9b01492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, R.</span></span> <span> </span><span class="NLM_article-title">Lactoflavin (Vitamin B2)</span>. <i>Angew. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1936</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1002/ange.19360490103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Fange.19360490103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADyaA28Xhs12rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1936&pages=6-10&issue=1&author=R.+Kuhn&title=Lactoflavin+%28Vitamin+B2%29&doi=10.1002%2Fange.19360490103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Lactoflavin (vitamin B2)</span></div><div class="casAuthors">Kuhn, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie</span>
        (<span class="NLM_cas:date">1936</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6-10</span>CODEN:
                <span class="NLM_cas:coden">ANCEAD</span>;
        ISSN:<span class="NLM_cas:issn">0044-8249</span>.
    </div><div class="casAbstract">cf. C. A. 29, 6616.1.  The following subjects are discussed: (1) isolation, growth action, (2) decompn., primary stage of an enzyme (proenzyme), (3) synthesis of lumiflavin, (4) the OH-contg. side chain, (5) synthesis of lactoflavin, (6) intermediary products, boric acid method, (7) specificity, (8) flavin glucoside, (9) phosphoric acid ester and (10) bios, vitamin, proenzyme, coenzyme, enzyme.  Forty-one references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphXBFGpELGbLVg90H21EOLACvtfcHk0ljz1a1rRE9y9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA28Xhs12rtQ%253D%253D&md5=88867e6d50899f96dbe4a4cefed2b9b5</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1002%2Fange.19360490103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fange.19360490103%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DR.%26atitle%3DLactoflavin%2520%2528Vitamin%2520B2%2529%26jtitle%3DAngew.%2520Chem.%26date%3D1936%26volume%3D49%26issue%3D1%26spage%3D6%26epage%3D10%26doi%3D10.1002%2Fange.19360490103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schramm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schramm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluschko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utermöhlen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krönke, M.</span></span> <span> </span><span class="NLM_article-title">Riboflavin (Vitamin B 2) Deficiency Impairs NADPH Oxidase 2 (Nox2) Priming and Defense against Listeria Monocytogenes</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1002/eji.201343940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.1002%2Feji.201343940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=24272050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWisrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=728-741&issue=3&author=M.+Schrammauthor=K.+Wiegmannauthor=S.+Schrammauthor=A.+Gluschkoauthor=M.+Herbauthor=O.+Uterm%C3%B6hlenauthor=M.+Kr%C3%B6nke&title=Riboflavin+%28Vitamin+B+2%29+Deficiency+Impairs+NADPH+Oxidase+2+%28Nox2%29+Priming+and+Defense+against+Listeria+Monocytogenes&doi=10.1002%2Feji.201343940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Riboflavin (vitamin B2) deficiency impairs NADPH oxidase 2 (Nox2) priming and defense against Listeria monocytogenes</span></div><div class="casAuthors">Schramm, Michael; Wiegmann, Katja; Schramm, Sandra; Gluschko, Alexander; Herb, Marc; Utermoehlen, Olaf; Kroenke, Martin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">728-741</span>CODEN:
                <span class="NLM_cas:coden">EJIMAF</span>;
        ISSN:<span class="NLM_cas:issn">0014-2980</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Riboflavin, also known as vitamin B2, is converted by riboflavin kinase (RFK) into FMN (FMN) and FAD (FAD), which are essential cofactors of dehydrogenases, reductases, and oxidases including the phagocytic NADPH oxidase 2 (Nox2).  Riboflavin deficiency is common in young adults and elderly individuals, who are at the coincidental risk for listeriosis.  To address the impact of acute riboflavin deficiency on host defense against Listeria monocytogenes (L.m.), we generated conditional RFK knockout (KO) strains of mice.  Phagocyte-specific RFK KO impaired the capability of phagocytes to control intracellular L.m., which corresponded to a greater susceptibility of mice to in vivo challenge with L.m.  The oxidative burst of RFK-deficient phagocytes in response to L.m. infection was significantly reduced.  Mechanistically, TNF-induced priming of Nox2, which is needed for oxidative burst, was defective in RFK-deficient phagocytes.  Lack of riboflavin in wild-type macrophages for only 6 h shut down TNF-induced, RFK-mediated de novo FMN/FAD generation, which was accompanied by diminished ROS prodn. and impaired anti-listerial activity.  Vice versa, ROS prodn. by riboflavin-deprived macrophages was rapidly restored by riboflavin supplementation.  Our results suggest that acute riboflavin deficiency immediately impairs priming of Nox2, which is of crucial relevance for an effective phagocytic immune response in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9JYAk_Wks47Vg90H21EOLACvtfcHk0ljz1a1rRE9y9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWisrbF&md5=327bada69324b1103f6aaf6b9b5fbc05</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1002%2Feji.201343940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.201343940%26sid%3Dliteratum%253Aachs%26aulast%3DSchramm%26aufirst%3DM.%26aulast%3DWiegmann%26aufirst%3DK.%26aulast%3DSchramm%26aufirst%3DS.%26aulast%3DGluschko%26aufirst%3DA.%26aulast%3DHerb%26aufirst%3DM.%26aulast%3DUterm%25C3%25B6hlen%26aufirst%3DO.%26aulast%3DKr%25C3%25B6nke%26aufirst%3DM.%26atitle%3DRiboflavin%2520%2528Vitamin%2520B%25202%2529%2520Deficiency%2520Impairs%2520NADPH%2520Oxidase%25202%2520%2528Nox2%2529%2520Priming%2520and%2520Defense%2520against%2520Listeria%2520Monocytogenes%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2014%26volume%3D44%26issue%3D3%26spage%3D728%26epage%3D741%26doi%3D10.1002%2Feji.201343940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span> <span> </span><span class="NLM_article-title">Vitamin B2 Blocks Development of Alzheimer ’ s Disease in APP/PS1 Transgenic Mice via Anti-Oxidative Mechanism</span>. <i>Trop. J. Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1054</span>, <span class="refDoi"> DOI: 10.4314/tjpr.v17i6.10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.4314%2Ftjpr.v17i6.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlymtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1049-1054&issue=6&author=R.+Zhaoauthor=H.+Wangauthor=C.+Qiaoauthor=K.+Zhao&title=Vitamin+B2+Blocks+Development+of+Alzheimer+%E2%80%99+s+Disease+in+APP%2FPS1+Transgenic+Mice+via+Anti-Oxidative+Mechanism&doi=10.4314%2Ftjpr.v17i6.10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Vitamin B2 blocks development of Alzheimer's disease in APP/PS1 transgenic mice via anti-oxidative mechanism</span></div><div class="casAuthors">Zhao, Rong; Wang, Huajun; Qiao, Chen; Zhao, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Tropical Journal of Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1049-1054</span>CODEN:
                <span class="NLM_cas:coden">TJPRAQ</span>;
        ISSN:<span class="NLM_cas:issn">1596-9827</span>.
    
            (<span class="NLM_cas:orgname">Pharmacotherapy Group</span>)
        </div><div class="casAbstract">Purpose: To study the effect of vitamin B2 (VB2) on the development of Alzheimer's disease (AD).  Methods: Memory and learning abilities were assessed in amyloid precursor protein/presenilin-1 (APP/PSI) transgenic mice aged 3 mo, and C57BL/6 mice, using Morris water maze test.  Brain tissue levels of key antioxidant enzymes, malondialdehyde (MDA), and reactive oxygen species (ROS) were assayed using ELISA kits.  Western blot assay was used to monitor the expressions of Nrf2 and Keap1 proteins.  Results: Treatment with VB 2 significantly improved cognitive function of APP/PS1 mice with respect to no. of crossings, duration of stay in target quadrant (TQ), and escape latency time (p < 0.01).  Moreover, VB2 also significantly reduced the levels of MDA and ROS.  It also brought about significant increases in brain activities of CAT, SOD, and GSH-Px in APP/PS1 mice, relative to the control group (p < 0.01).  Moreover, VB2 up-regulated Nrf2 expression but down-regulated the expression of Keap1 in brain tissue of transgenic mice.  Conclusion: These results indicate that VB2 protects the brain from ROS-induced AD damage, most likely due to its potential anti-oxidant property and activation of the Nrf2 pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Kks30ugefrVg90H21EOLACvtfcHk0lhTrOq5LkO2EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlymtbo%253D&md5=8e5da253448cf946eff225299ce5f173</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.4314%2Ftjpr.v17i6.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4314%252Ftjpr.v17i6.10%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DQiao%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DK.%26atitle%3DVitamin%2520B2%2520Blocks%2520Development%2520of%2520Alzheimer%2520%25E2%2580%2599%2520s%2520Disease%2520in%2520APP%252FPS1%2520Transgenic%2520Mice%2520via%2520Anti-Oxidative%2520Mechanism%26jtitle%3DTrop.%2520J.%2520Pharm.%2520Res.%26date%3D2018%26volume%3D17%26issue%3D6%26spage%3D1049%26epage%3D1054%26doi%3D10.4314%2Ftjpr.v17i6.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Torres, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarner-Lans, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio-Ruiz, M. E.</span></span> <span> </span><span class="NLM_article-title">Reductive Stress in Inflammation-Associated Diseases and the pro-Oxidant Effect of Antioxidant Agents</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2098</span>, <span class="refDoi"> DOI: 10.3390/ijms18102098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=10.3390%2Fijms18102098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOjtrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=2098&issue=10&author=I.+P%C3%A9rez-Torresauthor=V.+Guarner-Lansauthor=M.+E.+Rubio-Ruiz&title=Reductive+Stress+in+Inflammation-Associated+Diseases+and+the+pro-Oxidant+Effect+of+Antioxidant+Agents&doi=10.3390%2Fijms18102098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive stress in inflammation-associated diseases and the pro-oxidant effect of antioxidant agents</span></div><div class="casAuthors">Perez-Torres, Israel; Guarner-Lans, Veronica; Rubio-Ruiz, Maria Esther</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2098/1-2098/26</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Reductive stress (RS) is the counterpart oxidative stress (OS), and can occur in response to conditions that shift the redox balance of important biol. redox couples, such as the NAD+/NADH, NADP+/NADPH, and GSH/GSSG, to a more reducing state.  Overexpression of antioxidant enzymic systems leads to excess reducing equiv. that can deplete reactive oxidative species, driving the cells to RS.  A feedback regulation is established in which chronic RS induces OS, which in turn, stimulates again RS.  Excess reducing equiv. may regulate cellular signaling pathways, modify transcriptional activity, induce alterations in the formation of disulfide bonds in proteins, reduce mitochondrial function, decrease cellular metab., and thus, contribute to the development of some diseases in which NF-κB, a redox-sensitive transcription factor, participates.  Here, we described the diseases in which an inflammatory condition is assocd. to RS, and where delayed folding, disordered transport, failed oxidn., and aggregation are found.  Some of these diseases are aggregation protein cardiomyopathy, hypertrophic cardiomyopathy, muscular dystrophy, pulmonary hypertension, rheumatoid arthritis, Alzheimer's disease, and metabolic syndrome, among others.  Moreover, chronic consumption of antioxidant supplements, such as vitamins and/or flavonoids, may have pro-oxidant effects that may alter the redox cellular equil. and contribute to RS, even diminishing life expectancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs4JNUGpcAQLVg90H21EOLACvtfcHk0lhTrOq5LkO2EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOjtrrF&md5=a121085197df30ca0124558817fbd6b0</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.3390%2Fijms18102098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18102098%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Torres%26aufirst%3DI.%26aulast%3DGuarner-Lans%26aufirst%3DV.%26aulast%3DRubio-Ruiz%26aufirst%3DM.%2BE.%26atitle%3DReductive%2520Stress%2520in%2520Inflammation-Associated%2520Diseases%2520and%2520the%2520pro-Oxidant%2520Effect%2520of%2520Antioxidant%2520Agents%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26issue%3D10%26spage%3D2098%26doi%3D10.3390%2Fijms18102098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z','PDB','2V5Z'); return false;">PDB: 2V5Z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AM9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AM9','PDB','3AM9'); return false;">PDB: 3AM9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V3U" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V3U','PDB','4V3U'); return false;">PDB: 4V3U</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01914&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-9%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01914%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01914" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679929ae898e3d6c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
